Citrus Sinensis ID: 026660

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-----
Protein Sequence
MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Secondary Structure (PSIPRED)
ccEEEEcccccccEEEEEEEEccHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEccccccEEEcccccccccccccccccccEEEEccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccccccccccHHHccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEcccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccccccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHHcHHHHHcccccc
Coil and Loop (DISEMBL)
mdvkqgqnkegrTVLYLVFEYMDTDLKKYIRSFRqtgenipvntVKSLMYQLCKGvafchghgilhrdlkphnllmdrkTMTLKIADLGLARAFTLPIKKYTHEILTLWyrapevllgsthysTAVDMWSVACIFAELVTktalfpgdsELQQLLHIFRllgtpnekvwpgvsslmnwheypqwnpqslatavpnldkDGLDLLEQMLQydpskrisakkamehpyfddldktrl
Flexible Loop (DISEMBL)
mdvkqgqnkegrtvlYLVFEYMDTDLKKYIRSFrqtgenipvNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPskrisakkamehpyfddldktrl
Low Complexity Region (SEG)
MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Disordered region (IsUnstruct)
***********RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLE******************************
Disordered Region (DISOPRED)
MDVKQ**NKEGRTVLYLVFEYMDTDLKKYIRSFRQ*G*NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT**
Disordered Region (DISEMBL)
********KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF********
Disordered Region (DISPRO)
MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	235	2.2.26 [Sep-21-2011]
Q8LG64	315	Cyclin-dependent kinase B	yes	no	1.0	0.746	0.851	1e-120
Q38775	312	Cell division control pro	N/A	no	1.0	0.753	0.838	1e-120
Q8LF80	313	Cyclin-dependent kinase B	no	no	0.978	0.734	0.830	1e-117
Q0J4I1	326	Cyclin-dependent kinase B	yes	no	0.987	0.711	0.784	1e-110
Q8L4P8	303	Cyclin-dependent kinase B	no	no	0.991	0.768	0.676	2e-96
Q38774	305	Cell division control pro	N/A	no	0.961	0.740	0.678	6e-91
P25859	309	Cyclin-dependent kinase B	no	no	0.974	0.741	0.653	3e-90
Q2V419	311	Cyclin-dependent kinase B	no	no	0.953	0.720	0.663	8e-90
P29618	294	Cyclin-dependent kinase A	no	no	0.914	0.731	0.600	5e-78
P23111	294	Cell division control pro	N/A	no	0.914	0.731	0.596	3e-77

>sp|Q8LG64|CKB22_ARATH Cyclin-dependent kinase B2-2 OS=Arabidopsis thaliana GN=CDKB2-2 PE=1 SV=2

 Score =  429 bits (1104), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 201/236 (85%), Positives = 219/236 (92%), Gaps = 1/236 (0%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQG NKEG+TVLYLVFEY+DTDLKK+IRSFRQ G+NIP NTVK LMYQLCKG+AFCH
Sbjct: 80  MDVKQGINKEGKTVLYLVFEYVDTDLKKFIRSFRQAGQNIPQNTVKCLMYQLCKGMAFCH 139

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP+KKYTHEILTLWYRAPEVLLG+T
Sbjct: 140 GHGVLHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPMKKYTHEILTLWYRAPEVLLGAT 199

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYST VDMWSV CIFAELVTK A+F GDSELQQLL IFRLLGTPNE+VWPGVS L +WHE
Sbjct: 200 HYSTGVDMWSVGCIFAELVTKQAIFAGDSELQQLLRIFRLLGTPNEEVWPGVSKLKDWHE 259

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-DKTRL 235
           YPQW P SL+TAVPNLD+ GLDLL +ML+Y+P+KRISAKKAMEHPYFDDL DK+ L
Sbjct: 260 YPQWKPLSLSTAVPNLDEAGLDLLSKMLEYEPAKRISAKKAMEHPYFDDLPDKSSL 315

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q38775|CDC2D_ANTMA Cell division control protein 2 homolog D OS=Antirrhinum majus GN=CDC2D PE=2 SV=1

 Score =  429 bits (1103), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 197/235 (83%), Positives = 220/235 (93%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKKYIRSF+QTGE+I    VKSLMYQLCKGVAFCH
Sbjct: 78  LDVKQGQNKEGKTVLYLVFEYMDTDLKKYIRSFKQTGESIAPMNVKSLMYQLCKGVAFCH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKTM LKIADLGLARA+TLPIKKYTHEILTLWYRAPEVLLG+T
Sbjct: 138 GHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAYTLPIKKYTHEILTLWYRAPEVLLGAT 197

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYS AVDMWSVACIFAELVT+ ALFPGDSELQQLLHIFRLLGTPNE++WPGVS+L++WHE
Sbjct: 198 HYSPAVDMWSVACIFAELVTQKALFPGDSELQQLLHIFRLLGTPNEEIWPGVSTLVDWHE 257

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW  Q +++AVP LD+ GL+LL +ML Y+PS+RISAKKAMEHPYFD+LDK+ L
Sbjct: 258 YPQWTAQPISSAVPGLDEKGLNLLSEMLHYEPSRRISAKKAMEHPYFDELDKSGL 312

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8LF80|CKB21_ARATH Cyclin-dependent kinase B2-1 OS=Arabidopsis thaliana GN=CDKB2-1 PE=1 SV=2

 Score =  420 bits (1079), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 191/230 (83%), Positives = 213/230 (92%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQG +KEG+TVLYLVFEYMDTD+KK+IRSFR TG+NIP  T+KSLMYQLCKG+AFCH
Sbjct: 78  MDVKQGLSKEGKTVLYLVFEYMDTDVKKFIRSFRSTGKNIPTQTIKSLMYQLCKGMAFCH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMD KTM LKIADLGLARAFTLP+KKYTHEILTLWYRAPEVLLG+T
Sbjct: 138 GHGILHRDLKPHNLLMDPKTMRLKIADLGLARAFTLPMKKYTHEILTLWYRAPEVLLGAT 197

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVDMWSV CIFAELVT  A+F GDSELQQLLHIF+L GTPNE++WPGVS+L NWHE
Sbjct: 198 HYSTAVDMWSVGCIFAELVTNQAIFQGDSELQQLLHIFKLFGTPNEEMWPGVSTLKNWHE 257

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           YPQW P +L++AVPNLD+ G+DLL +MLQY+P+KRISAK AMEHPYFDDL
Sbjct: 258 YPQWKPSTLSSAVPNLDEAGVDLLSKMLQYEPAKRISAKMAMEHPYFDDL 307

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q0J4I1|CKB21_ORYSJ Cyclin-dependent kinase B2-1 OS=Oryza sativa subsp. japonica GN=CDKB2-1 PE=1 SV=1

 Score =  397 bits (1019), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 182/232 (78%), Positives = 206/232 (88%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +D+KQGQNKEG+T+LYLVFEYMDTDLKK+IR+ RQ  + IPV TVK LMYQLCKGVAFCH
Sbjct: 92  LDLKQGQNKEGQTILYLVFEYMDTDLKKFIRAHRQNLQKIPVPTVKILMYQLCKGVAFCH 151

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           G G+LHRDLKPHNLLMDRKTM LKIADLGL+R+FT+P+KKYTHEILTLWYRAPEVLLG+ 
Sbjct: 152 GRGVLHRDLKPHNLLMDRKTMALKIADLGLSRSFTVPLKKYTHEILTLWYRAPEVLLGAA 211

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYST VD+WSV CIFAEL T   LF GDSE+QQLLHIF+LLGTPNE+VWPGVS L NWHE
Sbjct: 212 HYSTPVDIWSVGCIFAELATNQPLFAGDSEVQQLLHIFKLLGTPNEQVWPGVSKLPNWHE 271

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           YPQWNP  ++  V  LD D LDLLE+MLQY+PSKRISAKKAMEHPYF+D++K
Sbjct: 272 YPQWNPSKVSDLVHGLDADALDLLEKMLQYEPSKRISAKKAMEHPYFNDVNK 323

Forms a complex with CYCB2-1 or CYCB2-2 that activates CDK kinase in tobacco BY2 cells during G2/M (mitosis) phases. May be involved in the regulation of the cell cycle at the G2/M transition.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8L4P8|CKB11_ORYSJ Cyclin-dependent kinase B1-1 OS=Oryza sativa subsp. japonica GN=CDKB1-1 PE=2 SV=1

 Score =  351 bits (901), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 161/238 (67%), Positives = 197/238 (82%), Gaps = 5/238 (2%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVA 57
           + V+Q   K G+ VLYLVFE++DTDLKK++ ++R+ G N   +P N +KS +YQLCKGVA
Sbjct: 68  LSVEQA-TKNGKPVLYLVFEFLDTDLKKFVDAYRK-GPNPRPLPTNVIKSFLYQLCKGVA 125

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 117
            CHGHG+LHRDLKP NLL+D++   LKIADLGL RAFT+P+K YTHEI+TLWYRAPEVLL
Sbjct: 126 HCHGHGVLHRDLKPQNLLVDKEKGILKIADLGLGRAFTVPMKSYTHEIVTLWYRAPEVLL 185

Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
           GSTHYST VD+WSV CIFAE+V + ALFPGDSELQQLLHIFRLLGTP E+ WPGV+ L +
Sbjct: 186 GSTHYSTGVDIWSVGCIFAEMVRRQALFPGDSELQQLLHIFRLLGTPTEEQWPGVTDLRD 245

Query: 178 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           WHE+PQW PQ L   VP+L+ +G+DLL +MLQY+P+ RISAK AMEHPYFD LDK++ 
Sbjct: 246 WHEFPQWKPQILERQVPSLEPEGVDLLSKMLQYNPANRISAKAAMEHPYFDSLDKSQF 303

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q38774|CDC2C_ANTMA Cell division control protein 2 homolog C OS=Antirrhinum majus GN=CDC2C PE=2 SV=1

 Score =  333 bits (854), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 156/230 (67%), Positives = 189/230 (82%), Gaps = 4/230 (1%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGIL 65
           K G+ +LYLVFEY+DTDLKK+I S R+ G N   +P   ++S ++QLCKGV+ CH HG+L
Sbjct: 77  KNGKPLLYLVFEYLDTDLKKFIDSHRK-GPNPRPLPPQQIQSFLFQLCKGVSHCHAHGVL 135

Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           HRDLKP NLL+D+    LKIADLGLARAFT+P+K YTHEI+TL YRAPEVLLGS+HYSTA
Sbjct: 136 HRDLKPQNLLLDKDKGVLKIADLGLARAFTVPLKSYTHEIVTLSYRAPEVLLGSSHYSTA 195

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VDM SV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP+++ WPGVSSL +WH YPQW 
Sbjct: 196 VDMSSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPSDEQWPGVSSLRDWHVYPQWE 255

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           PQ+ A AVP+L  DGLDLL + L+YDP+ RISAK A++HPYFD LDK++ 
Sbjct: 256 PQNSAPAVPSLGPDGLDLLTKTLKYDPADRISAKAALDHPYFDTLDKSQF 305

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P25859|CKB11_ARATH Cyclin-dependent kinase B1-1 OS=Arabidopsis thaliana GN=CDKB1-1 PE=1 SV=2

 Score =  331 bits (848), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 151/231 (65%), Positives = 187/231 (80%), Gaps = 2/231 (0%)

Query: 7   QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGI 64
           +++  ++ LYLVFEY+DTDLKK+I S+R+     P+    ++ LM+QLCKGVA CH HG+
Sbjct: 79  KSQSTKSNLYLVFEYLDTDLKKFIDSYRKGPNPKPLEPFLIQKLMFQLCKGVAHCHSHGV 138

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           LHRDLKP NLL+ +    LKIADLGL RAFT+P+K YTHEI+TLWYRAPEVLLGSTHYST
Sbjct: 139 LHRDLKPQNLLLVKDKELLKIADLGLGRAFTVPLKSYTHEIVTLWYRAPEVLLGSTHYST 198

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
            VDMWSV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP E+ WPGVS+L +WH YP+W
Sbjct: 199 GVDMWSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPTEQQWPGVSTLRDWHVYPKW 258

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
            PQ L  AVP+L   G+DLL +ML+Y+P++RISAK A++HPYFD LDK++ 
Sbjct: 259 EPQDLTLAVPSLSPQGVDLLTKMLKYNPAERISAKTALDHPYFDSLDKSQF 309

May control G2/M (mitosis) phase progression. Plays a role in regulating seedling growth in darkness via regulation of hypocotyl cell elongation and cotyledon cell development. Plays a role in stomatal development. Required to suppress endoreduplication.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q2V419|CKB12_ARATH Cyclin-dependent kinase B1-2 OS=Arabidopsis thaliana GN=CDKB1-2 PE=1 SV=2

 Score =  330 bits (845), Expect = 8e-90,   Method: Compositional matrix adjust.
 Identities = 150/226 (66%), Positives = 185/226 (81%), Gaps = 2/226 (0%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHRDL 69
           ++ LYLVFEY+DTDLKK+I S R+     P+    V+  M+QL KGVA CH HG+LHRDL
Sbjct: 86  KSNLYLVFEYLDTDLKKFIDSHRKGSNPRPLEASLVQRFMFQLFKGVAHCHSHGVLHRDL 145

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
           KP NLL+D+    LKIADLGL+RAFT+P+K YTHEI+TLWYRAPEVLLGSTHYSTAVD+W
Sbjct: 146 KPQNLLLDKDKGILKIADLGLSRAFTVPLKAYTHEIVTLWYRAPEVLLGSTHYSTAVDIW 205

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           SV CIFAE++ + ALFPGDSE QQLLHIFRLLGTP E+ WPGV +L +WH YP+W PQ L
Sbjct: 206 SVGCIFAEMIRRQALFPGDSEFQQLLHIFRLLGTPTEQQWPGVMALRDWHVYPKWEPQDL 265

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           + AVP+L  +G+DLL QML+Y+P++RISAK A++HPYFD LDK++ 
Sbjct: 266 SRAVPSLSPEGIDLLTQMLKYNPAERISAKAALDHPYFDSLDKSQF 311

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  290 bits (742), Expect = 5e-78,   Method: Compositional matrix adjust.
 Identities = 131/218 (60%), Positives = 172/218 (78%), Gaps = 3/218 (1%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVFEY+D DLKK++ S  +  +N     +KS +YQ+ +GVA+CH H +LHRDLKP NL
Sbjct: 76  IYLVFEYLDLDLKKFMDSCPEFAKN--PTLIKSYLYQILRGVAYCHSHRVLHRDLKPQNL 133

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAPE+LLGS  YST VDMWSV CI
Sbjct: 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDMWSVGCI 193

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
           FAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVSSL ++   +P+W  Q LAT V
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQDLATIV 253

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           P LD  GLDLL +ML+Y+P+KRI+A++A+EH YF DL+
Sbjct: 254 PTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1

 Score =  288 bits (736), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 130/218 (59%), Positives = 171/218 (78%), Gaps = 3/218 (1%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVFEY+D DLKK++ S  +  +N     +KS +YQ+  GVA+CH H +LHRDLKP NL
Sbjct: 76  IYLVFEYLDLDLKKFMDSCPEFAKN--PTLIKSYLYQILHGVAYCHSHRVLHRDLKPQNL 133

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAPE+LLG+  YST VD+WSV CI
Sbjct: 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYSTPVDVWSVGCI 193

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLATAV 193
           FAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVS L ++   +P+W  Q LAT V
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEQSWPGVSCLPDFKTAFPRWQAQDLATVV 253

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           PNLD  GLDLL +ML+Y+PSKRI+A++A+EH YF DL+
Sbjct: 254 PNLDPAGLDLLSKMLRYEPSKRITARQALEHEYFKDLE 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	235
255539342	313	CDK, putative [Ricinus communis] gi|2235	1.0	0.750	0.923	1e-128
449455643	312	PREDICTED: cyclin-dependent kinase B2-2-	1.0	0.753	0.906	1e-126
32187089	306	cyclin-dependent kinase [Populus tremula	1.0	0.767	0.893	1e-125
224086116	306	predicted protein [Populus trichocarpa]	1.0	0.767	0.897	1e-125
210148100	306	cyclin-dependent kinase B [Populus tomen	1.0	0.767	0.889	1e-125
344221929	307	cyclin-dependent kinase [Camellia sinens	1.0	0.765	0.893	1e-125
319439587	302	cyclin dependent kinase B2 [Cucurbita ma	1.0	0.778	0.897	1e-124
1806146	316	cdc2MsF [Medicago sativa]	1.0	0.743	0.885	1e-123
388514733	312	unknown [Lotus japonicus]	1.0	0.753	0.893	1e-123
357441091	316	Cyclin-dependent kinase [Medicago trunca	1.0	0.743	0.885	1e-123

>gi|255539342|ref|XP_002510736.1| CDK, putative [Ricinus communis] gi|223551437|gb|EEF52923.1| CDK, putative [Ricinus communis]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 217/235 (92%), Positives = 227/235 (96%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIPV +VKSLMYQLCKGVAFCH
Sbjct: 79  MDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPVKSVKSLMYQLCKGVAFCH 138

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST
Sbjct: 139 GHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 198

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVDMWSV CIFAELVTK ALFPGDSELQQLLHIFRLLGTPNEK+WPGVS L+NWHE
Sbjct: 199 HYSTAVDMWSVGCIFAELVTKQALFPGDSELQQLLHIFRLLGTPNEKLWPGVSKLVNWHE 258

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW+PQSL++AVPNLDKDGLDLL QMLQY+PSKRISAKKAMEHPYFDDL+K  L
Sbjct: 259 YPQWSPQSLSSAVPNLDKDGLDLLAQMLQYEPSKRISAKKAMEHPYFDDLNKAIL 313

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449455643|ref|XP_004145561.1| PREDICTED: cyclin-dependent kinase B2-2-like [Cucumis sativus] gi|449531219|ref|XP_004172585.1| PREDICTED: cyclin-dependent kinase B2-2-like [Cucumis sativus]

 Score =  455 bits (1170), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 213/235 (90%), Positives = 223/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQGQNKEG+TVLYLVFEYMDTDLKK+I+SFR TGENIPVNTVKSLMYQLCKGVAFCH
Sbjct: 78  MDVKQGQNKEGKTVLYLVFEYMDTDLKKFIKSFRHTGENIPVNTVKSLMYQLCKGVAFCH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+PIKKYTHEILTLWYRAPEVLLG+T
Sbjct: 138 GHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPIKKYTHEILTLWYRAPEVLLGAT 197

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVDMWSVACIFAEL TK  LFPGDSELQQLLHIFRLLGTPNEKVWPGVS LMNWHE
Sbjct: 198 HYSTAVDMWSVACIFAELATKQPLFPGDSELQQLLHIFRLLGTPNEKVWPGVSKLMNWHE 257

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQWNPQSL+TAVPNLD  GLDLL +ML+Y+PS RISAKKAMEHPYFDDL+K  L
Sbjct: 258 YPQWNPQSLSTAVPNLDDKGLDLLSKMLKYEPSMRISAKKAMEHPYFDDLNKEYL 312

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|32187089|gb|AAP73784.1| cyclin-dependent kinase [Populus tremula x Populus tremuloides]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 210/235 (89%), Positives = 224/235 (95%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIP+  VKSLMYQLCKGVAFCH
Sbjct: 72  LDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPIKNVKSLMYQLCKGVAFCH 131

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYR+PEVLLG+T
Sbjct: 132 GHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRSPEVLLGAT 191

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGVS+LMNWHE
Sbjct: 192 HYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGVSNLMNWHE 251

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW PQSL++AV NLDKDGLDLL QMLQYDPSKRISAKKAMEHPYFDDL+K  L
Sbjct: 252 YPQWKPQSLSSAVTNLDKDGLDLLSQMLQYDPSKRISAKKAMEHPYFDDLEKDHL 306

Source: Populus tremula x Populus tremuloides

Species: Populus tremula x Populus tremuloides

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224086116|ref|XP_002307822.1| predicted protein [Populus trichocarpa] gi|222857271|gb|EEE94818.1| predicted protein [Populus trichocarpa]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 211/235 (89%), Positives = 224/235 (95%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIPV TVKSLMYQLCKGVAFCH
Sbjct: 72  LDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPVKTVKSLMYQLCKGVAFCH 131

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKT  LKIADLGLARAFTLPIKKYTHEILTLWYR+PEVLLG+T
Sbjct: 132 GHGVLHRDLKPHNLLMDRKTTMLKIADLGLARAFTLPIKKYTHEILTLWYRSPEVLLGAT 191

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            YSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGVS+LMNWHE
Sbjct: 192 RYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGVSNLMNWHE 251

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW PQSL++AV NLDKDGLDLL QMLQYDPSKRISAKKAMEHPYFDDL+K RL
Sbjct: 252 YPQWKPQSLSSAVTNLDKDGLDLLSQMLQYDPSKRISAKKAMEHPYFDDLEKDRL 306

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|210148100|gb|ACJ09092.1| cyclin-dependent kinase B [Populus tomentosa]

 Score =  452 bits (1163), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 209/235 (88%), Positives = 225/235 (95%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIP+ TVKSLMYQLCKGVAFCH
Sbjct: 72  LDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPIKTVKSLMYQLCKGVAFCH 131

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYR+PEVLLG+T
Sbjct: 132 GHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRSPEVLLGAT 191

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGVS+LMNWHE
Sbjct: 192 HYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGVSNLMNWHE 251

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW PQSL++AV NLD+DGL+LL QMLQYDPSKRISAKKAMEHPYFDDL+K  L
Sbjct: 252 YPQWKPQSLSSAVTNLDEDGLNLLSQMLQYDPSKRISAKKAMEHPYFDDLEKDHL 306

Source: Populus tomentosa

Species: Populus tomentosa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|344221929|gb|AEN02468.1| cyclin-dependent kinase [Camellia sinensis]

 Score =  451 bits (1161), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 210/235 (89%), Positives = 222/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQGQNKEG+TVLYLVFEYMDTDLKK+IR+FRQTGENIP  TVK LMYQLCKGVAFCH
Sbjct: 73  MDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRTFRQTGENIPNKTVKCLMYQLCKGVAFCH 132

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHG+LHRDLKPHNLLMDRKTM LKIADLGLARAF LPIKKYTHEILTLWYRAPEVLLG+T
Sbjct: 133 GHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFVLPIKKYTHEILTLWYRAPEVLLGAT 192

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVDMWSV CIFAEL+TK ALFPGDSELQQLLHIFRLLGTPNE+VWPGVS LMNWHE
Sbjct: 193 HYSTAVDMWSVGCIFAELITKQALFPGDSELQQLLHIFRLLGTPNEQVWPGVSKLMNWHE 252

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQWNPQ L++AVPNLD+DG DLL +MLQY+PSKRISAKKAMEHPYFDDLDK  L
Sbjct: 253 YPQWNPQKLSSAVPNLDEDGQDLLLKMLQYEPSKRISAKKAMEHPYFDDLDKAYL 307

Source: Camellia sinensis

Species: Camellia sinensis

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|319439587|emb|CBJ18167.1| cyclin dependent kinase B2 [Cucurbita maxima]

 Score =  449 bits (1155), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 211/235 (89%), Positives = 221/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQGQNKEG+TVLYLVFEYMDTDLKK+I+SFR TGE+IPVNTVKSLMYQLCKGVAFCH
Sbjct: 68  MDVKQGQNKEGKTVLYLVFEYMDTDLKKFIKSFRHTGESIPVNTVKSLMYQLCKGVAFCH 127

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG+T
Sbjct: 128 GHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGAT 187

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYSTAVDMWSV CIFAEL TK ALFPGD ELQQLLHIFRLLGTPNEKVWPGVS LMNW E
Sbjct: 188 HYSTAVDMWSVGCIFAELATKQALFPGDFELQQLLHIFRLLGTPNEKVWPGVSKLMNWPE 247

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQWNPQSL+TAVPNLD   LDLL QML+Y+PSKRISAK+AMEHPYFDDL+K  L
Sbjct: 248 YPQWNPQSLSTAVPNLDDKALDLLAQMLKYEPSKRISAKRAMEHPYFDDLNKAYL 302

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1806146|emb|CAA65982.1| cdc2MsF [Medicago sativa]

 Score =  448 bits (1152), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 208/235 (88%), Positives = 222/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTG+NIP  T+K LMYQLCKGVAFCH
Sbjct: 82  LDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGQNIPPPTIKGLMYQLCKGVAFCH 141

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+P+KKYTHEILTLWYRAPEVLLG+T
Sbjct: 142 GHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPLKKYTHEILTLWYRAPEVLLGAT 201

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYS AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE VWPGVS LMNWHE
Sbjct: 202 HYSMAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEDVWPGVSKLMNWHE 261

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW PQSL+ AVP L++ G+DLL QMLQY+PSKR+SAKKAMEHPYFDDLDKT L
Sbjct: 262 YPQWGPQSLSKAVPGLEEAGVDLLSQMLQYEPSKRLSAKKAMEHPYFDDLDKTHL 316

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388514733|gb|AFK45428.1| unknown [Lotus japonicus]

 Score =  447 bits (1151), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 210/235 (89%), Positives = 223/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDVKQGQ+KEG+TVLYLVFEYMDTDLKK+IR+FRQTG+N+P  TVKSLMYQLCKGVAFCH
Sbjct: 78  MDVKQGQSKEGKTVLYLVFEYMDTDLKKFIRTFRQTGQNVPPKTVKSLMYQLCKGVAFCH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKT  LKIADLGLARAFT+PIKKYTHEILTLWYRAPEVLLG+T
Sbjct: 138 GHGILHRDLKPHNLLMDRKTNMLKIADLGLARAFTVPIKKYTHEILTLWYRAPEVLLGAT 197

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYS AVDMWSVACIFAELVTK ALFPGDSELQQLLHIFRLLGTPNE+VWPGVS LMNWHE
Sbjct: 198 HYSMAVDMWSVACIFAELVTKQALFPGDSELQQLLHIFRLLGTPNEEVWPGVSKLMNWHE 257

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQWNPQSL+TAVPNLD+ GLDLL +ML Y+PSKRISAKKAMEH YFDDLDKT L
Sbjct: 258 YPQWNPQSLSTAVPNLDELGLDLLSEMLHYEPSKRISAKKAMEHCYFDDLDKTYL 312

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357441091|ref|XP_003590823.1| Cyclin-dependent kinase [Medicago truncatula] gi|355479871|gb|AES61074.1| Cyclin-dependent kinase [Medicago truncatula]

 Score =  447 bits (1151), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 208/235 (88%), Positives = 222/235 (94%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTG+NIP  T+K LMYQLCKGVAFCH
Sbjct: 82  LDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGQNIPPPTIKGLMYQLCKGVAFCH 141

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           GHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+P+KKYTHEILTLWYRAPEVLLG+T
Sbjct: 142 GHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPLKKYTHEILTLWYRAPEVLLGAT 201

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           HYS AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE VWPGVS LMNWHE
Sbjct: 202 HYSMAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEDVWPGVSKLMNWHE 261

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           YPQW PQSL+ AVP L++ G+DLL QMLQY+PSKR+SAKKAMEHPYFDDLDKT L
Sbjct: 262 YPQWGPQSLSKAVPGLEETGVDLLSQMLQYEPSKRLSAKKAMEHPYFDDLDKTYL 316

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	235
TAIR|locus:2037410	315	CDKB2;2 "cyclin-dependent kina	1.0	0.746	0.851	4.8e-110
TAIR|locus:2011761	313	CDKB2;1 "cyclin-dependent kina	1.0	0.750	0.817	4.4e-107
TAIR|locus:2080290	309	CDKB1;1 "cyclin-dependent kina	0.970	0.737	0.656	2.4e-83
TAIR|locus:2064087	311	CDKB1;2 "cyclin-dependent kina	0.931	0.704	0.677	1e-82
UNIPROTKB|P29618	294	CDKA-1 "Cyclin-dependent kinas	0.914	0.731	0.605	2e-72
UNIPROTKB|P35567	302	cdk1-a "Cyclin-dependent kinas	0.931	0.725	0.594	4.3e-70
UNIPROTKB|F1NBD7	303	CDK1 "Cyclin-dependent kinase	0.931	0.722	0.590	5.5e-70
TAIR|locus:2099478	294	CDC2 "cell division control 2"	0.910	0.727	0.576	8.9e-70
UNIPROTKB|P13863	303	CDK1 "Cyclin-dependent kinase	0.931	0.722	0.590	1.1e-69
CGD|CAL0002090	317	CDC28 [Candida albicans (taxid	0.914	0.678	0.582	1.4e-69

TAIR|locus:2037410 CDKB2;2 "cyclin-dependent kinase B2;2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
 Identities = 201/236 (85%), Positives = 219/236 (92%)

Query:     1 MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
             MDVKQG NKEG+TVLYLVFEY+DTDLKK+IRSFRQ G+NIP NTVK LMYQLCKG+AFCH
Sbjct:    80 MDVKQGINKEGKTVLYLVFEYVDTDLKKFIRSFRQAGQNIPQNTVKCLMYQLCKGMAFCH 139

Query:    61 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
             GHG+LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP+KKYTHEILTLWYRAPEVLLG+T
Sbjct:   140 GHGVLHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPMKKYTHEILTLWYRAPEVLLGAT 199

Query:   121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
             HYST VDMWSV CIFAELVTK A+F GDSELQQLL IFRLLGTPNE+VWPGVS L +WHE
Sbjct:   200 HYSTGVDMWSVGCIFAELVTKQAIFAGDSELQQLLRIFRLLGTPNEEVWPGVSKLKDWHE 259

Query:   181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-DKTRL 235
             YPQW P SL+TAVPNLD+ GLDLL +ML+Y+P+KRISAKKAMEHPYFDDL DK+ L
Sbjct:   260 YPQWKPLSLSTAVPNLDEAGLDLLSKMLEYEPAKRISAKKAMEHPYFDDLPDKSSL 315

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0007346 "regulation of mitotic cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009755 "hormone-mediated signaling pathway" evidence=IEP;IMP

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA;IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

TAIR|locus:2011761 CDKB2;1 "cyclin-dependent kinase B2;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1059 (377.8 bits), Expect = 4.4e-107, P = 4.4e-107
 Identities = 193/236 (81%), Positives = 217/236 (91%)

Query:     1 MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
             MDVKQG +KEG+TVLYLVFEYMDTD+KK+IRSFR TG+NIP  T+KSLMYQLCKG+AFCH
Sbjct:    78 MDVKQGLSKEGKTVLYLVFEYMDTDVKKFIRSFRSTGKNIPTQTIKSLMYQLCKGMAFCH 137

Query:    61 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
             GHGILHRDLKPHNLLMD KTM LKIADLGLARAFTLP+KKYTHEILTLWYRAPEVLLG+T
Sbjct:   138 GHGILHRDLKPHNLLMDPKTMRLKIADLGLARAFTLPMKKYTHEILTLWYRAPEVLLGAT 197

Query:   121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
             HYSTAVDMWSV CIFAELVT  A+F GDSELQQLLHIF+L GTPNE++WPGVS+L NWHE
Sbjct:   198 HYSTAVDMWSVGCIFAELVTNQAIFQGDSELQQLLHIFKLFGTPNEEMWPGVSTLKNWHE 257

Query:   181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-DKTRL 235
             YPQW P +L++AVPNLD+ G+DLL +MLQY+P+KRISAK AMEHPYFDDL +K+ L
Sbjct:   258 YPQWKPSTLSSAVPNLDEAGVDLLSKMLQYEPAKRISAKMAMEHPYFDDLPEKSSL 313

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=TAS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0009755 "hormone-mediated signaling pathway" evidence=IEP;IMP

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA;IMP

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0010583 "response to cyclopentenone" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2080290 CDKB1;1 "cyclin-dependent kinase B1;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
 Identities = 151/230 (65%), Positives = 187/230 (81%)

Query:     7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGI 64
             +++  ++ LYLVFEY+DTDLKK+I S+R+     P+    ++ LM+QLCKGVA CH HG+
Sbjct:    79 KSQSTKSNLYLVFEYLDTDLKKFIDSYRKGPNPKPLEPFLIQKLMFQLCKGVAHCHSHGV 138

Query:    65 LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST 124
             LHRDLKP NLL+ +    LKIADLGL RAFT+P+K YTHEI+TLWYRAPEVLLGSTHYST
Sbjct:   139 LHRDLKPQNLLLVKDKELLKIADLGLGRAFTVPLKSYTHEIVTLWYRAPEVLLGSTHYST 198

Query:   125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
              VDMWSV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP E+ WPGVS+L +WH YP+W
Sbjct:   199 GVDMWSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPTEQQWPGVSTLRDWHVYPKW 258

Query:   185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
              PQ L  AVP+L   G+DLL +ML+Y+P++RISAK A++HPYFD LDK++
Sbjct:   259 EPQDLTLAVPSLSPQGVDLLTKMLKYNPAERISAKTALDHPYFDSLDKSQ 308

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048825 "cotyledon development" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0010376 "stomatal complex formation" evidence=IEP;TAS

GO:0042023 "DNA endoreduplication" evidence=TAS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2064087 CDKB1;2 "cyclin-dependent kinase B1;2" [Arabidopsis thaliana (taxid:3702)]

 Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
 Identities = 151/223 (67%), Positives = 185/223 (82%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
             LYLVFEY+DTDLKK+I S R+ G N   +  + V+  M+QL KGVA CH HG+LHRDLKP
Sbjct:    89 LYLVFEYLDTDLKKFIDSHRK-GSNPRPLEASLVQRFMFQLFKGVAHCHSHGVLHRDLKP 147

Query:    72 HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
              NLL+D+    LKIADLGL+RAFT+P+K YTHEI+TLWYRAPEVLLGSTHYSTAVD+WSV
Sbjct:   148 QNLLLDKDKGILKIADLGLSRAFTVPLKAYTHEIVTLWYRAPEVLLGSTHYSTAVDIWSV 207

Query:   132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
              CIFAE++ + ALFPGDSE QQLLHIFRLLGTP E+ WPGV +L +WH YP+W PQ L+ 
Sbjct:   208 GCIFAEMIRRQALFPGDSEFQQLLHIFRLLGTPTEQQWPGVMALRDWHVYPKWEPQDLSR 267

Query:   192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
             AVP+L  +G+DLL QML+Y+P++RISAK A++HPYFD LDK++
Sbjct:   268 AVPSLSPEGIDLLTQMLKYNPAERISAKAALDHPYFDSLDKSQ 310

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0030332 "cyclin binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
 Identities = 132/218 (60%), Positives = 173/218 (79%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             +YLVFEY+D DLKK++ S  +  +N P   +KS +YQ+ +GVA+CH H +LHRDLKP NL
Sbjct:    76 IYLVFEYLDLDLKKFMDSCPEFAKN-PT-LIKSYLYQILRGVAYCHSHRVLHRDLKPQNL 133

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAPE+LLGS  YST VDMWSV CI
Sbjct:   134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDMWSVGCI 193

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
             FAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVSSL ++   +P+W  Q LAT V
Sbjct:   194 FAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQDLATIV 253

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
             P LD  GLDLL +ML+Y+P+KRI+A++A+EH YF DL+
Sbjct:   254 PTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|P35567 cdk1-a "Cyclin-dependent kinase 1-A" [Xenopus laevis (taxid:8355)]

 Score = 710 (255.0 bits), Expect = 4.3e-70, P = 4.3e-70
 Identities = 132/222 (59%), Positives = 169/222 (76%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LYL+FE++  DLKKY+ S   +G+ I    VKS +YQ+ +G+ FCH   +LHRDLKP NL
Sbjct:    76 LYLIFEFLSMDLKKYLDSI-PSGQYIDTMLVKSYLYQILQGIVFCHSRRVLHRDLKPQNL 134

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+D K + +K+AD GLARAF +P++ YTHE++TLWYRAPEVLLGS  YST VD+WS+  I
Sbjct:   135 LIDSKGV-IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSVRYSTPVDVWSIGTI 193

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAV 193
             FAE+ TK  LF GDSE+ QL  IFR LGTPN +VWP V SL ++ + +P+W   SL+  V
Sbjct:   194 FAEIATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNSFPKWKGGSLSANV 253

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
              N+DKDGLDLL +ML YDP+KRISA+KA+ HPYFDDLDK+ L
Sbjct:   254 KNIDKDGLDLLAKMLIYDPAKRISARKALLHPYFDDLDKSSL 295

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|F1NBD7 CDK1 "Cyclin-dependent kinase 1" [Gallus gallus (taxid:9031)]

 Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
 Identities = 131/222 (59%), Positives = 168/222 (75%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LYL+FE++  DLKKY+ +   +G+ +  + VKS +YQ+ +G+ FCH   +LHRDLKP NL
Sbjct:    76 LYLIFEFLSMDLKKYLDTI-PSGQYLDRSRVKSYLYQILQGIVFCHSRRVLHRDLKPQNL 134

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+D K + +K+AD GLARAF +P++ YTHE++TLWYR+PEVLLGS  YST VD+WS+  I
Sbjct:   135 LIDDKGV-IKLADFGLARAFGIPVRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTI 193

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAV 193
             FAEL TK  LF GDSE+ QL  IFR LGTPN  VWP V SL ++ + +P+W P SL T V
Sbjct:   194 FAELATKKPLFHGDSEIDQLFRIFRALGTPNNDVWPDVESLQDYKNTFPKWKPGSLGTHV 253

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
              NLD+DGLDLL +ML YDP+KRIS K A+ HPYFDDLDK+ L
Sbjct:   254 QNLDEDGLDLLSKMLIYDPAKRISGKMALNHPYFDDLDKSTL 295

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0030544 "Hsp70 protein binding" evidence=IEA

GO:0034501 "protein localization to kinetochore" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 707 (253.9 bits), Expect = 8.9e-70, P = 8.9e-70
 Identities = 125/217 (57%), Positives = 170/217 (78%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LYLVFEY+D DLKK++ S     +++  + +K+ +YQ+ +G+A+CH H +LHRDLKP NL
Sbjct:    76 LYLVFEYLDLDLKKHMDSTPDFSKDL--HMIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+DR+T +LK+AD GLARAF +P++ +THE++TLWYRAPE+LLGS HYST VD+WSV CI
Sbjct:   134 LIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYSTPVDIWSVGCI 193

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
             FAE++++  LFPGDSE+ QL  IFR++GTP E  W GV+SL ++   +P+W P  L T V
Sbjct:   194 FAEMISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFPKWKPTDLETFV 253

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
             PNLD DG+DLL +ML  DP+KRI+A+ A+EH YF DL
Sbjct:   254 PNLDPDGVDLLSKMLLMDPTKRINARAALEHEYFKDL 290

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0042023 "DNA endoreduplication" evidence=RCA;IMP

GO:0009555 "pollen development" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0040020 "regulation of meiosis" evidence=IMP

GO:0048229 "gametophyte development" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=IGI

GO:0000910 "cytokinesis" evidence=IMP

GO:0009409 "response to cold" evidence=IEP

GO:0009574 "preprophase band" evidence=TAS

GO:0010005 "cortical microtubule, transverse to long axis" evidence=IDA

UNIPROTKB|P13863 CDK1 "Cyclin-dependent kinase 1" [Gallus gallus (taxid:9031)]

 Score = 706 (253.6 bits), Expect = 1.1e-69, P = 1.1e-69
 Identities = 131/222 (59%), Positives = 168/222 (75%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LYL+FE++  DLKKY+ +   +G+ +  + VKS +YQ+ +G+ FCH   +LHRDLKP NL
Sbjct:    76 LYLIFEFLSMDLKKYLDTI-PSGQYLDRSRVKSYLYQILQGIVFCHSRRVLHRDLKPQNL 134

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+D K + +K+AD GLARAF +P++ YTHE++TLWYR+PEVLLGS  YST VD+WS+  I
Sbjct:   135 LIDDKGV-IKLADFGLARAFGIPVRVYTHEVVTLWYRSPEVLLGSALYSTPVDIWSIGTI 193

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAV 193
             FAEL TK  LF GDSE+ QL  IFR LGTPN  VWP V SL ++ + +P+W P SL T V
Sbjct:   194 FAELATKKPLFHGDSEIDQLFRIFRALGTPNNDVWPDVESLQDYKNTFPKWKPGSLGTHV 253

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
              NLD+DGLDLL +ML YDP+KRIS K A+ HPYFDDLDK+ L
Sbjct:   254 QNLDEDGLDLLSKMLIYDPAKRISGKMALNHPYFDDLDKSTL 295

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0000724 "double-strand break repair via homologous recombination" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006281 "DNA repair" evidence=TAS

GO:0006302 "double-strand break repair" evidence=TAS

CGD|CAL0002090 CDC28 [Candida albicans (taxid:5476)]

 Score = 705 (253.2 bits), Expect = 1.4e-69, P = 1.4e-69
 Identities = 127/218 (58%), Positives = 167/218 (76%)

Query:    15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LYLVFE++D DLKKY+ S  Q G  +  N +K  M QL +G+  CH H +LHRDLKP NL
Sbjct:    81 LYLVFEFLDLDLKKYMESIPQ-GVGLGANMIKRFMNQLIRGIKHCHSHRVLHRDLKPQNL 139

Query:    75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
             L+D++   LK+AD GLARAF +P++ YTHE++TLWYRAPE+LLG   YST VDMWSV CI
Sbjct:   140 LIDKEG-NLKLADFGLARAFGVPLRAYTHEVVTLWYRAPEILLGGKQYSTGVDMWSVGCI 198

Query:   135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
             FAE+  +  LFPGDSE+ ++  IFR+LGTPNE++WP V+ L ++   +PQW  + L+ AV
Sbjct:   199 FAEMCNRKPLFPGDSEIDEIFRIFRILGTPNEEIWPDVNYLPDFKSSFPQWKKKPLSEAV 258

Query:   194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
             P+LD +G+DLL+QML YDPS+RISAK+A+ HPYF+D D
Sbjct:   259 PSLDANGIDLLDQMLVYDPSRRISAKRALIHPYFNDND 296

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IGI;ISS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IGI;IDA

GO:0006468 "protein phosphorylation" evidence=IGI;ISS;IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IGI;ISS;IDA

GO:0051726 "regulation of cell cycle" evidence=IGI

GO:0030448 "hyphal growth" evidence=IMP

GO:0005840 "ribosome" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005935 "cellular bud neck" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0000235 "astral microtubule" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IEA

GO:0010898 "positive regulation of triglyceride catabolic process" evidence=IEA

GO:0006338 "chromatin remodeling" evidence=IEA

GO:0045930 "negative regulation of mitotic cell cycle" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0051446 "positive regulation of meiotic cell cycle" evidence=IEA

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0016192 "vesicle-mediated transport" evidence=IEA

GO:0010696 "positive regulation of spindle pole body separation" evidence=IEA

GO:0051447 "negative regulation of meiotic cell cycle" evidence=IEA

GO:0010571 "positive regulation of DNA replication involved in S phase" evidence=IEA

GO:0010568 "regulation of budding cell apical bud growth" evidence=IEA

GO:0070317 "negative regulation of G0 to G1 transition" evidence=IEA

GO:0010570 "regulation of filamentous growth" evidence=IEA

GO:0042393 "histone binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.5579	0.9531	0.7516	yes	no
Q8LG64	CKB22_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.8516	1.0	0.7460	yes	no
O55076	CDK2_CRIGR	2, ., 7, ., 1, 1, ., 2, 2	0.5622	0.9531	0.7516	yes	no
Q00646	CDK1_EMENI	2, ., 7, ., 1, 1, ., 2, 3	0.5217	0.9021	0.6563	yes	no
P34112	CDK1_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5470	0.9489	0.7533	yes	no
Q38773	CDC2B_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5800	0.9617	0.8071	N/A	no
Q0J4I1	CKB21_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.7844	0.9872	0.7116	yes	no
Q38775	CDC2D_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.8382	1.0	0.7532	N/A	no
P24941	CDK2_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.5622	0.9531	0.7516	yes	no
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.5504	0.9148	0.7239	yes	no
P00546	CDK1_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.5416	0.9063	0.7147	yes	no
Q5E9Y0	CDK2_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.5622	0.9531	0.7516	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.991
3rd Layer	2.7.11.23	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	235
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-138
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-128
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-122
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-111
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-110
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-109
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-96
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-95
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-92
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-92
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-92
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-90
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-87
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-86
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-81
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-77
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-77
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-75
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-74
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-72
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-72
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-71
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-68
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-67
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-66
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-65
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-65
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-64
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-60
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-60
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-60
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-60
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-59
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-58
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-58
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-57
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-56
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-55
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-54
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-54
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-51
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-51
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-51
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-49
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-48
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-47
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-46
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-44
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-43
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-43
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-42
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-41
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-40
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-36
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-33
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-33
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-30
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-20
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-16
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.002
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  390 bits (1003), Expect = e-138
 Identities = 155/229 (67%), Positives = 188/229 (82%), Gaps = 1/229 (0%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFC 59
           +DV+  + K G+  LYLVFEY+D+DLKK++ S  R  G  +P  T+KS MYQL KGVA C
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
           H HG++HRDLKP NLL+D++   LKIADLGL RAF++P+K YTHEI+TLWYRAPEVLLGS
Sbjct: 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS 186

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
           THYST VD+WSV CIFAE+  K  LFPGDSELQQLLHIF+LLGTP E+VWPGVS L +WH
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           E+PQW PQ L+ AVP+L  +GLDLL++ML+YDP+KRISAK A+ HPYFD
Sbjct: 247 EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  363 bits (935), Expect = e-128
 Identities = 126/214 (58%), Positives = 166/214 (77%), Gaps = 5/214 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLVFEY D DLKKY+         +  N +KS+MYQL +G+A+CH H ILHRDLKP N+
Sbjct: 73  LYLVFEYCDMDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R    LK+AD GLARAF +P++ YTHE++TLWYRAPE+LLGS HYSTAVD+WSV CI
Sbjct: 130 LINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI 188

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAV 193
           FAE++T   LFPGDSE+ QL  IF++LGTP E+ WPGV+ L ++   +P++ P+ L   +
Sbjct: 189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL 248

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           P LD +G+DLL +MLQY+P+KRISAK+A++HPYF
Sbjct: 249 PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  348 bits (894), Expect = e-122
 Identities = 133/214 (62%), Positives = 169/214 (78%), Gaps = 4/214 (1%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLVFE++D DLKKY+ S   TG + P+  +KS +YQL +G+A+CH H +LHRDLKP NL
Sbjct: 73  LYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSYLYQLLQGIAYCHSHRVLHRDLKPQNL 130

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+DR    LK+AD GLARAF +P++ YTHE++TLWYRAPE+LLGS  YST VD+WS+ CI
Sbjct: 131 LIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
           FAE+V +  LFPGDSE+ QL  IFR LGTP+E VWPGV+SL ++   +P+W  Q L+  V
Sbjct: 190 FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV 249

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           PNLD+DGLDLL +ML YDP+KRISAK A++HPYF
Sbjct: 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  320 bits (821), Expect = e-111
 Identities = 130/228 (57%), Positives = 172/228 (75%), Gaps = 9/228 (3%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   +G  IP+  +KS ++QL +G+AFCH
Sbjct: 65  LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFCH 117

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++     +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+SL ++  
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            +P+W  Q  +  VP LD+DG DLL QML YDP+KRISAK A+ HP+F
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  318 bits (816), Expect = e-110
 Identities = 128/217 (58%), Positives = 171/217 (78%), Gaps = 3/217 (1%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLVFEY+D DLKK++ S     +N  +  +K+ +YQ+ +G+A+CH H +LHRDLKP NL
Sbjct: 76  LYLVFEYLDLDLKKHMDSSPDFAKNPRL--IKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAPE+LLGS HYST VD+WSV CI
Sbjct: 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCI 193

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSLATAV 193
           FAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGV+SL ++   +P+W P+ LAT V
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV 253

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           P L+  G+DLL +ML+ DPSKRI+A+ A+EH YF DL
Sbjct: 254 PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  314 bits (807), Expect = e-109
 Identities = 129/214 (60%), Positives = 165/214 (77%), Gaps = 3/214 (1%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYL+FE++  DLKKY+ S  + G+ +    VKS +YQ+ +G+ FCH   +LHRDLKP NL
Sbjct: 74  LYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNL 132

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D K   +K+AD GLARAF +P++ YTHE++TLWYRAPEVLLGS  YST VD+WS+  I
Sbjct: 133 LIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTI 191

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAV 193
           FAE+ TK  LF GDSE+ QL  IFR+LGTP E VWPGV+SL ++ + +P+W   SL +AV
Sbjct: 192 FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAV 251

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            NLD+DGLDLLE+ML YDP+KRISAKKA+ HPYF
Sbjct: 252 KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  283 bits (727), Expect = 1e-96
 Identities = 104/216 (48%), Positives = 143/216 (66%), Gaps = 10/216 (4%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLMYQLCKGVAFCHGHGILHRDLKP 71
           + LVFE+M+TDL+K I+          V T   +KS M    +G+ + H + ILHRDLKP
Sbjct: 77  INLVFEFMETDLEKVIKD------KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +NLL+      LK+AD GLAR+F  P +K TH+++T WYRAPE+L G+ HY   VDMWSV
Sbjct: 131 NNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSV 189

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CIFAEL+ +    PGDS++ QL  IF  LGTP E+ WPGV+SL ++ E+  + P  L  
Sbjct: 190 GCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ 249

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             P    D LDLL+++L  +P+KRI+A++A+EHPYF
Sbjct: 250 IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  279 bits (717), Expect = 2e-95
 Identities = 120/215 (55%), Positives = 151/215 (70%), Gaps = 6/215 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLVFE+MDTDL K I+  RQ G  +P + +KS +YQL +G+AFCH HGILHRDLKP NL
Sbjct: 73  LYLVFEFMDTDLYKLIKD-RQRG--LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++     LK+AD GLAR+F  P++ YTH ++T WYRAPE+LLG   YST VD+WSV CI
Sbjct: 130 LIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM--NWHEYPQWNPQSLATA 192
           FAEL+++  LFPG SE+ QL  IFR LGTP+ +VWP  +SL       +P+     L   
Sbjct: 189 FAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKL 248

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            PN     LDLL QML YDP KRI+A++A+ HPYF
Sbjct: 249 FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  273 bits (701), Expect = 1e-92
 Identities = 113/220 (51%), Positives = 146/220 (66%), Gaps = 16/220 (7%)

Query: 16  YLVFEYMDTDLKKYIRSFRQ---TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           Y+V EY++ DLK  + + +Q     E      VK LM QL  GVA  H + ILHRDLK  
Sbjct: 82  YMVMEYVEHDLKSLMETMKQPFLQSE------VKCLMLQLLSGVAHLHDNWILHRDLKTS 135

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL++ + + LKI D GLAR +  P+K YT  ++TLWYRAPE+LLG+  YSTA+DMWSV 
Sbjct: 136 NLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL-----MNWHEYPQWNPQ 187
           CIFAEL+TK  LFPG SE+ QL  IF+LLGTP EK+WPG S L       + +YP    +
Sbjct: 195 CIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLR 254

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               A  +L  +G DLL ++L YDP+KRISA+ A++HPYF
Sbjct: 255 KKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  273 bits (699), Expect = 1e-92
 Identities = 118/227 (51%), Positives = 159/227 (70%), Gaps = 8/227 (3%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           DV   +NK     L LVFEYMD DLKKY+ +    G  +  NTVKS  YQL KG+AFCH 
Sbjct: 65  DVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHE 118

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           + +LHRDLKP NLL++++   LK+AD GLARAF +P+  +++E++TLWYRAP+VLLGS  
Sbjct: 119 NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-E 180
           YST++D+WSV CI AE++T   LFPG +   QLL IFR++GTP E  WPG+S L  +   
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P++ PQ L    P+ D  G+DLL ++LQ +P  RISA  A++HP+F
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  271 bits (694), Expect = 8e-92
 Identities = 120/228 (52%), Positives = 151/228 (66%), Gaps = 11/228 (4%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           DV     K     L LVFEY D DLKKY  S    G+ I    VKS M+QL KG+AFCH 
Sbjct: 66  DVLHSDKK-----LTLVFEYCDQDLKKYFDSCN--GD-IDPEIVKSFMFQLLKGLAFCHS 117

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           H +LHRDLKP NLL++ K   LK+AD GLARAF +P++ Y+ E++TLWYR P+VL G+  
Sbjct: 118 HNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 122 YSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
           YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WPGVS L ++  
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236

Query: 181 YPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           YP +    SL   VP L+  G DLL+ +L  +P +RISA++A++HPYF
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  266 bits (682), Expect = 6e-90
 Identities = 108/227 (47%), Positives = 147/227 (64%), Gaps = 6/227 (2%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV  G   +    L LVFE++D DL  Y+    + G  +P  T+K LM QL +GV F H
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGVDFLH 124

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H I+HRDLKP N+L+      +KIAD GLAR ++  +   T  ++TLWYRAPEVLL S+
Sbjct: 125 SHRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSS 182

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAEL  +  LF G SE  QL  IF ++G P+E+ WP   SL     
Sbjct: 183 -YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL-PRSS 240

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P + P+S  + VP + ++GLDLL++ML ++P KRISA +A++HPYF
Sbjct: 241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  260 bits (666), Expect = 2e-87
 Identities = 96/222 (43%), Positives = 135/222 (60%), Gaps = 8/222 (3%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           +G+  +Y+VFEYMD DL   + S          + +K  M QL +G+ + H +GILHRD+
Sbjct: 70  KGKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDI 126

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           K  N+L++   + LK+AD GLAR +T      YT+ ++TLWYR PE+LLG+T Y   VDM
Sbjct: 127 KGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDM 185

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNP 186
           WSV CI AEL     +F G +EL+QL  IF L G+P ++ WPGVS L  +      +   
Sbjct: 186 WSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYK 245

Query: 187 QSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           + L     +L D   LDLL+++L  DP KRISA +A++H YF
Sbjct: 246 RRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  258 bits (662), Expect = 7e-87
 Identities = 103/216 (47%), Positives = 145/216 (67%), Gaps = 7/216 (3%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LV EYM +DL + +R   +    +P   VKS M  L KGVA+ H +GI+HRDLKP NL
Sbjct: 74  FVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+      LKIAD GLAR F+    + Y+H++ T WYRAPE+L G+  Y   VD+W+V C
Sbjct: 131 LISA-DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE--YPQWNPQSLAT 191
           IFAEL+  + LFPG+++++QL  +FR LGTPNE+ WPG++SL ++++  +P+  P  L  
Sbjct: 190 IFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEE 249

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             P+   + LDLL+ +L YDPSKR+SA +A+ HPYF
Sbjct: 250 IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  258 bits (660), Expect = 2e-86
 Identities = 110/221 (49%), Positives = 154/221 (69%), Gaps = 9/221 (4%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           +  L LVFEY+DTDLK+Y+      G  + ++ V+  ++QL +G+A+CH   +LHRDLKP
Sbjct: 75  KKTLTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKP 131

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            NLL+  +   LK+AD GLARA ++P K Y++E++TLWYR P+VLLGST YST++DMW V
Sbjct: 132 QNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190

Query: 132 ACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGVSSLMNW--HEYPQWNPQS 188
            CIF E+ T   LFPG ++++ QL  IFR+LGTP E+ WPGVSS   +  + +P + P+ 
Sbjct: 191 GCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250

Query: 189 LATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           L    P LD+   G +L  + LQY+P KRISA +AM+HPYF
Sbjct: 251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  245 bits (628), Expect = 4e-81
 Identities = 89/225 (39%), Positives = 132/225 (58%), Gaps = 17/225 (7%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +Y+V E M+TDL K I+S        P+    ++  +YQ+ +G+ + H   ++HRDLKP 
Sbjct: 79  VYIVTELMETDLHKVIKS------PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPS 132

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMW 129
           N+L++     LKI D GLAR       +    T  ++T WYRAPE+LL S+ Y+ A+D+W
Sbjct: 133 NILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIW 191

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWN 185
           SV CIFAEL+T+  LFPG   + QL  I  +LGTP+E+    ++S      Y    P+  
Sbjct: 192 SVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS-EKARNYLKSLPKKP 250

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            + L+   P    + +DLLE+ML +DP KRI+A +A+ HPY   L
Sbjct: 251 KKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  233 bits (596), Expect = 5e-77
 Identities = 108/215 (50%), Positives = 147/215 (68%), Gaps = 6/215 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFEY+D+DLK+Y+ +    G  + ++ VK  M+QL +G+++CH   ILHRDLKP NL
Sbjct: 78  LTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++ K   LK+AD GLARA ++P K Y++E++TLWYR P+VLLGST YST +DMW V CI
Sbjct: 135 LINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCI 193

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATA 192
             E+ T   +FPG +  ++L  IFRLLGTP E+ WPG++S   +  Y  PQ+  Q L   
Sbjct: 194 LYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH 253

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P LD DG+DLL  +L Y+   RISA+ A+ H YF
Sbjct: 254 APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  233 bits (596), Expect = 8e-77
 Identities = 108/218 (49%), Positives = 151/218 (69%), Gaps = 6/218 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFEY+D DLK+Y+      G +I ++ VK  ++QL +G+ +CH   +LHRDLKP NL
Sbjct: 79  LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++ +   LK+AD GLARA ++P K Y++E++TLWYR P++LLGST YST +DMW V CI
Sbjct: 136 LINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW--HEYPQWNPQSLATA 192
           F E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ S   +  + YP++    L   
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            P LD DG +LL ++LQ++  KRISA++AM+HPYF  L
Sbjct: 255 APRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  230 bits (588), Expect = 1e-75
 Identities = 95/215 (44%), Positives = 136/215 (63%), Gaps = 6/215 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LY VFEYM+ +L + ++   + G+    + ++S++YQ+ +G+A  H HG  HRDLKP NL
Sbjct: 73  LYFVFEYMEGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL 130

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +KIAD GLAR        YT  + T WYRAPE+LL ST YS+ VD+W++ CI
Sbjct: 131 LVSGPE-VVKIADFGLARE-IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCI 188

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATA 192
            AEL T   LFPG SE+ QL  I  +LGTP ++ WP    L +   +  PQ+ P SL   
Sbjct: 189 MAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +PN   + +DL++ ML++DP KR +A +A++HPYF
Sbjct: 249 IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  228 bits (582), Expect = 1e-74
 Identities = 109/218 (50%), Positives = 151/218 (69%), Gaps = 6/218 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFEY+D DLK+Y+      G  + ++ VK  +YQ+ +G+A+CH   +LHRDLKP NL
Sbjct: 79  LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++ +   LK+AD GLARA ++P K Y++E++TLWYR P+VLLGS+ YST +DMW V CI
Sbjct: 136 LINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCI 194

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATA 192
           F E+ +   LFPG +   +L  IFRLLGTP E+ WPG+SS   +  Y  P++ PQ L   
Sbjct: 195 FFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH 254

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            P LD +G++LL + LQY+  KRISA++AM+H YF  L
Sbjct: 255 APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  222 bits (568), Expect = 2e-72
 Identities = 100/215 (46%), Positives = 135/215 (62%), Gaps = 6/215 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           ++LV EY + DL   + +          + VK LM QL +G+ + H + I+HRDLK  NL
Sbjct: 83  IFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+  K   LKIAD GLAR + LP K  T +++TLWYRAPE+LLG T Y+TA+DMW+V CI
Sbjct: 140 LLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI 198

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATA 192
            AEL+    L PG SE++QL  I +LLGTPNE +WPG S L    ++  P+    +L   
Sbjct: 199 LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P L + GL LL  +L YDP KR +A++A+E  YF
Sbjct: 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  222 bits (567), Expect = 3e-72
 Identities = 98/239 (41%), Positives = 141/239 (58%), Gaps = 27/239 (11%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +YL+F+Y + DL + I+  RQ    +IP + VKSL++Q+  GV + H + +LHRDLKP N
Sbjct: 79  VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPAN 138

Query: 74  -LLMDRKTM--TLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVD 127
            L+M        +KI DLGLAR F  P+K        ++T+WYRAPE+LLG+ HY+ A+D
Sbjct: 139 ILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAID 198

Query: 128 MWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
           +W++ CIFAEL+T   +F G              QL  IF +LGTP EK WP +  +  +
Sbjct: 199 IWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEY 258

Query: 179 HEYPQ-------WNPQSLAT---AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               +        +  SLA         D  G DLL ++L+YDP+KRI+A++A+EHPYF
Sbjct: 259 DTLMKDFKTKTYPSN-SLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  221 bits (565), Expect = 1e-71
 Identities = 97/226 (42%), Positives = 134/226 (59%), Gaps = 21/226 (9%)

Query: 17  LVFEYMDTDLKKYI-RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           LV + M +DLKK + R  R T        VK ++ Q+  G+   H    +HRDL P N+ 
Sbjct: 97  LVMDIMASDLKKVVDRKIRLTESQ-----VKCILLQILNGLNVLHKWYFMHRDLSPANIF 151

Query: 76  MDRKTMTLKIADLGLARAFTLPI--------------KKYTHEILTLWYRAPEVLLGSTH 121
           ++ K +  KIAD GLAR +  P               ++ T +++TLWYRAPE+L+G+  
Sbjct: 152 INSKGI-CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK 210

Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           Y  AVDMWSV CIFAEL+T   LFPG++E+ QL  IF LLGTPNE  WP    L  + E+
Sbjct: 211 YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF 270

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               P+ L T  PN   D +DLL+ +L+ +P +RISAK+A++H YF
Sbjct: 271 TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  212 bits (542), Expect = 5e-68
 Identities = 90/227 (39%), Positives = 135/227 (59%), Gaps = 26/227 (11%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +YLVFEYM+TDL   IR+      NI   V+  + +MYQL K + + H   ++HRDLKP 
Sbjct: 84  IYLVFEYMETDLHAVIRA------NILEDVH-KRYIMYQLLKALKYIHSGNVIHRDLKPS 136

Query: 73  NLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           N+L++     +K+AD GLAR+ +        P+   T  + T WYRAPE+LLGST Y+  
Sbjct: 137 NILLNSDC-RVKLADFGLARSLSELEENPENPV--LTDYVATRWYRAPEILLGSTRYTKG 193

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK-----VWPGVSSLMNWHE 180
           VDMWSV CI  E++    LFPG S L QL  I  ++G P+ +       P  +++++   
Sbjct: 194 VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD--S 251

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P    + L   +P    D LDLL+++L ++P+KR++A++A+EHPY 
Sbjct: 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  206 bits (527), Expect = 7e-67
 Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 32/214 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY +  DL   ++   +    +  +  +  + Q+   + + H  GI+HRDLKP N
Sbjct: 72  LYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSKGIVHRDLKPEN 127

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D     +K+AD GLAR    P +K T  + T  Y APEVLLG   Y  AVD+WS+  
Sbjct: 128 ILLDED-GHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGV 184

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           I  EL+T    FPGD +L +   +F+ +G P     P                       
Sbjct: 185 ILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPP---------------------PE 220

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            ++  +  DL+ ++L  DP KR++A++A++HP+F
Sbjct: 221 WDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  205 bits (523), Expect = 3e-66
 Identities = 78/217 (35%), Positives = 116/217 (53%), Gaps = 27/217 (12%)

Query: 12  RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           +  LYLV EY +  DL  Y+      G  +  +  K +  Q+ +G+ + H +GI+HRDLK
Sbjct: 70  KDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P N+L+D +   +KIAD GLA+         T  + T WY APEVLLG   Y   VD+WS
Sbjct: 126 PENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  I  EL+T    F G++ L QL  I R+LG P E             + P+W+  S  
Sbjct: 185 LGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE------------FDEPKWSSGS-- 230

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                  ++  DL+++ L  DPSKR +A++ ++HP+F
Sbjct: 231 -------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  202 bits (517), Expect = 5e-65
 Identities = 95/224 (42%), Positives = 132/224 (58%), Gaps = 15/224 (6%)

Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
            K GR  L LVFE MD +L + I+  ++    +P   VKS MYQL K +   H +GI HR
Sbjct: 70  RKTGR--LALVFELMDMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMHRNGIFHR 124

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           D+KP N+L+      LK+AD G  R      P   YT  I T WYRAPE LL   +Y   
Sbjct: 125 DIKPENILIKDDI--LKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPK 179

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV--SSLMNWHEYPQ 183
           +D+W+V C+F E+++   LFPG +EL Q+  I  +LGTP+ +V      S  MN++ +P 
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN-FPS 238

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                L   +PN   +GLDLL+++L YDP +RI+AK+A+ HPYF
Sbjct: 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  203 bits (519), Expect = 6e-65
 Identities = 98/245 (40%), Positives = 139/245 (56%), Gaps = 31/245 (12%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTG--ENIPVN----TVKSLMYQLCKGV 56
            +  ++K  R  +Y+V  YMD DL         +G  EN  V      +K  M QL +G+
Sbjct: 78  ERPDKSKRKRGSVYMVTPYMDHDL---------SGLLENPSVKLTESQIKCYMLQLLEGI 128

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-----------KYTHEI 105
            + H + ILHRD+K  N+L+D +   LKIAD GLAR +  P             KYT+ +
Sbjct: 129 NYLHENHILHRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
           +T WYR PE+LLG   Y+TAVD+W + C+FAE+ T+  +  G S++ QL  IF+L GTP 
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 166 EKVWPGVSSL---MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
           E+ WPG  SL      H +  + P++L      L  +GLDLL ++L  DP KR++A  A+
Sbjct: 248 EETWPGWRSLPGCEGVHSFTNY-PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306

Query: 223 EHPYF 227
           EHPYF
Sbjct: 307 EHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  199 bits (508), Expect = 8e-64
 Identities = 99/227 (43%), Positives = 140/227 (61%), Gaps = 6/227 (2%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +  T + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGLDFLH 125

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+      +K+AD GLAR ++  +   T  ++TLWYRAPEVLL ST
Sbjct: 126 ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQST 183

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   +L     
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR-GA 241

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +    P+ + + VP +++ G  LL +ML ++P KRISA +A++HP+F
Sbjct: 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  191 bits (487), Expect = 2e-60
 Identities = 103/223 (46%), Positives = 136/223 (60%), Gaps = 13/223 (5%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           +  L  VFEYM TDL +Y+   +  G   P N V+  M+QL +G+A+ HG  ILHRDLKP
Sbjct: 75  KETLTFVFEYMHTDLAQYM--IQHPGGLHPYN-VRLFMFQLLRGLAYIHGQHILHRDLKP 131

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            NLL+      LK+AD GLARA ++P + Y+ E++TLWYR P+VLLG+T YS+A+D+W  
Sbjct: 132 QNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190

Query: 132 ACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW----NP 186
            CIF E++     FPG S+  +QL  I+ +LG P E  WPGVS L N+   P+W     P
Sbjct: 191 GCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK--PEWFLPCKP 248

Query: 187 QSLATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           Q L      L +     DL  QML   P  RISA+ A+ HPYF
Sbjct: 249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  192 bits (491), Expect = 2e-60
 Identities = 97/225 (43%), Positives = 133/225 (59%), Gaps = 20/225 (8%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V+E MDTDL + IRS  QT  +   +  +  +YQL +G+ + H   +LHRDLKP NL
Sbjct: 84  VYIVYELMDTDLHQIIRS-SQTLSD---DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++     LKI D GLAR  +      T  ++T WYRAPE+LL  + Y+TA+D+WSV CI
Sbjct: 140 LLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCI 198

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWN 185
           FAEL+ +  LFPG   + QL  I  LLG+P         NEK    + SL      P   
Sbjct: 199 FAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL------PYTP 252

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            QS A   P+ +   +DLLE+ML +DPSKRI+ ++A+ HPY   L
Sbjct: 253 RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  192 bits (490), Expect = 3e-60
 Identities = 84/226 (37%), Positives = 133/226 (58%), Gaps = 13/226 (5%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
            + + V Y+V + M++DL   I S  Q         ++  +YQL +G+ + H   ++HRD
Sbjct: 78  ADFKDV-YVVMDLMESDLHHIIHS-DQPLTE---EHIRYFLYQLLRGLKYIHSANVIHRD 132

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAF-TLPIKK---YTHEILTLWYRAPEVLLGSTHYST 124
           LKP NLL++ +   L+I D G+AR   + P +     T  + T WYRAPE+LL    Y+T
Sbjct: 133 LKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTT 191

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHE-Y 181
           A+DMWSV CIFAE++ +  LFPG + + QL  I  +LG+P+E+V   + S  +  + +  
Sbjct: 192 AIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNL 251

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           P+  P   +   P    + LDLL QMLQ+DP +RI+ ++A++HP+ 
Sbjct: 252 PRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  190 bits (486), Expect = 9e-60
 Identities = 86/232 (37%), Positives = 129/232 (55%), Gaps = 14/232 (6%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +  + E    +Y+V E M+TDL K I++   + ++I     +  +YQ+ +G+ + H 
Sbjct: 70  DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI-----QYFLYQILRGLKYIHS 124

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEILTLWYRAPEVLLG 118
             +LHRDLKP NLL++     LKI D GLAR            T  + T WYRAPE++L 
Sbjct: 125 ANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183

Query: 119 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
           S  Y+ A+D+WSV CI AE+++   LFPG   L QL  I  +LGTP+++    + S +  
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS-LRA 242

Query: 179 HEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
             Y    P           PN D   LDLL++ML ++P KRI+ ++A+ HPY
Sbjct: 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  187 bits (478), Expect = 4e-59
 Identities = 84/228 (36%), Positives = 129/228 (56%), Gaps = 19/228 (8%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           ++GR  LYLVFEY++  L + + +    G  +P + V+S ++QL + +A+CH H I+HRD
Sbjct: 71  RKGR--LYLVFEYVERTLLELLEASP-GG--LPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           +KP N+L+   +  LK+ D G ARA    P    T  + T WYRAPE+L+G T+Y   VD
Sbjct: 126 IKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVD 184

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY------ 181
           +W++ CI AEL+    LFPGDS++ QL  I + LG     + P    L + +        
Sbjct: 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG----PLPPSHQELFSSNPRFAGVAF 240

Query: 182 -PQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                P+SL    P  +    LD L+  L+ DP +R++  + ++HPYF
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  185 bits (472), Expect = 4e-58
 Identities = 89/225 (39%), Positives = 126/225 (56%), Gaps = 15/225 (6%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRS----FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 64
           K+ +   YLVFEYMD DL   + S    F +       + +KS M QL +G+ +CH    
Sbjct: 85  KKDKGAFYLVFEYMDHDLMGLLESGLVHFSE-------DHIKSFMKQLLEGLNYCHKKNF 137

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYS 123
           LHRD+K  N+L++ K   +K+AD GLAR +     + YT++++TLWYR PE+LLG   Y 
Sbjct: 138 LHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYG 196

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
            A+D+WS  CI  EL TK  +F  + EL QL  I RL G+P   VWP V  L  ++    
Sbjct: 197 PAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKP 256

Query: 184 WNP--QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                + L      +    LDLL+ ML  DPSKR +A++A+  P+
Sbjct: 257 KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  184 bits (469), Expect = 9e-58
 Identities = 105/224 (46%), Positives = 143/224 (63%), Gaps = 9/224 (4%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           +  L LVFEY+ TDL +Y+   +  G   P N VK  ++QL +G+++ H   ILHRDLKP
Sbjct: 75  KETLTLVFEYVHTDLCQYMD--KHPGGLHPEN-VKLFLFQLLRGLSYIHQRYILHRDLKP 131

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            NLL+   T  LK+AD GLARA ++P   Y++E++TLWYR P+VLLGST YST +DMW V
Sbjct: 132 QNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190

Query: 132 ACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGVSSLMNW--HEYPQWNPQS 188
            CIF E++   A FPG  ++Q QL  IF +LGTPNE  WPGV SL ++    +  ++P++
Sbjct: 191 GCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN 250

Query: 189 LATAVPNLD--KDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           L  A   L       DL  ++LQ  P  R+SA+ A+ H YF DL
Sbjct: 251 LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  183 bits (466), Expect = 4e-57
 Identities = 83/230 (36%), Positives = 123/230 (53%), Gaps = 24/230 (10%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           +   YLVFE+ + DL   + S +     +    +K +M  L  G+ + H + ILHRD+K 
Sbjct: 91  KGSFYLVFEFCEHDLAGLL-SNKNVKFTLSE--IKKVMKMLLNGLYYIHRNKILHRDMKA 147

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVD 127
            N+L+  K   LK+AD GLARAF+L       +YT+ ++TLWYR PE+LLG   Y   +D
Sbjct: 148 ANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN-- 185
           MW   CI AE+ T++ +  G++E  QL  I +L G+   +VWPGV       +   +   
Sbjct: 207 MWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD------KLELFKKM 260

Query: 186 --PQSLATAVP------NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             PQ     V         D   LDL++++L  DP+KRI A  A+ H +F
Sbjct: 261 ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  182 bits (465), Expect = 2e-56
 Identities = 84/215 (39%), Positives = 123/215 (57%), Gaps = 12/215 (5%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           YLV   M  DL   ++  + + ++I     + L+YQ+ +G+ + H  GI+HRDLKP N+ 
Sbjct: 96  YLVTHLMGADLNNIVKCQKLSDDHI-----QFLVYQILRGLKYIHSAGIIHRDLKPSNIA 150

Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF 135
           ++ +   LKI D GLAR       + T  + T WYRAPE++L   HY+  VD+WSV CI 
Sbjct: 151 VN-EDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206

Query: 136 AELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHE-YPQWNPQSLATA 192
           AEL+T   LFPG   + QL  I  L+GTP+E++   +SS    N+ +  PQ   +     
Sbjct: 207 AELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV 266

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               +   +DLLE+ML  DP KRI+A +A+ HPY 
Sbjct: 267 FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  177 bits (451), Expect = 4e-55
 Identities = 95/226 (42%), Positives = 140/226 (61%), Gaps = 6/226 (2%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H 
Sbjct: 71  DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLHS 128

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAPEVLL S+ 
Sbjct: 129 HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS- 185

Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     +
Sbjct: 186 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR-QAF 244

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  177 bits (452), Expect = 1e-54
 Identities = 85/219 (38%), Positives = 124/219 (56%), Gaps = 12/219 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYL  E M+ DL + IRS +   +       +S +YQ+  G+ + H   +LHRDLKP NL
Sbjct: 81  LYLYEELMEADLHQIIRSGQPLTDA----HFQSFIYQILCGLKYIHSANVLHRDLKPGNL 136

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L++     LKI D GLAR F+    +     T  + T WYRAPE++L    Y+ A+D+WS
Sbjct: 137 LVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWS 195

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---HEYPQWNPQ 187
           V CI AEL+ +  +F G   + QL  I ++LGTP+E+    + S          P    +
Sbjct: 196 VGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKK 255

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
              +  PN +   LDLLE++L +DP+KRIS ++A+EHPY
Sbjct: 256 PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  178 bits (452), Expect = 3e-54
 Identities = 96/226 (42%), Positives = 131/226 (57%), Gaps = 13/226 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E M +DL K I S     + +  + VK  +YQ+ +G+ + H  GILHRD+KP NL
Sbjct: 79  IYVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L++   + LKI D GLAR       K+ T E++T +YRAPE+L+GS HY++AVD+WSV C
Sbjct: 135 LVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGC 193

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNP--QSL 189
           IFAEL+ +  LF   S +QQL  I  LLGTP+ +           H    P   P    L
Sbjct: 194 IFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL 253

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
            T       + + LL +ML +DP KRISA  A+ HPY   LD+ RL
Sbjct: 254 YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY---LDEGRL 296

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  168 bits (428), Expect = 1e-51
 Identities = 82/220 (37%), Positives = 122/220 (55%), Gaps = 15/220 (6%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           LYLVFE++D     DL+KY          +  + V+  ++Q+ +G+ FCH H I+HRD+K
Sbjct: 75  LYLVFEFVDHTVLDDLEKY-------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P N+L+ +  +  K+ D G AR    P + YT  + T WYRAPE+L+G T Y  AVD+W+
Sbjct: 128 PENILVSQSGVV-KLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA 186

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGT--PNEKVWPGVSSLMNWHEYPQW-NPQ 187
           V C+  E++T   LFPGDS++ QL HI + LG   P  +     + L      P+    +
Sbjct: 187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE 246

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            L    P L    LDL +Q L+ DP  R S+ + + H +F
Sbjct: 247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  167 bits (425), Expect = 3e-51
 Identities = 82/225 (36%), Positives = 127/225 (56%), Gaps = 25/225 (11%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+LVFEY D     +L+K  R        +P + +K +++Q  + V FCH H  +HRD+K
Sbjct: 75  LHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P N+L+  K   +K+ D G AR  T P   YT  + T WYRAPE+L+G T Y   VD+W+
Sbjct: 128 PENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--------P 182
           + C+FAEL+T   L+PG S++ QL  I + LG     + P    + + +++        P
Sbjct: 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQIFSTNQFFKGLSIPEP 242

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   + L +  PN+    L  L+  LQ DP++R+S ++ +EHPYF
Sbjct: 243 E-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  168 bits (428), Expect = 5e-51
 Identities = 76/227 (33%), Positives = 121/227 (53%), Gaps = 26/227 (11%)

Query: 14  VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            +Y+V EYM+TDL   +         +     +  MYQL +G+ + H   +LHRDLKP N
Sbjct: 90  SVYIVQEYMETDLANVLEQGP-----LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 144

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE------ILTLWYRAPEVLLGSTHYSTAVD 127
           + ++ + + LKI D GLAR        Y+H+      ++T WYR+P +LL   +Y+ A+D
Sbjct: 145 VFINTEDLVLKIGDFGLARIVD---PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK-------VWPGVSSLMNWHE 180
           MW+  CIFAE++T   LF G  EL+Q+  I   +    E+       V P          
Sbjct: 202 MWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG-- 259

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   + L   +P ++ + LD LEQ+L ++P  R++A++A+ HPY 
Sbjct: 260 EPR---RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  163 bits (415), Expect = 3e-49
 Identities = 81/218 (37%), Positives = 118/218 (54%), Gaps = 12/218 (5%)

Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
              +Y V E + TDL + + S       +    ++  +YQ+ +G+ + H  G++HRDLKP
Sbjct: 82  LEDIYFVTELLGTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP 136

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L++ +   LKI D GLAR   +   + T  + T +YRAPE++L    Y   VD+WS 
Sbjct: 137 SNILIN-ENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQS 188
            CIFAE++    LFPG   + Q   I  LLGTP + V   + S   L      P+  P  
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVP 252

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            +    N D   +DLLE+ML +DP KRISA +A+ HPY
Sbjct: 253 FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  162 bits (412), Expect = 7e-48
 Identities = 80/225 (35%), Positives = 131/225 (58%), Gaps = 2/225 (0%)

Query: 7   QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
           +  E    L +V E++   + KY++ + +    +P+  VK   YQLC+ +A+ H   I H
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICH 193

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP NLL+D  T TLK+ D G A+   L  ++    I + +YRAPE++LG+T+Y+T +
Sbjct: 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRFYRAPELMLGATNYTTHI 252

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS+ CI AE++    +F G S + QL+ I ++LGTP E     ++      ++P   P
Sbjct: 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKP 312

Query: 187 QSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           + L    P     D ++ + Q L+Y+P KR++  +A+  P+FDDL
Sbjct: 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  160 bits (405), Expect = 1e-47
 Identities = 86/220 (39%), Positives = 121/220 (55%), Gaps = 15/220 (6%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  YM TDL+K +      G  +  + V+ L+YQ+  G+ + H  GI+HRDLKP NL
Sbjct: 95  FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL 148

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   HY+  VD+WSV CI
Sbjct: 149 AVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNPQSLA 190
            AE++T   LF G   L QL  I ++ G P  +    +        Y    P++  +  +
Sbjct: 205 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED-KAAKSYIKSLPKYPRKDFS 263

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           T  P      +DLLE+ML+ D  KR++A +A+EHPYFD  
Sbjct: 264 TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  156 bits (396), Expect = 2e-46
 Identities = 89/232 (38%), Positives = 129/232 (55%), Gaps = 26/232 (11%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+VFE M++DL + I++     +++     +  +YQL + + + H   + HRDLKP N+
Sbjct: 79  IYVVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134

Query: 75  LMDRKTMTLKIADLGLAR-AF--TLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMW 129
           L +     LKI D GLAR AF  T     +T  + T WYRAPE L GS  + Y+ A+D+W
Sbjct: 135 LANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIW 192

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHE 180
           S+ CIFAE++T   LFPG + + QL  I  LLGTP         NEK    +SS+     
Sbjct: 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMR---- 248

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             +  P   +   PN D   L LLE++L +DP  R +A++A+  PYF  L K
Sbjct: 249 --KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  155 bits (393), Expect = 6e-46
 Identities = 83/222 (37%), Positives = 129/222 (58%), Gaps = 12/222 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  +M TDL K ++      E +  + ++ L+YQ+ KG+ + H  GI+HRDLKP NL
Sbjct: 95  FYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL 149

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   HY+  VD+WSV CI
Sbjct: 150 AVNEDC-ELKILDFGLARQTDSEMTGY---VVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNW-HEYPQWNPQSLAT 191
            AE++T   LF G   L QL+ I ++ GTP+++    + S    N+  + P++  +   +
Sbjct: 206 MAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS 265

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
            +PN +   +++LE+ML  D   RI+A +A+ HPYF++    
Sbjct: 266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (375), Expect = 1e-44
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 63/212 (29%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY +   LK  ++        +  + +  ++ Q+ +G+ + H +GI+HRDLKP N
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN 122

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D     +K+AD GL++  T         + T  Y APEVLLG  +YS   D+WS+  
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           I  EL           EL+ L                                       
Sbjct: 183 ILYEL----------PELKDL--------------------------------------- 193

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                     + +MLQ DP KR SAK+ +EH 
Sbjct: 194 ----------IRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  149 bits (378), Expect = 1e-43
 Identities = 84/216 (38%), Positives = 120/216 (55%), Gaps = 12/216 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + + E++     + L+YQL +G+ + H  GI+HRDLKP N+
Sbjct: 95  VYLVTNLMGADLNNIVKCQKLSDEHV-----QFLIYQLLRGLKYIHSAGIIHRDLKPSNV 149

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     L+I D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 150 AVNEDC-ELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQSLAT 191
            AEL+   ALFPG+  + QL  I  ++GTP+ +V   +SS          P    Q L  
Sbjct: 206 MAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK 265

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                +   +DLLE+ML  D  KRISA +A+ HPYF
Sbjct: 266 IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  148 bits (375), Expect = 3e-43
 Identities = 84/216 (38%), Positives = 119/216 (55%), Gaps = 12/216 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 97  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 151

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 152 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNW-HEYPQWNPQSLAT 191
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS    N+     Q    + A 
Sbjct: 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 267

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 268 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  144 bits (363), Expect = 9e-42
 Identities = 88/243 (36%), Positives = 133/243 (54%), Gaps = 30/243 (12%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           ++L+F+Y + DL   I+  R +  N     +P   VKSL+YQ+  G+ + H + +LHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 70  KPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYS 123
           KP N+L+     +   +KIAD+G AR F  P+K        ++T WYRAPE+LLG+ HY+
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLGTPNEKVW----- 169
            A+D+W++ CIFAEL+T   +F    E           QL  IF ++G P +K W     
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 254

Query: 170 -PGVSSLMNWHEYPQWNPQSLATAVPNL----DKDGLDLLEQMLQYDPSKRISAKKAMEH 224
            P  S+LM       +   SL   +       D     LL+++L  DP KRI++++AM+ 
Sbjct: 255 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314

Query: 225 PYF 227
           PYF
Sbjct: 315 PYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  143 bits (361), Expect = 2e-41
 Identities = 86/246 (34%), Positives = 133/246 (54%), Gaps = 36/246 (14%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           ++L+F+Y + DL   I+  R +  N     +P + VKSL+YQ+  G+ + H + +LHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 70  KPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYS 123
           KP N+L+     +   +KIAD+G AR F  P+K        ++T WYRAPE+LLG+ HY+
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLGTPNEKVWPGVSS 174
            A+D+W++ CIFAEL+T   +F    E           QL  IF ++G P +K W  +  
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRK 254

Query: 175 LMNWHEYPQWNPQSLATAVPNL-------------DKDGLDLLEQMLQYDPSKRISAKKA 221
           +    EYP        T   N              D     LL+++L  DP+KRI++++A
Sbjct: 255 M---PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA 311

Query: 222 MEHPYF 227
           ++ PYF
Sbjct: 312 LQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  140 bits (355), Expect = 4e-40
 Identities = 85/244 (34%), Positives = 122/244 (50%), Gaps = 48/244 (19%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+       ++    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 96  VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 149

Query: 75  LMDRKTMTLKIADLGLAR----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           ++ +   TLKI D GLAR    +F +     T  ++T +YRAPEV+LG   Y   VD+WS
Sbjct: 150 VV-KSDCTLKILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILG-MGYKENVDIWS 202

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE----KVWPGVSSLMNWHEYPQWNP 186
           V CI  E++  T LFPG   + Q   I   LGTP++    ++ P V +      Y +  P
Sbjct: 203 VGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN------YVENRP 256

Query: 187 QSLATAVPNLDKDGL-----------------DLLEQMLQYDPSKRISAKKAMEHPY--- 226
           +    +   L  D L                 DLL +ML  DP KRIS   A++HPY   
Sbjct: 257 KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316

Query: 227 -FDD 229
            +D 
Sbjct: 317 WYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  137 bits (346), Expect = 1e-39
 Identities = 88/236 (37%), Positives = 130/236 (55%), Gaps = 20/236 (8%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +++K+   + G+  LYLVFEY++   K  +    +    +P   V+S +YQL K + +CH
Sbjct: 63  VELKEAFRRRGK--LYLVFEYVE---KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGS 119
            + I+HRD+KP NLL+    + LK+ D G AR  +      YT  + T WYR+PE+LLG+
Sbjct: 118 KNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT-PNEKVW-----PGVS 173
             Y  AVDMWSV CI  EL     LFPG+SE+ QL  I ++LG  P E++      P   
Sbjct: 177 P-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235

Query: 174 SLMNWHEYPQWN-PQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            L     +P  N PQSL       L    LDL++ +L+ +P+ R   ++ + HP F
Sbjct: 236 GL----RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (330), Expect = 2e-36
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 25/229 (10%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY+D   L+  ++   + G  +  +    ++ Q+   + + H  GI+HRD+KP N
Sbjct: 73  LYLVMEYVDGGSLEDLLKKIGRKG-PLSESEALFILAQILSALEYLHSKGIIHRDIKPEN 131

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGST--HYSTA 125
           +L+DR    +K+ D GLA+    P    +   L      T  Y APEVLLG +  + S++
Sbjct: 132 ILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS 191

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            D+WS+     EL+T    F G+                 + +    +  +     P   
Sbjct: 192 SDIWSLGITLYELLTGLPPFEGEKNSSATSQTL-------KIILELPTPSLASPLSPSNP 244

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                     + K   DLL+++L  DP  R+S+   + H     L    
Sbjct: 245 --------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  123 bits (310), Expect = 1e-33
 Identities = 84/228 (36%), Positives = 119/228 (52%), Gaps = 23/228 (10%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 97  VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 151 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 207

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTP----NEKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS  +A++HPY +
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  122 bits (308), Expect = 3e-33
 Identities = 82/230 (35%), Positives = 112/230 (48%), Gaps = 31/230 (13%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I         +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 101 VYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 155 VV-KSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 211

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTP-----------------NEKVWPGVSSLMN 177
             ELV  + +F G   + Q   +   LGTP                 N   +PG+S    
Sbjct: 212 MGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGIS---- 267

Query: 178 WHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           + E +P W   S +           DLL +ML  DP KRIS  +A+ HPY
Sbjct: 268 FEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  122 bits (306), Expect = 5e-33
 Identities = 79/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTP----NEKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272

Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (285), Expect = 1e-30
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 44/229 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY+   DL   + +      ++  +  +  + ++   + + H +GI+HRDLKP N
Sbjct: 68  LYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 74  LLMDRKTMTLKIADLGLARA-------FTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTA 125
           +L+D     LK+ D GL++             +K    I+ T  Y APEV+LG  H S  
Sbjct: 124 ILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKT 181

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD WS+ CI  E +     F G++  +   +I              ++  + W E     
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--------------LNGKIEWPED---- 223

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYFDDLD 231
                     +  + +DL+ ++L  DP KR+ AK       HP+F  +D
Sbjct: 224 --------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  102 bits (256), Expect = 2e-26
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 9   KEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
            E +  L +  EY+   +     + S  +    +P   ++    Q+ +G+A+ H +GI+H
Sbjct: 70  DEEKNTLNIFLEYVSGGS-----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAF-TLPIKKYTHEIL-TLWYRAPEVLLGSTHYST 124
           RD+K  N+L+D     +K+AD G A+    +   + T  +  T ++ APEV+ G   Y  
Sbjct: 125 RDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGR 182

Query: 125 AVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
           A D+WS+ C   E+ T K       + +  L  I      P               E P+
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP---------------EIPE 227

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                       L ++  D L + L+ DP KR +A + ++HP+ 
Sbjct: 228 H-----------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 6e-25
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY    +L  ++    +          +    ++   + + H  GI++RDLKP N
Sbjct: 68  LYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D     +K+ D GLA+  +    +      T  Y APEVLLG   Y  AVD WS+  
Sbjct: 124 ILLDA-DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGV 181

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E++T    F  +   +    I+       + +            +P           
Sbjct: 182 LLYEMLTGKPPFYAEDRKE----IYEK--ILKDPL-----------RFP----------- 213

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYF 227
             L  +  DL+  +LQ DP+KR+ +  A E   HP+F
Sbjct: 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.3 bits (246), Expect = 7e-25
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  L +V EY D  DL + I+  ++ G+  P   +     QLC  + + H   ILHRD
Sbjct: 69  EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRD 128

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           +KP N+ +      +K+ D G+++    T+ + K    + T +Y +PE+      Y+   
Sbjct: 129 IKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSPELCQNKP-YNYKS 184

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS+ C+  EL T    F G++ L +L    ++L      +    SS +          
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGEN-LLEL--ALKILKGQYPPIPSQYSSELR--------- 232

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                          +L+  +LQ DP +R S  + ++ P+ 
Sbjct: 233 ---------------NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 3e-24
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 40/222 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY++  D    I    +T   +P +  K  + ++  GV   H  GI+HRD+KP N
Sbjct: 72  LYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           LL+D +T  LK+ D GL+R      KK+   + T  Y APE +LG        D WS+ C
Sbjct: 128 LLID-QTGHLKLTDFGLSRNGLEN-KKF---VGTPDYLAPETILGVGD-DKMSDWWSLGC 181

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV-SSLMNWHEYPQWNPQSLATA 192
           +  E +     F                 TP + V+  + S  +NW E            
Sbjct: 182 VIFEFLFGYPPFHA--------------ETP-DAVFDNILSRRINWPEE----------V 216

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
                 + +DL+ ++L  DP+KR+ A    E   HP+F  ++
Sbjct: 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.7 bits (236), Expect = 2e-23
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 33/197 (16%)

Query: 37  GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG----LAR 92
           G  +  + ++    QL +G+A+ H HGI+HRD+KP N+ +D   + +K+ D G    L  
Sbjct: 93  GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKN 151

Query: 93  AFTLPIKKYTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPG-DS 149
             T   ++      T  Y APEV+ G     +  A D+WS+ C+  E+ T    +   D+
Sbjct: 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211

Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           E Q + H+                        P   P SL      L  +G D L++ L+
Sbjct: 212 EFQIMFHV-------------------GAGHKPPI-PDSL-----QLSPEGKDFLDRCLE 246

Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR +A + ++HP+
Sbjct: 247 SDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.2 bits (235), Expect = 4e-23
 Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 59/238 (24%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY  + +L +YIR +     ++     +    ++   + + H  GI+HRDLKP N
Sbjct: 77  LYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132

Query: 74  LLMDRKTMTLKIADLGLARAF--------TLPIKKYTHEIL------------TLWYRAP 113
           +L+D+  M +KI D G A+                     +            T  Y +P
Sbjct: 133 ILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           E LL       + D+W++ CI  +++T    F G +E      I +L             
Sbjct: 192 E-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE------------ 238

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----HPYF 227
                + +P           PN   D  DL+E++L  DP  R+   +  +    HP+F
Sbjct: 239 -----YSFP-----------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 36/215 (16%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY++ EY +   L++ I+ F    E++    V   +YQ+ +G+A+ H  G++HRD+K  N
Sbjct: 74  LYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +L   K   +K+AD G+A      + K    ++ T ++ APEV+  S   STA D+WS+ 
Sbjct: 130 ILTT-KDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLG 186

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           C   EL+T     P   +L  +  +FR++   +  +  G+S  +                
Sbjct: 187 CTVIELLTGN---PPYYDLNPMAALFRIVQDDHPPLPEGISPEL---------------- 227

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                    D L Q  Q DP+ R +AK+ ++HP+ 
Sbjct: 228 --------KDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.0 bits (221), Expect = 2e-21
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 42/186 (22%)

Query: 49  MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKY 101
           +Y  Q+  G+ + H    +HRD+K  N+L+D   + +K+AD G+A+     +F    K  
Sbjct: 106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFSFAKSFKG- 163

Query: 102 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 161
                + ++ APEV+     Y  A D+WS+ C   E+ T     P  S+L+ +  +F++ 
Sbjct: 164 -----SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK---PPWSQLEGVAAVFKI- 214

Query: 162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKK 220
                K  P                      +P+ L  +  D + + LQ DPS R +A +
Sbjct: 215 --GRSKELP---------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251

Query: 221 AMEHPY 226
            +EHP+
Sbjct: 252 LLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 8/146 (5%)

Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILH 66
             LY+V EY +  DL + I+  ++  + I    +  ++ QL   +  CH     G+ +LH
Sbjct: 74  QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+ +D     +K+ D GLA+            + T +Y +PE L   + Y    
Sbjct: 134 RDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKS 191

Query: 127 DMWSVACIFAELVTKTALFPGDSELQ 152
           D+WS+ C+  EL   +  F   ++LQ
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 85.0 bits (211), Expect = 5e-20
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L++V E+     LK  ++S  QT   +  + +  +  +L KG+ + H +GI+HRD+K  N
Sbjct: 72  LWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN 128

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+      +K+ D GL+   +   K     + T ++ APEV+ G   Y    D+WS+  
Sbjct: 129 ILLTSDG-EVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVING-KPYDYKADIWSLGI 185

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
              EL       P  SE    L   + L        PG+ +   W +  +          
Sbjct: 186 TAIELAEGK---PPYSE----LPPMKALFKIATNGPPGLRNPEKWSDEFK---------- 228

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                   D L++ LQ +P KR +A++ ++HP+
Sbjct: 229 --------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.2 bits (211), Expect = 6e-20
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 34/213 (15%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V EY    DL K I   ++  + IP   +  +  QL +G+   H   ILHRDLK  N
Sbjct: 74  LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+    + +KI DLG+++     + K   +I T  Y APEV  G   YS   D+WS+ C
Sbjct: 134 ILLVANDL-VKIGDLGISKVLKKNMAKT--QIGTPHYMAPEVWKG-RPYSYKSDIWSLGC 189

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E+ T    F   S +Q L            KV  G        +YP          +
Sbjct: 190 LLYEMATFAPPFEARS-MQDL----------RYKVQRG--------KYP---------PI 221

Query: 194 PNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHP 225
           P +    L + +  MLQ  P  R +  K +  P
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.0 bits (211), Expect = 7e-20
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 32/177 (18%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
           H  GI++RDLKP NLL+D     +K+ D G A+      K +T    T  Y APE++L  
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILNK 167

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
             Y  +VD WS+  +  EL+T    F  D E    + I+  +   N K            
Sbjct: 168 -GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGK-----------L 213

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
           E+P             +DK   DL++Q+L+ +P +R+       K   +H +F+  D
Sbjct: 214 EFPN-----------YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 82.6 bits (205), Expect = 4e-19
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM+  DL  Y+R   +    + ++ + S   Q+ +G+ +      +HRDL   N
Sbjct: 76  LYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 132

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L+  + + +KI+D GL+R              LPI+         W  APE L     +
Sbjct: 133 CLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR---------WM-APESLK-EGKF 180

Query: 123 STAVDMWS 130
           ++  D+WS
Sbjct: 181 TSKSDVWS 188

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 82.7 bits (205), Expect = 4e-19
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 39/221 (17%)

Query: 12  RTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
              +YLV + +   DL+ ++    +  E      VK  + ++   + + H  GI+HRD+K
Sbjct: 72  EENMYLVVDLLLGGDLRYHLSQKVKFSEE----QVKFWICEIVLALEYLHSKGIIHRDIK 127

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P N+L+D +   + I D  +A   T P    T    T  Y APEVL     YS AVD WS
Sbjct: 128 PDNILLDEQGH-VHITDFNIATKVT-PDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWS 184

Query: 131 VACIFAELVTKTALFPGDSEL--QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           +     E +     + G S     Q+        T +                  W+   
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPAT------------WS--- 226

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRIS--AKKAMEHPYF 227
                     + +D + ++L+ DP KR+    K    HPYF
Sbjct: 227 ---------TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 7e-19
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 3/135 (2%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V E  D  DL + I+ F++    IP  T+     QLC  +   H   I+HRD+KP N
Sbjct: 77  LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN 136

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +K+ DLGL R F+         + T +Y +PE +     Y+   D+WS+ C
Sbjct: 137 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGC 194

Query: 134 IFAELVTKTALFPGD 148
           +  E+    + F GD
Sbjct: 195 LLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (206), Expect = 7e-19
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 29/189 (15%)

Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-T 107
           M ++ + V   H  G +HRDLKP N L+D  +  +K+ D GL++        Y + ++ +
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDA-SGHIKLTDFGLSKGIV----TYANSVVGS 161

Query: 108 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 167
             Y APEVL G   Y   VD WS+ C+  E +     F G               TPNE 
Sbjct: 162 PDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNE- 205

Query: 168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-AMEHPY 226
            W    +L  W E  Q           NL  +  DL+ +++  DPS+R  + +    HP+
Sbjct: 206 TW---ENLKYWKETLQR--PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259

Query: 227 FDDLDKTRL 235
           F ++D   L
Sbjct: 260 FKEVDWNEL 268

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 3e-18
 Identities = 58/204 (28%), Positives = 85/204 (41%), Gaps = 30/204 (14%)

Query: 23  DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT 82
             DL   +   + TG+ +  N V     QL  GV + H   ILHRDLK  N+ +  K   
Sbjct: 86  GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL--KNNL 143

Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT 142
           LKI D G++R         T    T +Y +PE  L    Y +  D+WS+ CI  E+    
Sbjct: 144 LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCCLA 202

Query: 143 ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLD 202
             F G + L  +L I          V     SL      P+   + L +           
Sbjct: 203 HAFEGQNFLSVVLRI----------VEGPTPSL------PETYSRQLNS----------- 235

Query: 203 LLEQMLQYDPSKRISAKKAMEHPY 226
           +++ ML  DPS R SA + + +P+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 80.3 bits (199), Expect = 4e-18
 Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 30/144 (20%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQT-----GENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           LYLV EYM+  DL  Y+R  R          + +  + S   Q+ KG+ +      +HRD
Sbjct: 71  LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130

Query: 69  LKPHNLLMDRKTMTLKIADLGLAR------------AFTLPIKKYTHEILTLWYRAPEVL 116
           L   N L+    + +KI+D GL+R               LPI+         W  APE L
Sbjct: 131 LAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---------WM-APESL 179

Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
                +++  D+WS   +  E+ T
Sbjct: 180 KDGI-FTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 79.9 bits (198), Expect = 5e-18
 Identities = 36/128 (28%), Positives = 57/128 (44%), Gaps = 26/128 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V EYM   DL  Y+R  R   + + ++ + S   Q+ +G+ +      +HRDL   N
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 133

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L+      +KI+D GL+R              LPI+         W  APE L     +
Sbjct: 134 CLVGENL-VVKISDFGLSRDLYDDDYYKVKGGKLPIR---------WM-APESLK-EGKF 181

Query: 123 STAVDMWS 130
           ++  D+WS
Sbjct: 182 TSKSDVWS 189

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 1e-17
 Identities = 53/188 (28%), Positives = 95/188 (50%), Gaps = 35/188 (18%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR---AFTLPIKKY 101
           V++ + Q+ KG+ + H  GI+HRD+K  N+L+D K   +KI+D G+++   A +L  K  
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTN 166

Query: 102 THEIL---TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 158
                   ++++ APEV +  T Y+   D+WS+ C+  E++T    FP   +  QL  IF
Sbjct: 167 GARPSLQGSVFWMAPEV-VKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIF 222

Query: 159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 218
           ++     E   P + S                    N+  + +D LE+  + D +KR +A
Sbjct: 223 KI----GENASPEIPS--------------------NISSEAIDFLEKTFEIDHNKRPTA 258

Query: 219 KKAMEHPY 226
            + ++HP+
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPH 72
           + +  EYMD   L K ++  +     IP   +  +   + KG+ + H  H I+HRD+KP 
Sbjct: 74  ISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L++ +   +K+ D G++      + K    + T  Y APE + G   YS   D+WS+ 
Sbjct: 131 NILVNSRG-QIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQG-NDYSVKSDIWSLG 186

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
               EL T    FP   E      IF LL             ++N  E P   P      
Sbjct: 187 LSLIELATGR--FPYPPENDPPDGIFELL-----------QYIVN--EPPPRLPSG---- 227

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                 D  D +   L  DP +R S K+ +EHP+ 
Sbjct: 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 41/223 (18%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHR 67
           KEG   + +V EYMD      +    +    IP   +  +  Q+ KG+ + H    I+HR
Sbjct: 70  KEGE--ISIVLEYMD---GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL++ K   +KIAD G+++     + +    + T+ Y +PE + G   YS A D
Sbjct: 125 DIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAAD 182

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS+     E       FP           F   G P+   +     LM           
Sbjct: 183 IWSLGLTLLECA--LGKFP-----------FLPPGQPS---FF---ELMQ---------A 214

Query: 188 SLATAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAMEHP 225
                 P+L  +       D +   LQ DP KR SA + ++HP
Sbjct: 215 ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 78.1 bits (192), Expect = 5e-17
 Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 39/231 (16%)

Query: 7   QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           Q KE    L+ V EY++  DL  +I+S  +   ++P  T  +   ++  G+ F H  GI+
Sbjct: 66  QTKEN---LFFVMEYLNGGDLMFHIQSCHKF--DLPRATFYAA--EIICGLQFLHSKGIV 118

Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           +RDLK  N+L+D     +KIAD G+ +   L   K      T  Y APE+LLG   Y+T+
Sbjct: 119 YRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTS 176

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD WS   +  E++   + F G  E ++L    R                M+   YP+W 
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIR----------------MDNPCYPRW- 218

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLDKTRL 235
                     L ++  D+L ++   +P +R+  K  + +HP+F ++D + L
Sbjct: 219 ----------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.1 bits (190), Expect = 7e-17
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 58/236 (24%)

Query: 14  VLYLVFEYMDTDLKKYI---------RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 64
           V YL FE  +  L  ++            R  G       V+    Q+ +G+A+ H  GI
Sbjct: 71  VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFTEQVLEGLAYLHSKGI 129

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL----------TLWYRAPE 114
           LHRDLK  NLL+D      KI+D G        I K + +I           ++++ APE
Sbjct: 130 LHRDLKADNLLVDADG-ICKISDFG--------ISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 115 VL-LGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLLGTPNEKVWP 170
           V+   S  YS  VD+WS+ C+  E      +F G    S+ + +  +F+L    N++  P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLE------MFAGRRPWSDEEAIAAMFKLG---NKRSAP 231

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            +             P  +     NL    LD L      +P  R +A++ ++HP+
Sbjct: 232 PI-------------PPDV---SMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 69/235 (29%), Positives = 99/235 (42%), Gaps = 41/235 (17%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +  L LV   M+  DLK +I +  + G        +++ Y  Q+  G+   H   I++
Sbjct: 63  ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA----RAIFYAAQIICGLEHLHQRRIVY 118

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTA 125
           RDLKP N+L+D     ++I+DLGL  A  L   K       T  Y APEVL G   Y  +
Sbjct: 119 RDLKPENVLLDDHG-NVRISDLGL--AVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFS 174

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD +++ C   E++   + F    E  +   + R                    EYP   
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------------EYPDKF 221

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
                           DL E +LQ DP KR+     SA +  EHP F DL+  RL
Sbjct: 222 SPEAK-----------DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 40/225 (17%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V EY++  DL  +I+S  +  E       ++  Y  ++  G+ F H  GI++RDLK 
Sbjct: 71  LFFVMEYLNGGDLMFHIQSSGRFDEA------RARFYAAEIICGLQFLHKKGIIYRDLKL 124

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L+D+    +KIAD G+ +       K +    T  Y APE+L G   Y+ +VD WS 
Sbjct: 125 DNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSF 182

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E++   + F G+ E  +L          N++             +P+W       
Sbjct: 183 GVLLYEMLIGQSPFHGEDE-DELFDSIL-----NDRPH-----------FPRW------- 218

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLDKTRL 235
               + K+  D L ++ + DP+KR+     + +HP+F  +D  RL
Sbjct: 219 ----ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 75.2 bits (186), Expect = 3e-16
 Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 28/129 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL  ++R   + GE + +  +  +  Q+ KG+ +      +HRDL   N
Sbjct: 76  LYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARN 132

Query: 74  LLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVLLGSTH 121
            L+    + +KI+D GL+R               LPIK         W  APE L     
Sbjct: 133 CLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIK---------WM-APESLKDG-K 180

Query: 122 YSTAVDMWS 130
           +++  D+WS
Sbjct: 181 FTSKSDVWS 189

Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 47/217 (21%), Positives = 89/217 (41%), Gaps = 36/217 (16%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +  EYM    +K  ++++    E +     +    Q+ +GV + H + I+HRD+K  N
Sbjct: 79  LSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVEYLHSNMIVHRDIKGAN 134

Query: 74  LLMDRKTMTLKIADLGLAR---AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L D     +K+ D G ++                 T ++ +PEV+ G  +   A D+WS
Sbjct: 135 ILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA-DVWS 192

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           V C   E++T+    P  +E + +  IF++   P     P                    
Sbjct: 193 VGCTVVEMLTEK---PPWAEFEAMAAIFKIATQPTNPQLP-------------------- 229

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               ++  D  + L +    +  KR SA++ + H + 
Sbjct: 230 ---SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 29/192 (15%)

Query: 34  RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA 93
           RQ G+      V   ++Q+   V++ H  GILHRD+K  N+ + +  + +K+ D G+++ 
Sbjct: 92  RQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKI 150

Query: 94  FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 153
                      + T +Y +PE+  G   Y+   D+W++ C+  EL+T    F   + L  
Sbjct: 151 LGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209

Query: 154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 213
           ++ I +   TP   V+   SS +                        + L+  +LQ DP 
Sbjct: 210 VVKIVQGNYTPVVSVY---SSEL------------------------ISLVHSLLQQDPE 242

Query: 214 KRISAKKAMEHP 225
           KR +A + ++ P
Sbjct: 243 KRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.8 bits (186), Expect = 3e-16
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 31/182 (17%)

Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 114
           G+ F H  GI++RDLK  N+++DR    +KIAD G+ +       + +    T  Y APE
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPE 166

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 174
           +L G   Y+ +VD WS   +  E++   + F GD E  +L    R + TP+         
Sbjct: 167 ILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIR-VDTPH--------- 214

Query: 175 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-HPYFDDLDKT 233
                 YP+W           + K+  D+LE++ + DP++R+     +  HP+F  ++ T
Sbjct: 215 ------YPRW-----------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257

Query: 234 RL 235
            L
Sbjct: 258 AL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.5 bits (183), Expect = 5e-16
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V EY     L +YI+  ++    +  +T+     Q+   +   H   ILHRDLK  N
Sbjct: 74  LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQN 131

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D+  M +KI D G+++  +   K YT  + T  Y +PE+  G   Y+   D+W++ C
Sbjct: 132 ILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKP-YNQKSDIWALGC 189

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  EL +    F   +    +L I    GT                    + P S     
Sbjct: 190 VLYELASLKRAFEAANLPALVLKIMS--GT--------------------FAPIS----- 222

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                D   L+  ML  DPSKR    + M  P
Sbjct: 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 73.9 bits (182), Expect = 9e-16
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 39/226 (17%)

Query: 12  RTVLYLVFEYMDT----DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
              L+LV  Y+      D+ K         E I    +K ++    KG+ + H +G +HR
Sbjct: 71  GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL----KGLEYLHSNGQIHR 126

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           D+K  N+L+     ++KIAD G++ +         K     + T  + APEV+     Y 
Sbjct: 127 DIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
              D+WS      EL T  A                    P  K +P +  LM      Q
Sbjct: 186 FKADIWSFGITAIELATGAA--------------------PYSK-YPPMKVLML---TLQ 221

Query: 184 WNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            +P SL T        K    ++   LQ DPSKR +A++ ++H +F
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.1 bits (182), Expect = 9e-16
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 32/194 (16%)

Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 97
           E + +N  +    QL +G+++ H + I+HRD+K  NLL+D     L+IAD G A      
Sbjct: 102 EAVIINYTE----QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157

Query: 98  IK---KYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 153
                ++  ++L T+ + APEVL G   Y  + D+WSV C+  E+ T    +  +     
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216

Query: 154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 213
           L  IF+ + +      P +             P+ L+  +        D+  + L+  P 
Sbjct: 217 LALIFK-IASATTA--PSI-------------PEHLSPGLR-------DVTLRCLELQPE 253

Query: 214 KRISAKKAMEHPYF 227
            R  +++ ++HP F
Sbjct: 254 DRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           + GR  L++V EY D  DL K I   RQ G     + + S   Q+  G+   H   ILHR
Sbjct: 70  ENGR--LFIVMEYCDGGDLMKRIN--RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR 125

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+K  N+ + +  M  K+ D G+AR     ++     + T +Y +PE+   +  Y+   D
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPYNNKTD 184

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS+ C+  EL T    F G++  Q +L I +                            
Sbjct: 185 IWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---------------------------G 217

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             A   PN  +D   L+ Q+ +  P  R S    ++ P+ 
Sbjct: 218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 30/177 (16%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLL- 117
           H  GI++RD+K  N+L+D     + + D GL++ F    ++  +    T+ Y APEV+  
Sbjct: 122 HQLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
           GS  +  AVD WS+  +  EL+T  + F  D E      I R +                
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP---------- 230

Query: 178 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
              +P             +  +  D ++++L+ DP KR+ A  A E   HP+F  +D
Sbjct: 231 ---FP-----------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 67/256 (26%), Positives = 98/256 (38%), Gaps = 70/256 (27%)

Query: 15  LYLVFEYM-DTDLKKY-IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           LYLV EYM   DL    IR      +  P  T +  + +L   +   H  G +HRD+KP 
Sbjct: 76  LYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPD 130

Query: 73  NLLMDRKTMTLKIADLGLA-------------------------RAFTLPIKKYTH---- 103
           N+L+D     +K+AD GL                                 K+       
Sbjct: 131 NILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189

Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
            + T  Y APEVL G T Y    D WS+  I  E++     F  D+          L  T
Sbjct: 190 TVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT----------LQET 238

Query: 164 PNEKVWPGVSSLMNWHE---YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAK 219
                    + ++NW E   +P   P S          + +DL+ ++L  DP  R+ S +
Sbjct: 239 --------YNKIINWKESLRFPPDPPVS---------PEAIDLICRLLC-DPEDRLGSFE 280

Query: 220 KAMEHPYFDDLDKTRL 235
           +   HP+F  +D   L
Sbjct: 281 EIKSHPFFKGIDWENL 296

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.1 bits (179), Expect = 2e-15
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 3/135 (2%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V E  D  DL + I+ F++    IP  TV     QLC  +   H   ++HRD+KP N
Sbjct: 77  LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 136

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +K+ DLGL R F+         + T +Y +PE  +    Y+   D+WS+ C
Sbjct: 137 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGC 194

Query: 134 IFAELVTKTALFPGD 148
           +  E+    + F GD
Sbjct: 195 LLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.5 bits (176), Expect = 8e-15
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 37/217 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V EYMD    TD+        Q    +    +  +  ++ +G+ + H   ++HRD+K
Sbjct: 90  LWVVMEYMDGGSLTDI------ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK 143

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L+  K  ++K+AD G A   T    K    + T ++ APEV+     Y   VD+WS
Sbjct: 144 SDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWS 201

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E+      +  +  L+ L  I    G P  K                 NP+   
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIPPLK-----------------NPEK-- 241

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   +  D L + L  DP KR SA++ ++HP+ 
Sbjct: 242 -----WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 3/135 (2%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V E  D  DL + I+ F++    IP  TV     QLC  V   H   ++HRD+KP N
Sbjct: 77  LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +K+ DLGL R F+         + T +Y +PE  +    Y+   D+WS+ C
Sbjct: 137 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGC 194

Query: 134 IFAELVTKTALFPGD 148
           +  E+    + F GD
Sbjct: 195 LLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 46/214 (21%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++++M Q+   +   H  GI+HRD+KP N++    + + KI DLG A    + I     E
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE 316

Query: 105 -ILTLWYRAPEVLLGSTHYSTA---------------------VDMWSVACIFAELVTKT 142
            +L   Y APE  + ST   +A                      D++S   IF ++    
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA--- 373

Query: 143 ALFPG---DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATAVPNLD 197
             FP    DS L Q           N ++      L+ W +   P+ +P  L      LD
Sbjct: 374 --FPNLRSDSNLIQF----------NRQLKRNDYDLVAWRKLVEPRASPD-LRRGFEVLD 420

Query: 198 KD---GLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            D   G +LL+ M+++   +RISAK A+ HPYFD
Sbjct: 421 LDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 44/229 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC--KGVAFCHGHGILHRDLKP 71
           L+ V EY++  DL  +I+   +  E       ++  Y      G+ F H  GI++RDLK 
Sbjct: 71  LFFVMEYVNGGDLMFHIQRSGRFDEP------RARFYAAEIVLGLQFLHERGIIYRDLKL 124

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L+D +   +KIAD G+ +   L     +    T  Y APE+L     Y  AVD W++
Sbjct: 125 DNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWAL 182

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E++   + F GD E  +L           ++V            YP+W       
Sbjct: 183 GVLLYEMLAGQSPFEGDDE-DELFQSIL-----EDEV-----------RYPRW------- 218

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-----HPYFDDLDKTRL 235
               L K+   +L+  L  +P KR+      E     HP+F ++D  +L
Sbjct: 219 ----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL 263

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 35/184 (19%)

Query: 53  CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 112
             G+ + H + I++RDLK  NLL+D +   +KIAD GL +       + +    T  + A
Sbjct: 111 VLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 113 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
           PEVL   T Y+ AVD W +  +  E++   + FPGD E +    I       N++V    
Sbjct: 170 PEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------NDEV---- 218

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
                   YP+            L ++ + ++ ++L+ +P +R+      A+   + P+F
Sbjct: 219 -------RYPR-----------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Query: 228 DDLD 231
            D++
Sbjct: 261 RDIN 264

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 4e-14
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 40/216 (18%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+++ EY       DL K  +        +    +  ++ ++  G+ + H  G +HRD+K
Sbjct: 74  LWIIMEYCGGGSCLDLLKPGK--------LDETYIAFILREVLLGLEYLHEEGKIHRDIK 125

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L+  +   +K+AD G++   T  + K    + T ++ APEV+  S  Y    D+WS
Sbjct: 126 AANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWS 183

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL        G+  L  L H  R+L                    P+ NP SL 
Sbjct: 184 LGITAIELAK------GEPPLSDL-HPMRVL-----------------FLIPKNNPPSLE 219

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                  K   D +   L  DP +R SAK+ ++H +
Sbjct: 220 G--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.5 bits (167), Expect = 6e-14
 Identities = 47/141 (33%), Positives = 69/141 (48%), Gaps = 5/141 (3%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LY+V EY D  DL + I+   Q G+  P +T+     Q+C GV   H   +LHRD
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRD 125

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +K  N+ + +    +K+ D G AR  T P       + T +Y  PE+   +  Y+   D+
Sbjct: 126 IKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI-WENMPYNNKSDI 183

Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+ CI  EL T    F  +S
Sbjct: 184 WSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.0 bits (169), Expect = 8e-14
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 45/214 (21%)

Query: 40  IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-- 97
           +PV+  +    +    + + H +GI+HRDLKP NLL+      +K+ D GL++   +   
Sbjct: 98  LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLT 156

Query: 98  -------IKKYTHEIL------TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL 144
                  I+K T E L      T  Y APEV+L    Y   VD W++  I  E +     
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVP 215

Query: 145 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLL 204
           F GD              TP E     +S  + W E  +        A+P    D  DL+
Sbjct: 216 FFGD--------------TPEELFGQVISDDIEWPEGDE--------ALPA---DAQDLI 250

Query: 205 EQMLQYDPSKRI---SAKKAMEHPYFDDLDKTRL 235
            ++L+ +P +R+    A +  +H +F  LD   L
Sbjct: 251 SRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 66.8 bits (163), Expect = 3e-13
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V EY +  DL K ++   Q G  +P + V     Q+  G+A  H   ILHRD+K  N
Sbjct: 74  LNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLN 131

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           L +D     +KI DLG+A+  +     + + I+ T +Y +PE L     Y+   D+W++ 
Sbjct: 132 LFLD-AYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALG 188

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E  T    F  +++   +L I R        V+P VS + +         Q LA  
Sbjct: 189 VVLYECCTGKHPFDANNQGALILKIIR-------GVFPPVSQMYS---------QQLA-- 230

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                     L++Q L  D  +R    + + +P
Sbjct: 231 ---------QLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 4e-13
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 43/236 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +  L LV   M+  DLK +I +    G     +  +++ Y  ++  G+   H   I++
Sbjct: 70  ETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFT--LPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           RDLKP N+L+D     ++I+DLGLA        I+     + T+ Y APEV + +  Y+ 
Sbjct: 126 RDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRG---RVGTVGYMAPEV-VKNERYTF 180

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
           + D W + C+  E++       G S  +Q            EKV           E  + 
Sbjct: 181 SPDWWGLGCLIYEMIE------GKSPFRQR----------KEKV--------KREEVERR 216

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
             +          +    +  Q+L  DP  R+      A++   HP+F   +  RL
Sbjct: 217 VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 46/193 (23%), Positives = 80/193 (41%), Gaps = 32/193 (16%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q+ + + F H H ++HRDLK  N+L+      +K+AD G++      ++K    
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTF 163

Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
           I T ++ APEV+   T     Y    D+WS+     EL       P   EL  +  + ++
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME---PPHHELNPMRVLLKI 220

Query: 161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAK 219
           L +                      P +L    P+       D L+  L  DP  R +A 
Sbjct: 221 LKSE---------------------PPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAA 257

Query: 220 KAMEHPYFDDLDK 232
           + ++HP+  D   
Sbjct: 258 ELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 4e-13
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 28/233 (12%)

Query: 17  LVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +V  +  +DL  Y+  RS       +P++    +  Q+ +G+ + H   I+HRD+K  N+
Sbjct: 134 MVLPHYSSDLYTYLTKRSRP-----LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     + I DLG A+ F +    +     T+   APEV L    Y++  D+WS   +
Sbjct: 189 FINDVD-QVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAPEV-LARDKYNSKADIWSAGIV 245

Query: 135 FAELVT--KTALFPGDSELQ--------QLLHIFRLLGTPNEKV--WPGVSSLMNWHEYP 182
             E++    T      S  +         LL I   L    E+    PG   +  + EY 
Sbjct: 246 LFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYA 305

Query: 183 QWNPQSLATAVP-----NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
               Q   T  P     NL  DG  L+ +ML +D + R SA++ + +P F  L
Sbjct: 306 SLERQPY-TRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 66.7 bits (162), Expect = 1e-12
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 28/167 (16%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-------GHGILH 66
           LY++ E+ D  DL + I+   +    I  + +  +  QL   +A+CH       G  +LH
Sbjct: 89  LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148

Query: 67  RDLKPHNLLMDRKTMTL----------------KIADLGLARAFTLPIKKYTHEIL-TLW 109
           RDLKP N+ +      +                KI D GL++   + I+   H  + T +
Sbjct: 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPY 206

Query: 110 YRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           Y +PE+LL  T  Y    DMW++ CI  EL +    F   +   QL+
Sbjct: 207 YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253

Length = 1021

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 65.6 bits (161), Expect = 1e-12
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 53/228 (23%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY+   +L  ++R         P    +    Q+   + + H   I++RDLKP N
Sbjct: 76  LYLVMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPEN 131

Query: 74  LLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LL+D     +KI D G A     R +TL     T E     Y APE++L S  Y  AVD 
Sbjct: 132 LLLDS-DGYIKITDFGFAKRVKGRTYTLC---GTPE-----YLAPEIIL-SKGYGKAVDW 181

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           W++  +  E++     F  D+ +Q    I+        KV            +P +    
Sbjct: 182 WALGILIYEMLAGYPPFFDDNPIQ----IYEK--ILEGKV-----------RFPSF---- 220

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDDLD 231
                     D  DL+  +LQ D +KR+   K        HP+F  +D
Sbjct: 221 -------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 45/188 (23%)

Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFS---KKKPHASVGTHGYMAP 164

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL-----LHIFRLLGTPNEKV 168
           EVL     Y ++ D +S+ C+  +L+       G S  +Q        I R+  T   + 
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQHKTKDKHEIDRMTLTMAVE- 217

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAME 223
            P   S                        +   LLE +LQ D ++R+      A++  E
Sbjct: 218 LPDSFS-----------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254

Query: 224 HPYFDDLD 231
           HP+F  LD
Sbjct: 255 HPFFRSLD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 39/217 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V E+++    TD+   +   R   E I      ++   + K ++F H  G++HRD+K
Sbjct: 91  LWVVMEFLEGGALTDI---VTHTRMNEEQI-----ATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             ++L+      +K++D G     +  + +    + T ++ APEV+     Y T VD+WS
Sbjct: 143 SDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTEVDIWS 200

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E+V     +  +  LQ +  I R    P  K    VS  +              
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKVSPRL-------------- 245

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                        L++ML  DP++R +A + + HP+ 
Sbjct: 246 ----------RSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.5 bits (157), Expect = 2e-12
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 5/151 (3%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LY+V +Y +  DL K I +  Q G   P + +     Q+C  +   H   ILHRD
Sbjct: 69  EENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +K  N+ +  K  T+K+ D G+AR     ++     I T +Y +PE+   +  Y+   D+
Sbjct: 127 IKSQNIFL-TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CENRPYNNKSDI 184

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFR 159
           W++ C+  E+ T    F   +    +L I R
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 12/161 (7%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKPH 72
           LY+V + ++   L ++  S ++  +      + ++  Q+   + + H    I+HRDL P+
Sbjct: 84  LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143

Query: 73  NLLM---DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
           N+++   D+ T+T    D GLA+    P  K T  + T+ Y  PE+ + +  Y    D+W
Sbjct: 144 NIMLGEDDKVTIT----DFGLAKQKQ-PESKLTSVVGTILYSCPEI-VKNEPYGEKADVW 197

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP-NEKVW 169
           +  CI  ++ T    F   + L     I   +  P  E ++
Sbjct: 198 AFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 33/214 (15%)

Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+++ E++    L   +   R   E I     +S++  LC    + H  G++HRD+K  +
Sbjct: 93  LWVLMEFLQGGALTDIVSQTRLNEEQI-ATVCESVLQALC----YLHSQGVIHRDIKSDS 147

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+      +K++D G     +  + K    + T ++ APEV+   T Y T VD+WS+  
Sbjct: 148 ILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYGTEVDIWSLGI 205

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E+V     +  DS +Q +    RL  +P  K       L N H+             
Sbjct: 206 MVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPK-------LKNAHK-----------IS 244

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           P L     D LE+ML  +P +R +A++ ++HP+ 
Sbjct: 245 PVLR----DFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.1 bits (153), Expect = 8e-12
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 41/235 (17%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +  L LV   M+  DLK +I    + G        +++ Y  ++C G+   H   I++
Sbjct: 70  ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQERIVY 125

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAPEVLLGSTHYSTA 125
           RDLKP N+L+D     ++I+DLGL  A  +P  +     + T+ Y APEV + +  Y+ +
Sbjct: 126 RDLKPENILLDDHGH-IRISDLGL--AVHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFS 181

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            D W++ C+  E++       G S  QQ     R      E+V   V  +    EY +  
Sbjct: 182 PDWWALGCLLYEMIA------GQSPFQQ-----RKKKIKREEVERLVKEVQ--EEYSE-- 226

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
                        D   L + +L  DP +R+      A++  EHP F  ++  RL
Sbjct: 227 ---------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 8e-12
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 31/178 (17%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG 118
           H  GI++RD+K  N+L+D +   + + D GL++ F    K+ T+    T+ Y APE++ G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 119 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
              +  AVD WS+  +  EL+T  + F  + E      + R +     K  P   S    
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI----LKCDPPFPSF--- 233

Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
                            +  +  DLL ++L+ DP KR+      A +  EHP+F  LD
Sbjct: 234 -----------------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 20/168 (11%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +  EYM    +K  ++++    EN+     +    Q+ +GV++ H + I+HRD+K  N
Sbjct: 81  LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSYLHSNMIVHRDIKGAN 136

Query: 74  LLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           +L D     +K+ D G ++           IK  T    T ++ +PEV+ G   Y    D
Sbjct: 137 ILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMSPEVISGEG-YGRKAD 191

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP-GVSS 174
           +WSVAC   E++T+    P  +E + +  IF++   P + + P GVS 
Sbjct: 192 VWSVACTVVEMLTEK---PPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 67/210 (31%), Positives = 92/210 (43%), Gaps = 48/210 (22%)

Query: 55  GVAFCHGHG---ILHRDLKPHNLLMDRKTMTL---------------KIADLGLA---RA 93
           GVA  + H    ++H DLKP N+LM+     +               +I DLG     R 
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300

Query: 94  FTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
               I    H      YR+PEV+LG    YST  DMWS+ CI  EL T   L+     L+
Sbjct: 301 SRTAIVSTRH------YRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLE 352

Query: 153 QLLHIFRLLGT-PNEKVWPG------VSSLMN--WHEYPQWNPQSLAT-----AVPNLDK 198
            L  + + LG  P+E  W G         L N      P  +P+ LA       V  + +
Sbjct: 353 HLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410

Query: 199 DGL--DLLEQMLQYDPSKRISAKKAMEHPY 226
           D L  DL+  +L YD  KR++A++   HPY
Sbjct: 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 58/235 (24%)

Query: 15  LYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           LYLV EY       + L +Y   F +       +  +  + +L   +   H  G +HRD+
Sbjct: 76  LYLVMEYQPGGDLLSLLNRYEDQFDE-------DMAQFYLAELVLAIHSVHQMGYVHRDI 128

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFT--------LPIKKYTHEILTLWYRAPEVLL---- 117
           KP N+L+DR T  +K+AD G A   T        LP+        T  Y APEVL     
Sbjct: 129 KPENVLIDR-TGHIKLADFGSAARLTANKMVNSKLPVG-------TPDYIAPEVLTTMNG 180

Query: 118 -GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
            G   Y    D WS+  I  E++   + F   +  +                    +++M
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------------------NNIM 222

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           N+  + ++         P +  D LDL++ +L     +R+  +    HP+F  +D
Sbjct: 223 NFQRFLKF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 41/235 (17%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +  L LV   M+  DLK +I +    G     +  +++ Y  +LC G+       I++
Sbjct: 70  ETKDALCLVLTIMNGGDLKFHIYNMGNPG----FDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAPEVLLGSTHYSTA 125
           RDLKP N+L+D +   ++I+DLGL  A  +P  +     + T+ Y APEV + +  Y+ +
Sbjct: 126 RDLKPENILLDDRGH-IRISDLGL--AVQIPEGETVRGRVGTVGYMAPEV-INNEKYTFS 181

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            D W + C+  E++       G S  ++            E+V           E  +  
Sbjct: 182 PDWWGLGCLIYEMIQ------GQSPFRKR----------KERV--------KREEVDRRV 217

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
            +          +D   +   +L  +P +R+      A    +HP F +++  RL
Sbjct: 218 KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 39/218 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V EY      +D+ K I +   T E I       ++YQ  KG+ + H +  +HRD+K
Sbjct: 73  LWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIK 126

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L++ +    K+AD G++   T  + K    I T ++ APEV+    + + A D+WS
Sbjct: 127 AGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-DIWS 184

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     E+       P  S++  +  IF +                     P   P +L+
Sbjct: 185 LGITAIEMAE---GKPPYSDIHPMRAIFMI---------------------PNKPPPTLS 220

Query: 191 TAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              P     +  D +++ L  DP +R SA + ++HP+ 
Sbjct: 221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 14  VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +LY+V  + +  DL  Y +   Q G+ +P N V     Q+   + + H   ILHRDLK  
Sbjct: 74  LLYIVMGFCEGGDL--YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ 131

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+ + R T  +K+ DLG+AR         +  I T +Y +PE L  +  Y+   D+W++ 
Sbjct: 132 NVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALG 189

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           C   E+ T    F    ++  L  ++R++    E   P +                    
Sbjct: 190 CCVYEMATLKHAFNA-KDMNSL--VYRII----EGKLPPMPK------------------ 224

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
             +   +  +L+  ML   P KR S K  +  PY
Sbjct: 225 --DYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 32/213 (15%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           K G   L L+ EY+ +  L+ Y++  R   + I +  +     Q+CKG+ +      +HR
Sbjct: 77  KPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHR 133

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYS 123
           DL   N+L++     +KI+D GLA+        Y      E    WY APE L  S   S
Sbjct: 134 DLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSS 191

Query: 124 TAVDMWSVACIFAELVT----------KTALFPGDSELQ-QLLHIFRLLGTPNEKVWP-- 170
            A D+WS      EL T          +     G ++ Q  +  +  LL    E++    
Sbjct: 192 -ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL-KEGERLPRPP 249

Query: 171 ----GVSSLMN--WHEYPQWNPQSLATAVPNLD 197
                V  LM   W   PQ  P S A  +  +D
Sbjct: 250 SCPDEVYDLMKLCWEAEPQDRP-SFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.8 bits (150), Expect = 3e-11
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 29/180 (16%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           Q+  G+A+ H   I+HRD+KP NLL++     +KIAD G++R     +      + T+ Y
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAY 234

Query: 111 RAPEVL---LGSTHYS-TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
            +PE +   L    Y   A D+WS+               G S L+  L  F   G   +
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSL---------------GVSILEFYLGRFP-FGVGRQ 278

Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
             W   +SLM      Q  P++ ATA           +   LQ +P+KR SA + ++HP+
Sbjct: 279 GDW---ASLMCAICMSQ-PPEAPATASREFR----HFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 11/134 (8%)

Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL--MY----QLCKGVAFCHGHGILHRD 68
            +V E M   DLK Y+RS R   EN P     +L        ++  G+A+      +HRD
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRD 144

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           L   N ++    +T+KI D G+ R    T   +K    +L + + APE L     ++T  
Sbjct: 145 LAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKS 202

Query: 127 DMWSVACIFAELVT 140
           D+WS   +  E+ T
Sbjct: 203 DVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 55/229 (24%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           LY++ EY+   +L  Y+R+  +       +    L Y  ++   + + H   I++RDLKP
Sbjct: 76  LYMLMEYVPGGELFSYLRNSGR------FSNSTGLFYASEIVCALEYLHSKEIVYRDLKP 129

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW----YRAPEVLLGSTHYSTAVD 127
            N+L+D++   +K+ D G A       KK      TL     Y APEV + S  ++ AVD
Sbjct: 130 ENILLDKEGH-IKLTDFGFA-------KKLRDRTWTLCGTPEYLAPEV-IQSKGHNKAVD 180

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
            W++  +  E++     F  D        I+       EK+   ++  + +       P+
Sbjct: 181 WWALGILIYEMLVGYPPFFDD----NPFGIY-------EKI---LAGKLEF-------PR 219

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-----AMEHPYFDDLD 231
            L            DL++++L  D ++R+   K        H +F  +D
Sbjct: 220 HLDLYAK-------DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 15/181 (8%)

Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +++V EYM    L  Y+R  +          +  +   +C+ + +   +G +HRDL   N
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D GLAR + L   +YT    T +   +  PEV    + +S+  D+WS
Sbjct: 131 CLVG-EDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWS 186

Query: 131 VACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP-GVSSLMN--WHEYPQWNP 186
              +  E+ ++  + +   S  + +  +         K+ P  V ++M   WHE P+  P
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246

Query: 187 Q 187
            
Sbjct: 247 A 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 4e-11
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 51/227 (22%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y + E+ +  +L  ++R         P +  K    +L     + H   I++RDLKP N
Sbjct: 93  VYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPEN 148

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW----YRAPEVLLGSTHYSTAVDMW 129
           LL+D K   +K+ D G A       KK      TL     Y APEV+    H   AVD W
Sbjct: 149 LLLDNKG-HVKVTDFGFA-------KKVPDRTFTLCGTPEYLAPEVIQSKGH-GKAVDWW 199

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           ++  +  E +     F  D+        FR+     EK+  G        ++P W     
Sbjct: 200 TMGVLLYEFIAGYPPFFDDTP-------FRIY----EKILAGRL------KFPNW----- 237

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-----AMEHPYFDDLD 231
                  D    DL++ +LQ D +KR+   K        HPYF   +
Sbjct: 238 ------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278

Length = 329

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 9e-11
 Identities = 47/223 (21%), Positives = 94/223 (42%), Gaps = 43/223 (19%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+LV E       TDL   ++  R+ G+ +    +  ++ +  +G+A+ H + ++HRD+K
Sbjct: 84  LWLVMELCGGGSVTDL---VKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAV 126
             N+L+  K   +K+ D G++      + +    I T ++ APEV+         Y    
Sbjct: 141 GQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARS 199

Query: 127 DMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
           D+WS+       +T   L  G     ++  +  +F++   P     P + S  NW +   
Sbjct: 200 DVWSLG------ITAIELADGKPPLCDMHPMRALFKIPRNPP----PTLKSPENWSKKFN 249

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                             D + + L  +  +R   ++ +EHP+
Sbjct: 250 ------------------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 15/153 (9%)

Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           Y++ E M+   L  ++RS    G+ +PV ++  +  Q+ +G+A+      +HRDL   N+
Sbjct: 78  YIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L+       K+AD GLAR     +  Y     +I   W  APE       +ST  D+WS 
Sbjct: 136 LVGEDL-VCKVADFGLARLIKEDV--YLSSDKKIPYKW-TAPEA-ASHGTFSTKSDVWSF 190

Query: 132 ACIFAELVTKTAL-FPGDSE---LQQLLHIFRL 160
             +  E+ T   + +PG +      Q+   +R+
Sbjct: 191 GILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM 223

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 44/132 (33%), Positives = 67/132 (50%), Gaps = 8/132 (6%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +T L LV   M+  DLK +I +  + G  + +  V     Q+  G+   H   I++RD
Sbjct: 63  ESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           +KP N+L+D +    +++DLGL  A  L   K  T    T  Y APE+L     YS  VD
Sbjct: 121 MKPENVLLDDQG-NCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVD 176

Query: 128 MWSVACIFAELV 139
            +++ C   E+V
Sbjct: 177 WFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 19/163 (11%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +  E+M    +K  ++S+    EN+     +    Q+ +GV++ H + I+HRD+K  N
Sbjct: 81  LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSYLHSNMIVHRDIKGAN 136

Query: 74  LLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           +L D     +K+ D G ++           +K  T    T ++ +PEV+ G   Y    D
Sbjct: 137 ILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPYWMSPEVISGEG-YGRKAD 191

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
           +WSV C   E++T+    P  +E + +  IF++   P   V P
Sbjct: 192 IWSVGCTVVEMLTEK---PPWAEFEAMAAIFKIATQPTNPVLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 30/188 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++    G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 75  IYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAAN 132

Query: 74  LLMDRKTMTLKIADLGLARAF-----------TLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+  +T+  KIAD GLAR               PIK          + APE +   T +
Sbjct: 133 ILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIK----------WTAPEAINYGT-F 180

Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPG-VSSLMN--W 178
           +   D+WS   +  E+VT   + +PG +  + + ++ R    P     P  +  LM   W
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCW 240

Query: 179 HEYPQWNP 186
            E P+  P
Sbjct: 241 KEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 52/234 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V EY++  DL   I+  R+  E       +S  Y  ++   + F H HG+++RDLK 
Sbjct: 71  LFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHRHGVIYRDLKL 124

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L+D +    K+AD G+ +   L     T    T  Y APE+ L    Y  +VD W++
Sbjct: 125 DNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI-LQELEYGPSVDWWAL 182

Query: 132 ACIFAELVTKTALFPGDSE---LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
             +  E++     F  D+E    + +LH   L                    YP W    
Sbjct: 183 GVLMYEMMAGQPPFEADNEDDLFESILHDDVL--------------------YPVW---- 218

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISA-------KKAMEHPYFDDLDKTRL 235
                  L K+ + +L+  +  +P+KR+             +HP+F ++D   L
Sbjct: 219 -------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 48/139 (34%), Positives = 69/139 (49%), Gaps = 19/139 (13%)

Query: 11  GRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L LV EY+    L+ Y++  R+      ++  K L+Y  Q+CKG+ +      +HR
Sbjct: 78  GRRNLRLVMEYLPYGSLRDYLQKHRER-----LDHRKLLLYASQICKGMEYLGSKRYVHR 132

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YT----HEILTLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K  Y      E    WY APE L  S  
Sbjct: 133 DLATRNILVESENR-VKIGDFGLTK--VLPQDKEYYKVREPGESPIFWY-APESLTESK- 187

Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 188 FSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 3e-10
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 35/198 (17%)

Query: 43  NTVKSLMY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK 100
           +  ++  Y  +L   +   H   +++RDLKP N+L+D     + + D GL +       K
Sbjct: 91  DLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149

Query: 101 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
                 T  Y APE+LLG   Y+ AVD W++  +  E++T    F  D  + ++    ++
Sbjct: 150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYR--KI 205

Query: 161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           L  P    +P                          D+D  DLL  +L  DP++R+    
Sbjct: 206 LQEP--LRFPD-----------------------GFDRDAKDLLIGLLSRDPTRRLGYNG 240

Query: 221 AME---HPYFDDLDKTRL 235
           A E   HP+F  L   +L
Sbjct: 241 AQEIKNHPFFSQLSWKKL 258

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.6 bits (141), Expect = 3e-10
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 27/174 (15%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ AP
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EV+     Y   VD+WS+  +  E+V     +  ++ L+ L ++    GTP  +      
Sbjct: 185 EVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQ------ 236

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      NP+ L+           D L + L+ D  KR SAK+ ++HP+ 
Sbjct: 237 -----------NPEKLSPIFR-------DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 12/145 (8%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +  L LV   M+  DLK +I +    G        ++L Y  ++  G+   H    ++
Sbjct: 70  ETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLEDLHRENTVY 125

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAPEVLLGSTHYSTA 125
           RDLKP N+L+D     ++I+DLGL  A  +P  +     + T+ Y APEV L +  Y+ +
Sbjct: 126 RDLKPENILLDDYGH-IRISDLGL--AVKIPEGESIRGRVGTVGYMAPEV-LNNQRYTLS 181

Query: 126 VDMWSVACIFAELVTKTALFPGDSE 150
            D W + C+  E++   + F G  E
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.4 bits (141), Expect = 4e-10
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 45/230 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V E+++  DL  +I+  R+  E       ++  Y  ++   + F H  GI++RDLK 
Sbjct: 71  LFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEITSALMFLHDKGIIYRDLKL 124

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L+D +    K+AD G+ +      K  +    T  Y APE+ L    Y  +VD W++
Sbjct: 125 DNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEMLYGPSVDWWAM 182

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E++   A F  ++E      I       N++V            YP W       
Sbjct: 183 GVLLYEMLCGHAPFEAENEDDLFEAIL------NDEV-----------VYPTW------- 218

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTRL 235
               L +D +D+L+  +  +P+ R+ +      +  + HP+F +LD  +L
Sbjct: 219 ----LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 35/183 (19%)

Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D      +I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFS---KKKPHASVGTHGYMAP 164

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EVL   T Y ++ D +S+ C+  +L+       G S        FR   T ++     ++
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLR------GHSP-------FRQHKTKDKHEIDRMT 211

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFD 228
             +N  E P        +  P L      LLE +LQ D SKR+      A++  EH +F 
Sbjct: 212 LTVNV-ELPD-------SFSPELKS----LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259

Query: 229 DLD 231
            +D
Sbjct: 260 GID 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.6 bits (140), Expect = 6e-10
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 30/194 (15%)

Query: 35  QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 94
           +    +    VK ++ QL + +   H H I+H D+K  N+L DR    + + D GL +  
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 95  TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL 154
             P     ++  TL Y +PE + G  +Y  + D W+V  +  EL+T    F  D      
Sbjct: 161 GTP---SCYD-GTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKED------ 209

Query: 155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK 214
                     +E++   + SL    +  Q         + N+ K+  D ++ ML+Y+ + 
Sbjct: 210 ---------EDEEL--DLESL---LKRQQKKL----PFIKNVSKNANDFVQSMLKYNINY 251

Query: 215 R-ISAKKAMEHPYF 227
           R  +  + ++HP+ 
Sbjct: 252 RLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 6e-10
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 23/221 (10%)

Query: 8   NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
            ++G   + L+ E++ +  LK+Y+    +    I +        Q+CKG+ +      +H
Sbjct: 76  TEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSRQYVH 132

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHY 122
           RDL   N+L++ +   +KI D GL +A     + YT     +    WY APE L+ S  Y
Sbjct: 133 RDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFY 190

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
             A D+WS      EL+T       DSE   +    +++G  + ++   V+ L+   E  
Sbjct: 191 -IASDVWSFGVTLYELLTYC-----DSESSPMTLFLKMIGPTHGQM--TVTRLVRVLEEG 242

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
           +  P+      PN  ++   L+ +  ++ PSKR + +  +E
Sbjct: 243 KRLPRP-----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 32/179 (17%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG 118
           H  GI++RD+K  N+L+D     + + D GL++ F     +  +    T+ Y AP+++ G
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 119 -STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
               +  AVD WS+  +  EL+T  + F  D E      I R +             L +
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI-------------LKS 227

Query: 178 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
              YPQ            +     D+++++L  DP KR+      A +  +HP+F  ++
Sbjct: 228 EPPYPQ-----------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 7e-10
 Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 27/174 (15%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ AP
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EV+     Y   VD+WS+  +  E+V     +  ++ L+ L ++    GTP  +      
Sbjct: 185 EVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQ------ 236

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      NP+ L+           D L + L+ D  +R SAK+ ++HP+ 
Sbjct: 237 -----------NPERLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.4 bits (138), Expect = 7e-10
 Identities = 49/217 (22%), Positives = 97/217 (44%), Gaps = 39/217 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V E+++    TD+  + R   +    + ++ +++L Y         H  G++HRD+K
Sbjct: 94  LWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSY--------LHNQGVIHRDIK 145

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             ++L+      +K++D G     +  + K    + T ++ APEV +    Y T VD+WS
Sbjct: 146 SDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV-ISRLPYGTEVDIWS 203

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E++     +  +  LQ +  I   L  P  K    VSS++              
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR------------- 249

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                        L+ ML  +PS+R +A++ ++HP+ 
Sbjct: 250 -----------GFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 8e-10
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 27/232 (11%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+     TDL  Y+ + R    NI +  + ++   + + + + H + I+HRD+K  N+ +
Sbjct: 160 LILPRYKTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215

Query: 77  DRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           +     + + D G A  F + I   KY     T+   APE LL    Y  AVD+WS   +
Sbjct: 216 NHPG-DVCLGDFG-AACFPVDINANKYYGWAGTIATNAPE-LLARDPYGPAVDIWSAGIV 272

Query: 135 FAELVT-KTALFPG-------DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH------- 179
             E+ T   +LF         DS+ Q  L I R    PNE      ++L   +       
Sbjct: 273 LFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS 332

Query: 180 -EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              P   P  L T +  L  D   L+ +ML +D   R SA+  ++   F D+
Sbjct: 333 SRKPGSRP--LWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382

Length = 391

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 27/174 (15%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ AP
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EV+     Y   VD+WS+  +  E+V     +  ++ L+ L ++    GTP  +      
Sbjct: 185 EVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQ------ 236

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      NP+ L+           D L + L+ D  KR SAK+ ++HP+ 
Sbjct: 237 -----------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 1/85 (1%)

Query: 56  VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 115
           + + H  G++HRD+K  N+L+   T  +K+ D G+A        K +  + T ++ APEV
Sbjct: 114 LKYIHKVGVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172

Query: 116 LLGSTHYSTAVDMWSVACIFAELVT 140
           +    +Y T  D+WS+     E+ T
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 37/174 (21%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG 118
           H  GI++RDLKP N+L+D +   +K+ D GL +  ++     TH    T+ Y APE+L+ 
Sbjct: 117 HQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMR 174

Query: 119 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
           S H   AVD WS+  +  +++T    F  ++  + +           +K+  G  +L   
Sbjct: 175 SGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-----------DKILKGKLNL--- 219

Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
              P           P L  +  DLL+++L+ +PS R+      A +   HP+F
Sbjct: 220 ---P-----------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           + LYLV +YM   +L  ++    Q       +  K  + +L   +   H + I++RDLKP
Sbjct: 69  SDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKP 124

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+D  T  + + D GL++A  L   K T+    T  Y APEVLL    Y+  VD WS
Sbjct: 125 ENILLD-ATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E+    + F  + + QQ+   +R +     +    V S                
Sbjct: 183 LGVLVFEMCCGWSPFYAE-DTQQM---YRNIAFGKVRFPKNVLSD--------------- 223

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM----EHPYFDDLD 231
                   +G   ++ +L  +P  R+ A +      EHP+F D+D
Sbjct: 224 --------EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 53/234 (22%)

Query: 10  EGRTVLYLVFEYM-----DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 64
           E  + + +  EY      D+  KK  +   + GE +     +S++    KG+++ H   I
Sbjct: 71  ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL----KGLSYLHSRKI 126

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLG--------LARAFTLPIKKYTHEILTLWYRAPEVL 116
           +HRD+KP N+L+ RK   +K+ D G        LA  FT           T +Y APE +
Sbjct: 127 IHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSLAGTFT----------GTSFYMAPERI 175

Query: 117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ----QLLHIFRLLGTPNEKVWPGV 172
            G   YS   D+WS+     E+      FP + E      +LL     +  P  K  PG 
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
              + W E  +                  D ++Q L+ DP++R +    +EHP+
Sbjct: 235 G--IKWSEEFK------------------DFIKQCLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 42/233 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           + +T L LV   M+  DL+ +I +  +  EN      ++  Y  Q+  G+   H   I++
Sbjct: 63  QTKTDLCLVMTIMNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+L+D     ++I+DLGLA        K      T  + APE+L G   Y  +V
Sbjct: 121 RDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSV 178

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D +++     E++   A  P           FR  G   EKV           E  +   
Sbjct: 179 DYFALGVTLYEMI--AARGP-----------FRARG---EKV-----------ENKELKQ 211

Query: 187 QSLATAVPNLDK---DGLDLLEQMLQYDPSKRISAK-----KAMEHPYFDDLD 231
           + L  +V   DK         E +L  DP KR+  +         HP F DL+
Sbjct: 212 RILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHRDLKP 71
           L L+ EY    DL K I+  ++  E++P     V  L YQ+   +   H   ++HRDLK 
Sbjct: 140 LLLIMEYGSGGDLNKQIK--QRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 72  HNLLMDRKTMTLKIADLGLARAFT--LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
            N+ +   T  +K+ D G ++ ++  + +   +    T +Y APE L     YS   DMW
Sbjct: 198 ANIFL-MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMW 255

Query: 130 SVACIFAELVTKTALFPGDSE---LQQLLH 156
           S+  I  EL+T    F G S+   +QQ+L+
Sbjct: 256 SLGVILYELLTLHRPFKGPSQREIMQQVLY 285

Length = 478

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 11/221 (4%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIP-VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           Y++ +  D DL  ++       ++ P +   +++M QL   V + H   ++HRD+K  N+
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHE-ILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
            ++     + + D G A  F    + + +  + T+   +PE+L G   Y    D+WS   
Sbjct: 299 FLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGL 356

Query: 134 IFAELVTKTALFPGD---SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN--PQS 188
           I  ++++      GD      +QLL I   L   +E+       L ++ +  + +    S
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHS 416

Query: 189 LATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   + N  L  D    L +ML +D   R  A + +  P F
Sbjct: 417 VPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457

Length = 501

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 30/194 (15%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q+ + + + H   I+HRDLK  N+L+      +K+AD G++      +++    
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSF 170

Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
           I T ++ APEV++  T     Y    D+WS+     E+     + P   EL  +    R+
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPM----RV 223

Query: 161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           L    +   P +S    W    ++                 D L+  L   P  R SA +
Sbjct: 224 LLKIAKSEPPTLSQPSKWS--MEFR----------------DFLKTALDKHPETRPSAAQ 265

Query: 221 AMEHPYFDDLDKTR 234
            +EHP+   +   R
Sbjct: 266 LLEHPFVSSVTSNR 279

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 37/197 (18%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           VK  + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK    
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSF 158

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGT 163
             T+ Y APEV+    H + + D WS   +  E++T +  F G    + +  I +  LG 
Sbjct: 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217

Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----- 218
           P                               L  +   LL  + + +P+ R+ A     
Sbjct: 218 PQ-----------------------------FLSPEAQSLLRALFKRNPANRLGAGPDGV 248

Query: 219 KKAMEHPYFDDLDKTRL 235
           ++   HP+F  +D  +L
Sbjct: 249 EEIKRHPFFSTIDWNKL 265

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 29/182 (15%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    
Sbjct: 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTF 161

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P +S++  +  +F +    
Sbjct: 162 VGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI---- 213

Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L        K   + ++  L  DPS R +AK+ ++H
Sbjct: 214 -----------------PKNNPPTL---TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253

Query: 225 PY 226
            +
Sbjct: 254 KF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 3e-09
 Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 13/139 (9%)

Query: 8   NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
           +++G   L L+ EY+    L+ Y+         + +  +     Q+C+G+A+ H    +H
Sbjct: 76  SEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIH 130

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTHY 122
           RDL   N+L+D   + +KI D GLA+A     + Y      +    WY A E  L    +
Sbjct: 131 RDLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC-LKENKF 187

Query: 123 STAVDMWSVACIFAELVTK 141
           S A D+WS      EL+T 
Sbjct: 188 SYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 4e-09
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK------------SLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G +   +T K            S  YQ+ +G+ +   
Sbjct: 93  LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 153 QKCIHRDLAARNVLVTEDNV-MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211

Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 212 V-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTHELY 266

Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK--------DGLDLLEQMLQYDPS 213
            +M   WH  P   P +    V +LD+        + LDL     QY P 
Sbjct: 267 MIMRECWHAVPSQRP-TFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.0 bits (135), Expect = 4e-09
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L+ VFEY+     + +R        +P      LM Q+   +A  H  GI+HRDLKP N+
Sbjct: 54  LFAVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 75  LMDRKTMT--LKIADLGL------ARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTA 125
           ++ +  +    K+ D G+       R   +     T E+L T  Y APE L G    +  
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPN 169

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
            D+++   IF E +T   +  G S + ++L  ++ L 
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQGAS-VAEIL--YQQLS 203

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 55.1 bits (132), Expect = 5e-09
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 29/182 (15%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    
Sbjct: 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTF 161

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +    
Sbjct: 162 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI---- 213

Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H
Sbjct: 214 -----------------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253

Query: 225 PY 226
            +
Sbjct: 254 KF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 54.7 bits (131), Expect = 6e-09
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 19/171 (11%)

Query: 11  GRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
               L +  EYM    +K  ++++    E++     +    Q+ +G+++ H + I+HRD+
Sbjct: 77  AEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSYLHSNMIVHRDI 132

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           K  N+L D     +K+ D G ++           I+  T    T ++ +PEV+ G   Y 
Sbjct: 133 KGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYWMSPEVISGEG-YG 187

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 174
              D+WS+ C   E++T+    P  +E + +  IF++   P     P   S
Sbjct: 188 RKADVWSLGCTVVEMLTEK---PPWAEYEAMAAIFKIATQPTNPQLPSHIS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.5 bits (131), Expect = 7e-09
 Identities = 48/224 (21%), Positives = 88/224 (39%), Gaps = 45/224 (20%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPHN 73
           +Y+  EYMD      + +     E IP + ++ + Y + KG+ F    H I+HRD+KP N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST-----HYSTAVDM 128
           +L++     +K+ D G++      + K    I    Y APE +          Y+   D+
Sbjct: 134 VLVNGNG-QVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDV 190

Query: 129 WSVACIFAELVTKTALFPGD------SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
           WS+     E+      +P +      ++L  ++      G P     P +          
Sbjct: 191 WSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-----GDP-----PTLP--------- 231

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                           D  D + + L   P++R +  + +EHP+
Sbjct: 232 -----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 54.2 bits (130), Expect = 7e-09
 Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)

Query: 12  RTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           R+ + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVD 127
             N L+    + +K++D G+ R F L   +YT    T +   + +PEV   S  YS+  D
Sbjct: 128 ARNCLVGENQV-VKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSD 183

Query: 128 MWSVACIFAELVTK 141
           +WS   +  E+ ++
Sbjct: 184 VWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 8e-09
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 17/141 (12%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 96  LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 156 QKCIHRDLAARNVLVTENNV-MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214

Query: 120 THYSTAVDMWSVACIFAELVT 140
             Y+   D+WS   +  E+ T
Sbjct: 215 V-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 27/174 (15%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +      
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ------ 237

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      NP+ L+           D L + L  D  KR SAK+ ++H + 
Sbjct: 238 -----------NPEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 54.2 bits (130), Expect = 8e-09
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 99  LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 159 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217

Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 218 I-YTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPSNCTNELY 272

Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 273 MMMRDCWHAVPSQRP-TFKQLVEDLDR 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 54.1 bits (130), Expect = 9e-09
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 3/100 (3%)

Query: 43  NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 102
            T+     Q+ +G+ + H + I+HRD+K  N+L++  +  +KI+D G ++     I   T
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCT 166

Query: 103 HEIL-TLWYRAPEVL-LGSTHYSTAVDMWSVACIFAELVT 140
                TL Y APEV+  G   Y    D+WS+ C   E+ T
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 26/139 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++S    G+ + +  +  +  Q+ +G+A+      +HRDL   N
Sbjct: 76  IYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARN 133

Query: 74  LLMDRKTMTLKIADLGLARAF-----------TLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+  + +  KIAD GLAR               PIK         W  APE       +
Sbjct: 134 ILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIK---------W-TAPEAANYGR-F 181

Query: 123 STAVDMWSVACIFAELVTK 141
           +   D+WS   +  E+VT 
Sbjct: 182 TIKSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 26/193 (13%)

Query: 40  IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK 99
           IP + +  +   + KG+ +     ILHRD+KP N+L++ +   +K+ D G++      I 
Sbjct: 92  IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIA 150

Query: 100 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
           K T+ + T  Y APE + G   Y    D+WS+   F EL      +P   + Q  L   +
Sbjct: 151 K-TY-VGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ 207

Query: 160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
           LL                  E P   P      V    +  +  + Q ++  P +R + +
Sbjct: 208 LLQCI-------------VDEDPPVLP------VGQFSEKFVHFITQCMRKQPKERPAPE 248

Query: 220 KAMEHPY---FDD 229
             M+HP+   ++D
Sbjct: 249 NLMDHPFIVQYND 261

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 51/240 (21%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 20  EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMD 77
           E+MD   L + ++   +    IP N +  +   + +G+ +    H I+HRD+KP N+L++
Sbjct: 79  EHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134

Query: 78  RKTMTLKIADLG--------LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
            +   +K+ D G        +A +F          + T  Y +PE L G THY+   D+W
Sbjct: 135 SRG-EIKLCDFGVSGQLIDSMANSF----------VGTRSYMSPERLQG-THYTVQSDIW 182

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           S+     E+       P     ++L  +F               S      +P  +P+ +
Sbjct: 183 SLGLSLVEMAIGRYPIPPPDA-KELEAMF----GRPVSEGEAKESHRPVSGHPPDSPRPM 237

Query: 190 A----------TAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           A             P L          D +++ L+ +P +R   K+  +HP+    +   
Sbjct: 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 11/130 (8%)

Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  Y+R     G+    + +  +   +C+G+A+      +HRDL   N
Sbjct: 74  IYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+D +   +K++D GL+R + L   +YT  + + +   +  PEVLL S  +S+  D+W+
Sbjct: 131 CLVDDQ-GCVKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWA 186

Query: 131 VACIFAELVT 140
              +  E+ +
Sbjct: 187 FGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 23/189 (12%)

Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM---YQLCKGVAFCHGHGILHRDLKP 71
           Y++ E M+  DL  Y+R  R      P+ T+K L+     + KG  +      +HRDL  
Sbjct: 75  YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAA 134

Query: 72  HNLLMDRKTM----TLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTA 125
            N L+  K       +KI D GLAR        +K    +L + + APE LL    ++T 
Sbjct: 135 RNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQ 193

Query: 126 VDMWSVACIFAELVT-KTALFPGDSELQQLLHIF---RLLGTPN--EKVWPGVSSLMN-- 177
            D+WS   +  E++T     +P  +  + L H+    RL    N  +K++     LM   
Sbjct: 194 SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY----QLMTNC 249

Query: 178 WHEYPQWNP 186
           W + P   P
Sbjct: 250 WAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 16/135 (11%)

Query: 17  LVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLM---YQLCKGVAFCHGHGILHRDLKPH 72
           +V  YM   DL+ +IRS      + P  TVK L+    Q+ KG+ +      +HRDL   
Sbjct: 74  VVLPYMKHGDLRNFIRS----ETHNP--TVKDLIGFGLQVAKGMEYLASKKFVHRDLAAR 127

Query: 73  NLLMDRKTMTLKIADLGLARAFT----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           N ++D ++ T+K+AD GLAR         +  +T   L + + A E L     ++T  D+
Sbjct: 128 NCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDV 185

Query: 129 WSVACIFAELVTKTA 143
           WS   +  EL+T+ A
Sbjct: 186 WSFGVLLWELMTRGA 200

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 49/213 (23%), Positives = 76/213 (35%), Gaps = 68/213 (31%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----TLPIKKYTH----------- 103
           H  G +HRD+KP NLL+D K   +K++D GL         T   +  +H           
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 104 ------EILTLW----------------YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 141
                      W                Y APEV L  T Y+   D WS+  I  E++  
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVG 235

Query: 142 TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL 201
              F  D+  +    I                  +NW E  Q+ P  +      L  +  
Sbjct: 236 YPPFCSDNPQETYRKI------------------INWKETLQF-PDEV-----PLSPEAK 271

Query: 202 DLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
           DL++++   +  +R+      E   HP+F  +D
Sbjct: 272 DLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 10/143 (6%)

Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 76  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL 135

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N  M  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 136 NANKFVHRDLAARN-CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194

Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 195 DGV-FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.9 bits (127), Expect = 3e-08
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 44/229 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           LY V EY++  DL  +I+   +  E   V       Y  ++  G+ F H  GI++RDLK 
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKL 129

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+++D +   +KIAD G+ +      K       T  Y APE++     Y  +VD W+ 
Sbjct: 130 DNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAF 187

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E++     F G+ E  +L                   S+M   E+    P+SL+ 
Sbjct: 188 GVLLYEMLAGQPPFDGEDE-DELF-----------------QSIM---EHNVSYPKSLS- 225

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTRL 235
                 K+ + + + +L   P+KR+       +   EH +F  +D  +L
Sbjct: 226 ------KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 32/208 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGE----NIPVN-----TVKSLM---YQLCKGVAFCHG 61
           LY+V EY    +L+ ++R+ R  GE    + P       T K L+   YQ+ +G+ F   
Sbjct: 91  LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        +K T+  L + + APE L   
Sbjct: 151 KKCIHRDLAARNVLVTEDHV-MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-D 208

Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDS--ELQQLL----HIFRLLGTPNEKVWPGV 172
             Y+   D+WS   +  E+ T   + +PG    EL +LL     + +      E     +
Sbjct: 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQE-----L 263

Query: 173 SSLMN--WHEYPQWNPQSLATAVPNLDK 198
             LM   WHE P   P +    V +LD+
Sbjct: 264 YHLMRDCWHEVPSQRP-TFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 41/217 (18%)

Query: 20  EYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDR 78
           E MDT L K+ +     G  IP + +  +   + K + + H    ++HRD+KP N+L++R
Sbjct: 80  EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR 139

Query: 79  KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIF 135
               +K+ D G++      + K T +     Y APE +        Y    D+WS+    
Sbjct: 140 NG-QVKLCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 136 AELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN 195
            EL T    FP D                            +W    Q   Q +    P 
Sbjct: 198 IELATGR--FPYD----------------------------SWKTPFQQLKQVVEEPSPQ 227

Query: 196 LDKDGL-----DLLEQMLQYDPSKRISAKKAMEHPYF 227
           L  +       D + + L+ +  +R +  + ++HP+F
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 33/147 (22%)

Query: 15  LYLVFEYMDT-DLKKY-----IRSFRQTGENIPVNTVKSLMY---QLCKGVAFCHGHGIL 65
           L ++ EYM+  DL ++     I S      NIP  ++ +L+Y   Q+  G+ +      +
Sbjct: 92  LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV 151

Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEILTLWYRAP 113
           HRDL   N L+     T+KIAD G++R               LPI+         W    
Sbjct: 152 HRDLATRNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---------WMAWE 201

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVT 140
            +LLG   ++TA D+W+      E+ T
Sbjct: 202 SILLGK--FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+LV EY++  DL  +++  R+    +P    +    ++C  + F H  GI++RDLK  N
Sbjct: 71  LFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D     +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 127 VLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGV 184

Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 185 LMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 11/140 (7%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    +    ++   +   H  G +HRD+KP N
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 74  LLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K+  LK+AD G         + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 173 MLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 232 SVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 51.4 bits (123), Expect = 7e-08
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EIL--- 106
           Q+  GVA+ H + ++HRD+K +N+++      +K+ D G AR         TH  +L   
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 107 --TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
             T ++ APEV +  + Y    D+WS+ C   E+ T
Sbjct: 169 HGTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMAT 203

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 7e-08
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V E M    L +Y++     G  + +  +  +  Q+  G+A+      +HRDL   N
Sbjct: 76  IYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN 133

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI-LTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +L+  +    K+AD GLAR     I +        + + APE  L    +S   D+WS  
Sbjct: 134 VLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFG 191

Query: 133 CIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
            +  E+VT   + +PG +    LQQ+   +R+   P 
Sbjct: 192 ILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.4 bits (123), Expect = 9e-08
 Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 37/180 (20%)

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 117
           + H   +++RDLK  NL++D K   +KI D GL +              T  Y APEV L
Sbjct: 110 YLHSCDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-L 167

Query: 118 GSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
               Y  AVD W +  +  E++  +   +  D E      +F L+             LM
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELI-------------LM 209

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
               +P+            L  +   LL  +L+ DP +R+      AK+ MEH +F  ++
Sbjct: 210 EEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 11/140 (7%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    K    ++   +   H  G++HRD+KP N
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 172

Query: 74  LLMDRKTMTLKIADLGLARAF-TLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K   LK+AD G         + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 173 MLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 232 SVGVFLFEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 45/217 (20%), Positives = 93/217 (42%), Gaps = 39/217 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V E+++    TD+  + R   +    + +  +K+L        +  H  G++HRD+K
Sbjct: 92  LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKAL--------SVLHAQGVIHRDIK 143

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             ++L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS
Sbjct: 144 SDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWS 201

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E+V     +  +  L+ +  I   L  P  K    VS  +              
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKVSPSLK------------- 247

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                        L+++L  DP++R +A + ++HP+ 
Sbjct: 248 -----------GFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 41/228 (17%)

Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           + LYLV E++   +     +F +  +  P +       Q+     +     I++RDLKP 
Sbjct: 104 SYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+D+    +K+ D G A+   +  + YT    T  Y APE+LL   H   A D W++ 
Sbjct: 161 NLLLDKDGF-IKMTDFGFAK--VVDTRTYTL-CGTPEYIAPEILLNVGH-GKAADWWTLG 215

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
               E++     F  +  L  L++         +K+  G+        +P++        
Sbjct: 216 IFIYEILVGCPPFYANEPL--LIY---------QKILEGIIY------FPKF-------- 250

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
              LD +   L++++L +D +KR       A+   EHP+F ++D   L
Sbjct: 251 ---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 9/136 (6%)

Query: 16  YLVFEYMD-TDLKKYIRSFRQTGENI---PVNTVK--SLMYQLCKGVAFCHGHGILHRDL 69
           Y++ EY D  DLK+++R+ +   E +   P++T +  +L  Q+  G+        +HRDL
Sbjct: 84  YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143

Query: 70  KPHNLLMDRKTMTLKIADLGLAR-AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
              N L+      +K++ L L++  +     K  + ++ L + APE +     +ST  D+
Sbjct: 144 AARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDV 201

Query: 129 WSVACIFAELVTKTAL 144
           WS   +  E+ T+  L
Sbjct: 202 WSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 29/225 (12%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK------------SLMYQLCKGVAFCHG 61
           LY++ EY    +L++++R+ R  G +   +  K            S  YQ+ +G+ +   
Sbjct: 93  LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK ++  L + + APE L   
Sbjct: 153 RRCIHRDLAARNVLVTEDNV-MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211

Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+      +  LM
Sbjct: 212 V-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHE-LYMLM 269

Query: 177 N--WHEYPQWNP------QSLATAVPNLDKDGLDLLEQMLQYDPS 213
              WH  P   P      ++L   +  + ++ LDL     QY PS
Sbjct: 270 RECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 21/147 (14%)

Query: 20  EYMDTDLKK-YIRSFRQTGENIP--------VNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           E MD  L K Y   +      IP        V TVK+L Y             I+HRD+K
Sbjct: 83  ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY-------LKEELKIIHRDVK 135

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDM 128
           P N+L+DR    +K+ D G++      I K T +     Y APE +  S    Y    D+
Sbjct: 136 PSNILLDRNG-NIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDV 193

Query: 129 WSVACIFAELVTKTALFPG-DSELQQL 154
           WS+     E+ T    +P  +S   QL
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 32/178 (17%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           KG+A+ H  G +HRD+K  N+L+      +K+AD G++   T  I K    I T ++ AP
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170

Query: 114 EVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQL---LHIFRLLGTPNEKV 168
           EV        Y    D+W++     EL          +ELQ     LH  R L       
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIEL----------AELQPPMFDLHPMRAL------- 213

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                 L++   +P   P  L            D +++ L  DP KR +A K ++HP+
Sbjct: 214 -----FLISKSNFP---PPKL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 32/225 (14%)

Query: 4   KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           K  +N E   ++ LV +Y +  DL++ I+S  +T      +    L  Q+   V   H  
Sbjct: 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGST 120
            ++HRD+K  N+L+    + +K+ D G ++ +   +          T +Y APE+     
Sbjct: 163 HMIHRDIKSANILLCSNGL-VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RK 220

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            YS   DM+S+  +  EL+T    F G++ +++++H          K   G         
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMH----------KTLAG--------- 260

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
             +++P       P++  +  +++  +L  DP +R S+ K +  P
Sbjct: 261 --RYDPLP-----PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           +  +Y++ E+M    L  +++S    G   P+  +     Q+ +G+AF      +HRDL+
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVL-LGSTHYSTAV 126
             N+L+   ++  KIAD GLAR   +   +YT        + + APE +  GS  ++   
Sbjct: 130 AANILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 184

Query: 127 DMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRL 160
           D+WS   +  E+VT   + +PG S    ++ L   +R+
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 222

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 53/223 (23%), Positives = 75/223 (33%), Gaps = 83/223 (37%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---------------- 103
           H  G +HRD+KP N+L+DR    +K+ D GL   F     ++TH                
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF-----RWTHDSKYYQKGDHHRQDSM 171

Query: 104 EILTLW--------------------------------YRAPEVLLGSTHYSTAVDMWSV 131
           E    W                                Y APEVLL  T Y+   D WSV
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSV 230

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             I  E++     F  D              TP E        ++NW        Q+   
Sbjct: 231 GVILYEMLVGQPPFLAD--------------TPAETQL----KVINWETTLHIPSQA--- 269

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
               L ++  DL+ ++       R+    A E   HP+F  +D
Sbjct: 270 ---KLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGID 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 75  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 132

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 133 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 188

Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 189 FGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 16/181 (8%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN--IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +Y+V E+M    K  +  F + G+   + +  +  +  Q+  G+A+      +HRDL+  
Sbjct: 75  IYIVTEFMG---KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMW 129
           N+L+    +  KIAD GLAR   +   +YT        + + APE  L    ++   D+W
Sbjct: 132 NILVG-DNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVW 187

Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP-GVSSLMN--WHEYPQWN 185
           S   +  ELVTK  + +PG    + L  + R    P  +  P  +  LM   W + P   
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247

Query: 186 P 186
           P
Sbjct: 248 P 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 28/127 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM---YQLCKGVAFCHGHGILHRDLK 70
           LY+V EYM    L  Y+RS         V T+   +     +C+G+ +      +HRDL 
Sbjct: 75  LYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129

Query: 71  PHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTHYS 123
             N+L+    +  K++D GLA+  +       LP+K          + APE L     +S
Sbjct: 130 ARNVLVSEDLVA-KVSDFGLAKEASQGQDSGKLPVK----------WTAPEALREKK-FS 177

Query: 124 TAVDMWS 130
           T  D+WS
Sbjct: 178 TKSDVWS 184

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)

Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 90  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 141

Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-V 139
            +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+     E+ +
Sbjct: 142 EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAI 197

Query: 140 TKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
            +  + P D++  +L+    + G P E    
Sbjct: 198 GRYPIPPPDAKELELMFGCPVEGDPAESETS 228

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 29/182 (15%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTF 161

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y    D+WS+     EL       P +S+L  +  +F +    
Sbjct: 162 VGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLFLI---- 213

Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ +P +L        K   + +E  L  DP  R +AK+ ++H
Sbjct: 214 -----------------PKNSPPTLEG---QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253

Query: 225 PY 226
            +
Sbjct: 254 KF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 19/164 (11%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM    L  +++S    G  + +  +     Q+ +G+A+      +HRDL+  N
Sbjct: 76  IYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN 133

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVL-LGSTHYSTAVDMW 129
           +L+    M  KIAD GLAR   +   +YT        + + APE +  GS  ++   D+W
Sbjct: 134 VLVSESLMC-KIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVW 188

Query: 130 SVACIFAELVTKTAL-FPGDSE------LQQLLHIFRLLGTPNE 166
           S   +  E+VT   + +PG S       LQ+   + R+   P+E
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 29/151 (19%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTG--------------------ENIPVNTVKSLMYQLC 53
           L L+ EY     L+ ++R  R+ G                      + +  + S  +Q+ 
Sbjct: 78  LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137

Query: 54  KGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAF---TLPIKKYTHEILTLW 109
           +G+ +     ++HRDL   N+L+ + + M  KI+D GL+R        +K+    I   W
Sbjct: 138 RGMQYLAEMKLVHRDLAARNVLVAEGRKM--KISDFGLSRDVYEEDSYVKRSKGRIPVKW 195

Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
             A E L     Y+T  D+WS   +  E+VT
Sbjct: 196 M-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 39/178 (21%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           +G+A+ H H  +HRD+K  N+L+     T+K+AD G A +   P   +   + T ++ AP
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSA-SLVSPANSF---VGTPYWMAP 180

Query: 114 EVLLG--STHYSTAVDMWS--VACI-FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
           EV+L      Y   VD+WS  + CI  AE   K  LF  ++ +  L HI +     N+  
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLFNMNA-MSALYHIAQ-----NDS- 231

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            P +SS  +W +Y                    + ++  LQ  P  R S+++ ++H +
Sbjct: 232 -PTLSS-NDWSDY------------------FRNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 15/146 (10%)

Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPHNL 74
           +  E+MD   L + ++  ++    IP   +  +   + +G+A+    H I+HRD+KP N+
Sbjct: 80  ICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L++ +   +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+  
Sbjct: 136 LVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGL 190

Query: 134 IFAEL-VTKTALFPGDSELQQLLHIF 158
              EL + +  + P D+  ++L  IF
Sbjct: 191 SLVELAIGRYPIPPPDA--KELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 29/140 (20%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + ++ EY    DL  ++R  R++   + +  + S  YQ+ KG+AF      +HRDL   N
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171

Query: 74  LLMDRKTMTLKIADLGLAR-------------AFTLPIKKYTHEILTLWYRAPEVLLGST 120
           +L+    +  KI D GLAR             A  LP+K          + APE +    
Sbjct: 172 VLLTHGKIV-KICDFGLARDIMNDSNYVVKGNAR-LPVK----------WMAPESIFNCV 219

Query: 121 HYSTAVDMWSVACIFAELVT 140
            Y+   D+WS   +  E+ +
Sbjct: 220 -YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 49.3 bits (117), Expect = 5e-07
 Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 7/115 (6%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++ +   +G+A+ H H ++HRD+K  N+L+      +K+AD G A +   P   +   
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSA-SIASPANSF--- 181

Query: 105 ILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 157
           + T ++ APEV+L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 5e-07
 Identities = 59/257 (22%), Positives = 95/257 (36%), Gaps = 72/257 (28%)

Query: 13  TVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           T L LV +Y    +L + ++  RQ G+ +     +    ++   + + H  GI++RDLKP
Sbjct: 74  TYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKP 131

Query: 72  HNLLM------------------DRKTMTLKIADLGLARAFTLPIKKY------------ 101
            N+L+                         K    G  R+    I               
Sbjct: 132 ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNS 191

Query: 102 ---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 158
              T E     Y APEV+ G  H  +AVD W++  +  E++  T  F G +  +   +I 
Sbjct: 192 FVGTEE-----YIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI- 244

Query: 159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-S 217
            L                    +P   P S             DL+ ++L  DPSKR+ S
Sbjct: 245 -LKKEVT---------------FPGSPPVS---------SSARDLIRKLLVKDPSKRLGS 279

Query: 218 AKKAME---HPYFDDLD 231
            + A E   HP+F  ++
Sbjct: 280 KRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 6e-07
 Identities = 34/132 (25%), Positives = 62/132 (46%), Gaps = 28/132 (21%)

Query: 25  DLKKYIRSFRQTGENIP--VNT--VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT 80
           +LK +++  R    N P  ++T  +  +  Q+  G+++ H  G++H+D+   N ++D + 
Sbjct: 95  NLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID-EE 153

Query: 81  MTLKIADLGLARAF------------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           + +KI D  L+R                P+K         W  A E L+    YS+A D+
Sbjct: 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVK---------WM-ALESLVNK-EYSSASDV 202

Query: 129 WSVACIFAELVT 140
           WS   +  EL+T
Sbjct: 203 WSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 13/151 (8%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGE--NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +Y+V EYM    K  +  F + GE   + +  +  +  Q+  G+A+      +HRDL+  
Sbjct: 75  IYIVTEYMS---KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA 131

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMW 129
           N+L+    +  KIAD GLAR   +   +YT        + + APE  L    ++   D+W
Sbjct: 132 NILVG-DGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVW 187

Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHIFR 159
           S   +  ELVTK  + +PG +  + L  + R
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 11/133 (8%)

Query: 17  LVFEYM-DTDLKKYIRSFRQTGEN---IPVNTVKSLMY---QLCKGVAFCHGHGILHRDL 69
           +V E M   DLK Y+RS R   EN    P  T++ ++    ++  G+A+ +    +HRDL
Sbjct: 86  VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145

Query: 70  KPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
              N  M     T+KI D G+ R    T   +K    +L + + APE L     ++T+ D
Sbjct: 146 AARN-CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSD 203

Query: 128 MWSVACIFAELVT 140
           MWS   +  E+ +
Sbjct: 204 MWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 5/96 (5%)

Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 97
           + I V+ V  LM+Q+  G+ +  G   +HRDL   N+L+  +    KI+D GL++A    
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA-KISDFGLSKALGAD 148

Query: 98  IKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
              Y       W   + APE +     +S+  D+WS
Sbjct: 149 DSYYKARSAGKWPLKWYAPECIN-FRKFSSRSDVWS 183

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 37/187 (19%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   I++RDLK  NL++D K   +KI D GL +              T  Y
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161

Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 162 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------- 207

Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEH 224
                LM   ++P+            L  D   LL  +L  DP+KR+      AK+ M H
Sbjct: 208 -----LMEDIKFPR-----------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251

Query: 225 PYFDDLD 231
            +F  ++
Sbjct: 252 SFFTGVN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 8e-07
 Identities = 32/128 (25%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           ++ EYM+   L K++R     G+      V  ++  +  G+ +      +HRDL   N+L
Sbjct: 82  IITEYMENGSLDKFLR--ENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNIL 138

Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           ++   +  K++D GL+R        YT    +I   W  APE  +    +++A D+WS  
Sbjct: 139 VNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA-IAYRKFTSASDVWSFG 195

Query: 133 CIFAELVT 140
            +  E+++
Sbjct: 196 IVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 11/140 (7%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     +IP    +    ++   +   H  G +HRD+KP N
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 74  LLMDRKTMTLKIADLGLA-RAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K+  LK+AD G   +     + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 173 MLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 232 SVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 36/188 (19%)

Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +      +HRDL   N 
Sbjct: 78  YIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135

Query: 75  LMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           L+    + +K+AD GL+R  T            PIK          + APE L  +  +S
Sbjct: 136 LVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK----------WTAPESLAYNK-FS 183

Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI----FRLLGTPNEKVWPGVSSLMNW 178
              D+W+   +  E+ T   + +PG  +L Q+  +    +R+         P V  LM  
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRMERPEG--CPPKVYELM-- 238

Query: 179 HEYPQWNP 186
               QWNP
Sbjct: 239 RACWQWNP 246

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 7/115 (6%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++ +   +G+A+ H H ++HRD+K  N+L+      +K+AD G A   + P   +   
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASKSS-PANSF--- 177

Query: 105 ILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 157
           + T ++ APEV+L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 26/175 (14%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           +G+ + H  G +HRD+K  N+L+      +K+AD G++   T  I K    I T ++ AP
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAP 175

Query: 114 EVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 171
           EV        Y+   D+W+V     EL     L P   +L  +  +F  L T +    P 
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL---AELQPPMFDLHPMRALF--LMTKSNFQPPK 230

Query: 172 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           +   M W                         ++  L  +P KR +A+K ++HP+
Sbjct: 231 LKDKMKW------------------SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 27/219 (12%)

Query: 25  DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK 84
           DL  Y+         +P+    ++  +L + +A+ HG GI+HRD+K  N+ +D     + 
Sbjct: 171 DLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV- 225

Query: 85  IADLGLARAFTLPIKKYTHEIL----TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
           + D G A          T +      TL   +PE LL    Y    D+WS   +  E+  
Sbjct: 226 LGDFGAACKLDAHP--DTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 141 KTALFPG---DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN---------PQS 188
           K     G    S   QL  I R +   +   +P   S      + Q+          P  
Sbjct: 283 KNVTLFGKQVKSSSSQLRSIIRCMQV-HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV 341

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +     ++D +   L+ +ML +D   R SA+  +  P F
Sbjct: 342 IRKYGMHMDVEY--LIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 46/230 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           LY V EY++  DL  +I+   +  E       +++ Y  ++  G+ F H  GI++RDLK 
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEP------QAVFYAAEISVGLFFLHRRGIIYRDLKL 129

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+++D +   +KIAD G+ +   +          T  Y APE+ +    Y  +VD W+ 
Sbjct: 130 DNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI-IAYQPYGKSVDWWAY 187

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLA 190
             +  E++     F G+ E +    +F+              S+M  +  YP+       
Sbjct: 188 GVLLYEMLAGQPPFDGEDEDE----LFQ--------------SIMEHNVSYPK------- 222

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTRL 235
               +L K+ + + + ++   PSKR+       +   EH +F  +D  +L
Sbjct: 223 ----SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 46/199 (23%), Positives = 72/199 (36%), Gaps = 38/199 (19%)

Query: 40  IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK 99
           + V  VK+L Y   K       HG++HRD+KP N+L+D     +K+ D G++    +  K
Sbjct: 119 MTVAIVKALHYLKEK-------HGVIHRDVKPSNILLDASG-NVKLCDFGIS-GRLVDSK 169

Query: 100 KYTHEILTLWYRAPEVLLGSTH---YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLL 155
             T       Y APE +        Y    D+WS+     EL T    +    +E + L 
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT 229

Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            I                         Q  P SL         D    ++  L  D  KR
Sbjct: 230 KIL------------------------QEEPPSLPPNE-GFSPDFCSFVDLCLTKDHRKR 264

Query: 216 ISAKKAMEHPYFDDLDKTR 234
              ++ ++HP+    +   
Sbjct: 265 PKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 23/184 (12%)

Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V E+M+   L  Y+R   Q    +  + + S+   +C+G+ +   +  +HRDL   N
Sbjct: 74  LYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L+   T  +K++D G+ R + L   +YT        + +  PEV   S  YS+  D+WS
Sbjct: 131 CLVS-STGVVKVSDFGMTR-YVLD-DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWS 186

Query: 131 VACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSS-------LMNWHEYP 182
              +  E+ T+  + F   S  +    +  ++        P ++S          WHE P
Sbjct: 187 FGVLMWEVFTEGKMPFEKKSNYE----VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKP 242

Query: 183 QWNP 186
           +  P
Sbjct: 243 EGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 7/115 (6%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++ +   +G+A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF--- 171

Query: 105 ILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 157
           + T ++ APEV+L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 27/140 (19%)

Query: 26  LKKYIRSFRQT-------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR 78
           LK  ++S  Q         E   V    S+ +++C  + + H  G+LHRDLKP N+L+  
Sbjct: 89  LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL 148

Query: 79  KTMTLKIADLGLARA----------FTLPIKKYTHEILTLW--------YRAPEVLLGST 120
               + I D G A              +  +   +  +T+         Y APE LLG  
Sbjct: 149 FGEVV-ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-V 206

Query: 121 HYSTAVDMWSVACIFAELVT 140
             S + D++++  I  +++T
Sbjct: 207 PASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 3/87 (3%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 113
           +G+A+ H  G +HRD+K  N+L+      +K+AD G+A   T  I K    I T ++ AP
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175

Query: 114 EVLLGSTH--YSTAVDMWSVACIFAEL 138
           EV     +  Y+   D+W+V     EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 7/132 (5%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +++  R+    +P    +    ++   + + H  GI++RDLK  N
Sbjct: 71  LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 126

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 127 VLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGV 184

Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 185 LMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 25/190 (13%)

Query: 15  LYLVFEYMD-TDLKKYIRSF------------RQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           L +VFEYM   DL K++R+             RQ    + ++ +  +  Q+  G+ +   
Sbjct: 82  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N L+    + +KI D G++R    T   +   H +L + +  PE ++  
Sbjct: 142 QHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-Y 199

Query: 120 THYSTAVDMWSVACIFAELVT--KTALFP-GDSELQQLLHIFRLLGTPNEKVWPG-VSSL 175
             ++T  D+WS   I  E+ T  K   F   ++E+ + +   R+L  P  +V P  V  +
Sbjct: 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP--RVCPKEVYDI 257

Query: 176 M--NWHEYPQ 183
           M   W   PQ
Sbjct: 258 MLGCWQREPQ 267

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 60/218 (27%)

Query: 30  IRSFRQTG-ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL 88
           +RS+ Q    ++ + ++    YQL   +A+      +HRD+   N+L+      +K+ D 
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDF 151

Query: 89  GLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE 137
           GL+R              LPIK         W  APE  +    +++A D+W       E
Sbjct: 152 GLSRYLEDESYYKASKGKLPIK---------WM-APES-INFRRFTSASDVWMFGVCMWE 200

Query: 138 LVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLD 197
           +     L  G    Q         G  N  V   +  + N    P   P +    + +  
Sbjct: 201 I-----LMLGVKPFQ---------GVKNNDV---IGRIENGERLPM--PPNCPPTLYS-- 239

Query: 198 KDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
                L+ +   YDPSKR         P F +L K +L
Sbjct: 240 -----LMTKCWAYDPSKR---------PRFTEL-KAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 39/189 (20%)

Query: 56  VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 115
           + + H   I++RDLKP N+L+D +   + + D GL +      K  +    T  Y APEV
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167

Query: 116 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
           L     Y   VD W +  +  E++     F      +   +I                  
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN---------------- 210

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----HPYF---- 227
                     P  L    PN+      LLE +LQ D +KR+ AK        H +F    
Sbjct: 211 ---------KPLRLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258

Query: 228 -DDLDKTRL 235
            DDL   ++
Sbjct: 259 WDDLVNKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 34/126 (26%), Positives = 61/126 (48%), Gaps = 10/126 (7%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL--CKGVAFCHGHGILHRDLKPH 72
           LY+V E M    K  + +F +T     V+ ++ L + L   +G+ +     ++HRDL   
Sbjct: 73  LYIVMELMS---KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR 129

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L+    +  K++D GLAR  +       +  L + + APE  L    +S+  D+WS  
Sbjct: 130 NILVSEDGVA-KVSDFGLARVGS---MGVDNSKLPVKWTAPEA-LKHKKFSSKSDVWSYG 184

Query: 133 CIFAEL 138
            +  E+
Sbjct: 185 VLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 7/137 (5%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY++  DL   I+   +  E   V        ++  G+ F H  GI++RDLK  N
Sbjct: 76  LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAA----EIAIGLFFLHSKGIIYRDLKLDN 131

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   +KIAD G+ +              T  Y APE+ +    Y  +VD W+   
Sbjct: 132 VMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGV 189

Query: 134 IFAELVTKTALFPGDSE 150
           +  E++   A F G+ E
Sbjct: 190 LLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 24/71 (33%), Positives = 42/71 (59%), Gaps = 6/71 (8%)

Query: 26  LKKYIRSFRQTGENIP-----VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT 80
           L++++ + ++  +N+P     +N +K +M Q+  G+   H  GI+HRD+KP NLL+    
Sbjct: 287 LEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346

Query: 81  MTLKIADLGLA 91
             +KI D G A
Sbjct: 347 Q-VKIIDFGAA 356

Length = 507

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 5e-06
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 7/114 (6%)

Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 97
           E +    + S  YQ+ +G+ F      +HRDL   N+L+ +  + +KI D GLAR   + 
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-VKICDFGLARDI-MH 289

Query: 98  IKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 147
              Y  +    L + + APE +  +  Y+T  D+WS   +  E+ +     +PG
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 15/126 (11%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA----RAFTLPIKK 100
           V ++  QL   + + HG GI+HRD+K  N+L++     + + D G A     +++ P   
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPF-- 318

Query: 101 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA-CIFAELVTKTALF--PGDSELQ----Q 153
           +     T+   APEVL G   Y+ +VD+WS    IF   V   +LF      E +    Q
Sbjct: 319 HYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377

Query: 154 LLHIFR 159
           +L I R
Sbjct: 378 ILRIIR 383

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 6/79 (7%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +YLV EY+   D+K  +  +    E + V  +  +   L     + H HGI+HRDLKP N
Sbjct: 79  VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL----DYLHRHGIIHRDLKPDN 134

Query: 74  LLMDRKTMTLKIADLGLAR 92
           +L+  +   +K+ D GL++
Sbjct: 135 MLISNEGH-IKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 6e-06
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 53/222 (23%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++LV ++ +   L  +I  F     NIP   VK    ++   +   H  GI+ RDL P+N
Sbjct: 60  VFLVLQHAEGGKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +++                  E +   Y APEV  G +  + A D WS+  
Sbjct: 116 ILLDDRGH-IQLTYFSRWSEVE---DSCDGEAVENMYCAPEV-GGISEETEACDWWSLGA 170

Query: 134 IFAELVTKTALF---PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           I  EL+T   L    P        L+I                        P+W      
Sbjct: 171 ILFELLTGKTLVECHPSGINTHTTLNI------------------------PEW------ 200

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYF 227
                + ++   LL+Q+LQ++P++R+ A     +    HP+F
Sbjct: 201 -----VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 17/170 (10%)

Query: 26  LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMTLK 84
           L KY++  R     IPV+ +K L +Q+  G+A+      +HRDL   N LL++R     K
Sbjct: 82  LLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA--K 135

Query: 85  IADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 141
           I+D G++RA       Y       W   + APE +     +S+  D+WS      E  + 
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSY 194

Query: 142 TALFPGD---SELQQLLHIFRLLGTPNEKVWPGVSSLMN--WHEYPQWNP 186
            A   G+   +E+  +L     L  P E     + S+M   W   P+  P
Sbjct: 195 GAKPYGEMKGAEVIAMLESGERLPRPEE-CPQEIYSIMLSCWKYRPEDRP 243

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 45.5 bits (108), Expect = 7e-06
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE-- 104
            +  Q+  G+ +   H  +HRDL   N L+    +T+KI+D GL+R        Y+ +  
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-LTVKISDFGLSRDI------YSADYY 180

Query: 105 ------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQL 154
                 +L + +  PE +L    ++T  D+WS   +  E+ +   L P     + E+ ++
Sbjct: 181 RVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFS-YGLQPYYGFSNQEVIEM 238

Query: 155 LHIFRLLGTPNEKVWPGVSSLMN--WHEYPQWNP 186
           +   +LL  P E     V +LM   W+E P   P
Sbjct: 239 IRSRQLLPCP-EDCPARVYALMIECWNEIPARRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.8 bits (108), Expect = 7e-06
 Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 37/187 (19%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 162 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 207

Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 208 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251

Query: 225 PYFDDLD 231
            +F  ++
Sbjct: 252 RFFLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 40/187 (21%), Positives = 80/187 (42%), Gaps = 32/187 (17%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q  + + + H + I+HRDLK  N+L       +K+AD G++   T  I++    
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSF 163

Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
           I T ++ APEV++  T     Y    D+WS+     E+     + P   EL  +  + ++
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKI 220

Query: 161 LGT-PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
             + P     P            +W+             +  D L++ L+ +   R +  
Sbjct: 221 AKSEPPTLAQPS-----------RWSS------------EFKDFLKKCLEKNVDARWTTT 257

Query: 220 KAMEHPY 226
           + ++HP+
Sbjct: 258 QLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 46/194 (23%), Positives = 74/194 (38%), Gaps = 39/194 (20%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   I++RDLKP N+L+D +   + + D GL +         +    T  Y
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEY 162

Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
            APEV L    Y   VD W +  +  E++     F   +  +   +I             
Sbjct: 163 LAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----------- 210

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPY 226
                          P  L    PN+      LLE +LQ D +KR+ AK    +   H +
Sbjct: 211 --------------KPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253

Query: 227 F-----DDLDKTRL 235
           F     DDL   ++
Sbjct: 254 FSPINWDDLINKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.4 bits (107), Expect = 9e-06
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 14/132 (10%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+LV E+      TDL K  +     G  +  + +  +  ++ +G+A  H H ++HRD+K
Sbjct: 94  LWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAHKVIHRDIK 148

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH----YSTAV 126
             N+L+  +   +K+ D G++      + +    I T ++ APEV+    +    Y    
Sbjct: 149 GQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRS 207

Query: 127 DMWSVACIFAEL 138
           D+WS+     E+
Sbjct: 208 DIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.3 bits (107), Expect = 9e-06
 Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 32/146 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGE-------NIPVNTVKSLMYQLCKGVAFCHGHGILH 66
           L ++ EYM+  DL +++                I  +T+  +  Q+  G+ +      +H
Sbjct: 94  LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEILTLWYRAPE 114
           RDL   N L+  K  T+KIAD G++R               LPI+         W     
Sbjct: 154 RDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---------WMSWES 203

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVT 140
           +LLG   ++TA D+W+      E++T
Sbjct: 204 ILLGK--FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 37/148 (25%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEI 105
           +  Q+  G+ +   H  +H+DL   N+L+  + + +KI+DLGL+R        +     +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQLLHIFRLL 161
           L + +  PE ++    +S+  D+WS   +  E+ +   L P     + E+ +++   +LL
Sbjct: 188 LPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFS-FGLQPYYGFSNQEVIEMVRKRQLL 245

Query: 162 GTPNEKVWPGVSSLMN--WHEYPQWNPQ 187
               E   P + SLM   W E P   P+
Sbjct: 246 PCS-EDCPPRMYSLMTECWQEGPSRRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV +Y +  DL   +  F    + +P +  +  + ++   +   H  G +HRD+KP N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132

Query: 74  LLMDRKTMTLKIADLG-LARAFTLPIKKYTHEILTLWYRAPEVLL----GSTHYSTAVDM 128
           +L+D+    +++AD G   R       +    + T  Y +PE+L     G   Y    D 
Sbjct: 133 VLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDW 191

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS+     E++     F  +S ++    I                  MN  E+ Q+ P  
Sbjct: 192 WSLGVCMYEMLYGETPFYAESLVETYGKI------------------MNHKEHFQFPPD- 232

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLD 231
               V ++ ++  DL+ +++   P  R+     +   +HP+F+ +D
Sbjct: 233 ----VTDVSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFEGID 273

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 5/93 (5%)

Query: 41  PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK 100
            ++T+     Q+  G+ +      +HRDL   N+L+      +KI D GL RA       
Sbjct: 95  LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDH 153

Query: 101 YT---HEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           Y    H  +   + APE L   T +S A D+W 
Sbjct: 154 YVMEEHLKVPFAWCAPESLRTRT-FSHASDVWM 185

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)

Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+    + +KI D GLAR  +  P  ++K     L
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDAR-L 243

Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
            L + APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 244 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRP 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 22/137 (16%)

Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  ++   +  + +      +C+ + +   +  +HRD
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+    +  K++D GL +  +       LP+K          + APE L     
Sbjct: 128 LAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK----------WTAPEALR-EKK 175

Query: 122 YSTAVDMWSVACIFAEL 138
           +ST  D+WS   +  E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 28/111 (25%), Positives = 52/111 (46%), Gaps = 5/111 (4%)

Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  F Q  +++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA-KISDFG 140

Query: 90  LARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE 137
           L++A       Y   TH    + + APE  +    +S+  D+WS   +  E
Sbjct: 141 LSKALGADENYYKAKTHGKWPVKWYAPEC-MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 43/182 (23%), Positives = 73/182 (40%), Gaps = 18/182 (9%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V E +    L  ++R   +    + V  +  +      G+ +      +HRDL   N
Sbjct: 67  IYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN 123

Query: 74  LLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
            L+    + LKI+D G++R      +T+       +I   W  APE  L    Y++  D+
Sbjct: 124 CLVGENNV-LKISDFGMSREEEGGIYTVSDG--LKQIPIKW-TAPEA-LNYGRYTSESDV 178

Query: 129 WSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP-GVSSLMN--WHEYPQW 184
           WS   +  E  +     +PG S  Q    I      P  ++ P  +  LM   W   P+ 
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238

Query: 185 NP 186
            P
Sbjct: 239 RP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 31/158 (19%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------ 94
           S  +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR              
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDA 235

Query: 95  TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSE 150
            LP+K          + APE +     Y+T  D+WS   +  E+ +  A  +PG   D E
Sbjct: 236 RLPLK----------WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284

Query: 151 LQQLLHIFRLLGTPNEKVWPGVSSLM--NWHEYPQWNP 186
             + L     +  P E   P + S+M   WH  P+  P
Sbjct: 285 FCRRLKEGTRMRAP-EYATPEIYSIMLDCWHNNPEDRP 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 24/115 (20%)

Query: 39  NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------ 92
            +P+ T+   M  +  G+ +      +HRDL   N +++ + MT+ +AD GL++      
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGD 167

Query: 93  ------AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 141
                 A  LP+K    E            L    Y+T  D+W+      E++T+
Sbjct: 168 YYRQGCASKLPVKWLALES-----------LADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)

Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR  +  P  ++K +   L
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGSAR-L 238

Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
            L + APE +     Y+T  D+WS   +  E+ +  A  +PG   + E  Q L     + 
Sbjct: 239 PLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 163 TPNEKVWPGVSSLM--NWHEYPQWNP 186
            P E   P +  +M   W   P+  P
Sbjct: 298 AP-ENATPEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 28/125 (22%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----------- 95
           S  YQ+ KG++F      +HRDL   N+L+    +T KI D GLAR              
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIRNDSNYVVKGNA 276

Query: 96  -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSE 150
            LP+K          + APE +     Y+   D+WS   +  E+ +  ++ +PG   DS+
Sbjct: 277 RLPVK----------WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Query: 151 LQQLL 155
             +++
Sbjct: 326 FYKMI 330

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 14/132 (10%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+LV E+      TDL K  +     G  +    +  +  ++ +G++  H H ++HRD+K
Sbjct: 84  LWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 138

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH----YSTAV 126
             N+L+  +   +K+ D G++      + +    I T ++ APEV+    +    Y    
Sbjct: 139 GQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197

Query: 127 DMWSVACIFAEL 138
           D+WS+     E+
Sbjct: 198 DLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 27/169 (15%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 57
           DVK G        L+LV E  +    TDL   ++ F + GE +    +  ++++   G+ 
Sbjct: 88  DVKNGDQ------LWLVLELCNGGSVTDL---VKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL- 116
             H +  +HRD+K +N+L+  +   +K+ D G++   T    +    + T ++ APEV+ 
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 117 ----LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 161
               L ST Y    D+WS+       +T   L  GD  L   LH  R L
Sbjct: 198 CEQQLDST-YDARCDVWSLG------ITAIELGDGDPPLAD-LHPMRAL 238

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 16/144 (11%)

Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGV 56
           E R  LYL  EY    +L  ++R  R             T   +    +      + +G+
Sbjct: 78  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 137

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+  +    KIAD GL+R   + +KK    +   W       
Sbjct: 138 DYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES-- 194

Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
           L  + Y+T  D+WS   +  E+V+
Sbjct: 195 LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 43.4 bits (102), Expect = 4e-05
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 2/89 (2%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   I++RDLKP N+L+D +   + + D GL +    P +  +    T  Y
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEY 162

Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELV 139
            APEVL     Y   VD W +  +  E++
Sbjct: 163 LAPEVLRKEP-YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 35/203 (17%)

Query: 5   QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG--ENIPVNTVKSLMYQLCKGVAFCHG 61
           +  + +      ++  +M   DL  ++   R  G  E +P+ T+   M  +  G+ +   
Sbjct: 72  EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN 131

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------AFTLPIKKYTHEILTLW 109
              +HRDL   N  M R+ MT+ +AD GL++               +P+K    E L   
Sbjct: 132 RNFIHRDLAARN-CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL--- 187

Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPG--DSELQQLL-HIFRLLGTPN 165
             A  V      Y++  D+W+      E+ T+    +PG  + E+   L H  RL    +
Sbjct: 188 --ADRV------YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239

Query: 166 --EKVWPGVSSLMNWHEYPQWNP 186
             ++++  + S   W   P+  P
Sbjct: 240 CLDELYDLMYSC--WRADPKDRP 260

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 31/221 (14%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLL 75
           +  E+MD       R +++ G  IPV  +  +   + +G+ + +  H I+HRD+KP N+L
Sbjct: 80  MCMEFMDCG--SLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136

Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF 135
           ++ +   +K+ D G++      I      + T  Y +PE + G   Y+   D+WS+    
Sbjct: 137 VNSRG-QIKLCDFGVSGELINSIADTF--VGTSTYMSPERIQGG-KYTVKSDVWSLGISI 192

Query: 136 AELVTKTALF---PGDSELQ-QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            EL      F     D + Q   + I  LL                  +  Q  P  L +
Sbjct: 193 IELALGKFPFAFSNIDDDGQDDPMGILDLL-----------------QQIVQEPPPRLPS 235

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           +  +  +D  D ++  L  DP++R + ++    P F    +
Sbjct: 236 S--DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 12/155 (7%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+LV E  +   + + ++     G+ +    +  ++Y    G+   H + I+HRD+K +N
Sbjct: 99  LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA----VDMW 129
           +L+  +   +K+ D G++   T    +    + T ++ APEV+     Y  +     D+W
Sbjct: 159 ILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           S+       +T   L  GD  L  +  +  L   P
Sbjct: 218 SLG------ITAIELGDGDPPLFDMHPVKTLFKIP 246

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---IKKYTHEIL 106
           YQ+  G+ F      +HRDL   N+L+    + +KI D GLAR        I K +   L
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKL-VKICDFGLARDIMRDSNYISKGS-TFL 303

Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            L + APE +  +  Y+T  D+WS   +  E+ T
Sbjct: 304 PLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.5 bits (100), Expect = 8e-05
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 7/132 (5%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V E++   DL  +++  R+    +P    +    ++   + F H  GI++RDLK  N
Sbjct: 71  LFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDN 126

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 127 VLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGV 184

Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 185 LMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 10/144 (6%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTL 108
           Q+  G+ F   H ++H+DL   N+L+  K + +KI+DLGL R        K   + +L +
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQLLHIFRLLGTP 164
            + +PE ++    +S   D+WS   +  E+ +   L P     + ++ +++   ++L  P
Sbjct: 191 RWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFS-YGLQPYCGYSNQDVIEMIRNRQVLPCP 248

Query: 165 NE-KVWPGVSSLMNWHEYPQWNPQ 187
           ++   W     L  W+E+P   P+
Sbjct: 249 DDCPAWVYTLMLECWNEFPSRRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 16/144 (11%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGV 56
           E R  LY+  EY    +L  ++R  R             T   +    +      +  G+
Sbjct: 73  ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+  + +  KIAD GL+R   + +KK    +   W  A E L
Sbjct: 133 QYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWM-AIESL 190

Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
             S  Y+T  D+WS   +  E+V+
Sbjct: 191 NYSV-YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 16/144 (11%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGV 56
           E R  LYL  EY    +L  ++R  R             T   +    +      + +G+
Sbjct: 66  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 125

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+  +    KIAD GL+R   + +KK    +   W       
Sbjct: 126 DYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES-- 182

Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
           L  + Y+T  D+WS   +  E+V+
Sbjct: 183 LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 48/202 (23%), Positives = 81/202 (40%), Gaps = 33/202 (16%)

Query: 5   QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHG 61
           Q    EG     ++  +M   DL  ++   R     + +P   +   M  +  G+ +   
Sbjct: 71  QTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS 130

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLA------------RAFTLPIKKYTHEILTLW 109
              +HRDL   N +++ + M + +AD GL+            R   +P+K    E L   
Sbjct: 131 KSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL--- 186

Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPG--DSELQQLLHIFRLLGTPNE 166
             A  V      Y+T  D+WS      E+ T+    +PG  +SE+   L     L  P +
Sbjct: 187 --ADRV------YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238

Query: 167 KVWPGVSSLMN--WHEYPQWNP 186
            +  G+ SLM+  W   P+  P
Sbjct: 239 CL-DGLYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 43/232 (18%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGE---------NIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           L + +  T+   ++  F   GE         + P    +    ++   + + H   I++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           DLKP N+L+D +   + + D GL +         T    T  Y APEV+     Y   VD
Sbjct: 121 DLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVD 178

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
            W +  +  E++     F      +   +I          + PG  SL  W         
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRPGA-SLTAW--------- 224

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPYFDDLDKTRL 235
                          +LE++L+ D  +R+ AK    +  EHP+F+ L  T L
Sbjct: 225 --------------SILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 10/127 (7%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V E +   D   ++R+    G  + V  +  ++     G+ +      +HRDL   N
Sbjct: 68  IYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN 124

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWS 130
            L+  K   LKI+D G++R     +   T    +I   W  APE  L    YS+  D+WS
Sbjct: 125 CLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEA-LNYGRYSSESDVWS 181

Query: 131 VACIFAE 137
              +  E
Sbjct: 182 FGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 34/148 (22%)

Query: 14  VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS-----LMY---QLCKGVAFCHGHGI 64
            L ++ EYM+  DL ++++       +      KS     L+Y   Q+  G+ +      
Sbjct: 93  PLCMIMEYMENGDLNQFLQK-HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLAR-AFT-----------LPIKKYTHEILTLWYRA 112
           +HRDL   N L+ +   T+KIAD G++R  ++           LPI+         W   
Sbjct: 152 VHRDLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIR---------WMAW 201

Query: 113 PEVLLGSTHYSTAVDMWSVACIFAELVT 140
             VLLG   ++T  D+W+      E++T
Sbjct: 202 ESVLLGK--FTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 117 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYG 174

Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 216

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 217 R-----------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 17/145 (11%)

Query: 10  EGRTVLYLVFEYM-DTDLKKYIRS------FRQTGENIPVN--TVKSLMY---QLCKGVA 57
           EGR  L +VFEYM   DL +++RS          GE++     T+  ++    Q+  G+ 
Sbjct: 78  EGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEV 115
           +      +HRDL   N L+ +  + +KI D G++R    T   +     +L + +  PE 
Sbjct: 137 YLASLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 195

Query: 116 LLGSTHYSTAVDMWSVACIFAELVT 140
           +L    ++T  D+WS   +  E+ T
Sbjct: 196 IL-YRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 27/145 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRS-------FRQTGENIPVNTVKSLMY---QLCKGVAFCHGHG 63
             +VFEYM+  DL K++RS        +     +   T+  L+    Q+  G+ +     
Sbjct: 83  PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT--------HEILTLWYRAPEV 115
            +HRDL   N L+    + +KI D G++R        YT        H +L + +  PE 
Sbjct: 143 FVHRDLATRNCLVGYD-LVVKIGDFGMSRDV------YTTDYYRVGGHTMLPIRWMPPES 195

Query: 116 LLGSTHYSTAVDMWSVACIFAELVT 140
           ++    ++T  D+WS   +  E+ T
Sbjct: 196 IMYRK-FTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 23/143 (16%)

Query: 17  LVFEYMDT-DLKKYIRS----------------FRQTGENIPVNTVKSLMY--QLCKGVA 57
           L+FEYM   DL +++R                  +     +P++  + L    Q+  G+A
Sbjct: 85  LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEV 115
           +      +HRDL   N L+  + M +KIAD GL+R        K   ++ + + +  PE 
Sbjct: 145 YLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES 203

Query: 116 LLGSTHYSTAVDMWSVACIFAEL 138
           +     Y+T  D+W+   +  E+
Sbjct: 204 IF-YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 4/109 (3%)

Query: 34  RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA 93
           R+  +NI    + +   Q+ KG+ +     ++HRDL   N+L+ +    +KI D GLA+ 
Sbjct: 100 REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV-KTPQHVKITDFGLAKL 158

Query: 94  FTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
                K+Y  E   + + + A E +L    Y+   D+WS      EL+T
Sbjct: 159 LGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 54/212 (25%), Positives = 80/212 (37%), Gaps = 69/212 (32%)

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----TLPIKKYTHE---------- 104
           H  G +HRD+KP NLL+D K   +K++D GL         T   +  TH           
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 105 --------------------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL 144
                               + T  Y APEV +  T Y+   D WS+  I  E++     
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 145 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLL 204
           F  +              TP E        +MNW E   + P+     VP + +   DL+
Sbjct: 236 FCSE--------------TPQET----YRKVMNWKETLVFPPE-----VP-ISEKAKDLI 271

Query: 205 EQMLQY--DPSKRISAKKAME---HPYFDDLD 231
              L++  D   RI +    E   HP+F+ +D
Sbjct: 272 ---LRFCTDSENRIGSNGVEEIKSHPFFEGVD 300

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 13/154 (8%)

Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           LVFEY +  DLK Y+   +    N  +  ++ +  ++  GV   H H  LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 76  MDRKTMTLKIAD--LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-------YSTAV 126
           +    +T+K+ D  +G +R     I+    + + L + APE L+G  H        +   
Sbjct: 132 LT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE-LVGEFHGGLITAEQTKPS 189

Query: 127 DMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 159
           ++W++     EL    A  +   S+ + L H+ +
Sbjct: 190 NVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 40/153 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFR---QTGEN---------IPVNTVKSLMY---QLCKGVAF 58
           L ++ EYM+  DL +++ S     +             +P  +  SL++   Q+  G+ +
Sbjct: 94  LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153

Query: 59  CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEIL 106
                 +HRDL   N L+  + +T+KIAD G++R               LPI+       
Sbjct: 154 LSSLNFVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR------- 205

Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 139
             W     +L+G   ++TA D+W+      E++
Sbjct: 206 --WMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 11/138 (7%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV +Y +  DL   +  F    + +P +  +  + ++   +   H    +HRD+KP N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132

Query: 74  LLMDRKTMTLKIADLG-LARAFTLPIKKYTHEILTLWYRAPEVLL----GSTHYSTAVDM 128
           +LMD     +++AD G   +       + +  + T  Y +PE+L     G   Y    D 
Sbjct: 133 ILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDW 191

Query: 129 WSVA-CIFAELVTKTALF 145
           WS+  C++  L  +T  +
Sbjct: 192 WSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 20/128 (15%)

Query: 25  DLKKYIRSFRQTGENIP-VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL 83
           DLK Y+RS R+     P   T++ +  ++  G+   H +  +H DL   N L+    +T+
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT-ADLTV 139

Query: 84  KIADLGLARA------FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV-------DMWS 130
           KI D GL+        +  P + +    + L + APE L+   H +  V       ++WS
Sbjct: 140 KIGDYGLSHNKYKEDYYVTPDQLW----VPLRWIAPE-LVDEVHGNLLVVDQTKESNVWS 194

Query: 131 VACIFAEL 138
           +     EL
Sbjct: 195 LGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 42/217 (19%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++++   +G+ + H +G +HR++K  ++L+    +   ++  GL+  ++L       +
Sbjct: 103 IGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKAK 159

Query: 105 IL---------TLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQL 154
           ++          L + +PE+L    + Y+   D++SV     EL T    F      Q L
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Query: 155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS-----------------------LAT 191
           L   +L G P     P   +     E    N QS                       L T
Sbjct: 220 LQ--KLKGPPY---SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT 274

Query: 192 AVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      +L+E  LQ DP KR SA   + H +F
Sbjct: 275 PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 29/133 (21%)

Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC---KGVAFCHGHGILHRDLKP 71
           +++ E M   DLK ++R  R   E     T+K L++      KG  +   +  +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 72  HNLLMDRK--TMTLKIADLGLARAF------------TLPIKKYTHEILTLWYRAPEVLL 117
            N L+  K      KIAD G+AR               LPIK          +  PE  L
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK----------WMPPEAFL 194

Query: 118 GSTHYSTAVDMWS 130
               +++  D+WS
Sbjct: 195 DGI-FTSKTDVWS 206

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 12/129 (9%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+ + M   L   +   R   +NI    + +   Q+ KG+++     ++HRDL   N+L+
Sbjct: 85  LITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142

Query: 77  DRKTMTL-KIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGS--THYSTAVDMWSV 131
             KT    KI D GLA+   +  K+Y  E   + + + A E +L    TH S   D+WS 
Sbjct: 143 --KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKS---DVWSY 197

Query: 132 ACIFAELVT 140
                EL+T
Sbjct: 198 GVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 35/123 (28%), Positives = 50/123 (40%), Gaps = 28/123 (22%)

Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV- 168
           Y APE+LLG  H   AVD W++     E +T    F  ++  Q   +I       N  + 
Sbjct: 546 YLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL------NRDIP 598

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           WP         E    N Q+   A+           E +L  DP+KR   K+  +HP F 
Sbjct: 599 WP------EGEEKLSVNAQN---AI-----------EILLTMDPTKRAGLKELKQHPLFH 638

Query: 229 DLD 231
            +D
Sbjct: 639 GVD 641

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILT-- 107
           Q+ KG+ +   H ++HR+L   N+L+ +    ++IAD G+A       KKY + E  T  
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILL-KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 108 LWYRAPEVLLGS-THYSTAVDMWSVACIFAELVT 140
            W     +L G  TH S   D+WS      E+++
Sbjct: 176 KWMALESILFGRYTHQS---DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 34/129 (26%), Positives = 64/129 (49%), Gaps = 11/129 (8%)

Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V EYM+   L  ++R  +  G+   +  V  ++  +  G+ +    G +HRDL   N+L
Sbjct: 82  IVTEYMENGSLDAFLR--KHDGQFTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNIL 138

Query: 76  MDRKTMTLKIADLGLARAFT-LPIKKYTH---EILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           ++   +  K++D GL+R     P   YT    +I   W  APE  +    +++A D+WS 
Sbjct: 139 VN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEA-IAYRKFTSASDVWSY 195

Query: 132 ACIFAELVT 140
             +  E+++
Sbjct: 196 GIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 6/81 (7%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYL+ E++   DL   +  +    E++     +  M +    +   H  G +HRD+KP N
Sbjct: 76  LYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVHKLGFIHRDIKPDN 131

Query: 74  LLMDRKTMTLKIADLGLARAF 94
           +L+DR    +K++D GL+  F
Sbjct: 132 ILIDRGGH-IKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 15/100 (15%)

Query: 14  VLYLVFEYMDTDLKKYIRSFRQTGENI---------PVNTVKSLMYQLCKGVAFCHGHGI 64
           V+ L + + D D   ++  +   G+ +         P +  +  + +L   V   H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           +HRD+KP N+L+DR    +K+ D GL   F     ++TH+
Sbjct: 123 IHRDIKPDNILIDRDGH-IKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	235
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.98
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.98
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.98
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.98
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.91
KOG3653	534	consensus Transforming growth factor beta/activin	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.69
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
PRK12274	218	serine/threonine protein kinase; Provisional	99.56
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.53
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.48
PRK09188	365	serine/threonine protein kinase; Provisional	99.47
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
smart00090	237	RIO RIO-like kinase.	99.33
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.23
PRK10345	210	hypothetical protein; Provisional	99.23
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.22
PRK14879	211	serine/threonine protein kinase; Provisional	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.19
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.18
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.12
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.04
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.89
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.88
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.66
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.66
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.58
PRK09902	216	hypothetical protein; Provisional	98.57
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.31
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.81
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.47
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.17
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.31
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.14
KOG0576	829	consensus Mitogen-activated protein kinase kinase	95.8
PRK05231	319	homoserine kinase; Provisional	95.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.93
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.88
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.86
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.79
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.72
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.07
PF01636	239	APH: Phosphotransferase enzyme family This family	94.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	93.89
PLN02876	822	acyl-CoA dehydrogenase	93.77
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.71
PLN02236	344	choline kinase	93.49
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	93.1
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.86
KOG2268	465	consensus Serine/threonine protein kinase [Signal	92.84
PHA03111	444	Ser/Thr kinase; Provisional	92.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.34
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.2
PRK10271	188	thiK thiamine kinase; Provisional	92.13
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.98
COG2334	331	Putative homoserine kinase type II (protein kinase	91.35
KOG2270	520	consensus Serine/threonine protein kinase involved	91.18
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.35
PRK06149	972	hypothetical protein; Provisional	89.23
COG4499	434	Predicted membrane protein [Function unknown]	88.96
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	88.74
PRK11768	325	serine/threonine protein kinase; Provisional	88.19
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	87.97
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	86.8
PRK06148	1013	hypothetical protein; Provisional	86.21
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	85.67
KOG1236	565	consensus Predicted unusual protein kinase [Genera	85.35

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=295.49  Aligned_cols=214  Identities=43%  Similarity=0.824  Sum_probs=188.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      |.++.+|+|||||.+||.+++..+   ++.+++..+..|+.||++||+|+|++|+.|||+||+|||+.... .+||+|||
T Consensus        80 d~~~~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFG  155 (538)
T KOG0661|consen   80 DNDRILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFG  155 (538)
T ss_pred             ccCceEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccc
Confidence            344499999999999999999874   67899999999999999999999999999999999999999554 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... ...+....|.+|+|||++.....|+.+.|+|++||+++|+++.+..|++.++.+++.++...++.|.+.-|
T Consensus       156 LARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  156 LAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            99876533 33455677999999999998788999999999999999999999999999999999999999999999988


Q ss_pred             ccc---cccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          170 PGV---SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       170 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...   .+.++ ...++..+..+....++.++++.++|.+|+.+||.+||||.++|+||||+.
T Consensus       235 ~eg~~La~~mn-f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  235 PEGYNLASAMN-FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             hhHHHHHHHhc-cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence            763   22232 245566667777777789999999999999999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-44  Score=291.54  Aligned_cols=192  Identities=27%  Similarity=0.429  Sum_probs=170.1

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.+..+|+++++|||+|+|. ++|..++.+    .+.++|.+++.+++||+.||.|||+++|+|||||..|++++.+. 
T Consensus        81 V~f~~~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-  155 (592)
T KOG0575|consen   81 VQFYHFFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-  155 (592)
T ss_pred             EeeeeEeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-
Confidence            566788999999999999998 698888864    45799999999999999999999999999999999999999665 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      ++||+|||++..+..+........||+.|+|||++.... .+..+||||+||++|-|+.|++||....-.+.+..+...-
T Consensus       156 ~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~  234 (592)
T KOG0575|consen  156 NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE  234 (592)
T ss_pred             cEEecccceeeeecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence            999999999999988877778889999999999998544 7899999999999999999999999988888888776421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      -                            .....++.++++||+++|+.||.+|||++++|.|+||+
T Consensus       235 Y----------------------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  235 Y----------------------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             c----------------------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence            0                            01114788999999999999999999999999999993

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=279.54  Aligned_cols=199  Identities=25%  Similarity=0.429  Sum_probs=164.1

Q ss_pred             ccCCcCCCce-EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCC
Q 026660            4 KQGQNKEGRT-VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         4 ~~~~~~~~~~-~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~   80 (235)
                      ..++.+..+. .++|+||||+| ||.+++...    +.+++....+++.+++.||.|||+ ++++||||||+|+|++..+
T Consensus       141 ~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG  216 (364)
T KOG0581|consen  141 GFYGAFYSNGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG  216 (364)
T ss_pred             eEeEEEEeCCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC
Confidence            3445555666 69999999985 999999774    569999999999999999999995 8999999999999999887


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD--SELQQLLHIF  158 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~  158 (235)
                       .+||+|||.+..+...  ......||..|||||.+.+.. |+.++||||||++++|++.|+.||...  ........+.
T Consensus       217 -eVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~  292 (364)
T KOG0581|consen  217 -EVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC  292 (364)
T ss_pred             -CEEeccccccHHhhhh--hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH
Confidence             9999999999877655  556778999999999998766 899999999999999999999999774  2223333333


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ..+..++..+-.+                       .+|+++++||..||+.||.+|||+.|+++|||++....+
T Consensus       293 ~Iv~~ppP~lP~~-----------------------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  293 AIVDEPPPRLPEG-----------------------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHhcCCCCCCCcc-----------------------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            4444333222110                       388999999999999999999999999999999977653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-44  Score=271.59  Aligned_cols=227  Identities=47%  Similarity=0.830  Sum_probs=198.4

Q ss_pred             CcccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            2 DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         2 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      +|+..-.-.+-+.+|+|||||..||++.+.+..   ..++..+++.++.|++.|++|||++.++|||+|++|+|++..| 
T Consensus       139 ~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-  214 (419)
T KOG0663|consen  139 EVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-  214 (419)
T ss_pred             eeEEEEeccccceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-
Confidence            344444445556699999999999999999854   5799999999999999999999999999999999999999888 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||+++.++.+....+...-|.+|+|||.+.+...|+++.|+||+||++.+++.+.+.|.+....+++.++++.+
T Consensus       215 ~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll  294 (419)
T KOG0663|consen  215 ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL  294 (419)
T ss_pred             cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence            99999999999999988888888889999999999998889999999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccc--CCCCCCccchhhcCCC--CChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWH--EYPQWNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +.|.+..|++......+.  .....+...+-.....  +++...+|+..+|.+||.+|.||++.|+|+||.+...
T Consensus       295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence            999999999998866553  2333333334444443  4589999999999999999999999999999997543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=271.63  Aligned_cols=223  Identities=60%  Similarity=1.106  Sum_probs=201.7

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+....+++||||+.-+|..++.........++...++.+++||+.||+|+|+++++||||||.||+++..+ .++++||
T Consensus        86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDF  164 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADF  164 (323)
T ss_pred             ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeecc
Confidence            355568999999999999999999765445688899999999999999999999999999999999999877 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |+++....+....+....|.+|+|||++.+...+++..||||+||+++||++++..|.+..+.+++..+.+.++.|.+..
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99998887777788889999999999999987799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccc-CCCCCC-ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          169 WPGVSSLMNWH-EYPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       169 ~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      |++..+.-.+. ....+. +..+....+..+++..+++.+||+.+|.+|.|++.++.||||++...
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            99998877766 455565 56667777778889999999999999999999999999999998743

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-46  Score=287.13  Aligned_cols=200  Identities=30%  Similarity=0.427  Sum_probs=161.9

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-   80 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-   80 (235)
                      |...+.++...+.|+||||+.| +|.+.+..    ++.+.+..-+.+++|++.|+.|||++|++||||||+|||+..+. 
T Consensus       239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e  314 (475)
T KOG0615|consen  239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAE  314 (475)
T ss_pred             EEEeeeeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCc
Confidence            4456778888999999999985 99999977    45688999999999999999999999999999999999998652 


Q ss_pred             -CeEEEeecCCcccccCCCCCcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Q 026660           81 -MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLH  156 (235)
Q Consensus        81 -~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~  156 (235)
                       ..+||+|||+++..+ ....+....||+.|.|||++.+.  ..+..+.|+||+||++|-+++|..||.+..... ...+
T Consensus       315 ~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ  393 (475)
T KOG0615|consen  315 DCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ  393 (475)
T ss_pred             ceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence             268999999998776 34566778999999999999753  334568999999999999999999998765433 3333


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      +.+.--..                        ....+..++++.++||.+||..||++|||++|+|+||||+...
T Consensus       394 I~~G~y~f------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  394 ILKGRYAF------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HhcCcccc------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            32210000                        0112224789999999999999999999999999999999654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.7e-44  Score=262.49  Aligned_cols=223  Identities=47%  Similarity=0.824  Sum_probs=205.3

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+.+.....+-+|+|||+.||...+++   +...++...++.++.+++.|++|+|++.+.||||||+|+|++.++ .+|
T Consensus        66 LiD~F~~~~~l~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lK  141 (318)
T KOG0659|consen   66 LIDVFPHKSNLSLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLK  141 (318)
T ss_pred             hhhhccCCCceEEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEE
Confidence            4556667777999999999999999976   345789999999999999999999999999999999999999887 999


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||+++.+..+........-|.+|+|||.+.+...|+...|+||.||++.||+-+.+.|.+.++.+++..+.+.++.|
T Consensus       142 iADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP  221 (318)
T KOG0659|consen  142 IADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTP  221 (318)
T ss_pred             eecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCC
Confidence            99999999998887777777789999999999998889999999999999999999999999999999999999999999


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .+..|++..+..++......+........+..+++..+|+.+||..||.+|+++.|+++|+||++..
T Consensus       222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            9999999999988888887777777778888999999999999999999999999999999999643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=284.63  Aligned_cols=197  Identities=27%  Similarity=0.487  Sum_probs=169.6

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +++-.+.+...+|+|+||++ |+|.++|.++    +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus       138 kLy~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-h  212 (604)
T KOG0592|consen  138 KLYFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-H  212 (604)
T ss_pred             EEEEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-c
Confidence            44556778888999999997 6999999986    4699999999999999999999999999999999999999777 9


Q ss_pred             EEEeecCCcccccCCCC-------------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 026660           83 LKIADLGLARAFTLPIK-------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS  149 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  149 (235)
                      ++|+|||.++.+.....             ....+.||..|++||++.... .+..+|+|+|||++|+|+.|.+||.+.+
T Consensus       213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~N  291 (604)
T KOG0592|consen  213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAAN  291 (604)
T ss_pred             EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCcccc
Confidence            99999999976642211             114578999999999997655 7899999999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      +.-...+++...-                            ...+++++.+++||+++|..||.+|+|+.+|.+||||.+
T Consensus       292 eyliFqkI~~l~y----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  292 EYLIFQKIQALDY----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HHHHHHHHHHhcc----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            8777777765311                            112257789999999999999999999999999999999


Q ss_pred             CCcCC
Q 026660          230 LDKTR  234 (235)
Q Consensus       230 ~~~~~  234 (235)
                      ++|+-
T Consensus       344 Vdw~n  348 (604)
T KOG0592|consen  344 VDWEN  348 (604)
T ss_pred             CChhh
Confidence            99974

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=271.58  Aligned_cols=198  Identities=26%  Similarity=0.443  Sum_probs=172.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..-.+++...+|+|+||++| .|..+|++    .+.+++..++.++..|+.||.|||++||+|||+||+|||++.+| .+
T Consensus        90 l~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi  164 (357)
T KOG0598|consen   90 LIYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HI  164 (357)
T ss_pred             eEEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cE
Confidence            34467888999999999985 99999976    46799999999999999999999999999999999999999888 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.... ++.++|.||||+++|+|++|..||.+.+..+...++...-. 
T Consensus       165 ~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-  242 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-  242 (357)
T ss_pred             EEeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-
Confidence            9999999986655555566689999999999998765 89999999999999999999999999998888887765321 


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCCcCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI----SAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~ll~hp~f~~~~~~~~  235 (235)
                                                ......++++.+++++++|+.||.+|.    ++.++-+||||+.++|+.|
T Consensus       243 --------------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  243 --------------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             --------------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence                                      111113788999999999999999995    7889999999999999753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.2e-44  Score=266.63  Aligned_cols=220  Identities=37%  Similarity=0.713  Sum_probs=184.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..+..++.+++|+|||.-++.+-++.+.   ..++.+.+.++++|++.|+.|+|+++++||||||+||+++.++ .++++
T Consensus        68 EVFrrkrklhLVFE~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLC  143 (396)
T KOG0593|consen   68 EVFRRKRKLHLVFEYCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLC  143 (396)
T ss_pred             HHHHhcceeEEEeeecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEec
Confidence            3455677899999999999999888853   4689999999999999999999999999999999999999887 99999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||+++.+..+....+-...|.+|+|||.+.+..+|+..+||||+||++.||++|.+.|++..+.+++..+...++....
T Consensus       144 DFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  144 DFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             cchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            99999998877777777788999999999999788999999999999999999999999999999999988888776554


Q ss_pred             CCcccccc--cccccCCC-CCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          167 KVWPGVSS--LMNWHEYP-QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       167 ~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ....-..+  ...+...+ .-.+..+..+.++.+.-+.+++++||..||.+|++.++++.||||+++
T Consensus       224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            32211111  01111111 222345677778888999999999999999999999999999999765

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=271.60  Aligned_cols=225  Identities=40%  Similarity=0.710  Sum_probs=193.8

Q ss_pred             CcccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            2 DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         2 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |++.-...++-+-+|+|+|+|+.||...+..    +..++++.+..+++|++.||+|+|+.+++|||+||.|++++.+. 
T Consensus        88 di~~p~~~~~f~DvYiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-  162 (359)
T KOG0660|consen   88 DIFRPPSRDKFNDVYLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-  162 (359)
T ss_pred             eecccccccccceeEEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-
Confidence            4444455667778999999998899999976    44599999999999999999999999999999999999999777 


Q ss_pred             eEEEeecCCcccccCC--CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      ..+++|||+++.....  ...++....|.+|+|||++.....++.+.||||+||++.||++|+..|.+.+...++..+..
T Consensus       163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~  242 (359)
T KOG0660|consen  163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE  242 (359)
T ss_pred             CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence            8999999999876532  12334556699999999999888899999999999999999999999999999999999999


Q ss_pred             HhCCCCCCCccccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..+.|++.....+.+...   -...+..+...+....++.++.+.+|+.+||.+||.+|+|++|+|+|||+..+.
T Consensus       243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            999998877666553222   234566677778888999999999999999999999999999999999998765

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=258.51  Aligned_cols=195  Identities=27%  Similarity=0.435  Sum_probs=170.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +....+.+.+++|+||||.+| .|.+++++    .+.+++..++.++.||+.||+|||++++++||+||+|||++++| .
T Consensus       108 ~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~  182 (355)
T KOG0616|consen  108 KLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-H  182 (355)
T ss_pred             EEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-c
Confidence            345567788999999999985 99999987    46799999999999999999999999999999999999999888 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++++|||+++.+..   ...+.+||+.|+|||++.+.. ++.++|-||||+++|||+.|..||...+..+.+.++...--
T Consensus       183 iKitDFGFAK~v~~---rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v  258 (355)
T KOG0616|consen  183 IKITDFGFAKRVSG---RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV  258 (355)
T ss_pred             EEEEeccceEEecC---cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence            99999999987753   356678999999999998765 89999999999999999999999999999888888775311


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~~  235 (235)
                      .                            -.+.+++++++||+++|+.|-++|.     ...++.+||||++++|..+
T Consensus       259 ~----------------------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  259 K----------------------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             c----------------------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            1                            1124788999999999999999993     6789999999999999753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-42  Score=271.27  Aligned_cols=212  Identities=44%  Similarity=0.788  Sum_probs=183.5

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+|+|+|||+-||..++.+   .+-.+++.+++.++.||+.||+|+|++|+.|||||.+|||++.++ .++|+|||+
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGL  264 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGL  264 (560)
T ss_pred             CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccc
Confidence            3568999999999999999976   344699999999999999999999999999999999999999888 999999999


Q ss_pred             cccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           91 ARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        91 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ++.+..... ..+...-|.+|+|||++.+...|+.+.|+||.||++.||+.|+..|.+.++.+++..+...++.|.+..|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            997765443 3566667999999999999988999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCC-C-CCC-ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          170 PGVSSLMNWHEY-P-QWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       170 ~~~~~~~~~~~~-~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      + . ..+.+... . ... ...+......++....+|+..||..||.+|.||.++|+|+||.
T Consensus       345 ~-~-~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  345 P-V-SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             c-c-ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            8 2 22222111 1 111 2345555778999999999999999999999999999999994

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.3e-41  Score=266.68  Aligned_cols=217  Identities=49%  Similarity=0.945  Sum_probs=175.5

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +....++..|+||||++|+|.+++...   +..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++++
T Consensus        70 ~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~  145 (288)
T cd07871          70 DIIHTERCLTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLA  145 (288)
T ss_pred             EEEcCCCeEEEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEC
Confidence            345566789999999999999988652   34578999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||+++.............++..|+|||.+.+...++.++|+||+||++|+|++|..||.+....+....+.+..+.+..
T Consensus       146 DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         146 DFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             cCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99998765433333344567889999999876555889999999999999999999999998888888888888888777


Q ss_pred             CCcccccccccccC--CCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..++.......+..  .+.+.........+..+++++++|++||+.||.+|||++|+++||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            77665543322221  11222222333445678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-42  Score=279.51  Aligned_cols=195  Identities=33%  Similarity=0.536  Sum_probs=173.2

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      +..+++|+++.++|+|.||++ |.|.+++..    .+++++.++..+++||+.|+.|.|..+++|||+||+|+|++..+ 
T Consensus        75 l~LydVwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-  149 (786)
T KOG0588|consen   75 LRLYDVWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-  149 (786)
T ss_pred             eeeeeeeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-
Confidence            457889999999999999997 599999987    46799999999999999999999999999999999999999887 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      ++||+|||++.... +.....+.+|+++|.+||++.+..+.+.++||||+|+++|.|++|+.||++++-...+.+..+..
T Consensus       150 nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~  228 (786)
T KOG0588|consen  150 NIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV  228 (786)
T ss_pred             CEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc
Confidence            69999999996443 44566778999999999999999888999999999999999999999999888877777776543


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...+                            .+++.++++||++||..||.+|+|.++++.|||++.+.
T Consensus       229 f~MP----------------------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  229 FEMP----------------------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             ccCC----------------------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            2222                            35889999999999999999999999999999998764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.4e-42  Score=272.67  Aligned_cols=202  Identities=28%  Similarity=0.477  Sum_probs=169.9

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.+=.+.++.++|+||||++| |+..+|.+    .+.++++.++.++.+++.|++.||+.|++||||||+|+|++..| 
T Consensus       204 VKLyYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-  278 (550)
T KOG0605|consen  204 VKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-  278 (550)
T ss_pred             EEEEEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-
Confidence            4556678899999999999985 99999977    46799999999999999999999999999999999999999888 


Q ss_pred             eEEEeecCCcccccC-----------------------CCC------------------------CcccccccccccCch
Q 026660           82 TLKIADLGLARAFTL-----------------------PIK------------------------KYTHEILTLWYRAPE  114 (235)
Q Consensus        82 ~~~l~df~~~~~~~~-----------------------~~~------------------------~~~~~~~~~~y~~PE  114 (235)
                      .++|+|||++..+..                       ...                        ......|||.|+|||
T Consensus       279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE  358 (550)
T KOG0605|consen  279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE  358 (550)
T ss_pred             CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence            999999999843210                       000                        001246799999999


Q ss_pred             hhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCC
Q 026660          115 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP  194 (235)
Q Consensus       115 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (235)
                      ++.+.. ++..+|.|||||++||||.|.+||.+.+..+...+++..-....                        .....
T Consensus       359 Vll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------------------fP~~~  413 (550)
T KOG0605|consen  359 VLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------------------------FPEEV  413 (550)
T ss_pred             HHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------------------CCCcC
Confidence            998766 89999999999999999999999999999999998886421111                        11122


Q ss_pred             CCChhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcCCC
Q 026660          195 NLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       195 ~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~~~  235 (235)
                      ..++++++||.+||. ||..|.   +++||.+||||+.++|+.|
T Consensus       414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            467899999999999 999998   5999999999999999865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=271.97  Aligned_cols=193  Identities=31%  Similarity=0.437  Sum_probs=162.5

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .....+....+|+||||+.| +|.+++.+    .+.+++..+..+++|++.|++|+|++|++||||||+|++++....++
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCE
Confidence            34455667779999999985 99999977    45789999999999999999999999999999999999999772499


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +++|||++..............||+.|+|||++.+.. ..+.++||||+|+++|.|++|..||...+.......+....-
T Consensus       161 Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~  240 (370)
T KOG0583|consen  161 KLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF  240 (370)
T ss_pred             EEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence            9999999987643445567789999999999998866 567999999999999999999999999776666655432100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCC-ChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .                            ....+ ++++++++++||..||.+|+|+.++++||||+.
T Consensus       241 ~----------------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 K----------------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             c----------------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            0                            01124 889999999999999999999999999999996

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-42  Score=265.83  Aligned_cols=219  Identities=41%  Similarity=0.738  Sum_probs=187.1

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +-++.+|||||+.+|.+.++.+-..+..++.-.++.+.+||..||+|||+.|++||||||.|+|++.+...+||+|||.+
T Consensus        94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            56788899999999999999887778889999999999999999999999999999999999999988779999999999


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      +.+.... .......|..|+|||.+.+...|+.+.||||.||++.||+-|++.|.+....+++..+.+.++.|....+..
T Consensus       174 K~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            8776432 234445588999999999998899999999999999999999999999999999999999999998776655


Q ss_pred             ccccccccCCCCCCccchhh-cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          172 VSSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      +.-.......++........ .....++++.+|+.++|..+|.+|.++.|+++||||+...
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            44433333333333333322 4446889999999999999999999999999999998654

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.4e-41  Score=276.85  Aligned_cols=222  Identities=35%  Similarity=0.689  Sum_probs=171.6

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...++++||||++++|.+++..+...+..+++..++.++.||+.||+|||+++++||||||+||+++..+..++|+|||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            34557889999999999999987766777899999999999999999999999999999999999998666579999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++...... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+.+..+.+.....
T Consensus       217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            997654322 2234467889999999876656899999999999999999999999998888887777776665543322


Q ss_pred             ccccccccccCCCCCCccchhhc-CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATA-VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ............+......+... ....++++++||++||..||.+|||+.++++||||+++..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            21111000001111111112111 2246789999999999999999999999999999987653

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.5e-40  Score=260.93  Aligned_cols=213  Identities=43%  Similarity=0.809  Sum_probs=168.4

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+....+++||||++++|.+++...  ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++++||
T Consensus        78 ~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Df  154 (290)
T cd07862          78 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF  154 (290)
T ss_pred             CCCCCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccc
Confidence            4456679999999999999999763  344589999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+...... .......++..|+|||.+.+.. ++.++|+||+||++|++++|..||.+....+....+....+.+....
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            998765433 2233456788999999987654 78999999999999999999999999888888888877766555443


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ++..... .................+.+++.+++++.+||+.||.+|||+.++++||||
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         233 WPRDVAL-PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             chhhhcc-cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            3322111 001111112223333445688899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=270.50  Aligned_cols=185  Identities=28%  Similarity=0.516  Sum_probs=160.9

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ++.+++|||||.| +|.+.+...     .++|.++..|+++++.||+|||.+|++|+|||.+|||+..++ .++|+|||+
T Consensus       342 ~deLWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGF  415 (550)
T KOG0578|consen  342 GDELWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGF  415 (550)
T ss_pred             cceeEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeee
Confidence            3779999999985 999999774     499999999999999999999999999999999999999888 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +..+.....+.....||+.|||||++.... |+.+.||||||++..||+-|.+||-..+....+..+... +.+...   
T Consensus       416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk---  490 (550)
T KOG0578|consen  416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK---  490 (550)
T ss_pred             eeccccccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC---
Confidence            998887777788889999999999997555 999999999999999999999999987776666555432 111111   


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                                           ....+|+.+++|+.+||..|+.+|+++.|||+||||+
T Consensus       491 ---------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  491 ---------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             ---------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence                                 1225889999999999999999999999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=260.46  Aligned_cols=189  Identities=29%  Similarity=0.477  Sum_probs=150.4

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ..++++|||++ |+|.+++.++.  + .++++.++++++|+++||+|||++|++|+||||+|||++..+..++|+|||.+
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence            37999999998 59999998842  2 69999999999999999999999999999999999999974349999999998


Q ss_pred             ccccC---CCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTL---PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~  167 (235)
                      .....   .........||+.|+|||++........++||||+||++.+|++|..||... ...+....+..   ....+
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~~~P  242 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---EDSLP  242 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cCCCC
Confidence            76653   1122445788999999999985332345999999999999999999999874 22222222221   11000


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                             .....+++++++|+++|+..||.+||||+++|+|||.+.-
T Consensus       243 -----------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  243 -----------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -----------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                                   1122488999999999999999999999999999998753

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.1e-40  Score=259.65  Aligned_cols=222  Identities=44%  Similarity=0.798  Sum_probs=166.6

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +..+++...|+||||++++|.+++.+.   ...++++.+..++.|++.||+|||+++++|+||||+||+++.++ .++++
T Consensus        70 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~  145 (303)
T cd07869          70 DIIHTKETLTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLA  145 (303)
T ss_pred             EEEecCCeEEEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEC
Confidence            445567789999999999999988752   34689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPN  165 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~  165 (235)
                      |||++..............++..|+|||++.+...++.++|+||+||++|+|++|..||.+..+ .+....+....+.+.
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         146 DFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             CCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            9999875543333334456788999999987655578999999999999999999999987543 444555555555555


Q ss_pred             CCCcccccccccc--cCCCCCCccchhh--cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNW--HEYPQWNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...+.........  .......+.....  ....+++++.+++++||+.||.+|||+.++++||||+++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            4444432211000  0000111111111  11135678899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-39  Score=259.59  Aligned_cols=223  Identities=48%  Similarity=0.944  Sum_probs=176.9

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+....++..|+||||++++|.+++...   +..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .+++
T Consensus        70 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl  145 (309)
T cd07872          70 HDIVHTDKSLTLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKL  145 (309)
T ss_pred             EEEEeeCCeEEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEE
Confidence            3345566789999999999999888652   34588999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+||++++|++|..||.+.+..+....+.+..+.+.
T Consensus       146 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  225 (309)
T cd07872         146 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT  225 (309)
T ss_pred             CccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99999876544333334456688999999987655578999999999999999999999999888888888888777777


Q ss_pred             CCCccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...|+.........  ..............+.++++++++|++||+.||.+|||+.++++||||+.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             HHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            66655443322111  11111222223344568899999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=273.50  Aligned_cols=196  Identities=28%  Similarity=0.429  Sum_probs=171.2

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+.-+.++.++|+||||++| |+..+     ...+.+++..++.++..++.||.|||++||+|||||.+|||++.+| .+
T Consensus       434 L~~~fQT~~~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~  507 (694)
T KOG0694|consen  434 LFSCFQTKEHLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HV  507 (694)
T ss_pred             cccccccCCeEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cE
Confidence            45678899999999999986 72222     3446799999999999999999999999999999999999999998 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.........++..||+.|+|||++.+.. |+.++|.|||||++|+|+.|..||.++++.+....+...-- 
T Consensus       508 kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-  585 (694)
T KOG0694|consen  508 KIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-  585 (694)
T ss_pred             EecccccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-
Confidence            9999999988776666788899999999999998766 99999999999999999999999999999999888874210 


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~~  235 (235)
                                                 .....+|.++.++++++|..||++|..     +++|..||||++++|+.|
T Consensus       586 ---------------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  586 ---------------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             ---------------------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence                                       011248899999999999999999985     578999999999999764

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-40  Score=269.92  Aligned_cols=220  Identities=33%  Similarity=0.557  Sum_probs=171.7

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~~~   83 (235)
                      ..+.+--.+|+|||+|.++.||.+++...  +-..++...++.++.||+.||..||+.+|+|+||||+|||+... ...+
T Consensus       253 m~d~F~fr~HlciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  253 MLDYFYFRNHLCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eeeccccccceeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCce
Confidence            34455556779999999999999999883  34459999999999999999999999999999999999998643 3379


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      ||+|||.+.......   .....+..|+|||++.+.. ++.+.|||||||++.||++|.+.|.+.+..+++..++..++.
T Consensus       331 KVIDFGSSc~~~q~v---ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRV---YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL  406 (586)
T ss_pred             eEEecccccccCCcc---eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence            999999997654321   2556688999999999876 899999999999999999999999999999999999999998


Q ss_pred             CCCCCcccccccccccCC-------C-------------------------CCC--ccchhhcCC-CCChhHHHHHHHhc
Q 026660          164 PNEKVWPGVSSLMNWHEY-------P-------------------------QWN--PQSLATAVP-NLDKDGLDLLEQML  208 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~-------~-------------------------~~~--~~~~~~~~~-~~~~~~~~li~~~l  208 (235)
                      |+..+.....+.....+.       .                         ..+  ...+..... .....+.++|++||
T Consensus       407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L  486 (586)
T KOG0667|consen  407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL  486 (586)
T ss_pred             CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence            886544332221111110       0                         000  001111111 23356789999999


Q ss_pred             ccCCCCCCCHHHHhCCCCCCCC
Q 026660          209 QYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       209 ~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .+||.+|+|+.++++||||...
T Consensus       487 ~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  487 EWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             ccCchhcCCHHHHhcCcccccc
Confidence            9999999999999999999843

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-40  Score=264.62  Aligned_cols=195  Identities=24%  Similarity=0.337  Sum_probs=159.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++++.+|+||||++| +|.+++.+    .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        61 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~k  135 (323)
T cd05571          61 KYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIK  135 (323)
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEE
Confidence            3455677889999999985 99888865    35689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.............|++.|+|||++.+.. ++.++|+||+||++|+|++|..||...........+....   
T Consensus       136 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---  211 (323)
T cd05571         136 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---  211 (323)
T ss_pred             EeeCCCCcccccCCCcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---
Confidence            999999875433333344556899999999987654 7899999999999999999999998776554444332110   


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                       .                        .....+++++.++|++||..||.+||     ++.++++||||++++|+.
T Consensus       212 -~------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~  261 (323)
T cd05571         212 -I------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQD  261 (323)
T ss_pred             -C------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence             0                        00124778999999999999999999     899999999999987753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.6e-39  Score=253.78  Aligned_cols=219  Identities=69%  Similarity=1.247  Sum_probs=175.9

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ++....|+||||++++|.+++...... ...+++..++.++.||+.||.|||+++++|+||+|+||+++..+..++++||
T Consensus        76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeec
Confidence            344568999999999999998764333 4568999999999999999999999999999999999999973448999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+....+....+......+....
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99876654433334445678899999987655578999999999999999999999998888777777777666666555


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      +....+...+...+.+.+.......+.+++++.++|++||..||.+||++.++++||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            554444444444444444444444557889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-39  Score=255.04  Aligned_cols=224  Identities=48%  Similarity=0.930  Sum_probs=177.2

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++..|+||||++++|.+++.+.   ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .+++
T Consensus        70 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl  145 (301)
T cd07873          70 HDIIHTEKSLTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKL  145 (301)
T ss_pred             EEEEecCCeEEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEE
Confidence            3445667789999999999999988762   34688999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+.....+........++..|+|||.+.+...++.++|+||+|+++++|++|..||...+..+....+.+....+.
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  225 (301)
T cd07873         146 ADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT  225 (301)
T ss_pred             CcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999876544333333445678899999987655578899999999999999999999998888788777777777776


Q ss_pred             CCCccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          166 EKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       166 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ...|....+...+.  ................+++.++++|.+||..||.+|||++++++||||+.+...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            66665443221111  111222222233445688899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-39  Score=261.22  Aligned_cols=219  Identities=36%  Similarity=0.652  Sum_probs=165.3

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .++...+|+||||++++|.+++.+    ...++++.+..++.||+.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus        73 ~~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Df  147 (338)
T cd07859          73 RREFKDIYVVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDF  147 (338)
T ss_pred             CCCCceEEEEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccC
Confidence            344567899999999999998865    34689999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCC---CcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           89 GLARAFTLPIK---KYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        89 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+++.......   ......++..|+|||++.+. ..++.++||||+||++|+|++|..||.+.........+....+.+
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99875432211   12344678899999998642 347889999999999999999999998887766666655555554


Q ss_pred             CCCCccccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          165 NEKVWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       165 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .............   ........+.......++.++++.+++++||..||.+|||++++++||||+.+..
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            4332222111000   0000111112233344567889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-40  Score=247.76  Aligned_cols=183  Identities=28%  Similarity=0.471  Sum_probs=159.3

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceecCCCCCcEEEcCCCCe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG--HG--ILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~--~~--~~H~di~~~nil~~~~~~~   82 (235)
                      ..+++..++||||+|+ |||..++..+++.++.+++..+|+++.|++.||..+|+  .+  +.||||||.||+++..| .
T Consensus        88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-v  166 (375)
T KOG0591|consen   88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-V  166 (375)
T ss_pred             hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-c
Confidence            4556666999999998 69999999999999999999999999999999999998  44  88999999999999777 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|++|||+++.+...........||+.|||||.+.+.. ++.+|||||+||++|||...+.||.+.+-.+...++.+..-
T Consensus       167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY  245 (375)
T ss_pred             eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence            99999999999887777777889999999999998766 89999999999999999999999999977666666654311


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      ++.                          ....+|.+++.+|..|+.+||..||+.
T Consensus       246 ~~~--------------------------p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 PPL--------------------------PDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCC--------------------------cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            100                          012488999999999999999999985

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-39  Score=255.51  Aligned_cols=203  Identities=26%  Similarity=0.355  Sum_probs=160.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++.+...|+||||++| +|.+++.........+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        59 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~  137 (280)
T cd05608          59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVR  137 (280)
T ss_pred             eEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEE
Confidence            3445667789999999985 99988876555566799999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............+++.|+|||.+.+.. ++.++|+||+|+++|++++|..||...................
T Consensus       138 l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  216 (280)
T cd05608         138 ISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND  216 (280)
T ss_pred             EeeCccceecCCCCccccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc
Confidence            999999876544333334456788999999997654 7899999999999999999999997654322111111111100


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .                        ......+++++.+++++||+.||.+||     +++++++||||+.++|+.
T Consensus       217 ~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         217 S------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             C------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            0                        001124778999999999999999999     889999999999988864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9e-40  Score=261.18  Aligned_cols=195  Identities=25%  Similarity=0.396  Sum_probs=159.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++.+.+|+||||++| +|.+++.+    ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~k  136 (320)
T cd05590          62 YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCK  136 (320)
T ss_pred             eeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEE
Confidence            4455677889999999985 99988865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|++.|+|||++.+.. ++.++|+||+||++|+|++|..||...+..+....+.....  
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--  213 (320)
T cd05590         137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--  213 (320)
T ss_pred             EeeCCCCeecCcCCCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--
Confidence            999999865433333334456899999999987554 78999999999999999999999988876665554432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~ll~hp~f~~~~~~~  234 (235)
                                                .....++.+++++|++||+.||.+||++      +++++||||++++|+.
T Consensus       214 --------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~  263 (320)
T cd05590         214 --------------------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK  263 (320)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                      0011367889999999999999999998      8999999999988753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=256.26  Aligned_cols=203  Identities=24%  Similarity=0.398  Sum_probs=162.4

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .|-.+..+++||+||. |++.+.+..+...+  +++..|..++++++.||.|||.+|.+|||||+.|||++.+| .++|+
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLa  168 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLA  168 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEc
Confidence            3445667999999998 59999999977655  99999999999999999999999999999999999999888 99999


Q ss_pred             ecCCcccccCCCCC----cccccccccccCchh-hhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           87 DLGLARAFTLPIKK----YTHEILTLWYRAPEV-LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        87 df~~~~~~~~~~~~----~~~~~~~~~y~~PE~-~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      |||.+..+-.....    .....++++|+|||+ ......|+.|+||||||++..|+.+|..||......+.+-.-.+  
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--  246 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--  246 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            99987544332222    255688999999999 44555689999999999999999999999998777665544332  


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..++... ..               .........++..++.+|..||..||.+|||++++++|+||+...
T Consensus       247 n~pp~~~-t~---------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  247 NDPPTLL-TS---------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             CCCCCcc-cc---------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            2222111 10               011122235778999999999999999999999999999999754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-39  Score=251.89  Aligned_cols=199  Identities=26%  Similarity=0.395  Sum_probs=168.1

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ++..++.+.+.|++||||+| +|..+.++  +.++.++++.++.++..++.||+|||-.|+++|||||+|||+-++| .+
T Consensus       142 LYa~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HI  218 (459)
T KOG0610|consen  142 LYASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HI  218 (459)
T ss_pred             hhheeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cE
Confidence            46788999999999999985 99999988  6677899999999999999999999999999999999999999888 89


Q ss_pred             EEeecCCcccccCC----------------------------------C----------------------CCccccccc
Q 026660           84 KIADLGLARAFTLP----------------------------------I----------------------KKYTHEILT  107 (235)
Q Consensus        84 ~l~df~~~~~~~~~----------------------------------~----------------------~~~~~~~~~  107 (235)
                      .|+||.++..+...                                  .                      .....+.||
T Consensus       219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT  298 (459)
T KOG0610|consen  219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT  298 (459)
T ss_pred             EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence            99999987433100                                  0                      001223567


Q ss_pred             ccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCcc
Q 026660          108 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ  187 (235)
Q Consensus       108 ~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (235)
                      -.|.|||++.+.. -+.++|.|+||+++|||+.|..||.+.+..+.+.+++.....                        
T Consensus       299 hEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~------------------------  353 (459)
T KOG0610|consen  299 HEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK------------------------  353 (459)
T ss_pred             cccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc------------------------
Confidence            7899999998766 689999999999999999999999999998888887642111                        


Q ss_pred             chhhcCCCCChhHHHHHHHhcccCCCCCCC----HHHHhCCCCCCCCCcC
Q 026660          188 SLATAVPNLDKDGLDLLEQMLQYDPSKRIS----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       188 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~ll~hp~f~~~~~~  233 (235)
                        ....++.+.++++||+++|..||.+|..    +.||.+||||+.++|.
T Consensus       354 --Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  354 --FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             --CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence              1112256789999999999999999997    9999999999999996

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.5e-41  Score=247.38  Aligned_cols=197  Identities=30%  Similarity=0.473  Sum_probs=166.0

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ...+..|++..+++|+|.|+ |.|.|++.+    .-.+|+....++++|+.+|++|||.++++|+|+||+|||++++. +
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~  161 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-N  161 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-c
Confidence            34567788888999999998 799999977    23589999999999999999999999999999999999999665 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      ++++|||++..+.. ..+.....||++|.|||.+..     ...|+...|+|++|+++|.++.|.+||......-.+..+
T Consensus       162 i~isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I  240 (411)
T KOG0599|consen  162 IKISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI  240 (411)
T ss_pred             eEEeccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence            99999999987664 356677899999999999862     345789999999999999999999999988777666666


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      +..--+                        -.+..+.+++...++||.+||+.||.+|.|++|+|+||||..+
T Consensus       241 meGkyq------------------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  241 MEGKYQ------------------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             Hhcccc------------------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            543111                        1122334578889999999999999999999999999999654

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-38  Score=251.49  Aligned_cols=214  Identities=44%  Similarity=0.809  Sum_probs=167.2

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..+....++++||+++++|.+++...  ....++++.++.++.|++.||+|||+.|++|+||+|+||+++.++ .++++|
T Consensus        75 ~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECc
Confidence            34456779999999999999998763  334589999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+...... .......++..|+|||++.+.. ++.++|+||+||++|+|++|..||......+....+....+.+...
T Consensus       152 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         152 FGLARIYSCQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cCccccccCc-ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            9998765432 1223345688899999987654 7899999999999999999999998888877777777766655544


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .++...... ................+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       230 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         230 DWPRDVTLP-RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hCccccccc-ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            333221110 11111222223334445688899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=235.88  Aligned_cols=198  Identities=28%  Similarity=0.423  Sum_probs=165.2

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--C
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--K   79 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~   79 (235)
                      |...+...+..+.|+|+|+|.| +|-.-+...    ..+|+..+--.+.||++||+|.|.++++|||+||+|+++..  .
T Consensus        73 vrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~  148 (355)
T KOG0033|consen   73 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAK  148 (355)
T ss_pred             eehhhhhcccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccC
Confidence            3455667788899999999986 776655542    45899999999999999999999999999999999999843  3


Q ss_pred             CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           80 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +..++++|||++..+. +........||+.|+|||++.... ++..+|||+.|+++|-++.|..||.+......+.++.+
T Consensus       149 ~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~  226 (355)
T KOG0033|consen  149 GAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA  226 (355)
T ss_pred             CCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            4478999999998887 556667788999999999997554 89999999999999999999999999888777777664


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..-..                        ....+++++++.++||++||..||.+|+|+.|.|+|||+.+-
T Consensus       227 g~yd~------------------------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  227 GAYDY------------------------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             cccCC------------------------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            31111                        112344688999999999999999999999999999998764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.9e-39  Score=251.35  Aligned_cols=218  Identities=52%  Similarity=0.948  Sum_probs=167.7

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...+....|+|+||++++|.+++.+.   ...++++.++.++.||+.||.|||+++++|+||+|+||+++.++ .+++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l  140 (284)
T cd07839          65 YDVLHSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKL  140 (284)
T ss_pred             HHHhccCCceEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEE
Confidence            3445667789999999999999887652   34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+||++++|++|..|+ .+....+....+....+.+
T Consensus       141 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07839         141 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  220 (284)
T ss_pred             CccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999998765544333344556788999999876655789999999999999999998885 4455555666666666655


Q ss_pred             CCCCcccccccccccCCCCCCcc-chhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ....+.................. ......+.++++++++|++||..||.+|||++++++||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            55444433332222222222111 1123445688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.6e-39  Score=251.80  Aligned_cols=219  Identities=59%  Similarity=1.077  Sum_probs=170.4

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +...++..+|+||||++++|.+++.... .+..+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++++
T Consensus        66 ~~~~~~~~~~~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~  143 (285)
T cd07861          66 DVLMQESRLYLIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLA  143 (285)
T ss_pred             EEEeeCCeEEEEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEEC
Confidence            3445677899999999999999987643 235689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||++.....+........++..|+|||.+.+...++.++|+||+|++++++++|..||.+..............+.+..
T Consensus       144 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         144 DFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             cccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99998765544333344456788999999876555788999999999999999999999988877777666666655554


Q ss_pred             CCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..|.......++. ....+...........++++++++|++||..||.+|||+.++++||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            4443332221111 111122222233344688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-39  Score=258.00  Aligned_cols=194  Identities=27%  Similarity=0.449  Sum_probs=157.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++++|+||||++| +|.+++..    +..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~k  136 (316)
T cd05620          62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIK  136 (316)
T ss_pred             eEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEE
Confidence            3455677899999999985 99988865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++..............|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+....+....  +
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~  213 (316)
T cd05620         137 IADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P  213 (316)
T ss_pred             eCccCCCeecccCCCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C
Confidence            999998864332223344556799999999997654 7899999999999999999999998776655444332110  0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-HHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-KKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~hp~f~~~~~~  233 (235)
                                                .....++.+++++|++||..||.+||++ +++++||||+.++|.
T Consensus       214 --------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         214 --------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence                                      0011367889999999999999999998 589999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-39  Score=258.85  Aligned_cols=195  Identities=25%  Similarity=0.383  Sum_probs=160.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.+++++.+|+||||++| +|..++.+    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~k  136 (321)
T cd05591          62 HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCK  136 (321)
T ss_pred             eeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEE
Confidence            3455677789999999985 99988865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|+..|+|||++.+.. ++.++|+||+||++|+|++|..||......+....+.....  
T Consensus       137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--  213 (321)
T cd05591         137 LADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--  213 (321)
T ss_pred             EeecccceecccCCccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999999875443333344456789999999987654 78999999999999999999999998877666555432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-------CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-------SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~~ll~hp~f~~~~~~~  234 (235)
                                                .....++.++.++|++||..||.+||       ++.++++||||..++|+.
T Consensus       214 --------------------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~  264 (321)
T cd05591         214 --------------------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL  264 (321)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence                                      00113678899999999999999999       899999999999988753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=253.57  Aligned_cols=191  Identities=25%  Similarity=0.377  Sum_probs=157.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++.+|+||||++| +|.+++.+    .+.++++.+..++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~k  141 (291)
T cd05612          67 FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIK  141 (291)
T ss_pred             HhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEE
Confidence            4455677889999999985 99999976    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++......   .....|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+.....  
T Consensus       142 l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--  215 (291)
T cd05612         142 LTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--  215 (291)
T ss_pred             EEecCcchhccCC---cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--
Confidence            9999998765422   22346788999999987654 78999999999999999999999988776555554432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                                                .....+++.++++|++||+.||.+||+     ++++++||||+.++|.
T Consensus       216 --------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         216 --------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                                      001135788999999999999999995     9999999999988875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-39  Score=254.04  Aligned_cols=199  Identities=25%  Similarity=0.406  Sum_probs=156.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++++..++||||+++ +|.+++...  ....+++..++.++.|++.||+|||+++++|+||||+||+++.++ .+++
T Consensus        67 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl  143 (285)
T cd05631          67 YAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRI  143 (285)
T ss_pred             EEEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEE
Confidence            345667789999999985 998888652  334689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++...... .......++..|+|||++.+.. ++.++||||+||++|++++|..||....................
T Consensus       144 ~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05631         144 SDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ  221 (285)
T ss_pred             eeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc
Confidence            999998764322 1223446789999999997654 78999999999999999999999987554322222222111100


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                                              ......+++++.+++++||+.||.+||+     ++++++||||++++|+.
T Consensus       222 ------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         222 ------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             ------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence                                    0111247789999999999999999997     89999999999998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=256.72  Aligned_cols=194  Identities=26%  Similarity=0.430  Sum_probs=157.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++++.+|+||||++| +|.+++..    .+.+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++
T Consensus        59 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~k  133 (312)
T cd05585          59 KFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIA  133 (312)
T ss_pred             eeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEE
Confidence            3455677889999999985 99999865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||......+........   +
T Consensus       134 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~  209 (312)
T cd05585         134 LCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P  209 (312)
T ss_pred             EEECcccccCccCCCccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C
Confidence            999999875433333334456899999999997654 789999999999999999999999887665544443321   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~  233 (235)
                       .                        .....++++++++|++||+.||.+||   ++.++++||||.+.++.
T Consensus       210 -~------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~  256 (312)
T cd05585         210 -L------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWK  256 (312)
T ss_pred             -C------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHH
Confidence             0                        01124678899999999999999997   58999999999987653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-38  Score=250.02  Aligned_cols=217  Identities=36%  Similarity=0.679  Sum_probs=159.8

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..+++..+|+||||+++++.+.+..   ....++++.++.++.|++.||.|||+.+++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl  141 (287)
T cd07848          66 KEAFRRRGKLYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKL  141 (287)
T ss_pred             hhhEecCCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEE
Confidence            345567788999999999866665543   234689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+........ ......++..|+|||++.+.. ++.++|+||+||++|++++|..||......+....+....+..
T Consensus       142 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07848         142 CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL  220 (287)
T ss_pred             eeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            99999876543222 223446788999999987655 7899999999999999999999999877766666555544443


Q ss_pred             CCCCcccccccccccC--CCCC--CccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHE--YPQW--NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      +...+....+......  ....  ...........++.++.++|++||+.||.+|||++++++||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            3221111111000000  0000  0000111122478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-39  Score=257.68  Aligned_cols=194  Identities=25%  Similarity=0.359  Sum_probs=157.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++++.+|+||||+++ +|.+++..    ...+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++
T Consensus        61 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~k  135 (328)
T cd05593          61 KYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIK  135 (328)
T ss_pred             EEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEE
Confidence            3455677889999999985 99888755    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.............|++.|+|||++.+.. ++.++|+||+||++|++++|..||......+....+...    
T Consensus       136 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~----  210 (328)
T cd05593         136 ITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----  210 (328)
T ss_pred             EecCcCCccCCCcccccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC----
Confidence            999999865433333334456899999999987654 789999999999999999999999876654443332210    


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                      ..                        .....+++++.++|++||..||.+|+     ++.++++||||.+.+|.
T Consensus       211 ~~------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         211 DI------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             Cc------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            00                        01124678999999999999999997     89999999999988775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-39  Score=256.48  Aligned_cols=194  Identities=25%  Similarity=0.404  Sum_probs=157.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..+++++.+|+||||++| +|.+++..    ...++++.+..++.||+.||+|||++|++|+||||+||+++.++ .+++
T Consensus        68 ~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL  142 (324)
T cd05587          68 SCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKI  142 (324)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEE
Confidence            345567789999999985 99998865    34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+....+.....   
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---  218 (324)
T cd05587         143 ADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---  218 (324)
T ss_pred             eecCcceecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---
Confidence            99998865432223334456789999999997655 78999999999999999999999988776655554432100   


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~hp~f~~~~~~~  234 (235)
                                               .....+++++.+++++||..||.+|++.     +++++||||+.++|+.
T Consensus       219 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~  267 (324)
T cd05587         219 -------------------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK  267 (324)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                                     0011367889999999999999999976     8999999999988753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.1e-39  Score=255.22  Aligned_cols=194  Identities=27%  Similarity=0.418  Sum_probs=158.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++++|+||||++| +|.+++.+    ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~k  136 (318)
T cd05570          62 HSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIK  136 (318)
T ss_pred             eeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEE
Confidence            3455677889999999985 99888865    34699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++..............++..|+|||++.+.. ++.++|+||+||++|++++|..||.+....+....+.....  
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--  213 (318)
T cd05570         137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--  213 (318)
T ss_pred             ecccCCCeecCcCCCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999998865333333334456788999999997655 78999999999999999999999987776554443322100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~hp~f~~~~~~  233 (235)
                                                .....++.++.++|++||..||.+|||+     .++++||||++++|+
T Consensus       214 --------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         214 --------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             --------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                                      0011367889999999999999999999     999999999998874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.9e-39  Score=255.03  Aligned_cols=194  Identities=28%  Similarity=0.446  Sum_probs=157.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....+.+..+|+||||++| +|.+++..    ...+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~k  136 (316)
T cd05592          62 FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIK  136 (316)
T ss_pred             eeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEE
Confidence            3445667789999999975 99988865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+....+....  +
T Consensus       137 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~  213 (316)
T cd05592         137 IADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P  213 (316)
T ss_pred             EccCcCCeECCCCCCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C
Confidence            999999875443333444557899999999987655 7899999999999999999999998877655544432110  0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~hp~f~~~~~~  233 (235)
                                                .....++.++.+++++||..||.+||++. ++++||||..++|.
T Consensus       214 --------------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         214 --------------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence                                      00113678899999999999999999865 88999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=251.99  Aligned_cols=219  Identities=29%  Similarity=0.520  Sum_probs=172.9

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-------
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-------   79 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-------   79 (235)
                      +-++-.++.|||+|.++-|+.+++.+  +.-.+++...++.|+.|++.++++||+.+++|-|+||+||++...       
T Consensus       158 ~wFdyrghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hhhhccCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            34677888999999999999999977  444568999999999999999999999999999999999998321       


Q ss_pred             ------------CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 026660           80 ------------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG  147 (235)
Q Consensus        80 ------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  147 (235)
                                  +..++++|||.++...   ...+....|..|+|||++.+.. ++..+||||+||+++|+++|...|..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceeccc
Confidence                        2268999999986543   3335667799999999999766 99999999999999999999999999


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCccccc-------ccccccCCCCCC-----------ccchhhcCCCCChhHHHHHHHhcc
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVS-------SLMNWHEYPQWN-----------PQSLATAVPNLDKDGLDLLEQMLQ  209 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~  209 (235)
                      .++.+.++.+.+.+++.+........       ...+|.......           .............++.+|+++||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            99999999999999977766554441       122222211111           011111111233568999999999


Q ss_pred             cCCCCCCCHHHHhCCCCCCCCC
Q 026660          210 YDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       210 ~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      +||.+|+|+.|+|.||||+...
T Consensus       392 fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cCccccccHHHHhcCHHhhcCC
Confidence            9999999999999999998654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-39  Score=257.39  Aligned_cols=192  Identities=26%  Similarity=0.382  Sum_probs=158.5

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++...+|+||||++ |+|.+++.+    ...++++.+..++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus        96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~i  170 (340)
T PTZ00426         96 LYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FI  170 (340)
T ss_pred             eEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CE
Confidence            3445567788999999997 499999876    34689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||++.....   ......||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.........+......
T Consensus       171 kL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~  246 (340)
T PTZ00426        171 KMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY  246 (340)
T ss_pred             EEecCCCCeecCC---CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999875532   223456788999999997654 789999999999999999999999887766555544321100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                                                  .....+++++++|++||+.||.+|+     +++++++||||++++|.
T Consensus       247 ----------------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        247 ----------------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                        0123678899999999999999995     89999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.8e-39  Score=257.44  Aligned_cols=192  Identities=26%  Similarity=0.374  Sum_probs=157.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+.+++++.+|+||||+.| +|.+++.+    .+.++++.+..++.||+.||+|||+++++|+||||+||+++.++ .+
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~  157 (329)
T PTZ00263         83 MMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HV  157 (329)
T ss_pred             EEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CE
Confidence            34456677889999999975 99999876    34689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||++......   .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....+....+..... 
T Consensus       158 kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-  232 (329)
T PTZ00263        158 KVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL-  232 (329)
T ss_pred             EEeeccCceEcCCC---cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc-
Confidence            99999998765422   22346789999999997655 78999999999999999999999988776555444332100 


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                                                 .....++..++++|++||+.||.+||+     ++++++||||++.+|+
T Consensus       233 ---------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        233 ---------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                                       001136678999999999999999996     7999999999988775

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-38  Score=253.98  Aligned_cols=194  Identities=29%  Similarity=0.457  Sum_probs=157.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++.+|+||||++| +|.+++.+    ...+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~k  136 (316)
T cd05619          62 YCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIK  136 (316)
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEE
Confidence            3445667789999999975 99998875    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++..............+|..|+|||++.+.. ++.++|+||+||++|+|++|..||......+....+....  +
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~  213 (316)
T cd05619         137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P  213 (316)
T ss_pred             EccCCcceECCCCCCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C
Confidence            999999865433323334456789999999987654 7899999999999999999999998877655444332110  0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~hp~f~~~~~~  233 (235)
                        .                        ....++.+++++|.+||..||.+||++. ++++||||+.++|+
T Consensus       214 --~------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         214 --C------------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             --C------------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence              0                        0113668899999999999999999996 89999999998875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-38  Score=254.84  Aligned_cols=194  Identities=23%  Similarity=0.327  Sum_probs=157.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++.++..|+||||++| +|..++..    .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        61 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~k  135 (323)
T cd05595          61 KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIK  135 (323)
T ss_pred             eeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEE
Confidence            3455677889999999985 99888755    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.................  
T Consensus       136 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--  212 (323)
T cd05595         136 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--  212 (323)
T ss_pred             ecccHHhccccCCCCccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--
Confidence            999998865433323334456789999999987654 78999999999999999999999987766554443321100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                                                .....+++++.++|++||..||.+|+     ++.++++||||.+++|.
T Consensus       213 --------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         213 --------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                      00124678999999999999999998     89999999999988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.4e-39  Score=255.96  Aligned_cols=194  Identities=24%  Similarity=0.383  Sum_probs=158.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..++++...|+||||++| +|..++.+    .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|
T Consensus        63 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl  137 (323)
T cd05575          63 YSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVL  137 (323)
T ss_pred             EEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEE
Confidence            445667889999999985 99988865    34689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....    
T Consensus       138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----  212 (323)
T cd05575         138 TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----  212 (323)
T ss_pred             eccCCCcccccCCCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----
Confidence            99999865433333344556789999999987654 7899999999999999999999998877655544443210    


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll~hp~f~~~~~~~  234 (235)
                                              ....+.+++.+.++|++||+.||.+||++    .++++||||.+++|+.
T Consensus       213 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~  261 (323)
T cd05575         213 ------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD  261 (323)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                    00112467889999999999999999987    6999999999988753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-38  Score=254.24  Aligned_cols=193  Identities=25%  Similarity=0.377  Sum_probs=158.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.++.++..|+||||++| +|..++..     +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        68 ~~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~k  141 (324)
T cd05589          68 FACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVK  141 (324)
T ss_pred             eeEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEE
Confidence            4455677889999999985 98877743     4699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+....+....+...... 
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-  219 (324)
T cd05589         142 IADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-  219 (324)
T ss_pred             eCcccCCccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-
Confidence            999998865433333344567889999999987654 789999999999999999999999887766555544321000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                                                 ....+++.+.++|++||..||.+||     ++.++++||||+++++.
T Consensus       220 ---------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         220 ---------------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                                       0124678899999999999999999     69999999999988764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=255.16  Aligned_cols=199  Identities=25%  Similarity=0.428  Sum_probs=160.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++.++.|+||||++| +|.+++.+    ...+++..++.++.|++.||.|||+++++|+||||+||+++.++ .++|
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL  142 (333)
T cd05600          68 YAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKL  142 (333)
T ss_pred             EEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEE
Confidence            445667789999999975 99999965    34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++.....   ......|++.|+|||++.+.. ++.++|+||+||++|+|++|..||......+....+........
T Consensus       143 ~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  218 (333)
T cd05600         143 TDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ  218 (333)
T ss_pred             EeCcCCccccc---ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc
Confidence            99999875543   233456789999999987664 88999999999999999999999988776665554433211110


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ...                    .......+++++.++|++||..+|.+||++.++++||||++++|..
T Consensus       219 ~~~--------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         219 RPV--------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             CCC--------------------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence            000                    0000134788999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-38  Score=255.96  Aligned_cols=198  Identities=26%  Similarity=0.397  Sum_probs=154.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..++.++.+|+||||++| +|.+++..    ...++++.+..++.||+.||+|||++|++|+||||+||+++.++ .++|
T Consensus        72 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl  146 (332)
T cd05614          72 YAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVL  146 (332)
T ss_pred             EEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEE
Confidence            445677889999999985 99999865    34689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||+++....... ......||..|+|||++.+...++.++||||+||++|+|++|..||...................
T Consensus       147 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  226 (332)
T cd05614         147 TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC  226 (332)
T ss_pred             eeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC
Confidence            99999875433222 22345679999999998765557889999999999999999999996432211111111111000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                      ..                        .....+++.+++++++||..||.+||     +++++++||||++.+|+
T Consensus       227 ~~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         227 DP------------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CC------------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            00                        01123678899999999999999999     88899999999987764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-38  Score=253.98  Aligned_cols=194  Identities=24%  Similarity=0.385  Sum_probs=158.6

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++++.+|+||||++ |+|.+++..    ...+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|
T Consensus        68 ~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL  142 (323)
T cd05616          68 SCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKI  142 (323)
T ss_pred             EEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEE
Confidence            34566778999999997 499988865    34689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............|++.|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+....+......  
T Consensus       143 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--  219 (323)
T cd05616         143 ADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--  219 (323)
T ss_pred             ccCCCceecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--
Confidence            99999875433333334456789999999997655 789999999999999999999999887766555544321100  


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~hp~f~~~~~~~  234 (235)
                                                ....+++++.+++++||+.||.+|++.     .++++||||+.++|..
T Consensus       220 --------------------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         220 --------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             --------------------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                                      011367889999999999999999974     8999999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=257.47  Aligned_cols=195  Identities=27%  Similarity=0.382  Sum_probs=157.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..++++...|+||||++| +|.+++.+    .+.++++.++.++.||+.||+|||+++++|+||||+||+++.++ .++|
T Consensus        63 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl  137 (330)
T cd05586          63 FSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIAL  137 (330)
T ss_pred             EEEecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEE
Confidence            345667889999999975 99988865    35689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............|+..|+|||++.+...++.++|+||+||++|+|++|..||......+....+......  
T Consensus       138 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--  215 (330)
T cd05586         138 CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--  215 (330)
T ss_pred             ecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            999998654333333344568899999999876555789999999999999999999999887665544433211000  


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCCcC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~ll~hp~f~~~~~~  233 (235)
                                               .....++++++++|++||..||.+||    ++.++++||||.+..|.
T Consensus       216 -------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~  262 (330)
T cd05586         216 -------------------------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD  262 (330)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence                                     00113678899999999999999998    79999999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.2e-38  Score=245.55  Aligned_cols=219  Identities=57%  Similarity=1.072  Sum_probs=171.6

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++..++||||++++|.+++..  ..+..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .+++
T Consensus        65 ~~~~~~~~~~~~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l  141 (284)
T cd07860          65 LDVIHTENKLYLVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKL  141 (284)
T ss_pred             hhhcccCCcEEEEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEE
Confidence            345567788999999998899998876  3345689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+|+++|++++|..||.............+....+.
T Consensus       142 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07860         142 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD  221 (284)
T ss_pred             eeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999876544333334445577899999887655468899999999999999999999998887777777777666665


Q ss_pred             CCCcccccccccc-cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          166 EKVWPGVSSLMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       166 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...++........ .....+.........+.++++++++|++||+.||.+|||+.++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            5444332211110 1122223333344445678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8e-39  Score=257.30  Aligned_cols=191  Identities=29%  Similarity=0.481  Sum_probs=167.0

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      -.+.+|++.++++|+|||.|+|..++..    ++.++++.+..++.|++.||.|||++++.|+|+||.||++...+ .+|
T Consensus        66 m~esfEt~~~~~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~K  140 (808)
T KOG0597|consen   66 MLESFETSAHLWVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLK  140 (808)
T ss_pred             HHHhhcccceEEEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-cee
Confidence            3467899999999999999999999976    67899999999999999999999999999999999999999776 999


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||+++..+......+...||+.|||||++.+.. ++..+|+||+||++||++.|++||....-.+....+..-... 
T Consensus       141 lcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-  218 (808)
T KOG0597|consen  141 LCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-  218 (808)
T ss_pred             echhhhhhhcccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-
Confidence            999999998877666777889999999999998655 899999999999999999999999877666655555431111 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                                 ...+.+..+.++++.+|..||.+|.++.+++.|||++.
T Consensus       219 ---------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  219 ---------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             ---------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence                                       11257889999999999999999999999999999874

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=256.66  Aligned_cols=198  Identities=28%  Similarity=0.461  Sum_probs=160.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++++++|+||||++| +|.+++.+.    ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~k  141 (350)
T cd05573          67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIK  141 (350)
T ss_pred             hhheecCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEE
Confidence            4456677889999999975 999999763    5699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCC-----------------------------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHH
Q 026660           85 IADLGLARAFTLPI-----------------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF  135 (235)
Q Consensus        85 l~df~~~~~~~~~~-----------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l  135 (235)
                      |+|||++.......                             .......||+.|+|||++.+.. ++.++|||||||++
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  220 (350)
T cd05573         142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVIL  220 (350)
T ss_pred             eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhh
Confidence            99999987654332                             1233456789999999997664 88999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCC
Q 026660          136 AELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR  215 (235)
Q Consensus       136 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  215 (235)
                      |+|++|..||......+....+........                        ......+++++.++|++||. ||.+|
T Consensus       221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~~~~~~li~~ll~-dp~~R  275 (350)
T cd05573         221 YEMLYGFPPFYSDTLQETYNKIINWKESLR------------------------FPPDPPVSPEAIDLICRLLC-DPEDR  275 (350)
T ss_pred             hhhccCCCCCCCCCHHHHHHHHhccCCccc------------------------CCCCCCCCHHHHHHHHHHcc-Chhhc
Confidence            999999999988876655554443110000                        00111268899999999998 99999


Q ss_pred             CC-HHHHhCCCCCCCCCcCC
Q 026660          216 IS-AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       216 ps-~~~ll~hp~f~~~~~~~  234 (235)
                      |+ ++++++||||++++|+.
T Consensus       276 ~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         276 LGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             CCCHHHHhcCCCcCCCCHHH
Confidence            99 99999999999988753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-38  Score=252.98  Aligned_cols=194  Identities=26%  Similarity=0.412  Sum_probs=157.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++.++..|+||||++| +|.+++.+    .+.++++.+..++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~k  140 (323)
T cd05584          66 IYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVK  140 (323)
T ss_pred             eeEEecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEE
Confidence            3455667789999999985 99998865    34688999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............+++.|+|||++.+.. ++.++||||+||++|+|++|..||......+....+.....  
T Consensus       141 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--  217 (323)
T cd05584         141 LTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--  217 (323)
T ss_pred             EeeCcCCeecccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999999865433333333456789999999987654 78899999999999999999999988776555444432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                                                .....+++++.++|++||..||.+||     ++.++++||||+..+|.
T Consensus       218 --------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~  265 (323)
T cd05584         218 --------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD  265 (323)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                                      01123678899999999999999999     89999999999987664

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-38  Score=255.24  Aligned_cols=194  Identities=23%  Similarity=0.327  Sum_probs=156.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ...++.++.+|+||||++| +|..++..    ...++++.++.++.||+.||+|||+ .|++|+||||+||+++.++ .+
T Consensus        61 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~  135 (325)
T cd05594          61 KYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HI  135 (325)
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CE
Confidence            3455677889999999985 99888765    3468999999999999999999997 7999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||++..............|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+.......... 
T Consensus       136 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-  213 (325)
T cd05594         136 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-  213 (325)
T ss_pred             EEecCCCCeecCCCCcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-
Confidence            9999999865433323334456889999999987654 78999999999999999999999987765544433321100 


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                                                 .....+++++.++|++||..||.+|+     ++.++++||||.++.|+
T Consensus       214 ---------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         214 ---------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                                       00123678899999999999999997     89999999999988765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.5e-38  Score=255.49  Aligned_cols=199  Identities=20%  Similarity=0.339  Sum_probs=155.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....++++..+|+||||++| +|.+++.+    .+.+++..++.++.|++.||+|||++|++||||||+||+++.++ .+
T Consensus        66 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~v  140 (363)
T cd05628          66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HV  140 (363)
T ss_pred             EEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CE
Confidence            34456677889999999985 99999875    35699999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-----------------------------------CcccccccccccCchhhhCCCCCCchhhH
Q 026660           84 KIADLGLARAFTLPIK-----------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDM  128 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di  128 (235)
                      +|+|||+++.......                                   ......||+.|+|||++.+.. ++.++|+
T Consensus       141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~Dv  219 (363)
T cd05628         141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDW  219 (363)
T ss_pred             EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhh
Confidence            9999999865432100                                   012346899999999987654 7899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhc
Q 026660          129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML  208 (235)
Q Consensus       129 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  208 (235)
                      ||+||++|+|++|..||.+....+....+........                        ......++++++++|.+|+
T Consensus       220 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~s~~~~~li~~l~  275 (363)
T cd05628         220 WSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI------------------------FPPEVPISEKAKDLILRFC  275 (363)
T ss_pred             hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc------------------------CCCcCCCCHHHHHHHHHHc
Confidence            9999999999999999988776665555443110000                        0011136788999999976


Q ss_pred             ccCCC---CCCCHHHHhCCCCCCCCCcCC
Q 026660          209 QYDPS---KRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       209 ~~~p~---~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      . +|.   .||+++++++||||++++|+.
T Consensus       276 ~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         276 C-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             C-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            5 444   468999999999999998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-37  Score=245.23  Aligned_cols=222  Identities=46%  Similarity=0.846  Sum_probs=172.6

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +...+++..|+||||+.|+|.+++.+.   ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~  144 (298)
T cd07841          69 DVFGHKSNINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLA  144 (298)
T ss_pred             heeecCCEEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEc
Confidence            444557789999999977999999762   13689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||++..............++..|+|||.+.+...++.++|+||+||+++++++|..||......+...........+..
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  224 (298)
T cd07841         145 DFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE  224 (298)
T ss_pred             cceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence            99999776554333444456778999999866555789999999999999999998888877776666666665555554


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ..+...........................+.++.++|++||..||++|||+.++++||||++...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            444433332222222222223333344567889999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.4e-37  Score=244.39  Aligned_cols=225  Identities=56%  Similarity=1.063  Sum_probs=175.9

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...++.+.|+||||++++|.+++...  ....+++..++.++.||+.||+|||+++++|+||+|+||+++..+..+++
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl  144 (294)
T PLN00009         67 QDVVHSEKRLYLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL  144 (294)
T ss_pred             EEEEecCCeEEEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEE
Confidence            3445566789999999998999888652  23346888999999999999999999999999999999999866557999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+|++++++++|..||......+...........+.
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        145 ADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             cccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999876544333334445678899999987655578999999999999999999999998887777777777777766


Q ss_pred             CCCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...|........+. ....+.........+.+++++.+++++||+.+|.+||++.++++||||.++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            66655433322221 11222233334445678899999999999999999999999999999998754

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.2e-38  Score=262.80  Aligned_cols=216  Identities=27%  Similarity=0.390  Sum_probs=159.4

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCC--------
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM--------   81 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~--------   81 (235)
                      +..++|+|||+++++|.+++.+    .+.+++..+..++.||+.||+|||+ .|++|+||||+||+++..+.        
T Consensus       203 ~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        203 ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            3467999999999899998876    3468999999999999999999998 59999999999999986542        


Q ss_pred             -------eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 026660           82 -------TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL  154 (235)
Q Consensus        82 -------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  154 (235)
                             .++|+|||.+....   .......+|..|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+..
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             ccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   48999999875322   2234457799999999997655 889999999999999999999999988887777


Q ss_pred             HHHHHHhCCCCCCCcccccc-----cccccC--CCCCCccchh-------hcCCCCChhHHHHHHHhcccCCCCCCCHHH
Q 026660          155 LHIFRLLGTPNEKVWPGVSS-----LMNWHE--YPQWNPQSLA-------TAVPNLDKDGLDLLEQMLQYDPSKRISAKK  220 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  220 (235)
                      ..+....+..+..+......     ......  .....+....       ......++.+.+||++||.+||.+|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            77766666544332111000     000000  0000000000       000012466789999999999999999999


Q ss_pred             HhCCCCCCCCCcCC
Q 026660          221 AMEHPYFDDLDKTR  234 (235)
Q Consensus       221 ll~hp~f~~~~~~~  234 (235)
                      +|+||||..+..+|
T Consensus       435 ~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        435 MTTHPYVLKYYPEC  448 (467)
T ss_pred             HhcCccccccCCcc
Confidence            99999999865543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-37  Score=248.25  Aligned_cols=218  Identities=38%  Similarity=0.739  Sum_probs=156.9

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC---CCC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQ-----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTM   81 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~---~~~   81 (235)
                      +.+..+|++|||++++|.+++.....     ....+++..++.++.||+.||+|||++|++|+||||+||++..   ...
T Consensus        70 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~  149 (317)
T cd07868          70 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  149 (317)
T ss_pred             CCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC
Confidence            34567899999999999998865321     2235899999999999999999999999999999999999942   223


Q ss_pred             eEEEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Q 026660           82 TLKIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--------  150 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------  150 (235)
                      .++++|||+++.......   ......+|+.|+|||++.+...++.++|+||+||++++|++|..||.....        
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~  229 (317)
T cd07868         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  229 (317)
T ss_pred             cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence            799999999976543221   223456788999999998765588999999999999999999999964332        


Q ss_pred             -HHHHHHHHHHhCCCCCCCcccccccccccC---------CCCCC-ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH
Q 026660          151 -LQQLLHIFRLLGTPNEKVWPGVSSLMNWHE---------YPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK  219 (235)
Q Consensus       151 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  219 (235)
                       ......+....+.+....+...........         ..... ...........+.++.++|++||+.||.+|||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~  309 (317)
T cd07868         230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence             344555555555554443333221110000         00000 0001111223456789999999999999999999


Q ss_pred             HHhCCCCC
Q 026660          220 KAMEHPYF  227 (235)
Q Consensus       220 ~ll~hp~f  227 (235)
                      |+++||||
T Consensus       310 e~l~hp~f  317 (317)
T cd07868         310 QAMQDPYF  317 (317)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-38  Score=252.77  Aligned_cols=198  Identities=23%  Similarity=0.385  Sum_probs=152.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.+++++.+|+||||++| +|.+++.+    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~k  136 (329)
T cd05588          62 HSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIK  136 (329)
T ss_pred             EEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEE
Confidence            3445677889999999985 99888865    35699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-----QLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~  159 (235)
                      |+|||+++.............||..|+|||++.+.. ++.++|+||+||++|++++|..||.......     ......+
T Consensus       137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (329)
T cd05588         137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ  215 (329)
T ss_pred             ECcCccccccccCCCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH
Confidence            999999865332223334456789999999997654 7899999999999999999999996321100     0000111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCcC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~ll~hp~f~~~~~~  233 (235)
                      ......                        ......++.++.++|++||+.||.+|++      ++++++||||.+++|.
T Consensus       216 ~~~~~~------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         216 VILEKQ------------------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             HHHcCC------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            000000                        0011246788999999999999999987      7899999999988774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=252.86  Aligned_cols=197  Identities=27%  Similarity=0.428  Sum_probs=173.1

Q ss_pred             cccCCcCCCceE-EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            3 VKQGQNKEGRTV-LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         3 ~~~~~~~~~~~~-~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      |.+.+.|++++. +||+|+||.| ++.+.+..  +++..++++.++.|+.|++.|+.|||+++++|||||+.||++..++
T Consensus        66 v~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~  143 (426)
T KOG0589|consen   66 VEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK  143 (426)
T ss_pred             eeeccchhcCCceEEEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC
Confidence            345567777777 9999999985 99999988  4467899999999999999999999999999999999999999777


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                       .++++|||+++.............||+.|++||++.+.. |+.++|||||||++|++++-+.+|...+-.....++.+.
T Consensus       144 -~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  144 -KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG  221 (426)
T ss_pred             -ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence             789999999998887766777889999999999998766 899999999999999999999999999988888887765


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...|.                           ...++.+++.+|+.||..+|..||++.++|.+|....+
T Consensus       222 ~~~Pl---------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  222 LYSPL---------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             cCCCC---------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            43222                           23588999999999999999999999999999987643

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.8e-38  Score=249.75  Aligned_cols=194  Identities=25%  Similarity=0.390  Sum_probs=157.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++.+|+||||++| +|.+++..    ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ik  141 (323)
T cd05615          67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIK  141 (323)
T ss_pred             eeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEE
Confidence            3445667789999999985 99988865    34699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............||..|+|||++.+.. ++.++|+||+||++++|++|..||.+....+....+...... 
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-  219 (323)
T cd05615         142 IADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-  219 (323)
T ss_pred             EeccccccccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-
Confidence            999999875433323333456789999999987654 789999999999999999999999887765555444321000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                                                 ....++.++.+++++||..+|.+|++     ..++++||||+.++|.
T Consensus       220 ---------------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         220 ---------------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             ---------------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence                                       01136788999999999999999997     5789999999998874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-38  Score=252.19  Aligned_cols=194  Identities=24%  Similarity=0.361  Sum_probs=159.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++.+.+|+||||++| +|.+++.+    ...+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~k  136 (325)
T cd05602          62 HFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIV  136 (325)
T ss_pred             eEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEE
Confidence            3455677889999999985 99998865    34688999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|++.|+|||++.+.. ++.++|+||+||++|+|++|..||......+....+.....  
T Consensus       137 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--  213 (325)
T cd05602         137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--  213 (325)
T ss_pred             EccCCCCcccccCCCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--
Confidence            999999875443333344556899999999987654 78999999999999999999999988776665554432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH----HHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~ll~hp~f~~~~~~  233 (235)
                                                ...+.+++.+.++|++||+.||.+|+++.    ++++|+||..++|.
T Consensus       214 --------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         214 --------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence                                      01124778899999999999999999876    89999999998874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-37  Score=250.35  Aligned_cols=212  Identities=35%  Similarity=0.576  Sum_probs=160.1

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++...+|+||||++++|.+.+..      .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus        99 ~~~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG  171 (364)
T cd07875          99 EEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG  171 (364)
T ss_pred             cccCeEEEEEeCCCCCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCC
Confidence            45567899999999999888754      488999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... .......++..|+|||++.+.. ++.++|+|||||++|+|++|..||.+....+.........+.+...+.
T Consensus       172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCC-CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99755432 2223446788999999997654 789999999999999999999999988887777777666555543322


Q ss_pred             ccccccccc-----cCCCC---------CCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          170 PGVSSLMNW-----HEYPQ---------WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .........     .....         .............+.+++++|.+||..||.+|||+.++++||||..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            221110000     00000         00000011111245678999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=242.69  Aligned_cols=196  Identities=32%  Similarity=0.495  Sum_probs=161.4

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-C
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-T   80 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~   80 (235)
                      |...+..+.++++|+|||||+ |||.+|++++    +.+++..++.++.||+.||++||+++++||||||.|||++.. .
T Consensus        72 V~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~  147 (429)
T KOG0595|consen   72 VRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR  147 (429)
T ss_pred             eeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC
Confidence            345566778889999999998 5999999884    479999999999999999999999999999999999999864 2


Q ss_pred             ----CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           81 ----MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        81 ----~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                          -.+||+|||+++.+.. ........|++.|||||++.... |..|+|+||+|+++|++++|..||...+..+....
T Consensus       148 ~~~~~~LKIADFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  148 NDTSPVLKIADFGFARFLQP-GSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             CCCCceEEecccchhhhCCc-hhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence                2589999999998763 34456778999999999997555 89999999999999999999999999988887775


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      +.+.....                         .......++...+++...++.+|..|.+..+.+.|+|...
T Consensus       226 ~~k~~~~~-------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  226 IKKGNEIV-------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             Hhcccccc-------------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence            44321111                         0111135566779999999999999999999999998753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-38  Score=253.78  Aligned_cols=195  Identities=25%  Similarity=0.402  Sum_probs=159.2

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.++++..+|+||||++ |+|.+++.+    ...++++.++.++.||+.||+|||+++++|+||+|+||+++.++ .++
T Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~k  138 (318)
T cd05582          64 HYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIK  138 (318)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEE
Confidence            345567788999999997 599998865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|+..|+|||.+.+.. ++.++|+||+||++|+|++|..||......+....+.....  
T Consensus       139 L~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--  215 (318)
T cd05582         139 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--  215 (318)
T ss_pred             EeeccCCcccCCCCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999999876544333344556789999999987644 78899999999999999999999988776555544332100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                                                .....+++++.++|++||+.||.+||+     +.++++||||+.++|++
T Consensus       216 --------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~  264 (318)
T cd05582         216 --------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK  264 (318)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence                                      001236788999999999999999999     77899999999987753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-37  Score=249.91  Aligned_cols=198  Identities=23%  Similarity=0.388  Sum_probs=152.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.++..|+||||+++ +|..++..    .+.+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~k  136 (329)
T cd05618          62 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIK  136 (329)
T ss_pred             eeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEE
Confidence            3445667789999999985 99888765    34699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-----LQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~  159 (235)
                      |+|||+++.............||..|+|||++.+.. ++.++|+||+||++|+|++|..||.....     .........
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (329)
T cd05618         137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  215 (329)
T ss_pred             EeeCCccccccCCCCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH
Confidence            999999875433333334557789999999997654 78899999999999999999999953110     000001111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCcC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~ll~hp~f~~~~~~  233 (235)
                      ......                        ......++.++.++|++||..||.+||+      +.++++||||++++|.
T Consensus       216 ~i~~~~------------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         216 VILEKQ------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             HHhcCC------------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            100000                        0011246788999999999999999998      5799999999998874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=249.27  Aligned_cols=198  Identities=29%  Similarity=0.493  Sum_probs=168.7

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-   80 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-   80 (235)
                      |...+.+|++..+++|||+|.| .|.+.+...     .+++..+..+++|++.+++|||+.|++|+|+||+|+++.... 
T Consensus        99 v~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen   99 VQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             EEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC
Confidence            3456778889999999999985 999999884     399999999999999999999999999999999999996543 


Q ss_pred             --CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           81 --MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        81 --~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                        ..++++|||++..... ........||+.|+|||++.... ++..+|+||+|+++|.|++|..||.+....+....+.
T Consensus       174 ~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~  251 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL  251 (382)
T ss_pred             CCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence              2799999999988776 45667789999999999987544 8999999999999999999999999988777766554


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..-..                        .....+..++..++++|++||..||.+|+|+.++|+|||+++..
T Consensus       252 ~~~~~------------------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  252 RGDFD------------------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             cCCCC------------------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            43211                        11223446889999999999999999999999999999999763

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.3e-38  Score=250.28  Aligned_cols=195  Identities=24%  Similarity=0.394  Sum_probs=153.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++.+.+|+||||++| +|..++..    .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|
T Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl  137 (327)
T cd05617          63 SCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKL  137 (327)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEE
Confidence            345667789999999985 99888865    34699999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~  159 (235)
                      +|||+++.............|++.|+|||.+.+.. ++.++|+||+||++|+|++|..||....      ..+.......
T Consensus       138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  216 (327)
T cd05617         138 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL  216 (327)
T ss_pred             eccccceeccCCCCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence            99999875433333334556899999999987654 7899999999999999999999995321      1111111111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCcC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~ll~hp~f~~~~~~  233 (235)
                         ...                        ......++..+.+++++||..||.+|++      +.++++||||+.++|+
T Consensus       217 ---~~~------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         217 ---EKP------------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ---hCC------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence               000                        0011236788899999999999999998      5799999999999875


Q ss_pred             C
Q 026660          234 R  234 (235)
Q Consensus       234 ~  234 (235)
                      .
T Consensus       270 ~  270 (327)
T cd05617         270 L  270 (327)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=249.10  Aligned_cols=212  Identities=40%  Similarity=0.694  Sum_probs=163.1

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .....|+++|+++++|.+++..     ..++++.++.++.||+.||.|||++|++|+||||+||+++.++ .++++|||+
T Consensus        91 ~~~~~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCcc
Confidence            3456899999998899887753     4699999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +......   .....++..|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....+.+......
T Consensus       165 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         165 ARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             ceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8765432   2334678899999998775558899999999999999999999998887777766666655554433222


Q ss_pred             cccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          171 GVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       171 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ........   ..........+.......++.+.++|++||..||.+|||+.++++||||..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            21111000   01111112222233345677889999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=268.40  Aligned_cols=198  Identities=25%  Similarity=0.446  Sum_probs=169.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      -+.+++++|+|||||+| ||..++-++.    .+|+..++.++..|+.||..||+.|+|||||||+|||++..| .++++
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLA  217 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLA  217 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeec
Confidence            36788999999999985 9999998753    699999999999999999999999999999999999999888 99999


Q ss_pred             ecCCcccccCCCC-CcccccccccccCchhhhC---C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           87 DLGLARAFTLPIK-KYTHEILTLWYRAPEVLLG---S-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        87 df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~---~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      |||.+-....... ......|||.|+|||++..   . ..|+..+|.||+|+++|+|+.|..||..+.-.+.+.++++.-
T Consensus       218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk  297 (1317)
T KOG0612|consen  218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK  297 (1317)
T ss_pred             cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence            9999977764433 4567799999999999973   2 458899999999999999999999999999888888887530


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCcCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~hp~f~~~~~~~~  235 (235)
                                  ...      .+      +....+|++.++||++++. +|..|.+   ++++.+||||.+++|..+
T Consensus       298 ------------~~l------~F------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  298 ------------ESL------SF------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             ------------hhc------CC------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence                        000      00      1122488999999999988 8889987   999999999999999753

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-37  Score=252.87  Aligned_cols=221  Identities=23%  Similarity=0.290  Sum_probs=158.1

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+.++.+...|+|+|++.++|..++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++..+ .++|
T Consensus       149 ~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL  223 (391)
T PHA03212        149 KGTFTYNKFTCLILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCL  223 (391)
T ss_pred             eEEEEECCeeEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEE
Confidence            344556778999999999999988865    34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCC-CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Q 026660           86 ADLGLARAFTLP-IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-------ELQQLLHI  157 (235)
Q Consensus        86 ~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~  157 (235)
                      +|||++...... ........||+.|+|||++.+.. ++.++|+||+||++|++++|..||....       .......+
T Consensus       224 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i  302 (391)
T PHA03212        224 GDFGAACFPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI  302 (391)
T ss_pred             EeCCcccccccccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence            999998643321 12233457899999999987654 7899999999999999999998875321       23344444


Q ss_pred             HHHhCCCCCCCccccccccc------cc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMN------WH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ....+..+..+.........      .. ................++.++.++|++||+.||.+|||+.|+++||||+++
T Consensus       303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            44444433222111000000      00 000000000011112356789999999999999999999999999999986


Q ss_pred             Cc
Q 026660          231 DK  232 (235)
Q Consensus       231 ~~  232 (235)
                      ..
T Consensus       383 ~~  384 (391)
T PHA03212        383 PD  384 (391)
T ss_pred             CC
Confidence            53

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.9e-37  Score=242.59  Aligned_cols=216  Identities=46%  Similarity=0.810  Sum_probs=170.3

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .+.+|+||||++++|.+++...   ...++++.++.++.|++.||.|||+.|++|+||+|+||+++.++ .++++|||.+
T Consensus        80 ~~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcccee
Confidence            3568999999999999998763   24689999999999999999999999999999999999999776 8999999998


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      ..............++..|+|||.+.+...++.++|+||+|+++|++++|..||...+..+....+....+.+....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            76654433333344577899999987655578999999999999999999999999888888888888777766665554


Q ss_pred             ccccccccCC--CCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          172 VSSLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       172 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..........  ...............++++.++|++||..||.+|||+.++++||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            3322111111  11111122223334688999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-37  Score=242.66  Aligned_cols=201  Identities=26%  Similarity=0.369  Sum_probs=155.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....+++.+.|+||||++| +|.+++...  ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++
T Consensus        59 ~~~~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~  135 (277)
T cd05607          59 AYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCR  135 (277)
T ss_pred             EEEEecCCeEEEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEE
Confidence            3455677889999999985 999888663  344588999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++....... ......++..|+|||++.+.. ++.++|+||+||++|++++|..||...................
T Consensus       136 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  213 (277)
T cd05607         136 LSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED  213 (277)
T ss_pred             EeeceeeeecCCCc-eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc
Confidence            99999987554321 223346788999999987665 8899999999999999999999997643322211211111100


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll~hp~f~~~~~~~  234 (235)
                      .                       .......+++++++++++||+.||.+||++    ++++.||||+.++|.+
T Consensus       214 ~-----------------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         214 E-----------------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             c-----------------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            0                       000112478899999999999999999999    6788999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=248.23  Aligned_cols=199  Identities=29%  Similarity=0.417  Sum_probs=164.5

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .+|+++.+|+|+..|+| ||.-+|.+.++  +.++++.++.++.+|+.||++||+.++|+||+||+|||+|+.| .++|+
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRIS  329 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRIS  329 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEee
Confidence            46889999999999985 99999988554  5699999999999999999999999999999999999999888 99999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |.|++..+....... ...||.+|||||++.+.. |+...|-||+||++|+|+.|+.||...........+.+.....+.
T Consensus       330 DLGLAvei~~g~~~~-~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~  407 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPIR-GRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE  407 (591)
T ss_pred             ccceEEecCCCCccc-cccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh
Confidence            999997765443332 338899999999998766 999999999999999999999999765543333222221111111


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~~  235 (235)
                                              ....++|++++++++.+|..||.+|.     +++++.+||||++++|++|
T Consensus       408 ------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  408 ------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             ------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence                                    11135889999999999999999997     5789999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-37  Score=251.44  Aligned_cols=213  Identities=42%  Similarity=0.687  Sum_probs=161.8

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..+|+|+||+.++|.+.+.+    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~~lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~  151 (372)
T cd07853          77 EEIYVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLAR  151 (372)
T ss_pred             ceEEEEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEecccccee
Confidence            37999999999999888754    34689999999999999999999999999999999999999776 89999999987


Q ss_pred             cccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           93 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        93 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      ....... ......++..|+|||.+.+...++.++|+||+||++++|++|+.||.+....+....+....+.+....+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            5443222 223345688899999998765578999999999999999999999998888887777776666544322111


Q ss_pred             ccccc-cccCCCCCCc---cchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          172 VSSLM-NWHEYPQWNP---QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       172 ~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..... ..........   ..........++++.++|.+||+.||.+|||+.++++||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            10000 0000000000   01111223467899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-37  Score=251.67  Aligned_cols=198  Identities=25%  Similarity=0.372  Sum_probs=157.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++++++|+||||++| +|.+++.+     ..++++.+..++.||+.||+|||+.+++|+||||+||+++.++ .++
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~k  182 (370)
T cd05596         109 HYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLK  182 (370)
T ss_pred             EEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEE
Confidence            3455677889999999975 99998865     2588999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      |+|||.+........ ......||+.|+|||++.+.   ..++.++|+||+||++|+|++|..||...........+...
T Consensus       183 L~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  262 (370)
T cd05596         183 LADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH  262 (370)
T ss_pred             EEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence            999999876543221 22345689999999998643   23678999999999999999999999887765555544321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~  233 (235)
                      ....                        .......++.+++++|++||+.+|.+  |++++++++||||++.+|.
T Consensus       263 ~~~~------------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         263 KNSL------------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             CCcC------------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            0000                        00112247889999999999999988  9999999999999986653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=216.51  Aligned_cols=224  Identities=48%  Similarity=0.925  Sum_probs=202.6

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..++..-+++.+-+|+|||..+|+.+..+   .++.++.+.+..++.|++.|+.+.|++++.|+|+||.|.+++.++ ..
T Consensus        65 rl~dvlhsdkkltlvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-el  140 (292)
T KOG0662|consen   65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-EL  140 (292)
T ss_pred             ehhhhhccCceeEEeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cE
Confidence            44555567778999999999999999876   457899999999999999999999999999999999999999777 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +++|||+++.++.+....+...-|.+|++|.++.+..-+++..|+||.||++.|+.. |.+.|++.+-.+++.++...++
T Consensus       141 kladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg  220 (292)
T KOG0662|consen  141 KLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_pred             EecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence            999999999999888888888889999999999988889999999999999999998 7777888888999999999999


Q ss_pred             CCCCCCcccccccccccCCCCCCcc-chhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .+.+..|+++....+...++.++.. +..+..++++..-+++++++|.-+|.+|+++++.++||||.++.
T Consensus       221 ~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            9999999999888887777777653 56778888999999999999999999999999999999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-38  Score=253.78  Aligned_cols=197  Identities=24%  Similarity=0.405  Sum_probs=156.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +..+++++++|+||||++| +|.+++.+    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~k  141 (364)
T cd05599          67 YYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIK  141 (364)
T ss_pred             EEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEE
Confidence            4456678889999999975 99999866    34689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCC--------------------------------------CcccccccccccCchhhhCCCCCCchh
Q 026660           85 IADLGLARAFTLPIK--------------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAV  126 (235)
Q Consensus        85 l~df~~~~~~~~~~~--------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~  126 (235)
                      ++|||++........                                      ......||+.|+|||++.... ++.++
T Consensus       142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  220 (364)
T cd05599         142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKEC  220 (364)
T ss_pred             EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCee
Confidence            999998864422110                                      001235789999999987554 78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHH
Q 026660          127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ  206 (235)
Q Consensus       127 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  206 (235)
                      |+||+||++|+|++|..||......+....+......                        ........++++++++|++
T Consensus       221 DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~s~~~~~li~~  276 (364)
T cd05599         221 DWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET------------------------LQFPDEVPLSPEAKDLIKR  276 (364)
T ss_pred             eeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc------------------------cCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999999887765554444321000                        0000111467899999999


Q ss_pred             hcccCCCCCCC---HHHHhCCCCCCCCCcC
Q 026660          207 MLQYDPSKRIS---AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       207 ~l~~~p~~Rps---~~~ll~hp~f~~~~~~  233 (235)
                      |+. +|.+|++   +.++++||||+.++|+
T Consensus       277 ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         277 LCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             Hcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            997 9999998   9999999999998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.1e-38  Score=251.73  Aligned_cols=199  Identities=26%  Similarity=0.404  Sum_probs=159.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+++...|+||||++| +|.+++.+.   ...++++.+..++.|++.||+|||+++++|+||||+||+++..+ .++|
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL  143 (330)
T cd05601          68 YAFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKL  143 (330)
T ss_pred             eEEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEe
Confidence            445667789999999975 999999763   24689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|||++......... .....+++.|+|||++..     ...++.++||||+||++|+|++|..||......+....+..
T Consensus       144 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  223 (330)
T cd05601         144 ADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN  223 (330)
T ss_pred             ccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence            999998765433221 223467889999999863     33467899999999999999999999988776665555433


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      .....                        .....+.+++++.++|++||. +|.+||+++++++||||+.++|+.
T Consensus       224 ~~~~~------------------------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         224 FQRFL------------------------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             CCCcc------------------------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence            20000                        001122477899999999998 999999999999999999887753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=244.62  Aligned_cols=222  Identities=42%  Similarity=0.755  Sum_probs=172.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +....+.+.|+||||++|+|.+++.+    ...++++.+..++.|++.||++||+.|++|+||+|+||+++..+ .++++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence            34456678999999999999998865    34589999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCC--------------CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 026660           87 DLGLARAFTLP--------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ  152 (235)
Q Consensus        87 df~~~~~~~~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  152 (235)
                      |||.+.....+              ........++..|+|||.+.+...++.++|+||+||+++++++|..||.+.+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998765411              1112223457789999998765557899999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ....+......+....|+...............+..........+.++.++|++||+.+|.+|||+++++.||||+....
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            77777777666655544433221111111122223333344567889999999999999999999999999999998765


Q ss_pred             C
Q 026660          233 T  233 (235)
Q Consensus       233 ~  233 (235)
                      .
T Consensus       322 ~  322 (335)
T PTZ00024        322 P  322 (335)
T ss_pred             C
Confidence            3

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-37  Score=248.31  Aligned_cols=210  Identities=37%  Similarity=0.603  Sum_probs=156.4

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +...+|+||||++++|.+.+..      .++++.+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||+
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~  169 (359)
T cd07876          97 EFQDVYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL  169 (359)
T ss_pred             ccceeEEEEeCCCcCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCC
Confidence            4456899999999988887743      488999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +...... .......+|..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+............+.+...+..
T Consensus       170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         170 ARTACTN-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccccC-ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            8654322 2233446788999999987654 7899999999999999999999999887766666665555444332211


Q ss_pred             ccccc----------cccc----CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          171 GVSSL----------MNWH----EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       171 ~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .....          ....    ....+............+++++++|.+||..||.+|||+.|+++||||..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            11000          0000    00000000111112235678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-37  Score=249.54  Aligned_cols=194  Identities=23%  Similarity=0.384  Sum_probs=157.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++.++..|+||||++| +|..++.+    ...+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~k  136 (325)
T cd05604          62 HYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVV  136 (325)
T ss_pred             EEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEE
Confidence            3455677889999999985 99888765    45689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............|+..|+|||++.+.. ++.++|+||+||++|+|++|..||......+.........   
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---  212 (325)
T cd05604         137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---  212 (325)
T ss_pred             EeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---
Confidence            999999865433333334556889999999987654 7899999999999999999999998877655544433210   


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll~hp~f~~~~~~  233 (235)
                                               ....+..+..+.++|++||..||.+||++    .++++||||..+.|.
T Consensus       213 -------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         213 -------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             -------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence                                     00112467888999999999999999976    589999999987763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-37  Score=248.38  Aligned_cols=194  Identities=23%  Similarity=0.345  Sum_probs=156.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ....++.+..|+||||++| +|...+.+    ...+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~k  136 (321)
T cd05603          62 HYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVV  136 (321)
T ss_pred             eeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEE
Confidence            3445677889999999985 99887765    34689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+..+....+...   +
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~  212 (321)
T cd05603         137 LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P  212 (321)
T ss_pred             EccCCCCccCCCCCCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C
Confidence            999999875433333334456789999999987544 788999999999999999999999887765554443321   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll~hp~f~~~~~~  233 (235)
                                               .......+.++.++|++||+.||.+||++    .++++||||.+++|.
T Consensus       213 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         213 -------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence                                     00112456788999999999999999975    599999999988774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.1e-37  Score=249.25  Aligned_cols=212  Identities=36%  Similarity=0.595  Sum_probs=158.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++....|+||||++++|.+.+..      .++++.++.++.|++.||+|||++|++|+||||+||+++.++ .++++|||
T Consensus        92 ~~~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg  164 (355)
T cd07874          92 EEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG  164 (355)
T ss_pred             cccceeEEEhhhhcccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCc
Confidence            34567899999999998887754      488999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... .......++..|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+...........+.....
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98755432 2223456788999999987654 789999999999999999999999988877776666655554433222


Q ss_pred             ccccccc----------cccCCCCC----CccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          170 PGVSSLM----------NWHEYPQW----NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~----------~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .......          ........    ............+.+++++|.+||..||.+|||+.|+++||||..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            1111000          00000000    0000011122346788999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=239.50  Aligned_cols=217  Identities=51%  Similarity=0.958  Sum_probs=163.1

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +..+++.+.|+||||++++|.+++.+.   ...++++.++.++.|++.||.|||+++++|+||+|+||+++.++ .++++
T Consensus        70 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~  145 (291)
T cd07844          70 DIIHTKKTLTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLA  145 (291)
T ss_pred             EEEecCCeEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEEC
Confidence            345667789999999999999988763   23689999999999999999999999999999999999999777 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPN  165 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~  165 (235)
                      |||.+.....+........++..|+|||.+.+...++.++|+||+|++++++++|..||.... ..+......+....+.
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07844         146 DFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT  225 (291)
T ss_pred             ccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence            999886543332222333457789999998765557899999999999999999999997665 4455555555555555


Q ss_pred             CCCcccccccccccC--CCCCCccchhhcCCCCC--hhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          166 EKVWPGVSSLMNWHE--YPQWNPQSLATAVPNLD--KDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...+...........  ................+  .++.+++++||+.+|.+|||+.++++||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            444443332211111  11111222222333344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.3e-38  Score=253.44  Aligned_cols=198  Identities=22%  Similarity=0.401  Sum_probs=156.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++++|+||||++| +|.+++.+    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vk  141 (360)
T cd05627          67 FYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVK  141 (360)
T ss_pred             EEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEE
Confidence            3456677889999999985 99999865    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-----------------------------------CcccccccccccCchhhhCCCCCCchhhHH
Q 026660           85 IADLGLARAFTLPIK-----------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMW  129 (235)
Q Consensus        85 l~df~~~~~~~~~~~-----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~  129 (235)
                      |+|||++........                                   ......||+.|+|||++.+.. ++.++|+|
T Consensus       142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~Diw  220 (360)
T cd05627         142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWW  220 (360)
T ss_pred             EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceec
Confidence            999998864421100                                   011346789999999987655 78999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcc
Q 026660          130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ  209 (235)
Q Consensus       130 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  209 (235)
                      |+||++|+|++|..||......+....+......                        ........++++++++|.+|+.
T Consensus       221 SlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~------------------------~~~p~~~~~s~~~~~li~~l~~  276 (360)
T cd05627         221 SLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET------------------------LVFPPEVPISEKAKDLILRFCT  276 (360)
T ss_pred             cccceeeecccCCCCCCCCCHHHHHHHHHcCCCc------------------------eecCCCCCCCHHHHHHHHHhcc
Confidence            9999999999999999887766555544321000                        0001112367889999999875


Q ss_pred             cCCCCCC---CHHHHhCCCCCCCCCcCC
Q 026660          210 YDPSKRI---SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       210 ~~p~~Rp---s~~~ll~hp~f~~~~~~~  234 (235)
                       ||.+|+   ++.++++||||++++|..
T Consensus       277 -~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         277 -DSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             -ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence             999998   489999999999998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=238.69  Aligned_cols=219  Identities=59%  Similarity=1.101  Sum_probs=168.4

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...+.+..|++|||++++|.+++....  ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .+++
T Consensus        64 ~~~~~~~~~~~iv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l  140 (283)
T cd07835          64 LDVVHSENKLYLVFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKL  140 (283)
T ss_pred             hheeccCCeEEEEEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEE
Confidence            34455668899999999889999987632  24689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+|+++|++++|..||.............+....+.
T Consensus       141 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07835         141 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD  220 (283)
T ss_pred             eecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999875543333333445578899999886655468899999999999999999999998887777666666655555


Q ss_pred             CCCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          166 EKVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       166 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...+.......... ....+.........+.++.++.++|++||+.+|.+|||+.++++||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            44433222211110 111122222233345688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=241.25  Aligned_cols=199  Identities=26%  Similarity=0.389  Sum_probs=157.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+++.++|+||||+.| +|.+++..  .....++++.+..++.|++.||.|||+.+++|+||+|+||+++..+ .+++
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l  143 (285)
T cd05605          67 YAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRI  143 (285)
T ss_pred             eeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEE
Confidence            345666789999999985 99988875  2334689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++...... .......++..|+|||.+.+.. ++.++|+||+|+++|++++|..||.+..................
T Consensus       144 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05605         144 SDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ  221 (285)
T ss_pred             eeCCCceecCCC-CccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc
Confidence            999998764322 1223346788999999987654 78999999999999999999999987654333333222211110


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      ..                        ....++..+.+++.+||..||.+||     +++++++||||...+|++
T Consensus       222 ~~------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         222 EE------------------------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             cc------------------------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence            00                        1123678899999999999999999     999999999999988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-36  Score=239.51  Aligned_cols=218  Identities=47%  Similarity=0.867  Sum_probs=170.8

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +........|+|+||++++|.+++.+..   ..+++..++.++.|++.||+|||+.+++|+||+|+||+++..+ .++++
T Consensus        66 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~  141 (286)
T cd07832          66 DVFPHGSGFVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIA  141 (286)
T ss_pred             eEEecCCeeEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEe
Confidence            3445577899999999669999987632   5689999999999999999999999999999999999999766 89999


Q ss_pred             ecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           87 DLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        87 df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      |||.+........ ......++..|+|||.+.+...++.++|+||+|++++++++|..||....+...........+.+.
T Consensus       142 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~  221 (286)
T cd07832         142 DFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPN  221 (286)
T ss_pred             eeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCC
Confidence            9998876543321 233456788899999987655568999999999999999999988988888777777777777666


Q ss_pred             CCCcccccccccccCC--CCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      ...++.......+...  ............++.+..+.++|++||..+|.+|||++++++||||.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            5555544433322111  11111122333456778999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-36  Score=242.60  Aligned_cols=218  Identities=37%  Similarity=0.728  Sum_probs=156.6

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC---CCC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQ-----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTM   81 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~---~~~   81 (235)
                      .++..+|+|+||++++|.+++.....     ....+++..++.++.|++.||.|||+.+++|+||||+||++..   ...
T Consensus        70 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  149 (317)
T cd07867          70 HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  149 (317)
T ss_pred             cCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC
Confidence            45677899999999999998864321     2234889999999999999999999999999999999999942   223


Q ss_pred             eEEEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Q 026660           82 TLKIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--------  150 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------  150 (235)
                      .++|+|||+++.......   ......+|..|+|||.+.+...++.++||||+||++|++++|..||.....        
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~  229 (317)
T cd07867         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF  229 (317)
T ss_pred             cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence            799999999976543322   223346688999999987655578999999999999999999999965332        


Q ss_pred             -HHHHHHHHHHhCCCCCCCcccccccccccCCC------CCCcc----chhhcCCCCChhHHHHHHHhcccCCCCCCCHH
Q 026660          151 -LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP------QWNPQ----SLATAVPNLDKDGLDLLEQMLQYDPSKRISAK  219 (235)
Q Consensus       151 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  219 (235)
                       ...........+.+....|........+....      .....    .........+..+++++++||..||.+|||+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~  309 (317)
T cd07867         230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence             23344455555555544444332211110000      00000    01111223456789999999999999999999


Q ss_pred             HHhCCCCC
Q 026660          220 KAMEHPYF  227 (235)
Q Consensus       220 ~ll~hp~f  227 (235)
                      |+++||||
T Consensus       310 e~l~hp~f  317 (317)
T cd07867         310 QALQDPYF  317 (317)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-36  Score=243.45  Aligned_cols=220  Identities=20%  Similarity=0.283  Sum_probs=155.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+....++.+++||||++| +|.+++.+    ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .+
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~  143 (331)
T cd06649          69 YGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EI  143 (331)
T ss_pred             EEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cE
Confidence            3444566789999999985 99999866    34589999999999999999999986 699999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||++......  ......++..|+|||.+.+.. ++.++|+||+||++|++++|..||......+...........
T Consensus       144 kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  220 (331)
T cd06649         144 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD  220 (331)
T ss_pred             EEccCccccccccc--ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence            99999998755332  223446788999999987654 789999999999999999999999876654432221111000


Q ss_pred             CCCCCcccccc-------cccccCCCCCCcc-------------chhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSS-------LMNWHEYPQWNPQ-------------SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~-------~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...........       .............             ........+++++++||++||..||.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000       0000000000000             000011246789999999999999999999999999


Q ss_pred             CCCCCCCCcC
Q 026660          224 HPYFDDLDKT  233 (235)
Q Consensus       224 hp~f~~~~~~  233 (235)
                      ||||+....+
T Consensus       301 h~~~~~~~~~  310 (331)
T cd06649         301 HTFIKRSEVE  310 (331)
T ss_pred             ChHHhhcccc
Confidence            9999876544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.7e-37  Score=249.75  Aligned_cols=199  Identities=25%  Similarity=0.414  Sum_probs=153.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+...++..++|+||||++| +|.+++.+    .+.+++..++.++.||+.||+|||+.|++|+||||+||+++.++ .+
T Consensus        66 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~  140 (381)
T cd05626          66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HI  140 (381)
T ss_pred             eEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CE
Confidence            34455677889999999975 99999876    34689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-----------------------------------------------CcccccccccccCchhh
Q 026660           84 KIADLGLARAFTLPIK-----------------------------------------------KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~  116 (235)
                      +++|||++..+.....                                               ......||..|+|||++
T Consensus       141 kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  220 (381)
T cd05626         141 KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL  220 (381)
T ss_pred             EEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH
Confidence            9999998753311000                                               01124688999999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL  196 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (235)
                      .+.. ++.++||||+||++|+|++|..||......+....+........                        ......+
T Consensus       221 ~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~  275 (381)
T cd05626         221 LRKG-YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH------------------------IPPQVKL  275 (381)
T ss_pred             cCCC-CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC------------------------CCCCCCC
Confidence            7654 78999999999999999999999988765544443332100000                        0011247


Q ss_pred             ChhHHHHHHHhc--ccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          197 DKDGLDLLEQML--QYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       197 ~~~~~~li~~~l--~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      +++++++|++|+  ..++..|+++.++++||||++++|+
T Consensus       276 s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            889999999955  4455569999999999999998775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-37  Score=255.69  Aligned_cols=198  Identities=23%  Similarity=0.350  Sum_probs=160.7

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++..+.++++|+||||++ |+|.+++.........+++..+..++.|++.||+|||+++++||||||+||+++..+ .
T Consensus       129 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~  207 (478)
T PTZ00267        129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-I  207 (478)
T ss_pred             EEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-c
Confidence            34455677788999999997 499999987656666799999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||+++.......  ......||+.|+|||.+.+.. ++.++||||+||++|+|++|..||......+........
T Consensus       208 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~  286 (478)
T PTZ00267        208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG  286 (478)
T ss_pred             EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            99999999976543222  233456899999999987654 789999999999999999999999887765555444321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...                           .....++.+++++|.+||..||.+||++.+++.|||++.+
T Consensus       287 ~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        287 KYD---------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCC---------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            000                           0012467889999999999999999999999999998643

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-36  Score=239.42  Aligned_cols=211  Identities=52%  Similarity=0.943  Sum_probs=164.6

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ...|+|+||++++|.+++...   ...++++.++.++.|++.||+|||+.+++|+||+|+||+++.++ .++++|||.+.
T Consensus        79 ~~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCcee
Confidence            789999999999999998763   23689999999999999999999999999999999999999776 89999999987


Q ss_pred             cccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccc
Q 026660           93 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  172 (235)
Q Consensus        93 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (235)
                      .............++..|+|||.+.+....+.++|+||+|++++++++|..||......+.........+.+....|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         155 EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             eccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            76654334444556788999999876555689999999999999999999999988887777777776666555444332


Q ss_pred             cccccccC--CCCCCccchhhcCCC--CChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          173 SSLMNWHE--YPQWNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       173 ~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ........  .............+.  +++.+.++|++||+.+|++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            22111110  000001111122222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-37  Score=250.27  Aligned_cols=222  Identities=22%  Similarity=0.299  Sum_probs=163.3

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++....+|++||++.++|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++..+ .++|
T Consensus       152 ~~~~~~~~~~~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l  226 (392)
T PHA03207        152 IHAYRWKSTVCMVMPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVL  226 (392)
T ss_pred             eeeEeeCCEEEEEehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEE
Confidence            345566778999999999999998843    35689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---ELQQLLHIFRL  160 (235)
Q Consensus        86 ~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~  160 (235)
                      +|||++........  ......||..|+|||++.+.. ++.++|+||+||++|+|++|..||.+..   ....+..+.+.
T Consensus       227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             ccCccccccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            99999875543222  223456799999999987554 7899999999999999999999996543   34445555555


Q ss_pred             hCCCCCCCccccccc-------ccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          161 LGTPNEKVWPGVSSL-------MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ++..+..+.......       .....-..+.... ......++.++.++|++||..||.+|||+.++++||||....++
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPP-VIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccc-hhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence            444333221111000       0000000000000 00112466788999999999999999999999999999987776


Q ss_pred             C
Q 026660          234 R  234 (235)
Q Consensus       234 ~  234 (235)
                      .
T Consensus       385 ~  385 (392)
T PHA03207        385 L  385 (392)
T ss_pred             h
Confidence            4

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-36  Score=237.36  Aligned_cols=219  Identities=52%  Similarity=0.982  Sum_probs=168.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +...+.+..++||||++++|.+++..... ...++++.+..++.|++.||.|||+.|++|+||+|+||+++.++ .++++
T Consensus        65 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~  142 (284)
T cd07836          65 DVIHTENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLA  142 (284)
T ss_pred             eeEeeCCcEEEEEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEe
Confidence            44556677899999999999999876432 34689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+..............++..|++||.+.+...++.++|+||+|++++++++|..||.+....+...........+..
T Consensus       143 d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07836         143 DFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE  222 (284)
T ss_pred             ecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence            99998765443333334456788999999876555789999999999999999999999988777777777666665555


Q ss_pred             CCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..+........+. ..............+..+..+++++++||+.||.+||++.++++||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            4444333211111 111111112222333568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=232.10  Aligned_cols=197  Identities=27%  Similarity=0.448  Sum_probs=155.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTL   83 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~   83 (235)
                      ..+.+...+.+|||.|.| .|.+.+...  ....+++.++..|++||+.|+.|||+.+|+||||||+|+|....+  ..+
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence            345568889999999985 999999884  445599999999999999999999999999999999999996543  357


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ----QLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~  159 (235)
                      |++|||+++....+ .....+..|+.|.|||++.. +++...+|+||+|+++|-|++|..||.......    ...++..
T Consensus       204 KLtDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  204 KLTDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             EecccccccccCCC-ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            99999999765543 34555677999999998854 448999999999999999999999997654311    1122111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..                    .    ..-...+..+|++.+++|+.+|..+|++|.|+.++++|||+....
T Consensus       282 gq--------------------y----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  282 GQ--------------------Y----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             cC--------------------c----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            00                    0    001123335789999999999999999999999999999987654

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.5e-37  Score=247.98  Aligned_cols=198  Identities=25%  Similarity=0.369  Sum_probs=155.7

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++++|+||||++| +|.+++..     ..++++.+..++.||+.||+|||+++++||||||+||+++.++ .+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~  181 (370)
T cd05621         108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HL  181 (370)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CE
Confidence            34456677889999999975 99999865     2489999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-CcccccccccccCchhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|+|||++........ ......||+.|+|||++.+..   .++.++|+||+||++|+|++|..||...........+..
T Consensus       182 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05621         182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             EEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999876543222 223456899999999987532   367899999999999999999999988776665555443


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCc
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~  232 (235)
                      ......                        ......++..+++++++||..++.+  |+++.++++||||+...|
T Consensus       262 ~~~~~~------------------------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         262 HKNSLN------------------------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             CCcccC------------------------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            111000                        0011246788999999999865543  889999999999997554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=245.50  Aligned_cols=191  Identities=26%  Similarity=0.433  Sum_probs=156.7

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN-IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~-~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      -.+...+.+|||+|||. |.+...-     ..+. ++++++++++++++.||+|||.+|++||||||.|+|++.++ .+|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VK  250 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVK  250 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEE
Confidence            44567788999999998 5655322     2334 89999999999999999999999999999999999999887 999


Q ss_pred             EeecCCcccccCC-----CCCcccccccccccCchhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           85 IADLGLARAFTLP-----IKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        85 l~df~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      |+|||.+......     ........||+.|+|||++.+.   ...+.+.||||+|+++|.++.|..||.+....+...+
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            9999998755221     1223457899999999999862   3356889999999999999999999999999888888


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      +....-.                          ....+.+.++++++|++||..||.+|.++.++..|||...
T Consensus       331 Ivn~pL~--------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  331 IVNDPLE--------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HhcCccc--------------------------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            8753111                          1222246789999999999999999999999999999764

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.6e-37  Score=249.94  Aligned_cols=198  Identities=26%  Similarity=0.454  Sum_probs=154.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....++++.++|+||||++| +|.+++.+    .+.++++.++.++.||+.||+|||+++++|+||||+||+++.++ .+
T Consensus        66 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~  140 (382)
T cd05625          66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HI  140 (382)
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CE
Confidence            34456677889999999985 99999866    24689999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCC-----------------------------------------------CCcccccccccccCchhh
Q 026660           84 KIADLGLARAFTLPI-----------------------------------------------KKYTHEILTLWYRAPEVL  116 (235)
Q Consensus        84 ~l~df~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~  116 (235)
                      +|+|||++.......                                               .......||+.|+|||++
T Consensus       141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  220 (382)
T cd05625         141 KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL  220 (382)
T ss_pred             EEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh
Confidence            999999874321000                                               001123578999999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL  196 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (235)
                      .+.. ++.++|+||+||++|+|++|..||......+....+........                        ......+
T Consensus       221 ~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~  275 (382)
T cd05625         221 LRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH------------------------IPPQAKL  275 (382)
T ss_pred             cCCC-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC------------------------CCCcccC
Confidence            7654 78999999999999999999999988776555444332110000                        0111247


Q ss_pred             ChhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCcC
Q 026660          197 DKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       197 ~~~~~~li~~~l~~~p~~Rps---~~~ll~hp~f~~~~~~  233 (235)
                      ++++.++|.+|+. +|.+|++   ++++++||||+.++|.
T Consensus       276 s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         276 SPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             CHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            8899999999864 9999997   9999999999988764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=235.57  Aligned_cols=217  Identities=58%  Similarity=1.084  Sum_probs=173.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +..++....++|+||++++|.+++.+..   ..+++..+..++.|++.||++||+++++|+||+|+||+++.++ .++++
T Consensus        65 ~~~~~~~~~~~v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~  140 (282)
T cd07829          65 DVIHTERKLYLVFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLA  140 (282)
T ss_pred             hhhhcCCceEEEecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEe
Confidence            3445567899999999999999998732   4689999999999999999999999999999999999999766 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+...............+..|+|||.+.+....+.++|+||+|++++++++|..||......+....+......+..
T Consensus       141 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
T cd07829         141 DFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE  220 (282)
T ss_pred             cCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH
Confidence            99998766544333344455778999999876645889999999999999999999999998888888888777777666


Q ss_pred             CCcccccccc-cccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLM-NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..+....... .......+.........+..+.++.++|++||..||.+||++.++++||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            5554433322 111222333333344455678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=240.28  Aligned_cols=182  Identities=29%  Similarity=0.394  Sum_probs=151.6

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~-~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++|||||++ |+|..++.+.  ....++...+..++.||+.|++|||+++ ++|+|||++|+|++.+...+||+|||++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            6999999998 5999999874  4568999999999999999999999999 9999999999999976558999999999


Q ss_pred             ccccCCCCCcccccccccccCchhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +.........+...||..|||||++.+ ...++.++||||+|+++||+++|..||.+....+...........+..+   
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p---  268 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP---  268 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC---
Confidence            766544344445788999999999985 3458999999999999999999999999988855555544332222211   


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             ...++.+..++.+||..||.+||++.+++.
T Consensus       269 -----------------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  269 -----------------------KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             -----------------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                   126788999999999999999999998753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=250.15  Aligned_cols=198  Identities=24%  Similarity=0.383  Sum_probs=153.9

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .++.++++.++|+||||++| +|.+++.+    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus        66 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~  140 (377)
T cd05629          66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HI  140 (377)
T ss_pred             EEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CE
Confidence            34556678889999999974 99999865    34689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-----------------------------------------------CcccccccccccCchhh
Q 026660           84 KIADLGLARAFTLPIK-----------------------------------------------KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~  116 (235)
                      +++|||+++.+.....                                               ......||+.|+|||++
T Consensus       141 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  220 (377)
T cd05629         141 KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF  220 (377)
T ss_pred             EEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH
Confidence            9999998853211000                                               00123578999999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL  196 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (235)
                      .+.. ++.++|+||+||++|+|++|..||......+....+........                        ......+
T Consensus       221 ~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~  275 (377)
T cd05629         221 LQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY------------------------FPDDIHL  275 (377)
T ss_pred             ccCC-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC------------------------CCCCCCC
Confidence            7654 78999999999999999999999988776555544432100000                        0011246


Q ss_pred             ChhHHHHHHHhcccCCCCC---CCHHHHhCCCCCCCCCcC
Q 026660          197 DKDGLDLLEQMLQYDPSKR---ISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       197 ~~~~~~li~~~l~~~p~~R---ps~~~ll~hp~f~~~~~~  233 (235)
                      +.+++++|++||. +|.+|   +++.++++||||++++|.
T Consensus       276 s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         276 SVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             CHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            7899999999998 67665   599999999999988764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-37  Score=251.13  Aligned_cols=197  Identities=25%  Similarity=0.427  Sum_probs=153.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++.+|+||||++| +|.+++.+    .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ik  141 (376)
T cd05598          67 YYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIK  141 (376)
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEE
Confidence            4456677899999999975 99999976    34689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCC-------------------------------------------CCCcccccccccccCchhhhCCCC
Q 026660           85 IADLGLARAFTLP-------------------------------------------IKKYTHEILTLWYRAPEVLLGSTH  121 (235)
Q Consensus        85 l~df~~~~~~~~~-------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~  121 (235)
                      |+|||++..+...                                           ........||+.|+|||++.+.. 
T Consensus       142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  220 (376)
T cd05598         142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-  220 (376)
T ss_pred             EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-
Confidence            9999987422100                                           00011246889999999987654 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHH
Q 026660          122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL  201 (235)
Q Consensus       122 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (235)
                      ++.++||||+||++|+|++|..||.+....+....+......                        ........+++++.
T Consensus       221 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~s~~~~  276 (376)
T cd05598         221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT------------------------LHIPSQAKLSREAS  276 (376)
T ss_pred             CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc------------------------ccCCCCCCCCHHHH
Confidence            789999999999999999999999887765544433211000                        00011124778899


Q ss_pred             HHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcC
Q 026660          202 DLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       202 ~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~  233 (235)
                      ++|.+|+ .+|.+|+   ++.++++||||+.+++.
T Consensus       277 ~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~  310 (376)
T cd05598         277 DLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFA  310 (376)
T ss_pred             HHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence            9999976 4999999   99999999999987754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=242.52  Aligned_cols=198  Identities=31%  Similarity=0.487  Sum_probs=173.1

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |.++........+|+|+|+-.| +|.+||.++   ...++++.+.+++.||+.|+.|.|...+||||+||+|+++...-.
T Consensus        80 VRLYEViDTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG  156 (864)
T KOG4717|consen   80 VRLYEVIDTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG  156 (864)
T ss_pred             eeeeehhcccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC
Confidence            4566677778889999999975 999999885   357999999999999999999999999999999999998876655


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      -+++.|||++.++.. ..+.....|+..|.|||++.+..+..++.||||||+++|.|++|+.||...++.+.+..++++-
T Consensus       157 lVKLTDFGFSNkf~P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK  235 (864)
T KOG4717|consen  157 LVKLTDFGFSNKFQP-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK  235 (864)
T ss_pred             ceEeeeccccccCCC-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc
Confidence            899999999988764 4667788999999999999998877899999999999999999999999988888888877531


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                                  -.....++.++++||.+||..||.+|.+.+++.+|+|++..+.
T Consensus       236 ----------------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  236 ----------------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ----------------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                                        0112257899999999999999999999999999999998764

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=235.29  Aligned_cols=216  Identities=54%  Similarity=0.977  Sum_probs=167.8

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ....+...|+|+||++++|.+++...   ...+++..+..++.|++.||++||+.+++|+||+|+||+++.++ .++++|
T Consensus        66 ~~~~~~~~~~v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~d  141 (283)
T cd05118          66 VFRHKGDLYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLAD  141 (283)
T ss_pred             hhccCCCEEEEEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEee
Confidence            34556789999999999999888762   24789999999999999999999999999999999999999766 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|+|||.+.+....+.++|+||+|++++++++|+.||...+..+...........+...
T Consensus       142 f~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd05118         142 FGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE  221 (283)
T ss_pred             eeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchH
Confidence            99887665443233344567789999998766458899999999999999999999999888877777766665555544


Q ss_pred             Cccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .+..........  ..............+.++.+++++|++||..||.+||++.++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            444332211100  111111112222334678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-36  Score=241.56  Aligned_cols=218  Identities=42%  Similarity=0.735  Sum_probs=164.5

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +....+|+++||++++|.+++.+    .+.+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++++|||
T Consensus        79 ~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg  153 (337)
T cd07858          79 EAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFG  153 (337)
T ss_pred             cccCcEEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCc
Confidence            34456899999999999888865    35699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ++..............++..|+|||.+.....++.++|+||+|++++++++|..||.+.+............+.+....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         154 LARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            98765443222334456788999999875444889999999999999999999999887766666666655555443322


Q ss_pred             cccccccc--c-cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          170 PGVSSLMN--W-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       170 ~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ........  + ...............+..++++.++|++||+.+|.+|||++++++||||+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            11110000  0 000011111222334468899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-36  Score=251.75  Aligned_cols=190  Identities=23%  Similarity=0.378  Sum_probs=155.6

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ...+++||||++ |+|.+++.........+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||+
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            346899999998 599999987666667899999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ++.......  ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+..........      
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence            876543211  223456789999999997654 88999999999999999999999988766554443322100      


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                           ......+++++.+++++||+.||.+||++.++++|||++.+
T Consensus       263 ---------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 ---------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                 01122477899999999999999999999999999998754

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-36  Score=242.58  Aligned_cols=220  Identities=23%  Similarity=0.359  Sum_probs=153.5

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+........|+|+|++.++|.+++.+   ....+++..++.++.||+.||.|||+++++|+||||+||+++..+ .++
T Consensus       122 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~k  197 (357)
T PHA03209        122 MKDTLVSGAITCMVLPHYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVC  197 (357)
T ss_pred             hhheEEeCCeeEEEEEccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEE
Confidence            3445556678999999999999998865   234689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCH---------HHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSE---------LQQL  154 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~---------~~~~  154 (235)
                      |+|||.++..... .......+|..|+|||++.+.. ++.++|+||+||++|+++++..++ .....         ...+
T Consensus       198 l~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l  275 (357)
T PHA03209        198 IGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL  275 (357)
T ss_pred             EecCccccccccC-cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence            9999998643221 2223446788999999987655 789999999999999999865554 32111         1222


Q ss_pred             HHHHHHhCCCCCCCcccccc-----cccccCCCCCCc-cchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSS-----LMNWHEYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      .......+..+..+......     ...+........ ........+.+.++.++|++||+.||.+|||+.|+++||||+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence            23333333222221110000     000000000000 001112225677888999999999999999999999999998


Q ss_pred             CC
Q 026660          229 DL  230 (235)
Q Consensus       229 ~~  230 (235)
                      ++
T Consensus       356 ~~  357 (357)
T PHA03209        356 QL  357 (357)
T ss_pred             cC
Confidence            74

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-36  Score=238.58  Aligned_cols=197  Identities=26%  Similarity=0.421  Sum_probs=152.9

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..+.++.+|+||||++| +|.+++...  ....+++..+..++.|++.||.|||+.+++|+||+|+||+++..+ .++++
T Consensus        68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~  144 (285)
T cd05630          68 AYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRIS  144 (285)
T ss_pred             EEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEe
Confidence            34566789999999975 999988653  234589999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||++....... ......++..|+|||.+.+.. ++.++|+||+|+++|++++|..||.................... 
T Consensus       145 Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-  221 (285)
T cd05630         145 DLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-  221 (285)
T ss_pred             eccceeecCCCc-cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-
Confidence            999886543221 222346788999999987655 78999999999999999999999986543211111111100000 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                                             ......+++++++++++||+.||.+|||     ++++++||||+.+++.
T Consensus       222 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         222 -----------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             -----------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                                   0011246788999999999999999999     8999999999987764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=242.72  Aligned_cols=188  Identities=26%  Similarity=0.391  Sum_probs=155.5

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ++++.-+....+|||||||+ |+|.+||+.  ..+..++....+.++.|||+|++||++++++||||.+.|||++.+. .
T Consensus       265 ~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~  341 (468)
T KOG0197|consen  265 KLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-V  341 (468)
T ss_pred             EEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-e
Confidence            34444455568999999997 899999998  5667899999999999999999999999999999999999999776 9


Q ss_pred             EEEeecCCcccccCC-CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      +||+|||+++..... .........+..|.|||.+.... ++.+|||||||++|+|++| |+.|+.+-...+....+.+.
T Consensus       342 vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G  420 (468)
T KOG0197|consen  342 VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG  420 (468)
T ss_pred             EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence            999999999843321 11122223367899999998655 9999999999999999999 99999998888888877764


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      ..-+.                           ..++++++-+++..|+..+|.+|||++.+.
T Consensus       421 yRlp~---------------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 YRLPR---------------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CcCCC---------------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            33322                           335889999999999999999999998664

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.4e-36  Score=236.18  Aligned_cols=193  Identities=27%  Similarity=0.404  Sum_probs=152.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .....+..|+||||++| +|.+++..    .+.++++.+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++
T Consensus        65 ~~~~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~  139 (279)
T cd05633          65 AFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRIS  139 (279)
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEc
Confidence            34456678999999985 99988865    34699999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~  164 (235)
                      |||++......  ......++..|+|||.+.....++.++|+||+||+++++++|..||.....  .........   ..
T Consensus       140 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~  214 (279)
T cd05633         140 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV  214 (279)
T ss_pred             cCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC
Confidence            99988654322  222346788999999986544478999999999999999999999975432  111111110   00


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .                        ......++.++.++|++||..||.+||     |+.++++||||+.+++++
T Consensus       215 ~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         215 N------------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             C------------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            0                        001124678999999999999999999     699999999999988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-35  Score=229.33  Aligned_cols=186  Identities=27%  Similarity=0.465  Sum_probs=150.7

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .+..+|++|||+++ +|.+++..  .....+++..++.++.|++.|+++||++|++|+||+|+||+++.++ .++++|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~  147 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLG  147 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEeccc
Confidence            45578999999985 99999976  3345689999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      .+..............+++.|+|||...+.. ++.++|+||+|++++++++|..||...+.............       
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------  219 (257)
T cd08223         148 IARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-------  219 (257)
T ss_pred             ceEEecccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            9876544333344456788999999987654 78899999999999999999999987665443333222100       


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                          ......+++++.+++.+|++.||.+||++.++++||||
T Consensus       220 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 --------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             --------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                00112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-35  Score=232.51  Aligned_cols=217  Identities=35%  Similarity=0.665  Sum_probs=157.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.+...++||||+++ +|..++.+    ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .++
T Consensus        66 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~  140 (286)
T cd07847          66 IEVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIK  140 (286)
T ss_pred             eeEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEE
Confidence            3445667789999999997 44444332    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+...++.++|+||+|++++++++|..||.+....+............
T Consensus       141 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  220 (286)
T cd07847         141 LCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL  220 (286)
T ss_pred             ECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987665443333344567889999998765557889999999999999999999998877666555554433322


Q ss_pred             CCCCcccc--cccccc-cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGV--SSLMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ........  ...... .................++..+.+++.+||+.+|.+||++.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            11100000  000000 0000001111222334678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=237.80  Aligned_cols=200  Identities=25%  Similarity=0.415  Sum_probs=158.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++....|+||||+.| +|.+++.+  ..+..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .+
T Consensus        66 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~  142 (316)
T cd05574          66 LYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HI  142 (316)
T ss_pred             heeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CE
Confidence            34556677889999999975 99999875  3345789999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-----------------------------CcccccccccccCchhhhCCCCCCchhhHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK-----------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI  134 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~  134 (235)
                      +++|||++........                             ......++..|+|||++.+.. ++.++|+||+|++
T Consensus       143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~l  221 (316)
T cd05574         143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGIL  221 (316)
T ss_pred             EEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHH
Confidence            9999998865432111                             011235677899999997654 7889999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC
Q 026660          135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK  214 (235)
Q Consensus       135 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  214 (235)
                      +|++++|..||......+........   .. .                      ......++.+++++|++||..||.+
T Consensus       222 l~~l~~g~~pf~~~~~~~~~~~~~~~---~~-~----------------------~~~~~~~~~~~~~li~~~l~~~p~~  275 (316)
T cd05574         222 LYEMLYGTTPFKGSNRDETFSNILKK---EV-T----------------------FPGSPPVSSSARDLIRKLLVKDPSK  275 (316)
T ss_pred             HHHHhhCCCCCCCCchHHHHHHHhcC---Cc-c----------------------CCCccccCHHHHHHHHHHccCCHhH
Confidence            99999999999877655544433210   00 0                      0001126789999999999999999


Q ss_pred             CCC----HHHHhCCCCCCCCCcCC
Q 026660          215 RIS----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       215 Rps----~~~ll~hp~f~~~~~~~  234 (235)
                      |||    ++++++||||++.+|..
T Consensus       276 R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         276 RLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             CCCchhhHHHHHcCchhhcCChhh
Confidence            999    99999999999988764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-35  Score=233.33  Aligned_cols=209  Identities=42%  Similarity=0.737  Sum_probs=158.2

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      +.+++|+||++++|.+++.+.   ...+++..++.++.|++.||+|||+.+++|+||+|+||+++. + .++++|||.+.
T Consensus        73 ~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~  147 (282)
T cd07831          73 GRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCR  147 (282)
T ss_pred             CcEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEeccccc
Confidence            678999999999999888652   246899999999999999999999999999999999999997 5 99999999987


Q ss_pred             cccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccc
Q 026660           93 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  172 (235)
Q Consensus        93 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (235)
                      ....... .....++..|+|||.+......+.++|+||+||+++++++|..||.+.+..+.........+.+........
T Consensus       148 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         148 GIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             ccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            6543222 223456788999998765455788999999999999999999999888777766666655554443221110


Q ss_pred             cccc-cccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          173 SSLM-NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       173 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .... ...................++.+++++|++||..+|.+||+++++++||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0000 000011111112222334678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-36  Score=240.07  Aligned_cols=220  Identities=38%  Similarity=0.698  Sum_probs=164.4

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ...++..+.|+++||++++|.+++..     ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++ .++++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~  148 (336)
T cd07849          75 PSFESFNDVYIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKIC  148 (336)
T ss_pred             ccccccceEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEC
Confidence            33455567899999999999887754     3689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           87 DLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        87 df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      |||++.........   .....++..|+|||.+.+...++.++|+||+|++++++++|..||.+.........+......
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~  228 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT  228 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99998765432221   123456888999998766555789999999999999999999999887766666666555554


Q ss_pred             CCCCCcccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +....+.........   ...+...........+..++++.++|++||+.+|.+|||+.++++||||..+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            433322211110000   000011111122233457889999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=231.26  Aligned_cols=195  Identities=28%  Similarity=0.443  Sum_probs=156.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..+++...|+|+||++| +|.+++..    ...++++.+..++.|++.||.|||+.+++|+||+|+||+++.++ .+
T Consensus        62 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~  136 (260)
T cd05611          62 LYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HL  136 (260)
T ss_pred             eeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cE
Confidence            34455677889999999985 99999865    24689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||.+.....    .....++..|++||.+.+.. ++.++|+||+|+++|++++|..||......+...........
T Consensus       137 ~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  211 (260)
T cd05611         137 KLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN  211 (260)
T ss_pred             EEeecccceeccc----cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC
Confidence            9999998865432    22345677899999987655 789999999999999999999999877665544443321100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~  233 (235)
                      ..                        ......+++++.++|++||+.+|.+||   +++|+++||||++++|.
T Consensus       212 ~~------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         212 WP------------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CC------------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence            00                        001114678999999999999999999   45799999999999884

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-36  Score=242.40  Aligned_cols=200  Identities=22%  Similarity=0.385  Sum_probs=155.9

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..++...+|+||||+. |+|.+++.+.   ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+
T Consensus        69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~  144 (332)
T cd05623          69 AFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLA  144 (332)
T ss_pred             EEecCCEEEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEe
Confidence            4456778999999997 5999999763   34689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCC-CcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           87 DLGLARAFTLPIK-KYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        87 df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      |||++........ ......||+.|+|||++..    ...++.++|+||+||++|+|++|..||......+....+....
T Consensus       145 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~  224 (332)
T cd05623         145 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  224 (332)
T ss_pred             ecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence            9999865433222 2233467999999999863    3347889999999999999999999998877666655543211


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ...                       ........+++++++++++||..++.+  |++++++++||||++++|+.
T Consensus       225 ~~~-----------------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         225 ERF-----------------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             ccc-----------------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence            000                       000111247889999999999765544  68999999999999988754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6e-36  Score=243.44  Aligned_cols=197  Identities=23%  Similarity=0.354  Sum_probs=154.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++++|+||||++| +|.+++..     ..+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ik  182 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLK  182 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEE
Confidence            3455677889999999975 99998865     2489999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      |+|||++........ ......||+.|+|||++.+..   .++.++|+||+||++|+|++|..||...+.......+...
T Consensus       183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  262 (371)
T cd05622         183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH  262 (371)
T ss_pred             EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            999999876543221 223456899999999987532   3678999999999999999999999987766555544321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCc
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~  232 (235)
                      .....                        ......++..++++|.+||..++.+  |++++++++||||++..|
T Consensus       263 ~~~~~------------------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         263 KNSLT------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCccc------------------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            11000                        0011247889999999999844433  789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-35  Score=234.09  Aligned_cols=191  Identities=22%  Similarity=0.364  Sum_probs=151.1

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....|+||||++| +|.+++......+..+++..++.++.|++.||++||+.+++|+||+|+||+++.++ .++++|||.
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~  174 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGV  174 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeeccc
Confidence            4578999999975 99999987655666799999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +..............++..|+|||.+....    .++.++|+||+||+++++++|..||......+........   ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~  251 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPP  251 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCC
Confidence            876543332333446678899999875432    2578999999999999999999999876654444332211   000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      ..                      ......+..+.++|.+||+.+|.+||++.++++||||+
T Consensus       252 ~~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 TL----------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CC----------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            00                      00113557789999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=239.63  Aligned_cols=200  Identities=22%  Similarity=0.407  Sum_probs=154.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++++++|+||||+.| +|.+++.+.   ...++++.+..++.||+.||+|||+++++|+||||+||+++.++ .++|
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl  143 (331)
T cd05597          68 YAFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRL  143 (331)
T ss_pred             EEEecCCeEEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEE
Confidence            345677889999999975 999999653   34689999999999999999999999999999999999998776 8999


Q ss_pred             eecCCcccccCCCC-CcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        86 ~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      +|||++........ ......+++.|+|||++..    ...++.++|+||+||++|+|++|..||......+....+...
T Consensus       144 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05597         144 ADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             EECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            99999865543222 1223457899999999863    233678999999999999999999999887665555444321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~  233 (235)
                      ....                       ........++++++++|++||..++.+  |+++.++++||||.+++|.
T Consensus       224 ~~~~-----------------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         224 KEHF-----------------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             CCcc-----------------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence            0000                       001111237889999999988764443  7899999999999988775

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-35  Score=231.29  Aligned_cols=194  Identities=27%  Similarity=0.429  Sum_probs=154.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+++...|+++||+++ +|.+++.+.    ..+++..+..++.|++.||++||+++++|+||+|+||+++.++ .+++
T Consensus        60 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l  134 (262)
T cd05572          60 RTFKDKKYIYMLMEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKL  134 (262)
T ss_pred             eeEEcCCccEEEEecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEE
Confidence            445667789999999975 999999762    3589999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS--ELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~  163 (235)
                      +|||.+....... ......++..|++||.+.+.. ++.++|+||+|+++|++++|..||....  ..+........   
T Consensus       135 ~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---  209 (262)
T cd05572         135 VDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG---  209 (262)
T ss_pred             eeCCcccccCccc-ccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc---
Confidence            9999987654332 223345678899999986544 7899999999999999999999998765  33333332210   


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                      ....                       ......++++.++|++||..+|.+||+     ++|+++||||++++|+
T Consensus       210 ~~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         210 NGKL-----------------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             CCCC-----------------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            0000                       001123678999999999999999999     9999999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.5e-36  Score=239.69  Aligned_cols=218  Identities=37%  Similarity=0.731  Sum_probs=168.7

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +....+|+||||++|+|.+++..    ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++++|||
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccc
Confidence            35568999999999999888754    34599999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCC----cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           90 LARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        90 ~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      .+.........    .....++..|+|||.+.+...++.++|+||+|+++|++++|..||.+.+............+.++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            98655432211    12346688899999987655578999999999999999999999998887777777777777666


Q ss_pred             CCCcccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...+.........   ...............+..++++.++|++||+.+|.+||++.++++||||+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            5554433221110   011111111222333467899999999999999999999999999999986654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-35  Score=230.82  Aligned_cols=187  Identities=22%  Similarity=0.417  Sum_probs=148.1

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....|++|||+++ +|.+++..  .....+++..+..++.|++.|++|||+++++|+||+|+||+++.++ .++++|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCC
Confidence            4678999999985 99999976  3345689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +..............++..|+|||++.+    ...++.++|+||+||++|++++|..||..............   .+. 
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~-  233 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPA-  233 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCC-
Confidence            8765433333445567888999999863    22367899999999999999999999976554333322111   000 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                            .......++.++.+++.+||..+|.+|||+.+++.||||
T Consensus       234 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 ----------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                  000112367789999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-35  Score=237.77  Aligned_cols=224  Identities=19%  Similarity=0.223  Sum_probs=152.8

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+....++..|+||||++ |+|.+++....  .+.+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~  141 (327)
T cd08227          65 RATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVY  141 (327)
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEE
Confidence            345566778999999998 59999997632  34589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-------CcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           85 IADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        85 l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      +.||+..........       ......++..|+|||.+.+. ..++.++|+||+||+++++++|..||......+....
T Consensus       142 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  221 (327)
T cd08227         142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (327)
T ss_pred             EcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence            999876543321111       01122346679999998753 3478999999999999999999999986554333322


Q ss_pred             HHHHhCC--------CCCCCccccccccc------ccC----CCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          157 IFRLLGT--------PNEKVWPGVSSLMN------WHE----YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       157 ~~~~~~~--------~~~~~~~~~~~~~~------~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      .......        +.............      +..    ...............+++++.+++++||+.||.+|||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  301 (327)
T cd08227         222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA  301 (327)
T ss_pred             HhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence            2211000        00000000000000      000    00000001111223467889999999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 026660          219 KKAMEHPYFDDLDK  232 (235)
Q Consensus       219 ~~ll~hp~f~~~~~  232 (235)
                      +++++||||+++..
T Consensus       302 ~ell~~p~f~~~~~  315 (327)
T cd08227         302 STLLNHSFFKQIKR  315 (327)
T ss_pred             HHHhcChhhhhcch
Confidence            99999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.2e-36  Score=242.14  Aligned_cols=193  Identities=22%  Similarity=0.326  Sum_probs=146.5

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..+.++.+|+||||+.+ +|.+.        ...++..+..++.||+.||+|||+++++|+|||++||+++.++ .+
T Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~  207 (353)
T PLN00034        137 CHDMFDHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NV  207 (353)
T ss_pred             eeeEeccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CE
Confidence            34556778889999999985 77542        2356788899999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|+|||++..............|+..|+|||.+..    ....+.++|||||||++|++++|..||......+.......
T Consensus       208 kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~  287 (353)
T PLN00034        208 KIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA  287 (353)
T ss_pred             EEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence            99999998765433333344577899999998743    22245689999999999999999999974332221111111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ......                        ......++.+++++|++||..||.+||++.|+++||||..-
T Consensus       288 ~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        288 ICMSQP------------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HhccCC------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            100000                        00112467899999999999999999999999999999864

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-35  Score=227.85  Aligned_cols=191  Identities=25%  Similarity=0.390  Sum_probs=154.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..|+||||++| +|.+++.+.  ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~  141 (256)
T cd08529          65 YESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVK  141 (256)
T ss_pred             eeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEE
Confidence            4455667789999999975 999999873  345689999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||++.+.. ++.++|+||||++++++++|..||......+........... 
T Consensus       142 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  219 (256)
T cd08529         142 IGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-  219 (256)
T ss_pred             EcccccceeccCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999999876654433334456788899999987655 788999999999999999999999877755444433221000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                                .....++.++.+++++|++.+|.+||++.+++.|||+
T Consensus       220 --------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         220 --------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             --------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                                      0011367889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-35  Score=238.40  Aligned_cols=218  Identities=40%  Similarity=0.732  Sum_probs=169.8

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +...+|++|||++++|.+++.+    ...++++.++.++.|++.||++||+.|++|+||+|.||+++.++ .++++|||.
T Consensus        75 ~~~~~~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGL  149 (330)
T ss_pred             cccceEEEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCc
Confidence            3457899999999988888865    34799999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCC---CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.......   .......++..|+|||.+.+....+.++|+||+|++++++++|..||......+....+....+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            97665443   123344567889999998876458899999999999999999999999988888877777766665544


Q ss_pred             Ccccccccc--ccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          168 VWPGVSSLM--NWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       168 ~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .+.......  .+. ..............+.++.++.++|++||+.+|.+||++.++++||||+++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            332111100  000 011111222333445678999999999999999999999999999999877653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-36  Score=239.08  Aligned_cols=195  Identities=29%  Similarity=0.444  Sum_probs=149.1

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ++..-+++++|+||||-..||..+|.+..   ...+.-.++.+..|++.|+.++|..|+||.||||.|+|+- .| .+||
T Consensus       426 ~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKL  500 (677)
T KOG0596|consen  426 YDYEVTDGYLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKL  500 (677)
T ss_pred             eeeeccCceEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEe
Confidence            34444577899999998889999998732   2344458999999999999999999999999999999988 55 8999


Q ss_pred             eecCCcccccCCCCC--cccccccccccCchhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 026660           86 ADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSELQQ  153 (235)
Q Consensus        86 ~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  153 (235)
                      +|||.+.........  .....||+.|||||.+...          .+.+.++|||||||++|+|+.|+.||+...+  .
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~  578 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--Q  578 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--H
Confidence            999999876654442  3355889999999999631          1246899999999999999999999976432  2


Q ss_pred             HHHHHHHhCCCCCC-CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          154 LLHIFRLLGTPNEK-VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       154 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ++++.. +..|+.. -++.+.                      -..++.++++.||.+||++|||+.++|+|||.+.+
T Consensus       579 ~aKl~a-I~~P~~~Iefp~~~----------------------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  579 IAKLHA-ITDPNHEIEFPDIP----------------------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             HHHHHh-hcCCCccccccCCC----------------------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            222222 2333221 111111                      11238899999999999999999999999999864

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=235.96  Aligned_cols=215  Identities=44%  Similarity=0.845  Sum_probs=156.6

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC----CCCeEEEe
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGE-NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR----KTMTLKIA   86 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~-~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~----~~~~~~l~   86 (235)
                      ...+|+||||++++|.+++........ .+++..++.++.|++.||+|||+.+++|+||+|+||+++.    .+ .++++
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~  154 (316)
T cd07842          76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIG  154 (316)
T ss_pred             CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEEC
Confidence            378999999999999998876544443 7899999999999999999999999999999999999997    55 89999


Q ss_pred             ecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 026660           87 DLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL---------QQL  154 (235)
Q Consensus        87 df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~  154 (235)
                      |||++........   ......++..|+|||.+.+...++.++|+||+|++++++++|..||......         ...
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999876543322   1223456788999999876555789999999999999999999999754322         233


Q ss_pred             HHHHHHhCCCCCCCcccccccccccC------CCCCC---ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHE------YPQWN---PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                      ......+..+....+....+...+..      .....   ...........+.++.+++.+||+.||.+|||+.++++||
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            34444444443332221111111000      00000   0001111125778899999999999999999999999999


Q ss_pred             CC
Q 026660          226 YF  227 (235)
Q Consensus       226 ~f  227 (235)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-35  Score=232.14  Aligned_cols=189  Identities=22%  Similarity=0.400  Sum_probs=149.1

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +.....|++|||+++ +|.+++...  ....++++.++.++.|++.|++|||+.+++|+||+|+||+++.++ .++++||
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~df  165 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDF  165 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeC
Confidence            346789999999985 999999763  344588999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |.+..............++..|+|||.+..    ...++.++|+||+|+++|++++|..||...............   .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~  242 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P  242 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C
Confidence            998755433333344567888999998752    233678999999999999999999999765543333221110   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .                       .......++.++.++|++||+.||.+||++.++++||||
T Consensus       243 ~-----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 P-----------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             C-----------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            0                       000112477899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.1e-35  Score=237.11  Aligned_cols=218  Identities=33%  Similarity=0.624  Sum_probs=158.7

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .+....|+|+||++++|.+++..     ..+++..++.++.||+.||+|||+.|++|+||+|+||+++..+..++++|||
T Consensus        86 ~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          86 TELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence            34457899999999999887753     3689999999999999999999999999999999999998666578999999


Q ss_pred             CcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+........   ......++..|+|||.+.+...++.++|+||+||+++++++|..||......+..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9865432211   1122345778999998766555788999999999999999999999888776665555443322221


Q ss_pred             CCcccccccccccC--CCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ..............  .............+.++.+++++|++||+.||.+|||+.++++||||+.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            11110000000000  0000111122233468889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-36  Score=233.66  Aligned_cols=194  Identities=29%  Similarity=0.518  Sum_probs=151.5

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+..+++|||++.+ +|.+++.+    ...+++..++.++.|++.||++||+.+++|+||+|+||+++.++ .++++
T Consensus        66 ~~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~  140 (260)
T PF00069_consen   66 VFQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLI  140 (260)
T ss_dssp             EEEESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEES
T ss_pred             cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence            33447788999999997 99999983    34689999999999999999999999999999999999999666 99999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+..............++..|+|||++......+.++|+||+|+++++|++|..||.....................
T Consensus       141 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~  220 (260)
T PF00069_consen  141 DFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP  220 (260)
T ss_dssp             SGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence            99998754333344455667889999999873444889999999999999999999999887433333333222111000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..                     .......+.++.++|++||+.||.+||++.++++||||
T Consensus       221 ~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  221 SS---------------------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HH---------------------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             cc---------------------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            00                     00000123789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-35  Score=232.81  Aligned_cols=200  Identities=32%  Similarity=0.418  Sum_probs=155.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++..+..|+||||++| +|.+++.+.  ....+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++ .++
T Consensus        59 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~  135 (277)
T cd05577          59 AYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVR  135 (277)
T ss_pred             eeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEE
Confidence            3445667789999999985 999999763  334689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+...... .......++..|+|||.+.+.. ++.++|+||+|++++++++|..||...........+.......
T Consensus       136 l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  213 (277)
T cd05577         136 ISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM  213 (277)
T ss_pred             EccCcchhhhccC-CccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc
Confidence            9999988654331 2223345577899999987655 7899999999999999999999997654321111111110000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                              .......+++++.++|++||+.||.+||     ++.++++||||.+++|.+
T Consensus       214 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         214 ------------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ------------------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence                                    0001123678899999999999999999     888899999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-35  Score=232.32  Aligned_cols=198  Identities=21%  Similarity=0.359  Sum_probs=153.7

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...|+||||++| +|..++.+.   ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++ .++|+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~  152 (292)
T cd06644          77 AFYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLA  152 (292)
T ss_pred             EEEeCCeEEEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEc
Confidence            34556789999999986 887777542   34589999999999999999999999999999999999998666 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |||.+..............++..|+|||.+.+    ...++.++|+||+||++|++++|..||......+........  
T Consensus       153 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--  230 (292)
T cd06644         153 DFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--  230 (292)
T ss_pred             cCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--
Confidence            99988654433333344566788999998852    223577899999999999999999999776554433332211  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                       ....                      ......++.++.++|++||+.+|.+||+++++++||||..+++.+
T Consensus       231 -~~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         231 -EPPT----------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             -CCcc----------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence             0000                      001124677899999999999999999999999999999988764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-35  Score=233.07  Aligned_cols=199  Identities=26%  Similarity=0.408  Sum_probs=157.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .....++..|++|||+.+ +|.+++...  ....+++..+..++.|++.||.|||+.+++|+||+|+||+++..+ .+++
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl  143 (285)
T cd05632          67 YAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRI  143 (285)
T ss_pred             EEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEE
Confidence            344566789999999985 999888653  334699999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+...... .......++..|+|||.+.+.. ++.++|+||+|++++++++|..||....................
T Consensus       144 ~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05632         144 SDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE  221 (285)
T ss_pred             ecCCcceecCCC-CcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc
Confidence            999988654322 1223346788999999987654 78999999999999999999999987665444333332211111


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                      ..                        ....+++++.+++.+||+.||.+||+     +.++++||||.++.+++
T Consensus       222 ~~------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         222 EV------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             cc------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence            11                        11246788899999999999999999     88999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.1e-35  Score=231.90  Aligned_cols=214  Identities=43%  Similarity=0.799  Sum_probs=163.0

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +....+|+|+||+.++|.+.+..   ....+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++++|||
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCc
Confidence            44567899999999988887765   234699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCC-----------cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           90 LARAFTLPIKK-----------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        90 ~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                      ++.........           .....++..|+|||.+.+...++.++|+||+|++++++++|..||.+.........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            98755432211           1223457789999998765557899999999999999999999999888877777777


Q ss_pred             HHhCCCCCCCccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .....+....+..........  ......+..........++.++++|++||..||.+|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            666655444333221111111  001111122333444567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.6e-35  Score=231.60  Aligned_cols=213  Identities=38%  Similarity=0.713  Sum_probs=159.7

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .....|+||||++++|.+++.+   ....++++.++.++.|++.||+|||+++++|+||+|+||+++..+ .++++|||.
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCC
Confidence            3456799999999999888865   234689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCC----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +........    ......++..|+|||.+.+...++.++|+||+|++++++++|..||.+.........+....+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            875543221    1123345778999999876555688999999999999999999999888777766666666665555


Q ss_pred             CCcccccccccccCCC--CCCccc--hhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWHEYP--QWNPQS--LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..++.......+....  .-....  ........+..++++|.+||..||.+|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            5444332211111000  000000  001111245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-35  Score=222.60  Aligned_cols=219  Identities=42%  Similarity=0.790  Sum_probs=177.3

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC----CCeEEEe
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----TMTLKIA   86 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~----~~~~~l~   86 (235)
                      +..+++++||..-||...|+-+.. .++.++...++.++.||+.|+.|||++-+.|||+||.||++-.+    | .++|+
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG-~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG-RVKIA  178 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC-eeEee
Confidence            778999999999999999866433 34578999999999999999999999999999999999999765    5 89999


Q ss_pred             ecCCcccccCCCCCc---ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHH
Q 026660           87 DLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---------SELQQL  154 (235)
Q Consensus        87 df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~~~~~  154 (235)
                      |+|+++.+..+-...   ....-|++|+|||.+.+...++.+.|+|++||++.||++..+.|.+.         ....++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887664432   23445889999999999999999999999999999999998888643         346678


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCC------CCCc---cchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYP------QWNP---QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                      .+++..++.|....|+.....-.++..-      .+..   .........-++...+|+.+||+.||.+|+|++++++|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            8899999999999998877655442110      1111   111122223445588999999999999999999999999


Q ss_pred             CCCCCC
Q 026660          226 YFDDLD  231 (235)
Q Consensus       226 ~f~~~~  231 (235)
                      ||..-+
T Consensus       339 yF~~d~  344 (438)
T KOG0666|consen  339 YFTEDP  344 (438)
T ss_pred             ccccCC
Confidence            998653

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=229.58  Aligned_cols=193  Identities=26%  Similarity=0.353  Sum_probs=166.4

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .+..++.+|+||||.+| .|.-++..    .+.++++..+.+...|+.||.|||++++++||+|.+|++++.++ .++|.
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKit  310 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKIT  310 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEee
Confidence            35678899999999985 98888755    56799999999999999999999999999999999999999888 99999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||+++..-........+.||+.|.|||++.... ++.+.|.|.+|+++|+|++|+.||.+.+.......+.-.-     
T Consensus       311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-----  384 (516)
T KOG0690|consen  311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-----  384 (516)
T ss_pred             ecccchhcccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-----
Confidence            9999987665666778899999999999997665 8999999999999999999999999887766655443210     


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                             ..-...++++.+.|+..+|..||.+|.     .+.|+.+|+||.+++|+.
T Consensus       385 -----------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  385 -----------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             -----------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                                   011125889999999999999999997     488999999999999974

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=230.12  Aligned_cols=192  Identities=22%  Similarity=0.412  Sum_probs=151.9

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +.....|+||||+++ +|.+++......+..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .++++||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~  157 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDF  157 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCC
Confidence            456779999999986 99999987655567799999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |.+..............++..|+|||.+...    ..++.++|+||+|++++++++|..||...........+...   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~  234 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---P  234 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---C
Confidence            9886554333333445678889999987532    23567899999999999999999999765544333332210   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...                      ......+++++.++|++||..||.+|||+.++++|||+
T Consensus       235 ~~~----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 PPT----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCC----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            000                      00111367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-35  Score=236.67  Aligned_cols=214  Identities=38%  Similarity=0.700  Sum_probs=164.4

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +....|+|+||++++|.+++..     ..++++.++.++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.
T Consensus        91 ~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~  164 (343)
T cd07851          91 DFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGL  164 (343)
T ss_pred             ccccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEccccc
Confidence            3456899999998899998865     4689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +......   .....++..|+|||.+.+...++.++|+||+|++++++++|..||.+....+.........+.+...++.
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            8765432   2233557789999998765457899999999999999999999999888777777666655554443332


Q ss_pred             cccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          171 GVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       171 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ........   .................+++++.++|++||+.+|.+|||+.++++||||+++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            22111000   0001111122223334568899999999999999999999999999999977543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-35  Score=236.54  Aligned_cols=219  Identities=20%  Similarity=0.305  Sum_probs=152.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+..++++++|+||||+.| +|.+++.+    .+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~  143 (333)
T cd06650          69 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EI  143 (333)
T ss_pred             eEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CE
Confidence            3445567789999999975 99999965    34589999999999999999999975 799999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG-  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-  162 (235)
                      +++|||++......  ......++..|+|||.+.+.. ++.++|+||+||++|++++|..||......+.......... 
T Consensus       144 kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  220 (333)
T cd06650         144 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG  220 (333)
T ss_pred             EEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccC
Confidence            99999998654322  223346788999999987654 78999999999999999999999987654332221110000 


Q ss_pred             CCCCCCc-cccc---ccccccCCCCCCccc--------hh-----hcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          163 TPNEKVW-PGVS---SLMNWHEYPQWNPQS--------LA-----TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       163 ~~~~~~~-~~~~---~~~~~~~~~~~~~~~--------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                      .+..... ....   ...........+...        ..     .....++.+++++|.+||+.||.+|||+.+++.||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         221 DPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             CccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence            0000000 0000   000000000000000        00     00113567899999999999999999999999999


Q ss_pred             CCCCCCc
Q 026660          226 YFDDLDK  232 (235)
Q Consensus       226 ~f~~~~~  232 (235)
                      ||+....
T Consensus       301 ~~~~~~~  307 (333)
T cd06650         301 FIKRSEA  307 (333)
T ss_pred             HHhcCcc
Confidence            9987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-35  Score=230.64  Aligned_cols=197  Identities=25%  Similarity=0.350  Sum_probs=153.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++++...|+||||+.| +|..++.+    .+.++++.++.++.|++.|++|||+.+++|+||+|+||+++.++ .++
T Consensus        63 ~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~k  137 (278)
T cd05606          63 SYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVR  137 (278)
T ss_pred             eeeeecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEE
Confidence            3445667789999999985 99888754    34699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+......  ......++..|+|||.+.+...++.++|+||+|++++++++|..||............... ...
T Consensus       138 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~  214 (278)
T cd05606         138 ISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTM  214 (278)
T ss_pred             EccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hcc
Confidence            9999988654322  2223467889999999875545789999999999999999999999765321111110000 000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      ..                        .....++.++.+++++||..+|.+||     ++.++++||||+.++|..
T Consensus       215 ~~------------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         215 AV------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             CC------------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            00                        01113578999999999999999999     999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-35  Score=232.10  Aligned_cols=192  Identities=28%  Similarity=0.414  Sum_probs=156.0

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+.+..|+||||++ ++|.+++.+.    ..+++..+..++.|++.||++||+.|++|+||+|.||+++.++ .++
T Consensus        67 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~k  141 (290)
T cd05580          67 YGSFQDDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIK  141 (290)
T ss_pred             eeEEEcCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEE
Confidence            344566788999999996 5999998762    5689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++......   .....+++.|+|||.+.+.. .+.++|+||+|+++++|++|..||......+.........   
T Consensus       142 l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---  214 (290)
T cd05580         142 ITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK---  214 (290)
T ss_pred             EeeCCCccccCCC---CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---
Confidence            9999998765433   23345688899999987554 7889999999999999999999998776444333332110   


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                       .                        .....+++.++++|++||..||.+|+     +++++++||||+.++|..
T Consensus       215 -~------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         215 -V------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             -c------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence             0                        00113578899999999999999999     999999999999998753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=242.32  Aligned_cols=192  Identities=24%  Similarity=0.399  Sum_probs=158.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..=.+..+.++||||.| ++.+.+..    +..+++..+.-++++++.|+.|||.++.+|+|||+.||++...+ .+++
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl  152 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKL  152 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEE
Confidence            333345568899999985 99999865    44569999999999999999999999999999999999999886 9999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+-...........++||+.|||||++.+.. |+.++||||||++.++|++|.+|+.....       ++.+...+
T Consensus       153 ~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hP-------mrvlflIp  224 (467)
T KOG0201|consen  153 ADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHP-------MRVLFLIP  224 (467)
T ss_pred             Eecceeeeeechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCc-------ceEEEecc
Confidence            99999988877666678899999999999998544 89999999999999999999999977654       11111111


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      +..                 +..+..   .+++.+++||..||..||..||||.++|.|+|++.-.
T Consensus       225 k~~-----------------PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  225 KSA-----------------PPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CCC-----------------CCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            111                 111111   5788999999999999999999999999999998743

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-35  Score=229.52  Aligned_cols=217  Identities=35%  Similarity=0.672  Sum_probs=158.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+|+||+++ +|..+...    ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .++
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~  140 (286)
T cd07846          66 IEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVK  140 (286)
T ss_pred             HHhcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEE
Confidence            3445677889999999997 55554432    34589999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++..............++..|+|||.+.+...++.++|+||+|++++++++|..||......+............
T Consensus       141 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  220 (286)
T cd07846         141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL  220 (286)
T ss_pred             EEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC
Confidence            99999987654443333445568889999998765557889999999999999999999998777666665555443332


Q ss_pred             CCCCccccccc--ccccCCCCC-CccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSL--MNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...........  ......... .........++++..+.+++++||..+|.+||++.++++||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            21110000000  000000000 0111222345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=230.74  Aligned_cols=197  Identities=23%  Similarity=0.382  Sum_probs=155.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...|+||||+++ +|.+++.+.   ...+++..++.++.|++.|+.|||+++++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l  144 (280)
T cd06611          69 EAYFYENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKL  144 (280)
T ss_pred             EEEecCCeEEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEE
Confidence            344567789999999986 999988763   34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +|||.+..............++..|+|||.+..    ...++.++|+||+|+++|++++|..||......+........ 
T Consensus       145 ~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  223 (280)
T cd06611         145 ADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-  223 (280)
T ss_pred             ccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC-
Confidence            999988665443333344567888999999752    233577999999999999999999999877655444333211 


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                        ....                      ......++.++.++|++||..+|.+||++.++++||||.+...
T Consensus       224 --~~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         224 --EPPT----------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             --CCCC----------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence              0000                      0011246788999999999999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-35  Score=232.26  Aligned_cols=192  Identities=21%  Similarity=0.418  Sum_probs=152.7

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .....++.|+||||+++ +|.+++..     ..++++.++.++.||+.|++|||+++++|+||+|+||+++.++ .++++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~  160 (292)
T cd06658          87 SYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLS  160 (292)
T ss_pred             heecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEc
Confidence            34556789999999986 88887743     3588999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||++..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+............. 
T Consensus       161 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-  238 (292)
T cd06658         161 DFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-  238 (292)
T ss_pred             cCcchhhcccccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-
Confidence            9998875543333334456788999999986544 78999999999999999999999987765554433322111000 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                              .....++..+.+++.+|+..||.+|||++++++||||....
T Consensus       239 ------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         239 ------------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             ------------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence                                    00113677889999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-35  Score=227.58  Aligned_cols=194  Identities=30%  Similarity=0.588  Sum_probs=156.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...++++..|+++||+.| +|.+++.+.    +.+++..++.++.|++.||.+||+++++|+||+|+||+++.++ .+++
T Consensus        60 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l  134 (265)
T cd05579          60 YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKL  134 (265)
T ss_pred             HheecCcEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEE
Confidence            445677889999999975 999999763    3689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCC--------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           86 ADLGLARAFTLPIK--------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        86 ~df~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      +|||++........        ......++..|++||...... .+.++|+||+|++++++++|..||......+.....
T Consensus       135 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~  213 (265)
T cd05579         135 TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI  213 (265)
T ss_pred             EecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99998865433211        223345677899999987655 788999999999999999999999877765554443


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH---HHHhCCCCCCCCCc
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAMEHPYFDDLDK  232 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~ll~hp~f~~~~~  232 (235)
                      ...  ...   ++                     .....+..+.+++++||+.+|.+|||+   .++++||||++++|
T Consensus       214 ~~~--~~~---~~---------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         214 LNG--KIE---WP---------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             hcC--CcC---CC---------------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            220  000   00                     001247889999999999999999999   99999999999987

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=227.19  Aligned_cols=190  Identities=22%  Similarity=0.393  Sum_probs=150.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+++..+|+|+||++| +|.+++.+.    ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++
T Consensus        70 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~  144 (263)
T cd06625          70 YGCLRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVK  144 (263)
T ss_pred             EEEEccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEE
Confidence            3445666799999999985 999988762    4589999999999999999999999999999999999999666 899


Q ss_pred             EeecCCcccccCCCCCc---ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           85 IADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      ++|||.+..........   ....++..|+|||.+.+.. .+.++|+||+|+++|++++|..||................
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  223 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP  223 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC
Confidence            99999986543221111   2345677899999987655 7899999999999999999999998765544433322110


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                         ..                       ......++..+.++|++||..+|.+|||+.++++||||
T Consensus       224 ---~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ---TN-----------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---CC-----------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence               00                       00112467889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-35  Score=238.73  Aligned_cols=212  Identities=37%  Similarity=0.630  Sum_probs=157.8

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++..+.|+||||++++|.+.+..      .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++++|||
T Consensus        91 ~~~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg  163 (353)
T cd07850          91 EEFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG  163 (353)
T ss_pred             cccCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCc
Confidence            34456899999999999988854      289999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      .+....... ......++..|+|||.+.+.. ++.++|+||+||++++|++|..||...+.......+....+.+...+.
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCC-CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            987654322 223345678899999987654 789999999999999999999999988777777666665555443221


Q ss_pred             cccccccc----------ccCCCCCC-----ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          170 PGVSSLMN----------WHEYPQWN-----PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~~----------~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ........          ........     +..........+++++++|++||..||.+|||+.++|+||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            11110000          00000000     000000122356678999999999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.6e-35  Score=228.86  Aligned_cols=196  Identities=19%  Similarity=0.311  Sum_probs=153.1

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...|+|+||+++ +|..++.+   ....++++.+..++.|++.||.|||+.|++|+||+|+||+++.++ .++++
T Consensus        70 ~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~  145 (282)
T cd06643          70 AFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLA  145 (282)
T ss_pred             EEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEc
Confidence            34456678999999985 88887764   234689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |||++..............++..|+|||++..    ...++.++|+||+||+++++++|..||......+..........
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~  225 (282)
T cd06643         146 DFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP  225 (282)
T ss_pred             cccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC
Confidence            99998655433333344567889999999742    23367799999999999999999999987765554444332110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .  .                       ......++.+++++|++||+.||.+||++.++++||||+....
T Consensus       226 ~--~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         226 P--T-----------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             C--C-----------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            0  0                       0011136788999999999999999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.3e-35  Score=227.29  Aligned_cols=189  Identities=25%  Similarity=0.427  Sum_probs=148.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +.+...+..|+||||++| +|.+++.+    +..++++.++.++.|++.|+.+||+.+++|+||+|+||+++..+..+++
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         76 YSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEE
Confidence            344456689999999975 99999976    2378999999999999999999999999999999999999876657999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-LLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~  164 (235)
                      +|||.+......    ....++..|+|||.+.+.. ++.++|+||+|++++++++|..||........ ...........
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK  226 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc
Confidence            999988655422    2235678899999987654 78899999999999999999999975433221 11111111000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-HHHHhCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-AKKAMEHPYFDD  229 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~ll~hp~f~~  229 (235)
                                               .......++.+.++|.+||+.+|.+||+ ++++++||||++
T Consensus       227 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 -------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                                     0111247889999999999999999996 699999999975

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=228.75  Aligned_cols=216  Identities=45%  Similarity=0.797  Sum_probs=156.5

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..+++...|+|+||++++|.+++...   ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++|
T Consensus        71 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~D  146 (291)
T cd07870          71 IIHTKETLTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLAD  146 (291)
T ss_pred             EEecCCeEEEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEec
Confidence            34566789999999998988887542   23578889999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNE  166 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~  166 (235)
                      ||.++.............++..|+|||.+.+...++.++|+||+|++++++++|..||..... .+.........+.+..
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07870         147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE  226 (291)
T ss_pred             cccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence            998875543333333445678899999987655578899999999999999999999976543 3444444444444443


Q ss_pred             CCcccccccccccCC--CCCCccchhhcCC--CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          167 KVWPGVSSLMNWHEY--PQWNPQSLATAVP--NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..+........+...  .............  ..+.++.+++++|+..||.+|||+.+++.||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            333222211111000  0000111111111  235788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-35  Score=241.49  Aligned_cols=216  Identities=25%  Similarity=0.310  Sum_probs=151.1

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ....+...|+|||++.++|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++..+ .++|+|
T Consensus       228 ~~~~~~~~~lv~e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~D  303 (461)
T PHA03211        228 VRVVGGLTCLVLPKYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGD  303 (461)
T ss_pred             EEEECCEEEEEEEccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcc
Confidence            33456678999999999999988652   23689999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH
Q 026660           88 LGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-------ELQQLLHIF  158 (235)
Q Consensus        88 f~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~  158 (235)
                      ||+++.......  ......||..|+|||++.+.. ++.++|||||||++|++++|..++....       ......++.
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i  382 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII  382 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence            999875533211  122346799999999997655 7899999999999999999876653211       122333333


Q ss_pred             HHhCCCCCCCccccc----ccc----cccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          159 RLLGTPNEKVWPGVS----SLM----NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...+.....+.....    ..+    .......+.. ..-.....++.++.+||++||+.||.+|||+.|+|+||||++
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTR-PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HhhccccccCCCCcchHHHHHHHhhhhcccCCccCC-cchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            322221111110000    000    0000000000 001112246678999999999999999999999999999975

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.1e-35  Score=226.20  Aligned_cols=191  Identities=26%  Similarity=0.483  Sum_probs=154.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+++++.|+|+||+.+ +|.+++..  .....+++..+..++.|++.|+.+||+++++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~  141 (256)
T cd08218          65 QESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIK  141 (256)
T ss_pred             EeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEE
Confidence            3455677889999999975 99998876  3334588999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||......+........... 
T Consensus       142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-  219 (256)
T cd08218         142 LGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-  219 (256)
T ss_pred             EeeccceeecCcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-
Confidence            999999876544333233345678899999987654 788999999999999999999999877665554443321100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                                .....++.++.++|++||+.+|.+||++.++++||||
T Consensus       220 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 --------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                                      0112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-35  Score=237.84  Aligned_cols=201  Identities=19%  Similarity=0.360  Sum_probs=156.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+++++.|+||||+.| +|.+++.+.   ...+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|
T Consensus        68 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl  143 (331)
T cd05624          68 YAFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRL  143 (331)
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEE
Confidence            345677889999999975 999999763   34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      +|||++......... .....|++.|+|||++.+.    ..++.++|+||+|+++|+|++|..||......+....+...
T Consensus       144 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05624         144 ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             EeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence            999998765433221 2234678999999998642    23678999999999999999999999887765555444321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ....                       ........+++++++++.+||...+.+  |++++++++||||+.++|+.
T Consensus       224 ~~~~-----------------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         224 EERF-----------------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             CCcc-----------------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence            1000                       000111246789999999999876544  46899999999999988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8e-35  Score=229.08  Aligned_cols=192  Identities=21%  Similarity=0.359  Sum_probs=150.8

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ++....|+||||++| +|.+++.........+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++++||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~df  168 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDF  168 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccC
Confidence            456789999999985 99999887655566789999999999999999999999999999999999999776 7999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |.+..............++..|+|||.+..    ...++.++|+||+||+++++++|..||...............   .
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~  245 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P  245 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C
Confidence            998765433333334467889999998753    233678999999999999999999999776543332221110   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...                      ......++..+.+++.+||+.||.+|||+.++++|+||
T Consensus       246 ~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPT----------------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCc----------------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            000                      00011256789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=219.75  Aligned_cols=196  Identities=22%  Similarity=0.385  Sum_probs=149.5

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~   80 (235)
                      .+.+....+...|++++|+. |+|.+.++....++..+++.+++.++.+++.||++||+..  ++|+||||.||+++..+
T Consensus        87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~  166 (302)
T KOG2345|consen   87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG  166 (302)
T ss_pred             HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence            34445557888999999997 7999999999888889999999999999999999999998  99999999999999766


Q ss_pred             CeEEEeecCCcccccCCCC---------CcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 026660           81 MTLKIADLGLARAFTLPIK---------KYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDS  149 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  149 (235)
                       .++++|||.+....-...         .......|..|+|||.+.-  ....+.++|||||||++|.|+.|..||....
T Consensus       167 -~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  167 -LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             -ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence             899999998864432111         1223355889999999863  2336789999999999999999999996432


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .  ....+.          .+-....++            ......+|+.+.++|++||+.||.+||++.+++++
T Consensus       246 ~--~GgSla----------LAv~n~q~s------------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 Q--QGGSLA----------LAVQNAQIS------------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             h--cCCeEE----------Eeeeccccc------------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1  000000          000000000            01112388999999999999999999999999864

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=227.38  Aligned_cols=210  Identities=49%  Similarity=0.887  Sum_probs=159.5

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++++|||++++|.+++...  ....+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++++|||.+
T Consensus        78 ~~~~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~  154 (287)
T cd07838          78 ELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLA  154 (287)
T ss_pred             CceeEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcc
Confidence            3459999999999999988763  233589999999999999999999999999999999999999776 8999999988


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      ........ .....++..|+|||.+.+.. ++.++|+||+||++++|++|..||......+....+......+....+..
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eeccCCcc-cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76543321 12234577899999987655 78999999999999999999999998887777777666554433222221


Q ss_pred             ccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          172 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ... ..................+.+++.+.++|++||+.||.+||++.++++||||
T Consensus       233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVS-LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             Ccc-cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            111 0001111111122233334567888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-35  Score=230.01  Aligned_cols=188  Identities=27%  Similarity=0.438  Sum_probs=162.5

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..+..+|+++.+.|||||.+ |.|.+|+..    .+.+++.++..+++||+.|+.|.|+++++|+|+|.+|||+++++ +
T Consensus       117 ~IyEVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-N  191 (668)
T KOG0611|consen  117 QIYEVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-N  191 (668)
T ss_pred             ehhhhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-C
Confidence            45778999999999999998 599999966    56799999999999999999999999999999999999999777 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||++..+.. ....+.+.|++-|.+||++.+..+-+...|.||||+++|.|+.|.-||++.+......++.+.  
T Consensus       192 iKIADFGLSNly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--  268 (668)
T KOG0611|consen  192 IKIADFGLSNLYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--  268 (668)
T ss_pred             eeeeccchhhhhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--
Confidence            99999999977654 345677899999999999988887789999999999999999999999998876655554431  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                                                 ....+.-+.+..-||+.||-.||++|.|+.++-+|=|
T Consensus       269 ---------------------------aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  269 ---------------------------AYREPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ---------------------------cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                                       1122234566778999999999999999999999977

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9e-35  Score=229.99  Aligned_cols=194  Identities=25%  Similarity=0.407  Sum_probs=154.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+........|+|+||++| +|..++.+     ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++ .++
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~k  155 (296)
T cd06655          82 LDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVK  155 (296)
T ss_pred             eeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEE
Confidence            3445567789999999985 99988864     3589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||++..............++..|+|||.+.+.. ++.++|+||+||++|++++|..||............... ..+
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~  233 (296)
T cd06655         156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP  233 (296)
T ss_pred             EccCccchhcccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc
Confidence            999998876543333333446678899999987544 789999999999999999999999887654443332211 000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .                        ......+++.+.++|++||..||.+||++.++++||||+...
T Consensus       234 ~------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         234 E------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             c------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            0                        001124678899999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.8e-35  Score=224.91  Aligned_cols=192  Identities=23%  Similarity=0.423  Sum_probs=151.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...++.+.|+++||+++ +|.+++..   ....+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++ .++
T Consensus        64 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~  139 (256)
T cd06612          64 YGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAK  139 (256)
T ss_pred             eeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEE
Confidence            3445566889999999986 99999865   235689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+.......   ..
T Consensus       140 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~  215 (256)
T cd06612         140 LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP  215 (256)
T ss_pred             EcccccchhcccCccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC
Confidence            999999876654433334445678899999987654 78999999999999999999999987554332221110   00


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .                      ........++.++.+++++||+.||.+|||+.++++||||
T Consensus       216 ~----------------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 P----------------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             C----------------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            0                      0000112367889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-34  Score=233.17  Aligned_cols=217  Identities=40%  Similarity=0.699  Sum_probs=167.0

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+|+++|+++++|.+++..    +..++++.++.++.||+.||+|||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        77 ~~~~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCC
Confidence            3456899999999999988854    45689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCC----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +........    ......++..|+|||...+...++.++|+||+|++++++++|..||................+.++.
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            875542211    1233467888999998876555789999999999999999999999988887777777777766554


Q ss_pred             CCcccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...........+   ...............+..+..+++++.+||+.||.+|||+.+++.|||++.++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence            332222111000   000111112223334456889999999999999999999999999999987754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-34  Score=227.45  Aligned_cols=213  Identities=41%  Similarity=0.742  Sum_probs=164.7

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +..++|+|+||+++++.+++.+.   ...++++.++.++.|++.||.|||+.+++|+||+|+||+++.++ .++++|||.
T Consensus        87 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~  162 (302)
T cd07864          87 DKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGL  162 (302)
T ss_pred             cCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcccc
Confidence            34589999999999888887652   34689999999999999999999999999999999999999776 899999998


Q ss_pred             cccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           91 ARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        91 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +........ ......++..|+|||.+.+....+.++|+||+||+++++++|+.||...+..+....+......+....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            876543321 1222344678999998875555688999999999999999999999988888888777777776666555


Q ss_pred             ccccccccccCCC--CCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          170 PGVSSLMNWHEYP--QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       170 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      +...+...+....  .............++..+.+++++||..||.+||++.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4433322111110  001112222333568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-34  Score=224.55  Aligned_cols=190  Identities=27%  Similarity=0.473  Sum_probs=154.4

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCceecCCCCCcEEEcCCCCe
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-----~~~~~H~di~~~nil~~~~~~~   82 (235)
                      .+++..+|++|||+++ +|.+++.........++++.++.++.|++.||++||     +.+++|+||+|+||+++.++ .
T Consensus        70 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~  148 (265)
T cd08217          70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-N  148 (265)
T ss_pred             cCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-C
Confidence            3456678999999985 999999887666678999999999999999999999     89999999999999999766 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++++|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||......+......... 
T Consensus       149 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-  226 (265)
T cd08217         149 VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-  226 (265)
T ss_pred             EEEecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-
Confidence            99999999876654433234456788999999987655 7889999999999999999999998776433332221100 


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                                .......++.++.+++++||+.+|.+||++.++++|||+
T Consensus       227 --------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                      000112467889999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=227.07  Aligned_cols=216  Identities=44%  Similarity=0.816  Sum_probs=165.0

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..++++..|+||||++|+|.+++...  .+..+++..++.++.|++.+|.|||+++++|+||+|+||+++..+ .++++|
T Consensus        66 ~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d  142 (283)
T cd07830          66 VFRENDELYFVFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIAD  142 (283)
T ss_pred             HhhcCCcEEEEEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEee
Confidence            34557789999999988999998763  234689999999999999999999999999999999999999766 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+....... ......++..|+|||.+.....++.++|+||+|++++++++|..||......+.........+.+...
T Consensus       143 ~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd07830         143 FGLAREIRSRP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ  221 (283)
T ss_pred             cccceeccCCC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence            99887554321 22334567789999988655557899999999999999999999998888777777776666665554


Q ss_pred             Cccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .+..........  ..............+..+..++++|++||+.+|.+|||+.|++.||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            433322111111  001111111222233447889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-35  Score=229.86  Aligned_cols=199  Identities=22%  Similarity=0.400  Sum_probs=155.2

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +....+...|++|||++|+|.+++......+..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl  145 (283)
T cd06617          67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKL  145 (283)
T ss_pred             EEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEE
Confidence            33455667999999999999999987655667799999999999999999999997 999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~  161 (235)
                      +|||.+....... ......++..|+|||.+.+.   ..++.++|+||+||+++++++|..||.... ..+.......  
T Consensus       146 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--  222 (283)
T cd06617         146 CDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--  222 (283)
T ss_pred             eeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--
Confidence            9999987554221 12234567889999988642   235789999999999999999999996532 2222222211  


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                       ......                       ....+++++.++|++||..+|.+||+++++++||||....++
T Consensus       223 -~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         223 -EPSPQL-----------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             -cCCCCC-----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence             100000                       011367889999999999999999999999999999987665

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-34  Score=223.30  Aligned_cols=191  Identities=27%  Similarity=0.415  Sum_probs=152.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..++||||++| +|.+++...  ....+++..++.++.|++.|+++||+++++|+||+|+||+++.++..++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~  142 (256)
T cd08220          65 YENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVK  142 (256)
T ss_pred             eeeEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence            3445667789999999986 999999763  3445899999999999999999999999999999999999986665789


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+....... ......++..|+|||.+.+.. .+.++|+||+|++++++++|..||...+.............. 
T Consensus       143 l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-  219 (256)
T cd08220         143 IGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-  219 (256)
T ss_pred             EccCCCceecCCCc-cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-
Confidence            99999987654322 223345678899999987644 788999999999999999999999876654443333221000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                                .....++.++.+++.+||..+|.+|||+.++++||||
T Consensus       220 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 --------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                                      0111367889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-35  Score=245.95  Aligned_cols=228  Identities=20%  Similarity=0.265  Sum_probs=157.3

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..+..+..|+|+|++.++|.+++..... .........+..++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus       228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~-~v  306 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-KI  306 (501)
T ss_pred             EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CE
Confidence            3444566778999999999999888765221 122345677889999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CC--CCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PG--DSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~--~~~~~~~~~~~~  159 (235)
                      +|+|||++..+..... ......|+..|+|||++.+.. ++.++||||+||++|+|++|..++ ..  ......+.....
T Consensus       307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999976543322 223456899999999987655 889999999999999999987654 32  233444444444


Q ss_pred             HhCCCCCCCcccccccccccCCCCC--Cccch--hhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQW--NPQSL--ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ........+.........+......  .....  ......++.++.++|.+||+.||.+|||+.|+++||||.....++
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~  464 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE  464 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence            3332222211110000000000000  00000  011124667888999999999999999999999999999876554

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=227.95  Aligned_cols=211  Identities=45%  Similarity=0.810  Sum_probs=163.9

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ...++|+||++++|.+++.+.   ...++++.++.++.|++.||++||+.+++|+||+|+||+++.++ .++++|||.+.
T Consensus        73 ~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~  148 (287)
T cd07840          73 GSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLAR  148 (287)
T ss_pred             CcEEEEeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEcccccee
Confidence            789999999999999888652   24689999999999999999999999999999999999999776 89999999987


Q ss_pred             cccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           93 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        93 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      ....... ......++..|+|||.+.+...++.++|+||+|++++++++|..||..................+....+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         149 PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG  228 (287)
T ss_pred             eccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence            6654321 122334577899999877655578999999999999999999999998888777777777766666555544


Q ss_pred             ccccccccCC--CCCCccchhhcCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          172 VSSLMNWHEY--PQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       172 ~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ......+...  .............. +++++.+++++||+.+|.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            3332111111  00111112222223 48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.4e-35  Score=229.90  Aligned_cols=191  Identities=24%  Similarity=0.407  Sum_probs=150.1

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ......+.|+||||++| +|.+++.+     ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~  158 (296)
T cd06654          85 SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLT  158 (296)
T ss_pred             EEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEC
Confidence            34456689999999985 99998864     3578999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+..............+++.|+|||.+.+.. .+.++|+||+||++|++++|..||............... ..+. 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-  235 (296)
T cd06654         159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE-  235 (296)
T ss_pred             ccccchhccccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC-
Confidence            9998875543322333446788899999987544 789999999999999999999999876653332221110 0000 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                             ......++..+.+++++||..+|.+||++.++++||||...
T Consensus       236 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         236 -----------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             -----------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                                   00012466788999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=227.01  Aligned_cols=193  Identities=23%  Similarity=0.378  Sum_probs=155.2

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ...++...|+|+||+++ +|.+++..     ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++ .++++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~  140 (274)
T cd06609          67 SFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLA  140 (274)
T ss_pred             EEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEc
Confidence            34456789999999985 99999875     2689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+..............++..|+|||.+.+.. ++.++|+||+|+++|++++|..||......+....+...   .. 
T Consensus       141 d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-  215 (274)
T cd06609         141 DFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---NP-  215 (274)
T ss_pred             ccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---CC-
Confidence            9999877654433444556788899999987655 889999999999999999999999776543332222111   00 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .                      ......+++++.+++.+||..+|.+|||++++++||||++...+
T Consensus       216 ~----------------------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         216 P----------------------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             C----------------------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            0                      00011267889999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=225.61  Aligned_cols=218  Identities=37%  Similarity=0.707  Sum_probs=158.2

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...+++..|++|||+++++.+.+..   ....++++.++.++.|++.|++|||+.+++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl  141 (288)
T cd07833          66 KEAFRRKGRLYLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKL  141 (288)
T ss_pred             hheEEECCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEE
Confidence            344455778999999999855554433   234589999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+........ ......++..|+|||++.+...++.++|+||+|++++++++|..||......+.........+..
T Consensus       142 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  221 (288)
T cd07833         142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL  221 (288)
T ss_pred             EeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999876654432 22334567889999999876457899999999999999999999998877666655555444433


Q ss_pred             CCCCcccccc--cccccCC-CCCCccchhhcCC-CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSS--LMNWHEY-PQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ..........  ....... ............+ .++.+++++|++||..+|.+||+++++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            3221111110  0000000 0000111111222 358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-34  Score=225.46  Aligned_cols=188  Identities=26%  Similarity=0.523  Sum_probs=149.5

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+++.+.++++||+++ +|.+++.+.    +.+++..+..++.|++.||++||+++++|+||+|+||+++.++ .+++
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l  147 (267)
T cd06628          73 GSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKI  147 (267)
T ss_pred             EEEEeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEe
Confidence            344566789999999986 999999763    4689999999999999999999999999999999999998666 8999


Q ss_pred             eecCCcccccCCCC------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIK------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|||.++.......      ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||..............
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE  226 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence            99998876542111      112234678899999987654 78899999999999999999999987665444332221


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      ...                           ......++.++.++|++||+.||.+||++.++++||||
T Consensus       227 ~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 NAS---------------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCC---------------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            000                           00112467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2e-34  Score=226.85  Aligned_cols=191  Identities=22%  Similarity=0.436  Sum_probs=152.6

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ....++.|+++||++| +|.+++..     ..++++.+..++.|++.|+++||++|++|+||+|+||+++.++ .++++|
T Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d  158 (285)
T cd06648          85 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSD  158 (285)
T ss_pred             EEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcc
Confidence            4456778999999975 99998866     3589999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|+|||...+.. ++.++|+||+|++++++++|..||......+........   ....
T Consensus       159 ~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~  234 (285)
T cd06648         159 FGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPK  234 (285)
T ss_pred             cccchhhccCCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCC
Confidence            998765543333333446788999999986654 789999999999999999999999876655444433221   0000


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                            ......++..+.+++++||+.+|.+||++.++++||||+...
T Consensus       235 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         235 ----------------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ----------------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence                                  001113678899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-34  Score=225.67  Aligned_cols=191  Identities=22%  Similarity=0.342  Sum_probs=147.8

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .....+..|++|||+++ +|.+++..    .+.+++..++.++.|++.|++|||+.|++|+||+|+||+++.++ .++++
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~  148 (267)
T cd06645          74 SYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLA  148 (267)
T ss_pred             EEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEC
Confidence            34456789999999985 99998865    34689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||.+..............++..|+|||.+..  ...++.++|+||+||++|++++|..||..................+
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~  228 (267)
T cd06645         149 DFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP  228 (267)
T ss_pred             cceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC
Confidence            99998665443333344567889999998742  2336789999999999999999999987654333222211100000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                        .                    . ......++..+.++|++||..+|.+||+++++++|||
T Consensus       229 --~--------------------~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         229 --P--------------------K-LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --C--------------------c-ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence              0                    0 0001136778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=237.30  Aligned_cols=184  Identities=32%  Similarity=0.506  Sum_probs=147.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc-CCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~-~~~~   81 (235)
                      ...+..++..++|+|||.+.| -+.+.+.+.     +.....+..|+++|+.|+.|||++|++|||+||+|||+. ..+ 
T Consensus       380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-  453 (612)
T KOG0603|consen  380 KSHDVYEDGKEIYLVMELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-  453 (612)
T ss_pred             eecceecCCceeeeeehhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-
Confidence            455677888999999999986 556555541     222267888999999999999999999999999999994 555 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRL  160 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~  160 (235)
                      .++++|||........   .....-|..|.|||+..... ++.++|+||||+++|+|++|..||...... +....+   
T Consensus       454 ~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---  526 (612)
T KOG0603|consen  454 HLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---  526 (612)
T ss_pred             cEEEEEechhhhCchh---hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---
Confidence            8999999998765543   33445588899999998544 899999999999999999999999765443 222222   


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                       +.+...                          ..+|.++++||.+||++||.+|+++.++..||||
T Consensus       527 -~~~~~s--------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 -QMPKFS--------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -cCCccc--------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence             221111                          2588999999999999999999999999999999

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-34  Score=227.31  Aligned_cols=203  Identities=22%  Similarity=0.347  Sum_probs=152.6

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFR-QTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +....+...+++|||+++++.++..... .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++
T Consensus        70 ~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~k  148 (288)
T cd06616          70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIK  148 (288)
T ss_pred             eEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEE
Confidence            3344566789999999888777654422 2346799999999999999999999975 999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||++.....+. ......++..|+|||.+.+.  ..++.++|+||+|++++++++|..||.....  ......+...
T Consensus       149 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~  225 (288)
T cd06616         149 LCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK  225 (288)
T ss_pred             EeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC
Confidence            99999986554322 12233567889999998765  3578999999999999999999999976542  1111111111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ......                    .......++.++.+++++||+.+|.+|||++++++||||+.+.+.
T Consensus       226 ~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         226 GDPPIL--------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             CCCCcC--------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            111000                    000112477899999999999999999999999999999987664

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-34  Score=227.46  Aligned_cols=193  Identities=21%  Similarity=0.415  Sum_probs=153.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.+...|+++||+++ +|.+++..     ..+++..++.++.|++.||++||+++++|+||+|+||+++.++ .++
T Consensus        84 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~k  157 (297)
T cd06659          84 YKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVK  157 (297)
T ss_pred             hhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEE
Confidence            3445567789999999985 89887744     3589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+........    
T Consensus       158 L~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----  232 (297)
T cd06659         158 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----  232 (297)
T ss_pred             EeechhHhhcccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----
Confidence            999998865543333334456788999999987654 789999999999999999999999876655444332211    


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ....                     ......++..+.++|++||+.+|.+||++.++++||||..-
T Consensus       233 ~~~~---------------------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         233 PPPK---------------------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CCCC---------------------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            0000                     00112467889999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=237.37  Aligned_cols=194  Identities=21%  Similarity=0.401  Sum_probs=160.1

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ++.++|+.|||+| -+...+-.   .+..+.+.+|..+++|++.||.|||+++++|||||+.|||+..+| .++++|||.
T Consensus       101 enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGV  176 (1187)
T KOG0579|consen  101 ENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGV  176 (1187)
T ss_pred             cCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccc
Confidence            3459999999986 66655544   467899999999999999999999999999999999999999888 999999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +.+......+...++||++|||||+...    ..+|..++||||||+++.+|..+.+|-...+....+..+...  .|+.
T Consensus       177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT  254 (1187)
T KOG0579|consen  177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT  254 (1187)
T ss_pred             cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc
Confidence            9777666666778899999999999853    344789999999999999999999988877776665555431  1111


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      .                       ......+..+.+++++||..||..||++.+++.||||++....+
T Consensus       255 L-----------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK  299 (1187)
T KOG0579|consen  255 L-----------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK  299 (1187)
T ss_pred             c-----------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence            1                       11224677899999999999999999999999999999876543

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-34  Score=224.89  Aligned_cols=194  Identities=26%  Similarity=0.476  Sum_probs=150.3

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEE
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ....++..|+++||+++ +|.+++....   ..+++..+..++.|++.|+++||+ .+++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l  142 (265)
T cd06605          67 AFYNNGDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKL  142 (265)
T ss_pred             eeecCCEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEE
Confidence            34556789999999995 9999997632   578999999999999999999999 9999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~  163 (235)
                      +|||.+.........  ...++..|+|||.+.+. .++.++|+||+|++++++++|..||.....  .............
T Consensus       143 ~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         143 CDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             eecccchhhHHHHhh--cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence            999988655322211  15567889999998765 488999999999999999999999975421  1111111111111


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .....                       ....++.+++++|.+||..||.+|||+.+++.||||+.++
T Consensus       220 ~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         220 PPPRL-----------------------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             CCCCC-----------------------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            10000                       0001678899999999999999999999999999998875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.3e-34  Score=227.85  Aligned_cols=221  Identities=21%  Similarity=0.274  Sum_probs=153.5

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.+.++...|++|||++ |+|.+++.+.  ....+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~k  141 (314)
T cd08216          65 VTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVV  141 (314)
T ss_pred             hheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceE
Confidence            344566778999999998 5999999873  234589999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCC-------CcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           85 IADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        85 l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      ++||+.+........       ......++..|+|||.+... ..++.++|+||+||+++++++|..||...........
T Consensus       142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~  221 (314)
T cd08216         142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (314)
T ss_pred             EecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999998764432111       11223456789999998653 3478899999999999999999999987655443322


Q ss_pred             HHHHhCCCCCCCc----ccccccccc----cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          157 IFRLLGTPNEKVW----PGVSSLMNW----HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       157 ~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      ...  +.......    +........    .................++.++.+++++||..||.+|||++++++||||+
T Consensus       222 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         222 KVR--GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             HHh--ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence            211  11110000    000000000    00000000000011113457889999999999999999999999999998


Q ss_pred             CCC
Q 026660          229 DLD  231 (235)
Q Consensus       229 ~~~  231 (235)
                      .+.
T Consensus       300 ~~~  302 (314)
T cd08216         300 QCK  302 (314)
T ss_pred             hhc
Confidence            764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.1e-34  Score=221.01  Aligned_cols=192  Identities=29%  Similarity=0.486  Sum_probs=153.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++....|+|+||+++ +|.+++..  .....+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++..++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~  142 (257)
T cd08225          65 FASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAK  142 (257)
T ss_pred             hheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEE
Confidence            3455677889999999975 99999976  23345799999999999999999999999999999999999987765679


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||......+........   .
T Consensus       143 l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~  218 (257)
T cd08225         143 LGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG---Y  218 (257)
T ss_pred             ecccccchhccCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---c
Confidence            999998876654333333445788899999886554 789999999999999999999999876554433322210   0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .                        ....+..+.++.++|++|+..+|.+|||+.++++||||
T Consensus       219 ~------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 F------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             C------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            0                        00112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-34  Score=227.71  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=153.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++++|+||||++| +|.+++.+    .+.++++.+..++.|++.|++|||+++++|+||+|+||+++..+ .++
T Consensus        67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~  141 (305)
T cd05609          67 FCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIK  141 (305)
T ss_pred             EEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEE
Confidence            3445677889999999986 99999966    34689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC---------------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 026660           85 IADLGLARAFTLPIK---------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS  149 (235)
Q Consensus        85 l~df~~~~~~~~~~~---------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  149 (235)
                      ++|||.++.......               ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||.+..
T Consensus       142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~  220 (305)
T cd05609         142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDT  220 (305)
T ss_pred             EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998763211000               011234577899999987644 7899999999999999999999998776


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPY  226 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~hp~  226 (235)
                      ..+............+                         .....++.+++++|++||+.+|.+||+   +.++++|||
T Consensus       221 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         221 PEELFGQVISDDIEWP-------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             HHHHHHHHHhcccCCC-------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            5554444332110000                         001136788999999999999999997   789999999


Q ss_pred             CCCCCcC
Q 026660          227 FDDLDKT  233 (235)
Q Consensus       227 f~~~~~~  233 (235)
                      |...++.
T Consensus       276 ~~~~~~~  282 (305)
T cd05609         276 FLGLDWN  282 (305)
T ss_pred             ccCCCHH
Confidence            9887764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=225.27  Aligned_cols=194  Identities=19%  Similarity=0.367  Sum_probs=153.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+++...|++|||++| +|.+++..     ..++++.++.++.|++.|+++||+.|++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l  142 (277)
T cd06917          69 GSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKL  142 (277)
T ss_pred             eeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEE
Confidence            344566788999999976 99988864     2689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+...++.++|+||+|+++|++++|..||...............   ..
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~  219 (277)
T cd06917         143 CDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KP  219 (277)
T ss_pred             ccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CC
Confidence            999998766544444445567888999999876555788999999999999999999999776543322111000   00


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                           ..  .....++.++.+++++||+.||.+||++.+++.||||++...
T Consensus       220 ---------------------~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         220 ---------------------PR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             ---------------------CC--CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence                                 00  001126678999999999999999999999999999987654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-34  Score=229.01  Aligned_cols=193  Identities=24%  Similarity=0.413  Sum_probs=150.5

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+...+.|+||||++| +|.+++.+     ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .+++
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l  156 (297)
T cd06656          83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKL  156 (297)
T ss_pred             EEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEE
Confidence            345567789999999985 99998865     3588999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............+++.|+|||.+.+.. ++.++|+||+|+++|++++|..||.............. ...+ 
T Consensus       157 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-  233 (297)
T cd06656         157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-  233 (297)
T ss_pred             CcCccceEccCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-
Confidence            99998875543333333456688899999987644 78999999999999999999999976543222111100 0000 


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                             .......++..+++++.+||..+|.+||++.++++||||+...
T Consensus       234 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         234 -----------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             -----------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                                   0001123677889999999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-34  Score=222.24  Aligned_cols=196  Identities=24%  Similarity=0.410  Sum_probs=150.9

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++....++|+||+.| +|.+++.+    ...+++..++.++.|++.||++||++|++|+||+|+||+++..+..+
T Consensus        68 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~  143 (268)
T cd06630          68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRL  143 (268)
T ss_pred             hhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            34455667789999999986 99999865    24689999999999999999999999999999999999998666579


Q ss_pred             EEeecCCcccccCCCCC----cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +++|||.+.........    .....++..|+|||.+.+.. ++.++|+||+|++++++++|..||.............+
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  222 (268)
T cd06630         144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK  222 (268)
T ss_pred             EEcccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH
Confidence            99999998765433211    12335678899999986544 78999999999999999999999975443222222211


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      ......                       .......+++++.+++.+||..+|.+||++.++++||||+
T Consensus       223 ~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         223 IASATT-----------------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HhccCC-----------------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            100000                       0011124678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-34  Score=231.04  Aligned_cols=210  Identities=40%  Similarity=0.727  Sum_probs=159.0

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ...|+|+||+.++|..+..      ..++++.+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++|||++.
T Consensus        93 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~  165 (342)
T cd07879          93 QDFYLVMPYMQTDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  165 (342)
T ss_pred             ceEEEEecccccCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCc
Confidence            4579999999888776652      3589999999999999999999999999999999999999776 89999999986


Q ss_pred             cccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccc
Q 026660           93 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  172 (235)
Q Consensus        93 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (235)
                      ....   ......++..|+|||.+.+...++.++|+||+|++++++++|+.||.+.........+....+.+...+....
T Consensus       166 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         166 HADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5432   2223455778999999876555789999999999999999999999988776666666655544433322211


Q ss_pred             cccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          173 SSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       173 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ......   ...............+..++++.++|++||+.||.+||++.+++.||||+.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            111000   001111122223333467888999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=225.36  Aligned_cols=198  Identities=22%  Similarity=0.358  Sum_probs=163.8

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |++++..=.+.-++||||||+ |++.+.++.+   ++.++++++..+++..+.||+|||...-+|||||+.|||++.++ 
T Consensus        91 VKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-  166 (502)
T KOG0574|consen   91 VKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-  166 (502)
T ss_pred             hhhhhhhccCCceEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-
Confidence            566666667777999999998 7999999873   45799999999999999999999999999999999999999888 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      ..+++|||.+-.++..-.+.....||+.|+|||++.... |..++||||||++..+|..|++||.+-.....+..   ..
T Consensus       167 ~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IP  242 (502)
T KOG0574|consen  167 IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IP  242 (502)
T ss_pred             hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEe---cc
Confidence            899999999987776666777889999999999997655 88999999999999999999999987654221111   01


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..|+..                      ..+....|.++.++|++||..+|++|.|+.++++|||+++-
T Consensus       243 T~PPPT----------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  243 TKPPPT----------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             CCCCCC----------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            111111                      11222467889999999999999999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-34  Score=227.15  Aligned_cols=193  Identities=23%  Similarity=0.357  Sum_probs=151.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..|+||||+++ +|.+++..     ..++++.+..++.|++.|+.|||+++++|+||+|+||+++.++ .++
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~  141 (277)
T cd06642          68 YGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVK  141 (277)
T ss_pred             hcccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEE
Confidence            3455667789999999985 99888753     4689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||..............    .
T Consensus       142 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----~  216 (277)
T cd06642         142 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----N  216 (277)
T ss_pred             EccccccccccCcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc----C
Confidence            999999876543332333345678899999987654 78999999999999999999999876543322221100    0


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .                       ........+.++.+++.+||..+|.+||++.++++||||..+.+
T Consensus       217 ~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         217 S-----------------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             C-----------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            0                       00011135678899999999999999999999999999986654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-34  Score=222.90  Aligned_cols=196  Identities=23%  Similarity=0.372  Sum_probs=153.8

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..+.++..|+++|++.| +|.+++.+... ...+++..+..++.|++.|+++||++|++|+||+|+||+++.++ .++++
T Consensus        67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~  144 (267)
T cd06610          67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIA  144 (267)
T ss_pred             EEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEc
Confidence            34556789999999985 99999976322 24689999999999999999999999999999999999999766 89999


Q ss_pred             ecCCcccccCCCCC----cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           87 DLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        87 df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |||.+.........    .....++..|+|||.+......+.++|+||+|++++++++|..||......+........  
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--  222 (267)
T cd06610         145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--  222 (267)
T ss_pred             ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--
Confidence            99998766543222    133356788999999876645789999999999999999999999876655444433221  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                       ..... .                  .......+++++.+++++||..||.+||++.++++||||
T Consensus       223 -~~~~~-~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         223 -DPPSL-E------------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -CCCCc-C------------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence             11000 0                  000122577889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=226.53  Aligned_cols=193  Identities=26%  Similarity=0.424  Sum_probs=166.0

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      +..-+.+|+||||++| +|.-.++.+.    .+.+..+..++..|+.||-+||++||++||||.+||+++.++ .++|+|
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~D  493 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIAD  493 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeee
Confidence            3455679999999985 9999998764    577889999999999999999999999999999999999888 999999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||+++.-..+........||+.|+|||++.-.. |+.++|.||+|+++|||+.|+.||.+.++.+....+.......+  
T Consensus       494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP--  570 (683)
T KOG0696|consen  494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP--  570 (683)
T ss_pred             cccccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc--
Confidence            999986655555667789999999999987544 89999999999999999999999999999888888775322211  


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~~  235 (235)
                                                ..+|.++.++++..|..+|.+|..     -.++-.||||+.++|+++
T Consensus       571 --------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  571 --------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             --------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence                                      137889999999999999999974     347889999999999864

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-34  Score=223.63  Aligned_cols=200  Identities=26%  Similarity=0.467  Sum_probs=152.0

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +....+|+||||++| +|.+++.........+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~df  149 (287)
T cd06621          71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDF  149 (287)
T ss_pred             cCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeec
Confidence            445678999999985 99999877656666789999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-----LQQLLHIFRLLGT  163 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~  163 (235)
                      |++.......  .....++..|++||...+.. ++.++|+||+|+++|++++|..||.....     .+.......   .
T Consensus       150 g~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~  223 (287)
T cd06621         150 GVSGELVNSL--AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---M  223 (287)
T ss_pred             cccccccccc--cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---C
Confidence            9876543221  12334577899999986544 78899999999999999999999976521     221111111   0


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ..... ..                 ........++.+.+++.+||..+|.+|||+.|++.||||++...++
T Consensus       224 ~~~~~-~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         224 PNPEL-KD-----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             Cchhh-cc-----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence            00000 00                 0000012457889999999999999999999999999998776543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.5e-34  Score=227.21  Aligned_cols=216  Identities=20%  Similarity=0.318  Sum_probs=151.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +...+++.+|+||||++| +|.+++.+.    +.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++
T Consensus        66 ~~~~~~~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~  140 (308)
T cd06615          66 GAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIK  140 (308)
T ss_pred             EEEeeCCEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEE
Confidence            344567789999999985 999999762    568999999999999999999997 5899999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT-  163 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  163 (235)
                      ++|||.+......  ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||......... ........ 
T Consensus       141 l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~  216 (308)
T cd06615         141 LCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSE  216 (308)
T ss_pred             EccCCCccccccc--ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCcccc
Confidence            9999988654322  223346688999999986544 788999999999999999999999765532222 11111000 


Q ss_pred             CCCCCcccccccccccCCCCCC-----------ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWN-----------PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .............. .......           ..........++.++++++.+||..+|.+||++.++++||||.+...
T Consensus       217 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         217 GEAKESHRPVSGHP-PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             ccccCCcccccCCC-CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence            00000000000000 0000000           00000111136788999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=240.67  Aligned_cols=202  Identities=24%  Similarity=0.353  Sum_probs=162.8

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK   79 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~--~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~   79 (235)
                      |.+-+...+++++-|.||-.+| +|.+++++.+  + ++  ++.++-.+.+||++||.|||++.|||||||-+|+|++.-
T Consensus       635 VrYLGs~senGf~kIFMEqVPGGSLSsLLrskW--G-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy  711 (1226)
T KOG4279|consen  635 VRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW--G-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY  711 (1226)
T ss_pred             HHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc--C-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec
Confidence            3455667788899999999985 9999999833  3 44  788999999999999999999999999999999999987


Q ss_pred             CCeEEEeecCCcccccCCCCCcccccccccccCchhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           80 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                      ...+||+|||.++.+..-......+.||..|||||++.. ...|+.++|||||||++.||.+|++||..-...+..  ++
T Consensus       712 SGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MF  789 (1226)
T KOG4279|consen  712 SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MF  789 (1226)
T ss_pred             cceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hh
Confidence            769999999999887765556677889999999999974 455899999999999999999999999765443221  11


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +.-.....+                       .....++.+.+.+|.+|+.+||.+||++.++|..||++.-++
T Consensus       790 kVGmyKvHP-----------------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  790 KVGMYKVHP-----------------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             hhcceecCC-----------------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence            110100000                       011146788899999999999999999999999999986543

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.5e-34  Score=220.89  Aligned_cols=190  Identities=22%  Similarity=0.364  Sum_probs=149.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..|+++||++| +|.+++.+.    ..++++.+..++.|++.||++||+.+++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l  143 (265)
T cd06631          69 GTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKL  143 (265)
T ss_pred             eEeecCCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEe
Confidence            344566789999999985 999999662    4588999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCC------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPI------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|||.+.......      .......++..|+|||.+.+.. ++.++|+||+|++++++++|..||..............
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  222 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA  222 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh
Confidence            9999886543211      1122345678899999987654 78999999999999999999999987655444333222


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .....                         ......++.++.++|++||..+|.+||++.++++||||
T Consensus       223 ~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         223 HRGLM-------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ccCCC-------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            10000                         00112467889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.6e-34  Score=230.49  Aligned_cols=216  Identities=40%  Similarity=0.739  Sum_probs=162.0

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +....|+||||++++|..++.+     +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++++|||.
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~  153 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGL  153 (337)
T ss_pred             CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccc
Confidence            4557899999999999988865     2678899999999999999999999999999999999999777 899999998


Q ss_pred             cccccCCCC-----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           91 ARAFTLPIK-----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        91 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +........     ......++..|+|||.+.+....+.++|+||+|++++++++|..||.+................+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            875543221     222345688899999887655578899999999999999999999988777766666655544433


Q ss_pred             CCCcccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...+.........   ...............++++.++.++|.+||+.||.+|||+.++++||||+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence            2211111100000   000011111222333457899999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.2e-34  Score=220.32  Aligned_cols=190  Identities=27%  Similarity=0.527  Sum_probs=154.3

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ...+...++|+|++++ +|.+++.+....+..+++..++.++.|++.|+++||+.|++|+||+|+||+++.++ .++++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d  146 (258)
T cd08215          68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGD  146 (258)
T ss_pred             EecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECC
Confidence            3345789999999986 99999988655567899999999999999999999999999999999999999766 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|+|||...+.. .+.++|+||+|++++++++|..||......+.........   .  
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~--  220 (258)
T cd08215         147 FGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---Y--  220 (258)
T ss_pred             ccceeecccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---C--
Confidence            999876554432333446678899999887654 7899999999999999999999998776544444332210   0  


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                            ......++.++.+++++||..+|.+||++.++++||||
T Consensus       221 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ----------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                                  00011467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-34  Score=249.73  Aligned_cols=194  Identities=26%  Similarity=0.476  Sum_probs=152.8

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CceecCCCCCcEEEcCC--
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-------GILHRDLKPHNLLMDRK--   79 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-------~~~H~di~~~nil~~~~--   79 (235)
                      +..+.+||||||+++ +|.+++.........+++..++.++.||+.||.|||+.       +++|+||||+||+++..  
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            456789999999985 99999988665566799999999999999999999984       49999999999999632  


Q ss_pred             --------------CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCC
Q 026660           80 --------------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTAL  144 (235)
Q Consensus        80 --------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p  144 (235)
                                    ...++|+|||++...... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..|
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                          124899999998765432 222345679999999998642 3478899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          145 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       145 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      |................  +.                         ......+.++.+||+.||..+|.+||++.++|.|
T Consensus       243 F~~~~~~~qli~~lk~~--p~-------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        243 FHKANNFSQLISELKRG--PD-------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcCCcHHHHHHHHhcC--CC-------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            98765544433322210  00                         0112357889999999999999999999999999


Q ss_pred             CCCCCCC
Q 026660          225 PYFDDLD  231 (235)
Q Consensus       225 p~f~~~~  231 (235)
                      ||++.+.
T Consensus       296 ~~ik~i~  302 (1021)
T PTZ00266        296 QIIKNVG  302 (1021)
T ss_pred             HHHhhcC
Confidence            9998654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=234.43  Aligned_cols=200  Identities=25%  Similarity=0.391  Sum_probs=173.4

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.+..+.+++++|++||.|- |.|...+++    .+.+.+..+..++..+++|++|||++|+++||+||+|++++..+ 
T Consensus       483 vrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-  557 (732)
T KOG0614|consen  483 VRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-  557 (732)
T ss_pred             HHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-
Confidence            445667788999999999985 699999987    45789999999999999999999999999999999999999888 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .+++.|||+++++... .+...+.||+.|.|||++.+.. ...++|.||||+++|||++|.+||.+.+....+..+...+
T Consensus       558 y~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi  635 (732)
T KOG0614|consen  558 YLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI  635 (732)
T ss_pred             ceEEeehhhHHHhccC-CceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence            8999999999988754 5566789999999999998766 5789999999999999999999999999999998887654


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~~  235 (235)
                      ....-                          ...++....++|+++...+|.+|..     +.++-.|-||.+++|+.|
T Consensus       636 d~i~~--------------------------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  636 DKIEF--------------------------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             hhhhc--------------------------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            32111                          1135667789999999999999985     899999999999999864

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.7e-34  Score=219.46  Aligned_cols=191  Identities=24%  Similarity=0.439  Sum_probs=155.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+.+.++++|||++| +|.+++.+.  ....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~k  141 (256)
T cd08221          65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIK  141 (256)
T ss_pred             EeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEE
Confidence            3445667789999999985 999999763  245689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||......+....+.....  
T Consensus       142 l~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--  218 (256)
T cd08221         142 LGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY--  218 (256)
T ss_pred             ECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999999876654433334456788999999987654 78899999999999999999999987666555444332100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                               ......++.++.+++.+||..+|.+||++.++++|||+
T Consensus       219 -------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 -------------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                                     00012467889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-33  Score=222.47  Aligned_cols=198  Identities=23%  Similarity=0.415  Sum_probs=152.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +....++..|+||||++| +|.+++... .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~  143 (286)
T cd06622          66 GAFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVK  143 (286)
T ss_pred             hheecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEE
Confidence            344567789999999986 998888762 223478999999999999999999997 5999999999999999766 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      ++|||.+......  ......++..|+|||.+.+..     .++.++|+||+||+++++++|..||..............
T Consensus       144 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  221 (286)
T cd06622         144 LCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA  221 (286)
T ss_pred             EeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence            9999988655332  222335677899999885432     247899999999999999999999976544333333222


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ........                        ....+++++.++|++||..+|.+||++.++++||||.....
T Consensus       222 ~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         222 IVDGDPPT------------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             HhhcCCCC------------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            21111111                        11247788999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-34  Score=223.99  Aligned_cols=192  Identities=24%  Similarity=0.370  Sum_probs=151.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..|+||||++| +|.+++..     ..+++..+..++.|++.|+++||+.+++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l  142 (277)
T cd06640          69 GSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKL  142 (277)
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEE
Confidence            345567789999999985 99998864     3588999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+.. .+.++|+||+|+++|++++|..||...............   ..
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~  218 (277)
T cd06640         143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---NP  218 (277)
T ss_pred             cccccceeccCCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC---CC
Confidence            99999876543332333345677899999987554 789999999999999999999999766543332211100   00


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                              ......++..+.+++++||..+|.+||++.++++||||.....
T Consensus       219 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         219 ------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                                    0001135678899999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.9e-34  Score=223.03  Aligned_cols=191  Identities=23%  Similarity=0.368  Sum_probs=146.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...|+||||+++ +|.+++.+    ...+++..+..++.|++.|++|||+.+++|+|++|+||+++.++ .++++
T Consensus        74 ~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~  148 (267)
T cd06646          74 SYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLA  148 (267)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEC
Confidence            34556788999999985 99998865    34689999999999999999999999999999999999998776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||.+..............++..|+|||.+..  ....+.++|+||+|++++++++|..||......+........    
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----  224 (267)
T cd06646         149 DFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----  224 (267)
T ss_pred             cCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC----
Confidence            99998766433333334466788999998752  233678999999999999999999998654432221111000    


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                        .                ...... .....++..+.++|++||+.+|.+||+++++++|+|
T Consensus       225 --~----------------~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 --N----------------FQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             --C----------------CCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence              0                000000 011246789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.7e-34  Score=220.24  Aligned_cols=189  Identities=30%  Similarity=0.492  Sum_probs=152.2

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..+....++|+||+++ +|.+++.........++++.++.++.|++.|+.+||+.|++|+||+|+||+++. + .++++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d  148 (260)
T cd08222          71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGD  148 (260)
T ss_pred             HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecc
Confidence            3455678999999985 999999876666678999999999999999999999999999999999999984 4 699999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+.......   .....
T Consensus       149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~  224 (260)
T cd08222         149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPTPS  224 (260)
T ss_pred             cCceeecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCCCC
Confidence            998876544333333455678899999886544 67899999999999999999999977655444433321   10000


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                              ....++.++.++|++||..+|.+||++.++++||||
T Consensus       225 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         225 ------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                    011467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-34  Score=220.00  Aligned_cols=193  Identities=25%  Similarity=0.363  Sum_probs=150.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++..+|++|||+++ +|.+++...   ...++++.++.++.|++.|+.|||+++++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l  142 (262)
T cd06613          67 GSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKL  142 (262)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEE
Confidence            344567789999999986 999888652   24689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+..............++..|+|||.+.+.  ..++.++|+||+|+++++|++|..||......+...........
T Consensus       143 ~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~  222 (262)
T cd06613         143 ADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP  222 (262)
T ss_pred             CccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Confidence            9999887654433333445667889999998654  13778999999999999999999999876654443322211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                      +. .                      ......++.++.+++++||..+|.+|||+.+++.|||
T Consensus       223 ~~-~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         223 PP-K----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             Cc-c----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            00 0                      0011135678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-33  Score=219.56  Aligned_cols=193  Identities=23%  Similarity=0.354  Sum_probs=146.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~--~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +........++|+||+++ +|.+++.+..   ..+  ++..+..++.|++.|++|||+++++|+||+|+||+++.....+
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~  148 (268)
T cd06624          72 GSDSENGFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV  148 (268)
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeE
Confidence            344566789999999985 9999997631   234  7888999999999999999999999999999999998645589


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +++|||.+..............++..|+|||.+... ..++.++|+||+|++++++++|..||.................
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~  228 (268)
T cd06624         149 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK  228 (268)
T ss_pred             EEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc
Confidence            999999886554322223334568889999998643 2367899999999999999999999975432111111000000


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                               ........+++++++++++||+.+|.+|||+.+++.||||
T Consensus       229 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                                     0000112467889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.7e-34  Score=221.11  Aligned_cols=191  Identities=28%  Similarity=0.472  Sum_probs=153.3

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEE
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ........++|+||++ ++|.+++...    ..++++.++.++.|++.|+++||+ .+++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l  141 (264)
T cd06623          67 AFYKEGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKI  141 (264)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEE
Confidence            3455678999999998 4999999763    568999999999999999999999 9999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---ELQQLLHIFRLLG  162 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~  162 (235)
                      +|||.+..............++..|+|||.+.+. .++.++|+||||+++|++++|..||....   ..+....+.   .
T Consensus       142 ~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~  217 (264)
T cd06623         142 ADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D  217 (264)
T ss_pred             ccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c
Confidence            9999987665443333345667889999998765 47899999999999999999999997764   222222221   1


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ....                        ..... ++..+.++|++||..+|.+||++.++++||||+.++
T Consensus       218 ~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         218 GPPP------------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCCC------------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            1000                        00112 678899999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-33  Score=223.32  Aligned_cols=193  Identities=19%  Similarity=0.414  Sum_probs=152.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +.....++.|++|||+++ +|.+++..     ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++ .+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l  157 (292)
T cd06657          84 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKL  157 (292)
T ss_pred             eEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEE
Confidence            344566789999999986 88887643     3589999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|++||.+.+.. ++.++|+||+|++++++++|..||......+............ 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-  235 (292)
T cd06657         158 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-  235 (292)
T ss_pred             cccccceecccccccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-
Confidence            99998865543333333445688899999886544 7899999999999999999999998766554443332211000 


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                              ......++..+.+++.+||..+|.+||++.++++||||...-
T Consensus       236 ------------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         236 ------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             ------------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence                                    001123677889999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-33  Score=219.48  Aligned_cols=185  Identities=22%  Similarity=0.436  Sum_probs=144.2

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ....+++++||+++ +|.+++.+    ...+++..++.++.|++.||++||+.+++|+||+|+||+++.++ .++++|||
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg  151 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFG  151 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCC
Confidence            34678999999985 99999976    23588999999999999999999999999999999999998666 89999999


Q ss_pred             CcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ++........   ......++..|+|||.+.+.. ++.++|+||+||+++++++|..||......+.......   ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~  227 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN  227 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC
Confidence            8865432211   112345678899999987644 78999999999999999999999987655444332221   1000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      .                       .....+++.+++++ +|+..+|.+||+++++++||||+
T Consensus       228 ~-----------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 P-----------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             C-----------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            0                       00113567788898 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=227.57  Aligned_cols=213  Identities=39%  Similarity=0.664  Sum_probs=160.0

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +.....|+++++++++|.+++..     ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++++|||
T Consensus        92 ~~~~~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg  165 (345)
T cd07877          92 EEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFG  165 (345)
T ss_pred             cccccEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccc
Confidence            34456899999998899887754     3589999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ++.....   ......++..|+|||.+.+...++.++|+||+||+++++++|..||.............+....+.....
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         166 LARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  242 (345)
T ss_pred             ccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            8865432   2233456788999999876555788999999999999999999999887776666666555544443332


Q ss_pred             ccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          170 PGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       170 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .........   ..................+++++++|.+||+.||.+||++.++++||||+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence            222111000   00001111112222235678899999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=226.77  Aligned_cols=210  Identities=39%  Similarity=0.734  Sum_probs=159.0

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ...++||||++++|.+++.+     ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            35699999998899888754     3689999999999999999999999999999999999999776 89999999987


Q ss_pred             cccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccc
Q 026660           93 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  172 (235)
Q Consensus        93 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (235)
                      .....   .....++..|++||.+.+...++.++|+||+|++++++++|..||...................+..+....
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         167 QTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             ccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            54322   223355788999999876445789999999999999999999999987776666665554444332222211


Q ss_pred             cccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          173 SSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       173 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ......   ...+.............+++++.++|.+||..||.+|||+.++++||||+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            110000   00011111122233456788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-34  Score=207.68  Aligned_cols=192  Identities=25%  Similarity=0.400  Sum_probs=163.6

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .++.+=++..+|+++||.+ |+|...+..  .....+++...+.++.|++.|+.|+|..+++||||||+|+|++..+ ..
T Consensus        87 lY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~l  163 (281)
T KOG0580|consen   87 LYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-EL  163 (281)
T ss_pred             hhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-Ce
Confidence            3455567788999999998 699999986  3456699999999999999999999999999999999999999887 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||-+...  +..+.....||..|.+||+..+.. .+...|+|++|++.|+++.|..||......+.+.++.+.-..
T Consensus       164 kiAdfGwsV~~--p~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~  240 (281)
T KOG0580|consen  164 KIADFGWSVHA--PSNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK  240 (281)
T ss_pred             eccCCCceeec--CCCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc
Confidence            99999988533  355667788999999999998766 689999999999999999999999988777777766543111


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                  ....++.+++++|.+|+..+|.+|.+..|++.|||+...
T Consensus       241 ----------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  241 ----------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ----------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                                        113578899999999999999999999999999998653

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=244.21  Aligned_cols=180  Identities=27%  Similarity=0.402  Sum_probs=146.6

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEeec
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .-.++|+||||. |+|.+++..+.+.+  |++.++++|+.|+++|+.+||...  ++|||||-+|||++.++ .++||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcc
Confidence            568999999999 59999999976655  999999999999999999999997  99999999999999787 9999999


Q ss_pred             CCcccccCCCC-C--------cccccccccccCchhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           89 GLARAFTLPIK-K--------YTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        89 ~~~~~~~~~~~-~--------~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      |.+........ .        ......|+.|+|||++.  .+..++.|+|||+|||+||-|+....||........+..-
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~  270 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN  270 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence            98864433221 1        11223489999999997  3445789999999999999999999999887543332221


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                    .-....+.++..+.+||+.||+.||.+||++-+++.+
T Consensus       271 ------------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  271 ------------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ------------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                                          1122334688999999999999999999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-33  Score=226.47  Aligned_cols=157  Identities=23%  Similarity=0.399  Sum_probs=120.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .++++.+..++.||+.||+|||+++++|+||||+||+++.++ .++++|||+++.......  ......++..|+|||++
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  248 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI  248 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence            477889999999999999999999999999999999999766 899999999875532211  12223446789999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++||||+||++|++++ |..||.+....+........  ...                        ......
T Consensus       249 ~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~------------------------~~~~~~  301 (338)
T cd05102         249 FDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GTR------------------------MRAPEN  301 (338)
T ss_pred             hcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc--CCC------------------------CCCCCC
Confidence            7654 7899999999999999997 99999775433322222110  000                        001124


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .++++.+++.+||+.||.+|||+.++++
T Consensus       302 ~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         302 ATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            6788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-33  Score=220.80  Aligned_cols=196  Identities=24%  Similarity=0.378  Sum_probs=150.0

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ...+....|+||||++ |+|.+++.+....      ....+...+..++.|++.||.|||+++++|+||+|+||+++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~  156 (288)
T cd05061          77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC
Confidence            3455567899999998 5999999874321      23346778999999999999999999999999999999999766


Q ss_pred             CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  157 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  157 (235)
                       .++++|||+++.......  ......++..|+|||.+.+.. ++.++|+||+||+++++++ |..||.+....+.....
T Consensus       157 -~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             -cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             899999999875432221  112223456799999987554 7899999999999999998 78888776654443332


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC------CCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME------HPYFDDLD  231 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~------hp~f~~~~  231 (235)
                      ...   ...                        ......++.+.+++++||+.||.+|||+.++++      ||||++++
T Consensus       235 ~~~---~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         235 MDG---GYL------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             HcC---CCC------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            210   000                        001135678999999999999999999999977      99999998


Q ss_pred             c
Q 026660          232 K  232 (235)
Q Consensus       232 ~  232 (235)
                      |
T Consensus       288 ~  288 (288)
T cd05061         288 F  288 (288)
T ss_pred             C
Confidence            7

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-33  Score=216.43  Aligned_cols=190  Identities=25%  Similarity=0.417  Sum_probs=151.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+++...|+++||+++ +|.+++.+.    ..+++..++.++.|++.|+++||+.+++|+||+|+||+++.++ .++
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~k  142 (258)
T cd06632          68 LGTEREEDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVK  142 (258)
T ss_pred             eeeEecCCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEE
Confidence            3455667789999999986 999998762    3588999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+....... ......++..|++||.+.....++.++|+||+|++++++++|..||......+........... 
T Consensus       143 l~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  220 (258)
T cd06632         143 LADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-  220 (258)
T ss_pred             EccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-
Confidence            99999886554322 2234456788999999865444789999999999999999999999876644433332210000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                               ......+++.+.+++++||+.+|.+||++.+++.|||+
T Consensus       221 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 -------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                                     00112467889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-33  Score=218.86  Aligned_cols=189  Identities=29%  Similarity=0.465  Sum_probs=150.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.+++++++|++|||+++ +|.+++..  ..+..++++.++.++.|++.||.+||+++++|+||+|+||+++.++ .++
T Consensus        64 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~  140 (255)
T cd08219          64 KESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVK  140 (255)
T ss_pred             EEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEE
Confidence            3455677889999999985 99998875  3345689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||++.+.. .+.++|+||+|++++++++|..||.................. 
T Consensus       141 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  218 (255)
T cd08219         141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-  218 (255)
T ss_pred             EcccCcceeecccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-
Confidence            999999876654333334456788899999987654 789999999999999999999999876654443333211000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                                                .....++..+.++|++||+.||.+||++.++++--
T Consensus       219 --------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         219 --------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             --------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                                      00113667889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=222.40  Aligned_cols=195  Identities=25%  Similarity=0.402  Sum_probs=154.8

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .......|+++||++| +|.+++....   ..++...+..++.|++.||++||+.|++|+||+|+||+++.++ .++++|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d  159 (286)
T cd06614          84 YLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLAD  159 (286)
T ss_pred             EEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECc
Confidence            3455789999999995 9999998732   3689999999999999999999999999999999999999766 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|++||.+.+.. ++.++|+||+|+++|++++|..||................  .. .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~  235 (286)
T cd06614         160 FGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG--IP-P  235 (286)
T ss_pred             cchhhhhccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CC-C
Confidence            998865543333333445677899999886544 7899999999999999999999998766554443322110  00 0


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                                            ......++..+.++|++||+.+|.+||++.++++||||+...+.
T Consensus       236 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         236 ----------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             ----------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence                                  00111367889999999999999999999999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=215.50  Aligned_cols=187  Identities=29%  Similarity=0.458  Sum_probs=151.3

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++++..|++||+++ ++|.+++.+.    ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++ .+++
T Consensus        60 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l  134 (250)
T cd05123          60 YAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKL  134 (250)
T ss_pred             HHeecCCeeEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEE
Confidence            44567888999999996 5999999762    3589999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||...+.. .+.++|+||+|++++++++|..||......+........    .
T Consensus       135 ~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----~  209 (250)
T cd05123         135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD----P  209 (250)
T ss_pred             eecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----C
Confidence            99998876544322334456678899999987554 788999999999999999999999877654433333220    0


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH---HHHhCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAMEHPYF  227 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~ll~hp~f  227 (235)
                      .                        ......+..+.+++++||..||.+||++   +++++||||
T Consensus       210 ~------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 L------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             C------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            0                        0011246788999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-33  Score=224.37  Aligned_cols=212  Identities=38%  Similarity=0.692  Sum_probs=160.0

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ....|+++||++++|.+++..     ..++++.+..++.|++.||++||+.+++|+||+|.||+++..+ .++++|||.+
T Consensus        82 ~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~  155 (328)
T cd07856          82 LEDIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLA  155 (328)
T ss_pred             CCcEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccc
Confidence            456899999998899888753     3588999999999999999999999999999999999999766 8999999988


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      .....   ......++..|+|||.+.+...++.++|+||+|++++++++|..||.............+..+.+.......
T Consensus       156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            64432   122335577899999876645578999999999999999999999988777666666666555554333222


Q ss_pred             cccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          172 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       172 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ......   ................+.++.+++++|++||+.+|.+||+++++++||||+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            111100   0000111111122233467889999999999999999999999999999976654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.3e-33  Score=215.15  Aligned_cols=190  Identities=29%  Similarity=0.421  Sum_probs=153.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...|+|+||+++ +|.+++.+.......++++.++.++.|++.||++||+.|++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl  144 (256)
T cd08530          66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKI  144 (256)
T ss_pred             hhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEE
Confidence            344556889999999986 99999988666667799999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+......  ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+..........   
T Consensus       145 ~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---  218 (256)
T cd08530         145 GDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---  218 (256)
T ss_pred             eeccchhhhccC--CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---
Confidence            999998765543  222345678899999987654 78899999999999999999999987765443333221000   


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                              ......++.++++++++||+.+|.+||++.++++||+.
T Consensus       219 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         219 ------------------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ------------------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                                    00011467889999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.4e-34  Score=228.25  Aligned_cols=226  Identities=19%  Similarity=0.280  Sum_probs=152.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+.++.++..|+|+||+.+ +|.+++.+..  ...+++..+..++.|++.||+|||+++++|+||||+||+++.++ .+
T Consensus        64 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~  140 (328)
T cd08226          64 SWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LV  140 (328)
T ss_pred             EeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cE
Confidence            34455567789999999985 9999988743  23589999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCC-------cccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 026660           84 KIADLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL  155 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  155 (235)
                      ++.||+...........       .....++..|+|||.+.+. ..++.++|+||+||+++++++|..||......+...
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  220 (328)
T cd08226         141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL  220 (328)
T ss_pred             EEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence            99998754322111110       0111234569999998653 336789999999999999999999998766544433


Q ss_pred             HHHHHhCCCCCC--CcccccccccccC------------CC----CCCccc-hhhcCCCCChhHHHHHHHhcccCCCCCC
Q 026660          156 HIFRLLGTPNEK--VWPGVSSLMNWHE------------YP----QWNPQS-LATAVPNLDKDGLDLLEQMLQYDPSKRI  216 (235)
Q Consensus       156 ~~~~~~~~~~~~--~~~~~~~~~~~~~------------~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp  216 (235)
                      .........+..  ......+......            ..    ...... .......+++++.+++++||+.||.+||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  300 (328)
T cd08226         221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP  300 (328)
T ss_pred             HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence            322211110000  0000000000000            00    000000 0011224677899999999999999999


Q ss_pred             CHHHHhCCCCCCCCCcC
Q 026660          217 SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       217 s~~~ll~hp~f~~~~~~  233 (235)
                      |++++++||||.++..+
T Consensus       301 ta~e~l~~~~~~~~~~~  317 (328)
T cd08226         301 SASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             CHHHHhhCHHHHHHHHh
Confidence            99999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-33  Score=217.10  Aligned_cols=194  Identities=24%  Similarity=0.457  Sum_probs=149.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++....++||||++| +|.+++.+.    ..++++.+..++.|++.||.+||+++++|+||+|+||+++.++ .+++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l  149 (272)
T cd06629          75 GFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKI  149 (272)
T ss_pred             EEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEE
Confidence            345667789999999975 999999763    4689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCC--CcccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           86 ADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        86 ~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|||.+........  ......++..|+|||.+.... .++.++|+||+|++++++++|..||......+........  
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--  227 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--  227 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--
Confidence            99998865432211  122345678899999987543 3688999999999999999999999765544333322110  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                       ....                   .........++.+++++|.+||..+|.+||+++++++||||
T Consensus       228 -~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         228 -RSAP-------------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -ccCC-------------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence             0000                   00011122467899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.7e-33  Score=219.38  Aligned_cols=180  Identities=17%  Similarity=0.201  Sum_probs=144.2

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEEee
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ++...+++||||++| +|.+++.+    .+.+++.....++.|++.|+.+||+. +++|+||+|+||+++.++ .++++|
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~d  166 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIIC  166 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcc
Confidence            345678999999985 99999975    34688999999999999999999984 899999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ||++.....+.   ....++..|+|||++.+. ..++.++|||||||++|++++|..||.+....+...........+. 
T Consensus       167 fg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-  242 (283)
T PHA02988        167 HGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-  242 (283)
T ss_pred             cchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence            99987554322   234567889999998652 3478999999999999999999999988776555544432111100 


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                               .....++++.+++.+||+.||.+|||+.++++
T Consensus       243 -------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 -------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                     01136788999999999999999999999975

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.5e-34  Score=222.34  Aligned_cols=193  Identities=23%  Similarity=0.400  Sum_probs=146.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.++..++||||+++ +|..+        ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~  135 (279)
T cd06619          65 YGAFFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVK  135 (279)
T ss_pred             EEEEEECCEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEE
Confidence            3445566778999999986 76543        2478899999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ---LLHIFRLL  161 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~  161 (235)
                      ++|||++......  ......++..|+|||.+.+.. ++.++|+||+|+++|++++|..||........   ........
T Consensus       136 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (279)
T cd06619         136 LCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI  212 (279)
T ss_pred             EeeCCcceecccc--cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence            9999998755432  223456788999999987655 78999999999999999999999965321110   00111111


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ......                      .......++++++++.+||..+|.+||+++++++||||...+.
T Consensus       213 ~~~~~~----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         213 VDEDPP----------------------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             hccCCC----------------------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            100000                      0011236788999999999999999999999999999987754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-33  Score=222.73  Aligned_cols=192  Identities=23%  Similarity=0.388  Sum_probs=150.8

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .....+..|+|+||+++ +|.+++.+     ..+++..+..++.|++.|+++||++|++|+||+|+||+++.++ .++++
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~  157 (293)
T cd06647          84 SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLT  157 (293)
T ss_pred             eeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEc
Confidence            34456778999999985 99999865     3578999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+..............++..|++||.+.... ++.++|+||+|++++++++|..||..............  ..  .
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~--~  232 (293)
T cd06647         158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--T  232 (293)
T ss_pred             cCcceecccccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC--C
Confidence            9998865544333334456778899999987644 78899999999999999999999987654332221110  00  0


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .                     .......++..++++|++||..+|.+||++.+++.||||+...
T Consensus       233 ~---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         233 P---------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             C---------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            0                     0001113567899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-33  Score=215.58  Aligned_cols=181  Identities=26%  Similarity=0.389  Sum_probs=142.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+....|++|||++| +|.+++.+.    ..++++.+..++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        51 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~  125 (237)
T cd05576          51 HKYIVSEDSVFLVLQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQ  125 (237)
T ss_pred             hhheecCCeEEEEEecCCCCCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEE
Confidence            3445567789999999985 999998763    3589999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+......   .....++..|+|||...... ++.++|+||+|+++|++++|..|+........           
T Consensus       126 l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------  190 (237)
T cd05576         126 LTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------  190 (237)
T ss_pred             Eecccchhccccc---cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------
Confidence            9999987655432   12233466799999876444 68899999999999999999987643211000           


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYF  227 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~hp~f  227 (235)
                               .      ...      ......++++++++|++||+.||.+||++     +++++||||
T Consensus       191 ---------~------~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         191 ---------T------HTT------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ---------c------ccc------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                     0      000      00112467889999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4e-33  Score=218.54  Aligned_cols=186  Identities=29%  Similarity=0.580  Sum_probs=150.6

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..++++..+++||++. ++|.+++.+.    +.+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~  144 (280)
T cd05581          70 TFQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKIT  144 (280)
T ss_pred             HhcCCceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEec
Confidence            4566778999999996 5999999763    3699999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCC--------------------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 026660           87 DLGLARAFTLPI--------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  146 (235)
Q Consensus        87 df~~~~~~~~~~--------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  146 (235)
                      |||.+.......                    .......++..|+|||...... .+.++|+||+|++++++++|..||.
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~  223 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFR  223 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCC
Confidence            999887554322                    1122335577899999887654 7889999999999999999999998


Q ss_pred             CCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHh
Q 026660          147 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAM  222 (235)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll  222 (235)
                      ................                            .....+++.+.+++++||+.+|.+||++    ++++
T Consensus       224 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         224 GSNEYLTFQKILKLEY----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             CccHHHHHHHHHhcCC----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence            8765444443321100                            0011357889999999999999999999    9999


Q ss_pred             CCCCC
Q 026660          223 EHPYF  227 (235)
Q Consensus       223 ~hp~f  227 (235)
                      +||||
T Consensus       276 ~~~~~  280 (280)
T cd05581         276 AHPFF  280 (280)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.3e-33  Score=218.90  Aligned_cols=188  Identities=20%  Similarity=0.311  Sum_probs=146.3

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ...+....|++|||+++ +|.+++......            ...+++..++.++.|++.||+|||+++++|+||+|+||
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni  155 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC  155 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence            34456678999999984 999999774221            14588999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++++|||++.......  .......++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+....
T Consensus       156 l~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         156 LVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             EEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999766 89999999986543221  1123334577899999887654 7899999999999999998 99999877665


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +....+.....                           ......++.++.+++++||+.||.+||++.+++++
T Consensus       234 ~~~~~i~~~~~---------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQL---------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCc---------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            44433321100                           00112478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-33  Score=214.66  Aligned_cols=189  Identities=26%  Similarity=0.404  Sum_probs=150.0

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT-----GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      +....+...+++|||++ ++|.+++......     ...+++..++.++.|++.||++||+++++|+||+|+||+++.++
T Consensus        63 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~  142 (262)
T cd00192          63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL  142 (262)
T ss_pred             eeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC
Confidence            34455778999999996 5999999875322     36799999999999999999999999999999999999999776


Q ss_pred             CeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  157 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  157 (235)
                       .++++|||.+.......  .......++..|+|||.+.... ++.++|+||+|++++++++ |..||......+.....
T Consensus       143 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  220 (262)
T cd00192         143 -VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL  220 (262)
T ss_pred             -cEEEcccccccccccccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence             89999999987655332  2233345577899999987654 7899999999999999999 69999887655544443


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .....                           ......+++++.+++++||..+|.+|||+.+++++
T Consensus       221 ~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         221 RKGYR---------------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HcCCC---------------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            32100                           00112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-33  Score=205.53  Aligned_cols=215  Identities=37%  Similarity=0.714  Sum_probs=176.6

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+|+||.+|.-||..++.+.   ...++..+|.+++.++..||.|+|+..++|||+|+.|+|++.++ .++++|||+
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeecccc
Confidence            45679999999999999999653   34689999999999999999999999999999999999999877 999999999


Q ss_pred             cccccCCCC----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ++.+..+..    ..+...-|.+|++||.+.+...++++.|+|+.||++.+|.++...+.+..+.+++..+...++....
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            976654322    2333445889999999999888999999999999999999999999999999999999999999999


Q ss_pred             CCcccccccccccCCCC--CCcc---chhhcCC--CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQ--WNPQ---SLATAVP--NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ..|+.....--+.....  .+..   .+.....  .-.++..+|+.++|..||.+|+.++++++|.||..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            99998766544443311  1111   1111111  12457889999999999999999999999999864

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6e-33  Score=218.91  Aligned_cols=198  Identities=24%  Similarity=0.391  Sum_probs=151.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..++.+...|+||||+++ +|.+++..    ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .+++
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl  146 (290)
T cd05613          72 YAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVL  146 (290)
T ss_pred             eEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEE
Confidence            345566789999999985 99999875    34688999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCC-CCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPI-KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+....... .......++..|+|||.+.+. ...+.++|+||+|++++++++|..||...........+......
T Consensus       147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  226 (290)
T cd05613         147 TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK  226 (290)
T ss_pred             eeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence            9999886543321 112234567889999998643 23578899999999999999999999753322221111111110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~  233 (235)
                      ....                        ....+++.+.+++++||..||.+||     +++++++||||+.++|+
T Consensus       227 ~~~~------------------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         227 SEPP------------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             cCCC------------------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence            0000                        0113667889999999999999997     89999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.9e-33  Score=214.38  Aligned_cols=186  Identities=24%  Similarity=0.392  Sum_probs=147.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++....++||||+++ +|.+++.+  ..+..++++.+..++.|++.|+.|||++|++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl  145 (261)
T cd05148          69 AVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKV  145 (261)
T ss_pred             eeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEE
Confidence            344566778999999985 99999976  3345689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+..............++..|++||...... ++.++|+||+|++++++++ |..||......+...........+
T Consensus       146 ~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05148         146 ADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP  224 (261)
T ss_pred             ccccchhhcCCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC
Confidence            99999876544333233334466799999986544 7889999999999999998 899998766555544433211100


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 .....++.+.+++.+||+.||.+|||+.++++
T Consensus       225 ---------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         225 ---------------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       01246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=212.03  Aligned_cols=206  Identities=23%  Similarity=0.370  Sum_probs=157.1

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--   80 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--   80 (235)
                      .++..+|++...|+|||-|.| +|+++|.+.    ..+++.++.++..+|+.||.+||++||+|||+||+|||-...+  
T Consensus       140 qLiefFEdd~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  140 QLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             HHHHHhcccceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence            456788999999999999975 999999773    4699999999999999999999999999999999999986433  


Q ss_pred             CeEEEeecCCccccc--CC-----CCCcccccccccccCchhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 026660           81 MTLKIADLGLARAFT--LP-----IKKYTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDS  149 (235)
Q Consensus        81 ~~~~l~df~~~~~~~--~~-----~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  149 (235)
                      ..++|+||.+.....  .+     ......+.|+..|||||++.    ....|..++|.||||+++|-|++|..||.+.=
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence            368999997764321  11     11234567788899999985    23457899999999999999999999996421


Q ss_pred             H-----------HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          150 E-----------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       150 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      .           ..-...++..++...-.+                    ....+..+|.+.+++|+.+|..|+.+|.++
T Consensus       296 g~dCGWdrGe~Cr~CQ~~LFesIQEGkYeF--------------------PdkdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  296 GADCGWDRGEVCRVCQNKLFESIQEGKYEF--------------------PDKDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             CCcCCccCCCccHHHHHHHHHHHhccCCcC--------------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence            1           111222222222111111                    122334688999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcC
Q 026660          219 KKAMEHPYFDDLDKT  233 (235)
Q Consensus       219 ~~ll~hp~f~~~~~~  233 (235)
                      .++++|||++....+
T Consensus       356 ~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  356 AQVLNHPWVQRCAPE  370 (463)
T ss_pred             hhccCCccccccchh
Confidence            999999999877654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5e-33  Score=215.77  Aligned_cols=187  Identities=28%  Similarity=0.448  Sum_probs=149.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+++...|+|+||+.| +|.+++.+.    ..++++.+..++.|++.||.|||+++++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l  141 (258)
T cd05578          67 YSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHI  141 (258)
T ss_pred             HhhcCCCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEE
Confidence            345677889999999986 999998762    4689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~  163 (235)
                      +|||.+....... ......++..|+|||.+.+.. .+.++|+||+|+++|++++|..||.....  .........   .
T Consensus       142 ~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~  216 (258)
T cd05578         142 TDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T  216 (258)
T ss_pred             eecccccccCCCc-cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c
Confidence            9999887654332 223445678899999987655 78999999999999999999999987653  222211111   0


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH--HHHhCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA--KKAMEHPYF  227 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~ll~hp~f  227 (235)
                      ..                        .......+.++.++|++||+.||.+||++  .++++||||
T Consensus       217 ~~------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 AD------------------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cc------------------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            00                        00111356889999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.7e-33  Score=218.15  Aligned_cols=191  Identities=24%  Similarity=0.371  Sum_probs=151.5

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...|+||||+++ +|.+++.+     ..++++.+..++.|++.|+.+||+.+++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l  142 (277)
T cd06641          69 GSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKL  142 (277)
T ss_pred             EEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEE
Confidence            345567789999999985 99988864     3589999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||...............   ..
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~  218 (277)
T cd06641         143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---NP  218 (277)
T ss_pred             eecccceecccchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---CC
Confidence            99998866543332333445678899999886544 788999999999999999999999766543333322110   00


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                              ......++.++.+++.+||..+|.+||++.++++||||.+..
T Consensus       219 ------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         219 ------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             ------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                                    001124678899999999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-32  Score=214.15  Aligned_cols=185  Identities=21%  Similarity=0.328  Sum_probs=143.5

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...+++|||++ ++|.+++...  ....+++..++.++.|++.||++||+++++|+||+|+||+++.++ .++++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~  146 (263)
T cd05052          70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVA  146 (263)
T ss_pred             EEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeC
Confidence            3455667899999997 5999999762  334589999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCc-ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||.+.......... .....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....+........... 
T Consensus       147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-  224 (263)
T cd05052         147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM-  224 (263)
T ss_pred             CCccccccccceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-
Confidence            999987654332211 1122355799999886554 7899999999999999998 89999876654443333211000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                ......+.++.+++++||+.||.+||++.++++
T Consensus       225 --------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         225 --------------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                      011246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-32  Score=216.21  Aligned_cols=188  Identities=23%  Similarity=0.357  Sum_probs=146.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFR----------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL   75 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~----------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil   75 (235)
                      +........+++|||++| +|.+++....          .....+++..+..++.|++.|+.+||+++++|+||+|+||+
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nil  154 (280)
T cd05049          75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL  154 (280)
T ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEE
Confidence            344556789999999985 9999998742          22345789999999999999999999999999999999999


Q ss_pred             EcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 026660           76 MDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQ  152 (235)
Q Consensus        76 ~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  152 (235)
                      ++.++ .++++|||.+.......  .......++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+
T Consensus       155 i~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         155 VGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EcCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99776 99999999886543211  1122334467899999987655 7899999999999999998 999998766655


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..........                           .......+..+.+++++||..||.+||++.|+++
T Consensus       233 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         233 VIECITQGRL---------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4443321100                           0011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-32  Score=218.73  Aligned_cols=191  Identities=21%  Similarity=0.328  Sum_probs=150.8

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..++....|+||||+.|+|.+++...   ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++++|
T Consensus        89 ~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~d  164 (313)
T cd06633          89 CYLKEHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLAD  164 (313)
T ss_pred             EEEeCCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEee
Confidence            34556778999999999998888652   34689999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      ||.+....    ......++..|+|||.+..  ...++.++|+||+|++++++++|..||...............  ..+
T Consensus       165 fg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~  238 (313)
T cd06633         165 FGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP  238 (313)
T ss_pred             cCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCC
Confidence            99875432    1223456788999999852  234678999999999999999999999876654444433211  000


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                              ......++..+++++.+||+.+|.+||++.++++||||.....
T Consensus       239 ------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         239 ------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             ------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence                                    0001235677899999999999999999999999999987553

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1e-32  Score=217.40  Aligned_cols=198  Identities=26%  Similarity=0.421  Sum_probs=149.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ..++.+...|+||||+++ +|.+++..    ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .+++
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l  146 (288)
T cd05583          72 YAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVL  146 (288)
T ss_pred             eeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEE
Confidence            345566789999999985 99998865    34689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||++......... .....++..|++||.+.+.. ..+.++|+||+|++++++++|..||.............+....
T Consensus       147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  226 (288)
T cd05583         147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK  226 (288)
T ss_pred             EECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence            999988654432211 22335678899999986532 2578999999999999999999999643221111111111000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~hp~f~~~~~~  233 (235)
                      ..                        ......++..+.+++++||+.||.+|||   +.++++||||++++|.
T Consensus       227 ~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         227 SK------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             cC------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            00                        0001136678899999999999999998   5678999999999885

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-32  Score=216.49  Aligned_cols=187  Identities=22%  Similarity=0.335  Sum_probs=144.3

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ---------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD   77 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~---------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~   77 (235)
                      ........++||||+++ +|.+++.+...         ....+++..++.++.|++.||+|||++|++|+||+|+||+++
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~  154 (288)
T cd05093          75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG  154 (288)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence            34556779999999985 99999976431         223489999999999999999999999999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQL  154 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~  154 (235)
                      .++ .++++|||.+........  ......++..|+|||.+.+.. ++.++|+||||+++++|++ |..||......+..
T Consensus       155 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~  232 (288)
T cd05093         155 ENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  232 (288)
T ss_pred             cCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            776 899999999875532211  122333466799999987544 7899999999999999998 89999776654444


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ........                           .......+.++.+++.+||+.||.+|||+.++++
T Consensus       233 ~~i~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         233 ECITQGRV---------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33322100                           0001136788999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-32  Score=214.66  Aligned_cols=191  Identities=26%  Similarity=0.429  Sum_probs=147.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+.+..++++||+++ +|.+++.........++++.++.++.|++.||+|||+++++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l  147 (267)
T cd08228          69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKL  147 (267)
T ss_pred             eeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEE
Confidence            344556789999999985 99999987655566789999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~  164 (235)
                      +|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||..... .............+
T Consensus       148 ~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd08228         148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP  226 (267)
T ss_pred             CccccceeccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC
Confidence            99998876543332233446778899999987654 78899999999999999999999965432 11222211111110


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +.                         ....++..+.+++++||..+|.+||++.++++.
T Consensus       227 ~~-------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         227 PL-------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             CC-------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            00                         011356789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-32  Score=218.06  Aligned_cols=193  Identities=21%  Similarity=0.301  Sum_probs=143.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ---------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP   71 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~---------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~   71 (235)
                      ...+....|+||||+++ +|.+++.....               ....+++..++.++.||+.||.|||+.+++|+||||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp  166 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT  166 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcch
Confidence            34455678999999975 99999976321               112467889999999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 026660           72 HNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPG  147 (235)
Q Consensus        72 ~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~  147 (235)
                      +||+++.++ .++++|||.++.......  ......++..|+|||.+.+.. ++.++|+||||+++|++++  +..||..
T Consensus       167 ~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~  244 (304)
T cd05096         167 RNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGE  244 (304)
T ss_pred             hheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence            999999776 899999999875432211  122334467899999987654 8899999999999999986  5678877


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      ....+................                    .....+..++.+.+++.+||+.||.+|||+.++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         245 LTDEQVIENAGEFFRDQGRQV--------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCHHHHHHHHHHHhhhccccc--------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            665554443332211111000                    0011224678899999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-32  Score=216.87  Aligned_cols=188  Identities=22%  Similarity=0.340  Sum_probs=145.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      +..++....++||||+++ +|.+++.....            ....+++..++.++.||+.|++|||+++++|+||+|+|
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  153 (291)
T cd05094          74 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN  153 (291)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcce
Confidence            344566778999999975 99999976431            22458999999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      |+++.++ .++++|||.+........  ......++..|+|||.+.+.. ++.++|+||+|+++|+|++ |..||.....
T Consensus       154 il~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         154 CLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             EEEccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999776 899999999865433211  122344567899999887654 7889999999999999998 9999977665


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .+..........                           .......+..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         232 TEVIECITQGRV---------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHhCCCC---------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            544333221000                           0001135678999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=214.79  Aligned_cols=210  Identities=39%  Similarity=0.618  Sum_probs=167.8

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++-+.+|+|||+|..||...+.-      .++.+.+.+++.|++.|+++||+.|++||||||+||++..+. .+++.|||
T Consensus        91 ~~~~e~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg  163 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFG  163 (369)
T ss_pred             HHHHhHHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccch
Confidence            34456899999999999998874      478889999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... ...+....+..|+|||++.+.. +...+||||+||++.+|+.|+..|.+....++..++.+..+.++..+.
T Consensus       164 ~ar~e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  164 LARTEDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hhcccCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            99866544 3455566688899999999866 889999999999999999999999999999999999999999987766


Q ss_pred             cccccccccc--CCCCCCccchh-----------hcC-CCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          170 PGVSSLMNWH--EYPQWNPQSLA-----------TAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       170 ~~~~~~~~~~--~~~~~~~~~~~-----------~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      .+...-....  ..++.......           ... +--...+++++.+||..||++|.|++++|+||||+
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            5432210000  00000000000           011 12235678999999999999999999999999997

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.9e-32  Score=212.00  Aligned_cols=192  Identities=28%  Similarity=0.497  Sum_probs=147.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+....++|+||+++ +|.+++.+    +..++++.++.++.|++.|+++||+.+++|+||+|+||+++..+ .+++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl  140 (264)
T cd06626          66 GVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKL  140 (264)
T ss_pred             eeEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEE
Confidence            344567789999999985 99998865    34588999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcc----cccccccccCchhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|||.+...........    ...++..|+|||.+.+..  ..+.++|+||+|++++++++|..||..............
T Consensus       141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~  220 (264)
T cd06626         141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG  220 (264)
T ss_pred             cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh
Confidence            99998876543322211    245678899999987543  267899999999999999999999976532222211111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      . .... .                      .......++.+.++|++||+.+|.+||++.+++.|||+
T Consensus       221 ~-~~~~-~----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         221 A-GHKP-P----------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             c-CCCC-C----------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1 0000 0                      00111357888999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-32  Score=212.86  Aligned_cols=184  Identities=24%  Similarity=0.460  Sum_probs=144.1

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ...++++|||++| +|.+++.+.    ..+++..+..++.|++.||++||+++++|+||+|+||+++.++ .++++|||.
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~  152 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGA  152 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCcc
Confidence            4578999999985 999998752    3578999999999999999999999999999999999999766 899999998


Q ss_pred             cccccCCC---CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.......   .......++..|+|||.+.+.. .+.++|+||||+++|++++|..||.............   ..+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~  228 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP  228 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCCC
Confidence            86543211   1122345678899999987644 7899999999999999999999998765444433221   111100


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      .                       ....++..+.+++++|+. +|.+||+++++++|||+.
T Consensus       229 ~-----------------------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         229 V-----------------------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             C-----------------------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            0                       112356788899999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=211.41  Aligned_cols=186  Identities=31%  Similarity=0.535  Sum_probs=151.1

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ..+.+..++++|++++ +|.+++...    ..++++.++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++++|
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d  142 (254)
T cd06627          68 IETSDSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLAD  142 (254)
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEec
Confidence            3456789999999986 999998763    5689999999999999999999999999999999999999766 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+..............++..|++||...+.. .+.++|+|++|++++++++|..||..............   ...  
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~--  216 (254)
T cd06627         143 FGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDH--  216 (254)
T ss_pred             cccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCC--
Confidence            999876654443334456688899999987655 78999999999999999999999987664443333221   000  


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                            .......++.+.+++.+||..+|++||++.++++||||
T Consensus       217 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         217 ----------------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                                  00112467889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-32  Score=219.06  Aligned_cols=189  Identities=22%  Similarity=0.343  Sum_probs=148.5

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ...++...|+|+||+.|+|.+++...   ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++++|
T Consensus        83 ~~~~~~~~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~d  158 (307)
T cd06607          83 CYLREHTAWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLAD  158 (307)
T ss_pred             EEEeCCeEEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEee
Confidence            34456678999999999998888652   24689999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      ||.+......    ....++..|+|||.+.+  ...++.++|+||+|+++|++++|..||..............   ...
T Consensus       159 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~  231 (307)
T cd06607         159 FGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDS  231 (307)
T ss_pred             cCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCC
Confidence            9988654322    23356778999998742  23477899999999999999999999987665443322211   000


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..                       .....++.++.++|++||+.+|.+||++.+++.||||..-
T Consensus       232 ~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         232 PT-----------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CC-----------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            00                       0011356789999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.6e-32  Score=212.74  Aligned_cols=191  Identities=26%  Similarity=0.432  Sum_probs=147.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .....+++..+++|||++| +|.+++.........+++..++.++.|++.|++|||++|++|+||+|+||+++.++ .++
T Consensus        68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~  146 (267)
T cd08229          68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVK  146 (267)
T ss_pred             hheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEE
Confidence            3444566789999999985 99999987655666789999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGT  163 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  163 (235)
                      ++|||.+..............++..|+|||.+.+.. .+.++|+||+|++++++++|..||.+.... ............
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  225 (267)
T cd08229         147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY  225 (267)
T ss_pred             ECcchhhhccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC
Confidence            999998876544333333446788899999986554 788999999999999999999999654321 111111100000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +                         .......++++.+++.+||..||.+|||+.++++
T Consensus       226 ~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 P-------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             C-------------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            0                         0001136788999999999999999999997754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-32  Score=210.76  Aligned_cols=188  Identities=25%  Similarity=0.456  Sum_probs=149.2

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...++++||++| +|.+++....   ..+++..+..++.|++.|+++||+++++|+||+|+||+++.++ .++|+
T Consensus        65 ~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~  140 (253)
T cd05122          65 SYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLI  140 (253)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEe
Confidence            34455778999999995 9999887632   5689999999999999999999999999999999999999766 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+........ .....++..|+|||.+.+.. .+.++|+||+|++++++++|..||...............  ....
T Consensus       141 d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~  216 (253)
T cd05122         141 DFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPG  216 (253)
T ss_pred             ecccccccccccc-ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCC
Confidence            9998876554322 33445678899999987655 788999999999999999999999876544433332210  0000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                                             ......++..+.++|++||+.||.+|||+.+++.|||
T Consensus       217 -----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 -----------------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -----------------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                                   0001124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-32  Score=216.48  Aligned_cols=197  Identities=21%  Similarity=0.380  Sum_probs=150.0

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...|++|||++++|.+++...   ...+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++ .++|
T Consensus        81 ~~~~~~~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL  156 (296)
T cd06618          81 GYFITDSDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKL  156 (296)
T ss_pred             eeeecCCeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEE
Confidence            344566779999999998888887663   2378999999999999999999997 5999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~  161 (235)
                      +|||.+........ .....++..|+|||.+.+.   ..++.++|+||+|++++++++|..||..... .+.......  
T Consensus       157 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--  233 (296)
T cd06618         157 CDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--  233 (296)
T ss_pred             CccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc--
Confidence            99999865543222 2233457789999998643   2367899999999999999999999976432 222222211  


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                       ......                      .....++.++.+++++||..||.+||+++++++||||..+..+
T Consensus       234 -~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         234 -EEPPSL----------------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             -CCCCCC----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence             110000                      0001367889999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-32  Score=224.02  Aligned_cols=157  Identities=18%  Similarity=0.318  Sum_probs=120.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .++++.+++++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++.......  ......++..|+|||.+
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  286 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI  286 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence            478889999999999999999999999999999999999666 899999999875543221  11222345679999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++|+||+||++|++++ |..||..................+.                          ....
T Consensus       287 ~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~  339 (374)
T cd05106         287 FDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--------------------------RPDF  339 (374)
T ss_pred             cCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--------------------------CCCC
Confidence            7554 8899999999999999997 9999976544333332222100000                          0112


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .++++.+++++||+.||.+|||+.++++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5688999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=210.05  Aligned_cols=188  Identities=23%  Similarity=0.441  Sum_probs=150.8

Q ss_pred             EEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      ++|.||.|+..+..++...   .+++++..+-++...++.||.||.++ +++|||+||+|||+++.+ +++++|||.+-.
T Consensus       166 V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccce
Confidence            5566788876666666553   24699999999999999999999955 899999999999999888 999999999876


Q ss_pred             ccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +..+ ...+...|-+.|||||.+.-  ...|..++|+||||+++++|.+|..||.+. .+.+.+..+.+  ..|+ .+  
T Consensus       242 lvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP-~L--  315 (391)
T KOG0983|consen  242 LVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPP-LL--  315 (391)
T ss_pred             eecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCC-CC--
Confidence            6543 34455567788999999863  345778999999999999999999999874 55666666654  1111 10  


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                          ....++|+++.++++.||+.|+.+||...++|+|||+..++.
T Consensus       316 --------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  316 --------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             --------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence                                011138899999999999999999999999999999987764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.1e-32  Score=216.63  Aligned_cols=188  Identities=22%  Similarity=0.346  Sum_probs=147.8

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ..++...++|+||+.|+|.+.+...   ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++ .++++||
T Consensus        84 ~~~~~~~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~df  159 (308)
T cd06634          84 YLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDF  159 (308)
T ss_pred             EEcCCeeEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCc
Confidence            3455678999999999988887642   34589999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |.+......    ....++..|+|||.+.+  ....+.++|+||+||+++++++|..||......+.......... +  
T Consensus       160 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--  232 (308)
T cd06634         160 GSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--  232 (308)
T ss_pred             ccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C--
Confidence            988654322    23356778999999753  23367899999999999999999999977654433332221100 0  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                             ......++..++++|++||..+|.+||++.++++|||+...
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 -----------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -----------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                                   00112467789999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-32  Score=211.97  Aligned_cols=185  Identities=22%  Similarity=0.348  Sum_probs=144.6

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ...+....+++|||++ ++|.+++.+.  ....++++.++.++.|++.||+|||+.+++|+||+|+||+++.++ .++++
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~  145 (261)
T cd05072          69 VVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIA  145 (261)
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEEC
Confidence            3456677899999997 5999999763  345688999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||.+........ ......++..|+|||.+.... ++.++|+||+|+++|++++ |..||......+........... 
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-  223 (261)
T cd05072         146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-  223 (261)
T ss_pred             CCccceecCCCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999876543221 112223456799999986544 7889999999999999998 99999877655544443221100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                .....++.++.+++.+|+..+|.+||+++++.+
T Consensus       224 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 --------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                      011246788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-32  Score=213.26  Aligned_cols=190  Identities=21%  Similarity=0.339  Sum_probs=144.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT---GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--   80 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~---~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--   80 (235)
                      +...++...++||||+.| +|.+++......   ...+++..+..++.||+.|++|||+++++|+||+|+||+++..+  
T Consensus        76 ~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             EEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC
Confidence            334556678999999975 999999774321   12588999999999999999999999999999999999998543  


Q ss_pred             CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  157 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  157 (235)
                      ..++++|||+++.......  .......+..|+|||.+.+.. ++.++|||||||+++++++ |..||......+.....
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            2589999999876532211  112223356799999987655 8899999999999999997 99999876655443322


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ... ...                          .....++..+.+++++|++.+|.+|||+.++++|
T Consensus       235 ~~~-~~~--------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         235 TGG-GRL--------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HcC-CcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            210 000                          0012467889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-32  Score=212.20  Aligned_cols=185  Identities=16%  Similarity=0.209  Sum_probs=142.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +....+.+.|+||||+++ +|.+++.+.   ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .+++
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l  148 (266)
T cd05064          73 GVITRGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKI  148 (266)
T ss_pred             EEEecCCCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEE
Confidence            344566789999999985 999988752   34689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+......... .....++..|+|||.+.+.. ++.++|+||+||+++++++ |..||.+....+....+.+....
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~  227 (266)
T cd05064         149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL  227 (266)
T ss_pred             CCCcccccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence            999976543222111 11223356799999987654 7899999999999999775 99999877665544433221100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 .....++..+.+++.+||+.+|.+||+++++++
T Consensus       228 ---------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 ---------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                       011246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-32  Score=216.54  Aligned_cols=189  Identities=26%  Similarity=0.407  Sum_probs=146.1

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      +..+.+...+++|||++ |+|.+++....            .....+++..++.++.|++.||+|||+.+++|+||+|+|
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            34456667999999997 59999997632            234568999999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      |+++.++ .++++|||.++.......  ......++..|+|||.+.+.. ++.++|+||+||++|++++ |..||.....
T Consensus       163 il~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         163 VLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             EEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999776 899999999876543221  112223456799999886544 7899999999999999997 9999987665


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+..........                           .......+.++.+++.+|+..||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         241 EELFKLLKEGYR---------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            544433321100                           00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.5e-32  Score=213.21  Aligned_cols=188  Identities=23%  Similarity=0.333  Sum_probs=143.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ...+....++||||+++ +|.+++.+....      ...++...+..++.|++.||+|||+.+++|+||+|+||+++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence            34566678999999985 999999764321      22357788999999999999999999999999999999999776


Q ss_pred             CeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  157 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  157 (235)
                       .++++|||.++........  .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....+.....
T Consensus       157 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             -CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             8999999988654322111  11223466799999987544 7899999999999999998 78888776654444332


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..... +                          ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~-~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         235 MEGGL-L--------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HcCCc-C--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21100 0                          0011356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.8e-32  Score=210.23  Aligned_cols=189  Identities=26%  Similarity=0.445  Sum_probs=146.5

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +....++..++||||+++ +|.+++.+....+..++++.++.++.|++.|+++||+.|++|+||+|+||+++.++ .+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l  147 (267)
T cd08224          69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKL  147 (267)
T ss_pred             eeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEE
Confidence            344556789999999985 99999987656666789999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H-HHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-L-QQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~-~~~~~~~~~~~~  163 (235)
                      +|||.+..............++..|+|||.+.+.. ++.++|+||+|++++++++|..||..... . +.......... 
T Consensus       148 ~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  225 (267)
T cd08224         148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-  225 (267)
T ss_pred             eccceeeeccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-
Confidence            99999876543333333446678899999987544 78899999999999999999999965431 1 11111110000 


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           .    ......++..+.++|.+||..+|.+|||+.++++
T Consensus       226 ---------------------~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         226 ---------------------P----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------------------C----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                 0    0001136678999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-32  Score=210.48  Aligned_cols=186  Identities=19%  Similarity=0.286  Sum_probs=144.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++....|+||||++| +|.+++...   ...++++.++.++.|++.|+.+||+++++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl  141 (256)
T cd05059          66 GVCTKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKV  141 (256)
T ss_pred             EEEcCCCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEE
Confidence            344566779999999975 999999762   23689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.++........ .....++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||......+...........
T Consensus       142 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05059         142 SDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL  220 (256)
T ss_pred             CCcccceecccccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC
Confidence            999988755432111 11122345799999987654 7889999999999999998 89999876655544433211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                 ......+.++.+++.+||..+|.+|||+.++++.
T Consensus       221 ---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 ---------------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                       0111367889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.4e-32  Score=209.98  Aligned_cols=184  Identities=27%  Similarity=0.515  Sum_probs=146.4

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..++++|+++ ++|.+++.+.    ..+++..++.++.|++.|++|||+.+++|+||+|+||+++.++ .++++|||.+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~  148 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCA  148 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccE
Confidence            78999999996 4999999773    2789999999999999999999999999999999999999766 8999999998


Q ss_pred             ccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........  ......++..|+|||...+.. .+.++|+||+|++++++++|..||.........  .......      
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~------  219 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--LYKIGSS------  219 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HHhcccc------
Confidence            76654432  133456678899999987655 789999999999999999999999876521111  1111000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                       ..........+..+.+++.+|+..+|.+||++.++++||||
T Consensus       220 -----------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         220 -----------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -----------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                             00001112357889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.4e-32  Score=210.35  Aligned_cols=186  Identities=19%  Similarity=0.328  Sum_probs=144.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+....|++|||+.+ +|.+++.+.   ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl  141 (256)
T cd05113          66 GVCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKV  141 (256)
T ss_pred             EEEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEE
Confidence            334556678999999975 999998762   23689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.++....+... .....++..|+|||...+.. ++.++|+||||+++|++++ |..||......+......+....
T Consensus       142 ~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05113         142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL  220 (256)
T ss_pred             CCCccceecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC
Confidence            999988755432211 11223456799999987554 7889999999999999998 99999876655444433221100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                 ......++.+++++.+||+.+|.+||++.+++++
T Consensus       221 ---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ---------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                       0011356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6e-32  Score=209.50  Aligned_cols=186  Identities=20%  Similarity=0.303  Sum_probs=144.2

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+++...++||||++ |+|.+++...   ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~k  140 (256)
T cd05114          65 YGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVK  140 (256)
T ss_pred             EEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEE
Confidence            334566778999999997 5999988752   23589999999999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||.++........ .....++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||......+..........
T Consensus       141 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~  219 (256)
T cd05114         141 VSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR  219 (256)
T ss_pred             ECCCCCccccCCCceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence            9999988755322211 12223456799999986544 7899999999999999999 8999987766555444432100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..                           .....+.++.+++++|+..+|.+||+++++++
T Consensus       220 ~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 LY---------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CC---------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00                           00124577899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-33  Score=227.79  Aligned_cols=201  Identities=26%  Similarity=0.460  Sum_probs=158.6

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+++=.+.+++.+|+||+|.+| |+.++|-+.    +.+.++.++.++..+.+|+++.|+.|++||||||+||||+.+| 
T Consensus       692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-  766 (1034)
T KOG0608|consen  692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-  766 (1034)
T ss_pred             EEEEEEeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-
Confidence            4566678999999999999985 999999773    5799999999999999999999999999999999999999888 


Q ss_pred             eEEEeecCCccccc---------CC-----------------CC----------------CcccccccccccCchhhhCC
Q 026660           82 TLKIADLGLARAFT---------LP-----------------IK----------------KYTHEILTLWYRAPEVLLGS  119 (235)
Q Consensus        82 ~~~l~df~~~~~~~---------~~-----------------~~----------------~~~~~~~~~~y~~PE~~~~~  119 (235)
                      .+||.|||+|+.+.         ..                 ..                ..-...||..|+|||++...
T Consensus       767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~  846 (1034)
T KOG0608|consen  767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART  846 (1034)
T ss_pred             ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence            99999999985331         00                 00                00123679999999999754


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChh
Q 026660          120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKD  199 (235)
Q Consensus       120 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (235)
                      . ++..+|.||.|+++|+|+.|+.||......+...++..                  |..      ........+++.+
T Consensus       847 g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n------------------w~~------~l~~~~~~~ls~e  901 (1034)
T KOG0608|consen  847 G-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN------------------WRN------FLHIPYQGNLSKE  901 (1034)
T ss_pred             C-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee------------------hhh------ccccccccccCHH
Confidence            4 88999999999999999999999987665433322221                  111      1112233478999


Q ss_pred             HHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcCC
Q 026660          200 GLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       200 ~~~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~~  234 (235)
                      +.++|.++.. +++.|.   .++++.+||||+.++|.-
T Consensus       902 ~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  902 ALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             HHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence            9999998655 777887   577899999999998853

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.5e-32  Score=212.09  Aligned_cols=193  Identities=22%  Similarity=0.397  Sum_probs=147.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+........|+||||+++ +|.+++.+    .+.+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++ .+
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~  143 (284)
T cd06620          69 YGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QI  143 (284)
T ss_pred             eeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cE
Confidence            3445566789999999985 99888865    3468999999999999999999997 5899999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ--------QLL  155 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~  155 (235)
                      +++|||++......  ......++..|+|||.+.+. .++.++|+||+||+++++++|..||......+        ...
T Consensus       144 ~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~  220 (284)
T cd06620         144 KLCDFGVSGELINS--IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD  220 (284)
T ss_pred             EEccCCcccchhhh--ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence            99999987644322  12234678899999998655 47899999999999999999999997654321        111


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ............+                       .....+.++.+++++|++.||.+|||+.++++||||..
T Consensus       221 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         221 LLQQIVQEPPPRL-----------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHhhccCCCC-----------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            1111111000000                       00125678899999999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-31  Score=214.31  Aligned_cols=189  Identities=21%  Similarity=0.328  Sum_probs=149.2

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ..+++..++||||++|+|.+.+...   ...+++..+..++.|++.|+.+||+++++|+||+|+||+++.++ .++++||
T Consensus        94 ~~~~~~~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~df  169 (317)
T cd06635          94 YLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADF  169 (317)
T ss_pred             EeeCCeEEEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecC
Confidence            4456678999999999988887652   34689999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |.+.....    .....++..|+|||.+..  ....+.++|+||+|++++++++|..||...................  
T Consensus       170 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  243 (317)
T cd06635         170 GSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--  243 (317)
T ss_pred             CCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--
Confidence            98764432    223456788999999742  2347789999999999999999999998766554444333211000  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                              .....+++.+++++.+||+.+|.+||++.++++|+|+..-.
T Consensus       244 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 ------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                    00113667899999999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-32  Score=223.15  Aligned_cols=192  Identities=24%  Similarity=0.398  Sum_probs=156.0

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCC
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~   81 (235)
                      ..+....++.+-+|+|.+. |+|+.|+.++    +.++...++.|++||+.||.|||++.  ++|||||.+||+++....
T Consensus       108 ~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G  183 (632)
T KOG0584|consen  108 DSWVDTDNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG  183 (632)
T ss_pred             eheecCCCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC
Confidence            3445555677999999997 7999999886    45888899999999999999999995  999999999999988777


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .|||+|+|++.....+..  ...+|||.|||||++.  ..|....||||||+.++||+|+..||..-.+..++.+.+-. 
T Consensus       184 ~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-  258 (632)
T KOG0584|consen  184 EVKIGDLGLATLLRKSHA--KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-  258 (632)
T ss_pred             ceeecchhHHHHhhcccc--ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-
Confidence            999999999976654322  3479999999999996  44899999999999999999999999987665555443321 


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      +.++..+                     ..   --.++++++|.+||.. .++|+|+.|+|+||||+.-
T Consensus       259 GiKP~sl---------------------~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  259 GIKPAAL---------------------SK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CCCHHHh---------------------hc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            1111111                     10   1247899999999998 9999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.3e-32  Score=220.68  Aligned_cols=158  Identities=23%  Similarity=0.377  Sum_probs=120.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~  116 (235)
                      .++++.+..++.||+.||+|||+++++|+||||+||+++.++ .++++|||++.........  .....++..|+|||.+
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  288 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI  288 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccccccCCCCCCcceeChhHh
Confidence            478889999999999999999999999999999999999665 8999999998755432221  1223345679999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++|+|||||+++++++ |..||..................+                          .....
T Consensus       289 ~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  341 (375)
T cd05104         289 FNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------------------------LSPEC  341 (375)
T ss_pred             cCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------------------------CCCCC
Confidence            7654 7899999999999999998 888987654333332222110000                          00112


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+.++.+++.+||+.||.+|||+.++++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            46789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.2e-32  Score=208.75  Aligned_cols=180  Identities=23%  Similarity=0.365  Sum_probs=140.9

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +++...|+++||+++ +|.+++.+  .....+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++++||
T Consensus        70 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df  146 (256)
T cd05082          70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDF  146 (256)
T ss_pred             cCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCC
Confidence            455678999999985 99999876  2334588999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      |.+.......   .....+..|+|||.+.+.. ++.++|+||+||++|++++ |..||......+..........     
T Consensus       147 g~~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----  217 (256)
T cd05082         147 GLTKEASSTQ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----  217 (256)
T ss_pred             ccceeccccC---CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----
Confidence            9886543221   2223356799999886544 7889999999999999997 9999876654443333221100     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ......+++.+.+++.+|++.+|.+|||+.++++
T Consensus       218 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 ----------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  0011246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-32  Score=211.90  Aligned_cols=189  Identities=24%  Similarity=0.345  Sum_probs=145.6

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR   78 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~   78 (235)
                      .+..+.....|+||||++ |+|.+++......      ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            344556678999999997 5999999764322      234788999999999999999999999999999999999997


Q ss_pred             CCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026660           79 KTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  155 (235)
Q Consensus        79 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  155 (235)
                      ++ .++++|||.++.......  ......++..|+|||.+.+.. ++.++|+|||||++|++++ |..||......+...
T Consensus       155 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         155 DL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            77 899999999875543221  122334567899999987554 7899999999999999998 899997766544433


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..... ..                          .......+.++.+++++||+.+|++|||+.++++
T Consensus       233 ~~~~~-~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         233 FVIDG-GH--------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHhcC-CC--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            32210 00                          0011135688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1e-31  Score=213.13  Aligned_cols=186  Identities=23%  Similarity=0.368  Sum_probs=143.1

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .....+..|++|||++ |+|.+++..  .....+++..+..++.|++.||.|||+++++|+||+|+||+++..+ .++++
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~  183 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKIC  183 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEEC
Confidence            3455667899999998 599999976  2334489999999999999999999999999999999999999666 89999


Q ss_pred             ecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           87 DLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        87 df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      |||.+........  ......++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+...........
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9999875543221  112234467899999987655 7899999999999999998 99999776544433332211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +                          ......++++.+++++||+.+|.+|||+.++++
T Consensus       263 ~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 M--------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             C--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            0                          001135678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-31  Score=209.38  Aligned_cols=189  Identities=21%  Similarity=0.381  Sum_probs=150.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +...+++..+++|||++| +|.+++.........+++..++.++.|++.||.+||+ .+++|+||+|.||+++.++ .++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence            345667789999999986 9999997765566679999999999999999999996 6899999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+....... ......++..|++||.+.+.. ++.++|+||+|+++|++++|..||..................+
T Consensus       155 l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd08528         155 ITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP  232 (269)
T ss_pred             Eecccceeeccccc-ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence            99999987654332 334456788899999997654 7899999999999999999999998766544443332211000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                .....+++++.+++++||+.||.+||++.|+.++
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      0011356889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-31  Score=207.58  Aligned_cols=179  Identities=20%  Similarity=0.279  Sum_probs=139.6

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....++||||+++ +|.+++.+    ...++++.+..++.|++.|+++||++|++|+||+|.||+++.++ .++++|||.
T Consensus        67 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~  141 (257)
T cd05116          67 AESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGL  141 (257)
T ss_pred             CCCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCcc
Confidence            3456899999984 99999865    34689999999999999999999999999999999999999766 899999999


Q ss_pred             cccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +.........   .....++..|+|||.+.... ++.++|+||||+++|++++ |..||......+....+..... +  
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--  217 (257)
T cd05116         142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M--  217 (257)
T ss_pred             ccccCCCCCeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C--
Confidence            8765433221   11223356899999886544 7889999999999999998 9999987665444333321100 0  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                              ......++++.++|++|++.||.+||+++++..
T Consensus       218 ------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 ------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                                    011247789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-32  Score=209.19  Aligned_cols=186  Identities=24%  Similarity=0.380  Sum_probs=144.8

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+..+..|++|||++ ++|.+++...  .+..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++ .+++
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l  144 (261)
T cd05068          68 AVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKV  144 (261)
T ss_pred             EEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEE
Confidence            34556677899999996 5999999763  245689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+......... ......+..|+|||...+.. ++.++|+||||++++++++ |..||.+....+....+......
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~  223 (261)
T cd05068         145 ADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM  223 (261)
T ss_pred             CCcceEEEccCCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999998766532211 11122245799999886544 7899999999999999999 99999877655544433221000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 ......++.+.+++.+|++.+|.+||++.+++.
T Consensus       224 ---------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ---------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ---------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                       001136688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.5e-32  Score=215.88  Aligned_cols=189  Identities=25%  Similarity=0.339  Sum_probs=143.3

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      .+..+.++..|+||||++ ++|.+++.....            .+..++++.++.++.|++.|++|||++|++|+||+|+
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~  153 (303)
T cd05088          74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR  153 (303)
T ss_pred             EEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchh
Confidence            344566778999999997 499999976421            2235889999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      ||+++.++ .++++|||++....... .......+..|+|||...+.. ++.++|+||+|++++++++ |..||......
T Consensus       154 Nili~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         154 NILVGENY-VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             eEEecCCC-cEEeCccccCcccchhh-hcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            99999776 89999999886332111 111222356799999886544 7899999999999999998 99999766554


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +........   ...                        ......++++.+++.+||+.+|.+||++++++++
T Consensus       231 ~~~~~~~~~---~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         231 ELYEKLPQG---YRL------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHHHhcC---CcC------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            433322110   000                        0011356789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-32  Score=209.68  Aligned_cols=186  Identities=18%  Similarity=0.301  Sum_probs=144.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++++..+++|||+++ +|.+++...   .+.+++..++.++.|++.|++|||+++++|+||+|+||+++.++ .+++
T Consensus        72 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l  147 (266)
T cd05033          72 GVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKV  147 (266)
T ss_pred             EEEecCCceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEE
Confidence            334566778999999985 999998762   23689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           86 ADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        86 ~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|||.++........  .....++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+....+.....
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  226 (266)
T cd05033         148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR  226 (266)
T ss_pred             CccchhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998766422111  11223356799999887544 7899999999999999997 9999977665444433322100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+                           ....+++.+.+++++|++.+|.+||++.+++++
T Consensus       227 ~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         227 LP---------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00                           012467889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.3e-32  Score=212.88  Aligned_cols=187  Identities=24%  Similarity=0.345  Sum_probs=141.9

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ..++....|+++||++ ++|.+++.....            ....+++..++.++.|++.||++||++|++|+||||+||
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  150 (297)
T cd05089          71 ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV  150 (297)
T ss_pred             EEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceE
Confidence            3455667899999997 599999976321            123588999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  153 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  153 (235)
                      +++.++ .++++|||++........ ......+..|+|||...+.. ++.++|+|||||++|+|++ |..||......+.
T Consensus       151 ll~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~  227 (297)
T cd05089         151 LVGENL-ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL  227 (297)
T ss_pred             EECCCC-eEEECCcCCCccccceec-cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999766 899999998854322111 11122245699999886544 7899999999999999997 9999987665444


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..........                           .....++..+++++.+||..+|.+||+++++++.
T Consensus       228 ~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         228 YEKLPQGYRM---------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3332211000                           0112467889999999999999999999998553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-31  Score=207.56  Aligned_cols=184  Identities=22%  Similarity=0.347  Sum_probs=140.0

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ....+...|+||||+++ +|.+++.+   .+..+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++++
T Consensus        61 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~  136 (252)
T cd05084          61 VCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKIS  136 (252)
T ss_pred             EEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEEC
Confidence            34556679999999975 99999865   234589999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCc--ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           87 DLGLARAFTLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        87 df~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      |||.+..........  .....+..|+|||.+.+.. ++.++|+||+|+++|++++ |..||..................
T Consensus       137 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~  215 (252)
T cd05084         137 DFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL  215 (252)
T ss_pred             ccccCcccccccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC
Confidence            999986543221111  1112245699999986655 7899999999999999997 88888766554333322211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 ......+..+.+++++||..+|.+|||+.++++
T Consensus       216 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 ---------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       001135788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.7e-32  Score=228.86  Aligned_cols=216  Identities=25%  Similarity=0.352  Sum_probs=140.0

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhc----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQ----------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~----------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      ++....++|+||+++ +|.+++.....                .........+..++.|++.||+|||+++++|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            456789999999985 99999865210                0011224457789999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCCC-CcccccccccccCchhhhCCC---------------------CCCchhhHHH
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGST---------------------HYSTAVDMWS  130 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Di~s  130 (235)
                      |||++.+...++|+|||+++....... ......+++.|+|||.+....                     .+..++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986544899999999975432221 223456788999999764221                     1234569999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhccc
Q 026660          131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQY  210 (235)
Q Consensus       131 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  210 (235)
                      +||++|+|+++..++.  .............+... ..|..........+     ...........+....+||++||+.
T Consensus       365 lGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        365 AGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDL-VAWRKLVEPRASPD-----LRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcH-HHHHHhhccccchh-----hhhhhhhccccchHHHHHHHHHccC
Confidence            9999999998665533  23223322222111110 00000000000000     0000000111234567999999999


Q ss_pred             CCCCCCCHHHHhCCCCCCCCCcC
Q 026660          211 DPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       211 ~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ||.+|||+.++++||||+.....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999976653

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-31  Score=207.08  Aligned_cols=180  Identities=23%  Similarity=0.384  Sum_probs=141.2

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|++|||+++ +|.+++.+  .....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++++|||.+
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~  149 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccc
Confidence            457999999985 99999976  2344588999999999999999999999999999999999999776 8999999998


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........ ......++..|+|||...+.. .+.++|+||+|+++|++++ |..||.+....+....+......      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------  222 (260)
T cd05069         150 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------  222 (260)
T ss_pred             eEccCCcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            65533221 112233466799999886554 7899999999999999999 89999877665544433221000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+..+.+++++||..||.+||+++++++
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 ---------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 001136688999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.8e-32  Score=228.83  Aligned_cols=191  Identities=24%  Similarity=0.377  Sum_probs=155.9

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCC------C----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG------E----NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP   71 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~------~----~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~   71 (235)
                      |+..+.=.+++.+|+|+|||. |||..||+......      .    .++..+.+.|+.||+.|+.||-++.+|||||-.
T Consensus       552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT  631 (774)
T KOG1026|consen  552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT  631 (774)
T ss_pred             EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence            344555567888999999998 89999998863322      2    277889999999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEEeecCCcccccC--CCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 026660           72 HNLLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD  148 (235)
Q Consensus        72 ~nil~~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  148 (235)
                      .|+||+.+- .|||+|||+++..-.  ..+...+..-++.|||||.+..+. ++++|||||+||++||+++ |..||.+.
T Consensus       632 RNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~gl  709 (774)
T KOG1026|consen  632 RNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGL  709 (774)
T ss_pred             hhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCccccc
Confidence            999999555 999999999985431  122222334477899999998766 9999999999999999999 99999998


Q ss_pred             CHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          149 SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .+.+.+..+.+.                           .+-....+.+.++.+|+..||+.+|.+||++.||-
T Consensus       710 Sn~EVIe~i~~g---------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  710 SNQEVIECIRAG---------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             chHHHHHHHHcC---------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            888887776542                           22333446889999999999999999999999873

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-31  Score=215.60  Aligned_cols=158  Identities=22%  Similarity=0.379  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .++++.+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++..+.....  ......++..|+|||.+
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            578999999999999999999999999999999999999766 899999999876532221  12223446679999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++||||+||+++++++ |..||.+....+...........                          ......
T Consensus       248 ~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~  300 (337)
T cd05054         248 FDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------------------------MRAPEY  300 (337)
T ss_pred             cCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------------------------CCCCcc
Confidence            7655 8899999999999999998 99999764432222222110000                          000113


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .++++.+++.+||+.+|.+||++.++++|
T Consensus       301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         301 ATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            56789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-31  Score=207.45  Aligned_cols=180  Identities=24%  Similarity=0.386  Sum_probs=140.5

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|++|||+++ +|.+++.+  .....++++.++.++.|++.||+|||+++++|+||+|+||+++.++ .++++|||.+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~  149 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceee
Confidence            347899999985 99999976  3345689999999999999999999999999999999999999766 8999999998


Q ss_pred             ccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ......... .....++..|+|||...+.. ++.++|+||||++++++++ |..||.+....+....+......      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  222 (260)
T cd05070         150 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM------  222 (260)
T ss_pred             eeccCcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            765432211 11223456799999886544 7899999999999999999 88999876655544433211000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+..+.+++++|+..+|.+|||++++.+
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 ---------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 001246678999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-31  Score=210.60  Aligned_cols=189  Identities=20%  Similarity=0.284  Sum_probs=144.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      +..+.....++++||+.+ +|.+++....            .....+++..++.++.|++.||.|||++|++|+||||+|
T Consensus        75 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N  154 (283)
T cd05091          75 GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN  154 (283)
T ss_pred             EEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence            344556678999999985 9999986421            112347888999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      |+++.++ .++++|||+++.......  ......+++.|+|||.+.+.. ++.++|+||+||+++++++ |..||.+...
T Consensus       155 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         155 VLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             eEecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999666 899999998875533221  122334467899999987655 7899999999999999998 8888887666


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+....+......                           .....++..+.+++.+||+.+|.+||++.++++.
T Consensus       233 ~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         233 QDVIEMIRNRQVL---------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            5544443321100                           0112467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-32  Score=211.18  Aligned_cols=182  Identities=27%  Similarity=0.427  Sum_probs=139.2

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .....++|+||++ |+|.+++...  ....++...++.++.|++.||.|||+++++|++|+++||+++.++ .++|+|||
T Consensus        72 ~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~  148 (259)
T PF07714_consen   72 ENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFG  148 (259)
T ss_dssp             SSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTT
T ss_pred             cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            3444899999998 6999999883  345789999999999999999999999999999999999999776 99999999


Q ss_pred             CcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ++........  ..........|+|||.+.... ++.++||||||++++++++ |..||......+....+.....    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----  223 (259)
T PF07714_consen  149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----  223 (259)
T ss_dssp             TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----
T ss_pred             ccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc----
Confidence            9876632211  122234466799999987655 7899999999999999999 7899988766665555532111    


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             ......++..+.++|..||..||.+|||+.++++
T Consensus       224 -----------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 -----------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                   1112247788999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-31  Score=207.67  Aligned_cols=181  Identities=24%  Similarity=0.427  Sum_probs=142.3

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ++..|++|||+.+ +|.+++..  ..+..++...+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++|||.
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~  148 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGL  148 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcc
Confidence            3458999999974 99999876  3445689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      +........ ......++..|+|||.+.... ++.++|+||+|++++++++ |..||.+....+...........+    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----  223 (260)
T cd05067         149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----  223 (260)
T ss_pred             eeecCCCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----
Confidence            876542211 122334466799999886544 7889999999999999998 999998776555444332211100    


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             .....+.++.+++++||..+|.+||+++++++
T Consensus       224 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 -----------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   11135678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-33  Score=225.60  Aligned_cols=194  Identities=29%  Similarity=0.423  Sum_probs=164.6

Q ss_pred             cccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+++...+....+|+||||+. |.+.+++.+.    +...+..+..++.|++.|++|+|+++++|+|||++|++++++. 
T Consensus       118 vkl~~v~~t~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-  192 (596)
T KOG0586|consen  118 VKLFSVIETEATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-  192 (596)
T ss_pred             eeeeeeeeecceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-
Confidence            467788889999999999997 5999999884    4466789999999999999999999999999999999999776 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +++|+|||++..+. .......+.|++.|.|||++.+....+..+|+||+|+++|.+++|..||.+.+-.+........ 
T Consensus       193 nikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-  270 (596)
T KOG0586|consen  193 NIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-  270 (596)
T ss_pred             ceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-
Confidence            89999999998877 4455677889999999999999888899999999999999999999999987654433332211 


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                 ......-++.++.++|+++|..+|.+|++.+++..|.|....
T Consensus       271 ---------------------------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  271 ---------------------------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             ---------------------------eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence                                       111222467888999999999999999999999999997643

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-31  Score=212.59  Aligned_cols=187  Identities=24%  Similarity=0.384  Sum_probs=143.1

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ....+...|++|||++ |+|.+++.....            ....++...+..++.|++.||.|||++|++|+||+|+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            3445667899999998 499999977432            124588999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++++|||.++........  .....++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||......
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         166 LVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999776 8999999998755422111  11223345799999987544 7899999999999999999 88899776554


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +..........                           .......+.++.+++++||..+|.+|||+.++++
T Consensus       244 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREGHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44433321100                           0011246778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=1.3e-31  Score=213.04  Aligned_cols=188  Identities=25%  Similarity=0.400  Sum_probs=142.8

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ...++...|+||||+++ +|.+++.....            ....++...++.++.|++.||+|||++|++|+||+|+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            34455678999999985 99999987432            123588999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++++|||.+.........  .....++..|+|||.+.+.. ++.++|+||+|+++|+|++ |..||......
T Consensus       172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999776 8999999998655322111  11222346799999887654 7899999999999999998 88888765543


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +........ ..                          .......+.++.+++++||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~-~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEG-HR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcC-CC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            333322210 00                          00112367889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=2.5e-31  Score=206.23  Aligned_cols=179  Identities=23%  Similarity=0.303  Sum_probs=139.5

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++||||+++ +|.+++..   ....+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++++|||.+
T Consensus        67 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~  142 (257)
T cd05115          67 EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLS  142 (257)
T ss_pred             CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCcc
Confidence            457999999985 99998865   234689999999999999999999999999999999999999766 8999999998


Q ss_pred             ccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      .........   .....++..|+|||.+.... ++.++|+||||+++|++++ |..||......+..........     
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  216 (257)
T cd05115         143 KALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-----  216 (257)
T ss_pred             ccccCCccceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----
Confidence            755432221   11122246799999886544 7889999999999999996 9999987765554433322100     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            .......++++.+++.+||+.+|.+||++.++.+
T Consensus       217 ----------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ----------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0011246789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=1.6e-31  Score=207.45  Aligned_cols=182  Identities=18%  Similarity=0.226  Sum_probs=137.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe---
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---   82 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~---   82 (235)
                      +....++..++||||+++ +|.+++...   ...+++..+..++.||+.||+|||+++++|+||||+||+++.++..   
T Consensus        66 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~  142 (258)
T cd05078          66 GVCVCGDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTG  142 (258)
T ss_pred             eEEEeCCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccC
Confidence            344455678999999985 999998752   2368999999999999999999999999999999999999866532   


Q ss_pred             ----EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHH
Q 026660           83 ----LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT-ALFPGDSELQQLLHI  157 (235)
Q Consensus        83 ----~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~~~~~  157 (235)
                          ++++|||.+.....    .....++..|+|||.+.+...++.++|+||+|+++|++++|. .||.......... .
T Consensus       143 ~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~  217 (258)
T cd05078         143 NPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-F  217 (258)
T ss_pred             CCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-H
Confidence                78999998764432    122355778999999876555788999999999999999985 5554443332221 1


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .....                            ......+.++.+++.+||+.||.+|||++++++.
T Consensus       218 ~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         218 YEDRH----------------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHccc----------------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            11000                            0001244678899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.98  E-value=2.9e-31  Score=206.46  Aligned_cols=180  Identities=24%  Similarity=0.389  Sum_probs=140.7

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|+||||+++ +|.+++.+.  .+..++++.+..++.|++.||++||+.+++|+||+|+||+++.++ .++++|||.+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~  149 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLA  149 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCce
Confidence            447999999985 999999762  344679999999999999999999999999999999999999776 8999999998


Q ss_pred             ccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ......... .....++..|+|||...... ++.++|+||+|+++|++++ |..||.+....+...........      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------  222 (262)
T cd05071         150 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------  222 (262)
T ss_pred             eeccccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC------
Confidence            755432221 12234466799999886544 7899999999999999999 88888776655444333211000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           .....++..+.+++.+|++.+|.+||++.++++
T Consensus       223 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 ---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ---------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                 001246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=1.9e-31  Score=210.90  Aligned_cols=193  Identities=20%  Similarity=0.328  Sum_probs=144.8

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ-------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ...+...++++|++.+ +|.+++.+...       ....+++..++.++.|++.||+|||+.+++|+||+|+||+++..+
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~  167 (296)
T cd05051          88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY  167 (296)
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC
Confidence            3455778999999985 99999977431       123589999999999999999999999999999999999999776


Q ss_pred             CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQQLLH  156 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~  156 (235)
                       .++++|||.+........  ......++..|+|||.+.+.. ++.++|+||+|+++|++++  +..||......+....
T Consensus       168 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05051         168 -TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN  245 (296)
T ss_pred             -ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence             899999999865432211  122334467899999987644 7899999999999999988  7778876655554444


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...........                    .........+.++.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         246 AGHFFRDDGRQ--------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHhcccccccc--------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            33221111000                    000111246788999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.98  E-value=1.6e-31  Score=210.76  Aligned_cols=188  Identities=22%  Similarity=0.357  Sum_probs=143.6

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ--------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGIL   65 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~   65 (235)
                      +..+.+...++++||+. |+|.+++.....                    ....+++..++.++.|++.||+|||+++++
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv  149 (290)
T cd05045          70 GACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV  149 (290)
T ss_pred             EEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34455667899999998 599999876321                    223578999999999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CC
Q 026660           66 HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KT  142 (235)
Q Consensus        66 H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~  142 (235)
                      |+||+|+||+++.++ .++++|||.++.......  ......++..|+|||.+.+.. ++.++|+||||++++++++ |.
T Consensus       150 H~dikp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         150 HRDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             hhhhhhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCC
Confidence            999999999999766 899999999865432221  112233456799999886554 7899999999999999998 99


Q ss_pred             CCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          143 ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       143 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .||.+....+...........                           .....++.++.+++++||+.+|.+||++.+++
T Consensus       228 ~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         228 NPYPGIAPERLFNLLKTGYRM---------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CCCCCCCHHHHHHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            999776654443322211000                           00124678899999999999999999999986


Q ss_pred             C
Q 026660          223 E  223 (235)
Q Consensus       223 ~  223 (235)
                      +
T Consensus       281 ~  281 (290)
T cd05045         281 K  281 (290)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.98  E-value=2.4e-31  Score=207.83  Aligned_cols=184  Identities=18%  Similarity=0.275  Sum_probs=141.2

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ....+++|||+. |+|.+++....  .....++++.+..++.|++.||+|||+++++|+||||+||+++.++ .++++||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df  156 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADF  156 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCC
Confidence            346799999998 59999885421  2234589999999999999999999999999999999999998666 8999999


Q ss_pred             CCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           89 GLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        89 ~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      |.+.........  .....++..|++||...+.. ++.++|+||+|+++|++++ |..||......+..........   
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---  232 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR---  232 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            998765432211  12223466799999987654 7899999999999999999 8889987665544433321100   


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                              .......+..+.++|.+||..||.+|||+.+++++
T Consensus       233 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 ------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    00112466789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=2e-31  Score=207.03  Aligned_cols=187  Identities=25%  Similarity=0.400  Sum_probs=145.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.....+++|||+++ +|.+++.+  ..+..++++.+..++.|++.|+.|||+++++|+||+|+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~  143 (261)
T cd05034          67 YAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCK  143 (261)
T ss_pred             eeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEE
Confidence            3344556778999999985 99999976  3345689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||.+........ .......+..|+|||.+.+.. .+.++|+||+|++++++++ |..||.+...............
T Consensus       144 l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~  222 (261)
T cd05034         144 IADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR  222 (261)
T ss_pred             ECccccceeccchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998876542211 111223356799999987554 7899999999999999998 9999987766555444332111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .+                           .....+.++.+++.+||+.+|.+||+++++.+
T Consensus       223 ~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         223 MP---------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CC---------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            00                           01134678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=2.2e-31  Score=211.42  Aligned_cols=189  Identities=25%  Similarity=0.390  Sum_probs=145.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      +........|++|||+++ +|.+++.+....            ...++...+..++.|++.||.|||++|++|+||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            345566788999999985 999999874221            2357888999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      |+++.++ .++++|||.++........  .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.....
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999766 8999999998765432211  22233456799999987654 7899999999999999998 7888877665


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+..........                           .......+.++++++.+||..+|.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            444443321100                           00112467899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=4.1e-31  Score=204.83  Aligned_cols=181  Identities=24%  Similarity=0.298  Sum_probs=142.9

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++++||++ ++|.+++.+...  ..+++..++.++.|++.||.+||+++++|+||+|+||+++.++ .++++|||.+
T Consensus        68 ~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~  144 (257)
T cd05040          68 HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLM  144 (257)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccc
Confidence            77899999997 599999987322  5689999999999999999999999999999999999999776 9999999998


Q ss_pred             ccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      .........   .....++..|+|||.+.+.. ++.++|+||+||++++|++ |..||......+.........   ...
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~  220 (257)
T cd05040         145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---ERL  220 (257)
T ss_pred             ccccccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CcC
Confidence            766432211   11234567899999886554 7899999999999999998 999997766555444332210   000


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             ......+..+.+++.+|++.+|.+||++.++++
T Consensus       221 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 -----------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                                   001135688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=1.9e-31  Score=209.45  Aligned_cols=188  Identities=21%  Similarity=0.330  Sum_probs=143.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT-----------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~-----------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      +...++...+++|||+++ +|.+++.+....           ...+++..+..++.|++.|++|||+.+++|+||+|+||
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ni  153 (280)
T cd05092          74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNC  153 (280)
T ss_pred             EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhE
Confidence            344556778999999984 999999874311           13478999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++++|||++........  ......++..|+|||.+.+.. ++.++|+|||||++|++++ |..||......
T Consensus       154 l~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         154 LVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             EEcCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            999766 899999998864432211  112223457799999887654 7899999999999999998 89999776655


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +.........  .                         ......+++.+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~~--~-------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         232 EAIECITQGR--E-------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHcCc--c-------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            4443332110  0                         0011246788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.98  E-value=1.7e-31  Score=208.56  Aligned_cols=186  Identities=26%  Similarity=0.363  Sum_probs=140.4

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ..+.+...|++|||++ |+|.+++.....            ....++++.++.++.|++.|++|||+++++|+||+|+||
T Consensus        64 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ni  143 (270)
T cd05047          64 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  143 (270)
T ss_pred             EEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceE
Confidence            4455667899999997 599999976321            123578999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  153 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  153 (235)
                      +++.++ .++++|||++....... .......+..|+|||.+.... ++.++|+||||++++++++ |..||......+.
T Consensus       144 li~~~~-~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~  220 (270)
T cd05047         144 LVGENY-VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  220 (270)
T ss_pred             EEcCCC-eEEECCCCCccccchhh-hccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence            999776 89999999875322111 111122355799999886544 7899999999999999997 9999976554433


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ........   .                        .......+.++.+++.+|+..||.+|||+.++++
T Consensus       221 ~~~~~~~~---~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         221 YEKLPQGY---R------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHhCCC---C------------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            33221100   0                        0001135678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.1e-31  Score=205.61  Aligned_cols=178  Identities=23%  Similarity=0.339  Sum_probs=139.5

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++||||+. |+|.+++.+.    ..+++..++.++.|++.|+++||+.+++|+||+|+||+++.++ .++++|||.+
T Consensus        68 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~  142 (257)
T cd05060          68 EPLMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMS  142 (257)
T ss_pred             CceEEEEEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEecccccc
Confidence            35799999997 4999999762    3689999999999999999999999999999999999999776 8999999998


Q ss_pred             ccccCCCCCc---ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ..........   ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||......+........ ..    
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~----  216 (257)
T cd05060         143 RALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER----  216 (257)
T ss_pred             ceeecCCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc----
Confidence            7654332221   1122245799999986554 7899999999999999998 99999876654433332211 00    


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ......++..+++++.+||+.+|.+||++.++++
T Consensus       217 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 ----------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  0111246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=1.8e-31  Score=209.80  Aligned_cols=188  Identities=19%  Similarity=0.332  Sum_probs=142.9

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ-------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~-------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      ........|++|||+++ +|.+++.....             ....+++..+..++.|++.||+|||+++++|+||+|+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n  154 (283)
T cd05090          75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN  154 (283)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence            34456678999999985 99999864211             12347889999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      |+++.++ .++++|||+++.......  ......++..|+|||.+.+.. ++.++|+||||++++++++ |..||.+...
T Consensus       155 ili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         155 ILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             EEEcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999776 899999999876532211  122333456799999987554 7899999999999999998 8889977654


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...........   .                        ......+++.+.+++.+|++.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~---~------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         233 QEVIEMVRKRQ---L------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHcCC---c------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33333222100   0                        00112467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=3.8e-31  Score=209.29  Aligned_cols=193  Identities=20%  Similarity=0.281  Sum_probs=142.6

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT-------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ...++..+++|||+++ +|.+++.+....       ...+++..+..++.|++.|++|||+.+++|+||||+||+++.++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~  167 (296)
T cd05095          88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY  167 (296)
T ss_pred             EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC
Confidence            3455668999999984 999999874322       12477889999999999999999999999999999999999666


Q ss_pred             CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQQLLH  156 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~  156 (235)
                       .++++|||.+........  .......+..|++||...+.. ++.++|+||+||++|++++  |..||......+....
T Consensus       168 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05095         168 -TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN  245 (296)
T ss_pred             -CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence             899999999875532211  122233356799999876554 8899999999999999998  7788876665554433


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...........                    .........++.+.+++.+||+.||.+||++.++++
T Consensus       246 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         246 TGEFFRDQGRQ--------------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHhhcccc--------------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22211100000                    000111246688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=4.5e-33  Score=222.34  Aligned_cols=221  Identities=30%  Similarity=0.528  Sum_probs=166.6

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ++-+|.-++|+|+|||.+.-+|...|.+++.. -.+....+..++.|+..||..|-..|++|+||||+|||++.....++
T Consensus       499 l~r~F~hknHLClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HHHHhhhcceeEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence            44567778999999999999999999998654 46889999999999999999999999999999999999998877889


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||||.+......  ..+...-+..|+|||++.+.. |....|+||.||++|++++|+..|++.++.+.+...+..-+..
T Consensus       578 LCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASEN--EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCccccccccc--cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            9999988655432  222223356799999999876 8999999999999999999999999998888877777665554


Q ss_pred             CCCCccc------ccc-cccc--cCCC------------CCCc-cchhhcC---CCCC-------hhHHHHHHHhcccCC
Q 026660          165 NEKVWPG------VSS-LMNW--HEYP------------QWNP-QSLATAV---PNLD-------KDGLDLLEQMLQYDP  212 (235)
Q Consensus       165 ~~~~~~~------~~~-~~~~--~~~~------------~~~~-~~~~~~~---~~~~-------~~~~~li~~~l~~~p  212 (235)
                      +..+...      ... ..++  .+..            ...+ ..+....   +.++       .++++|+.+||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            4332211      000 0000  0000            0011 1111111   1122       467899999999999


Q ss_pred             CCCCCHHHHhCCCCCCC
Q 026660          213 SKRISAKKAMEHPYFDD  229 (235)
Q Consensus       213 ~~Rps~~~ll~hp~f~~  229 (235)
                      .+|.|..++|.||||+.
T Consensus       735 ~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  735 EKRITVNQALKHPFITE  751 (752)
T ss_pred             hhcCCHHHHhcCCcccC
Confidence            99999999999999973

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=5.1e-31  Score=204.28  Aligned_cols=183  Identities=24%  Similarity=0.379  Sum_probs=143.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+....|+||||+++ +|.+++...  ....+++..++.++.|++.|+.|||+++++|+||+|+||+++.++ .+++
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l  143 (256)
T cd05039          67 GVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKV  143 (256)
T ss_pred             EEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEE
Confidence            334456778999999985 999999763  233689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.++.......   ....+..|+|||.+.... ++.++|+||+|++++++++ |..||......+..........  
T Consensus       144 ~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--  217 (256)
T cd05039         144 SDFGLAKEASQGQD---SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--  217 (256)
T ss_pred             cccccccccccccc---cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--
Confidence            99999876532221   223356799999886544 7889999999999999997 9999977665443332221000  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                               .......++++.++|++||..+|.+|||+.++++
T Consensus       218 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         218 -------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                                     0001236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=2.9e-31  Score=206.45  Aligned_cols=181  Identities=17%  Similarity=0.258  Sum_probs=136.4

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC-----
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-----   81 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~-----   81 (235)
                      ...++...+++|||+++ +|..++..   ....+++..++.++.||+.||+|||+++++|+||+|+||+++.++.     
T Consensus        72 ~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~  148 (262)
T cd05077          72 VCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG  148 (262)
T ss_pred             EEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCC
Confidence            33455677999999985 88877754   2346899999999999999999999999999999999999975542     


Q ss_pred             -eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHH
Q 026660           82 -TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        82 -~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~  159 (235)
                       .++++|||.+......    ....++..|+|||.+.....++.++||||+||++|+++ .|..||......+.. ....
T Consensus       149 ~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~  223 (262)
T cd05077         149 PFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE  223 (262)
T ss_pred             ceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh
Confidence             2899999987644321    23345778999998865555889999999999999998 588887665432221 1111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .   ..                         ......+.++.+++++||+.||.+||++.+++++
T Consensus       224 ~---~~-------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         224 G---QC-------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c---Cc-------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            0   00                         0001234678899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=221.55  Aligned_cols=181  Identities=22%  Similarity=0.320  Sum_probs=148.3

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ......|||||||. |-|...|+.    ++.+.......|..+|+.|+.|||.+.|+|||||..||||+.+. .+||+||
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDF  256 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDF  256 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccc
Confidence            34567899999998 788888865    66799999999999999999999999999999999999999776 9999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.++......+ .-.+.||..|||||++.... .+.|+||||||||+|||++|..||.+-.....+...-          
T Consensus       257 GTS~e~~~~ST-kMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG----------  324 (904)
T KOG4721|consen  257 GTSKELSDKST-KMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG----------  324 (904)
T ss_pred             cchHhhhhhhh-hhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEecc----------
Confidence            99987765533 33568899999999998655 7899999999999999999999998765433322110          


Q ss_pred             cccccccccccCCCCCCccchhh-cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                       .-.+.. .....++-++=||+.||+-.|..|||+.+++.|
T Consensus       325 -----------------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  325 -----------------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             -----------------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                             011111 122577888899999999999999999999988

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=229.11  Aligned_cols=200  Identities=29%  Similarity=0.394  Sum_probs=151.2

Q ss_pred             cccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC---
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK---   79 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~---   79 (235)
                      |.++....+.+.+||..|.|.++|.++++...........-..+.++.|++.||++||+.+++||||||.|||++..   
T Consensus       566 iRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~  645 (903)
T KOG1027|consen  566 IRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSAD  645 (903)
T ss_pred             EEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCC
Confidence            34566677889999999999999999998831111112225678899999999999999999999999999999862   


Q ss_pred             C-CeEEEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 026660           80 T-MTLKIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQL  154 (235)
Q Consensus        80 ~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~  154 (235)
                      + ..++|+|||+++++.....   ......||-+|+|||++.... .+.++||||+||++|+.++| ..||+.....  .
T Consensus       646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~  722 (903)
T KOG1027|consen  646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--Q  722 (903)
T ss_pred             cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--h
Confidence            2 4789999999998865543   345567899999999998665 56799999999999999885 9999775431  1


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .++...                         ...+....+....++.+||.+|+.++|..||+|.++|+||||=+.
T Consensus       723 ~NIl~~-------------------------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  723 ANILTG-------------------------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             hhhhcC-------------------------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            222110                         001111111122278899999999999999999999999998543

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=5.3e-31  Score=208.37  Aligned_cols=195  Identities=20%  Similarity=0.292  Sum_probs=143.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD   77 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~--------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~   77 (235)
                      +....+...++||||+++ +|.+++.....        ....+++..++.++.|++.||.|||+++++|+||+|+||+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            344566778999999985 99999965321        112468899999999999999999999999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQQ  153 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~  153 (235)
                      .++ .++++|||++........  ......++..|+|||.+.+.. ++.++|+||||++++++++  +..||......+.
T Consensus       164 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         164 NHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            666 899999999865432211  122234466899999887655 7899999999999999988  6778877655444


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...............                    .....+..++.+++++++|++.||.+|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQI--------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccc--------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            443322111100000                    00112236788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.1e-31  Score=204.10  Aligned_cols=183  Identities=24%  Similarity=0.455  Sum_probs=144.5

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ...+++++||++| +|.+++.+    ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++++|||.
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            4568999999985 99999875    23588999999999999999999999999999999999999766 899999999


Q ss_pred             cccccCCC---CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.......   .......++..|+|||.+.+.. .+.++|+||+|++++++++|..||......+...+..   ..+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~  228 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP  228 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC
Confidence            87553211   1122345678899999987644 7899999999999999999999998765544433322   111111


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .                       ....+++++.+++++|+. +|..||++.++++|||.
T Consensus       229 ~-----------------------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         229 M-----------------------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             C-----------------------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            0                       112467889999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=6.7e-31  Score=204.92  Aligned_cols=185  Identities=19%  Similarity=0.302  Sum_probs=142.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+.+..|+||||+++ +|.+++.+   ....+++..+..++.|++.|++|||+.+++|+||+|+||+++.++ .+++
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl  148 (268)
T cd05063          73 GVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKV  148 (268)
T ss_pred             EEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEE
Confidence            344566778999999985 99999865   234689999999999999999999999999999999999999766 8999


Q ss_pred             eecCCcccccCCCCCcc---cccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +|||.+...........   ....+..|+|||.+.... ++.++|+||+|+++|++++ |..||......+....+....
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~  227 (268)
T cd05063         149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF  227 (268)
T ss_pred             CCCccceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC
Confidence            99999875543222111   112245699999987654 7899999999999999987 999997766554444332210


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..+                           .....+.++.+++.+|++.+|.+||++.++++
T Consensus       228 ~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         228 RLP---------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000                           01135688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=7.8e-31  Score=204.59  Aligned_cols=189  Identities=25%  Similarity=0.357  Sum_probs=143.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ---TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--   80 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--   80 (235)
                      +....+...++||||+++ +|.+++.+...   ....+++..+..++.|++.|++|||+.+++|+||+|+||+++.++  
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~  145 (269)
T cd05044          66 GVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD  145 (269)
T ss_pred             eeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCC
Confidence            344566679999999985 99999976432   224478999999999999999999999999999999999998543  


Q ss_pred             --CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026660           81 --MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  155 (235)
Q Consensus        81 --~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  155 (235)
                        ..++++|||++........  ......++..|+|||.+.+.. .+.++|+||||+++|++++ |..||......+...
T Consensus       146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~  224 (269)
T cd05044         146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ  224 (269)
T ss_pred             CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH
Confidence              2689999998865432211  112234467899999987655 7899999999999999998 999998776554433


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ......                           ........++.+.+++.+||..+|.+||+++++++
T Consensus       225 ~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         225 HVTAGG---------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHhcCC---------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            321100                           00011246788999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=8.3e-31  Score=202.32  Aligned_cols=184  Identities=21%  Similarity=0.355  Sum_probs=141.4

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ........++||||+++ +|.+++...   ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++
T Consensus        60 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~  135 (250)
T cd05085          60 VCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKIS  135 (250)
T ss_pred             EEecCCccEEEEECCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEEC
Confidence            34556678999999985 999988652   23578999999999999999999999999999999999999766 89999


Q ss_pred             ecCCcccccCCCCCc-ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           87 DLGLARAFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        87 df~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |||.+.......... ....++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||.................. 
T Consensus       136 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-  213 (250)
T cd05085         136 DFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-  213 (250)
T ss_pred             CCccceeccccccccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999886543221111 1123355799999986544 7899999999999999998 99999876554433332211000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                ......+.++.+++.+|++.+|.+||++.++++
T Consensus       214 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         214 --------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                      001236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=8.5e-31  Score=202.92  Aligned_cols=187  Identities=25%  Similarity=0.373  Sum_probs=144.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+.+..|++||++++ +|.+++....  ...+++..+..++.|++.|+++||+.+++|+||+|+||+++.++ .++
T Consensus        67 ~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~  143 (258)
T smart00219       67 LGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVK  143 (258)
T ss_pred             EEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEE
Confidence            3444555789999999985 9999997632  22289999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcc-cccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIKKYT-HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||.+........... ...++..|+|||...+.. ++.++|+||+|++++++++ |..||.................
T Consensus       144 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~  222 (258)
T smart00219      144 ISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR  222 (258)
T ss_pred             EcccCCceecccccccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999876554312111 223567899999985444 7899999999999999998 7888877655444443322110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                           ......+.++.+++.+|++.||.+|||+.++++
T Consensus       223 ~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 L---------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             C---------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            0                           001136788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=6e-31  Score=203.22  Aligned_cols=184  Identities=23%  Similarity=0.350  Sum_probs=140.9

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ...+..+.++||||++| +|.+++.+.   ...+++..+..++.|++.|+++||+++++|+||+|+||+++.++ .++++
T Consensus        60 ~~~~~~~~~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~  135 (251)
T cd05041          60 VCVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKIS  135 (251)
T ss_pred             EEecCCCeEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEe
Confidence            34566778999999975 999998762   33688999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCCc--ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           87 DLGLARAFTLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        87 df~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      |||.+..........  .....+..|+|||.+.+.. ++.++|+||+|++++++++ |..||..................
T Consensus       136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~  214 (251)
T cd05041         136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM  214 (251)
T ss_pred             eccccccccCCcceeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC
Confidence            999886543211111  1122245699999987554 7899999999999999998 88888776554333322211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +                           .....+.++.+++.+||..+|.+||++.++++
T Consensus       215 ~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 P---------------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             C---------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            0                           01135678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=7.2e-31  Score=204.89  Aligned_cols=193  Identities=22%  Similarity=0.289  Sum_probs=140.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~-~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +........|+||||+++ +|.+++.+.... ....++..+..++.||+.|++|||+++++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~k  140 (269)
T cd05042          62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVK  140 (269)
T ss_pred             EEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEE
Confidence            344556779999999985 999999874322 23356788999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC--CcccccccccccCchhhhC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026660           85 IADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  155 (235)
Q Consensus        85 l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  155 (235)
                      ++|||.+........  ......++..|+|||++..      ....+.++|+||+||++|++++ |..||....+.+...
T Consensus       141 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~  220 (269)
T cd05042         141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK  220 (269)
T ss_pred             EeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            999998864322111  1122334567999999753      2336789999999999999999 788888776655444


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ............                      ......+++.+.+++..|+ .||.+|||++++++
T Consensus       221 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         221 QVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            332211100000                      0111246788889999998 49999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=9e-31  Score=204.55  Aligned_cols=186  Identities=19%  Similarity=0.286  Sum_probs=143.1

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +.....++++||++ |+|.+++....  .....+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++++
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~  155 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVA  155 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEEC
Confidence            44456899999998 59999986642  2234689999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           87 DLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        87 df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      |||.++........  .....++..|++||.+.+.. ++.++|+||+||++|++++ |..||.+....+.........  
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--  232 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--  232 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--
Confidence            99998755432211  11123356799999886544 7899999999999999999 889997766555443332210  


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                       .                        .......++++.+++++||+.||.+|||+.+++++
T Consensus       233 -~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -R------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -C------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             0                        00112467889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=1.3e-30  Score=204.59  Aligned_cols=179  Identities=19%  Similarity=0.245  Sum_probs=138.0

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++++||++ |+|.+++...   ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++++|||.+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~  156 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVA  156 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccc
Confidence            34688999997 5999999752   34689999999999999999999999999999999999999766 8999999998


Q ss_pred             ccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           92 RAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        92 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      +.......  ......++..|++||.+.+.. ++.++|+||+|+++|++++ |..||.+............. ..+.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~---  231 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLA---  231 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC---
Confidence            75532221  122334567899999987554 7899999999999999998 99999776543322222110 0000   


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             .....+.++.+++.+|+..||.+|||+.++++
T Consensus       232 -----------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 -----------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                   00124567889999999999999999999865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=6.7e-31  Score=204.88  Aligned_cols=185  Identities=19%  Similarity=0.295  Sum_probs=143.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..++++..|+||||++| +|.+++.+.   ...+++..+..++.|++.|+++||+++++|+||+|+||+++.++ .+++
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l  147 (267)
T cd05066          72 GVVTKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKV  147 (267)
T ss_pred             EEEecCCccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEe
Confidence            344566789999999985 999999762   34689999999999999999999999999999999999998766 8999


Q ss_pred             eecCCcccccCCCCCc---ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +|||.+..........   ....++..|++||.+.+.. ++.++|+||+|++++++++ |..||......+....+.+..
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~  226 (267)
T cd05066         148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY  226 (267)
T ss_pred             CCCCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC
Confidence            9999987654332211   1122245799999987644 7899999999999999886 999998766544433332110


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..                           ......++.+.+++.+|++.+|.+||++.++++
T Consensus       227 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 RL---------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             cC---------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            00                           001236788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=8.1e-31  Score=206.58  Aligned_cols=188  Identities=20%  Similarity=0.297  Sum_probs=142.4

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceec
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHR   67 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~   67 (235)
                      +..+.....|++|||+++ +|.+++.....                  ....+++..++.++.|++.||.+||+++++|+
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~  154 (288)
T cd05050          75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR  154 (288)
T ss_pred             EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            344556678999999985 99999976321                  12347888999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 026660           68 DLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTAL  144 (235)
Q Consensus        68 di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  144 (235)
                      ||+|+||+++.++ .++++|||.+........  .......+..|+|||.+.+.. ++.++|+||+||++|+|++ |..|
T Consensus       155 dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p  232 (288)
T cd05050         155 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQP  232 (288)
T ss_pred             cccHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999776 899999998865432211  112223356799999887654 8899999999999999997 8888


Q ss_pred             CCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          145 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       145 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      |.+....+.........                           ........+.++.+++.+||+.+|.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         233 YYGMAHEEVIYYVRDGN---------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCHHHHHHHHhcCC---------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            87665544433322100                           00011236788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=7.5e-31  Score=210.98  Aligned_cols=188  Identities=25%  Similarity=0.393  Sum_probs=143.8

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      ....+..+++++||+++ +|.+++.....            ....++...+..++.|++.||+|||++|++|+||+|+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            34456678999999985 99999976421            123478889999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++++|||.++........  .....++..|+|||.+.+.. ++.++|+||+|+++|+|++ |..||......
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999776 8999999998755432111  11223346799999987654 7889999999999999998 88888876655


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +..........                           .......+.++.+++++||..+|.+||++.+++++
T Consensus       244 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGHR---------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            54443321100                           00112466789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=8.8e-31  Score=205.04  Aligned_cols=180  Identities=19%  Similarity=0.278  Sum_probs=136.1

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC------C
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT------M   81 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~------~   81 (235)
                      ..++...++||||+++ +|..++.+   ..+.+++..+..++.|++.||+|||+++++|+||||+||+++..+      .
T Consensus        85 ~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          85 CVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            3455678999999985 88888864   234689999999999999999999999999999999999997532      1


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      .++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||......+.... ...
T Consensus       162 ~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~  236 (274)
T cd05076         162 FIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEK  236 (274)
T ss_pred             eeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHh
Confidence            4799999987543221    12245677999998876555789999999999999985 68999876554332221 110


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...                            .....++++.++|.+||+.+|.+|||+.+++++
T Consensus       237 ~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 KHR----------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ccC----------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            000                            001234678899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4e-33  Score=241.85  Aligned_cols=193  Identities=28%  Similarity=0.459  Sum_probs=154.1

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +++..=....++|.||||. |+|.+.++.    ++..++.....+..|++.|++|||+.|+|||||||.||+++..+ .+
T Consensus      1299 YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~i 1373 (1509)
T KOG4645|consen 1299 YYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LI 1373 (1509)
T ss_pred             cCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cE
Confidence            4444444566889999998 599999976    55688889999999999999999999999999999999999777 99


Q ss_pred             EEeecCCcccccCCCC----CcccccccccccCchhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLH  156 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~  156 (235)
                      |++|||.+.++.....    ......||+.|||||++.+..  .-..+.||||||||+.||+||+.||... ++.+.+..
T Consensus      1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred             EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence            9999999988775542    233557899999999998532  3457899999999999999999999764 44444443


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .... ..|.                          ....++++.+++|..||..||++|.++.|+++|.|=+.
T Consensus      1454 V~~g-h~Pq--------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1454 VAAG-HKPQ--------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             Hhcc-CCCC--------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            3221 1110                          01137789999999999999999999999999998653

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.2e-30  Score=202.03  Aligned_cols=176  Identities=24%  Similarity=0.366  Sum_probs=138.4

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..|++|||+++ +|.+++...  ....+++..++.++.|++.|+.+||++|++|+||+|+||+++.++ .++++|||.+.
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccce
Confidence            36999999985 999999763  334689999999999999999999999999999999999999776 89999999886


Q ss_pred             cccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           93 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        93 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      .....   ......+..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+...........        
T Consensus       149 ~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------  216 (254)
T cd05083         149 VGSMG---VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------  216 (254)
T ss_pred             ecccc---CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------
Confidence            54322   11223356799999886544 7899999999999999998 99999876654443332211000        


Q ss_pred             ccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          172 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                         .....+++.+.+++++||+.+|.+||++++++.
T Consensus       217 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         217 -------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               001246788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.2e-30  Score=204.65  Aligned_cols=178  Identities=21%  Similarity=0.281  Sum_probs=138.1

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++++||++ |+|.+++...   ...++++.++.++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||+++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~  157 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLAR  157 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCcee
Confidence            4679999998 5999998652   34689999999999999999999999999999999999998666 89999999987


Q ss_pred             cccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           93 AFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        93 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........  .....++..|+|||...+.. ++.++|+|||||++|++++ |..||............... ..+     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----  230 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL-----  230 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC-----
Confidence            66432221  11123356799999987554 7899999999999999998 88998776554433322211 000     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+.++.+++.+||..||.+||++.+++.
T Consensus       231 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 ---------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 011236778999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.2e-30  Score=202.14  Aligned_cols=186  Identities=22%  Similarity=0.352  Sum_probs=142.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+.....|++|||+.+ +|.+++...   ...++++.++.++.|++.|+++||+.+++|+||+|+||+++.++ .+++
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l  141 (256)
T cd05112          66 GVCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKV  141 (256)
T ss_pred             EEEccCCceEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEE
Confidence            344566678999999985 999888652   23588999999999999999999999999999999999999666 8999


Q ss_pred             eecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+......... .....++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||..................
T Consensus       142 ~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05112         142 SDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL  220 (256)
T ss_pred             CCCcceeecccCcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC
Confidence            999988654332111 11223356799999887544 7889999999999999998 99999876654444433211000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .                           .....+..+.+++++||..+|.+|||+.+++++
T Consensus       221 ~---------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         221 Y---------------------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             C---------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            0                           001246788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=1.1e-30  Score=213.89  Aligned_cols=157  Identities=22%  Similarity=0.371  Sum_probs=119.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++++|||+++.......  ......++..|+|||.+
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  311 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI  311 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence            478888999999999999999999999999999999999766 899999999876543222  12233456789999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++||||||++++++++ |..||..................                          ......
T Consensus       312 ~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~  364 (400)
T cd05105         312 FDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR--------------------------MAKPDH  364 (400)
T ss_pred             cCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC--------------------------CCCCcc
Confidence            7654 7899999999999999997 88998765432222221110000                          001124


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ++.++.+++.+||+.||.+||++.++.+
T Consensus       365 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         365 ATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            6788999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.8e-30  Score=202.62  Aligned_cols=193  Identities=20%  Similarity=0.286  Sum_probs=140.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+....|+||||+++ +|.+++.+........+...++.++.||+.||+|||+.+++|+||+|+||+++.++ .+++
T Consensus        62 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l  140 (268)
T cd05086          62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKV  140 (268)
T ss_pred             EEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEe
Confidence            344556678999999985 99999987443444577888899999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCC--CCcccccccccccCchhhhCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026660           86 ADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGS------THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  156 (235)
Q Consensus        86 ~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  156 (235)
                      +|||.+.......  .......++..|+|||+....      ...+.++|+||+|+++|++++ |..||......+....
T Consensus       141 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  220 (268)
T cd05086         141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH  220 (268)
T ss_pred             cccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999875322111  112234567889999987431      124678999999999999997 5678877666555444


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .......  ....                    ......+++.+.++++.|+ .+|.+||+++++++
T Consensus       221 ~~~~~~~--~~~~--------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         221 VIKDQQV--KLFK--------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHhhccc--ccCC--------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            3321110  0000                    0001136788899999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=202.99  Aligned_cols=194  Identities=24%  Similarity=0.408  Sum_probs=158.2

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      +..+..+++|.||.+| +|.-+++.    .++++++.+..+...|+.||.|||++|++++|+|.+|+|++..+ .+++.|
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltd  394 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTD  394 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecc
Confidence            4567789999999985 98877755    46799999999999999999999999999999999999999888 999999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC---C----CCHHHHHHHHHHH
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP---G----DSELQQLLHIFRL  160 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~---~----~~~~~~~~~~~~~  160 (235)
                      +|+++....+....+.+.||+.|+|||++.+.. |+...|.|+||+++++|+.|+.||.   .    .+.++.+.++.  
T Consensus       395 ygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--  471 (593)
T KOG0695|consen  395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--  471 (593)
T ss_pred             cchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--
Confidence            999987766667778899999999999998766 8999999999999999999999995   1    12233322211  


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC------CHHHHhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI------SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~ll~hp~f~~~~~~~  234 (235)
                       -..                        .......+|-....+++..|+.||++|.      .+.++..||||+.++|+-
T Consensus       472 -lek------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  472 -LEK------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             -hhh------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence             000                        0011112445566899999999999996      478999999999999975


Q ss_pred             C
Q 026660          235 L  235 (235)
Q Consensus       235 ~  235 (235)
                      |
T Consensus       527 l  527 (593)
T KOG0695|consen  527 L  527 (593)
T ss_pred             H
Confidence            3

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2e-30  Score=201.55  Aligned_cols=181  Identities=23%  Similarity=0.338  Sum_probs=135.9

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .++..++++||+. |+|.+++.+.   ....+...+..++.|++.||+|||+.+++|+||+|+||+++.++ .++++|||
T Consensus        68 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg  143 (262)
T cd05058          68 SEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFG  143 (262)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCcc
Confidence            3456789999998 5999999762   23467788899999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCC----CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCC
Q 026660           90 LARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        90 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      .++......    .......++..|+|||.+.+.. ++.++|+||||++++++++| ..||......+......... .+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~  221 (262)
T cd05058         144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RL  221 (262)
T ss_pred             ccccccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CC
Confidence            986543211    1112233466799999887554 78999999999999999995 55666554443332221100 00


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                ......++.+.+++.+||..+|.+||++.++++
T Consensus       222 --------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 --------------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             --------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                      001135678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.5e-30  Score=203.74  Aligned_cols=190  Identities=21%  Similarity=0.303  Sum_probs=144.7

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG-----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ....+....|+||||++ |+|.+++.......     ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~  154 (275)
T cd05046          75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR  154 (275)
T ss_pred             EEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC
Confidence            34556677899999998 59999998743222     2589999999999999999999999999999999999999776


Q ss_pred             CeEEEeecCCcccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF  158 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  158 (235)
                       .++++|||.+....... .......++..|+|||.+.+.. .+.++|+||+|++++++++ |..||......+......
T Consensus       155 -~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         155 -EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             -cEEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence             89999999876433211 1222334567799999887554 6889999999999999998 788987655544333322


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...  ..                        ......++..+.+++.+||+.+|.+||++.+++++
T Consensus       233 ~~~--~~------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         233 AGK--LE------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cCC--cC------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            110  00                        00012467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=219.31  Aligned_cols=192  Identities=21%  Similarity=0.268  Sum_probs=149.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ++...-.+..+.||+..|+| +|..+++-.   ..++.....+.|+.|+++|+.|||.++|+|+|||..||++.+++ .|
T Consensus       452 LFMG~~~~p~~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kV  527 (678)
T KOG0193|consen  452 LFMGACMNPPLAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KV  527 (678)
T ss_pred             eeehhhcCCceeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cE
Confidence            34444455566999999998 999999763   25688999999999999999999999999999999999999776 99


Q ss_pred             EEeecCCcccccCC--CCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|+|||++..-..-  ........+...|+|||++.-  ...++..+||||||+++|||++|..||......+.+.+.-+
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr  607 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR  607 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc
Confidence            99999998543322  223445667889999999863  34589999999999999999999999995444333332222


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..                       -.........+.+.++++|+..|+.+++.+||.+.+|+.
T Consensus       608 G~-----------------------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  608 GY-----------------------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cc-----------------------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            11                       112233334467789999999999999999999998876

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.2e-30  Score=208.25  Aligned_cols=179  Identities=22%  Similarity=0.317  Sum_probs=138.4

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++++||+. |+|.+++...   ...++...++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||+++
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~  157 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAK  157 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccc
Confidence            3579999997 5999998762   34588999999999999999999999999999999999999766 89999999997


Q ss_pred             cccCCCCCc--ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           93 AFTLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        93 ~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      .........  .....+..|++||.+.+.. ++.++|+||||+++|++++ |..||.+....+... ........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-----  230 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERL-----  230 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCC-----
Confidence            665332221  1222356799999987554 7899999999999999987 999998765444322 22110000     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                           ......+.++.+++.+|+..+|.+||++.+++.+
T Consensus       231 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ---------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                 0011356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=2.6e-30  Score=201.75  Aligned_cols=193  Identities=22%  Similarity=0.249  Sum_probs=139.5

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +..++....++||||++ |+|.+++.+.... ....+...+..++.|++.|++|||+.+++|+||||+||+++.++ .++
T Consensus        62 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~k  140 (269)
T cd05087          62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVK  140 (269)
T ss_pred             EEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEE
Confidence            34455667899999998 5999999774332 23456778889999999999999999999999999999999766 899


Q ss_pred             EeecCCcccccCCCC--CcccccccccccCchhhhCCC------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026660           85 IADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGST------HYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  155 (235)
Q Consensus        85 l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  155 (235)
                      ++|||.+........  ......++..|+|||++.+..      .++.++|+||+|++++++++ |..||......+...
T Consensus       141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  220 (269)
T cd05087         141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT  220 (269)
T ss_pred             ECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence            999998864332211  112234567799999986321      24789999999999999996 999998766544433


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ............                      .......++.+.++++.|+ .+|.+|||+++++.
T Consensus       221 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         221 YTVREQQLKLPK----------------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHhhcccCCCCC----------------------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            221110000000                      0001135677889999998 58999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.1e-30  Score=205.44  Aligned_cols=194  Identities=21%  Similarity=0.325  Sum_probs=138.6

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...+|++|||+++ +|.+++..     ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++++|||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg  152 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFG  152 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecc
Confidence            45678999999985 99999865     2589999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+.........   .....++..|+|||...+.. .+.++|+||||++++++++|..||......  ..........  .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~--~  227 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQG--Q  227 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccc--c
Confidence            98765432211   11223355699999886544 789999999999999999999998654321  0011100000  0


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...........        ..........++.++.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         228 MTVVRLIELLE--------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cchhhhhhhhh--------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00000000000        00000112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1.9e-30  Score=201.52  Aligned_cols=180  Identities=23%  Similarity=0.391  Sum_probs=139.8

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...+++|||++ ++|.+++.+  ..+..++...+..++.|++.||.+||+.+++|+||+|+||+++..+ .++++|||.+
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~  149 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLA  149 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcce
Confidence            55799999997 499999977  3345688899999999999999999999999999999999999776 8999999988


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........ ......++..|+|||.+.... ++.++|+||+|++++++++ |..||..................      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------  222 (260)
T cd05073         150 RVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------  222 (260)
T ss_pred             eeccCCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC------
Confidence            65432211 112223456799999986544 7889999999999999998 89999876654444332211000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+.++.+++.+|+..+|.+||++.++++
T Consensus       223 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ---------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 011246788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=2.1e-30  Score=203.36  Aligned_cols=184  Identities=20%  Similarity=0.324  Sum_probs=142.4

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTG----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~----~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ++...++++||++ |+|.+++.......    ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .+++
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEE
Confidence            3566899999998 59999997743321    4689999999999999999999999999999999999998766 8999


Q ss_pred             eecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           86 ADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        86 ~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|||+++.+......  .....++..|+|||.+.+.. ++.++||||+|++++++++ |..||......+..........
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence            999998755322111  11223456799999987554 7899999999999999998 9999987665443332221100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                           .....+++++.+++++|+..||++|||+.++++
T Consensus       238 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 L---------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C---------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                           001135788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3.2e-31  Score=234.24  Aligned_cols=186  Identities=17%  Similarity=0.243  Sum_probs=134.8

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-----------
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-----------   80 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-----------   80 (235)
                      ...++.++|+++++|.+++.+   ....+++..++.++.||+.||+|||++|++||||||+|||++..+           
T Consensus        52 ~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~  128 (793)
T PLN00181         52 DDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCS  128 (793)
T ss_pred             cchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccC
Confidence            356788999998999999964   234699999999999999999999999999999999999996432           


Q ss_pred             -------CeEEEeecCCcccccCCC----------------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHH
Q 026660           81 -------MTLKIADLGLARAFTLPI----------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE  137 (235)
Q Consensus        81 -------~~~~l~df~~~~~~~~~~----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~  137 (235)
                             ..++++|||+++......                .......+|+.|+|||++.+.. ++.++||||+||++||
T Consensus       129 ~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGviL~E  207 (793)
T PLN00181        129 DSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVLLFE  207 (793)
T ss_pred             cccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHHHHH
Confidence                   245666666664321100                0011234688899999987655 7899999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC
Q 026660          138 LVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS  217 (235)
Q Consensus       138 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  217 (235)
                      |++|..|+.....  .......... ++..                          ....++..+++.+||..+|.+||+
T Consensus       208 Ll~~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        208 LFCPVSSREEKSR--TMSSLRHRVL-PPQI--------------------------LLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             HhhCCCchhhHHH--HHHHHHHhhc-Chhh--------------------------hhcCHHHHHHHHHhCCCChhhCcC
Confidence            9998877653221  1111111100 0000                          011245568999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 026660          218 AKKAMEHPYFDDL  230 (235)
Q Consensus       218 ~~~ll~hp~f~~~  230 (235)
                      +.++++||||...
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999764

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=1.7e-30  Score=225.88  Aligned_cols=189  Identities=23%  Similarity=0.341  Sum_probs=140.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT-------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR   78 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~   78 (235)
                      +..++++..|++|||++| +|.+++.+....       ....+...++.++.||+.||+|||++|++||||||+||+++.
T Consensus        69 ~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~  148 (932)
T PRK13184         69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL  148 (932)
T ss_pred             EEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC
Confidence            344567789999999985 999999764322       233566788999999999999999999999999999999997


Q ss_pred             CCCeEEEeecCCcccccCCC------------------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh
Q 026660           79 KTMTLKIADLGLARAFTLPI------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT  140 (235)
Q Consensus        79 ~~~~~~l~df~~~~~~~~~~------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~  140 (235)
                      .+ .++++|||++.......                  .......||+.|+|||.+.+.. ++.++|+||+||++++|++
T Consensus       149 dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLT  226 (932)
T PRK13184        149 FG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLT  226 (932)
T ss_pred             CC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHH
Confidence            76 89999999987552110                  0112346899999999987655 7899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH
Q 026660          141 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK  220 (235)
Q Consensus       141 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  220 (235)
                      |..||...........  .....+                       ........+++.+.+++.+||..||.+||+..+
T Consensus       227 G~~PF~~~~~~ki~~~--~~i~~P-----------------------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e  281 (932)
T PRK13184        227 LSFPYRRKKGRKISYR--DVILSP-----------------------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ  281 (932)
T ss_pred             CCCCCCCcchhhhhhh--hhccCh-----------------------hhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999976443222111  000000                       000112257788999999999999999987554


Q ss_pred             Hh
Q 026660          221 AM  222 (235)
Q Consensus       221 ll  222 (235)
                      .+
T Consensus       282 eL  283 (932)
T PRK13184        282 EL  283 (932)
T ss_pred             HH
Confidence            43

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=3.6e-30  Score=201.02  Aligned_cols=179  Identities=21%  Similarity=0.327  Sum_probs=139.8

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|+||||++ |+|.+++.+.   ...+++..++.++.|++.||+|||+.+++|+||+|+||+++..+ .++++|||.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCcee
Confidence            44689999998 4999999762   33589999999999999999999999999999999999999766 8999999988


Q ss_pred             ccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ......... .....++..|+|||.+.... ++.++|+||||++++++++ |..||......+...........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------  227 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------  227 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence            755433211 11223346799999886544 7899999999999999886 99999877665544433211000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+.++.+++.+|+..+|.+|||+.+++.
T Consensus       228 ---------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         228 ---------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=217.54  Aligned_cols=197  Identities=27%  Similarity=0.385  Sum_probs=162.3

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--Ce
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~   82 (235)
                      ..-.+|....+++|||-+.||.+.+|-+  +..+.+++...+.++.||+.||+|||-++++|+|+||+|||+....  -.
T Consensus       628 le~M~ET~ervFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQ  705 (888)
T KOG4236|consen  628 LECMFETPERVFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQ  705 (888)
T ss_pred             EEEeecCCceEEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCc
Confidence            4456889999999999999999998877  5667899999999999999999999999999999999999997543  26


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|++|||+++..+.... .....||+.|.|||++.... +...-|+||.|+++|--++|..||..+.+..  .++.+...
T Consensus       706 vKlCDFGfARiIgEksF-RrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaF  781 (888)
T KOG4236|consen  706 VKLCDFGFARIIGEKSF-RRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAF  781 (888)
T ss_pred             eeeccccceeecchhhh-hhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchh--HHhhcccc
Confidence            89999999998875433 34568899999999998655 8899999999999999999999998765422  22222111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      -.+..                        .+.+++++..+||..+|+..=.+|.|.+..+.|||++++.
T Consensus       782 MyPp~------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  782 MYPPN------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             ccCCC------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            11111                        2235888999999999999999999999999999999864

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=3.6e-30  Score=200.91  Aligned_cols=185  Identities=18%  Similarity=0.297  Sum_probs=141.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...++||||+++ +|.+++...   .+.+++..++.++.|++.|+++||++|++|+||+|+||+++.++ .+++
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl  147 (269)
T cd05065          72 GVVTKSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKV  147 (269)
T ss_pred             EEECCCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEE
Confidence            334566778999999985 999988752   34689999999999999999999999999999999999998666 8999


Q ss_pred             eecCCcccccCCCCC--ccccc---ccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 026660           86 ADLGLARAFTLPIKK--YTHEI---LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~~--~~~~~---~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|||.+.........  .....   .+..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+....+..
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~  226 (269)
T cd05065         148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ  226 (269)
T ss_pred             CCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence            999988654332211  11111   134699999987554 7899999999999999886 9999987665444333321


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ....                           .....++..+.+++.+||..+|.+||++.++++
T Consensus       227 ~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         227 DYRL---------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCcC---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1000                           001236678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.9e-30  Score=224.25  Aligned_cols=190  Identities=26%  Similarity=0.420  Sum_probs=137.8

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+||-||||..++.+.+.......  -.....|+++++|++||.|+|++|++||||||.||+++..+ .|+|+|||+
T Consensus       667 ~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGL  743 (1351)
T KOG1035|consen  667 KPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGL  743 (1351)
T ss_pred             cceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-Ceeeccccc
Confidence            347899999999975554444422111  14778999999999999999999999999999999999776 999999999


Q ss_pred             ccccc------------------CCCCCcccccccccccCchhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 026660           91 ARAFT------------------LPIKKYTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSE  150 (235)
Q Consensus        91 ~~~~~------------------~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  150 (235)
                      ++...                  .+....+...||..|+|||++.+..  +++.|+|+||||++++||+.   ||...-+
T Consensus       744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME  820 (1351)
T KOG1035|consen  744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME  820 (1351)
T ss_pred             chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence            97621                  1112345678899999999998655  68999999999999999985   4544322


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                         .......+..+..+..+..                    ..+.-+.-+.+|+.||+.||.+||||.|+|++.||-.
T Consensus       821 ---Ra~iL~~LR~g~iP~~~~f--------------------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  821 ---RASILTNLRKGSIPEPADF--------------------FDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             ---HHHHHHhcccCCCCCCccc--------------------ccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence               1222222221111110000                    0012234568999999999999999999999999874

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=3.9e-30  Score=203.32  Aligned_cols=182  Identities=18%  Similarity=0.264  Sum_probs=137.0

Q ss_pred             EEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           14 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        14 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      +.++++|++.+++.+.+...    ...++..++.++.|++.||+|||+.+++||||||+||+++..+ .++++|||+++.
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~DFGla~~  175 (294)
T PHA02882        101 YRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYIIDYGIASH  175 (294)
T ss_pred             EEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEEEcCCcee
Confidence            55788998887887777552    2357888999999999999999999999999999999998766 899999999876


Q ss_pred             ccCCC-------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHhCCC
Q 026660           94 FTLPI-------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF--RLLGTP  164 (235)
Q Consensus        94 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~  164 (235)
                      +....       .......+|+.|+|||...+.. ++.++||||+||+++++++|..||.............  +.....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~  254 (294)
T PHA02882        176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL  254 (294)
T ss_pred             eccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh
Confidence            53221       1112346789999999987655 7999999999999999999999998763322221111  110000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..                      .....++.++.+.++++.|++.+|.+||++.++++
T Consensus       255 ~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        255 HE----------------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hh----------------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            00                      00112245788999999999999999999999864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=8.7e-30  Score=205.48  Aligned_cols=158  Identities=22%  Similarity=0.377  Sum_probs=119.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .++...+..++.|++.||+|||+++++|+||||+||+++.++ .++++|||++........  ......++..|+|||.+
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  253 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  253 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence            367888899999999999999999999999999999999766 899999999875432211  11223345679999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++|+||+|++++++++ |..||......+............                          .....
T Consensus       254 ~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  306 (343)
T cd05103         254 FDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------------RAPDY  306 (343)
T ss_pred             cCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--------------------------CCCCC
Confidence            7554 7899999999999999997 888987654322222221110000                          00012


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .++++.+++..||..||.+|||+.++++|
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            56788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=9.3e-30  Score=208.46  Aligned_cols=158  Identities=20%  Similarity=0.317  Sum_probs=121.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhh
Q 026660           39 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVL  116 (235)
Q Consensus        39 ~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  116 (235)
                      .+++..++.++.|++.||+|||+.+++|+||+|+||+++..+ .++++|||+++.......  ......++..|+|||.+
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  313 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI  313 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence            467788899999999999999999999999999999999765 899999999875432211  12223456789999998


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. ++.++|+||+|++++++++ |..||......+...........+                          .....
T Consensus       314 ~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~--------------------------~~p~~  366 (401)
T cd05107         314 FNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM--------------------------AKPAH  366 (401)
T ss_pred             cCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC--------------------------CCCCC
Confidence            7554 7899999999999999998 889997655444333322110000                          01123


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .+.++.+++++|+..+|.+||+++++++.
T Consensus       367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            67889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-29  Score=199.47  Aligned_cols=179  Identities=23%  Similarity=0.327  Sum_probs=138.4

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++|+||++ |+|.+++.+.   ...+++..+..++.|++.|++|||+++++|+||+|+||+++.++ .++++|||.+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccc
Confidence            56799999997 5999998752   33589999999999999999999999999999999999998666 8999999998


Q ss_pred             ccccCCCCCcc--cccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           92 RAFTLPIKKYT--HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        92 ~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ...........  ...++..|+|||.+.... ++.++|+||+|++++++++ |..||......+....+.... ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~----  230 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL----  230 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC----
Confidence            76543322111  122245799999886544 7899999999999999998 999998766544333332110 00    


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ......+.++.+++.+||..||.+||++.++++
T Consensus       231 ----------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ----------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                  001125578889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=8.1e-30  Score=197.68  Aligned_cols=175  Identities=18%  Similarity=0.256  Sum_probs=133.0

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC------eEEE
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM------TLKI   85 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~------~~~l   85 (235)
                      ...++||||+++ +|.+++.+..   ..++...+..++.||+.||.|||+++++|+||+|+||+++.++.      .+++
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence            446899999985 9999987632   26899999999999999999999999999999999999986542      5899


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+.....    .....++..|+|||.+.+. ..++.++|+||+|++++++++ |..||......+.......    
T Consensus       150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----  221 (259)
T cd05037         150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----  221 (259)
T ss_pred             CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----
Confidence            99998875443    1223446679999998765 347899999999999999999 5777765542222111110    


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ....                         ......++.+++++||..+|.+|||+.++++
T Consensus       222 ~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 QHRL-------------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCC-------------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000                         0011267889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=8e-30  Score=200.56  Aligned_cols=195  Identities=23%  Similarity=0.411  Sum_probs=137.0

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....++||||++| +|.+++.+.   ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++++|||.
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~  155 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGL  155 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcc
Confidence            4668999999975 999998652   23589999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.........   .....++..|+|||.+.+.. ++.++|+||+|+++++++++..|........  .   ...+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~--~---~~~~~~~~~  229 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLF--L---KMIGPTHGQ  229 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchh--h---hhccccccc
Confidence            8765432211   12234466799999987654 7889999999999999999876653321100  0   000000000


Q ss_pred             Cc-ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          168 VW-PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       168 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .. ........   .     .........++..+.+++.+||+.+|.+||++.+++++
T Consensus       230 ~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         230 MTVTRLVRVLE---E-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccHHHHHHHHH---c-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            00 00000000   0     00001123477899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.5e-29  Score=193.82  Aligned_cols=187  Identities=37%  Similarity=0.627  Sum_probs=146.6

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ......++++|++++ +|.+++...    ..++...++.++.+++.++.+||+.+++|+||+|.||+++..+ .++++||
T Consensus        57 ~~~~~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~  131 (244)
T smart00220       57 EDEDKLYLVMEYCDGGDLFDLLKKR----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADF  131 (244)
T ss_pred             eeCCEEEEEEeCCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccc
Confidence            344678999999987 999998762    2389999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+....... ......++..|++||...+.. .+.++|+|++|++++++++|..||...............   .....
T Consensus       132 ~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~~  206 (244)
T smart00220      132 GLARQLDPGG-LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PKPPF  206 (244)
T ss_pred             cceeeecccc-ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cCCCC
Confidence            9987665432 233445677899999987544 678999999999999999999999774333332222211   00000


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                           ......++.++.+++++|+..+|.+||++.++++||||
T Consensus       207 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                                 00000166889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=6.9e-30  Score=221.28  Aligned_cols=81  Identities=28%  Similarity=0.591  Sum_probs=71.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+...++|+||||+.| +|.+++...    +.+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|
T Consensus        71 ~~~~~~~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL  145 (669)
T cd05610          71 YSLQSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKL  145 (669)
T ss_pred             EEEEECCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEE
Confidence            344566789999999975 999999763    4688999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcc
Q 026660           86 ADLGLAR   92 (235)
Q Consensus        86 ~df~~~~   92 (235)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=214.73  Aligned_cols=184  Identities=22%  Similarity=0.355  Sum_probs=151.1

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +...++|||||-|+-.|+++-+   .+++.+-+|..|+.+.+.||+|||+.+.+|+|||+.|||++..+ .|+++|||.+
T Consensus        98 e~TaWLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSA  173 (948)
T KOG0577|consen   98 EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSA  173 (948)
T ss_pred             cchHHHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccch
Confidence            3446789999998888888664   24789999999999999999999999999999999999999887 9999999988


Q ss_pred             ccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ....    ....++||+.|||||++..  ...|.-++||||||++..++...++|+.+-+....+..+.+.-   ++.  
T Consensus       174 si~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---sPt--  244 (948)
T KOG0577|consen  174 SIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPT--  244 (948)
T ss_pred             hhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---CCC--
Confidence            5433    2346789999999999973  4558999999999999999999999987776655555444321   100  


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                           ....+.|..|++||..||+.=|.+|||.++++.|+|...
T Consensus       245 ---------------------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  245 ---------------------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             ---------------------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                                 112246788999999999999999999999999999763

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=223.85  Aligned_cols=183  Identities=25%  Similarity=0.427  Sum_probs=149.0

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFR---QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ....+|++|||. |||++||++-.   -....++....+.++.||+.|++||++++++||||.+.|+|++... .+||+|
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaD  845 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIAD  845 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEcc
Confidence            555799999997 59999998831   1134588999999999999999999999999999999999999775 999999


Q ss_pred             cCCccccc-C-CCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           88 LGLARAFT-L-PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        88 f~~~~~~~-~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ||+++... . ..+......-+..|||||.+.... +++++||||||+++||+++ |..||++..+.+.+......-+  
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR--  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR--  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc--
Confidence            99998332 1 112222223357899999998755 9999999999999999999 9999999988888876554211  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                               ......+++.+-++|..||+.+|.+||++..+++
T Consensus       923 -------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 -------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                     1122357788889999999999999999999887

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.7e-30  Score=188.62  Aligned_cols=166  Identities=17%  Similarity=0.217  Sum_probs=124.2

Q ss_pred             cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccc
Q 026660           24 TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH  103 (235)
Q Consensus        24 g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~~~~~  103 (235)
                      |||.+++.+.   +..++++.++.++.|++.||.|||+++      ||+||+++.++ .+++  ||.+.......     
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc-----
Confidence            6889998763   346999999999999999999999998      99999998766 7777  99886544321     


Q ss_pred             ccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCCCCcccccccccccCCC
Q 026660          104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGVSSLMNWHEYP  182 (235)
Q Consensus       104 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (235)
                      ..+++.|+|||++.+.. ++.++||||+||++|++++|..||....... ................   .          
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~----------  129 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---R----------  129 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---c----------
Confidence            25688999999997655 7899999999999999999999997654322 2222222111100000   0          


Q ss_pred             CCCccchhhcCCCCCh--hHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          183 QWNPQSLATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       183 ~~~~~~~~~~~~~~~~--~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                          .    .....+.  ++.+++++||..+|.+||++.++++|+|+.
T Consensus       130 ----~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      130 ----S----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ----c----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                0    0001222  689999999999999999999999999865

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-30  Score=202.33  Aligned_cols=216  Identities=34%  Similarity=0.559  Sum_probs=154.2

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCC---------
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKT---------   80 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~---------   80 (235)
                      +.+|+|+|+|+++.+|+.+|.+  ..-+.++...+++|++|++.||.|||+. |++|.||||+|||+....         
T Consensus       157 NG~HVCMVfEvLGdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~  234 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE  234 (590)
T ss_pred             CCcEEEEEehhhhhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence            5689999999999999999988  4456699999999999999999999965 999999999999963000         


Q ss_pred             --------------------------------------------------------------------------------
Q 026660           81 --------------------------------------------------------------------------------   80 (235)
Q Consensus        81 --------------------------------------------------------------------------------   80 (235)
                                                                                                      
T Consensus       235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~  314 (590)
T KOG1290|consen  235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES  314 (590)
T ss_pred             hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CeEE
Q 026660           81 ----------------------------------------------------------------------------MTLK   84 (235)
Q Consensus        81 ----------------------------------------------------------------------------~~~~   84 (235)
                                                                                                  -.+|
T Consensus       315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK  394 (590)
T KOG1290|consen  315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK  394 (590)
T ss_pred             chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence                                                                                        0122


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG------DSELQQLLHIF  158 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~------~~~~~~~~~~~  158 (235)
                      |+|||.+....   ...+..+.|..|+|||++.+.. |++.+||||++|+++||+||...|..      ..+.+.++.++
T Consensus       395 IaDlGNACW~~---khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  395 IADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             Eeeccchhhhh---hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            22333222111   1112223477899999999876 99999999999999999999999953      34577788888


Q ss_pred             HHhCCCCCCCcccc----------cccccccCCCCCCccchhhcCCCC----ChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          159 RLLGTPNEKVWPGV----------SSLMNWHEYPQWNPQSLATAVPNL----DKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       159 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..++..+..+..+-          ..........-|+...+....=+.    ..++.+|+.-||+++|.+||||.+.|+|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            88777665543322          222222222222222211111122    2467899999999999999999999999


Q ss_pred             CCCCCCCc
Q 026660          225 PYFDDLDK  232 (235)
Q Consensus       225 p~f~~~~~  232 (235)
                      ||+.++..
T Consensus       551 PwLn~~~~  558 (590)
T KOG1290|consen  551 PWLNPVAG  558 (590)
T ss_pred             ccccCCCC
Confidence            99987643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=217.39  Aligned_cols=194  Identities=20%  Similarity=0.369  Sum_probs=162.4

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .....++.+++|||||+ ||..|++.+..  +..+.++.+..+++.++.|+.+||.+.++|+|||-.|||+..++ .+++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEE
Confidence            34477889999999998 59999999976  78899999999999999999999999999999999999999787 9999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .|||.+..++..........||+.|||||++....    -+...+|+||||++..||.-|.+|+-+......       +
T Consensus       165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------L  237 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------L  237 (953)
T ss_pred             eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------h
Confidence            99999998887777888899999999999997432    255789999999999999999999977654222       2


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      ...+.+.-+...                  ...+.+.++.++|..||..|..+||+..++|.|||++
T Consensus       238 F~IpRNPPPkLk------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  238 FLIPRNPPPKLK------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             ccCCCCCCcccc------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            222222111111                  1224678899999999999999999999999999987

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.5e-29  Score=197.63  Aligned_cols=196  Identities=24%  Similarity=0.416  Sum_probs=136.9

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+...+++||||++ |+|.+++.+.   ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++++||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~df  152 (284)
T cd05081          77 AGRRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDF  152 (284)
T ss_pred             CCCCceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCC
Confidence            34456899999997 5999998652   23589999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           89 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        89 ~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      |++.........   .....++..|+|||...+.. ++.++|+||+|++++++++|..++......  ..   ...+...
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~---~~~~~~~  226 (284)
T cd05081         153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE--FM---RMMGNDK  226 (284)
T ss_pred             cccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh--hh---hhccccc
Confidence            998765432221   11112244599999987554 789999999999999999987776443211  00   0000000


Q ss_pred             C--CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          166 E--KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       166 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .  ...........        ..........++.++.+++.+||..+|.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         227 QGQMIVYHLIELLK--------NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             ccccchHHHHHHHh--------cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0  00000000000        00000112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=211.52  Aligned_cols=190  Identities=23%  Similarity=0.346  Sum_probs=152.2

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.++.--.+..+++|||+|+| +|.++|.+..   +.++..+...++.+.+.||+|||+++++||||-++|+|++.++ 
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-  299 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-  299 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-
Confidence            3455666677889999999985 9999998842   2699999999999999999999999999999999999999766 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      .++++|||+++.............-+..|+|||.+.... ++.++||||+|+++||+++ |..||.+-...+....+...
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~  378 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN  378 (474)
T ss_pred             eEEeCccccccCCcceeeccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence            789999999876542222221223367899999998774 8999999999999999999 88899998887777776432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .-..                          ......+..+..++.+|+..+|..||++.++.+
T Consensus       379 ~~r~--------------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  379 GYRM--------------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CccC--------------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            1111                          111135678889999999999999999988754

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=3.6e-29  Score=198.63  Aligned_cols=177  Identities=21%  Similarity=0.263  Sum_probs=135.5

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++++||++ |+|.+++...   ...++++.++.++.|++.||.|||+++++|+||+|+||+++.++ .++++|||.++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~  158 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARL  158 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEcccccccc
Confidence            578999998 5999998652   33589999999999999999999999999999999999998666 899999999976


Q ss_pred             ccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      .......  .....++..|++||.+.+.. ++.++|+||+|+++|++++ |..||.+....+....... ....      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~------  230 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERL------  230 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCC------
Confidence            5432221  12223456899999986544 7899999999999999997 8899976554332222111 0000      


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                          ......+..+.+++.+|+..+|.+||++.++++
T Consensus       231 --------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         231 --------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                001135678899999999999999999999865

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=6.4e-30  Score=185.57  Aligned_cols=217  Identities=29%  Similarity=0.643  Sum_probs=158.1

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .+..++.-.+|+||.+. +...+...       ++.-.+..++.+++.||.|.|+.|+.|||+||.|++++......+++
T Consensus       103 ~Dp~SktpaLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlI  175 (338)
T KOG0668|consen  103 KDPESKTPSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLI  175 (338)
T ss_pred             cCccccCchhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeee
Confidence            44556677899999986 77777655       88889999999999999999999999999999999999888789999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP-GDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~  165 (235)
                      |+|++..+-.. ....-...+..|--||.+.....+..+-|+||+||++..|...+.||. +.++.+++.++...++...
T Consensus       176 DWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e  254 (338)
T KOG0668|consen  176 DWGLAEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE  254 (338)
T ss_pred             ecchHhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence            99999766533 333333446778999999887778899999999999999999998874 4555566655554443311


Q ss_pred             C---------CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 E---------KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .         .+-+....-+....-..|..-.-.....-.++++.+++.++|..|..+|+|+.|.+.||||..+..
T Consensus       255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence            0         011111110000011111111111111235689999999999999999999999999999986543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-31  Score=199.12  Aligned_cols=213  Identities=38%  Similarity=0.687  Sum_probs=165.3

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      +.+|+++|.|..||...+.+    -..++.+.++-+++||+.||+|||+.++.||||||.|.+++.+. ..||+|||+++
T Consensus       130 qEiYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLAR  204 (449)
T KOG0664|consen  130 QELYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEeccccccc
Confidence            34788999999899888866    34588999999999999999999999999999999999999666 89999999998


Q ss_pred             cccCC-CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           93 AFTLP-IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        93 ~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      ..... ...++...-|..|++||++.+...++.+.||||.||++.|++..+..|...+..+++..+-+.++.|..+....
T Consensus       205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            65433 33455566688999999999988899999999999999999999999999999999999888888877553332


Q ss_pred             ccccccccCCC-CCCcc---chh--hcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          172 VSSLMNWHEYP-QWNPQ---SLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       172 ~~~~~~~~~~~-~~~~~---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..+.-.....+ .....   .+-  .....-..+...++.++|.+||.+|.+..+.+.|++...-
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            22111111110 00001   110  1111223456788999999999999999999999997653

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=6.5e-29  Score=195.12  Aligned_cols=185  Identities=24%  Similarity=0.415  Sum_probs=138.1

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +....+++|||+++ +|.+++.+.   ...+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++++|||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg  154 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFG  154 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccc
Confidence            36678999999975 999999763   23589999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HH
Q 026660           90 LARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-----------LL  155 (235)
Q Consensus        90 ~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------~~  155 (235)
                      .+.........   .....++..|++||...+.. ++.++|+||+|++++++++|..|+........           ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            98766522211   11223345699999886554 78999999999999999999999865432110           00


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..........                 .      .......+.++.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~-----------------~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         234 RLLELLKEGE-----------------R------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHcCC-----------------c------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0111000000                 0      0001235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=1.5e-28  Score=192.08  Aligned_cols=181  Identities=20%  Similarity=0.343  Sum_probs=136.8

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQ--TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ..++++||+. |+|.+++.....  ....++.+.++.++.|++.|++|||+++++|+||+|+||+++..+ .++++|||.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECcccc
Confidence            3578899997 599988754221  223478999999999999999999999999999999999998665 899999998


Q ss_pred             cccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ++.......  ......++..|++||...... .+.++|+||+|+++|++++ |..||......+........    .. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----~~-  233 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG----NR-  233 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC----Cc-
Confidence            876543221  112223456799999886554 7889999999999999999 88888776554433322211    00 


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       234 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 ----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0011246678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-29  Score=202.30  Aligned_cols=181  Identities=22%  Similarity=0.359  Sum_probs=146.1

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +-..|||+|||. |+|++||+...+  ..++.-..++|+.||..|++||.+++++||||.+.|+|+..+. .++++|||+
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGL  411 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGL  411 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccch
Confidence            445899999997 799999998533  3477888999999999999999999999999999999999666 999999999


Q ss_pred             cccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ++..+.+. ......-.++.|.|||.+.-.. ++.++|+|+||+++|++.+ |-.||.+-+-.+.+..+...+.      
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR------  484 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR------  484 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc------
Confidence            98765431 1222233367899999987544 8999999999999999999 8999988776666655543211      


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           +....++++..-+|++.||+++|.+||++.|+-+
T Consensus       485 ---------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  485 ---------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             ---------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence                                 1122368888999999999999999999998743

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=205.64  Aligned_cols=181  Identities=23%  Similarity=0.406  Sum_probs=146.1

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .++..+||||+++ |.|..|++.   ....++......++.||+.||.|||+.++|||||...|||++... .+|++|||
T Consensus       461 ~e~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFG  536 (974)
T KOG4257|consen  461 VEQPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFG  536 (974)
T ss_pred             eccceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccc
Confidence            3456899999998 899999976   345799999999999999999999999999999999999999666 99999999


Q ss_pred             CcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           90 LARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        90 ~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +++......-. .+...-++.|+|||.+.-+. ++.++|+|.||+.+||+++ |..||.+-.+.+.+..+.+.-.     
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-----  610 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-----  610 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-----
Confidence            99877654322 12223367899999986444 8999999999999999888 9999988665444443332211     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ....+++++.+-.++.+||.++|.+||.+.++.+
T Consensus       611 ----------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  611 ----------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             ----------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence                                  2233468899999999999999999999888753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=190.48  Aligned_cols=198  Identities=21%  Similarity=0.307  Sum_probs=153.2

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEEeec
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .++-.+|.||+|.-||..+...... +...++++.+-.+....+.||+||.+. .++|||+||+|||++..| .++++||
T Consensus       134 ~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecc
Confidence            3445799999999877766654333 445699999999999999999999965 899999999999999888 9999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNE  166 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~  166 (235)
                      |.+-.+..+ ...+...|-..|+|||.+..... +..+||+||||++++|+.+|..|+..-.+ .+++...+..  .++.
T Consensus       213 GIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g--dpp~  289 (361)
T KOG1006|consen  213 GICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG--DPPI  289 (361)
T ss_pred             cchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC--CCCe
Confidence            998665543 23344556677999999975433 78999999999999999999999976443 4444443321  1111


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .                    .......+++..+..+|..||..|-+.||...+++.+||++.+..
T Consensus       290 l--------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  290 L--------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             e--------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            1                    111223468899999999999999999999999999999987654

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=206.07  Aligned_cols=202  Identities=23%  Similarity=0.286  Sum_probs=147.0

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--C-CeEEEeec
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--T-MTLKIADL   88 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~-~~~~l~df   88 (235)
                      +.-.++||||+| ||...+++. ..+..+++.+++.++.+++.||+|||++||+||||||+||++-..  + ...||+||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            356899999985 999999884 456689999999999999999999999999999999999987422  2 25799999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEK  167 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  167 (235)
                      |.++.+... .......||..|.+||++.....++..+|.||+||++|+++||..||-...... ....+......++..
T Consensus       169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            999987755 367788999999999999755668999999999999999999999996543322 333344444444544


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI  216 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  216 (235)
                      ..-......+.+.-.+..........+..-..+-.++..+|..+|.+|.
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            4433333333221111111111111112223445789999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.4e-28  Score=201.48  Aligned_cols=202  Identities=20%  Similarity=0.300  Sum_probs=135.7

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQ--------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK   70 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~   70 (235)
                      +...++||||+++ +|.+++.....                    ....+++..++.++.|++.||.|||+.+++|+|||
T Consensus       257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK  336 (507)
T PLN03224        257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK  336 (507)
T ss_pred             CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            4568999999985 99999875211                    11224667899999999999999999999999999


Q ss_pred             CCcEEEcCCCCeEEEeecCCcccccCCCCC-cccccccccccCchhhhCCCC---------------------CCchhhH
Q 026660           71 PHNLLMDRKTMTLKIADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTH---------------------YSTAVDM  128 (235)
Q Consensus        71 ~~nil~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~---------------------~~~~~Di  128 (235)
                      |+||+++.++ .++++|||++......... ......++.|+|||.+.....                     ...+.|+
T Consensus       337 p~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv  415 (507)
T PLN03224        337 PENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS  415 (507)
T ss_pred             hHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch
Confidence            9999999776 8999999998654322111 112233678999998753210                     1134699


Q ss_pred             HHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHh
Q 026660          129 WSVACIFAELVTKTA-LFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQM  207 (235)
Q Consensus       129 ~slG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  207 (235)
                      ||+||++++|+++.. ||.+.............    ....|......           ..........++..++++++|
T Consensus       416 wSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~----~~~~~r~~~~~-----------~~~~~~~d~~s~~~~dLi~~L  480 (507)
T PLN03224        416 YTAGVLLMQMCVPELRPVANIRLFNTELRQYDN----DLNRWRMYKGQ-----------KYDFSLLDRNKEAGWDLACKL  480 (507)
T ss_pred             hhHHHHHHHHHhCCCCCccchhhhhhHHhhccc----hHHHHHhhccc-----------CCCcccccccChHHHHHHHHH
Confidence            999999999999875 66432211110000000    00000000000           000112234678899999999


Q ss_pred             cccCC---CCCCCHHHHhCCCCCCC
Q 026660          208 LQYDP---SKRISAKKAMEHPYFDD  229 (235)
Q Consensus       208 l~~~p---~~Rps~~~ll~hp~f~~  229 (235)
                      |..+|   .+|+|++|+|+||||.+
T Consensus       481 L~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        481 ITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hccCCCCcccCCCHHHHhCCCCcCC
Confidence            99766   68999999999999964

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-29  Score=201.14  Aligned_cols=189  Identities=23%  Similarity=0.305  Sum_probs=134.2

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG---ILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~---~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +.++|+|||+ |+|.+++......  .++|....+|+.+++.||+|||...   ++|||||++|||+|.+ .+.|++|||
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFG  222 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFG  222 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCcc
Confidence            6899999997 7999999873222  7899999999999999999999853   9999999999999955 499999999


Q ss_pred             CcccccCCCCCcccc-cccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH-HHHHhCCCC
Q 026660           90 LARAFTLPIKKYTHE-ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS--ELQQLLH-IFRLLGTPN  165 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~-~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~-~~~~~~~~~  165 (235)
                      +++............ .||.+|++||...... .+.++||||+|++++|+++|+.+.....  ....... ........ 
T Consensus       223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-  300 (361)
T KOG1187|consen  223 LAKLGPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-  300 (361)
T ss_pred             CcccCCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-
Confidence            996544311111222 7899999999997644 8899999999999999999998876432  1111111 11111110 


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCC-----hhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLD-----KDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                           ...+         +....+..  ..++     ..+..+..+|++.+|.+||++.+++.
T Consensus       301 -----~~~e---------iiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -----KLRE---------IVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -----chhh---------eeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                 0000         00001000  0111     23567888999999999999999754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-28  Score=193.22  Aligned_cols=192  Identities=23%  Similarity=0.409  Sum_probs=148.7

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--CceecCCCCCcEEEcCC--CCeEEEe
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDLKPHNLLMDRK--TMTLKIA   86 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~--~~~H~di~~~nil~~~~--~~~~~l~   86 (235)
                      ....|-|+|||+| +|.-|+..    ++.+++.++..|+.||+.||.||...  -|+|-||||.|||+-..  ...++|.
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            3467999999998 88777754    56799999999999999999999977  49999999999998533  2379999


Q ss_pred             ecCCcccccCCCC-------CcccccccccccCchhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           87 DLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLG---STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        87 df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      |||+++......-       ..+...||.+|.|||++.-   ..+.+.++||||+|+++|..+.|+.||+.....+.+-.
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            9999986643321       2345678999999999863   34478999999999999999999999987654333222


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .--.+..                      .......-+-++++.+++|++||.+--.+|....++..||+|..
T Consensus       696 eNTIlkA----------------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILKA----------------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhchhcc----------------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            1111000                      00111223357889999999999999999999999999999865

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-29  Score=206.03  Aligned_cols=188  Identities=18%  Similarity=0.301  Sum_probs=158.6

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      .+++.-...+.+.||+|||. |+|..||+.  + .+.++.-++.-|++-|+.|++||-+.++|||||.+.|||++.+ ..
T Consensus       694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~--~-DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-Lv  769 (996)
T KOG0196|consen  694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQ--N-DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LV  769 (996)
T ss_pred             EEEEEEecCceeEEEhhhhhCCcHHHHHhh--c-CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eE
Confidence            34555667788999999996 799999988  3 3469999999999999999999999999999999999999955 48


Q ss_pred             EEEeecCCcccccCCCCCcccccc---cccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEIL---TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF  158 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~---~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  158 (235)
                      +|++|||+++.+.++........|   +..|+|||.+..++ ++.++|+||+|++|||.++ |..||.+-.+.+.+..+.
T Consensus       770 CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe  848 (996)
T KOG0196|consen  770 CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE  848 (996)
T ss_pred             EEeccccceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHH
Confidence            999999999977655432222222   56899999997655 8999999999999999888 999999988888888888


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +..+.|+..                           +++..+-+|+..||+.|=.+||.+.+|++
T Consensus       849 ~gyRLPpPm---------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  849 QGYRLPPPM---------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             hccCCCCCC---------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            766655443                           57888999999999999999999999876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=6.3e-28  Score=188.39  Aligned_cols=219  Identities=28%  Similarity=0.507  Sum_probs=152.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+..++.+++|+||++- +-.++...       ++...+..+++.++.||.++|++|++||||||.|++++.....-.
T Consensus       101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCce
Confidence            3455678889999999995 88888866       889999999999999999999999999999999999998877889


Q ss_pred             EeecCCccccc-----------------C----------------C-----------CCCcccccccccccCchhhhCCC
Q 026660           85 IADLGLARAFT-----------------L----------------P-----------IKKYTHEILTLWYRAPEVLLGST  120 (235)
Q Consensus        85 l~df~~~~~~~-----------------~----------------~-----------~~~~~~~~~~~~y~~PE~~~~~~  120 (235)
                      |+|||++....                 .                +           ........||++|+|||++....
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999985110                 0                0           00112336699999999998777


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCC---------CCC-CCcc-----cccc-cccccCCC-
Q 026660          121 HYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGT---------PNE-KVWP-----GVSS-LMNWHEYP-  182 (235)
Q Consensus       121 ~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~---------~~~-~~~~-----~~~~-~~~~~~~~-  182 (235)
                      ..+++.||||.|++++.++++..||.. ..+...+..+....+.         +.. ..|.     ...+ ..++.... 
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            678999999999999999999999853 2232222222221111         001 0111     0000 01111110 


Q ss_pred             CCCcc------chhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          183 QWNPQ------SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       183 ~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .....      .........+..+.+++.+||..||.+|.|++++|.||||...+
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            00000      01111113445788999999999999999999999999998654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=193.70  Aligned_cols=188  Identities=20%  Similarity=0.325  Sum_probs=149.7

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ++.+|+|+|||. |+|.+|+.....  +.+.-+...+|+.||+.|++||.+.++||||+.+.|+|++.+. .+||+|||+
T Consensus       607 DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgm  683 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGM  683 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCccc
Confidence            456999999997 799999988432  2355666788999999999999999999999999999999766 999999999


Q ss_pred             cccccC--CCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTL--PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ++.+..  .........-++.|+|||.+.-++ +++++|+|++|+++||+++  ...||....+.+...+.......+..
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~  762 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR  762 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence            985532  223344556678999999998666 8999999999999999655  78899888877777766654433322


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                    ......+-++..+.+++-+|+..+..+|||++++..
T Consensus       763 ~--------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  763 Q--------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             c--------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            2                    222333357788889999999999999999999854

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=196.57  Aligned_cols=180  Identities=23%  Similarity=0.310  Sum_probs=149.2

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+.+|||+++ |+|.+.|++  .....+.......++.||+.|+.||.+++++|||+...|+++.... .+||+|||+.
T Consensus       183 qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccce
Confidence            55788999998 699999998  5566799999999999999999999999999999999999998655 8999999999


Q ss_pred             ccccCCCCCccc---ccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~~~~---~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.++.....+..   .--...|+|||.+.... ++.++|+|++|+++|||++ |..||.+....+.+.++...       
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------  331 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------  331 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------
Confidence            988755443321   12255799999998666 9999999999999999999 89999998877776665421       


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                          ........+++++-++++.||..+|.+|||+..|.+
T Consensus       332 --------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  332 --------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             --------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                                112223357889999999999999999999998854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-27  Score=169.16  Aligned_cols=147  Identities=26%  Similarity=0.462  Sum_probs=124.7

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ....++|.||.|.-||..+.......+..+++..+-+++..++.||.|||++ .++|||+||+|||++..+ .++++|||
T Consensus       116 regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  116 REGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             ccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence            3445799999999999999999999999999999999999999999999976 899999999999999888 99999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLG---STHYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFR  159 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~  159 (235)
                      .+-.+..+.. .+...|-..|+|||.+..   ...|+.++||||||+++.||.+++.||.. ....+++.+.+.
T Consensus       195 IsG~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9976654422 233455667999999863   33588999999999999999999999975 566777766653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-26  Score=196.94  Aligned_cols=183  Identities=25%  Similarity=0.417  Sum_probs=141.4

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhh---c-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFR---Q-------TG--ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR   78 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~   78 (235)
                      +..+++|+||+. |+|..+++...   .       ..  ..++....+.++.||+.|++||++..++|||+-+.||++..
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK  453 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence            678999999998 79999998854   0       01  23889999999999999999999999999999999999996


Q ss_pred             CCCeEEEeecCCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHH
Q 026660           79 KTMTLKIADLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS-ELQQ  153 (235)
Q Consensus        79 ~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~-~~~~  153 (235)
                      +. .++++|||+++........   .+...-+..|+|||.+.. ..++.++||||+|+++||+++ |..||.+-. ..+.
T Consensus       454 ~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  454 NK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            65 9999999999854432221   111113556999999987 449999999999999999999 888887743 3333


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...+...                           .........++++-++++.|++.+|.+||++.++..
T Consensus       532 ~~~l~~G---------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEG---------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhcC---------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3222211                           111222346789999999999999999999998754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-25  Score=174.53  Aligned_cols=184  Identities=18%  Similarity=0.266  Sum_probs=147.6

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFR----QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...-++++++++ |||+.|+....    +..+.++-.++..|+.|++.|++|||+.|++|.||.+.|+++++. ..+++
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkl  437 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKL  437 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEe
Confidence            4445588999998 89999998422    223346778899999999999999999999999999999999966 49999


Q ss_pred             eecCCcccccCC-CC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           86 ADLGLARAFTLP-IK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        86 ~df~~~~~~~~~-~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|=.+++.+-.. .. .....-++..||+||.+.... ++.++|+||||+++|||++ |+.|+..-+..+....+.+...
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            999988754322 11 122334467899999998665 8999999999999999999 9999998888877776654321


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 .....++++++..++.-||...|++||+.+|+..
T Consensus       517 ---------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 ---------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ---------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                       1223378999999999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=2e-26  Score=208.34  Aligned_cols=194  Identities=17%  Similarity=0.252  Sum_probs=129.5

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hcCceecCCCCCcEEEcCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH---GHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh---~~~~~H~di~~~nil~~~~~~   81 (235)
                      ++...+....|+||||++ |+|.+++..       +++..+..++.|++.|++|||   +.+++|+||||+||+++.+. 
T Consensus       749 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-  820 (968)
T PLN00113        749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-  820 (968)
T ss_pred             EEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-
Confidence            344455667899999998 599999954       789999999999999999999   66999999999999998665 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRL  160 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~  160 (235)
                      ..++. ++.......    .....++..|+|||.+.+.. ++.++||||+||++||+++|+.||..... ........+.
T Consensus       821 ~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  894 (968)
T PLN00113        821 EPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY  894 (968)
T ss_pred             ceEEE-ecccccccc----CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHH
Confidence            45543 444322211    12235678999999987654 88999999999999999999999854221 0111111111


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..... . ...      +.+. .....  .........++.+++.+|++.||.+|||+.++++.
T Consensus       895 ~~~~~-~-~~~------~~~~-~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        895 CYSDC-H-LDM------WIDP-SIRGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             hcCcc-c-hhh------eeCc-cccCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000 0 000      0000 00000  00000122356789999999999999999998763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=167.07  Aligned_cols=180  Identities=22%  Similarity=0.301  Sum_probs=134.6

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CCeEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~~~~   84 (235)
                      ..++..++.++++||++ |||.+-+..     ..+-+....+++.|++.|+.|||++++||||||.+|||+... ...++
T Consensus        89 vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvK  163 (378)
T KOG1345|consen   89 VAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVK  163 (378)
T ss_pred             HHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEE
Confidence            34667778999999999 799887754     468899999999999999999999999999999999998543 34899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~  159 (235)
                      ++|||.++..+........   +..|.+||.+....    ...+.+|+|.||++++.+++|..||.... ..+.+.+.++
T Consensus       164 lcDFG~t~k~g~tV~~~~~---~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~  240 (378)
T KOG1345|consen  164 LCDFGLTRKVGTTVKYLEY---VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ  240 (378)
T ss_pred             eeecccccccCceehhhhh---hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence            9999998766543332222   45689999886422    23567899999999999999999997432 2233444444


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR  215 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  215 (235)
                      ..+.....                     +-.....+++.+..+.++-|+.++++|
T Consensus       241 w~~rk~~~---------------------~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  241 WLKRKNPA---------------------LPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             HhcccCcc---------------------CchhhcccCHHHHHHHHHhcCCccccc
Confidence            43332221                     111122477888999999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-26  Score=186.00  Aligned_cols=196  Identities=21%  Similarity=0.319  Sum_probs=155.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ++..-....++|.||||+| +|.+...    -.+.+++-++..+++..+.|++|||+.|-+|||||-.||++++.+ .++
T Consensus        78 ~gsylr~dklwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-Dvk  152 (829)
T KOG0576|consen   78 FGSYLRRDKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVK  152 (829)
T ss_pred             HhhhhhhcCcEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-cee
Confidence            3334445678999999985 8887653    356899999999999999999999999999999999999999887 999


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +.|||.+-.++....+...+.||+.|+|||+..-  ...+...+|+|++|+...++-..+.|-...........+-....
T Consensus       153 laDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~  232 (829)
T KOG0576|consen  153 LADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGF  232 (829)
T ss_pred             ecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCC
Confidence            9999999888777777788899999999999852  23378999999999999999888877665555444333322111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .++..     ..                  ....++.+-+|++.+|..+|++||+++.+|.|||...
T Consensus       233 qpp~l-----kD------------------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  233 QPPTL-----KD------------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             CCCcc-----cC------------------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            11111     00                  0135677889999999999999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=3.7e-24  Score=160.20  Aligned_cols=154  Identities=39%  Similarity=0.637  Sum_probs=128.3

Q ss_pred             CCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC-CCCeEEEe
Q 026660            9 KEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMTLKIA   86 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~-~~~~~~l~   86 (235)
                      .......++++|+++ ++|.+++....   ..++.+.++.++.+++.++.+||+.+++|+||+|.||+++. .+ .++++
T Consensus        60 ~~~~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~  135 (215)
T cd00180          60 FEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLA  135 (215)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEe
Confidence            334467899999999 59999987632   46899999999999999999999999999999999999997 45 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ||+.+..............+...|++||........+.++|+|++|++++++                            
T Consensus       136 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------  187 (215)
T cd00180         136 DFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------  187 (215)
T ss_pred             cCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------
Confidence            9999876544322233345577899999987653478999999999999998                            


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                                                     ..+.+++.+|++.||.+||++.++++|+
T Consensus       188 -------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                           2345899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.1e-25  Score=188.23  Aligned_cols=190  Identities=26%  Similarity=0.376  Sum_probs=147.9

Q ss_pred             EecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCC
Q 026660           19 FEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI   98 (235)
Q Consensus        19 ~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~   98 (235)
                      ||||++||..++..    ...+....+-.++.|++.|++|||+.|++|+|+|++|+++...+ .++++|||.+..+..+.
T Consensus       400 mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  400 MEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCc
Confidence            99999999999876    24588889999999999999999999999999999999999887 99999999886554443


Q ss_pred             C----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccc
Q 026660           99 K----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  174 (235)
Q Consensus        99 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (235)
                      .    ......|+..|+|||++.+........||||.|+++..|.+|+.||......+........              
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------------  540 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------------  540 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--------------
Confidence            3    3456788999999999998776677899999999999999999999754332221100000              


Q ss_pred             cccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          175 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                        .   ...............++.+.+.+|.+||++||.+|.|++++++.+||+.++-
T Consensus       541 --~---~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  541 --S---DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --c---cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence              0   0000001111222346778889999999999999999999999999998764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-24  Score=178.26  Aligned_cols=177  Identities=24%  Similarity=0.315  Sum_probs=143.3

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      +-||++||+ |+|.+|++..   ...+-.+..+.|..||++|+.|||+++++||||-+.|+|+..-+ .+++.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhc
Confidence            567899998 6999999873   45688899999999999999999999999999999999999776 899999999988


Q ss_pred             ccCCCCCcccccc--cccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~~~~~~~--~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +..+........+  .+.|+|-|.+.... ++.++||||+||++||++| |..|+.+....+....+.....        
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------  918 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------  918 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------
Confidence            8766555544443  45688888876544 8999999999999999998 8899888766655554433211        


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                         ....+..+-++--++.+||..|+..||+++++.+
T Consensus       919 -------------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  919 -------------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -------------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                               1122346677888999999999999999988743

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=9.4e-25  Score=176.85  Aligned_cols=138  Identities=26%  Similarity=0.367  Sum_probs=122.5

Q ss_pred             cccCCcCCCceEEEEEEecCc-c-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~   80 (235)
                      ++..+.+|++++.||+||..+ | +|.++++.    +..+++.++..+++|++.|+++||+.|++|||||-+|+.++.+|
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g  707 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG  707 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC
Confidence            466788999999999999986 7 99999987    45699999999999999999999999999999999999999887


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG  147 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  147 (235)
                       .++++|||.+......  ....++||..|.|||++.+..+.+...|||++|+++|.+.....||.+
T Consensus       708 -~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  708 -FVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -eEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             9999999988654432  234568899999999999888788999999999999999998888864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.1e-23  Score=163.36  Aligned_cols=185  Identities=23%  Similarity=0.355  Sum_probs=132.2

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCcEEEcCCC
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKT   80 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~--------~~~H~di~~~nil~~~~~   80 (235)
                      ..-..+++|++|.+ |||.|||..     ..++-+...+++..++.||++||-.        .++|||||+.|||+..++
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            34478999999998 899999987     3689999999999999999999953        399999999999999777


Q ss_pred             CeEEEeecCCcccccCCC----CCcccccccccccCchhhhCCCCCC-----chhhHHHHHHHHHHHHhC----------
Q 026660           81 MTLKIADLGLARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYS-----TAVDMWSVACIFAELVTK----------  141 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~-----~~~Di~slG~~l~~l~~g----------  141 (235)
                       .+.|+|+|++.......    .......||..|||||++....+..     ..+||||+|.++||++..          
T Consensus       354 -~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  354 -TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             -cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence             89999999996655432    2345668899999999997543221     468999999999998762          


Q ss_pred             CCCCCC----CCHHHHHHHHH--HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCC
Q 026660          142 TALFPG----DSELQQLLHIF--RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR  215 (235)
Q Consensus       142 ~~pf~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  215 (235)
                      ..||.+    +...+.+...+  +.+.+...+.|....                      .=..+..+++.||..||..|
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~----------------------~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDP----------------------ALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCH----------------------HHHHHHHHHHHhhcCCchhh
Confidence            445532    12222222221  111111111111100                      00234578999999999999


Q ss_pred             CCHHHHh
Q 026660          216 ISAKKAM  222 (235)
Q Consensus       216 ps~~~ll  222 (235)
                      .|+-.+.
T Consensus       491 ltALriK  497 (513)
T KOG2052|consen  491 LTALRIK  497 (513)
T ss_pred             hHHHHHH
Confidence            9987653

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-23  Score=165.09  Aligned_cols=180  Identities=24%  Similarity=0.322  Sum_probs=132.1

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceecCCCCCcEEEcCCCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---------GILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~---------~~~H~di~~~nil~~~~~~   81 (235)
                      ...+.+|++|.+ |+|.+||..     .-+++....+|+..++.||+|||+.         .|+|||||+.|||+..+. 
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-  353 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-  353 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-
Confidence            457899999997 799999987     3689999999999999999999974         499999999999999776 


Q ss_pred             eEEEeecCCcccccCC--CCCcccccccccccCchhhhCCCCCC-----chhhHHHHHHHHHHHHhCCCCCCC-------
Q 026660           82 TLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYS-----TAVDMWSVACIFAELVTKTALFPG-------  147 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~~pf~~-------  147 (235)
                      ...|+|||++..+...  ........||..|||||++.+..+..     .+.||||+|.++||+++...-+..       
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            8999999999776532  22344578899999999998754443     467999999999999985433310       


Q ss_pred             ----------CCHHHHHHHHHHHhCCC-CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC
Q 026660          148 ----------DSELQQLLHIFRLLGTP-NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI  216 (235)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  216 (235)
                                ....+.....++.-..| ....|...                      ..-..+.+.+..|+..||+.|.
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----------------------~~~~~l~et~EeCWDhDaeARL  491 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----------------------AGMAVLCETIEECWDHDAEARL  491 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----------------------ccHHHHHHHHHHHcCCchhhhh
Confidence                      11122222222221111 11111111                      1224577999999999999999


Q ss_pred             CHH
Q 026660          217 SAK  219 (235)
Q Consensus       217 s~~  219 (235)
                      |+.
T Consensus       492 TA~  494 (534)
T KOG3653|consen  492 TAG  494 (534)
T ss_pred             hhH
Confidence            975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.86  E-value=7.7e-21  Score=144.03  Aligned_cols=139  Identities=36%  Similarity=0.567  Sum_probs=112.7

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .......++++|++++ +|.+++.....   .+++..+..++.+++.++.+||+.+++|+|+++.||+++..+ .++++|
T Consensus        66 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d  141 (225)
T smart00221       66 FEDPEPLYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLAD  141 (225)
T ss_pred             eecCCceEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEee
Confidence            3445678999999997 99999977321   188999999999999999999999999999999999999775 899999


Q ss_pred             cCCcccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH
Q 026660           88 LGLARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSEL  151 (235)
Q Consensus        88 f~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~  151 (235)
                      ||.+....... .......++..|++||.+......+.++|+|++|++++++++|+.||.. ....
T Consensus       142 ~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      142 FGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             CceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            99887665432 1122335567899999984333467799999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=2e-21  Score=149.65  Aligned_cols=166  Identities=19%  Similarity=0.276  Sum_probs=110.8

Q ss_pred             EEEEEEecCccCHHHHHHHhhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           14 VLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        14 ~~~lv~e~~~g~L~~~l~~~~~~~~~---~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ..+++|+-+.+||.+++.........   +.......+..|++..+++||+.|++|+||+++|++++.+| .+.|+||+.
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~  191 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSS  191 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGG
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHH
Confidence            45889999999999987654333322   33444566778999999999999999999999999999887 999999987


Q ss_pred             cccccCCCCCcccccccccccCchhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGS-------THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      ....+.....   ...+..|.|||.....       ..++.+.|.|+||+++|.+.|+..||..........        
T Consensus       192 ~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~--------  260 (288)
T PF14531_consen  192 LVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE--------  260 (288)
T ss_dssp             EEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG--------
T ss_pred             HeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc--------
Confidence            7544432221   2335679999987542       236788999999999999999999998654310000        


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR  215 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  215 (235)
                                             .... .+.++++.+++||+.+|++||.+|
T Consensus       261 -----------------------~~f~-~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  261 -----------------------WDFS-RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -----------------------GGGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             -----------------------ccch-hcCCcCHHHHHHHHHHccCCcccC
Confidence                                   0111 222688999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.9e-20  Score=144.72  Aligned_cols=186  Identities=23%  Similarity=0.328  Sum_probs=133.5

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC---CeEE
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLK   84 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~---~~~~   84 (235)
                      .......+|+||..+..+|.+++..     +..+-....-++.|+++|+.|||++|++|+|+|++|||+.-+.   -...
T Consensus       311 g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV  385 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV  385 (598)
T ss_pred             ccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence            3456788999999999999999976     3467778899999999999999999999999999999994332   2568


Q ss_pred             EeecCCcccccC-----CCC-CcccccccccccCchhhhCCCCC-----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 026660           85 IADLGLARAFTL-----PIK-KYTHEILTLWYRAPEVLLGSTHY-----STAVDMWSVACIFAELVTKTALFPGDSELQQ  153 (235)
Q Consensus        85 l~df~~~~~~~~-----~~~-~~~~~~~~~~y~~PE~~~~~~~~-----~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  153 (235)
                      ++|||++-....     +.. .....-|+...+|||+.......     =.++|.|+.|.+.||++....||......-.
T Consensus       386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L  465 (598)
T KOG4158|consen  386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL  465 (598)
T ss_pred             EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence            899998732211     111 11222346678999998643211     1589999999999999999999987443211


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH---HHhCC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK---KAMEH  224 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~ll~h  224 (235)
                      -..-++.                          ..+-.....+++.+++++..+|+.||++|+|..   .+++-
T Consensus       466 ~~r~Yqe--------------------------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  466 DTRTYQE--------------------------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             chhhhhh--------------------------hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence            1111110                          111111224778899999999999999999854   45553

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-19  Score=144.98  Aligned_cols=186  Identities=18%  Similarity=0.166  Sum_probs=138.9

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC----CeEEE
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKI   85 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~----~~~~l   85 (235)
                      ..+.+-|+||+.++.||.++.....  .+.++..++..++.|++.+|++||+.|++||||||.|+++....    ..+.+
T Consensus        91 ~~~~~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   91 STEDFNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             CCCceeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence            4667889999999999999887743  56899999999999999999999999999999999999998653    46899


Q ss_pred             eecCCcc--cccCCC-------CC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 026660           86 ADLGLAR--AFTLPI-------KK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL  155 (235)
Q Consensus        86 ~df~~~~--~~~~~~-------~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  155 (235)
                      .|||+++  .+....       .. ....+||..|+|+.+..+.. .+.+.|+||++.++.++..|..||..........
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            9999998  332111       11 23456899999999988766 7899999999999999999999997655322222


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA  221 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  221 (235)
                      .............                       .....+.++..+...+-+.+...+|....+
T Consensus       248 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~  290 (322)
T KOG1164|consen  248 KFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKL  290 (322)
T ss_pred             HHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence            2222111000000                       111234566777777777888888876655

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=5.6e-21  Score=156.79  Aligned_cols=187  Identities=25%  Similarity=0.364  Sum_probs=148.7

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..-.++.+..+++++++..| +|...+.+    ...+.+.....+...++.+++++|+.+++|+|+|++||+++..| .+
T Consensus        62 lhyafqt~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi  136 (612)
T KOG0603|consen   62 LHYAFQTDGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HI  136 (612)
T ss_pred             eeeeeccccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-cc
Confidence            33456677778999999875 77766643    45577888899999999999999999999999999999999888 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      ++.|||.++........    .||..|||||++.+   ...++|.||+|++++++++|..||..    +...++...-..
T Consensus       137 ~~tdfglske~v~~~~~----cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~  205 (612)
T KOG0603|consen  137 KLTDFGLSKEAVKEKIA----CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE  205 (612)
T ss_pred             ccCCchhhhHhHhhhhc----ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC
Confidence            99999999765432222    77999999999862   56899999999999999999999988    333333321111


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~~  235 (235)
                      .                            ...++..++++++.++..+|..|..     +.++++|+||+.++|++|
T Consensus       206 ~----------------------------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  206 M----------------------------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             C----------------------------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence            0                            1135677889999999999999975     579999999999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=6.6e-20  Score=158.00  Aligned_cols=154  Identities=31%  Similarity=0.452  Sum_probs=127.3

Q ss_pred             HHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---------------CcccccccccccCchhhh
Q 026660           53 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK---------------KYTHEILTLWYRAPEVLL  117 (235)
Q Consensus        53 ~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~---------------~~~~~~~~~~y~~PE~~~  117 (235)
                      +.+++|||+.+++|+|+||+|.++..-+ .+++.|||+++.......               ......||+.|+|||++.
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            7789999999999999999999999666 999999999865432111               112347799999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCC
Q 026660          118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLD  197 (235)
Q Consensus       118 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (235)
                      -.. |+..+|.|++|+++|+.+-|..||.++..++...........-++.                         ...+.
T Consensus       232 rqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-------------------------dea~p  285 (1205)
T KOG0606|consen  232 RQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-------------------------DEALP  285 (1205)
T ss_pred             hhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-------------------------CcCCC
Confidence            555 8999999999999999999999999999988888877643322222                         22477


Q ss_pred             hhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCcC
Q 026660          198 KDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       198 ~~~~~li~~~l~~~p~~Rp---s~~~ll~hp~f~~~~~~  233 (235)
                      ++++++|.++|..+|..|-   ++-++.+|+||+..+|.
T Consensus       286 ~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  286 PEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             HHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            8999999999999999996   57789999999999997

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=2.7e-20  Score=160.88  Aligned_cols=183  Identities=28%  Similarity=0.398  Sum_probs=128.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +.++..|+|-+|...+|.|.+-    ..+.+.+-+++-++.||+.|+...|+.|++|||||.+|||+..-+ .+.++||.
T Consensus        91 ~t~kAAylvRqyvkhnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFA  165 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVKHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFA  165 (1431)
T ss_pred             HhhHHHHHHHHHHhhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhccc
Confidence            4566778888999889998884    456688899999999999999999999999999999999998665 78899998


Q ss_pred             CcccccCC---CCCcccccc----cccccCchhhhCCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           90 LARAFTLP---IKKYTHEIL----TLWYRAPEVLLGST----------HYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        90 ~~~~~~~~---~~~~~~~~~----~~~y~~PE~~~~~~----------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      .-+..--+   +...+.++.    -.+|+|||.+....          ..+++=||||+||++.|+++ |.+||....  
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--  243 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--  243 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--
Confidence            65432211   111121222    24799999996421          13467799999999999998 677773221  


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                        +-...+.                     .+..+.......  .+..++.+|..|++.||.+|.|+++.|+.
T Consensus       244 --L~aYr~~---------------------~~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 --LLAYRSG---------------------NADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             --HHhHhcc---------------------CccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence              1111100                     000011111111  23467899999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.80  E-value=8.1e-18  Score=134.08  Aligned_cols=200  Identities=31%  Similarity=0.505  Sum_probs=146.0

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ......+++++++.+ ++.+++...... ..++......++.|++.++.++|+.+++|+|+||+||+++..+..++++||
T Consensus        68 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          68 QDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEecc
Confidence            344448999999986 888666653221 368999999999999999999999999999999999999966546999999


Q ss_pred             CCcccccCCCC------CcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Q 026660           89 GLARAFTLPIK------KYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHI  157 (235)
Q Consensus        89 ~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~  157 (235)
                      |.+........      ......++..|++||...+.  ...+...|+|++|+++++++.|..||.....   .......
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            99875543332      23566779999999999763  4578999999999999999999999876653   2233222


Q ss_pred             HHHhCCC-CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          158 FRLLGTP-NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       158 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ......+ ....   ...        ...        ......+.+++.+++..+|..|.+..+...+++...
T Consensus       227 ~~~~~~~~~~~~---~~~--------~~~--------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         227 ILELPTPSLASP---LSP--------SNP--------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HHhcCCcccccc---cCc--------ccc--------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            2221111 0000   000        000        122356789999999999999999998888765543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=6.4e-20  Score=147.93  Aligned_cols=180  Identities=28%  Similarity=0.507  Sum_probs=132.7

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ..++||.|+.|. .+|.+++... ......+....+.++.|++.|++|   ++.+|+|++|.||.+..+. .++|+|||+
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl  402 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGL  402 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhh
Confidence            457999999998 5999999752 344567888999999999999999   9999999999999998776 899999999


Q ss_pred             cccccCCC------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           91 ARAFTLPI------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        91 ~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      ........      ...+...||..|++||.+.+.. ++.++|||+||+++++++. -...+..      .......   
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~---  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER------IATLTDI---  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhh---
Confidence            86554322      2456678899999999998766 8999999999999999997 2222111      1111000   


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                       ...               .+++....    ++ ++-..|+.+++...|.+||++.+.--|+|.
T Consensus       473 -r~g---------------~ip~~~~~----d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 -RDG---------------IIPPEFLQ----DY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -hcC---------------CCChHHhh----cC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence             000               00000000    11 233489999999999999988888778775

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=1.1e-17  Score=136.99  Aligned_cols=185  Identities=22%  Similarity=0.317  Sum_probs=133.2

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCc-eecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI-LHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~-~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ...++|.+||+ |+|.+.+.+   ....++.-....++++++.||+|||.-.+ .|+.+++.|++++ ..+.+++.|||+
T Consensus        20 ~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd-~~w~lklt~~Gl   95 (484)
T KOG1023|consen   20 PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD-SRWVLKLTDFGL   95 (484)
T ss_pred             CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee-eeEEEEechhhh
Confidence            67899999998 699999977   34467888999999999999999997654 9999999999999 445999999998


Q ss_pred             cccccC--CCCCcccccccccccCchhhhCCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Q 026660           91 ARAFTL--PIKKYTHEILTLWYRAPEVLLGSTH------YSTAVDMWSVACIFAELVTKTALFPGDSEL----QQLLHIF  158 (235)
Q Consensus        91 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~  158 (235)
                      ......  .........-...|.|||.+.+...      .+.+.|+||+|++++++++...||......    +....+.
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~  175 (484)
T KOG1023|consen   96 NSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVK  175 (484)
T ss_pred             cccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHH
Confidence            865532  1111111222456899999875321      356789999999999999999999764321    2222222


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      +   .....+.+.+..                 .. ...+++..+++.|+..+|.+||+++++-
T Consensus       176 ~---~~~~~~rP~i~~-----------------~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  176 K---GGSNPFRPSIEL-----------------LN-ELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             h---cCCCCcCcchhh-----------------hh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence            1   111111111110                 00 3455788999999999999999999874

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=3.3e-17  Score=125.62  Aligned_cols=184  Identities=18%  Similarity=0.259  Sum_probs=136.3

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC----CeEEEe
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIA   86 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~----~~~~l~   86 (235)
                      +..+-.+|+|+++.||.|++.-   .++.++..++..++.|++.-++++|++.+++|||||+|+||...+    ..+.++
T Consensus        95 eG~~NiLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   95 EGKYNILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             ccchhhhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence            3445578999999999998875   456899999999999999999999999999999999999996432    368999


Q ss_pred             ecCCcccccCCCCC-------cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           87 DLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        87 df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      |||+++.+-.+.++       .....||..||+--...+.+ .+...|+=|||-++.+.+-|..||.+........+...
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            99999888766553       33457799999988887777 68999999999999999999999987654333333332


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      + +....                   ...+.....+++.++...++-.-..+-.+-|..
T Consensus       251 I-Ge~Kr-------------------~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  251 I-GETKR-------------------STPIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             h-ccccc-------------------cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            2 11110                   012223333566676666655555555555553

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=3.9e-17  Score=120.17  Aligned_cols=145  Identities=21%  Similarity=0.263  Sum_probs=117.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--CCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~~~~~~   84 (235)
                      ....++.+-.+||+.++.+|.+++.-   ..+.++..+++-++-|++.-++|+|.++++||||||+|+|..-  ....+.
T Consensus        78 ~y~~e~~ynvlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~  154 (341)
T KOG1163|consen   78 HYGTEKDYNVLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLY  154 (341)
T ss_pred             hhccccccceeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEE
Confidence            34567778899999999999998754   2356899999999999999999999999999999999999853  344789


Q ss_pred             EeecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 026660           85 IADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL  155 (235)
Q Consensus        85 l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  155 (235)
                      ++|||+++.+....+       ......||..|.|--...+.. .+...|+=|+|.++.++.-|..||.+-.......
T Consensus       155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            999999988764433       334567788898877776655 5789999999999999999999998865433333

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.69  E-value=2.8e-16  Score=117.73  Aligned_cols=178  Identities=20%  Similarity=0.261  Sum_probs=128.3

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCC-CeEEE
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKT-MTLKI   85 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~-~~~~l   85 (235)
                      +...++.+|..||+ |+|...++.  ..+--++-.++.+++.+++.|++|||+..  +.--.+++..++++.+- ..+..
T Consensus       257 nsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism  334 (448)
T KOG0195|consen  257 NSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM  334 (448)
T ss_pred             cCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec
Confidence            45677899999999 799999976  33444678899999999999999999874  55667888899998553 12333


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|.-++...  ..+     .-++.|++||.+.....  .-.++|+|||+++++|+.+...||.+-...+...++.--   
T Consensus       335 ad~kfsfqe--~gr-----~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale---  404 (448)
T KOG0195|consen  335 ADTKFSFQE--VGR-----AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE---  404 (448)
T ss_pred             ccceeeeec--ccc-----ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc---
Confidence            443333211  111     22678999999874322  346899999999999999999999887765554433210   


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                                             ..-....++.+.....++.-|++.||.+||.++.++
T Consensus       405 -----------------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 -----------------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                                   001122346778889999999999999999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=8.8e-15  Score=112.43  Aligned_cols=191  Identities=15%  Similarity=0.229  Sum_probs=129.6

Q ss_pred             cCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEE
Q 026660            8 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+++....+++|||. |++.++|++....+..+......+|+.||+.||.|||+..  ++|+++..+.|.+..++ -++
T Consensus       140 K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIk  218 (458)
T KOG1266|consen  140 KYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIK  218 (458)
T ss_pred             ccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEE
Confidence            3456667899999997 7999999998888888999999999999999999999885  89999999999998555 555


Q ss_pred             EeecCCc--ccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Q 026660           85 IADLGLA--RAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~--~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~  159 (235)
                      +....-.  +.......  ......+.++|.+||.-.. .+.+.++|||++|+...++..+..--..... ...-..+.+
T Consensus       219 ig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~  297 (458)
T KOG1266|consen  219 IGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN  297 (458)
T ss_pred             ecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh
Confidence            5432211  10000000  1112234567889886433 2356789999999998888876543222111 111111111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCC-hhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLD-KDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .+                                ..++ +.-++++.+|++..|..||++..++-||..-++..
T Consensus       298 ~i--------------------------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  298 VI--------------------------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             he--------------------------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence            00                                0111 12247899999999999999999999997655543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.56  E-value=2.8e-14  Score=105.19  Aligned_cols=123  Identities=15%  Similarity=0.050  Sum_probs=87.7

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCcEEEcCCCCeEEEeecCCcc
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL-KPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di-~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .|++|||+.| +|...+..          . ...++.|++.+|+++|++|++|+|| ||+||+++.++ .++|+|||++.
T Consensus        73 ~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~  140 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAV  140 (218)
T ss_pred             EEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence            5999999988 77543211          1 1357789999999999999999999 79999998666 89999999997


Q ss_pred             cccCCCCC----c---------ccccccccccCchhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 026660           93 AFTLPIKK----Y---------THEILTLWYRAPEVLLGSTHYS-TAVDMWSVACIFAELVTKTALFPGDS  149 (235)
Q Consensus        93 ~~~~~~~~----~---------~~~~~~~~y~~PE~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~  149 (235)
                      ........    .         .....++.++.|+...-....+ ...+.++.|+-+|.++|+..+..+++
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            54432210    0         0011255667776554322233 56778889999999999998876544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=2.7e-14  Score=125.19  Aligned_cols=125  Identities=23%  Similarity=0.303  Sum_probs=105.4

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC------CCCeEEE
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR------KTMTLKI   85 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~------~~~~~~l   85 (235)
                      +.-++|+||.+ |+|.+++.    ..+.+++..++.++.|++.-++.||..+|+||||||+|+++..      +...++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence            34689999998 79999997    4667999999999999999999999999999999999999832      3346899


Q ss_pred             eecCCccccc--CCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFT--LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT  142 (235)
Q Consensus        86 ~df~~~~~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~  142 (235)
                      +|||.+....  .+........+|-.+-.+|+..+.. ++...|-|.++.+++-|+.|.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence            9999986443  2233455667788899999998766 999999999999999999975

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=3.8e-14  Score=116.61  Aligned_cols=194  Identities=21%  Similarity=0.237  Sum_probs=150.4

Q ss_pred             cccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCceecCCCCCcEEEcC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK----GVAFCHGHGILHRDLKPHNLLMDR   78 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~----~l~~Lh~~~~~H~di~~~nil~~~   78 (235)
                      |+....+++.+.+|+-+|+|+.+|.++....   +..+++..++....+...    |+.++|+.+++|.+++|.||....
T Consensus       181 v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  181 VRDSPAWEGSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS  257 (524)
T ss_pred             cccCcccccCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc
Confidence            5568899999999999999999999998773   445888999999999999    999999999999999999999987


Q ss_pred             CCCeEEEeecCCcccccCCCCCc-----ccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHH
Q 026660           79 KTMTLKIADLGLARAFTLPIKKY-----THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD--SEL  151 (235)
Q Consensus        79 ~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~  151 (235)
                      +....+++||+............     ....+...|++||...+.  ++..+|+|++|.++.+...+..+...+  ...
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W  335 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSW  335 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence            73488999999987776543222     223567789999988643  689999999999999988877665443  221


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .+.....                             .......+.+..+...+..|+..+|..|++.+.+.+|++....
T Consensus       336 ~~~r~~~-----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  336 SQLRQGY-----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ccccccc-----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            1111110                             0011122455667779999999999999999999999987644

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.53  E-value=2.6e-14  Score=105.62  Aligned_cols=73  Identities=19%  Similarity=0.255  Sum_probs=61.4

Q ss_pred             EEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           16 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        16 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~L-h~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      +|||||++| ++......    ...++.+.+..++.|++.+|.++ |+.|++|+||||+||+++ ++ .++++|||++..
T Consensus        93 ~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~-~v~LiDFG~a~~  166 (190)
T cd05147          93 VLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG-KLYIIDVSQSVE  166 (190)
T ss_pred             EEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC-cEEEEEcccccc
Confidence            899999997 55443322    24689999999999999999999 799999999999999998 44 799999999854


Q ss_pred             c
Q 026660           94 F   94 (235)
Q Consensus        94 ~   94 (235)
                      .
T Consensus       167 ~  167 (190)
T cd05147         167 H  167 (190)
T ss_pred             C
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.53  E-value=9.6e-15  Score=109.64  Aligned_cols=101  Identities=17%  Similarity=0.277  Sum_probs=73.9

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+++|||++| +|.++..        +++    ....+++.++..+|+.|++|+|++|+|++++.++  ++++|||.
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg~  180 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLSG  180 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECCC
Confidence            4468999999998 8877631        333    2456999999999999999999999999998665  99999997


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHH
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV  139 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~  139 (235)
                      ..........            ...+.... +..++|+|+||+++..+.
T Consensus       181 ~~~~~e~~a~------------d~~vler~-y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKAK------------DRIDLERH-YGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhhH------------HHHHHHhH-hcccccccceeEeehHHH
Confidence            7544211110            00222223 557999999999977654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=3.2e-15  Score=127.52  Aligned_cols=201  Identities=24%  Similarity=0.363  Sum_probs=150.5

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEcCCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~~~~~   81 (235)
                      .......+.+..++++++..| ++.+-+..  ......+...+..++.|+..++.|+| ..+++|+|++|+|.+++..+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~  162 (601)
T KOG0590|consen   85 HMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS  162 (601)
T ss_pred             ccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC
Confidence            345566778889999999875 77766631  12225778889999999999999999 999999999999999986654


Q ss_pred             eEEEeecCCcccccC-CCC--Ccccccc-cccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           82 TLKIADLGLARAFTL-PIK--KYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        82 ~~~l~df~~~~~~~~-~~~--~~~~~~~-~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      ..+..|||++..+.. ...  ......| ++.|++||...+........|+||.|+++..+++|..|+..........  
T Consensus       163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--  240 (601)
T KOG0590|consen  163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--  240 (601)
T ss_pred             cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--
Confidence            789999999977654 212  2334566 8899999999876556789999999999999999999987554322100  


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                        ..|....   ..........++....+++.+++..+|..|.+.+++..+||+..
T Consensus       241 ------------------~~~~~~~---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 ------------------SSWKSNK---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ------------------eeecccc---cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                              0011110   00012223356777889999999999999999999999999887

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.48  E-value=1.6e-13  Score=101.59  Aligned_cols=73  Identities=19%  Similarity=0.258  Sum_probs=61.2

Q ss_pred             EEEEecCcc-CHHHH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           16 YLVFEYMDT-DLKKY-IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        16 ~lv~e~~~g-~L~~~-l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      |+||||++| ++... +..     ..++.+.+..++.|++.++.++|+ .|++|+||||+||+++ ++ .++++|||++.
T Consensus        93 ~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-~~~liDFG~a~  165 (190)
T cd05145          93 VLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-KPYIIDVSQAV  165 (190)
T ss_pred             EEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-CEEEEEcccce
Confidence            899999987 44332 322     357888999999999999999999 9999999999999998 55 89999999986


Q ss_pred             ccc
Q 026660           93 AFT   95 (235)
Q Consensus        93 ~~~   95 (235)
                      ...
T Consensus       166 ~~~  168 (190)
T cd05145         166 ELD  168 (190)
T ss_pred             ecC
Confidence            543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.47  E-value=1.3e-13  Score=110.93  Aligned_cols=93  Identities=26%  Similarity=0.257  Sum_probs=70.0

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCcEEEcCCCCeEEEeecCCc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL-KPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di-~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ..|+||||+.| +|.. +.    .   ..   ...++.|++.||.+||++|++|+|| ||+||+++.++ .++|+|||++
T Consensus        92 ~~~LVmE~~~G~~L~~-~~----~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-AR----P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHH-hC----c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccc
Confidence            47999999987 7752 21    1   11   1467899999999999999999999 99999998666 8999999999


Q ss_pred             ccccCCCCCc--------ccccccccccCchhhhC
Q 026660           92 RAFTLPIKKY--------THEILTLWYRAPEVLLG  118 (235)
Q Consensus        92 ~~~~~~~~~~--------~~~~~~~~y~~PE~~~~  118 (235)
                      +.+.......        ....+++.|.+||....
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            8665432111        23345677899998863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=1.2e-13  Score=120.08  Aligned_cols=194  Identities=26%  Similarity=0.402  Sum_probs=147.0

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      -...++++++|++| +|..-+++-    +..+.+.....+..+.++.++||...+.|+|++|.|++....+ ...+.+|+
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~  949 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFG  949 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccc
Confidence            34567899999985 888888762    3567778888888999999999999999999999999998766 77777776


Q ss_pred             Cccccc---------------------CC----------CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHH
Q 026660           90 LARAFT---------------------LP----------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL  138 (235)
Q Consensus        90 ~~~~~~---------------------~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l  138 (235)
                      .....+                     ..          ........+|+.|.+||...+.. .+..+|.|+.|+++++.
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhh
Confidence            221110                     00          01123446688999999998766 67889999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          139 VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       139 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      ++|..||......+...++.....     .|+.                    -....+.+..+++.+.+..+|.+|..+
T Consensus      1029 l~g~pp~na~tpq~~f~ni~~~~~-----~~p~--------------------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIFENILNRDI-----PWPE--------------------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             hcCCCCCCCcchhhhhhccccCCC-----CCCC--------------------CccccChhhhhhhhhhhccCchhccCc
Confidence            999999998877665544432110     0111                    111366778899999999999999988


Q ss_pred             H---HHhCCCCCCCCCcCCC
Q 026660          219 K---KAMEHPYFDDLDKTRL  235 (235)
Q Consensus       219 ~---~ll~hp~f~~~~~~~~  235 (235)
                      .   ++-.||||++++|+.|
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             ccccccccCCccCCCCcccc
Confidence            8   8899999999999864

>smart00090 RIO RIO-like kinase

Probab=99.33  E-value=2.5e-12  Score=98.23  Aligned_cols=75  Identities=17%  Similarity=0.186  Sum_probs=61.5

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~-~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++||||++| +|......    ........+..++.|++.++.+||+.| ++|+||+|+||+++ ++ .++++|||.+.
T Consensus       123 ~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~  196 (237)
T smart00090      123 NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSV  196 (237)
T ss_pred             ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhh
Confidence            4899999998 66554322    234566778899999999999999999 99999999999998 55 89999999875


Q ss_pred             ccc
Q 026660           93 AFT   95 (235)
Q Consensus        93 ~~~   95 (235)
                      ...
T Consensus       197 ~~~  199 (237)
T smart00090      197 ELD  199 (237)
T ss_pred             ccC
Confidence            443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.7e-12  Score=108.80  Aligned_cols=161  Identities=20%  Similarity=0.318  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----Ccc-----cccccccccCchhh
Q 026660           47 SLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYT-----HEILTLWYRAPEVL  116 (235)
Q Consensus        47 ~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~----~~~-----~~~~~~~y~~PE~~  116 (235)
                      .=+.+.+.|+.++|. .+++|++|.|++|.++..+ .++++.|+++.....+..    .+.     .......|.+||.+
T Consensus       103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            334556689999995 5899999999999999776 899999988754433211    011     11224569999999


Q ss_pred             hCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCC
Q 026660          117 LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  195 (235)
Q Consensus       117 ~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (235)
                      .+.. .+.++|+||+|+++|.+..|..+ +...+....+.........                        .......+
T Consensus       182 ~~~~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~------------------------~~~~~s~~  236 (700)
T KOG2137|consen  182 LGTT-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA------------------------GAFGYSNN  236 (700)
T ss_pred             cccc-ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc------------------------cccccccc
Confidence            7744 78999999999999999954444 4443332222222111000                        00001136


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          196 LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       196 ~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      +++++++=+++++..++..||++.+++..|||++-.-.
T Consensus       237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK  274 (700)
T ss_pred             CcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence            88999999999999999999999999999999986543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.23  E-value=6.9e-10  Score=88.84  Aligned_cols=190  Identities=14%  Similarity=0.118  Sum_probs=123.5

Q ss_pred             EEEEEecCcc--CHHHHHHH--hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           15 LYLVFEYMDT--DLKKYIRS--FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        15 ~~lv~e~~~g--~L~~~l~~--~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +.++|+..+|  -+..++.-  ..+......++..+++++.++.+.+.||..|.+-+|+.++|+++++++ .+.+.|-..
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDs  163 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDS  163 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccc
Confidence            8899999875  45544422  112233467899999999999999999999999999999999999777 888887543


Q ss_pred             cccccCCCCCcccccccccccCchhhhCC----CCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------HHHHHHHHH
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTK-TALFPGDS-------ELQQLLHIF  158 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~-------~~~~~~~~~  158 (235)
                      .... ..........+...|++||...-.    -.-+...|.|.||+++++++.| ..||.+-.       ..+..  +.
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~--Ia  240 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD--IA  240 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh--hh
Confidence            3222 223344556778899999987511    1134678999999999999886 99996532       11100  00


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhccc--CCCCCCCHHH
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQY--DPSKRISAKK  220 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~  220 (235)
                      ...       +....     +......+...+-...-+++.+..+..+|+..  ++.-|||++.
T Consensus       241 ~g~-------f~ya~-----~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         241 HGR-------FAYAS-----DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             cce-------eeech-----hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            000       00000     00011111122223335778888999999875  3568999764

>PRK10345 hypothetical protein; Provisional

Probab=99.23  E-value=4.4e-11  Score=89.43  Aligned_cols=70  Identities=19%  Similarity=0.304  Sum_probs=54.2

Q ss_pred             eEEE-EEEecCc---cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCceecCCCCCcEEEcCC---CCeEE
Q 026660           13 TVLY-LVFEYMD---TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV-AFCHGHGILHRDLKPHNLLMDRK---TMTLK   84 (235)
Q Consensus        13 ~~~~-lv~e~~~---g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l-~~Lh~~~~~H~di~~~nil~~~~---~~~~~   84 (235)
                      +.++ +|+||++   |+|.+++.+     ..++++  ..++.|++.++ +|||+++++|+||||+||+++..   ...++
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEE
Confidence            3544 7899954   599999965     135555  35678888887 89999999999999999999742   23799


Q ss_pred             EeecC
Q 026660           85 IADLG   89 (235)
Q Consensus        85 l~df~   89 (235)
                      |+|++
T Consensus       150 LiDg~  154 (210)
T PRK10345        150 VCDNI  154 (210)
T ss_pred             EEECC
Confidence            99954

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.22  E-value=5.6e-11  Score=90.98  Aligned_cols=69  Identities=20%  Similarity=0.359  Sum_probs=56.9

Q ss_pred             EEEEEecCcc--CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           15 LYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        15 ~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|||+++|  +|.+++..     ..++++.    +.|++.++.+||++|++|+||+|.||+++.++ .++++|||.+.
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~~~  190 (239)
T PRK01723        121 ADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDRGE  190 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCCcc
Confidence            3599999985  88888754     2355443    57899999999999999999999999998766 89999999875


Q ss_pred             c
Q 026660           93 A   93 (235)
Q Consensus        93 ~   93 (235)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            3

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.21  E-value=6.8e-11  Score=88.98  Aligned_cols=72  Identities=28%  Similarity=0.429  Sum_probs=61.7

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....+++|||++| +|.+++...       .. ....++.+++.+|.++|+.+++|+|++|.||+++ .+ .+.++|||.
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~  140 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGL  140 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCc
Confidence            3456899999987 999988651       12 8889999999999999999999999999999999 44 799999998


Q ss_pred             ccc
Q 026660           91 ARA   93 (235)
Q Consensus        91 ~~~   93 (235)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=3.8e-10  Score=94.65  Aligned_cols=125  Identities=18%  Similarity=0.282  Sum_probs=92.4

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +....++++.+|+|+|.+.. |..++..       +....+..-++||+.||.+|| +.+++|+++....|+++..| .+
T Consensus        74 yL~t~e~~~~~ylvTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eW  144 (690)
T KOG1243|consen   74 YLDTTEEEGTLYLVTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EW  144 (690)
T ss_pred             hhhhhcccCceEEEeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cE
Confidence            45667888899999998863 4455655       447788999999999999998 66899999999999999888 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK  141 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g  141 (235)
                      +|++|.++..................|..|+....   ..-..|.|.|||++++++.|
T Consensus       145 kLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  145 KLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             EEeeeEEEeccccCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            99999877543322111111111234677775432   12467999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.19  E-value=5.5e-11  Score=88.65  Aligned_cols=71  Identities=23%  Similarity=0.354  Sum_probs=58.8

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++||||++| +|.....          ......++.+++.++.++|+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus       105 ~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~  173 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMV  173 (198)
T ss_pred             CceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccc
Confidence            45899999987 7765432          134578889999999999999999999999999999765 89999999885


Q ss_pred             ccc
Q 026660           93 AFT   95 (235)
Q Consensus        93 ~~~   95 (235)
                      ...
T Consensus       174 ~~~  176 (198)
T cd05144         174 STD  176 (198)
T ss_pred             cCC
Confidence            544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.18  E-value=7e-11  Score=88.07  Aligned_cols=67  Identities=28%  Similarity=0.467  Sum_probs=57.2

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++||||++| +|.+++....    .       .++.|++.+|.+||+.+++|+|++|.||+++ .+ .++++|||.+.
T Consensus        71 ~~~lv~e~~~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~  137 (199)
T TIGR03724        71 NKTIVMEYIEGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGK  137 (199)
T ss_pred             CCEEEEEEECCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCc
Confidence            45899999986 9988775411    0       8899999999999999999999999999999 54 89999999875


Q ss_pred             c
Q 026660           93 A   93 (235)
Q Consensus        93 ~   93 (235)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            4

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.12  E-value=1.4e-10  Score=98.96  Aligned_cols=67  Identities=30%  Similarity=0.453  Sum_probs=58.0

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++||||++| +|.+++.            ....++.|++.+|.+||+.+++|+|+||+||+++ ++ .++++|||++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla  474 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLG  474 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccc
Confidence            346899999986 9998875            3467899999999999999999999999999994 44 7999999988


Q ss_pred             cc
Q 026660           92 RA   93 (235)
Q Consensus        92 ~~   93 (235)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            54

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.04  E-value=7e-10  Score=81.82  Aligned_cols=73  Identities=22%  Similarity=0.332  Sum_probs=57.2

Q ss_pred             EEEEEecCcc-CHH-HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           15 LYLVFEYMDT-DLK-KYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        15 ~~lv~e~~~g-~L~-~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++||||++| ++. ..+....     . .+.+..++.+++.++.++|. .+++|+||+|+||+++ ++ .++++|||.+
T Consensus        90 ~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a  161 (187)
T cd05119          90 HVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQA  161 (187)
T ss_pred             CEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-cEEEEECccc
Confidence            5899999986 322 2222211     1 16788999999999999999 9999999999999999 55 8999999988


Q ss_pred             cccc
Q 026660           92 RAFT   95 (235)
Q Consensus        92 ~~~~   95 (235)
                      ....
T Consensus       162 ~~~~  165 (187)
T cd05119         162 VEID  165 (187)
T ss_pred             cccc
Confidence            5443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.99  E-value=1.7e-09  Score=79.69  Aligned_cols=74  Identities=16%  Similarity=0.249  Sum_probs=57.3

Q ss_pred             EEEEEecCcc-CHHH-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           15 LYLVFEYMDT-DLKK-YIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~-~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~L-h~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      -++||||+++ .+.. .+.+     ..++.+.+..+..+++.++..| |+.|++|+|+++.||++. ++ .+.++|||.+
T Consensus        99 ~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~-~v~iIDF~qa  171 (197)
T cd05146          99 HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DG-KVWFIDVSQS  171 (197)
T ss_pred             CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CC-cEEEEECCCc
Confidence            4789999986 3321 2222     2355667788889999999998 899999999999999998 44 7999999988


Q ss_pred             cccc
Q 026660           92 RAFT   95 (235)
Q Consensus        92 ~~~~   95 (235)
                      ....
T Consensus       172 v~~~  175 (197)
T cd05146         172 VEPT  175 (197)
T ss_pred             eeCC
Confidence            5443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=3.4e-09  Score=75.89  Aligned_cols=76  Identities=21%  Similarity=0.351  Sum_probs=62.8

Q ss_pred             EEEEEecCcc--CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE--EEeecCC
Q 026660           15 LYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL--KIADLGL   90 (235)
Q Consensus        15 ~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~--~l~df~~   90 (235)
                      -.|+||+..|  ++.+++....+.  ....+....++.++-..+.-||+++++|+|+..+||++..++..+  .++|||+
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence            3688999998  999999885432  244455588899999999999999999999999999997666544  8999998


Q ss_pred             cc
Q 026660           91 AR   92 (235)
Q Consensus        91 ~~   92 (235)
                      +.
T Consensus       163 s~  164 (229)
T KOG3087|consen  163 SS  164 (229)
T ss_pred             hh
Confidence            84

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=1.2e-08  Score=79.15  Aligned_cols=79  Identities=20%  Similarity=0.297  Sum_probs=65.5

Q ss_pred             ceEEEEEEecCcc--CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC------CCCeE
Q 026660           12 RTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR------KTMTL   83 (235)
Q Consensus        12 ~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~------~~~~~   83 (235)
                      ....++|||+++|  +|.+++..+..  ...+.+....++.+++..+.-||+.|++|+|+++.||+++.      +...+
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3457899999986  79999876432  34567788899999999999999999999999999999974      23478


Q ss_pred             EEeecCCcc
Q 026660           84 KIADLGLAR   92 (235)
Q Consensus        84 ~l~df~~~~   92 (235)
                      .++||+.+.
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999774

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=6.5e-09  Score=74.60  Aligned_cols=66  Identities=26%  Similarity=0.415  Sum_probs=54.3

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ...|+|||.+| .|++.+...       .    ..++..+-.-+.-||+.|++|+|+.++|+++..+  ++.++|||++.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~  139 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGE  139 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccc
Confidence            34699999998 888888762       2    4555666667788999999999999999999955  59999999984

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.88  E-value=9.4e-10  Score=91.05  Aligned_cols=184  Identities=18%  Similarity=0.176  Sum_probs=128.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...|...+..|+=.|||.+ ++...+..    ...+.+...+++..|++.++.++|+..++|.|++|+||++..++...+
T Consensus       332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             CCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhh
Confidence            3677888888999999964 66555522    234788899999999999999999999999999999999997655788


Q ss_pred             EeecCCcccccCCCCCccccccccccc-CchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYR-APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~-~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +.||+....+.   .........-.+. .+|.+........+.|++++|..+.+..++...-........+         
T Consensus       408 ~~~~~~~t~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i---------  475 (524)
T KOG0601|consen  408 LGDFGCWTRLA---FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI---------  475 (524)
T ss_pred             ccccccccccc---eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee---------
Confidence            89998775422   1111222233344 2565655555789999999999999988865433222210000         


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                               .             .......++.+.++..+.+.+...++..||++.++..|.=|
T Consensus       476 ---------~-------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  476 ---------R-------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ---------e-------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                     0             00111112333667789999999999999999999888644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.85  E-value=8e-09  Score=73.02  Aligned_cols=71  Identities=28%  Similarity=0.372  Sum_probs=58.4

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCcEEEcCCCCeEEE
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---GILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~---~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+..++++||++| ++..+           +......++.+++.+++.||..   +++|+|++++||+++..+ .+++
T Consensus        63 ~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l  130 (155)
T cd05120          63 ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGI  130 (155)
T ss_pred             CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEE
Confidence            334678999999987 55432           5567778899999999999985   699999999999999755 8999


Q ss_pred             eecCCcc
Q 026660           86 ADLGLAR   92 (235)
Q Consensus        86 ~df~~~~   92 (235)
                      +||+.+.
T Consensus       131 ~Df~~~~  137 (155)
T cd05120         131 IDWEYAG  137 (155)
T ss_pred             Eeccccc
Confidence            9999774

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=2.4e-08  Score=74.79  Aligned_cols=77  Identities=29%  Similarity=0.463  Sum_probs=65.2

Q ss_pred             eEEEEEEecCcc--CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeEEEeec
Q 026660           13 TVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADL   88 (235)
Q Consensus        13 ~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~~l~df   88 (235)
                      ...++|+|+++|  +|.+++.....    .+......++.+++..++-||++|++|+|+++.|||+..++  ..+.++||
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDl  165 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDL  165 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence            567999999986  79999977432    66778889999999999999999999999999999998654  36889999


Q ss_pred             CCccc
Q 026660           89 GLARA   93 (235)
Q Consensus        89 ~~~~~   93 (235)
                      +.++.
T Consensus       166 d~~~~  170 (206)
T PF06293_consen  166 DRMRF  170 (206)
T ss_pred             hhcee
Confidence            97653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.67  E-value=1e-06  Score=72.61  Aligned_cols=160  Identities=18%  Similarity=0.229  Sum_probs=111.5

Q ss_pred             CceEEEEEEecCcc--CHHHHHHH-----------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc
Q 026660           11 GRTVLYLVFEYMDT--DLKKYIRS-----------FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD   77 (235)
Q Consensus        11 ~~~~~~lv~e~~~g--~L~~~l~~-----------~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~   77 (235)
                      ++..+++|++|+++  +|.++.=.           +...+.+.+++.+|.++.|+..||.++|+.|++-+-+.+.+|++.
T Consensus       348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~  427 (655)
T KOG3741|consen  348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT  427 (655)
T ss_pred             CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee
Confidence            56679999999984  78776522           123445578999999999999999999999999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP-GDSELQQLLH  156 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~  156 (235)
                      .+. ++++..-|....+....            .  |-+.    --.+.|.=.||.+++.|.+|..--. .....+..  
T Consensus       428 G~~-RIriS~C~i~Dvl~~d~------------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--  486 (655)
T KOG3741|consen  428 GKM-RIRISGCGIMDVLQEDP------------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--  486 (655)
T ss_pred             Ccc-eEEEecccceeeecCCC------------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHH--
Confidence            665 77776555443332221            0  1111    2256789999999999999854311 11111110  


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                      +......++.+++++|.-+.+.++.+ -++.+++.+
T Consensus       487 --------------------------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 --------------------------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --------------------------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                                            11122257889999999999988887 677777654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.66  E-value=7e-08  Score=80.28  Aligned_cols=75  Identities=20%  Similarity=0.316  Sum_probs=56.5

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK-GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~-~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ..++||||++| +|.++....  .. ..   ....++.+++. .+..+|..|++|+|++|.||++..++ .++++|||++
T Consensus       232 ~~vLvmE~i~G~~L~~~~~~~--~~-~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g-~i~liDfG~~  304 (437)
T TIGR01982       232 ERVLTMEWIDGIPLSDIAALD--EA-GL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG-KIIALDFGIV  304 (437)
T ss_pred             CceEEEEeECCcccccHHHHH--hc-CC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC-cEEEEeCCCe
Confidence            35899999987 888876541  11 12   23445555555 46789999999999999999998776 8999999998


Q ss_pred             cccc
Q 026660           92 RAFT   95 (235)
Q Consensus        92 ~~~~   95 (235)
                      ..+.
T Consensus       305 ~~l~  308 (437)
T TIGR01982       305 GRLS  308 (437)
T ss_pred             eECC
Confidence            6554

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=3.9e-08  Score=72.16  Aligned_cols=71  Identities=27%  Similarity=0.457  Sum_probs=48.9

Q ss_pred             EEEEecCc--c-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           16 YLVFEYMD--T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF-CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        16 ~lv~e~~~--g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~-Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +|||||++  | .+.. +...     .++.+....++.+++..+.. +|+.|++|+|+++.||+++.+  .+.++|||.+
T Consensus        82 ~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qa  153 (188)
T PF01163_consen   82 VIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQA  153 (188)
T ss_dssp             EEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTE
T ss_pred             EEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCcc
Confidence            69999999  7 4444 3331     12255677788888885555 679999999999999999955  7999999987


Q ss_pred             ccc
Q 026660           92 RAF   94 (235)
Q Consensus        92 ~~~   94 (235)
                      ...
T Consensus       154 v~~  156 (188)
T PF01163_consen  154 VDS  156 (188)
T ss_dssp             EET
T ss_pred             eec
Confidence            543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.58  E-value=1e-07  Score=69.05  Aligned_cols=64  Identities=23%  Similarity=0.322  Sum_probs=50.1

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eecCCCCCcEEEcCCCCeEEEeec
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI-----LHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~-----~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      -++|||+++| ++.+.         ..   .....+.+++.+++.||+.++     +|+|+++.||+++ ++ .++++||
T Consensus        66 ~~lv~e~i~G~~l~~~---------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf  131 (170)
T cd05151          66 GVLITEFIEGSELLTE---------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDW  131 (170)
T ss_pred             CeEEEEecCCCccccc---------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEec
Confidence            3799999998 65432         01   123456789999999999885     9999999999999 44 7899999


Q ss_pred             CCcc
Q 026660           89 GLAR   92 (235)
Q Consensus        89 ~~~~   92 (235)
                      +.+.
T Consensus       132 ~~a~  135 (170)
T cd05151         132 EYAG  135 (170)
T ss_pred             cccc
Confidence            9764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09902 hypothetical protein; Provisional

Probab=98.57  E-value=5.7e-07  Score=66.67  Aligned_cols=81  Identities=12%  Similarity=0.090  Sum_probs=66.6

Q ss_pred             CceEEEEEEecCcc--CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-CeEEEee
Q 026660           11 GRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIAD   87 (235)
Q Consensus        11 ~~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-~~~~l~d   87 (235)
                      .....+||+|-++|  ||.+++.+.  .-...+......++.+++..++-||+.|+.|+|+.+.||+++.++ ..+.++|
T Consensus        96 ~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         96 GEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             CceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence            35668999998884  999998662  122467888899999999999999999999999999999998554 2499999


Q ss_pred             cCCccc
Q 026660           88 LGLARA   93 (235)
Q Consensus        88 f~~~~~   93 (235)
                      |..++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            997753

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.40  E-value=1.1e-06  Score=65.57  Aligned_cols=67  Identities=24%  Similarity=0.401  Sum_probs=51.2

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      -....+++|||++| .|.++..        +++    .+.-.+.+++.-||+.|++|+|++|.|+++..+  .++++|++
T Consensus       114 ~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~  179 (229)
T PF06176_consen  114 YTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQ  179 (229)
T ss_pred             ceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECc
Confidence            34556789999998 7665432        232    233556678999999999999999999999954  59999998


Q ss_pred             Cc
Q 026660           90 LA   91 (235)
Q Consensus        90 ~~   91 (235)
                      ..
T Consensus       180 ~k  181 (229)
T PF06176_consen  180 GK  181 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.31  E-value=7.9e-07  Score=75.35  Aligned_cols=74  Identities=19%  Similarity=0.331  Sum_probs=49.8

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC---CeEEEe
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTG---ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIA   86 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~---~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~---~~~~l~   86 (235)
                      .-++||||+.| ++.+.-.- ...+   ..+.+..+..++.|+       ...|++|+|++|.||+++.++   ..++++
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            34699999997 88774221 1111   123333444444444       468999999999999998654   278999


Q ss_pred             ecCCccccc
Q 026660           87 DLGLARAFT   95 (235)
Q Consensus        87 df~~~~~~~   95 (235)
                      |||++..+.
T Consensus       307 DFGivg~l~  315 (537)
T PRK04750        307 DFGIVGSLN  315 (537)
T ss_pred             ecceEEECC
Confidence            999986554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.07  E-value=2.8e-05  Score=70.06  Aligned_cols=170  Identities=21%  Similarity=0.309  Sum_probs=104.6

Q ss_pred             EEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE---EEcCCCCeEEEe--ecCCc
Q 026660           18 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL---LMDRKTMTLKIA--DLGLA   91 (235)
Q Consensus        18 v~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni---l~~~~~~~~~l~--df~~~   91 (235)
                      ..+++++ ++.+.+..    -..++.+..+.+..++++|++++|+..+.|.-+..+..   ..+..+ .+.+.  +|+.+
T Consensus       264 ~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss  338 (1351)
T KOG1035|consen  264 LQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSS  338 (1351)
T ss_pred             HHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc-eeecchhhhccc
Confidence            3456665 66666655    24588999999999999999999999666655554422   222222 33333  66666


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      ..+...... .....+..+.++|...... ..+...|+|.+|.....+..|..+-........   .+            
T Consensus       339 ~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~---~l------------  402 (1351)
T KOG1035|consen  339 KPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS---LL------------  402 (1351)
T ss_pred             ccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh---hh------------
Confidence            544332221 1122244566666654322 123457999999999998887544322111000   00            


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                         ..   .......+.+.+|+..++++|+++.+++.|||.+.-
T Consensus       403 -------------------~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  403 -------------------DV---LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             -------------------cc---ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence                               00   011156688999999999999999999999997643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.85  E-value=3.2e-05  Score=58.37  Aligned_cols=74  Identities=22%  Similarity=0.340  Sum_probs=51.2

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-------------------------------   61 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-------------------------------   61 (235)
                      ..++|||+++| ++.+.+..     ..++.+....++.+++.+|..||+                               
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence            56899999987 66553311     235555556666666666666653                               


Q ss_pred             -------------------------cCceecCCCCCcEEEcCC-CCeEEEeecCCcc
Q 026660           62 -------------------------HGILHRDLKPHNLLMDRK-TMTLKIADLGLAR   92 (235)
Q Consensus        62 -------------------------~~~~H~di~~~nil~~~~-~~~~~l~df~~~~   92 (235)
                                               ..++|+|+.+.||+++.+ +..+.++||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                     236899999999999873 3267899999763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.81  E-value=4.9e-05  Score=58.28  Aligned_cols=71  Identities=21%  Similarity=0.360  Sum_probs=52.5

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .-++|||+..| -|...         .++.+..-.++..|+.-+.-+-..|++|+|++.-||+++.++ .+.++||-.+.
T Consensus       181 RHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         181 RHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             cceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEEEEeCcccc
Confidence            34899999998 33321         123445555666666666666689999999999999999887 89999998774


Q ss_pred             cc
Q 026660           93 AF   94 (235)
Q Consensus        93 ~~   94 (235)
                      ..
T Consensus       251 ~~  252 (304)
T COG0478         251 PI  252 (304)
T ss_pred             cC
Confidence            43

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.55  E-value=0.00027  Score=53.65  Aligned_cols=75  Identities=20%  Similarity=0.267  Sum_probs=53.3

Q ss_pred             EEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      -.+||||++.. .  ...-.-+.-.+..+.+..+..++++.+.-|-. .++||+||+.=|||+. ++ .+.++|++.+..
T Consensus       141 nVLvMEfIg~~-g--~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~  215 (268)
T COG1718         141 NVLVMEFIGDD-G--LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVT  215 (268)
T ss_pred             CeEEEEeccCC-C--CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECccccc
Confidence            36899999853 1  00000001112333678888899999988876 8999999999999999 55 899999998854


Q ss_pred             c
Q 026660           94 F   94 (235)
Q Consensus        94 ~   94 (235)
                      .
T Consensus       216 ~  216 (268)
T COG1718         216 I  216 (268)
T ss_pred             c
Confidence            3

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.47  E-value=0.00012  Score=61.96  Aligned_cols=80  Identities=19%  Similarity=0.297  Sum_probs=54.5

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +-...-.++|||+.| .+.+..... +  ..++...+..-..++.  +..+-..|+.|+|.+|.||++..++ .+.+.||
T Consensus       236 e~t~~~VLtmE~i~Gi~i~d~~~l~-~--~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g-~i~~lDf  309 (517)
T COG0661         236 EYTTRRVLTMEWIDGIKISDIAALK-S--AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDG-RIVLLDF  309 (517)
T ss_pred             hccCCcEEEEEeeCCEecccHHHHH-h--cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCC-cEEEEcC
Confidence            334455799999999 888775331 1  2344333333222221  3445558999999999999999887 8999999


Q ss_pred             CCccccc
Q 026660           89 GLARAFT   95 (235)
Q Consensus        89 ~~~~~~~   95 (235)
                      |+...+.
T Consensus       310 Gi~g~l~  316 (517)
T COG0661         310 GIVGRLD  316 (517)
T ss_pred             cceecCC
Confidence            9986554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.17  E-value=0.0028  Score=53.88  Aligned_cols=77  Identities=21%  Similarity=0.332  Sum_probs=52.6

Q ss_pred             ceEEEEEEecCcc-CHHH--HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC---CCCeEEE
Q 026660           12 RTVLYLVFEYMDT-DLKK--YIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKI   85 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~--~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~---~~~~~~l   85 (235)
                      ...-.++||||+| .+.+  .+.+     ..++...+..-+.+..  .+-|-..|++|+|-+|.||++..   .+..+.+
T Consensus       274 st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivl  346 (538)
T KOG1235|consen  274 STKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVL  346 (538)
T ss_pred             CcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEE
Confidence            4456899999986 4444  3433     3466664444333332  23455779999999999999983   3558999


Q ss_pred             eecCCccccc
Q 026660           86 ADLGLARAFT   95 (235)
Q Consensus        86 ~df~~~~~~~   95 (235)
                      .|||+.....
T Consensus       347 lDhGl~~~is  356 (538)
T KOG1235|consen  347 LDHGLYAVIS  356 (538)
T ss_pred             Eccccccccc
Confidence            9999986554

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.75  E-value=0.0044  Score=49.98  Aligned_cols=74  Identities=20%  Similarity=0.287  Sum_probs=60.3

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+..+.|++|++-++++...        .....+++..++.+++.-+.-+.++ .+-|+++...||+++ .| ++.++||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            56778999999988765531        1245678899999998888877765 788999999999999 76 8999999


Q ss_pred             CCccc
Q 026660           89 GLARA   93 (235)
Q Consensus        89 ~~~~~   93 (235)
                      .+++.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99973

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.71  E-value=0.0002  Score=66.80  Aligned_cols=138  Identities=12%  Similarity=0.034  Sum_probs=98.6

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-C----ceecCCCCCcEEEcCC
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-G----ILHRDLKPHNLLMDRK   79 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~----~~H~di~~~nil~~~~   79 (235)
                      +..+.++...+..++|+. |++.+.+.+-..+..++....+.....+.+....-.|+. +    -+|.++++-|.++...
T Consensus      1297 rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn 1376 (2724)
T KOG1826|consen 1297 RIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN 1376 (2724)
T ss_pred             cCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC
Confidence            344556667788888886 699999888555555555555555555546666666644 1    5799999999998855


Q ss_pred             CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 026660           80 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF  145 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  145 (235)
                      . +++++++|+.+.........+...+++.|+.|+...... ++.++|+|..|+-+|..-.|..+|
T Consensus      1377 y-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1377 Y-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             C-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhcccHHH
Confidence            4 899999999874444434445566677888888776544 677799999999999888776654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.32  E-value=0.026  Score=42.91  Aligned_cols=28  Identities=32%  Similarity=0.294  Sum_probs=23.8

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.++  +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC--cEEEechhcC
Confidence            478999999999998654  8899999763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.31  E-value=0.015  Score=42.92  Aligned_cols=73  Identities=19%  Similarity=0.175  Sum_probs=55.9

Q ss_pred             EEEEecCc-cCHHHH---HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---cCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           16 YLVFEYMD-TDLKKY---IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG---HGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        16 ~lv~e~~~-g~L~~~---l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~---~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ++++||.+ +++.+.   +..    --.-+++...+++.+++..+++|+.   ..+.-.|++++|+.++.++ .++++|.
T Consensus        32 ~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDl  106 (188)
T PF12260_consen   32 FYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDG-RLKLIDL  106 (188)
T ss_pred             EEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCC-cEEEEec
Confidence            46888887 455422   111    1136899999999999999999997   3577899999999999766 8999999


Q ss_pred             CCccc
Q 026660           89 GLARA   93 (235)
Q Consensus        89 ~~~~~   93 (235)
                      .....
T Consensus       107 d~v~~  111 (188)
T PF12260_consen  107 DDVFV  111 (188)
T ss_pred             hhcch
Confidence            86643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.14  E-value=0.0016  Score=54.67  Aligned_cols=90  Identities=21%  Similarity=0.220  Sum_probs=60.7

Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHH
Q 026660          124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDL  203 (235)
Q Consensus       124 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  203 (235)
                      +++|||++|.++.++.-|...+......+....+......+.........                ......++..+..+
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e----------------~~~~~~~d~~~~~~  173 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME----------------HLIQLLADKKRLPL  173 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH----------------HHHHHhhhHhHHHH
Confidence            59999999999999999887776655555554444432222221111000                01111355667889


Q ss_pred             HHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          204 LEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       204 i~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .++|+...|..||...++..++-|..
T Consensus       174 ~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  174 LKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             hccCCccccccccchhHHhcCccHHH
Confidence            99999999999999999999987754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=95.80  E-value=0.0027  Score=54.55  Aligned_cols=133  Identities=19%  Similarity=0.144  Sum_probs=88.3

Q ss_pred             CcccCCcCCCceEEEEEEecCccC--HHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC
Q 026660            2 DVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK   79 (235)
Q Consensus         2 ~~~~~~~~~~~~~~~lv~e~~~g~--L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~   79 (235)
                      .|.+.+..+.+.+..+.++++++.  .......   ....+..-+.....+.-..+++++|+..-+|+|    ||+... 
T Consensus       296 ~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-  367 (829)
T KOG0576|consen  296 VVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-  367 (829)
T ss_pred             cccccccCCcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-
Confidence            456778888899999999999742  2211100   000122223445556666788999988767887    777663 


Q ss_pred             CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 026660           80 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF  145 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  145 (235)
                      + ..+..+|+....+.... ......+++.++|||+..... +....|.|++|.--.++.-|-.|-
T Consensus       368 ~-~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  368 E-EVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             c-ccccccccCCcccCccc-ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCC
Confidence            3 67888998876665432 334556788999999886554 678889999987656666555554

>PRK05231 homoserine kinase; Provisional

Probab=95.07  E-value=0.093  Score=42.04  Aligned_cols=30  Identities=27%  Similarity=0.414  Sum_probs=24.7

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .+++|+|+.+.||+++.+. ...++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            3799999999999998443 55899999763

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.93  E-value=0.04  Score=42.08  Aligned_cols=28  Identities=32%  Similarity=0.456  Sum_probs=23.6

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +++|+|+.+.|++++.+. ...++||+.+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCccc
Confidence            589999999999998543 5679999976

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.88  E-value=0.096  Score=41.63  Aligned_cols=29  Identities=31%  Similarity=0.388  Sum_probs=24.7

Q ss_pred             CceecCCCCCcEEEcCC---CCeEEEeecCCc
Q 026660           63 GILHRDLKPHNLLMDRK---TMTLKIADLGLA   91 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~---~~~~~l~df~~~   91 (235)
                      .++|+|+.+.||+++.+   ...+.++||..+
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            58999999999999864   237999999977

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.86  E-value=0.05  Score=41.46  Aligned_cols=29  Identities=24%  Similarity=0.369  Sum_probs=24.8

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++|+|+.+.||+++..+..+.++||..+
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            58999999999999963337999999976

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.79  E-value=0.074  Score=42.44  Aligned_cols=29  Identities=34%  Similarity=0.633  Sum_probs=25.2

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .+++|+|+.+.|++++.++ ...++||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCc-eEEEeecccc
Confidence            5799999999999998664 5689999976

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.72  E-value=0.093  Score=41.06  Aligned_cols=50  Identities=24%  Similarity=0.274  Sum_probs=37.6

Q ss_pred             HHHHHHHHHHHHHHHHHHHhc--CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           42 VNTVKSLMYQLCKGVAFCHGH--GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        42 ~~~~~~i~~ql~~~l~~Lh~~--~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .....+.+..+-.++.-.+..  -++|+|+.++|++.+..+ .+.++||..+.
T Consensus       131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg  182 (269)
T COG0510         131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAG  182 (269)
T ss_pred             hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCC
Confidence            334455566666666666655  589999999999999756 89999998773

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.69  E-value=0.098  Score=41.70  Aligned_cols=28  Identities=25%  Similarity=0.533  Sum_probs=24.2

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .+++|+|+.+.|++++. + .+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECccc
Confidence            47899999999999986 4 6889999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.07  E-value=0.11  Score=41.01  Aligned_cols=30  Identities=30%  Similarity=0.461  Sum_probs=25.1

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .+++|+|+.+.|++++.++ .+.++||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            3699999999999999654 56899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.04  E-value=0.091  Score=39.62  Aligned_cols=30  Identities=33%  Similarity=0.482  Sum_probs=19.8

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ..++|+|+.+.||+++.++..+.++||+.+
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             cEEEEeccccccceeeeccceeEEEecccc
Confidence            359999999999999944336689999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=93.89  E-value=0.66  Score=34.55  Aligned_cols=77  Identities=27%  Similarity=0.385  Sum_probs=48.3

Q ss_pred             CCcCCCceEEEEEEecCc---c----CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC
Q 026660            6 GQNKEGRTVLYLVFEYMD---T----DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR   78 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~---g----~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~   78 (235)
                      ++.-+++.=+.+|+|...   |    +|.+++.+     +.++. .....   +-+-.++|-+.+++.+|++|.||++..
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            344455666678888652   2    56666633     34554 33333   333456788899999999999999965


Q ss_pred             CC--C-eEEEee-cCCc
Q 026660           79 KT--M-TLKIAD-LGLA   91 (235)
Q Consensus        79 ~~--~-~~~l~d-f~~~   91 (235)
                      .+  . .+.++| ||..
T Consensus       154 ~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             cCCCceEEEEEeCCCCc
Confidence            43  2 456666 5643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=93.77  E-value=0.18  Score=45.97  Aligned_cols=31  Identities=29%  Similarity=0.485  Sum_probs=24.4

Q ss_pred             CceecCCCCCcEEEcCCC-CeEEEeecCCccc
Q 026660           63 GILHRDLKPHNLLMDRKT-MTLKIADLGLARA   93 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~-~~~~l~df~~~~~   93 (235)
                      .++|+|+++.|++++.++ ...-|.||..+..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            499999999999998533 2457999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.71  E-value=0.14  Score=38.45  Aligned_cols=29  Identities=34%  Similarity=0.560  Sum_probs=18.7

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++|+|+.+.||+++..+..++++||..+
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya  172 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYA  172 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHH
Confidence            58999999999999334448999999987

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02236 choline kinase

Probab=93.49  E-value=0.13  Score=41.80  Aligned_cols=30  Identities=33%  Similarity=0.555  Sum_probs=25.6

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+++.||+++.++..+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            589999999999998654479999999774

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.43  E-value=0.43  Score=38.59  Aligned_cols=28  Identities=25%  Similarity=0.396  Sum_probs=24.5

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ++|+|+.+.||+++.++..+.++||..+
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEccccc
Confidence            7999999999999755447999999987

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=93.10  E-value=0.1  Score=40.08  Aligned_cols=28  Identities=25%  Similarity=0.255  Sum_probs=24.2

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++|+|+.+.||+++.++ .+.|+||+.+
T Consensus       164 ~l~HgD~~~~Nil~~~~~-~~~iIDwe~a  191 (244)
T cd05150         164 VVTHGDACLPNIIVDPGK-FSGFIDLGRL  191 (244)
T ss_pred             EEECCCCCCccEEEeCCc-EEEEEEcccc
Confidence            489999999999999654 6789999966

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.86  E-value=0.36  Score=35.84  Aligned_cols=31  Identities=19%  Similarity=0.350  Sum_probs=24.7

Q ss_pred             cCceecCCCCCcEEEcCCCC----eEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTM----TLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~----~~~l~df~~~~   92 (235)
                      ..++|||+.+.|+++..++.    .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            35899999999999975432    58899999763

subfamily of choline kinases

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=92.84  E-value=0.15  Score=41.01  Aligned_cols=71  Identities=17%  Similarity=0.242  Sum_probs=47.6

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .-++|||+..| .|...- .      -.+...+   ...+..-+--|-..|++|+|..-=||++..++ .+.++||-...
T Consensus       182 RH~Vvmelv~g~Pl~~v~-~------v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  182 RHCVVMELVDGYPLRQVR-H------VEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             ceeeHHHhhcccceeeee-e------cCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecCC-CEEEeechHhh
Confidence            34889999887 544321 1      1223333   33333335567789999999999999999666 89999997664


Q ss_pred             ccc
Q 026660           93 AFT   95 (235)
Q Consensus        93 ~~~   95 (235)
                      ...
T Consensus       251 S~s  253 (465)
T KOG2268|consen  251 STS  253 (465)
T ss_pred             ccC
Confidence            443

>PHA03111 Ser/Thr kinase; Provisional

Probab=92.74  E-value=0.41  Score=38.52  Aligned_cols=66  Identities=20%  Similarity=0.172  Sum_probs=38.8

Q ss_pred             EEEEEecCccCHHHHHHHhhcCCCCCC-HHHHHHHHHHHHHHHHHH---H-hcCceecCCCCCcEEEcCCC
Q 026660           15 LYLVFEYMDTDLKKYIRSFRQTGENIP-VNTVKSLMYQLCKGVAFC---H-GHGILHRDLKPHNLLMDRKT   80 (235)
Q Consensus        15 ~~lv~e~~~g~L~~~l~~~~~~~~~~~-~~~~~~i~~ql~~~l~~L---h-~~~~~H~di~~~nil~~~~~   80 (235)
                      -.||++++-++-...-.......+-.| .+-++.++.|++.-.-.+   . -.+++|.||||+|||+-+..
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            367888875533332221111112223 445777888887654333   2 23699999999999986544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.34  E-value=0.12  Score=40.03  Aligned_cols=28  Identities=32%  Similarity=0.438  Sum_probs=24.1

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.++  +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG--LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC--CEEEeccccC
Confidence            489999999999998654  7899999774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.20  E-value=0.3  Score=39.05  Aligned_cols=29  Identities=17%  Similarity=0.192  Sum_probs=25.2

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      +++|+|+.+.|++++.++ .+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            699999999999998666 78899998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.13  E-value=0.17  Score=37.25  Aligned_cols=28  Identities=29%  Similarity=0.391  Sum_probs=23.5

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      -.+|+|+.|.|+++..++  ++++||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCccc
Confidence            368999999999998554  8899999874

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.98  E-value=0.16  Score=40.00  Aligned_cols=30  Identities=27%  Similarity=0.463  Sum_probs=24.4

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+++.|++++.++....|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            489999999999999644346799999763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.35  E-value=0.43  Score=38.56  Aligned_cols=28  Identities=39%  Similarity=0.559  Sum_probs=24.2

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ++|+|+.+.||+++.++..+.++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            8999999999999976533889999966

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=91.18  E-value=0.66  Score=38.09  Aligned_cols=74  Identities=20%  Similarity=0.302  Sum_probs=53.4

Q ss_pred             EEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEcCCCCeEEEeecCCcccc
Q 026660           16 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF   94 (235)
Q Consensus        16 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~   94 (235)
                      .+||++++++  ++-.- .-+.-.++...+..+-.|++.-+.-|- ..++||.||+-=|+|+- +| .+.++|.+.+...
T Consensus       240 VLVM~FlGrd--gw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  240 VLVMEFLGRD--GWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG-KLYIIDVSQSVEH  314 (520)
T ss_pred             eEeeeeccCC--CCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC-EEEEEEccccccC
Confidence            6899999852  11100 011234677778888888888888776 55899999999999998 55 7999999988543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.75  E-value=0.56  Score=37.98  Aligned_cols=64  Identities=23%  Similarity=0.190  Sum_probs=37.6

Q ss_pred             EEEEecCccCHHHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHH---HHH-hcCceecCCCCCcEEEcCC
Q 026660           16 YLVFEYMDTDLKKYIRSFRQTGEN-IPVNTVKSLMYQLCKGVA---FCH-GHGILHRDLKPHNLLMDRK   79 (235)
Q Consensus        16 ~lv~e~~~g~L~~~l~~~~~~~~~-~~~~~~~~i~~ql~~~l~---~Lh-~~~~~H~di~~~nil~~~~   79 (235)
                      .||++++-++-...-.+.....+- .-.+-++.++.|++.-.-   .|. -.+++|.||||+|||+-+.
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            488998765433333222122222 234456777778765331   233 2368999999999998644

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.35  E-value=0.82  Score=36.72  Aligned_cols=30  Identities=30%  Similarity=0.482  Sum_probs=26.6

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++|+|+.+.|++++..+ .+-++||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999777 599999998853

>PRK06149 hypothetical protein; Provisional

Probab=89.23  E-value=0.63  Score=43.42  Aligned_cols=30  Identities=20%  Similarity=0.266  Sum_probs=24.2

Q ss_pred             cCceecCCCCCcEEEcCCC----CeEEEeecCCc
Q 026660           62 HGILHRDLKPHNLLMDRKT----MTLKIADLGLA   91 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~----~~~~l~df~~~   91 (235)
                      .+++|+|+...||+++.+.    ....++|||-+
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~  241 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDL  241 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccc
Confidence            5799999999999998542    13579999976

>COG4499 Predicted membrane protein [Function unknown]

Probab=88.96  E-value=3.2  Score=33.86  Aligned_cols=106  Identities=13%  Similarity=0.070  Sum_probs=66.3

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .++++...|-++.... .-.+.+++       +.....++++.|.+..|..+. +...|-=+.|+||+++.+. .+.+..
T Consensus        57 t~~~Ds~vIsy~i~~~~~~F~~~k~-------~~k~~Klr~a~~~I~~l~e~~-~tr~~~~laPeNilf~~~l-~p~~vH  127 (434)
T COG4499          57 TEDNDSFVISYPIPEAAKSFASAKR-------KEKTRKLRLALQNIATLSELN-NTRYTFFLAPENILFDGGL-TPFFVH  127 (434)
T ss_pred             cccCceeEEEecCccccchHHHHHH-------HHHHHHHHHHHHHHHHHHHhh-ccceeEEecchheEEcCCC-ceEEEe
Confidence            3555666666665542 22223333       556678888899888888654 3346677889999999655 788888


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  146 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  146 (235)
                      +|+-..+.            |.=+.||.+..           .+-+++..++.|..+|.
T Consensus       128 ~Glk~~lp------------Pye~tee~f~~-----------~ykA~~~~~fn~k~~Fe  163 (434)
T COG4499         128 RGLKNSLP------------PYEMTEERFLK-----------EYKALAIYAFNGKFSFE  163 (434)
T ss_pred             cchhccCC------------CCCCCHHHHHH-----------HHHHHHHHHHcCCccHH
Confidence            88653322            22255665542           23456667777777773

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=88.74  E-value=0.46  Score=36.09  Aligned_cols=36  Identities=31%  Similarity=0.387  Sum_probs=29.6

Q ss_pred             HHHHHHHhc--CceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           54 KGVAFCHGH--GILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        54 ~~l~~Lh~~--~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .+|.-+|+.  +..|+|..|+||+-+..| .+|+.|-+.
T Consensus       152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~  189 (308)
T PF07387_consen  152 KDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVC  189 (308)
T ss_pred             HHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhh
Confidence            457778843  699999999999999887 899988764

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=88.19  E-value=0.95  Score=36.51  Aligned_cols=27  Identities=33%  Similarity=0.318  Sum_probs=22.7

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .+++|+|+.+.||++. +  .+.++||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCC
Confidence            3689999999999995 3  4778999976

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=87.97  E-value=1  Score=35.65  Aligned_cols=29  Identities=28%  Similarity=0.439  Sum_probs=23.9

Q ss_pred             ceecCCCCCcEEEcCCCC----eEEEeecCCcc
Q 026660           64 ILHRDLKPHNLLMDRKTM----TLKIADLGLAR   92 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~----~~~l~df~~~~   92 (235)
                      ++|||++.+||++..++.    .+.++||..++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            899999999999976532    58899998763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=86.80  E-value=1.7  Score=31.89  Aligned_cols=64  Identities=22%  Similarity=0.294  Sum_probs=43.4

Q ss_pred             EEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC--CcEEEcCCCCeEEEeecCCcc
Q 026660           16 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP--HNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        16 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~--~nil~~~~~~~~~l~df~~~~   92 (235)
                      ++.|||..| +|.+.-..       ...+.+    ..+++..--|-..|+-|+.|+-  .||++. ++ .+.|+||..++
T Consensus        88 ~i~me~i~G~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At  154 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIG-------GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhcCcchhhhhhc-------ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchh
Confidence            456999988 77765542       122333    3355554556678999999986  466666 44 79999999875

>PRK06148 hypothetical protein; Provisional

Probab=86.21  E-value=1.4  Score=41.28  Aligned_cols=31  Identities=26%  Similarity=0.375  Sum_probs=25.0

Q ss_pred             cCceecCCCCCcEEEcCCC--CeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKT--MTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~--~~~~l~df~~~~   92 (235)
                      .+++|+|+.+.||+++.++  ...-|+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998653  245699999763

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=85.67  E-value=1.4  Score=32.98  Aligned_cols=38  Identities=29%  Similarity=0.425  Sum_probs=29.8

Q ss_pred             HHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           48 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        48 i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      -+.+|..-+..+|+.|++-+|+++.|..      +-+++|||.+
T Consensus       169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLRDLKILHKLGIVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHHHCCeeeccCcccccc------CCEEEecccC
Confidence            3455666678899999999999999976      3468899864

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=85.35  E-value=3  Score=34.87  Aligned_cols=58  Identities=22%  Similarity=0.312  Sum_probs=41.7

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEc
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMD   77 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~   77 (235)
                      ..++=+|..| ++..++..     ...+++...+++.--+.|+--|- -.+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            4455567778 88888754     34566677777777677665443 45899999999999984

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	235
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-75
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-75
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-75
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-75
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-75
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-75
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-75
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-75
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-75
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-75
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-75
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-75
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-75
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-75
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-75
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-75
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-74
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-74
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-74
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-74
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-74
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-74
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-74
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-74
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-74
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-74
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-74
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-74
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-74
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-74
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-74
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-74
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-74
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-74
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-74
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-63
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-63
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-62
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-61
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-61
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-61
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-59
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-59
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-58
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-55
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-46
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-46
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-46
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-46
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-45
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-45
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-45
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-44
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-42
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-42
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-37
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-37
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-37
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-37
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-37
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-37
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-37
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-37
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-37
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-37
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-37
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-37
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-37
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-37
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-37
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-37
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-37
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-37
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-37
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-37
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-37
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-37
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-37
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-37
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-37
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-36
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-36
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-36
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-36
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-36
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-36
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-36
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-36
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-36
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-36
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-36
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-36
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-36
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-36
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-36
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-36
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-36
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-36
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-36
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-36
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-36
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-36
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-36
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-36
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-36
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-36
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-36
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-35
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-35
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-35
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-35
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-35
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-35
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-35
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-35
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-35
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-35
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-35
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-35
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-35
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-35
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-35
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-35
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-35
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-35
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-35
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-35
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-35
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-35
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-35
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-35
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-35
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-35
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-34
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-34
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-34
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-34
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-34
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-34
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-34
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-34
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-34
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-34
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-34
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-34
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-34
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-34
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-34
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-34
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-34
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-34
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-34
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-34
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-34
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-34
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-34
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-34
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-34
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-34
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-34
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-34
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-34
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-34
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-34
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-34
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-34
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-34
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-34
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-34
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-34
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-34
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-34
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-34
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-33
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-33
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-33
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-33
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-32
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-31
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-31
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-31
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-31
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-31
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-31
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-31
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-31
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-31
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-31
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-30
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-30
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-30
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-30
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-30
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-30
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-30
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-30
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-30
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-30
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-30
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-30
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-30
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-29
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-29
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-29
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-29
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-29
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-28
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-28
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-28
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-28
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-28
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-28
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-28
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-28
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-28
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-28
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-28
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-28
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-28
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-21
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-21
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-20
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-20
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-20
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-18
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-18
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-18
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-15
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-15
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-15
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		3e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-05
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-04

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 75  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 127
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 128 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 75  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 127
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 128 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  278 bits (710), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 69  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  277 bits (709), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 72  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 124
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  277 bits (709), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 131/233 (56%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++D DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEHVDQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  276 bits (707), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 175/233 (75%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G++FCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLSFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  276 bits (707), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 69  LDVIHTENK-----LYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 122 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  276 bits (707), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  276 bits (705), Expect = 9e-75,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 69  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 70  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 69  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 69  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 121
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 122 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 72  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 124
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 70  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 70  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 123 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  275 bits (702), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 129/233 (55%), Positives = 173/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 70  LDVIHTENK-----LYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 122
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  274 bits (701), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 130/233 (55%), Positives = 174/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 67  LDVIHTENK-----LYLVFEHVHQDLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  274 bits (701), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 172/230 (74%), Gaps = 9/230 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  274 bits (701), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 129/233 (55%), Positives = 173/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  273 bits (699), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 129/233 (55%), Positives = 173/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 68  LDVIHTENK-----LYLVFEFLHQDLKDFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 120
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 121 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  273 bits (698), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 129/233 (55%), Positives = 173/233 (74%), Gaps = 9/233 (3%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL +G+AFCH
Sbjct: 71  LDVIHTENK-----LYLVFEFLHQDLKTFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 123
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAPE+LLG  
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
           +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  238 bits (606), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/216 (53%), Positives = 154/216 (71%), Gaps = 5/216 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE++D DLKK +       E++   T KS + QL  G+A+CH   +LHRDLKP NL
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP+VL+GS  YST +D+WSV CI
Sbjct: 132 LINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLATAV 193
           FAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+ L  +   +  + P    + +
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
             LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  237 bits (604), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 114/216 (52%), Positives = 154/216 (71%), Gaps = 5/216 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE++D DLKK +       E++   T KS + QL  G+A+CH   +LHRDLKP NL
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R+   LKIAD GLARAF +P++KYTHE++TLWYRAP+VL+GS  YST +D+WSV CI
Sbjct: 132 LINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLATAV 193
           FAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+ L  +   +  + P    + +
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
             LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  235 bits (600), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 113/216 (52%), Positives = 153/216 (70%), Gaps = 5/216 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE++D DLKK +       E++   T KS + QL  G+A+CH   +LHRDLKP NL
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R+   LKIAD GLARAF +P++KYTHE++TLWYRAP+VL+GS  YST +D+WSV CI
Sbjct: 132 LINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLATAV 193
           FAE+V    LFPG SE  QL+ IFR+LGTPN K WP V+ L  +   +  + P    + +
Sbjct: 191 FAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
             LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  231 bits (589), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 119/223 (53%), Positives = 159/223 (71%), Gaps = 10/223 (4%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L+L+FEY + DLKKY+        ++ +  +KS +YQL  GV FCH    LHRDLKP NL
Sbjct: 108 LHLIFEYAENDLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163
Query: 75  LMD----RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L+      +T  LKI D GLARAF +PI+++THEI+TLWYR PE+LLGS HYST+VD+WS
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQSL 189
           +ACI+AE++ KT LFPGDSE+ QL  IF +LG P++  WPGV++L +W + +P++  ++L
Sbjct: 224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283
Query: 190 ATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
              +   LD +GLDLL  ML+ DP KRISAK A+EHPYF   D
Sbjct: 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  231 bits (589), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 113/219 (51%), Positives = 154/219 (70%), Gaps = 6/219 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE+M+ DLKK +    +TG  +  + +K  +YQL +GVA CH H ILHRDLKP NL
Sbjct: 94  LTLVFEFMEKDLKKVLDE-NKTG--LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++     LK+AD GLARAF +P++ YTHE++TLWYRAP+VL+GS  YST+VD+WS+ CI
Sbjct: 151 LINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE--YPQWNPQSLATA 192
           FAE++T   LFPG ++  QL  IF +LGTPN + WP V  L  W +  +  +  +  ++ 
Sbjct: 210 FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI 269
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DLD
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  231 bits (589), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 113/219 (51%), Positives = 154/219 (70%), Gaps = 6/219 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE+M+ DLKK +    +TG  +  + +K  +YQL +GVA CH H ILHRDLKP NL
Sbjct: 94  LTLVFEFMEKDLKKVLDE-NKTG--LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++     LK+AD GLARAF +P++ YTHE++TLWYRAP+VL+GS  YST+VD+WS+ CI
Sbjct: 151 LINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE--YPQWNPQSLATA 192
           FAE++T   LFPG ++  QL  IF +LGTPN + WP V  L  W +  +  +  +  ++ 
Sbjct: 210 FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI 269
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DLD
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  226 bits (575), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 107/215 (49%), Positives = 150/215 (69%), Gaps = 6/215 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFEY+D DLK+Y+      G  I ++ VK  ++QL +G+A+CH   +LHRDLKP NL
Sbjct: 75  LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++ +   LK+AD GLARA ++P K Y +E++TLWYR P++LLGST YST +DMW V CI
Sbjct: 132 LINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW--HEYPQWNPQSLATA 192
           F E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ S   +  + YP++  ++L + 
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P LD DG DLL ++LQ++   RISA+ AM+HP+F
Sbjct: 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  223 bits (567), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 109/218 (50%), Positives = 146/218 (66%), Gaps = 6/218 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE+ D DLKKY   F     ++    VKS ++QL KG+ FCH   +LHRDLKP NL
Sbjct: 76  LTLVFEFCDQDLKKY---FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R    LK+AD GLARAF +P++ Y+ E++TLWYR P+VL G+  YST++DMWS  CI
Sbjct: 133 LINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 135 FAELVTKT-ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW-NPQSLATA 192
           FAEL      LFPG+    QL  IFRLLGTP E+ WP ++ L ++  YP +    SL   
Sbjct: 192 FAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  220 bits (561), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 108/218 (49%), Positives = 146/218 (66%), Gaps = 6/218 (2%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE+ D DLKKY   F     ++    VKS ++QL KG+ FCH   +LHRDLKP NL
Sbjct: 76  LTLVFEFCDQDLKKY---FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P+VL G+  YST++DMWS  CI
Sbjct: 133 LINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 135 FAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW-NPQSLATA 192
           FAEL      LFPG+    QL  IFRLLGTP E+ WP ++ L ++  YP +    SL   
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  210 bits (535), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 110/237 (46%), Positives = 156/237 (65%), Gaps = 16/237 (6%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFC 59
           DV   +NK     L LVFE+MD DLKKY+  R+   T   + +N VK   +QL +G+AFC
Sbjct: 70  DVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
           H + ILHRDLKP NLL++++   LK+ D GLARAF +P+  ++ E++TLWYRAP+VL+GS
Sbjct: 125 HENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
             YST++D+WS  CI AE++T   LFPG ++ +QL  IF ++GTPNE +WP V+ L  ++
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243
Query: 180 EYPQWNP-----QSLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
              Q  P     Q L   T  P LD + +D L  +LQ +P  R+SAK+A+ HP+F +
Sbjct: 244 PNIQQRPPRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/234 (41%), Positives = 145/234 (61%), Gaps = 6/234 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLH 137
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAPEVLL S+
Sbjct: 138 SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS 195
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR-QA 253
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/234 (41%), Positives = 145/234 (61%), Gaps = 6/234 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLH 137
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAPEVLL S+
Sbjct: 138 SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS 195
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR-QA 253
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  181 bits (459), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 100/227 (44%), Positives = 139/227 (61%), Gaps = 6/227 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 137
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+     T+K+AD GLAR ++  +   T  ++TLWYRAPEVLL ST
Sbjct: 138 ANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQST 195
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   SL     
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-A 253
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  180 bits (457), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 99/227 (43%), Positives = 139/227 (61%), Gaps = 6/227 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+     T+K+AD GLAR ++  +  +   ++TLWYRAPEVLL ST
Sbjct: 130 ANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMALFP-VVVTLWYRAPEVLLQST 187
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   SL     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-A 245
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/227 (43%), Positives = 138/227 (60%), Gaps = 6/227 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+     T+K+AD GLAR ++  +      ++TLWYRAPEVLL ST
Sbjct: 130 ANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LAPVVVTLWYRAPEVLLQST 187
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   SL     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-A 245
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  179 bits (453), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/227 (43%), Positives = 138/227 (60%), Gaps = 6/227 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+     T+K+AD GLAR ++  +      ++TLWYRAPEVLL ST
Sbjct: 130 ANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LDPVVVTLWYRAPEVLLQST 187
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   SL     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-A 245
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  177 bits (448), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 95/227 (41%), Positives = 140/227 (61%), Gaps = 6/227 (2%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLH 137
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAPEVLL S+
Sbjct: 138 SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS 195
Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR-QA 253
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  173 bits (438), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 89/221 (40%), Positives = 135/221 (61%), Gaps = 10/221 (4%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLMYQLCKGVAFCHGHGILHRD 68
           ++ + LVF++M+TDL+  I+      +N  V T   +K+ M    +G+ + H H ILHRD
Sbjct: 84  KSNISLVFDFMETDLEVIIK------DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LKP+NLL+D   + LK+AD GLA++F  P + Y H+++T WYRAPE+L G+  Y   VDM
Sbjct: 138 LKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDM 196
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           W+V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP + SL ++  +  +    
Sbjct: 197 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 256
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           L         D LDL++ +  ++P  RI+A +A++  YF +
Sbjct: 257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 139/235 (59%), Gaps = 12/235 (5%)
Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           V   QNK     L ++ EY+   L K ++SF ++G +IP+N +   +YQL + V F H  
Sbjct: 105 VNPSQNK----YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160
Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           GI HRD+KP NLL++ K  TLK+ D G A+   +P +     I + +YRAPE++LG+T Y
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEY 219
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
           + ++D+WS+ C+F EL+    LF G++ + QL+ I +++GTP ++    ++       +P
Sbjct: 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279
Query: 183 QWNPQS----LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
               +     L    P+L    +DLLEQ+L+Y+P  RI+  +AM HP+FD L  +
Sbjct: 280 TLKAKDWRKILPEGTPSL---AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  166 bits (421), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 80/224 (35%), Positives = 135/224 (60%), Gaps = 2/224 (0%)
Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           +K+    L LV EY+   + +  R + +  + +P+  +K  MYQL + +A+ H  GI HR
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL+D  +  LK+ D G A+   +  +     I + +YRAPE++ G+T+Y+T +D
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSXICSRYYRAPELIFGATNYTTNID 224
Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS  C+ AEL+    LFPG+S + QL+ I ++LGTP+ +    ++     H++PQ  P 
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284
Query: 188 SLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
             +    P    D +DL+ ++L+Y PS R++A +A+ HP+FD+L
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 16/235 (6%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K ++S + + ++I        +YQ+ +G+ + H 
Sbjct: 108 DILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHS 162
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 163 ANVLHRDLKPSNLLIN-TTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + + M 
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-MK 279
Query: 178 WHEYPQWNPQSLATA----VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              Y Q  P     A     P  D   LDLL++ML ++P+KRI+ ++A+ HPY +
Sbjct: 280 ARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLE 334

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 82/220 (37%), Positives = 124/220 (56%), Gaps = 12/220 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V + M++DL + I S     + + +  V+  +YQL +G+ + H   ++HRDLKP NL
Sbjct: 134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189
Query: 75  LMDRKTMTLKIADLGLARAF-TLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L++ +   LKI D G+AR   T P +     T  + T WYRAPE++L    Y+ A+D+WS
Sbjct: 190 LVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQ 187
           V CIF E++ +  LFPG + + QL  I  +LGTP+  V   V +          P   P 
Sbjct: 249 VGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPV 308
Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              T  P  D+  L LL +ML+++PS RISA  A+ HP+ 
Sbjct: 309 PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  150 bits (380), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 87/241 (36%), Positives = 128/241 (53%), Gaps = 20/241 (8%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            ++++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   H
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----------TLPIKKYTHEILTLWY 110
           G  ++HRDLKP NLL++     LK+ D GLAR            T      T  + T WY
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
           RAPEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+     
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 171 GVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                    EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 227 F 227
Sbjct: 309 L 309

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 52/255 (20%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +YLVF+YM+TDL   IR+      NI  PV+  + ++YQL K + + H  G+LHRD+KP 
Sbjct: 86  VYLVFDYMETDLHAVIRA------NILEPVHK-QYVVYQLIKVIKYLHSGGLLHRDMKPS 138
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI----------------------LTLWY 110
           N+L++ +   +K+AD GL+R+F + I++ T+ I                       T WY
Sbjct: 139 NILLNAECH-VKVADFGLSRSF-VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP-NEKVW 169
           RAPE+LLGST Y+  +DMWS+ CI  E++    +FPG S + QL  I  ++  P NE V 
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVE 256
Query: 170 P--------GVSSLMNWHEYPQWNPQSLATAVPNL----------DKDGLDLLEQMLQYD 211
                     + SL    E  Q N + + T   NL          +++ LDLL+++LQ++
Sbjct: 257 SIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316
Query: 212 PSKRISAKKAMEHPY 226
           P+KRISA  A++HP+
Sbjct: 317 PNKRISANDALKHPF 331

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  150 bits (379), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/220 (36%), Positives = 123/220 (55%), Gaps = 12/220 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V + M++DL + I S     + + +  V+  +YQL +G+ + H   ++HRDLKP NL
Sbjct: 135 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 190
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L++ +   LKI D G+AR       ++    T  + T WYRAPE++L    Y+ A+D+WS
Sbjct: 191 LVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 249
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQ 187
           V CIF E++ +  LFPG + + QL  I  +LGTP+  V   V +          P   P 
Sbjct: 250 VGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPV 309
Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              T  P  D+  L LL +ML+++PS RISA  A+ HP+ 
Sbjct: 310 PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  150 bits (379), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLXEXVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  150 bits (379), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 147
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 148 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLXEXVATRWYRAPEIML 205
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  150 bits (378), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 87/241 (36%), Positives = 128/241 (53%), Gaps = 20/241 (8%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            ++++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   H
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----------TLPIKKYTHEILTLWY 110
           G  ++HRDLKP NLL++     LK+ D GLAR            T      T  + T WY
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
           RAPEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+     
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 171 GVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                    EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 227 F 227
Sbjct: 309 L 309

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 150
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 151 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 208
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 142
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 143 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 142
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 143 ANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 142
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 143 ANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 240
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  150 bits (378), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  150 bits (378), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 93  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 152
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 153 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 211
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 212 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 271
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 272 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 314

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 101 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 160
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 161 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 219
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 220 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 279
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 280 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 322

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 142
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 143 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 147
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 148 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 205
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 148
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 149 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 206
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 139
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 140 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 197
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  149 bits (377), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 116 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 175
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 176 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 234
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 235 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 294
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 295 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 337

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 144
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 145 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 124 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 183
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 184 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 242
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 243 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 302
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 303 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 345

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 167 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 226
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 227 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 285
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 286 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 345
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 346 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 388

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 142
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 143 ANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 200
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 162
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 163 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 220
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 126 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 185
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 186 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 244
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 245 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 304
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 305 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 347

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 132/234 (56%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 140
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 141 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 198
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 107 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 166
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 167 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 225
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 226 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 285
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 286 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 328

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 100 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 159
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 160 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 218
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 219 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 278
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 279 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 321

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 96  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 155
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 156 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 214
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 215 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 274
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 275 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 100 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 159
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 160 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 218
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 219 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 278
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 279 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 321

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 123/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++       +PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 89  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 148
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 149 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 207
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 208 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 267
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 268 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++       +PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 240
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 131/234 (55%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 140
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 141 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 198
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P ++    + +L  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 131/233 (56%), Gaps = 14/233 (6%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 144
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 145 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 131/234 (55%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K ++    + ++I        +YQ+ +G+ + H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-----FLYQILRGLKYIHS 146
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 147 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 204
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 128/219 (58%), Gaps = 7/219 (3%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L+LVFEY D  +   +  +++    +P + VKS+ +Q  + V FCH H  +HRD+KP N+
Sbjct: 77  LHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+ + ++ +K+ D G AR  T P   Y  E+ T WYR+PE+L+G T Y   VD+W++ C+
Sbjct: 134 LITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQ-WNPQSLAT 191
           FAEL++   L+PG S++ QL  I + LG   P  +     +   +  + P   + + L  
Sbjct: 193 FAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
             PN+    L LL+  L  DP++R++ ++ + HPYF+++
Sbjct: 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 124/223 (55%), Gaps = 2/223 (0%)
Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 92  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 151
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D+
Sbjct: 152 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSIDV 210
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 211 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 270
Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 271 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 313

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 126/224 (56%), Gaps = 4/224 (1%)
Query: 10  EGRTVLYL--VFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           E + V+YL  V +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HR
Sbjct: 87  EKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYTSSID 205
Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ    
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265
Query: 188 SLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                  P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/241 (35%), Positives = 130/241 (53%), Gaps = 20/241 (8%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            ++++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   H
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLH 129
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-------TLPIKKYT---HEILTLWY 110
           G  ++HRDLKP NLL++     LK+ D GLAR         + P  + +     + T WY
Sbjct: 130 GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
           RAPEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+     
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 171 GVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                    EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 227 F 227
Sbjct: 309 L 309

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 129/234 (55%), Gaps = 14/234 (5%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +YLV   M  DL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 162
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 163 ANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 220
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 178 WH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 132/235 (56%), Gaps = 18/235 (7%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS 144
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLL 117
             +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRAPE++L
Sbjct: 145 ANVLHRDLKPSNLLLN-TTSDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRAPEIML 202
Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN-EKVWPGVSSLM 176
            S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+ E +  G++  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGIN--L 260
Query: 177 NWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               Y    P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY 
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/216 (39%), Positives = 118/216 (54%), Gaps = 12/216 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 131 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 185
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 186 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNMTVDIWSVGCI 241
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV---WPGVSSLMNWHEYPQWNPQSLAT 191
            AEL+T   LFPG   + QL  I RL GTP   V    P   +    +  PQ   ++ A 
Sbjct: 242 MAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFAD 301
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                +   +DLLE+ML  D  KRI+A +A+ HPYF
Sbjct: 302 VFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/224 (37%), Positives = 126/224 (56%), Gaps = 12/224 (5%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T  YLV  +M TDL K ++      E +  + ++ L+YQ+ KG+ + H  GI+HRDLKP 
Sbjct: 103 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 157
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NL ++ +   LKI D GLAR       +    ++T WYRAPEV+L    Y+  VD+WSV 
Sbjct: 158 NLAVN-EDCELKILDFGLARQAD---SEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHE-YPQWNPQSL 189
           CI AE++T   LF G   L QL  I ++ GTP  +    + S    N+ +  P+   +  
Sbjct: 214 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 273
Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
           A+ + N     ++LLE+ML  D  +R++A +A+ HPYF+ L  T
Sbjct: 274 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L + HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNAMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/243 (36%), Positives = 133/243 (54%), Gaps = 30/243 (12%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           ++L+F+Y + DL   I+  R +  N     +P   VKSL+YQ+  G+ + H + +LHRDL
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154
Query: 70  KPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYS 123
           KP N+L+     +   +KIAD+G AR F  P+K        ++T WYRAPE+LLG+ HY+
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLGTPNEKVW----- 169
            A+D+W++ CIFAEL+T   +F    E           QL  IF ++G P +K W     
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 274
Query: 170 -PGVSSLMNWHEYPQWNPQSLATAVP----NLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
            P  S+LM       +   SL   +       D     LL+++L  DP KRI++++AM+ 
Sbjct: 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334
Query: 225 PYF 227
           PYF
Sbjct: 335 PYF 337

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++S + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKSQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++  +  LKI D GL R     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDS-ELKILDFGLCRHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  144 bits (362), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++  +  LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 159 AVNEDS-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 215 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 271
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 272 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  144 bits (362), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 116/217 (53%), Gaps = 13/217 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  +M TDL+K +      G       ++ L+YQ+ KG+ + H  G++HRDLKP NL
Sbjct: 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   HY+  VD+WSV CI
Sbjct: 176 AVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCI 231
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV---SSLMNWHEYPQWNPQSLAT 191
            AE++T   LF G   L QL  I ++ G P  +    +   ++       PQ   +    
Sbjct: 232 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ 291
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
             P       DLLE+ML+ D  KR++A +A+ HP+F+
Sbjct: 292 LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  144 bits (362), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 163
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 164 AVNEDC-ELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 276
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  144 bits (362), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++  +  LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDS-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 219 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 275
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 276 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 163
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 164 AVNEDC-ELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 276
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 163
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 164 AVNEDC-ELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 276
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 116/217 (53%), Gaps = 13/217 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  +M TDL+K +      G       ++ L+YQ+ KG+ + H  G++HRDLKP NL
Sbjct: 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   HY+  VD+WSV CI
Sbjct: 158 AVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV---SSLMNWHEYPQWNPQSLAT 191
            AE++T   LF G   L QL  I ++ G P  +    +   ++       PQ   +    
Sbjct: 214 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ 273
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
             P       DLLE+ML+ D  KR++A +A+ HP+F+
Sbjct: 274 LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 98  VYLVTHLMGADLNNIVKCAKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 153 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 265
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 125 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 179
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 180 AVNEDC-ELKILDFGLARHTDDEMXGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 236 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 292
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 293 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVN-EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 161
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 162 AVN-EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 218 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 274
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 275 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 161
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 162 AVN-EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 218 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 274
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 275 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 113 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 167
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 168 AVN-EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 223
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 224 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 280
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 281 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 159 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 215 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 271
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 272 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 219 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 275
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 276 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 112 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 166
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 167 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 222
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 223 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 279
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 280 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 125 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 179
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 180 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 236 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 292
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 293 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 113 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 167
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 168 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 223
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 224 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 280
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 281 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 163
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 164 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 276
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 161
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 162 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 218 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 274
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 275 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 101 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 155
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 156 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 211
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 212 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 268
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 269 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR       + T  + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVN-EDCELKILDFGLARHTD---DEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 219 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 275
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 276 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 121 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 175
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 176 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 231
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 232 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 288
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 289 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 168
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 169 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 224
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 225 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 281
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 282 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 168
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 169 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 224
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 225 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 281
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 282 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 161
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 162 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 218 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 274
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 275 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 168
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 169 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 224
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 225 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 281
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 282 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 159 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 215 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 271
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 272 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 159 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 215 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 271
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 272 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 122 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 176
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 177 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 232
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 233 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 289
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 290 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 121 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 175
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 176 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 231
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 232 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 288
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 289 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 122 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 176
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 177 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 232
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 233 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 289
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 290 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 98  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 153 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 265
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 99  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 153
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 154 AVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 209
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 210 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 266
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 267 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 100 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 154
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 155 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 210
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 211 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 267
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 268 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 98  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 153 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 265
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 219 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 275
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 276 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 99  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 153
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 154 AVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 209
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 210 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 266
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 267 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDAGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDYGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVN-EDCELKILDRGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/217 (38%), Positives = 123/217 (56%), Gaps = 14/217 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++S   + E+     V+ L+YQL +G+ + H  GI+HRDLKP N+
Sbjct: 108 VYLVTTLMGADLNNIVKSQALSDEH-----VQFLVYQLLRGLKYIHSAGIIHRDLKPSNV 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++  +  L+I D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDS-ELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP----QSLA 190
            AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS  +   Y Q  P    + L+
Sbjct: 219 MAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS-EHARTYIQSLPPMPQKDLS 277
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 278 SIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 137/275 (49%), Gaps = 60/275 (21%)
Query: 15  LYLVFEYMDTDLKKYIRS-FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V E  D+DLKK  ++    T E+I     K+++Y L  G  F H  GI+HRDLKP N
Sbjct: 105 LYIVLEIADSDLKKLFKTPIFLTEEHI-----KTILYNLLLGENFIHESGIIHRDLKPAN 159
Query: 74  LLMDRKTMTLKIADLGLARAFTLP----------------------IKKYTHEILTLWYR 111
            L+++   ++K+ D GLAR                            K+ T  ++T WYR
Sbjct: 160 CLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218
Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELV-----------TKTALFPGD------------ 148
           APE++L   +Y+ ++D+WS  CIFAEL+            +  LFPG             
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 149 -----SELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQSLATAVPNLDKDG 200
                S   QL  IF ++GTP E     ++    +     +P   P +L    P++  DG
Sbjct: 279 KVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338
Query: 201 LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           ++LLE ML+++P+KRI+  +A++HPY  D+ K +L
Sbjct: 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  +   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  +   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 84/219 (38%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDGGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 121/219 (55%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 98  VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR     +  +   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 153 AVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 265
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 7/215 (3%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           YLVFE++D  +   +  F      +    V+  ++Q+  G+ FCH H I+HRD+KP N+L
Sbjct: 100 YLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF 135
           +  ++  +K+ D G AR    P + Y  E+ T WYRAPE+L+G   Y  AVD+W++ C+ 
Sbjct: 157 VS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215
Query: 136 AELVTKTALFPGDSELQQLLHIFRLLGT--PNEKVWPGVSSLMNWHEYPQWNPQS-LATA 192
            E+     LFPGDS++ QL HI   LG   P  +     + +      P+   +  L   
Sbjct: 216 TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERR 275
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P L +  +DL ++ L  DP KR    + + H +F
Sbjct: 276 YPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 120/219 (54%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 122 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 176
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D GLAR       +    + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 177 AVNEDC-ELKILDFGLARHTD---DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 232
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 233 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMN--- 289
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 290 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 120/219 (54%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI   GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILGFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  140 bits (352), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 82/217 (37%), Positives = 122/217 (56%), Gaps = 14/217 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++    + E+     V+ L+YQL +G+ + H  GI+HRDLKP N+
Sbjct: 108 VYLVTTLMGADLNNIVKCQALSDEH-----VQFLVYQLLRGLKYIHSAGIIHRDLKPSNV 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++  +  L+I D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 163 AVNEDS-ELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP----QSLA 190
            AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS  +   Y Q  P    + L+
Sbjct: 219 MAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS-EHARTYIQSLPPMPQKDLS 277
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 278 SIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/219 (37%), Positives = 120/219 (54%), Gaps = 18/219 (8%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T ++     V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQILRGLKYIHSADIIHRDLKPSNL 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++     LKI D  LAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 157 AVNEDC-ELKILDFYLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS------LMNWHEYPQWNPQS 188
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS      + +  + P+ N   
Sbjct: 213 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN--- 269
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 270 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/236 (34%), Positives = 126/236 (53%), Gaps = 17/236 (7%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHG 63
           G+       L +V EY+   L +  R++ +     P   +K  ++QL + +   H     
Sbjct: 92  GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           + HRD+KPHN+L++    TLK+ D G A+  + P +     I + +YRAPE++ G+ HY+
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYT 210
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS------SLMN 177
           TAVD+WSV CIFAE++    +F GD+   QL  I R+LG P+ +V   ++       L N
Sbjct: 211 TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN 270
Query: 178 WHEYPQWN---PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
               P  N     SL  A     K+  DLL  +LQY P +R+   +A+ HPYFD+L
Sbjct: 271 SKGIPWSNVFSDHSLKDA-----KEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/217 (37%), Positives = 122/217 (56%), Gaps = 14/217 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++    + E+     V+ L+YQL +G+ + H  GI+HRDLKP N+
Sbjct: 100 VYLVTTLMGADLNNIVKCQALSDEH-----VQFLVYQLLRGLKYIHSAGIIHRDLKPSNV 154
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   L+I D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 155 AVN-EDCELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 210
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP----QSLA 190
            AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS  +   Y Q  P    + L+
Sbjct: 211 MAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS-EHARTYIQSLPPMPQKDLS 269
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 270 SIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 124/224 (55%), Gaps = 22/224 (9%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V EYM+TDL   +       E+      +  MYQL +G+ + H   +LHRDLKP NL
Sbjct: 97  VYIVQEYMETDLANVLEQGPLLEEH-----ARLFMYQLLRGLKYIHSANVLHRDLKPANL 151
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHE------ILTLWYRAPEVLLGSTHYSTAVDM 128
            ++ + + LKI D GLAR        Y+H+      ++T WYR+P +LL   +Y+ A+DM
Sbjct: 152 FINTEDLVLKIGDFGLARIMD---PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM-----NWHEYPQ 183
           W+  CIFAE++T   LF G  EL+Q+  I   +   +E+    + S++     N    P 
Sbjct: 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH 268
Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              + L   +P + ++ +D LEQ+L + P  R++A++A+ HPY 
Sbjct: 269 ---KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  133 bits (334), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 126/224 (56%), Gaps = 12/224 (5%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           +  +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + ILHRD+K 
Sbjct: 97  KASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 153
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVD 127
            N+L+ R  + LK+AD GLARAF+L       +Y + ++TLWYR PE+LLG   Y   +D
Sbjct: 154 ANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 212
Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHEYPQWN 185
           +W   CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +  L    E  +  
Sbjct: 213 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ 272
Query: 186 PQSLATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            + +   +    +D   LDL++++L  DP++RI +  A+ H +F
Sbjct: 273 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 125/221 (56%), Gaps = 12/221 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + ILHRD+K  N+
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L+ R  + LK+AD GLARAF+L       +Y + ++TLWYR PE+LLG   Y   +D+W 
Sbjct: 157 LITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWG 215
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHEYPQWNPQS 188
             CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +  L    E  +   + 
Sbjct: 216 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 275
Query: 189 LATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   +    +D   LDL++++L  DP++RI +  A+ H +F
Sbjct: 276 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 125/221 (56%), Gaps = 12/221 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + ILHRD+K  N+
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L+ R  + LK+AD GLARAF+L       +Y + ++TLWYR PE+LLG   Y   +D+W 
Sbjct: 157 LITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWG 215
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHEYPQWNPQS 188
             CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +  L    E  +   + 
Sbjct: 216 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 275
Query: 189 LATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   +    +D   LDL++++L  DP++RI +  A+ H +F
Sbjct: 276 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 125/221 (56%), Gaps = 12/221 (5%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + ILHRD+K  N+
Sbjct: 99  IYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 155
Query: 75  LMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L+ R  + LK+AD GLARAF+L       +Y + ++TLWYR PE+LLG   Y   +D+W 
Sbjct: 156 LITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWG 214
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS--LMNWHEYPQWNPQS 188
             CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +  L    E  +   + 
Sbjct: 215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 274
Query: 189 LATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +   +    +D   LDL++++L  DP++RI +  A+ H +F
Sbjct: 275 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 132/277 (47%), Gaps = 61/277 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LY+V E  D+DLKK  ++     E      VK+++Y L  G  F H  GI+HRDLKP N 
Sbjct: 107 LYIVLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLLGEKFIHESGIIHRDLKPANC 162
Query: 75  LMDRKTMTLKIADLGLARAFTLP-------------------------IKKYTHEILTLW 109
           L+++   ++KI D GLAR                               K+ T  ++T W
Sbjct: 163 LLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRW 221
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELV-----------TKTALFPGD---------- 148
           YRAPE++L   +Y+ ++D+WS  CIFAEL+            +  LFPG           
Sbjct: 222 YRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHN 281
Query: 149 -------SELQQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQSLATAVPNLDK 198
                  S   QL  IF ++GTP E+    ++    +     +P  +   L+    ++ K
Sbjct: 282 SKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISK 341
Query: 199 DGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
           +G+DLLE ML+++  KRI+  KA+ HPY  D+ K  L
Sbjct: 342 EGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENL 378

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 125/223 (56%), Gaps = 21/223 (9%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFEY++         F+Q  + +    ++  MY+L K + +CH  GI+HRD+KPHN+++
Sbjct: 112 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMI 165
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 166 DHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW-----------PGVSSLMNWHEYPQW 184
            ++  +   F G     QL+ I ++LGT  E+++           P  + ++  H   +W
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHFNDILGQHSRKRW 282
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                +     +  + LDLL+++L+YD  +R++AK+AMEHPYF
Sbjct: 283 ENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 125/223 (56%), Gaps = 21/223 (9%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFEY++         F+Q  + +    ++  MY+L K + +CH  GI+HRD+KPHN+++
Sbjct: 117 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMI 170
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 171 DHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW-----------PGVSSLMNWHEYPQW 184
            ++  +   F G     QL+ I ++LGT  E+++           P  + ++  H   +W
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHIDLDPHFNDILGQHSRKRW 287
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                +     +  + LDLL+++L+YD  +R++AK+AMEHPYF
Sbjct: 288 ENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 117/221 (52%), Gaps = 11/221 (4%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLV E M TDL + I   R     I    ++  MY +  G+   H  G++HRDL P N+
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 75  LM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+ D   +T  I D  LAR  T    K TH +   WYRAPE+++    ++  VDMWS  C
Sbjct: 166 LLADNNDIT--ICDFNLAREDTADANK-THYVTHRWYRAPELVMQFKGFTKLVDMWSAGC 222
Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTP--NEKVWPGVSSLMNWHEYPQWNPQSLA- 190
           + AE+  + ALF G +   QL  I  ++GTP   + V     S  ++      N  + A 
Sbjct: 223 VMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW 282
Query: 191 -TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              VP  D   LDL+ +ML+++P +RIS ++A+ HPYF+ L
Sbjct: 283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  130 bits (326), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 117/221 (52%), Gaps = 11/221 (4%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYLV E M TDL + I   R     I    ++  MY +  G+   H  G++HRDL P N+
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 75  LM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+ D   +T  I D  LAR  T    K TH +   WYRAPE+++    ++  VDMWS  C
Sbjct: 166 LLADNNDIT--ICDFNLAREDTADANK-THYVTHRWYRAPELVMQFKGFTKLVDMWSAGC 222
Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTP--NEKVWPGVSSLMNWHEYPQWNPQSLA- 190
           + AE+  + ALF G +   QL  I  ++GTP   + V     S  ++      N  + A 
Sbjct: 223 VMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW 282
Query: 191 -TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              VP  D   LDL+ +ML+++P +RIS ++A+ HPYF+ L
Sbjct: 283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+L+
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 110 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 164 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 139/295 (47%), Gaps = 74/295 (25%)
Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT----VKSLMYQLCKGV 56
           +D+   ++ E    LY+V E  D+D KK  R+        PV      +K+L+Y L  GV
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT--------PVYLTELHIKTLLYNLLVGV 169
Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--------TLPI---------- 98
            + H  GILHRDLKP N L++ +  ++K+ D GLAR           LPI          
Sbjct: 170 KYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 99  ---------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--------- 140
                    ++ T  ++T WYRAPE++L   +Y+ A+D+WS+ CIFAEL+          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 141 --KTALFPGDS--------------------ELQQLLHIFRLLGTPNEKVWPGVS---SL 175
             +  LFPG S                       QL  IF +LGTP+E+    +    + 
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                +P+     LA   P    D + LL++ML ++P+KRI+  + + HP+F ++
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 110 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 164 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 109 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 163 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 116 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 169
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 170 DHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 228
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 229 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 288
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 289 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           LVFE+++         F+Q  + +    ++  MY++ K + +CH  GI+HRD+KPHN+++
Sbjct: 111 LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 164
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C+ A
Sbjct: 165 DHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT          N ++ P  + ++  H   +W  
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 283
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              +     +  + LD L+++L+YD   R++A++AMEHPYF
Sbjct: 284 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLXQVIQM------ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLXQVIQM------ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  127 bits (318), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 97  VYLVMELMDANLXQVIQM------ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 150
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 151 VV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 207
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  126 bits (317), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLXQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 142 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 196 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 252
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 103 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 157 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 213
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 214 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 273
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 274 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 105 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 159 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 215
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 216 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 275
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 276 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 105 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 159 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 215
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 216 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 275
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 276 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 215 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 274
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 142 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 196 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 252
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 97  VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 151 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 207
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 98  VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 152 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 209 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 268
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 269 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/228 (36%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 98  VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 152 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWH------EYPQW 184
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +          +P+ 
Sbjct: 209 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 268
Query: 185 NPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            P SL  A    +K       DLL +ML  DP+KRIS   A++HPY +
Sbjct: 269 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 106 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 159
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 160 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 218
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 219 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 278
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 279 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 106 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 159
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 160 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 218
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 219 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 278
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 279 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  124 bits (311), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 107 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 160
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 161 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 219
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 220 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 279
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 280 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 105 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 158
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 159 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 217
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT    V+         P + +L+  H    W  
Sbjct: 218 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 278 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (310), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 80/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T E++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPEVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 118/221 (53%), Gaps = 17/221 (7%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FEY++         F+     +    ++  +Y+L K + +CH  GI+HRD+KPHN+++
Sbjct: 126 LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 179
Query: 77  DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
           D +   L++ D GLA  F  P K+Y   + + +++ PE+L+    Y  ++DMWS+ C+FA
Sbjct: 180 DHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 238
Query: 137 ELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQWNP 186
            ++  K   F G     QL+ I ++LGT     +         P + +L+  H    W  
Sbjct: 239 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLK 298
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              A     +  + +D L+++L+YD  +R++A +AM HPYF
Sbjct: 299 FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 339

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR           E++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MEPEVVTRYYRAPEVILG-MGYKENVDLWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 215 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR           E++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MEPEVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 215 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 113/231 (48%), Gaps = 31/231 (13%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I         +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 102 VYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 155
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR  +      T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 156 VV-KSDCTLKILDFGLARTASTNFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 212
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTP-----------------NEKVWPGVSSLMN 177
             ELV  + +F G   + Q   +   LGTP                 N   +PG++    
Sbjct: 213 MGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIA---- 268
Query: 178 WHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           + E +P W   S +           DLL +ML  DP KRIS  +A+ HPY 
Sbjct: 269 FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 105 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 159 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 215
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 216 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 273
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 274 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  120 bits (302), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 109 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 162
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 163 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCI 219
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 220 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 277
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 278 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/230 (34%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 98  VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 152 VV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCI 208
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E+V    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 209 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 266
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 267 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 316

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV  I
Sbjct: 158 VV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYIVMELMDANLSQVIQM------ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV  I
Sbjct: 158 VV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP+    +K+ P V + +     P++   S  
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV--ENRPKYAGYSFE 272
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  120 bits (300), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 79/227 (34%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I         +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 104 VYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR         T  ++T +YRAPEV+LG   Y+  VD+WSV CI
Sbjct: 158 VV-KSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPEVILG-MGYAANVDIWSVGCI 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS-SLMNWHE------------- 180
             ELV    +F G   + Q   +   LGTP+ +    +  ++ N+ E             
Sbjct: 215 MGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEEL 274
Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P W   S +           DLL +ML  DP KRIS  +A+ HPY 
Sbjct: 275 FPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 27/230 (11%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 106 VYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 159
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++ +   TLKI D GLAR            ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 160 VV-KSDCTLKILDFGLARTAGTSFMMVPF-VVTRYYRAPEVILG-MGYKENVDIWSVGCI 216
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPN----EKVWPGVSSLMNWHEYPQWNPQSLA 190
             E++    LFPG   + Q   +   LGTP     +K+ P V + +     P++   S  
Sbjct: 217 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV--ENRPKYAGYSFE 274
Query: 191 TAVPNL------------DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P++                 DLL +ML  D SKRIS  +A++HPY +
Sbjct: 275 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 324

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 48/253 (18%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           R  + + FE +  +L + I+  +  G ++P+  V+   + + + +   H + I+H DLKP
Sbjct: 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 72  HNLLMDRKTMT-LKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
            N+L+ ++  + +K+ D G +     R +T         I + +YRAPEV+LG+  Y   
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSCYEHQRVYT--------XIQSRFYRAPEVILGA-RYGMP 279
Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---HEYP 182
           +DMWS+ CI AEL+T   L PG+ E  QL  +  LLG P++K+        N+     YP
Sbjct: 280 IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYP 339
Query: 183 QWN-------------------------PQSL--ATAVPNLDKD-GLDLLEQMLQYDPSK 214
           ++                          P+S     A+   D    LD L+Q L++DP+ 
Sbjct: 340 RYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399
Query: 215 RISAKKAMEHPYF 227
           R++  +A+ HP+ 
Sbjct: 400 RMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 122/248 (49%), Gaps = 38/248 (15%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           R  + + FE +  +L + I+  +  G ++P+  V+   + + + +   H + I+H DLKP
Sbjct: 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 72  HNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+ ++  + +K+ D G   +     ++    I + +YRAPEV+LG+  Y   +DMWS
Sbjct: 229 ENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPEVILGA-RYGMPIDMWS 284
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---HEYPQWN-- 185
           + CI AEL+T   L PG+ E  QL  +  LLG P++K+        N+     YP++   
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTV 344
Query: 186 -----------------------PQSL--ATAVPNLDKD-GLDLLEQMLQYDPSKRISAK 219
                                  P+S     A+   D    LD L+Q L++DP+ R++  
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 220 KAMEHPYF 227
           +A+ HP+ 
Sbjct: 405 QALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 121/248 (48%), Gaps = 38/248 (15%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           R  + + FE +  +L + I+  +  G ++P+  V+   + + + +   H + I+H DLKP
Sbjct: 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 72  HNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+ ++  + +K+ D G   +     ++    I + +YRAPEV+LG+  Y   +DMWS
Sbjct: 229 ENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPEVILGA-RYGMPIDMWS 284
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---HEYPQWN-- 185
           + CI AEL+T   L PG+ E  QL  +  LLG P +K+        N+     YP++   
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTV 344
Query: 186 -----------------------PQSL--ATAVPNLDKD-GLDLLEQMLQYDPSKRISAK 219
                                  P+S     A+   D    LD L+Q L++DP+ R++  
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 220 KAMEHPYF 227
           +A+ HP+ 
Sbjct: 405 QALRHPWL 412

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/185 (33%), Positives = 95/185 (51%), Gaps = 29/185 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEI 105
           ++ Q+  GV + H H I+HRDLKP NLL++   K   +KI D GL+  F    KK    +
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERL 199
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y APEVL     Y    D+WS+  I   L+     F G ++ Q++L          
Sbjct: 200 GTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILR--------- 247
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            KV  G  +     + P+W          N+ +   DL++QMLQ+D  +RISA++A+EHP
Sbjct: 248 -KVEKGKYTF----DSPEW---------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 226 YFDDL 230
           +  ++
Sbjct: 294 WIKEM 298

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---------------DRKTMT---L 83
           ++ ++ + YQ+CK V F H + + H DLKP N+L                D +T+    +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 84  KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 143
           K+ D G A   T   + ++  + T  YRAPEV+L +  +S   D+WS+ CI  E      
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 144 LFPGDSELQQLLHIFRLLG-TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN------- 195
           +FP     + L  + R+LG  P   +          H+   W+  S A    +       
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 196 ---LDKDG-----LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
              L +D       DL+++ML+YDP+KRI+ ++A++HP+FD L K+
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 112/239 (46%), Gaps = 32/239 (13%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLL 75
           +VFE +  +L   I+ +   G  IP+  VK +  QL  G+ + H   GI+H D+KP N+L
Sbjct: 107 MVFEVLGENLLALIKKYEHRG--IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 76  MD-----RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           M+        + +KIADLG A  +    + YT+ I T  YR+PEVLLG+  +    D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCGADIWS 220
Query: 131 VACIFAELVTKTALFPGDS------ELQQLLHIFRLLGT-PNEKVWPGVSS--------- 174
            AC+  EL+T   LF  D       +   +  I  LLG  P+  +  G  +         
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280
Query: 175 LMNWHEYPQWNPQSLATAVPNLDKDGL----DLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           L N  +   W  + + T      KD      D L  MLQ DP KR  A   + HP+  D
Sbjct: 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 112/239 (46%), Gaps = 32/239 (13%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLL 75
           +VFE +  +L   I+ +   G  IP+  VK +  QL  G+ + H   GI+H D+KP N+L
Sbjct: 107 MVFEVLGENLLALIKKYEHRG--IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 76  MD-----RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           M+        + +KIADLG A  +    + YT+ I T  YR+PEVLLG+  +    D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCGADIWS 220
Query: 131 VACIFAELVTKTALFPGDS------ELQQLLHIFRLLGT-PNEKVWPGVSS--------- 174
            AC+  EL+T   LF  D       +   +  I  LLG  P+  +  G  +         
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280
Query: 175 LMNWHEYPQWNPQSLATAVPNLDKDGL----DLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           L N  +   W  + + T      KD      D L  MLQ DP KR  A   + HP+  D
Sbjct: 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 38/226 (16%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---------------DRKTMT---L 83
           ++ ++ + YQ+CK V F H + + H DLKP N+L                D +T+    +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 84  KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 143
           K+ D G A   T   + ++  +    YRAPEV+L +  +S   D+WS+ CI  E      
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFT 232
Query: 144 LFPGDSELQQLLHIFRLLG-TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN------- 195
           +FP     + L  + R+LG  P   +          H+   W+  S A    +       
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 196 ---LDKDG-----LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
              L +D       DL+++ML+YDP+KRI+ ++A++HP+FD L K+
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 45/255 (17%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDL 69
           R  L LVFE +  +L   +R+    G  + +N  +    Q+C  + F       I+H DL
Sbjct: 128 RNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185
Query: 70  KPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           KP N+L+ + K   +KI D G +       ++    I + +YR+PEVLLG   Y  A+DM
Sbjct: 186 KPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDM 241
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY---PQWN 185
           WS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +         + E      WN
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 186 PQ---------------------SLATAVPNLDKDG------------LDLLEQMLQYDP 212
            +                      + T  P   + G             DL+ +ML YDP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 213 SKRISAKKAMEHPYF 227
             RI    A++H +F
Sbjct: 362 KTRIQPYYALQHSFF 376

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 45/255 (17%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDL 69
           R  L LVFE +  +L   +R+    G  + +N  +    Q+C  + F       I+H DL
Sbjct: 128 RNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185
Query: 70  KPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           KP N+L+ + K   +KI D G +       ++    I + +YR+PEVLLG   Y  A+DM
Sbjct: 186 KPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDM 241
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY---PQWN 185
           WS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +         + E      WN
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 186 PQ---------------------SLATAVPNLDKDG------------LDLLEQMLQYDP 212
            +                      + T  P   + G             DL+ +ML YDP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 213 SKRISAKKAMEHPYF 227
             RI    A++H +F
Sbjct: 362 KTRIQPYYALQHSFF 376

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 45/255 (17%)
Query: 12  RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDL 69
           R  L LVFE +  +L   +R+    G  + +N  +    Q+C  + F       I+H DL
Sbjct: 109 RNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLATPELSIIHCDL 166
Query: 70  KPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           KP N+L+ + K   +KI D G +       ++    I + +YR+PEVLLG   Y  A+DM
Sbjct: 167 KPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDM 222
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY---PQWN 185
           WS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +         + E      WN
Sbjct: 223 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 282
Query: 186 PQ---------------------SLATAVPNLDKDG------------LDLLEQMLQYDP 212
            +                      + T  P   + G             DL+ +ML YDP
Sbjct: 283 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 342
Query: 213 SKRISAKKAMEHPYF 227
             RI    A++H +F
Sbjct: 343 KTRIQPYYALQHSFF 357

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 88/181 (48%), Gaps = 29/181 (16%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEI 105
           ++ Q+  G+ + H H I+HRDLKP N+L++   K   +KI D GL+  F     K    I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI 184
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y APEVL G+  Y    D+WS   I   L++ T  F G +E   L           
Sbjct: 185 GTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----------- 231
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           ++V  G  +     + PQW           +  D  DL+ +ML + PS RI+A + +EHP
Sbjct: 232 KRVETGKYAF----DLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 226 Y 226
           +
Sbjct: 279 W 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E Y   +L   I S ++  E   V+  + ++ Q+  G+ + H + I+HRD
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-IIRQVLSGITYMHKNKIVHRD 151
Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L           +KV  G  +     E PQW  
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYTF----ELPQWKK 253
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
            S +           DL+ +ML Y PS RISA+ A++H +     K ++
Sbjct: 254 VSESAK---------DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E Y   +L   I S ++  E   V+  + ++ Q+  G+ + H + I+HRD
Sbjct: 119 EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-IIRQVLSGITYMHKNKIVHRD 174
Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 231
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L           +KV  G  +     E PQW  
Sbjct: 232 DVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYTF----ELPQWKK 276
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
            S +           DL+ +ML Y PS RISA+ A++H +     K ++
Sbjct: 277 VSESAK---------DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E Y   +L   I S ++  E   V+  + ++ Q+  G+ + H + I+HRD
Sbjct: 120 EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-IIRQVLSGITYMHKNKIVHRD 175
Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 232
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L           +KV  G  +     E PQW  
Sbjct: 233 DVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYTF----ELPQWKK 277
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
            S +           DL+ +ML Y PS RISA+ A++H +     K ++
Sbjct: 278 VSESAK---------DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 317

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  +  Y+V E Y   +L   I   ++  E+     +K    Q+  G+ + H H I+HRD
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHKHNIVHRD 146
Query: 69  LKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N+L++   K   +KI D GL+  F     K    I T +Y APEVL G+  Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT--YDEKC 203
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++ T  F G +E   L           ++V  G  +     + PQW  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF----DLPQWR- 247
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                    +  D  DL+ +ML + PS RI+A + +EHP+
Sbjct: 248 --------TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  +  Y+V E Y   +L   I   ++  E+     +K    Q+  G+ + H H I+HRD
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHKHNIVHRD 146
Query: 69  LKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N+L++   K   +KI D GL+  F     K    I T +Y APEVL G+  Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT--YDEKC 203
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++ T  F G +E   L           ++V  G  +     + PQW  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF----DLPQWR- 247
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                    +  D  DL+ +ML + PS RI+A + +EHP+
Sbjct: 248 --------TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E Y   +L   I S ++  E   V+  + ++ Q+  G+ + H + I+HRD
Sbjct: 102 EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-IIRQVLSGITYMHKNKIVHRD 157
Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 214
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L           +KV  G  +     E PQW  
Sbjct: 215 DVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYTF----ELPQWKK 259
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            S +           DL+ +ML Y PS RISA+ A++H +
Sbjct: 260 VSESAK---------DLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 42/226 (18%)
Query: 41  PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMT 82
           P++ V+ + +QLC+ V F H + + H DLKP N+L                     K+  
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA 194
Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT 142
           +++ D G A   T   + ++  + T  YRAPEV+L    +S   D+WS+ CI  E     
Sbjct: 195 VRVVDFGSA---TFDHEHHSTIVSTRHYRAPEVIL-ELGWSQPCDVWSIGCIIFEYYVGF 250
Query: 143 ALFPGDSELQQLLHIFRLLG---------TPNEKVWPGVSSLMNWHE------YPQWNPQ 187
            LF      + L  + R+LG         T  +K +      ++W E      Y + N +
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYF--YRGRLDWDENTSAGRYVRENCK 308
Query: 188 SLA---TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            L    T+         DL+E ML+Y+P+KR++  +A++HP+F  L
Sbjct: 309 PLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 10  EGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 64
           E    +YLV E      M+  LK  ++ F +       N  +  M+Q+  G+ + H HGI
Sbjct: 81  EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE-------NEARHFMHQIITGMLYLHSHGI 133
Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           LHRDL   NLL+ R  M +KIAD GLA    +P +K+     T  Y +PE+   S H   
Sbjct: 134 LHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GL 191
Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
             D+WS+ C+F  L+     F  D+          +  T N+ V          +E P +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDT----------VKNTLNKVVLAD-------YEMPSF 234
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                      L  +  DL+ Q+L+ +P+ R+S    ++HP+      T+
Sbjct: 235 -----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 10  EGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E Y   +L   I S ++  E   V+  + ++ Q+  G+ + H + I+HRD
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-IIRQVLSGITYXHKNKIVHRD 151
Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L           +KV  G  +     E PQW  
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYTF----ELPQWKK 253
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            S +           DL+ + L Y PS RISA+ A++H + 
Sbjct: 254 VSESAK---------DLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 89/182 (48%), Gaps = 29/182 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 105
           +M Q+  G  + H H I+HRDLKP NLL++ K+    +KI D GL+  F +   K    +
Sbjct: 109 IMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL 167
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y APEVL     Y    D+WS   I   L+     F G ++ Q++L          
Sbjct: 168 GTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTD-QEIL---------- 214
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           ++V  G  S     + P W   S          +   L++ ML Y+PSKRISA++A+ HP
Sbjct: 215 KRVEKGKFSF----DPPDWTQVS---------DEAKQLVKLMLTYEPSKRISAEEALNHP 261
Query: 226 YF 227
           + 
Sbjct: 262 WI 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 89/182 (48%), Gaps = 29/182 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEI 105
           +M Q+  G  + H H I+HRDLKP NLL++ K+    +KI D GL+  F +   K    +
Sbjct: 126 IMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL 184
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y APEVL     Y    D+WS   I   L+     F G ++ Q++L          
Sbjct: 185 GTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTD-QEIL---------- 231
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           ++V  G  S     + P W           +  +   L++ ML Y+PSKRISA++A+ HP
Sbjct: 232 KRVEKGKFSF----DPPDWT---------QVSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 226 YF 227
           + 
Sbjct: 279 WI 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 38/226 (16%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHR 67
           E  + ++LVF     DL +    F    E + ++    +S+M  L + V+F H + I+HR
Sbjct: 170 ESSSFMFLVF-----DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR 224
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL---LGSTH--Y 122
           DLKP N+L+D   M ++++D G +     P +K      T  Y APE+L   +  TH  Y
Sbjct: 225 DLKPENILLD-DNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              VD+W+   I   L+  +  F    ++  L  I        E  +   S        P
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM-------EGQYQFSS--------P 327
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           +W+ +S             DL+ ++LQ DP  R++A++A++HP+F+
Sbjct: 328 EWDDRSSTVK---------DLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +++V EY+   +L  YI    +  E       + L  Q+  GV +CH H ++HRDLKP N
Sbjct: 91  IFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQQILSGVDYCHRHMVVHRDLKPEN 146
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHYSTAVDM 128
           +L+D   M  KIAD GL+   +        E L        Y APEV+ G  +    VD+
Sbjct: 147 VLLD-AHMNAKIADFGLSNMMS------DGEFLRXSCGSPNYAAPEVISGRLYAGPEVDI 199
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS   I   L+  T  F  D       H+  L     +K+  G+           + PQ 
Sbjct: 200 WSSGVILYALLCGTLPFDDD-------HVPTLF----KKICDGIF----------YTPQY 238
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           L  +V       + LL+ MLQ DP KR + K   EH +F
Sbjct: 239 LNPSV-------ISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 41  PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMT 82
           P+  V+ + YQLC  + F H + + H DLKP N+L                     K  +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT 142
           +++AD G A   T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E     
Sbjct: 181 IRVADFGSA---TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGF 236
Query: 143 ALFPGDSELQQLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNP 186
            LF      + L+ + ++LG         T  +K       VW   SS      Y + N 
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR---YVKENC 293
Query: 187 QSLATAV--PNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           + L + +   +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 41  PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMT 82
           P+  V+ + YQLC  + F H + + H DLKP N+L                     K  +
Sbjct: 130 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 189
Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT 142
           +++AD G A   T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E     
Sbjct: 190 IRVADFGSA---TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGF 245
Query: 143 ALFPGDSELQQLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNP 186
            LF      + L+ + ++LG         T  +K       VW   SS      Y + N 
Sbjct: 246 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR---YVKENC 302
Query: 187 QSLATAV--PNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           + L + +   +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 41  PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMT 82
           P+  V+ + YQLC  + F H + + H DLKP N+L                     K  +
Sbjct: 153 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 212
Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT 142
           +++AD G A   T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E     
Sbjct: 213 IRVADFGSA---TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGF 268
Query: 143 ALFPGDSELQQLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNP 186
            LF      + L+ + ++LG         T  +K       VW   SS      Y + N 
Sbjct: 269 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR---YVKENC 325
Query: 187 QSLATAV--PNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           + L + +   +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 7   QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           Q KE    L+ V EY++  DL  +I    Q+     ++       ++  G+ F H  GI+
Sbjct: 89  QTKEN---LFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 141
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           +RDLK  N+L+D K   +KIAD G+ +   L   K      T  Y APE+LLG   Y+ +
Sbjct: 142 YRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHS 199
Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD WS   +  E++   + F G  E ++L H  R                M+   YP+W 
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR----------------MDNPFYPRW- 241
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLD 231
                     L+K+  DLL ++   +P KR+  +  + +HP F +++
Sbjct: 242 ----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 278

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 7   QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           Q KE    L+ V EY++  DL  +I    Q+     ++       ++  G+ F H  GI+
Sbjct: 88  QTKEN---LFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           +RDLK  N+L+D K   +KIAD G+ +   L   K      T  Y APE+LLG   Y+ +
Sbjct: 141 YRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHS 198
Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD WS   +  E++   + F G  E ++L H  R                M+   YP+W 
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR----------------MDNPFYPRW- 240
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLD 231
                     L+K+  DLL ++   +P KR+  +  + +HP F +++
Sbjct: 241 ----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           T  ++V EY+   +L  YI    +  E       + L  Q+   V +CH H ++HRDLKP
Sbjct: 84  TDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGSTHYSTAV 126
            N+L+D   M  KIAD GL+   +        E L     +  Y APEV+ G  +    V
Sbjct: 140 ENVLLD-AHMNAKIADFGLSNMMS------DGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L+  T   P D E     H+  L     +K+  GV  +      P++  
Sbjct: 193 DIWSCGVILYALLCGT--LPFDDE-----HVPTLF----KKIRGGVFYI------PEYLN 235
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +S+AT           LL  MLQ DP KR + K   EH +F
Sbjct: 236 RSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           T  ++V EY+   +L  YI    +  E       + L  Q+   V +CH H ++HRDLKP
Sbjct: 84  TDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHYSTAV 126
            N+L+D   M  KIAD GL+   +        E L        Y APEV+ G  +    V
Sbjct: 140 ENVLLD-AHMNAKIADFGLSNMMS------DGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L+  T   P D E     H+  L     +K+  GV  +      P++  
Sbjct: 193 DIWSCGVILYALLCGT--LPFDDE-----HVPTLF----KKIRGGVFYI------PEYLN 235
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +S+AT           LL  MLQ DP KR + K   EH +F
Sbjct: 236 RSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 29/178 (16%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 104
           ++M Q+  G+ + H H I+HRD+KP N+L++ K   + +KI D GL+  F+    K    
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDR 208
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T +Y APEVL     Y+   D+WS   I   L+     F G ++ Q ++         
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDII--------- 256
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
            +KV  G      + ++  W          N+  +  +L++ ML YD +KR +A++A+
Sbjct: 257 -KKVEKGKY----YFDFNDW---------KNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 14  VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +LY+VFE+MD  DL   I      G           M Q+ + + +CH + I+HRD+KP 
Sbjct: 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPE 159
Query: 73  NLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           N+L+  K  +  +K+ D G+A             + T  + APEV +    Y   VD+W 
Sbjct: 160 NVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGKPVDVWG 218
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
              I   L++    F G  E      +F  +     K+ P            QW+     
Sbjct: 219 CGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP-----------RQWS----- 257
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
               ++ +   DL+ +ML  DP++RI+  +A+ HP+  + D+
Sbjct: 258 ----HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E +  + LV EY+D   + + R   ++     ++T+   M Q+C+G+   H   ILH DL
Sbjct: 156 ESKNDIVLVMEYVDGG-ELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQMYILHLDL 213
Query: 70  KPHNLL-MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           KP N+L ++R    +KI D GLAR +  P +K      T  + APEV +     S   DM
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEV-VNYDFVSFPTDM 271
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WSV  I   L++  + F GD++ + L +I                         +W+ + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILAC----------------------RWDLED 309
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
                 ++ ++  + + ++L  + S RISA +A++HP+  D
Sbjct: 310 --EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 3/135 (2%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V E  D  DL + I+ F++    IP  TV     QLC  +   H   ++HRD+KP N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +K+ DLGL R F+         + T +Y +PE  +    Y+   D+WS+ C
Sbjct: 167 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGC 224
Query: 134 IFAELVTKTALFPGD 148
           +  E+    + F GD
Sbjct: 225 LLYEMAALQSPFYGD 239

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 45/235 (19%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA  H   I+HRDLK
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSLKIIHRDLK 160
Query: 71  PHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL----TLWYRAPE 114
           P N+L+        D++T    + + I+D GL +        +   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 115 VLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
           +L  ST    + ++D++S+ C+F  +++K     GD   ++              +  G+
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------------SNIIRGI 268
Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            SL    E    + +SL         +  DL+ QM+ +DP KR +A K + HP F
Sbjct: 269 FSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 45/235 (19%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA  H   I+HRDLK
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSLKIIHRDLK 160
Query: 71  PHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL----TLWYRAPE 114
           P N+L+        D++T    + + I+D GL +        +   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 115 VLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
           +L  ST    + ++D++S+ C+F  +++K     GD   ++              +  G+
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------------SNIIRGI 268
Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            SL    E    + +SL         +  DL+ QM+ +DP KR +A K + HP F
Sbjct: 269 FSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 115/279 (41%), Gaps = 73/279 (26%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKPHNLL 75
           +VFE +   L K+I   +   + +PV  VKS++ Q+ +G+ + H    I+H D+KP N+L
Sbjct: 116 MVFEVLGHHLLKWI--IKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL 173
Query: 76  M----------------------------------------------DRKTMTLKIADLG 89
           M                                              +   + +KIADLG
Sbjct: 174 MCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG 233
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
            A       K +T +I T  YR+ EVL+G+  YST  D+WS AC+  EL T   LF   S
Sbjct: 234 NA---CWVHKHFTEDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHS 289
Query: 150 ------ELQQLLHIFRLLGT-PNEKVWPGVSSLMNWHEYPQ------WNPQSLATAV--- 193
                 +   + HI  LLG+ P      G  S   ++   +        P SL   +   
Sbjct: 290 GEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEK 349
Query: 194 ---PNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFD 228
              P+ D     D L  ML+  P KR SA + + HP+ +
Sbjct: 350 YGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLN 388

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 14  VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +LY+VFE+MD  DL   I      G           M Q+ + + +CH + I+HRD+KPH
Sbjct: 102 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 161
Query: 73  NLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
            +L+  K  +  +K+   G+A             + T  + APEV +    Y   VD+W 
Sbjct: 162 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGKPVDVWG 220
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
              I   L++    F G  E      +F  +     K+ P            QW+     
Sbjct: 221 CGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP-----------RQWS----- 259
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
               ++ +   DL+ +ML  DP++RI+  +A+ HP+  + D+
Sbjct: 260 ----HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 297

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA  H   I+HRDLK
Sbjct: 84  LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSLKIIHRDLK 142
Query: 71  PHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL----TLWYRAPE 114
           P N+L+        D++T    + + I+D GL +        +   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 115 VLLGSTHYST------AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
           +L  S +  T      ++D++S+ C+F  +++K     GD   ++              +
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------------SNI 250
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             G+ SL    E    + +SL         +  DL+ QM+ +DP KR +A K + HP F
Sbjct: 251 IRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA  H   I+HRDLK
Sbjct: 84  LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSLKIIHRDLK 142
Query: 71  PHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL----TLWYRAPE 114
           P N+L+        D++T    + + I+D GL +        +   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 115 VLLGSTHYST------AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
           +L  S +  T      ++D++S+ C+F  +++K     GD   ++              +
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------------SNI 250
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             G+ SL    E    + +SL         +  DL+ QM+ +DP KR +A K + HP F
Sbjct: 251 IRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 14  VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +LY+VFE+MD  DL   I      G           M Q+ + + +CH + I+HRD+KPH
Sbjct: 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159
Query: 73  NLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
            +L+  K  +  +K+   G+A             + T  + APEV +    Y   VD+W 
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGKPVDVWG 218
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
              I   L++    F G  E      +F  +     K+ P            QW+     
Sbjct: 219 CGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP-----------RQWS----- 257
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
               ++ +   DL+ +ML  DP++RI+  +A+ HP+  + D+
Sbjct: 258 ----HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           G+  L ++ E M+   + + R   +  +         +M  +   + F H H I HRD+K
Sbjct: 97  GKRCLLIIMECMEGG-ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK 155
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL     K   LK+ D G A+  T           T +Y APEV LG   Y  + DM
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEV-LGPEKYDKSCDM 212
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  ++                + + PG+   +   +Y    P+W
Sbjct: 213 WSLGVIMYILLCGFPPFYSNT---------------GQAISPGMKRRIRLGQYGFPNPEW 257
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           +          + +D   L+  +L+ DP++R++  + M HP+ +
Sbjct: 258 S---------EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           G+  L ++ E M+   + + R   +  +         +M  +   + F H H I HRD+K
Sbjct: 78  GKRCLLIIMECMEGG-ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK 136
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL     K   LK+ D G A+  T           T +Y APEV LG   Y  + DM
Sbjct: 137 PENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEV-LGPEKYDKSCDM 193
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  ++                + + PG+   +   +Y    P+W
Sbjct: 194 WSLGVIMYILLCGFPPFYSNT---------------GQAISPGMKRRIRLGQYGFPNPEW 238
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           +          + +D   L+  +L+ DP++R++  + M HP+ +
Sbjct: 239 S---------EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 273

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+    +   +KI D G ++     I   
Sbjct: 254 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 308
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 365
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 366 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 405
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 406 FTTEEALRHPWLQDEDMKR 424

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V E  +  +L + I S +  G+ +    V  LM Q+   +A+ H   ++H+DLKP N
Sbjct: 95  MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154
Query: 74  LLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L    +    +KI D GLA  F    +  T+   T  Y APEV      +    D+WS 
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRDVTFK--CDIWSA 211
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +   L+T    F G                         +SL    +   +   + A 
Sbjct: 212 GVVMYFLLTGCLPFTG-------------------------TSLEEVQQKATYKEPNYAV 246
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               L    +DLL+QML  DP +R SA + + H +F
Sbjct: 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+    +   +KI D G ++     I   
Sbjct: 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 294
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 351
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 352 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 391
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 392 FTTEEALRHPWLQDEDMKR 410

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   
Sbjct: 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 169
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 226
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 227 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 266
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 267 FTTEEALRHPWLQDEDMKR 285

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   
Sbjct: 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 169
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 226
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 227 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 266
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 267 FTTEEALRHPWLQDEDMKR 285

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   
Sbjct: 121 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 175
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 232
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 233 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 272
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 273 FTTEEALRHPWLQDEDMKR 291

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   
Sbjct: 114 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 168
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 169 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 225
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 226 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 265
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 266 FTTEEALRHPWLQDEDMKR 284

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 44  TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKY 101
           T K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   
Sbjct: 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGE 169
Query: 102 THEILTLW----YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
           T  + TL     Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  +
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQV 226
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
            +   + +      P V     W E               + +  LDL++++L  DP  R
Sbjct: 227 SLKDQITSGKYNFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKAR 266
Query: 216 ISAKKAMEHPYFDDLDKTR 234
            + ++A+ HP+  D D  R
Sbjct: 267 FTTEEALRHPWLQDEDMKR 285

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY     + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q                P  S      EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------------PSDSX----QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 70  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 126 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 185 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 218
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY     + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 72  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 128 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 187 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 220
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 88/184 (47%), Gaps = 27/184 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTH 103
           V + M Q C+G+   H H I+H D+KP N++ + +K  ++KI D GLA     P +    
Sbjct: 151 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKV 209
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
              T  + APE+ +         DMW++  +   L++  + F G+ +L+ L ++ R    
Sbjct: 210 TTATAEFAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--- 265
Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                        +W    +++  + ++  P    +  D ++ +LQ +P KR++   A+E
Sbjct: 266 -------------DW----EFDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALE 304
Query: 224 HPYF 227
           HP+ 
Sbjct: 305 HPWL 308

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 45/187 (24%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL-- 106
           Q+ + VA+ H +GI+HRDLKP NLL         LKIAD GL+       K   H++L  
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS-------KIVEHQVLMK 208
Query: 107 ----TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
               T  Y APE+L G   Y   VDMWSV  I   L+     F  +   Q    +FR   
Sbjct: 209 TVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFR--- 261
Query: 163 TPNEKVWPGVSSLMNWHEY---PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
                       ++N   Y   P W+  SL         +  DL+ +++  DP KR++  
Sbjct: 262 -----------RILNCEYYFISPWWDEVSL---------NAKDLVRKLIVLDPKKRLTTF 301
Query: 220 KAMEHPY 226
           +A++HP+
Sbjct: 302 QALQHPW 308

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 35/164 (21%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 100
           L  Q+ + +++ H  GI+HRDLKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 101 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-------------- 139
                   T  I T  Y A EVL G+ HY+  +DM+S+  IF E++              
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 140 ---TKTALFP---GDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
              + +  FP    D++++    I RLL   +    PG  +L+N
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           G  +EG  + YL  EY  +  + + R     G  +P    +   +QL  GV + HG GI 
Sbjct: 71  GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYS 123
           HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y APE+L     ++
Sbjct: 127 HRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   +       TA+  G+    Q          P++             EY  
Sbjct: 186 EPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC----------QEYSD 219
Query: 184 W-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 217
           W   ++       +D   L LL ++L  +PS RI+
Sbjct: 220 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 35/164 (21%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 100
           L  Q+ + +++ H  GI+HRDLKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 101 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-------------- 139
                   T  I T  Y A EVL G+ HY+  +DM+S+  IF E++              
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 140 ---TKTALFP---GDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
              + +  FP    D++++    I RLL   +    PG  +L+N
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 38/223 (17%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E +  +Y+V EY    +++ + S  +  +  PV        QL  G+ + H  GI+H+D+
Sbjct: 78  EEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDI 135
Query: 70  KPHNLLMDRKTMTLKIADLGLARA---FTLPIKKYTHEILTLWYRAPEVLLGSTHYST-A 125
           KP NLL+     TLKI+ LG+A A   F       T +  +  ++ PE+  G   +S   
Sbjct: 136 KPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLDTFSGFK 193
Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD+WS       + T    F GD       +I++L     E +  G              
Sbjct: 194 VDIWSAGVTLYNITTGLYPFEGD-------NIYKLF----ENIGKG-------------- 228
Query: 186 PQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
               + A+P      L DLL+ ML+Y+P+KR S ++  +H +F
Sbjct: 229 ----SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +M  +   VA+CH   + HRDLKP N L   D     LK+ D GLA  F  P K    ++
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV 169
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y +P+VL G   Y    D WS   +   L+     F   ++ + +L I     T  
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFP 227
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           EK W  VS            PQ+ +            L+ ++L   P +RI++ +A+EH 
Sbjct: 228 EKDWLNVS------------PQAES------------LIRRLLTKSPKQRITSLQALEHE 263
Query: 226 YFD 228
           +F+
Sbjct: 264 WFE 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +M  +   VA+CH   + HRDLKP N L   D     LK+ D GLA  F  P K    ++
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV 186
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T +Y +P+VL G   Y    D WS   +   L+     F   ++ + +L I     T  
Sbjct: 187 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFP 244
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           EK W  VS            PQ+ +            L+ ++L   P +RI++ +A+EH 
Sbjct: 245 EKDWLNVS------------PQAES------------LIRRLLTKSPKQRITSLQALEHE 280
Query: 226 YFD 228
           +F+
Sbjct: 281 WFE 283

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYL+ EY    ++  Y+ +  +  E       +S   Q+   V +CH   I+HRD
Sbjct: 81  ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVSAVQYCHQKRIVHRD 136
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT+  K  T    +  Y APE+  G  +    VD+
Sbjct: 137 LKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 194
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 195 WSLGVILYTLVSGSLPFDGQN 215

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 27/181 (14%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           + Q+ + V  CH +GI+HRDLKP NLL+  K+    +K+AD GLA       + +     
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
           T  Y +PEVL     Y   VDMW+   I   L+     F  D +  +L           +
Sbjct: 169 TPGYLSPEVLRKDP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLY----------Q 216
Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           ++  G     +    P+W+     T  P    +  DL+ +ML  +P+KRI+A +A++HP+
Sbjct: 217 QIKAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPAKRITASEALKHPW 263
Query: 227 F 227
Sbjct: 264 I 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTL 108
           Q+ + V  CH +GI+HRDLKP NLL+  K+    +K+AD GLA       + +     T 
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y +PEVL     Y   VDMW+   I   L+     F  D +  +L           +++
Sbjct: 171 GYLSPEVLRKDP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLY----------QQI 218
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             G     +    P+W+     T  P    +  DL+ +ML  +P+KRI+A +A++HP+ 
Sbjct: 219 KAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + +V EY   +L  YI    +  E       +    Q+   V +CH H I+HRDLKP NL
Sbjct: 83  IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRHKIVHRDLKPENL 138
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D + + +KIAD GL+   T           +  Y APEV+ G  +    VD+WS   I
Sbjct: 139 LLD-EHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 196
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
              ++ +    P D E   +L          + +  GV +L          P+ L+    
Sbjct: 197 LYVMLCRR--LPFDDESIPVLF---------KNISNGVYTL----------PKFLSPGAA 235
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   L+++ML  +P  RIS  + M+  +F
Sbjct: 236 G-------LIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + +V EY   +L  YI    +  E       +    Q+   V +CH H I+HRDLKP NL
Sbjct: 88  IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRHKIVHRDLKPENL 143
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D + + +KIAD GL+   T      T    +  Y APEV+ G  +    VD+WS   I
Sbjct: 144 LLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 201
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
              ++ +    P D E   +L          + +  GV +L          P+ L+    
Sbjct: 202 LYVMLCRR--LPFDDESIPVLF---------KNISNGVYTL----------PKFLSPGAA 240
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   L+++ML  +P  RIS  + M+  +F
Sbjct: 241 G-------LIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + +V EY   +L  YI    +  E       +    Q+   V +CH H I+HRDLKP NL
Sbjct: 79  IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRHKIVHRDLKPENL 134
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D + + +KIAD GL+   T      T    +  Y APEV+ G  +    VD+WS   I
Sbjct: 135 LLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 192
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
              ++ +    P D E   +L          + +  GV +L          P+ L+    
Sbjct: 193 LYVMLCRR--LPFDDESIPVLF---------KNISNGVYTL----------PKFLSPGAA 231
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   L+++ML  +P  RIS  + M+  +F
Sbjct: 232 G-------LIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + +V EY   +L  YI    +  E       +    Q+   V +CH H I+HRDLKP NL
Sbjct: 89  IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRHKIVHRDLKPENL 144
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D + + +KIAD GL+   T      T    +  Y APEV+ G  +    VD+WS   I
Sbjct: 145 LLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 202
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
              ++ +    P D E   +L          + +  GV +L          P+ L+    
Sbjct: 203 LYVMLCRR--LPFDDESIPVLF---------KNISNGVYTL----------PKFLSPGAA 241
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   L+++ML  +P  RIS  + M+  +F
Sbjct: 242 G-------LIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 84  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKYIVHRD 139
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT+  K  T    +  Y APE+  G  +    VD+
Sbjct: 140 LKAENLLLD-GDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 197
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 198 WSLGVILYTLVSGSLPFDGQN 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT    K      +  Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADMNIKIADFGFSNEFTFG-NKLDEFCGSPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGEN----IPVNTVKSLMYQLCKGVAFCHGH-GILHRD 68
           +Y+++EYM+ D + K+   F    +N    IP+  +K ++  +    ++ H    I HRD
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA-VD 127
           +KP N+LMD K   +K++D G +    +  KK      T  +  PE     + Y+ A VD
Sbjct: 178 VKPSNILMD-KNGRVKLSDFGESEY--MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 128 MWSVA-CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           +WS+  C++        + P   ++  L+ +F  + T N + +P      N   YP  N 
Sbjct: 235 IWSLGICLYVMFYN---VVPFSLKI-SLVELFNNIRTKNIE-YPLDR---NHFLYPLTNK 286
Query: 187 QSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           +S  T   N L  + +D L+  L+ +P++RI+++ A++H +  D
Sbjct: 287 KS--TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 70/140 (50%), Gaps = 8/140 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N+L
Sbjct: 92  YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIL 148
Query: 76  MDRKTMTLKIADLGLARAFT---LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA       + +    I T  Y +PE   G +      D++S+ 
Sbjct: 149 IS-ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 206
Query: 133 CIFAELVTKTALFPGDSELQ 152
           C+  E++T    F GDS + 
Sbjct: 207 CVLYEVLTGEPPFTGDSPVS 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T + +V EY   +L  YI   ++  E+      +    Q+   + +CH H I+HRDLKP 
Sbjct: 82  TDIVMVIEYAGGELFDYIVEKKRMTED----EGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+D   + +KIAD GL+   T      T    +  Y APEV+ G  +    VD+WS  
Sbjct: 138 NLLLD-DNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKLYAGPEVDVWS-- 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           C     V      P D E             PN  ++  V+S +  +  P +        
Sbjct: 194 CGIVLYVMLVGRLPFDDEF-----------IPN--LFKKVNSCV--YVMPDF-------- 230
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              L      L+ +M+  DP +RI+ ++    P+F+
Sbjct: 231 ---LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYL+ EY    ++  Y+ +  +  E       +S   Q+   V +CH   I+HRD
Sbjct: 84  ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT+   K         Y APE+  G  +    VD+
Sbjct: 140 LKAENLLLD-ADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 198 WSLGVILYTLVSGSLPFDGQN 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT    K         Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADMNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 30/200 (15%)
Query: 35  QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLAR 92
           +  E +  N V  L+ Q+ +GV + H + I+H DLKP N+L+        +KI D G++R
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 93  AFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
                 +    EI+ T  Y APE+ L     +TA DMW++  I   L+T T+ F G+   
Sbjct: 183 KIGHACE--LREIMGTPEYLAPEI-LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239
Query: 152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 211
           +  L+I ++    +E+ +  VS L                          D ++ +L  +
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQL------------------------ATDFIQSLLVKN 275
Query: 212 PSKRISAKKAMEHPYFDDLD 231
           P KR +A+  + H +    D
Sbjct: 276 PEKRPTAEICLSHSWLQQWD 295

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N++
Sbjct: 92  YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA        T     I T  Y +PE   G +      D++S+ 
Sbjct: 149 IS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 206
Query: 133 CIFAELVTKTALFPGDSELQ 152
           C+  E++T    F GDS + 
Sbjct: 207 CVLYEVLTGEPPFTGDSPVS 226

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N++
Sbjct: 92  YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA        T     I T  Y +PE   G +      D++S+ 
Sbjct: 149 IS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 206
Query: 133 CIFAELVTKTALFPGDS 149
           C+  E++T    F GDS
Sbjct: 207 CVLYEVLTGEPPFTGDS 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 29/181 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILT 107
           M Q+CKG+   H +  +H DLKP N++   +++  LK+ D GL  A   P +       T
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGT 319
Query: 108 LWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
             + APEV  G    Y T  DMWSV  +   L++  + F G+++ + L ++         
Sbjct: 320 AEFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------ 371
Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                            WN     +A   + +DG D + ++L  DP+ R++  +A+EHP+
Sbjct: 372 ----------------DWNMDD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 227 F 227
Sbjct: 414 L 414

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N++
Sbjct: 92  YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA        T     I T  Y +PE   G +      D++S+ 
Sbjct: 149 IS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 206
Query: 133 CIFAELVTKTALFPGDSELQ 152
           C+  E++T    F GDS + 
Sbjct: 207 CVLYEVLTGEPPFTGDSPVS 226

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 57/256 (22%)
Query: 32  SFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA 91
           SF     ++    V+  M  L K +   H  GI+HRD+KP N L +R+     + D GLA
Sbjct: 106 SFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165
Query: 92  RA---FTLPIKKYTH-------------------------EILTLWYRAPEVLLGSTHYS 123
           +      + + K+                              T  +RAPEVL    + +
Sbjct: 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS---SLMNWH 179
           TA+DMWS   IF  L++ +   +    +L  L  I  + G+  E +    +   S++   
Sbjct: 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS-RETIQAAKTFGKSILCSK 284
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQY------------------------DPSKR 215
           E P  + + L   +  +D     L   +  +                        +P+ R
Sbjct: 285 EVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASR 344
Query: 216 ISAKKAMEHPYFDDLD 231
           I+A++A+ HP+F D+ 
Sbjct: 345 ITAEEALLHPFFKDMS 360

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N++
Sbjct: 92  YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA        T     I T  Y +PE   G +      D++S+ 
Sbjct: 149 IS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 206
Query: 133 CIFAELVTKTALFPGDSELQ 152
           C+  E++T    F GDS + 
Sbjct: 207 CVLYEVLTGEPPFTGDSPVS 226

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++   + + +A+ H  G++HRD+K  ++L+      +K++D G     +  + K    
Sbjct: 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXL 201
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+   + Y+T VD+WS+  +  E+V     +  DS +Q +    RL  +P
Sbjct: 202 VGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSP 257
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             K       L N H+             P L     D LE+ML  DP +R +A++ ++H
Sbjct: 258 PPK-------LKNSHKVS-----------PVLR----DFLERMLVRDPQERATAQELLDH 295
Query: 225 PYF 227
           P+ 
Sbjct: 296 PFL 298

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  L LV   M+  DLK +I    Q G   P         ++C G+   H   I++RD
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LKP N+L+D     ++I+DLGLA       +     + T+ Y APEV + +  Y+ + D 
Sbjct: 312 LKPENILLDDHGH-IRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFSPDW 368
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ-WNPQ 187
           W++ C+  E++       G S  QQ     R      E+V   V  +    EY + ++PQ
Sbjct: 369 WALGCLLYEMIA------GQSPFQQ-----RKKKIKREEVERLVKEVP--EEYSERFSPQ 415
Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
           + +            L  Q+L  DP++R+     SA++  EHP F  L+  RL
Sbjct: 416 ARS------------LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 27/179 (15%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           Q+ + V  CH  G++HRDLKP NLL+    K   +K+AD GLA       + +     T 
Sbjct: 129 QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 188
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y +PEVL     Y   VD+W+   I   L+     F  D +  +L           +++
Sbjct: 189 GYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLY----------QQI 236
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             G     +    P+W+     T  P    +  DL+ +ML  +PSKRI+A +A++HP+ 
Sbjct: 237 KAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILH 66
           T LY+V EY +  DL   I    +  + +    V  +M QL   +  CH     GH +LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+ +D K   +K+ D GLAR            + T +Y +PE  +    Y+   
Sbjct: 140 RDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ-MNRMSYNEKS 197
Query: 127 DMWSVACIFAELVTKTALFP 146
           D+WS+ C+  EL    AL P
Sbjct: 198 DIWSLGCLLYELC---ALMP 214

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 29/181 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILT 107
           M Q+CKG+   H +  +H DLKP N++   +++  LK+ D GL  A   P +       T
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGT 213
Query: 108 LWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
             + APEV  G    Y T  DMWSV  +   L++  + F G+++ + L ++         
Sbjct: 214 AEFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------ 265
Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                            WN     +A   + +DG D + ++L  DP+ R++  +A+EHP+
Sbjct: 266 ----------------DWNMDD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 307
Query: 227 F 227
Sbjct: 308 L 308

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  L LV   M+  DLK +I    Q G   P         ++C G+   H   I++RD
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LKP N+L+D     ++I+DLGLA       +     + T+ Y APEV + +  Y+ + D 
Sbjct: 312 LKPENILLDDHGH-IRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFSPDW 368
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ-WNPQ 187
           W++ C+  E++       G S  QQ     R      E+V   V  +    EY + ++PQ
Sbjct: 369 WALGCLLYEMIA------GQSPFQQ-----RKKKIKREEVERLVKEVP--EEYSERFSPQ 415
Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
           + +            L  Q+L  DP++R+     SA++  EHP F  L+  RL
Sbjct: 416 ARS------------LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILH 66
           T LY+V EY +  DL   I    +  + +    V  +M QL   +  CH     GH +LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+ +D K   +K+ D GLAR            + T +Y +PE  +    Y+   
Sbjct: 140 RDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ-MNRMSYNEKS 197
Query: 127 DMWSVACIFAELVTKTALFP 146
           D+WS+ C+  EL    AL P
Sbjct: 198 DIWSLGCLLYELC---ALMP 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           Y+V EY+D    + I      G   P   ++ ++   C+ + F H +GI+HRD+KP N++
Sbjct: 109 YIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIM 165
Query: 76  MDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           +   T  +K+ D G+ARA        T     I T  Y +PE   G +      D++S+ 
Sbjct: 166 IS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG 223
Query: 133 CIFAELVTKTALFPGDSELQ 152
           C+  E++T    F GDS + 
Sbjct: 224 CVLYEVLTGEPPFTGDSPVS 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 8   NKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
            ++ R   Y+  E     L++Y+  + F   G   P+    +L+ Q   G+A  H   I+
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PI----TLLQQTTSGLAHLHSLNIV 140
Query: 66  HRDLKPHNLLMDRKTMTLKI----ADLGLARAFTLPIKKYTHEIL---TLWYRAPEVLLG 118
           HRDLKPHN+L+       KI    +D GL +   +    ++       T  + APE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 119 ST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
               + +  VD++S  C+F  ++++ +  P    LQ+  +I             G  SL 
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGS-HPFGKSLQRQANILL-----------GACSLD 248
Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             H  P+ +   +A           +L+E+M+  DP KR SAK  ++HP+F  L+K
Sbjct: 249 CLH--PEKHEDVIAR----------ELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILH 66
           T LY+V EY +  DL   I    +  + +    V  +M QL   +  CH     GH +LH
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+ +D K   +K+ D GLAR            + T +Y +PE  +    Y+   
Sbjct: 140 RDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQ-MNRMSYNEKS 197
Query: 127 DMWSVACIFAELVTKTALFP 146
           D+WS+ C+  EL    AL P
Sbjct: 198 DIWSLGCLLYELC---ALMP 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +     E       ++   Q+   V +CH   I+HRD
Sbjct: 76  ETEKTLYLVMEYASGGEVFDYLVAHGWMKEK----EARAKFRQIVSAVQYCHQKFIVHRD 131
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G  +    VD+
Sbjct: 132 LKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEVDV 189
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS+  I   LV+ +  F G + L++L           E+V  G   +          P  
Sbjct: 190 WSLGVILYTLVSGSLPFDGQN-LKEL----------RERVLRGKYRI----------PFY 228
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
           ++T   N       LL++ L  +PSKR + ++ M+
Sbjct: 229 MSTDCEN-------LLKKFLILNPSKRGTLEQIMK 256

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHR 67
           E  T  +LVF     DL K    F    E + ++    + +M  L + +   H   I+HR
Sbjct: 81  ETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 135
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-----Y 122
           DLKP N+L+D   M +K+ D G +     P +K      T  Y APE++  S +     Y
Sbjct: 136 DLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGY 193
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              VDMWS   I   L+  +  F      +Q+L + R++ + N +              P
Sbjct: 194 GKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRMIMSGNYQFGS-----------P 238
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +W+  S             DL+ + L   P KR +A++A+ HP+F
Sbjct: 239 EWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 84  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 142
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTEPCYTPYYVAPEV-LGPEKYDKSCDM 200
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 201 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 245
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 246 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHR 67
           E  T  +LVF     DL K    F    E + ++    + +M  L + +   H   I+HR
Sbjct: 94  ETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 148
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-----Y 122
           DLKP N+L+D   M +K+ D G +     P +K      T  Y APE++  S +     Y
Sbjct: 149 DLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              VDMWS   I   L+  +  F      +Q+L + R++ + N +              P
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRMIMSGNYQFGS-----------P 251
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +W+  S             DL+ + L   P KR +A++A+ HP+F
Sbjct: 252 EWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 29/183 (15%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNL--LMDRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           ++ Q+   V + H +GI+HRDLKP NL  L   +   + I D GL++     I   +   
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC 168
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  Y APEV L    YS AVD WS+  I   L+     F  ++E +             
Sbjct: 169 GTPGYVAPEV-LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF----------- 216
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           EK+  G        E P W+         ++ +   D +  +L+ DP++R + +KA+ HP
Sbjct: 217 EKIKEGYYEF----ESPFWD---------DISESAKDFICHLLEKDPNERYTCEKALSHP 263
Query: 226 YFD 228
           + D
Sbjct: 264 WID 266

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTL 108
           Q+ + V  CH  G++HRDLKP NLL+  K     +K+AD GLA       + +     T 
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y +PEVL     Y   VD+W+   I   L+     F  + +                K+
Sbjct: 171 GYLSPEVLRKEA-YGKPVDIWACGVILYILLVGYPPFWDEDQ---------------HKL 214
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           +  + +       P+W+     T  P    +  +L+ QML  +P+KRI+A +A++HP+
Sbjct: 215 YQQIKAGAYDFPSPEWD-----TVTP----EAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 16  YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           YLV EY++   L +YI S       + V+T  +   Q+  G+   H   I+HRD+KP N+
Sbjct: 87  YLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 75  LMDRKTMTLKIADLGLARAFT-LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+D    TLKI D G+A+A +   + +  H + T+ Y +PE   G        D++S+  
Sbjct: 143 LIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGI 200
Query: 134 IFAELVTKTALFPGDS 149
           +  E++     F G++
Sbjct: 201 VLYEMLVGEPPFNGET 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHR 67
           E  T  +LVF     DL K    F    E + ++    + +M  L + +   H   I+HR
Sbjct: 94  ETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 148
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-----Y 122
           DLKP N+L+D   M +K+ D G +     P +K      T  Y APE++  S +     Y
Sbjct: 149 DLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLRSVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              VDMWS   I   L+  +  F      +Q+L + R++ + N +              P
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRMIMSGNYQFGS-----------P 251
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +W+  S             DL+ + L   P KR +A++A+ HP+F
Sbjct: 252 EWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 136 GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 194
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 195 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 252
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 253 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 297
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 298 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 130 GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 188
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 246
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 291
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 292 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 86  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 202
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 203 WSLGVIMYILLCGYPPFYSNHGLA---------------ISPGMKTRIRMGQYEFPNPEW 247
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 248 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 90  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 148
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 149 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 206
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 207 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 251
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 252 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 91  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 149
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 150 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 207
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 208 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 252
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 253 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 92  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 150
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 151 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 208
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 209 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 253
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 254 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 84  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 142
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 200
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 201 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 245
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 246 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 100 GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 158
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 159 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 216
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 217 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 261
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 262 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 86  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 202
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 203 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 247
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 248 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 85  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 143
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + DM
Sbjct: 144 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDM 201
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 202 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 246
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 247 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 34/185 (18%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKYT 102
           L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    +
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVLS 176
Query: 103 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
               T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +   
Sbjct: 177 TACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235
Query: 163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
             +   W  +S                            D +  +++ DP KR + ++A+
Sbjct: 236 EFDSPYWDDISD------------------------SAKDFIRHLMEKDPEKRFTCEQAL 271
Query: 223 EHPYF 227
           +HP+ 
Sbjct: 272 QHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 34/185 (18%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKYT 102
           L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    +
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVLS 176
Query: 103 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
               T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +   
Sbjct: 177 TACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235
Query: 163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
             +   W  +S                            D +  +++ DP KR + ++A+
Sbjct: 236 EFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTCEQAL 271
Query: 223 EHPYF 227
           +HP+ 
Sbjct: 272 QHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 34/185 (18%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKYT 102
           L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    +
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVLS 176
Query: 103 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
               T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +   
Sbjct: 177 TACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235
Query: 163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
             +   W  +S                            D +  +++ DP KR + ++A+
Sbjct: 236 EFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTCEQAL 271
Query: 223 EHPYF 227
           +HP+ 
Sbjct: 272 QHPWI 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 34/185 (18%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKYT 102
           L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    +
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVLS 176
Query: 103 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
               T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +   
Sbjct: 177 TACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235
Query: 163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
             +   W  +S                            D +  +++ DP KR + ++A+
Sbjct: 236 EFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTCEQAL 271
Query: 223 EHPYF 227
           +HP+ 
Sbjct: 272 QHPWI 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 27/180 (15%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           Q+ + V  CH  G++HR+LKP NLL+    K   +K+AD GLA       + +     T 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y +PEVL     Y   VD+W+   I   L+     F  D +  +L           +++
Sbjct: 178 GYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLY----------QQI 225
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
             G     +    P+W+     T  P    +  DL+ +ML  +PSKRI+A +A++HP+  
Sbjct: 226 KAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRTELCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 65/141 (46%), Gaps = 7/141 (4%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +CH   I+HRD
Sbjct: 83  ETEKTLYLVXEYASGGEVFDYLVAHGRXKEK----EARAKFRQIVSAVQYCHQKFIVHRD 138
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  NLL+D     +KIAD G +  FT    K         Y APE+  G  +    VD+
Sbjct: 139 LKAENLLLD-ADXNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQGKKYDGPEVDV 196
Query: 129 WSVACIFAELVTKTALFPGDS 149
           WS+  I   LV+ +  F G +
Sbjct: 197 WSLGVILYTLVSGSLPFDGQN 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y     L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGCLLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE LL     S + D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSASKSSDLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 107 TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 163
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 164 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 219
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                 +P +        
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------------FPDF-------- 254
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              + +   DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 255 ---VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 161 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 218
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 260
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 161 ILLN-EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWAL 218
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 260
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           ++Q+ + V   H H I+HRDLKP NLL+  K     +K+AD GLA       + +     
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAG 195
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
           T  Y +PEVL     Y   VD+W+   I   L+     F  + +                
Sbjct: 196 TPGYLSPEVLRKDP-YGKPVDIWACGVILYILLVGYPPFWDEDQ---------------H 239
Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           K++  + +       P+W+     T  P    +  +L+ QML  +P+KRI+A +A++HP+
Sbjct: 240 KLYQQIKAGAYDFPSPEWD-----TVTP----EAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 161 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 218
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 260
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 108 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 164 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 221
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 222 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 263
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 264 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 298

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 161 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 218
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 260
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 85  LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 140
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+        T  Y +PE+L   +   ++ D+W++
Sbjct: 141 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 198
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 199 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 240
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 241 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 275

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 30/192 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAF-TLPIKKY- 101
           + ++M Q+   + + H  GI HRD+KP N L    K+  +K+ D GL++ F  L   +Y 
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 102 --THEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 158
             T +  T ++ APEVL  +   Y    D WS   +   L+     FPG ++   +  + 
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 218
                 N+K+           E P +N          L     DLL  +L  +  +R  A
Sbjct: 290 ------NKKL---------CFENPNYNV---------LSPLARDLLSNLLNRNVDERFDA 325
Query: 219 KKAMEHPYFDDL 230
            +A++HP+    
Sbjct: 326 MRALQHPWISQF 337

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 108 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 164 ILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWAL 221
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 222 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 263
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 264 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 298

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 112 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 167
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 168 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 225
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 226 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 267
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 268 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 84  LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 139
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 140 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 197
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 198 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 239
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 240 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 98  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 154
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 155 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 210
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 211 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 241
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 242 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 13  TVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           T +YL+ EY    ++ K ++   +  E        + + +L   +++CH   ++HRD+KP
Sbjct: 86  TRVYLILEYAPRGEVYKELQKLSKFDEQ----RTATYITELANALSYCHSKRVIHRDIKP 141
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+
Sbjct: 142 ENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSL 197
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E +     F  ++  +    I R+  T                            
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------------------- 229
Query: 192 AVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
             P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 35/188 (18%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTH 103
           + S ++Q+C+ + F H H I H D++P N++   R++ T+KI + G AR    P   +  
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF-- 160
Query: 104 EILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
               L + APE      H     STA DMWS+  +   L++    F  ++  Q + +I  
Sbjct: 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
              T +E+ +  +S                         + +D ++++L  +   R++A 
Sbjct: 218 AEYTFDEEAFKEISI------------------------EAMDFVDRLLVKERKSRMTAS 253
Query: 220 KAMEHPYF 227
           +A++HP+ 
Sbjct: 254 EALQHPWL 261

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 83  LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+        T  Y +PE+L   +   ++ D+W++
Sbjct: 139 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 196
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 238
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 239 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 273

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 82  LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 137
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+        T  Y +PE+L   +   ++ D+W++
Sbjct: 138 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 195
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 196 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 237
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 238 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 272

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 89  LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+        T  Y +PE+L   +   ++ D+W++
Sbjct: 145 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 202
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 203 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 244
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 245 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 279

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 163 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 220
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 221 GCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR------------------ 262
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 104 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+        T  Y +PE+L   +   ++ D+W++
Sbjct: 160 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 217
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 218 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 259
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 260 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 294

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 82  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 138
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 139 NLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 194
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 225
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 86  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 142
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE + G  H    VD+WS+ 
Sbjct: 143 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEXIEGRXH-DEKVDLWSLG 198
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 229
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 104 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K  +    + T  Y +PE+L   +   ++ D+W++
Sbjct: 160 ILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWAL 217
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 218 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------------------ 259
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
                     DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 260 ----------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 294

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 86  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 142
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 143 NLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 198
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 229
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 34/181 (18%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 106
           + M +L   + +CH   ++HRD+KP NLLM  K   LKIAD G   +   P  +      
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGW--SVHAPSLRRRXMCG 175
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPN 165
           TL Y  PE++ G TH    VD+W    +  E +     F   S  +    I  + L  P 
Sbjct: 176 TLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP- 233
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                                       P L     DL+ ++L+Y P +R+  K  MEHP
Sbjct: 234 ----------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 265
Query: 226 Y 226
           +
Sbjct: 266 W 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 100
           L  Q+ + +++ H  GI+HR+LKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 101 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 139
                   T  I T  Y A EVL G+ HY+  +D +S+  IF E +
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 86  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 142
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 143 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 198
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 229
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 34/181 (18%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 106
           + M +L   + +CH   ++HRD+KP NLLM  K   LKIAD G   +   P  +      
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGW--SVHAPSLRRRXMCG 174
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPN 165
           TL Y  PE++ G TH    VD+W    +  E +     F   S  +    I  + L  P 
Sbjct: 175 TLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP- 232
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                                       P L     DL+ ++L+Y P +R+  K  MEHP
Sbjct: 233 ----------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 226 Y 226
           +
Sbjct: 265 W 265

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHE 104
           +++ + K V + H  G++HRDLKP N+L   ++     L+I D G A+            
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGDSELQQLLHIFRLLGT 163
             T  + APEVL     Y    D+WS+  + +  L   T    G S+            T
Sbjct: 186 CYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD------------T 232
Query: 164 PNE---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           P E   ++  G  +L   +    WN          + +   DL+ +ML  DP +R++AK+
Sbjct: 233 PEEILTRIGSGKFTLSGGN----WN---------TVSETAKDLVSKMLHVDPHQRLTAKQ 279
Query: 221 AMEHPYFDDLDK 232
            ++HP+    DK
Sbjct: 280 VLQHPWVTQKDK 291

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 80  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 136
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 137 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 192
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 193 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 223
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 224 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 85  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 141
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 142 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 197
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 198 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 228
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 229 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHE 104
           +++ + K V + H  G++HRDLKP N+L   ++     L+I D G A+            
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGDSELQQLLHIFRLLGT 163
             T  + APEVL     Y    D+WS+  + +  L   T    G S+            T
Sbjct: 186 CYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD------------T 232
Query: 164 PNE---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           P E   ++  G  +L   +    WN          + +   DL+ +ML  DP +R++AK+
Sbjct: 233 PEEILTRIGSGKFTLSGGN----WN---------TVSETAKDLVSKMLHVDPHQRLTAKQ 279
Query: 221 AMEHPYFDDLDK 232
            ++HP+    DK
Sbjct: 280 VLQHPWVTQKDK 291

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 78  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 134
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 135 NLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 190
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 191 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 221
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 222 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H   
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 191
Query: 107 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  Y +PEVL     YS  VD+W+   I   L+     F  + +               
Sbjct: 192 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 235
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++ P
Sbjct: 236 HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALKVP 286
Query: 226 YFDDLDK 232
           +  + ++
Sbjct: 287 WICNRER 293

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 82  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 138
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 139 NLLLG-SAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPEMIEGRMH-DEKVDLWSLG 194
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 225
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 31/187 (16%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTH 103
           ++++ + K V + H  G++HRDLKP N+L   ++    +++I D G A+           
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
              T  + APEV L    Y  A D+WS+  +   ++T    F    +            T
Sbjct: 180 PCYTANFVAPEV-LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----------DT 227
Query: 164 PNE---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           P E   ++  G  SL   +    WN         ++     DL+ +ML  DP +R++A  
Sbjct: 228 PEEILARIGSGKFSLSGGY----WN---------SVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 221 AMEHPYF 227
            + HP+ 
Sbjct: 275 VLRHPWI 281

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 30/188 (15%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H   
Sbjct: 110 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 167
Query: 107 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  Y +PEVL     YS  VD+W+   I   L+     F  + +               
Sbjct: 168 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 211
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++ P
Sbjct: 212 HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALKVP 262
Query: 226 YFDDLDKT 233
           +  + ++ 
Sbjct: 263 WICNRERV 270

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 30/188 (15%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H   
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 168
Query: 107 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  Y +PEVL     YS  VD+W+   I   L+     F  + +               
Sbjct: 169 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 212
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++ P
Sbjct: 213 HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 226 YFDDLDKT 233
           +  + ++ 
Sbjct: 264 WICNRERV 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 107 TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 163
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 164 NLLLG-SAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 219
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 250
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 30/182 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 106
           + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H   
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 168
Query: 107 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  Y +PEVL     YS  VD+W+   I   L+     F  + +               
Sbjct: 169 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 212
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++ P
Sbjct: 213 HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 226 YF 227
           + 
Sbjct: 264 WI 265

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 13  TVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
           T +YL+ EY    ++ K ++   +  E        + + +L   +++CH   ++HRD+KP
Sbjct: 86  TRVYLILEYAPRGEVYKELQKLSKFDEQ----RTATYITELANALSYCHSKRVIHRDIKP 141
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+
Sbjct: 142 ENLLLG-SAGELKIADFGW--SVHAPSSRRXXLXGTLDYLPPEMIEGRMH-DEKVDLWSL 197
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E +     F  ++  +    I R+  T                            
Sbjct: 198 GVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------------------- 229
Query: 192 AVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
             P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 91/293 (31%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKP 71
           T + +VFE +   L K+I   +   + +P+  VK ++ Q+ +G+ + H    I+H D+KP
Sbjct: 118 THICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP 175
Query: 72  HNLLM------------------------------------------------DRKTMTL 83
            N+L+                                                + + + +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 84  KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 143
           KIADLG A       K +T +I T  YR+ EVL+GS  Y+T  D+WS AC+  EL T   
Sbjct: 236 KIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDY 291
Query: 144 LFPGDS------ELQQLLHIFRLLG-TPNEKVWPG---------------VSSLMNWH-- 179
           LF   S      +   +  I  LLG  P + +  G               ++ L  W   
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 180 ----EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
               E  +W+ +  A           D L  ML+  P KR +A + + HP+ +
Sbjct: 352 EVLVEKYEWSQEEAAGFT--------DFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 91/293 (31%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKP 71
           T + +VFE +   L K+I   +   + +P+  VK ++ Q+ +G+ + H    I+H D+KP
Sbjct: 102 THICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP 159
Query: 72  HNLLM------------------------------------------------DRKTMTL 83
            N+L+                                                + + + +
Sbjct: 160 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 219
Query: 84  KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 143
           KIADLG A       K +T +I T  YR+ EVL+GS  Y+T  D+WS AC+  EL T   
Sbjct: 220 KIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDY 275
Query: 144 LFPGDS------ELQQLLHIFRLLG-TPNEKVWPG---------------VSSLMNWH-- 179
           LF   S      +   +  I  LLG  P + +  G               ++ L  W   
Sbjct: 276 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 335
Query: 180 ----EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
               E  +W+ +  A           D L  ML+  P KR +A + + HP+ +
Sbjct: 336 EVLVEKYEWSQEEAAGFT--------DFLLPMLELIPEKRATAAECLRHPWLN 380

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 83  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 139
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 140 NLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 195
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 226
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y  + +L KYIR      E       +    ++   + + HG GI+HRDLKP N
Sbjct: 110 LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLHGKGIIHRDLKPEN 165
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++ + M ++I D G A+  +   K+      + T  Y +PE+L   +   ++ D+W++
Sbjct: 166 ILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWAL 223
Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L                  +++P       A 
Sbjct: 224 GCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------------EYDFP-------AA 259
Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 230
             P       DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 260 FFPK----ARDLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 300

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 83  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 139
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIA+ G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 140 NLLLG-SAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 195
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 226
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIA+ G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 20/171 (11%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +M +L   V+  H  G++HRDLKP NLL   +   + +KI D G AR      +      
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            TL Y APE LL    Y  + D+WS+  I   +++    F          H   L  T  
Sbjct: 171 FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQS--------HDRSLTCTSA 221
Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 216
            ++   +       E   W          N+ ++  DL++ +L  DP+KR+
Sbjct: 222 VEIMKKIKKGDFSFEGEAWK---------NVSQEAKDLIQGLLTVDPNKRL 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 5/145 (3%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V +Y +  DL K I +  Q G     + +     Q+C  +   H   ILHRD+K  N
Sbjct: 98  LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +  K  T+++ D G+AR     ++     I T +Y +PE+   +  Y+   D+W++ C
Sbjct: 156 IFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKPYNNKSDIWALGC 213
Query: 134 IFAELVTKTALFPGDSELQQLLHIF 158
           +  EL T    F   S    +L I 
Sbjct: 214 VLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 84  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 140
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 141 NLLLG-SAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 196
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 227
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 82  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 138
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 139 NLLLG-SAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 194
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++  +    I R+  T                             
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------------------- 225
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 227
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++  +     T  + + +L   +++CH   ++HRD+KP 
Sbjct: 81  TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKKVIHRDIKPE 137
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 138 NLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRMH-DEKVDLWSLG 193
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F  ++       I R+  T                             
Sbjct: 194 VLCYEFLVGKPPFEANTYQDTYKRISRVEFT----------------------------- 224
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++        T  + + +L   +++CH   ++HRD+KP 
Sbjct: 85  TRVYLILEY--APLGTVYRELQKLSRFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 141
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  + T    TL Y  PE++ G  H    VD+WS+ 
Sbjct: 142 NLLLG-SNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 197
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F   +  +    I R+  T                             
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEFT----------------------------- 228
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++ S+R++  + +EHP+
Sbjct: 229 FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 6/127 (4%)
Query: 14  VLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
            L++  E+ D   L+++I   R  GE +       L  Q+ KGV + H   ++HRDLKP 
Sbjct: 108 CLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPS 165
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+ +   T  +KI D GL  +     K+ T    TL Y +PE  + S  Y   VD++++ 
Sbjct: 166 NIFL-VDTKQVKIGDFGLVTSLKNDGKR-TRSKGTLRYMSPE-QISSQDYGKEVDLYALG 222
Query: 133 CIFAELV 139
            I AEL+
Sbjct: 223 LILAELL 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 27/147 (18%)
Query: 25  DLKKYIRSFRQTG------ENIPVNTVKSLMY------------------QLCKGVAFCH 60
           ++ +Y+ SF + G      E +P  ++ +L+                   Q+ +G+ + H
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVL-LG 118
            + I+HRD+K  N+L++  +  LKI+D G ++     I   T     TL Y APE++  G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKG 198
Query: 119 STHYSTAVDMWSVACIFAELVTKTALF 145
              Y  A D+WS+ C   E+ T    F
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 27/147 (18%)
Query: 25  DLKKYIRSFRQTG------ENIPVNTVKSLMY------------------QLCKGVAFCH 60
           ++ +Y+ SF + G      E +P  ++ +L+                   Q+ +G+ + H
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVL-LG 118
            + I+HRD+K  N+L++  +  LKI+D G ++     I   T     TL Y APE++  G
Sbjct: 126 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKG 184
Query: 119 STHYSTAVDMWSVACIFAELVTKTALF 145
              Y  A D+WS+ C   E+ T    F
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHN 73
           +++  E MDT L K+ +     G+ IP + +  +   + K +   H    ++HRD+KP N
Sbjct: 125 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 184
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL---LGSTHYSTAVDMWS 130
           +L++     +K+ D G++      + K T +     Y APE +   L    YS   D+WS
Sbjct: 185 VLIN-ALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL      FP DS            GTP ++       L    E P  +PQ  A
Sbjct: 243 LGITMIELA--ILRFPYDS-----------WGTPFQQ-------LKQVVEEP--SPQLPA 280
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   + +D   Q L+ +  +R +  + M+HP+F
Sbjct: 281 D---KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 31/187 (16%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTH 103
           ++++ + K V + H  G++HRDLKP N+L   ++    +++I D G A+           
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
              T  + APEV L    Y  A D+WS+  +    +T    F    +            T
Sbjct: 180 PCYTANFVAPEV-LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-----------DT 227
Query: 164 PNE---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
           P E   ++  G  SL   +    WN         ++     DL+ + L  DP +R++A  
Sbjct: 228 PEEILARIGSGKFSLSGGY----WN---------SVSDTAKDLVSKXLHVDPHQRLTAAL 274
Query: 221 AMEHPYF 227
            + HP+ 
Sbjct: 275 VLRHPWI 281

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 92  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 149
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 150 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 205
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
              +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 206 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 244

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 87  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 145 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
              +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 201 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 94/182 (51%), Gaps = 18/182 (9%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 77  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 134
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 135 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 190
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN--EKVWPGVSSLMNWHEYPQW 184
              +  E+VT   + +PG +    +Q L   +R++   N  E+++  +   + W E P+ 
Sbjct: 191 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR--LCWKERPED 248
Query: 185 NP 186
            P
Sbjct: 249 RP 250

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 88  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 145
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 146 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 201
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
              +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 202 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 49/237 (20%)
Query: 15  LYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
            YLVFE M    +  +I   R F +   ++ V  V S +        F H  GI HRDLK
Sbjct: 86  FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL-------DFLHNKGIAHRDLK 138
Query: 71  PHNLLMD--RKTMTLKIADLGLARAFTL-----PIKKYTHEILT----LWYRAPEVLLG- 118
           P N+L +   +   +KI D GL     L     PI   T E+LT      Y APEV+   
Sbjct: 139 PENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS--TPELLTPCGSAEYMAPEVVEAF 196
Query: 119 ---STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
              ++ Y    D+WS+  I   L++    F G              G    +  P   ++
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD--------CGWDRGEACPACQNM 248
Query: 176 M------NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           +        +E+P  +   ++ A         DL+ ++L  D  +R+SA + ++HP+
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAK-------DLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 108 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 167
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 168 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 226
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 227 V-YTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKPANCTNELY 281
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 282 MMMRDCWHAVPSQRP-TFKQLVEDLDR 307

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 105 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 164
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 165 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 223
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 224 V-YTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKPANCTNELY 278
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 279 MMMRDCWHAVPSQRP-TFKQLVEDLDR 304

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           L  EY +  DL+KY+  F      +    +++L+  +   + + H + I+HRDLKP N++
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 154
Query: 76  MDRKTMTL--KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +      L  KI DLG A+      +  T  + TL Y APE LL    Y+  VD WS   
Sbjct: 155 LQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGT 212
Query: 134 IFAELVT 140
           +  E +T
Sbjct: 213 LAFECIT 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 17  LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           L  EY +  DL+KY+  F      +    +++L+  +   + + H + I+HRDLKP N++
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 153
Query: 76  MDRKTMTL--KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +      L  KI DLG A+      +  T  + TL Y APE LL    Y+  VD WS   
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGT 211
Query: 134 IFAELVT 140
           +  E +T
Sbjct: 212 LAFECIT 218

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 103 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 162
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 163 QKCIHRDLTARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 221
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 222 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 276
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 277 MMMRDCWHAVPSQRP-TFKQLVEDLDR 302

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 222 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 281 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 335
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 336 MMMRDCWHAVPSQRP-TFKQLVEDLDR 361

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 82  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 140 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 195
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
              +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 88  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 145
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 146 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 193
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 90  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 147
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 148 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 195
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 242

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + ++IAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 83  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 140
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 141 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 188
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 235

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 82  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 140 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 187
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 91  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 148
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 149 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 196
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 243

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T +YL+ EY    L    R  ++        T  + + +L   +++CH   ++HRD+KP 
Sbjct: 85  TRVYLILEY--APLGTVYRELQKLSRFDEQRTA-TYITELANALSYCHSKRVIHRDIKPE 141
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H    VD+WS+ 
Sbjct: 142 NLLLG-SNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRMH-DEKVDLWSLG 197
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E +     F   +  +    I R+  T                             
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEFT----------------------------- 228
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P+   +G  DL+ ++L+++ S+R++  + +EHP+
Sbjct: 229 FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 82  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 140 ILVS-DTLSCKIADFGLARLIEDAEXTAREGAKFPIK----------WTAPEAINYGT-F 187
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 82  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 140 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 187
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 84  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 141
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK          + APE +   T +
Sbjct: 142 ILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK----------WTAPEAINYGT-F 189
Query: 123 STAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 165
           +   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 236

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    
Sbjct: 122 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTF 180
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P +S++  +  +F +    
Sbjct: 181 VGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI---- 232
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L   V +  K   + ++  L  DPS R +AK+ ++H
Sbjct: 233 -----------------PKNNPPTL---VGDFTKSFKEFIDACLNKDPSFRPTAKELLKH 272
Query: 225 PYF 227
            + 
Sbjct: 273 KFI 275

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 64/145 (44%), Gaps = 4/145 (2%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +  M Q  +GV + H + ++HRDLK  NL ++   M +KI D GLA       ++    
Sbjct: 128 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDL 186
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
             T  Y APEVL    H S  VD+WS+ CI   L+     F      +  + I +   + 
Sbjct: 187 CGTPNYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSV 245
Query: 165 NEKVWPGVSSLMN--WHEYPQWNPQ 187
              + P  S+L+    H  P   P 
Sbjct: 246 PRHINPVASALIRRMLHADPTLRPS 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           VK  + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK    
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSF 186
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGT 163
             T+ Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG 
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN 195
           P + + P   SL+      + NP +   A P+
Sbjct: 246 P-QFLSPEAQSLLRM--LFKRNPANRLGAGPD 274

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 62/122 (50%), Gaps = 3/122 (2%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           VK  + +L  G+   H  GI++RDLKP N+L+D +   +K+ D GL++      KK    
Sbjct: 132 VKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSF 190
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGT 163
             T+ Y APEV+    H S + D WS   +  E++T +  F G    + +  I +  LG 
Sbjct: 191 CGTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGM 249
Query: 164 PN 165
           P 
Sbjct: 250 PQ 251

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYL+ EY+     +      + G  +  +T    + ++   +   H  GI++RDLKP N+
Sbjct: 96  LYLILEYLSGG--ELFMQLEREGIFME-DTACFYLAEISMALGHLHQKGIIYRDLKPENI 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++ +   +K+ D GL +  ++     TH    T+ Y APE+L+ S H + AVD WS+  
Sbjct: 153 MLNHQGH-VKLTDFGLCKE-SIHDGTVTHXFCGTIEYMAPEILMRSGH-NRAVDWWSLGA 209
Query: 134 IFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           +  +++T    F G++  + +  I +  L  P                            
Sbjct: 210 LMYDMLTGAPPFTGENRKKTIDKILKCKLNLP---------------------------- 241
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLD 231
            P L ++  DLL+++L+ + + R+      A +   HP+F  ++
Sbjct: 242 -PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYL+ EY+     +      + G  +  +T    + ++   +   H  GI++RDLKP N+
Sbjct: 96  LYLILEYLSGG--ELFMQLEREGIFME-DTACFYLAEISMALGHLHQKGIIYRDLKPENI 152
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++ +   +K+ D GL +  ++     TH    T+ Y APE+L+ S H + AVD WS+  
Sbjct: 153 MLNHQGH-VKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGA 209
Query: 134 IFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           +  +++T    F G++  + +  I +  L  P                            
Sbjct: 210 LMYDMLTGAPPFTGENRKKTIDKILKCKLNLP---------------------------- 241
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLD 231
            P L ++  DLL+++L+ + + R+      A +   HP+F  ++
Sbjct: 242 -PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGIL 65
           ++G   + L+ E++ +  LK+Y+   +       +N  + L Y  Q+CKG+ +      +
Sbjct: 94  EDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMDYLGSRQYV 148
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTH 121
           HRDL   N+L++ +   +KI D GL +A     +  T     +    WY APE L+ S  
Sbjct: 149 HRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKF 206
Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           Y  A D+WS      EL+T       DS+   +    +++G  + ++   V+ L+N  + 
Sbjct: 207 Y-IASDVWSFGVTLHELLTYC-----DSDSSPMALFLKMIGPTHGQMT--VTRLVNTLKE 258
Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
            +  P       PN   +   L+ +  ++ PS R S +  +E
Sbjct: 259 GKRLP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHN 73
           +++  E MDT L K+ +     G+ IP + +  +   + K +   H    ++HRD+KP N
Sbjct: 81  VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL---LGSTHYSTAVDMWS 130
           +L++     +K+ D G++      + K   +     Y APE +   L    YS   D+WS
Sbjct: 141 VLIN-ALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL      FP DS            GTP ++       L    E P  +PQ  A
Sbjct: 199 LGITMIELA--ILRFPYDS-----------WGTPFQQ-------LKQVVEEP--SPQLPA 236
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   + +D   Q L+ +  +R +  + M+HP+F
Sbjct: 237 D---KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 22/184 (11%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+AF      +HR+L+  N
Sbjct: 78  IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAAN 135
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+   T++ KIAD GLAR   +   +YT        + + APE +   T ++   D+WS
Sbjct: 136 ILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWS 191
Query: 131 VACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN--EKVWPGVSSLMN--WHEYP 182
              +  E+VT   + +PG +    +Q L   +R++   N  E+++     LM   W E P
Sbjct: 192 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCWKERP 247
Query: 183 QWNP 186
           +  P
Sbjct: 248 EDRP 251

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 103 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 163 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 221 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 256
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 257 KDPKKRMTIQDSLQHPW 273

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +  M Q  +GV + H + ++HRDLK  NL ++   M +KI D GLA       ++    
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDL 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 145
             T  Y APEVL    H S  VD+WS+ CI   L+     F
Sbjct: 203 CGTPNYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 24/199 (12%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EY+    L  Y+RS    G+ +  + +  + Y +C+G+AF   H  +HRDL   N
Sbjct: 78  IYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+DR  + +K++D G+ R + L   +Y   + T +   + APEV      YS+  D+W+
Sbjct: 135 CLVDR-DLCVKVSDFGMTR-YVLD-DQYVSSVGTKFPVKWSAPEV-FHYFKYSSKSDVWA 190
Query: 131 VACIFAELVTKTALFPGD----SELQQLLHIFRLLGTP---NEKVWPGVSSLMNWHEYPQ 183
              +  E+ +   + P D    SE+   +     L  P   ++ ++  + S   WHE P+
Sbjct: 191 FGILMWEVFSLGKM-PYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC--WHELPE 247
Query: 184 WNP---QSLATAVPNLDKD 199
             P   Q L++  P  +KD
Sbjct: 248 KRPTFQQLLSSIEPLREKD 266

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL-LMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N+ L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 103 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 163 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 221 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 256
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 257 KDPKKRMTIQDSLQHPW 273

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +T L LV   M+  D++ +I +  +  +N      +++ Y  Q+  G+   H   I++
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+L+D     ++I+DLGLA        K      T  + APE+LLG   Y  +V
Sbjct: 313 RDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSV 370
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP-QWN 185
           D +++     E++                  FR  G   E        L     YP +++
Sbjct: 371 DYFALGVTLYEMIAARG-------------PFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 230
           P S             D  E +LQ DP KR+     S      HP F D+
Sbjct: 418 PAS------------KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +T L LV   M+  D++ +I +  +  +N      +++ Y  Q+  G+   H   I++
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+L+D     ++I+DLGLA        K      T  + APE+LLG   Y  +V
Sbjct: 313 RDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSV 370
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP-QWN 185
           D +++     E++                  FR  G   E        L     YP +++
Sbjct: 371 DYFALGVTLYEMIAARG-------------PFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 230
           P S             D  E +LQ DP KR+     S      HP F D+
Sbjct: 418 PAS------------KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +T L LV   M+  D++ +I +  +  +N      +++ Y  Q+  G+   H   I++
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+L+D     ++I+DLGLA        K      T  + APE+LLG   Y  +V
Sbjct: 313 RDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSV 370
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP-QWN 185
           D +++     E++                  FR  G   E        L     YP +++
Sbjct: 371 DYFALGVTLYEMIAARG-------------PFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 230
           P S             D  E +LQ DP KR+     S      HP F D+
Sbjct: 418 PAS------------KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           VK  + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK    
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSF 186
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGT 163
             T+ Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG 
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN 195
           P + + P   SL+      + NP +   A P+
Sbjct: 246 P-QFLSPEAQSLLRM--LFKRNPANRLGAGPD 274

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +  M Q  +GV + H + ++HRDLK  NL ++   M +KI D GLA       ++    
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXL 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 145
             T  Y APEVL    H S  VD+WS+ CI   L+     F
Sbjct: 203 CGTPNYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        K  T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 10  EGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILH 66
           +G+  + LV E   +  LK Y++ F+       +  ++S   Q+ KG+ F H     I+H
Sbjct: 99  KGKKCIVLVTELXTSGTLKTYLKRFKVX----KIKVLRSWCRQILKGLQFLHTRTPPIIH 154
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTA 125
           RDLK  N+ +   T ++KI DLGLA   TL    +   ++ T  + APE       Y  +
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXY--EEKYDES 209
Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD+++      E  T    +   SE Q    I+R       +V  GV             
Sbjct: 210 VDVYAFGXCXLEXATSEYPY---SECQNAAQIYR-------RVTSGV------------K 247
Query: 186 PQSL-ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           P S    A+P +     +++E  ++ +  +R S K  + H +F +
Sbjct: 248 PASFDKVAIPEVK----EIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           VK  + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK    
Sbjct: 129 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSF 187
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGT 163
             T+ Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG 
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 246
Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN 195
           P + + P   SL+      + NP +   A P+
Sbjct: 247 P-QFLSPEAQSLLRM--LFKRNPANRLGAGPD 275

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILH 66
           E +T L LV   M+  D++ +I +  +  +N      +++ Y  Q+  G+   H   I++
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLKP N+L+D     ++I+DLGLA        K      T  + APE+LLG   Y  +V
Sbjct: 313 RDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSV 370
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP-QWN 185
           D +++     E++                  FR  G   E        L     YP +++
Sbjct: 371 DYFALGVTLYEMIAARG-------------PFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 230
           P S             D  E +LQ DP KR+     S      HP F D+
Sbjct: 418 PAS------------KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 87  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 142 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 196
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGIL 65
           ++G   + L+ E++ +  LK+Y+   +       +N  + L Y  Q+CKG+ +      +
Sbjct: 82  EDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMDYLGSRQYV 136
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTH 121
           HRDL   N+L++ +   +KI D GL +A     +  T     +    WY APE L+ S  
Sbjct: 137 HRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKF 194
Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           Y  A D+WS      EL+T       DS+   +    +++G  + ++   V+ L+N  + 
Sbjct: 195 Y-IASDVWSFGVTLHELLTYC-----DSDSSPMALFLKMIGPTHGQMT--VTRLVNTLKE 246
Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
            +  P       PN   +   L+ +  ++ PS R S +  +E
Sbjct: 247 GKRLP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 89  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 143
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 144 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 198
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 199 FSVASDVWSFGVVLYELFT 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPAFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLG 89
           F    E++        + Q+  GV + H   I H DLKP N +L+DR      +KI D G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           LA        ++ +   T  + APE+ +         DMWS+  I   L++  + F GD+
Sbjct: 164 LAHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L ++                S +N+    ++   + A A         D + ++L 
Sbjct: 222 KQETLANV----------------SAVNYEFEDEYFSNTSALAK--------DFIRRLLV 257
Query: 210 YDPSKRISAKKAMEHPY 226
            DP KR++ + +++HP+
Sbjct: 258 KDPKKRMTIQDSLQHPW 274

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 169
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 170 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 224
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 225 FSVASDVWSFGVVLYELFT 243

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +  M Q  +GV + H + ++HRDLK  NL ++   M +KI D GLA       ++    
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTL 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 145
             T  Y APEVL    H S  VD+WS+ CI   L+     F
Sbjct: 203 CGTPNYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 91  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 145
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 146 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 200
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 201 FSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 90  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 144
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 145 DLATRNILVENEN-RVKIGDFGLTK--VLPQDKEXXKVKEPGESPIFWY-APESLTESK- 199
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 200 FSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 139 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 193
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 82  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 136
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 137 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 191
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 192 FSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 88  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 142
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 143 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 197
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 198 FSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 139 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 193
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 102 GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 156
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 157 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 211
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 83  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 137
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 138 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 192
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 193 FSVASDVWSFGVVLYELFT 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + +++ H  G++HRD+K  ++
Sbjct: 117 LWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQGVIHRDIKSDSI 172
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + K    + T ++ APEV +    Y T VD+WS+  +
Sbjct: 173 LLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV-ISRLPYGTEVDIWSLGIM 230
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E++     +  +  LQ +  I   L  P  K    VSS++                  
Sbjct: 231 VIEMIDGEPPYFNEPPLQAMRRIRDSL-PPRVKDLHKVSSVLR----------------- 272
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                    L+ ML  +PS+R +A++ + HP+ 
Sbjct: 273 -------GFLDLMLVREPSQRATAQELLGHPFL 298

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 102 GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 156
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 157 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 211
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++  Y    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 30/184 (16%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLL---MDRKTMTLKIADLGLARAFTLPIKKYTH 103
           +L+ Q+   V + H  GI+HRDLKP NLL    D ++  + I+D GL++         + 
Sbjct: 124 TLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIM-ISDFGLSK-MEGKGDVMST 181
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
              T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +    
Sbjct: 182 ACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYE 240
Query: 164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
            +   W  +S                            D +  +++ DP+KR + ++A  
Sbjct: 241 FDSPYWDDISD------------------------SAKDFIRNLMEKDPNKRYTCEQAAR 276
Query: 224 HPYF 227
           HP+ 
Sbjct: 277 HPWI 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   D+  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +K+AD G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IKVADFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   D+  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +K+AD G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IKVADFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 84  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 143
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 144 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLK 202
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 203 DGV-FTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 146
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 147 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLK 205
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 206 DGV-FTTSSDMWSFGVVLWEITS 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++  Y    +L++Y+R+ R  G            E +    + S  YQL +G+ +   
Sbjct: 116 LYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 176 QKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS---- 174
             Y+   D+WS   +  E+ T   + +PG      +  +F+LL   +    P   +    
Sbjct: 235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKPANCTNELY 289
Query: 175 -LMN--WHEYPQWNPQSLATAVPNLDK 198
            +M   WH  P   P +    V +LD+
Sbjct: 290 MMMRDCWHAVPSQRP-TFKQLVEDLDR 315

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 146
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 147 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLK 205
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 206 DGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T L+L+ +Y++      + +     E    + V+  + ++   +   H  GI++RD+K  
Sbjct: 132 TKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGS-THYSTAVDMWS 130
           N+L+D     + + D GL++ F     +  ++   T+ Y AP+++ G  + +  AVD WS
Sbjct: 189 NILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  EL+T  + F  D E      I R +             L +   YPQ    +LA
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRI-------------LKSEPPYPQ-EMSALA 293
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLD 231
                      DL++++L  DP KR+      A +  EH +F  ++
Sbjct: 294 K----------DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 139 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWY-APESLTESK- 193
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 146
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 147 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLK 205
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 206 DGV-FTTSSDMWSFGVVLWEITS 227

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ E++    L++Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 87  GRRNLKLIMEFLPYGSLREYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 142 DLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESPIFWY-APESLTESK- 196
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y+++  +      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 87  GRRNLKLIMEYLPYGSLRDYLQAHAER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           DL   N+L++ +   +KI D GL +   LP  K   ++         WY APE L  S  
Sbjct: 142 DLATRNILVENEN-RVKIGDFGLTK--VLPQDKEXXKVKEPGESPIFWY-APESLTESK- 196
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    
Sbjct: 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXF 179
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +    
Sbjct: 180 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI---- 231
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H
Sbjct: 232 -----------------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271
Query: 225 PYF 227
            + 
Sbjct: 272 KFI 274

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 49/237 (20%)
Query: 15  LYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
            YLVFE M    +  +I   R F +   ++ V  V S +        F H  GI HRDLK
Sbjct: 86  FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL-------DFLHNKGIAHRDLK 138
Query: 71  PHNLLMD--RKTMTLKIADLGLARAFTL-----PIKKYTHEILT----LWYRAPEVLLG- 118
           P N+L +   +   +KI D  L     L     PI   T E+LT      Y APEV+   
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS--TPELLTPCGSAEYMAPEVVEAF 196
Query: 119 ---STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
              ++ Y    D+WS+  I   L++    F G              G    +  P   ++
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD--------CGWDRGEACPACQNM 248
Query: 176 M------NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           +        +E+P  +   ++ A         DL+ ++L  D  +R+SA + ++HP+
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAK-------DLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    
Sbjct: 106 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXF 164
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +    
Sbjct: 165 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI---- 216
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H
Sbjct: 217 -----------------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 256
Query: 225 PYF 227
            + 
Sbjct: 257 KFI 259

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRD 68
           GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+CKG+ +      +HRD
Sbjct: 84  GRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 139
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYST 124
           L   N+L++ +   +KIAD GLA+   L    Y      +    WY APE L  +  +S 
Sbjct: 140 LAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNI-FSR 196
Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
             D+WS   +  EL T       D          R++G+  E+  P +S
Sbjct: 197 QSDVWSFGVVLYELFTYC-----DKSCSPSAEFLRMMGS--ERDVPALS 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    
Sbjct: 126 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTF 184
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +    
Sbjct: 185 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI---- 236
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H
Sbjct: 237 -----------------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 276
Query: 225 PYF 227
            + 
Sbjct: 277 KFI 279

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 109 LYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 168
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 169 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDR 227
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 228 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 286
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 287 DCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 6/126 (4%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L++  E+ D   L+++I   R  GE +       L  Q+ KGV + H   +++RDLKP N
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +KI D GL  +     K+   +  TL Y +PE  + S  Y   VD++++  
Sbjct: 153 IFL-VDTKQVKIGDFGLVTSLKNDGKRXRSK-GTLRYMSPE-QISSQDYGKEVDLYALGL 209
Query: 134 IFAELV 139
           I AEL+
Sbjct: 210 ILAELL 215

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 37/184 (20%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHASVGTHGYMAP 359
Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EVL     Y ++ D +S+ C+  +L+       G S  +Q                    
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ-------------------H 394
Query: 174 SLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
              + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A++  E P+F
Sbjct: 395 KTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 228 DDLD 231
             LD
Sbjct: 454 RSLD 457

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 37/184 (20%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHASVGTHGYMAP 359
Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EVL     Y ++ D +S+ C+  +L+       G S  +Q                    
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ-------------------H 394
Query: 174 SLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
              + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A++  E P+F
Sbjct: 395 KTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 228 DDLD 231
             LD
Sbjct: 454 RSLD 457

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 31/233 (13%)
Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  T  YLVFE +    +  +I+  +   E      V+ +   L     F H  GI HRD
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAAL----DFLHTKGIAHRD 136
Query: 69  LKPHNLLMD--RKTMTLKIADLGLARAFTL-----PIK--KYTHEILTLWYRAPEVLL-- 117
           LKP N+L +   K   +KI D  L     L     PI   + T    +  Y APEV+   
Sbjct: 137 LKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVF 196
Query: 118 --GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
              +T Y    D+WS+  +   +++    F G            +      K++  +   
Sbjct: 197 TDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE- 255
Query: 176 MNWHEYP--QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
              +E+P   W          ++  +  DL+ ++L  D  +R+SA + ++HP+
Sbjct: 256 -GKYEFPDKDW---------AHISSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 26/181 (14%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ E+M    L  +++S    G   P+  +     Q+ +G+AF      +HRDL+  N
Sbjct: 251 IYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 308
Query: 74  LLMDRKTMTLKIADLGLAR-AFTLPIKKYTHEILTLWYRAPEVL-LGSTHYSTAVDMWSV 131
           +L+   ++  KIAD GLAR     PIK          + APE +  GS  ++   D+WS 
Sbjct: 309 ILVS-ASLVCKIADFGLARVGAKFPIK----------WTAPEAINFGS--FTIKSDVWSF 355
Query: 132 ACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN-----WHEYPQWN 185
             +  E+VT   + +PG S  + +  + R    P  +  P    L N     W   P+  
Sbjct: 356 GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP--EELYNIMMRCWKNRPEER 413
Query: 186 P 186
           P
Sbjct: 414 P 414

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 19/139 (13%)
Query: 11  GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+CKG+ +      +HR
Sbjct: 85  GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYLGTKRYIHR 139
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTH 121
           +L   N+L++ +   +KI D GL +   LP  K  +++         WY APE L  S  
Sbjct: 140 NLATRNILVENEN-RVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWY-APESLTESK- 194
Query: 122 YSTAVDMWSVACIFAELVT 140
           +S A D+WS   +  EL T
Sbjct: 195 FSVASDVWSFGVVLYELFT 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    
Sbjct: 106 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTF 164
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +    
Sbjct: 165 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI---- 216
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H
Sbjct: 217 -----------------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 256
Query: 225 PYF 227
            + 
Sbjct: 257 KFI 259

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 80  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 139
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 140 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLK 198
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 199 DGV-FTTYSDVWSFGVVLWEIAT 220

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 37/184 (20%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 303 GLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHASVGTHGYMAP 358
Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EVL     Y ++ D +S+ C+  +L+       G S  +Q                    
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ-------------------H 393
Query: 174 SLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
              + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A++  E P+F
Sbjct: 394 KTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452
Query: 228 DDLD 231
             LD
Sbjct: 453 RSLD 456

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 37/184 (20%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAP 113
           G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y AP
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHASVGTHGYMAP 359
Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           EVL     Y ++ D +S+ C+  +L+       G S  +Q                    
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ-------------------H 394
Query: 174 SLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 227
              + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A++  E P+F
Sbjct: 395 KTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 228 DDLD 231
             LD
Sbjct: 454 RSLD 457

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +   + + + + H   I HRD+K
Sbjct: 130 GRKCLLIVXECLDGG-ELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVK 188
Query: 71  PHNLL--MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T      T    T +Y APEV LG   Y  + D 
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDX 246
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS+  I   L+     F  +  L                + PG  + +   +Y   NP+ 
Sbjct: 247 WSLGVIXYILLCGYPPFYSNHGL---------------AISPGXKTRIRXGQYEFPNPE- 290
Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                  + ++   L+  +L+ +P++R +  +   HP+ 
Sbjct: 291 ----WSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 149 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLK 207
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 208 DGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E RT + L+ E +       +  F    E++      S + Q+  GV + H   I H DL
Sbjct: 85  ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 70  KPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  K +    +K+ D GLA      + ++ +   T  + APE+ +         
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEA 199
Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S L           
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK--------- 250
Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                          D + ++L  +  KR++ ++A+ HP+   +D
Sbjct: 251 ---------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++  +  + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXM 176
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP
Sbjct: 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +                 NP+ L+           D L + L+ D  KR SAK+ ++H
Sbjct: 235 ELQ-----------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELLQH 270
Query: 225 PYF 227
            + 
Sbjct: 271 QFL 273

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 146
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 147 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 205
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 206 DGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++  +  + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXM 177
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP
Sbjct: 178 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 235
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +                 NP+ L+           D L + L+ D  KR SAK+ ++H
Sbjct: 236 ELQ-----------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELIQH 271
Query: 225 PYF 227
            + 
Sbjct: 272 QFL 274

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRD 68
           GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+CKG+ +      +HRD
Sbjct: 97  GRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 152
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYST 124
           L   N+L++ +   +KIAD GLA+   L    Y      +    WY APE L  +  +S 
Sbjct: 153 LAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNI-FSR 209
Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
             D+WS   +  EL T       D          R++G   E+  P +S
Sbjct: 210 QSDVWSFGVVLYELFTYC-----DKSCSPSAEFLRMMGC--ERDVPALS 251

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 81/183 (44%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++  +  + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEM 176
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP
Sbjct: 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +                 NP+ L+           D L + L  D  KR SAK+ ++H
Sbjct: 235 ELQ-----------------NPEKLSAIF-------RDFLNRCLDMDVEKRGSAKELLQH 270
Query: 225 PYF 227
            + 
Sbjct: 271 QFL 273

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRD 68
           GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+CKG+ +      +HRD
Sbjct: 85  GRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 140
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYST 124
           L   N+L++ +   +KIAD GLA+   L    Y      +    WY APE L  +  +S 
Sbjct: 141 LAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNI-FSR 197
Query: 125 AVDMWSVACIFAELVT 140
             D+WS   +  EL T
Sbjct: 198 QSDVWSFGVVLYELFT 213

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 86  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 145
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HRDL   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 146 NAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 204
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 205 DGV-FTTSSDMWSFGVVLWEITS 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 102 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 161
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 162 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 220
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 221 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 279
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 280 DCWHAVPSQRP-TFKQLVEDLDR 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 109 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 168
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 169 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 228 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 286
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 287 DCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 101 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 160
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 161 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 219
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 220 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 278
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 279 DCWHAVPSQRP-TFKQLVEDLDR 300

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 98  LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 157
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 158 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 216
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 217 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 275
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 276 DCWHAVPSQRP-TFKQLVEDLDR 297

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 109 LYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 168
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 169 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 228 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 286
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 287 DCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 94  LYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 154 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 213 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 271
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 272 DCWHAVPSQRP-TFKQLVEDLDR 293

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++CH   + HRDLK  N L+D      LKI D G +++  L  +  +  + T  
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 181
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKV 168
           Y APEVLL   +     D+WS       ++     F    E +     I R+L       
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------- 234
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                              ++  A+P+   +  +   L+ ++   DP+KRIS  +   H 
Sbjct: 235 -------------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 275
Query: 226 YF 227
           +F
Sbjct: 276 WF 277

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 155 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 214 DGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 11  GRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           GR  L LV EY+ +  L+ +++  R       ++  + L+Y  Q+CKG+ +      +HR
Sbjct: 81  GRPELRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGMEYLGSRRCVHR 135
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTL----PIKKYTHEILTLWYRAPEVLLGSTHYS 123
           DL   N+L++ +   +KIAD GLA+   L     + +   +    WY APE  L    +S
Sbjct: 136 DLAARNILVESEA-HVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-APES-LSDNIFS 192
Query: 124 TAVDMWSVACIFAELVT 140
              D+WS   +  EL T
Sbjct: 193 RQSDVWSFGVVLYELFT 209

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 131 IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 187 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 244 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 287
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 288 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++CH   + HRDLK  N L+D      LKI D G +++  L  +  +  + T  
Sbjct: 122 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 180
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKV 168
           Y APEVLL   +     D+WS       ++     F    E +     I R+L       
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------- 233
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                              ++  A+P+   +  +   L+ ++   DP+KRIS  +   H 
Sbjct: 234 -------------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 274
Query: 226 YF 227
           +F
Sbjct: 275 WF 276

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 131 IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 187 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 244 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 287
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 288 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 86  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 145
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 146 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 204
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 205 DGV-FTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 82  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 141
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 142 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 200
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 201 DGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 149 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 207
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 208 DGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 84  IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 140 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 197 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 240
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 241 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 2/114 (1%)
Query: 46  KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT   
Sbjct: 113 RSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFD 170
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
            T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 47/198 (23%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFT---------L 96
           +  Q+ + V F H  G++HRDLKP N+     TM   +K+ D GL  A            
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 97  PIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 153
           P+  Y   T ++ T  Y +PE + G++ YS  VD++S+  I  EL     L+P  +++++
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 213
           +    R L       +P + +     EY                     +++ ML   P 
Sbjct: 234 V----RTLTDVRNLKFPPLFTQKYPCEYV--------------------MVQDMLSPSPM 269
Query: 214 KRISAKKAMEHPYFDDLD 231
           +R  A   +E+  F+DLD
Sbjct: 270 ERPEAINIIENAVFEDLD 287

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 148 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 206
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 207 DGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 148 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 206
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 207 DGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 103 IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 159 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 216 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 259
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 260 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G            E +    + S  YQ+ +G+ +   
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 210 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 268
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 269 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 327
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 328 DCWHAVPSQRP-TFKQLVEDLDR 349

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 87  IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 142
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 143 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 199
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 200 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 243
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 244 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 279

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 83  IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 138
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++ T+ Y  PE +  + S+  +      
Sbjct: 139 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSK 195
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 196 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 239
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 240 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 275

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 81/183 (44%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++  +  + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM 176
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP
Sbjct: 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +                 NP+ L+           D L + L  D  KR SAK+ ++H
Sbjct: 235 ELQ-----------------NPEKLSAIF-------RDFLNRCLDMDVEKRGSAKELLQH 270
Query: 225 PYF 227
            + 
Sbjct: 271 QFL 273

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 174
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 173
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 117 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 176
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 177 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 235
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 236 DGV-FTTYSDVWSFGVVLWEIAT 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 174
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 48/254 (18%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FE +   L + I   R       +  +K    ++ K + +     + H DLKP N+L+
Sbjct: 113 LIFEPLGPSLYEIIT--RNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 77  D------------------------RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 112
           D                         K+  +K+ D G A   T     +   I T  YRA
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---TFKSDYHGSIINTRQYRA 227
Query: 113 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG-TPNEKVWPG 171
           PEV+L +  +  + DMWS  C+ AEL T + LF     ++ L  +  ++   P   ++  
Sbjct: 228 PEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEA 286
Query: 172 V----SSLMNWHEYPQWNPQSLAT--AVPNLDKD-----------GLDLLEQMLQYDPSK 214
                S  +N  E     P++ ++  ++ ++ K              D L  +LQ DP+ 
Sbjct: 287 TKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346
Query: 215 RISAKKAMEHPYFD 228
           R S  + ++H + +
Sbjct: 347 RPSPAELLKHKFLE 360

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 173
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++ H   + HRDLK  N L+D      LKIAD G ++A  L  +  +  + T  
Sbjct: 123 QLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS-AVGTPA 181
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKV 168
           Y APEVLL   +     D+WS       ++     F    E +     I R+L       
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------- 234
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                              ++  A+P+   +  +   L+ ++   DP+KRIS  +   H 
Sbjct: 235 -------------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 275
Query: 226 YF 227
           +F
Sbjct: 276 WF 277

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 2/114 (1%)
Query: 46  KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT   
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFD 170
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
            T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 2/114 (1%)
Query: 46  KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT   
Sbjct: 116 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFD 173
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
            T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 139 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 196
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 197 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 174
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 189
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 189
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 189
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 188
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 188
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 216
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 9/123 (7%)
Query: 25  DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK 84
           DL ++IRS ++   N  V  + S   Q+ +G+ +      +HRDL   N ++D ++ T+K
Sbjct: 109 DLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVK 164
Query: 85  IADLGLARAFT----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
           +AD GLAR         ++++ H  L + + A E  L +  ++T  D+WS   +  EL+T
Sbjct: 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALES-LQTYRFTTKSDVWSFGVLLWELLT 223
Query: 141 KTA 143
           + A
Sbjct: 224 RGA 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 208
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ E+M    L  +++S    G   P+  +     Q+ +G+AF      +HRDL+  N
Sbjct: 257 IYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVL-LGSTHYSTAVDMW 129
           +L+   ++  KIAD GLAR   +   +YT        + + APE +  GS  ++   D+W
Sbjct: 315 ILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVW 369
Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN-----WHEYPQ 183
           S   +  E+VT   + +PG S  + +  + R    P  +  P    L N     W   P+
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP--EELYNIMMRCWKNRPE 427
Query: 184 WNP 186
             P
Sbjct: 428 ERP 430

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 216
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 201
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 88  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 147
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HR+L   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 148 NAKKFVHRNLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 206
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 207 DGV-FTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLMYQLCKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN P      +  +  +  ++  G+A+ 
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 146
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           +    +HR+L   N ++     T+KI D G+ R    T   +K    +L + + APE L 
Sbjct: 147 NAKKFVHRNLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 205
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T+ DMWS   +  E+ +
Sbjct: 206 DGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 216
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    +    ++   +   H  G +HRD+KP N
Sbjct: 144 LYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 198
Query: 74  LLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K+  LK+AD G         + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 199 MLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 258 SVGVFLYEMLVGDTPFYADS 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 221
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 222 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 41/216 (18%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 94  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 145
Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            +K+ D G++      I +  +E + T  Y +PE L G THYS   D+WS+     E+  
Sbjct: 146 EIKLCDFGVSGQL---IDEMANEFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 201
Query: 141 KTALFPGDSELQQLLHIFRLLG-TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKD 199
                P        + IF LL    NE                   P  L +AV +L+  
Sbjct: 202 GRYPRPP-------MAIFELLDYIVNEP------------------PPKLPSAVFSLEFQ 236
Query: 200 GLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
             D + + L  +P++R   K+ M H +    D   +
Sbjct: 237 --DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 270

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++  +  + + F H + ++HR++K  N+L+     ++K+ D G     T    K +  
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM 177
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP
Sbjct: 178 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 235
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +                 NP+ L+           D L + L+ D  KR SAK+ ++H
Sbjct: 236 ELQ-----------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELIQH 271
Query: 225 PYF 227
            + 
Sbjct: 272 QFL 274

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 182 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 235
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 236 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+      G+A+ 
Sbjct: 82  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 141
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N  +  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 142 NANKFVHRDLAARNCXV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 200
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 201 DGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ E+M    L  +++S    G   P+  +     Q+ +G+AF      +HRDL+  N
Sbjct: 84  IYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 141
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVL-LGSTHYSTAVDMW 129
           +L+   ++  KIAD GLAR   +   +YT        + + APE +  GS  ++   D+W
Sbjct: 142 ILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVW 196
Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN-----WHEYPQ 183
           S   +  E+VT   + +PG S  + +  + R    P  +  P    L N     W   P+
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP--EELYNIMMRCWKNRPE 254
Query: 184 WNP 186
             P
Sbjct: 255 ERP 257

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    +    ++   +   H  G +HRD+KP N
Sbjct: 149 LYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 74  LLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K+  LK+AD G         + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 204 MLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 262
Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 263 SVGVFLYEMLVGDTPFYADS 282

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    +    ++   +   H  G +HRD+KP N
Sbjct: 149 LYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 74  LLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K+  LK+AD G         + +    + T  Y +PEVL    G  +Y    D W
Sbjct: 204 MLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 262
Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 263 SVGVFLYEMLVGDTPFYADS 282

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +K+AD G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IKVADFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 2/106 (1%)
Query: 46  KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT   
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFD 170
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
            T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 49/227 (21%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 103 IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYT--HEILTLWYRAPEVL--LGSTHYS------- 123
           L+      LK+ D G+A              ++ T+ Y  PE +  + S+  +       
Sbjct: 159 LI--VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 124 -TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNWH 179
               D+WS+ CI   +        G +  QQ+++    L     PN ++           
Sbjct: 217 SPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI----------- 259
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 260 EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 186 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 239
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 240 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 182 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 235
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 236 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 7/129 (5%)
Query: 18  VFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD 77
           +F  MD      + S  +  +  P    K    ++C  + + H   I++RDLKP N+L+D
Sbjct: 81  IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140
Query: 78  RKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFA 136
            K   +KI D G A+     +   T+ +  T  Y APEV + +  Y+ ++D WS   +  
Sbjct: 141 -KNGHIKITDFGFAKY----VPDVTYXLCGTPDYIAPEV-VSTKPYNKSIDWWSFGILIY 194
Query: 137 ELVTKTALF 145
           E++     F
Sbjct: 195 EMLAGYTPF 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V E+++  DL  +I+  R+  E       +    ++   + F H  GI++RDLK  N
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAAEIISALMFLHDKGIIYRDLKLDN 154
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +    K+AD G+ +              T  Y APE+ L    Y  AVD W++  
Sbjct: 155 VLLDHEGHC-KLADFGMCKEGICNGVTTATFCGTPDYIAPEI-LQEMLYGPAVDWWAMGV 212
Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E++   A F  ++E      I       N++V            YP W         
Sbjct: 213 LLYEMLCGHAPFEAENEDDLFEAIL------NDEVV-----------YPTW--------- 246
Query: 194 PNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTRL 235
             L +D   +L+  +  +P+ R+ +         + HP+F ++D  +L
Sbjct: 247 --LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 51/228 (22%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 131 IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 75  LMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVL--LGSTHYS------ 123
           L+      LK+ D G+A      T  + K + ++  + Y  PE +  + S+  +      
Sbjct: 187 LI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 124 --TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT---PNEKVWPGVSSLMNW 178
                D+WS+ CI   +        G +  QQ+++    L     PN ++          
Sbjct: 244 ISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHAIIDPNHEI---------- 287
Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
            E+P          +P  +KD  D+L+  L+ DP +RIS  + + HPY
Sbjct: 288 -EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R    N PV    SL  M Q+      G+A+ 
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 155 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 214 DGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 204 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 257
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 258 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 293

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRD 68
           G   L LV EY+       + S R       +   + L++  Q+C+G+A+ H    +HRD
Sbjct: 106 GAASLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRD 159
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYST 124
           L   N+L+D   + +KI D GLA+A     + Y      +    WY APE L     Y  
Sbjct: 160 LAARNVLLDNDRL-VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFY-Y 216
Query: 125 AVDMWSVACIFAELVT 140
           A D+WS      EL+T
Sbjct: 217 ASDVWSFGVTLYELLT 232

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 201
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +K+AD G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 29/159 (18%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN--IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           +Y+V EYM+   K  +  F + GE   + +  +  +  Q+  G+A+      +HRDL+  
Sbjct: 78  IYIVTEYMN---KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA 134
Query: 73  NLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           N+L+    +  KIAD GLAR               PIK          + APE  L    
Sbjct: 135 NILVG-NGLICKIADFGLARLIEDNEXTARQGAKFPIK----------WTAPEAAL-YGR 182
Query: 122 YSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 159
           ++   D+WS   +  ELVTK  + +PG +  + L  + R
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 206 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 259
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 260 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 295

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 201
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 201
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 202
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 151
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 31/215 (14%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           T L++V EY        I   R   + +  + + +++    KG+ + H    +HRD+K  
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L++ +    K+AD G+A   T  + K    I T ++ APEV +    Y+   D+WS+ 
Sbjct: 155 NILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEV-IQEIGYNCVADIWSLG 212
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
               E+       P  +++  +  IF +   P                     P +    
Sbjct: 213 ITAIEMAEGK---PPYADIHPMRAIFMIPTNP---------------------PPTFRK- 247
Query: 193 VPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 226
            P L  D   D ++Q L   P +R +A + ++HP+
Sbjct: 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 142
Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-V 139
            +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+     E+ V
Sbjct: 143 EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 198
Query: 140 TKTALFPGDS--ELQQLLHIFRLL----GTPNEKVWPGVSSL 175
            +  + P D+  + +  + IF LL      P  K+  GV SL
Sbjct: 199 GRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 240

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 56/206 (27%)
Query: 43  NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 102
           +T+ +++ ++ +G+ + H +G +HRD+K  N+L+     +++IAD G++ AF       T
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDIT 178
Query: 103 HE------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 156
                   + T  + APEV+     Y    D+WS      EL T  A             
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA------------- 225
Query: 157 IFRLLGTPNEKVWPGVSSLMNWHEYP---------QWNPQSLATAVPNLD------KDGL 201
                                +H+YP         Q +P SL T V + +      K   
Sbjct: 226 --------------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 265
Query: 202 DLLEQMLQYDPSKRISAKKAMEHPYF 227
            ++   LQ DP KR +A + + H +F
Sbjct: 266 KMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++    G            E +    + S  YQ+ +G+ +   
Sbjct: 109 LYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 168
Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+    + +KIAD GLAR        KK T+  L + + APE L   
Sbjct: 169 KKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 120 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             Y+   D+WS   +  E+ T   + +PG    EL +LL     +  P+         + 
Sbjct: 228 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 286
Query: 177 N-WHEYPQWNPQSLATAVPNLDK 198
           + WH  P   P +    V +LD+
Sbjct: 287 DCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 37/216 (17%)
Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           R  +YL+ EY    +L K +    Q           ++M +L   + +CHG  ++HRD+K
Sbjct: 95  RRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIK 150
Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P NLL+      LKIAD G   +   P  +      TL Y  PE++ G  H +  VD+W 
Sbjct: 151 PENLLLG-LKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIEGRMH-NEKVDLWC 206
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  EL+     F   S               NE     V   + +       P S+ 
Sbjct: 207 IGVLCYELLVGNPPFESASH--------------NETYRRIVKVDLKF-------PASVP 245
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
           T          DL+ ++L+++PS+R+   +   HP+
Sbjct: 246 TG-------AQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 2/83 (2%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++CH   I HRDLK  N L+D      LKI D G +++  L  +  +  + T  
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 182
Query: 110 YRAPEVLLGSTHYSTAVDMWSVA 132
           Y APEVLL   +     D+WS  
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCG 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 49  MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 108
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 180 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 233
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 234 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 269

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL----CKGVAFC 59
           G   +G+  L ++      DLK Y+RS R    N PV    SL  M Q+      G+A+ 
Sbjct: 85  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 144
Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
           + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + + +PE L 
Sbjct: 145 NANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 203
Query: 118 GSTHYSTAVDMWSVACIFAELVT 140
               ++T  D+WS   +  E+ T
Sbjct: 204 DGV-FTTYSDVWSFGVVLWEIAT 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 56/206 (27%)
Query: 43  NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 102
           +T+ +++ ++ +G+ + H +G +HRD+K  N+L+     +++IAD G++ AF       T
Sbjct: 116 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDIT 173
Query: 103 HE------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 156
                   + T  + APEV+     Y    D+WS      EL T  A             
Sbjct: 174 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA------------- 220
Query: 157 IFRLLGTPNEKVWPGVSSLMNWHEYP---------QWNPQSLATAVPNLD------KDGL 201
                                +H+YP         Q +P SL T V + +      K   
Sbjct: 221 --------------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 260
Query: 202 DLLEQMLQYDPSKRISAKKAMEHPYF 227
            ++   LQ DP KR +A + + H +F
Sbjct: 261 KMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 43/195 (22%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------LPI 98
           +  Q+ + V F H  G++HRDLKP N+      + +K+ D GL  A            P+
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 99  KKY-TH--EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 155
             Y TH  ++ T  Y +PE + G+ +YS  VD++S+  I  EL+     F    E  +++
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYS---FSTQMERVRII 283
Query: 156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
              R L  P          L+   +YPQ +                 +++ ML   P++R
Sbjct: 284 TDVRNLKFP----------LLFTQKYPQEHM----------------MVQDMLSPSPTER 317
Query: 216 ISAKKAMEHPYFDDL 230
             A   +E+  F++L
Sbjct: 318 PEATDIIENAIFENL 332

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 110 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 161
Query: 82  TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-VT 140
            +K+ D G++      +      + T  Y +PE L G THYS   D+WS+     E+ V 
Sbjct: 162 EIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVG 218
Query: 141 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDG 200
           +  +  G   +     +  ++  P  K+  GV SL    E+                   
Sbjct: 219 RYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSL----EFQ------------------ 256
Query: 201 LDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
            D + + L  +P++R   K+ M H +    D
Sbjct: 257 -DFVNKCLIKNPAERADLKQLMVHAFIKRSD 286

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 153 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 204
Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-V 139
            +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+     E+ V
Sbjct: 205 EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 260
Query: 140 TKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN-------------- 185
            +  + P D++  +L+   ++ G   E      +       Y   +              
Sbjct: 261 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 320
Query: 186 ---PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
              P  L +AV +L+    D + + L  +P++R   K+ M H +    D   +
Sbjct: 321 NEPPPKLPSAVFSLEFQ--DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 371

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 36  TGENIPVNTVKSLMYQLCKGVAFCHGHGI---LHRDLKPHNLLM-------DRKTMTLKI 85
           +G+ IP + + +   Q+ +G+ + H   I   +HRDLK  N+L+       D     LKI
Sbjct: 98  SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 86  ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 145
            D GLAR +    K          + APEV+  S  +S   D+WS   +  EL+T    F
Sbjct: 158 TDFGLAREWHRTTKMSAAGAYA--WMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPF 214
Query: 146 PG 147
            G
Sbjct: 215 RG 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 32/182 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++CH   + HRDLK  N L+D      LKI   G +++  L  +  +  + T  
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS-TVGTPA 181
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKV 168
           Y APEVLL   +     D+WS       ++     F    E +     I R+L       
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------- 234
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                              ++  A+P+   +  +   L+ ++   DP+KRIS  +   H 
Sbjct: 235 -------------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 275
Query: 226 YF 227
           +F
Sbjct: 276 WF 277

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++     ++P    K    ++   +   H  G++HRD+KP N
Sbjct: 150 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 204
Query: 74  LLMDRKTMTLKIADLGLA-RAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D K   LK+AD G   +     +      + T  Y +PEVL    G  +Y    D W
Sbjct: 205 MLLD-KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 263
Query: 130 SVACIFAELVTKTALFPGDS 149
           SV     E++     F  DS
Sbjct: 264 SVGVFLFEMLVGDTPFYADS 283

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM+   L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 84  IYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAAN 141
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 142 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 197
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 198 FGILLTELTTKGRVPYPG 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 336 IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 393
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 394 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 449
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 450 FGILLTELTTKGRVPYPG 467

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 169
Query: 82  TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-VT 140
            +K+ D G++      +      + T  Y +PE L G THYS   D+WS+     E+ V 
Sbjct: 170 EIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVG 226
Query: 141 KTALFPGDSELQQLLHIFRLLGTPNE 166
           +  + P D++  +L+   ++ G   E
Sbjct: 227 RYPIPPPDAKELELMFGCQVEGDAAE 252

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 142
Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-V 139
            +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+     E+ V
Sbjct: 143 EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 198
Query: 140 TKTALFPGDSELQQLLHIFRLLGTPNE 166
            +  + P D++  +L+   ++ G   E
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 142
Query: 82  TLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-V 139
            +K+ D G++      I    +  + T  Y +PE L G THYS   D+WS+     E+ V
Sbjct: 143 EIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAV 198
Query: 140 TKTALFPGDSELQQLLHIFRLLGTPNE 166
            +  + P D++  +L+   ++ G   E
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 142
Query: 82  TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-VT 140
            +K+ D G++      +      + T  Y +PE L G THYS   D+WS+     E+ V 
Sbjct: 143 EIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVG 199
Query: 141 KTALFPGDSELQQLLHIFRLLGTPNE 166
           +  + P D++  +L+   ++ G   E
Sbjct: 200 RYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 22  MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           +D  LKK  R   Q    + +  +K L Y   K       H I+HRD+KP N+L++ +  
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-------HKIMHRDVKPSNILVNSRG- 142
Query: 82  TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL-VT 140
            +K+ D G++      +      + T  Y +PE L G THYS   D+WS+     E+ V 
Sbjct: 143 EIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVG 199
Query: 141 KTALFPGDSELQQLLHIFRLLGTPNE 166
           +  + P D++  +L+   ++ G   E
Sbjct: 200 RYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 80  IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 137
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 138 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 193
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 194 FGILLTELTTKGRVPYPG 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 253 IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 311 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 366
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 367 FGILLTELTTKGRVPYPG 384

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEASVIHRDLAARN 133
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 134 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 189
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 190 FGVLMWEVFSE 200

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 15/148 (10%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPH 72
           + +  E+MD   L + ++  ++    IP   +  +   + +G+A+    H I+HRD+KP 
Sbjct: 89  ISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSV 131
           N+L++ +   +K+ D G++      I    +  + T  Y APE L G THYS   D+WS+
Sbjct: 145 NILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMAPERLQG-THYSVQSDIWSM 199
Query: 132 ACIFAEL-VTKTALFPGDSELQQLLHIF 158
                EL V +  + P D+  ++L  IF
Sbjct: 200 GLSLVELAVGRYPIPPPDA--KELEAIF 225

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 253 IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 311 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 366
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 367 FGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 253 IYIVGEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 311 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 366
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 367 FGILLTELTTKGRVPYPG 384

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D GLA+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGLAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 32/182 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKKYTHEILTLW 109
           QL  GV++CH   + HRDLK  N L+D      LKI   G +++  L   +    + T  
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH-SQPKDTVGTPA 181
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKV 168
           Y APEVLL   +     D+WS       ++     F    E +     I R+L       
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------- 234
Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                              ++  A+P+   +  +   L+ ++   DP+KRIS  +   H 
Sbjct: 235 -------------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 275
Query: 226 YF 227
           +F
Sbjct: 276 WF 277

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 27/146 (18%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM+   L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 84  IYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAAN 141
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+  + +  K+AD GLAR               PIK          + APE  L    +
Sbjct: 142 ILVG-ENLVCKVADFGLARLIEDNEWTARQGAKFPIK----------WTAPEAAL-YGRF 189
Query: 123 STAVDMWSVACIFAELVTKTAL-FPG 147
           +   D+WS   +  EL TK  + +PG
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++ +   +G+A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF--- 210
Query: 105 ILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
           + T ++ APEV+L      Y   VD+WS+     EL  +       + +  L HI +   
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--- 267
Query: 163 TPNEKVWPGVSSLMNWHEY 181
             NE   P + S  +W EY
Sbjct: 268 --NES--PALQS-GHWSEY 281

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHN 73
           +++  E  DT L K+ +     G+ IP + +  +   + K +   H    ++HRD+KP N
Sbjct: 108 VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 167
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL---LGSTHYSTAVDMWS 130
           +L++     +K  D G++      + K   +     Y APE +   L    YS   D+WS
Sbjct: 168 VLIN-ALGQVKXCDFGISGYLVDDVAKDI-DAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL      FP DS            GTP ++       L    E P  +PQ  A
Sbjct: 226 LGITXIELA--ILRFPYDS-----------WGTPFQQ-------LKQVVEEP--SPQLPA 263
Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   + +D   Q L+ +  +R +  +  +HP+F
Sbjct: 264 D---KFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           LY V EY++  DL  +I+   Q G+       +++ Y  ++  G+ F H  GI++RDLK 
Sbjct: 95  LYFVMEYVNGGDLMYHIQ---QVGK---FKEPQAVFYAAEISIGLFFLHKRGIIYRDLKL 148
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+++D +   +KIAD G+ +   +          T  Y APE+ +    Y  +VD W+ 
Sbjct: 149 DNVMLDSEG-HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI-IAYQPYGKSVDWWAY 206
Query: 132 ACIFAELVTKTALFPGDSE 150
             +  E++     F G+ E
Sbjct: 207 GVLLYEMLAGQPPFDGEDE 225

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           +G   L LV EY+       + S R       +   + L++  Q+C+G+A+ H    +HR
Sbjct: 88  QGEKSLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHR 141
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYS 123
           +L   N+L+D   + +KI D GLA+A     + Y      +    WY APE L     Y 
Sbjct: 142 NLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFY- 198
Query: 124 TAVDMWSVACIFAELVT 140
            A D+WS      EL+T
Sbjct: 199 YASDVWSFGVTLYELLT 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 136
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 137 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 192
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 193 FGVLMWEVFSE 203

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 39/217 (17%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LY+VFE ++      + + +   E+      +     L KG+ + H   I+HRD+KP NL
Sbjct: 113 LYMVFELVNQGPVMEVPTLKPLSED----QARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY--STAVDMWSVA 132
           L+      +KIAD G++  F       ++ + T  + APE L  +       A+D+W++ 
Sbjct: 169 LVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227
Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTP--NEKVWPGVSSLMNWH-EYPQWNPQSL 189
                                 L+ F     P  +E++    S + +   E+P       
Sbjct: 228 VT--------------------LYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQ----- 262
Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
               P++ +D  DL+ +ML  +P  RI   +   HP+
Sbjct: 263 ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 15/139 (10%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + ++ +   +G+A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF--- 171
Query: 105 ILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 162
           + T ++ APEV+L      Y   VD+WS+     EL  +       + +  L HI     
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----- 226
Query: 163 TPNEKVWPGVSSLMNWHEY 181
             NE   P + S  +W EY
Sbjct: 227 AQNES--PALQS-GHWSEY 242

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 84/197 (42%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLG 89
           F    E++  +     + Q+  GV + H   I H DLKP N+++  K +    +K+ D G
Sbjct: 98  FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           +A        ++ +   T  + APE+ +         DMWS+  I   L++  + F G++
Sbjct: 158 IAHKIEAG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGET 215
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L +I  +    +E+ +   S L                          D + ++L 
Sbjct: 216 KQETLTNISAVNYDFDEEYFSNTSELAK------------------------DFIRRLLV 251
Query: 210 YDPSKRISAKKAMEHPY 226
            DP +R++  +++EH +
Sbjct: 252 KDPKRRMTIAQSLEHSW 268

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 133
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 134 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 189
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 190 FGVLMWEVFSE 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           +G   L LV EY+       + S R       +   + L++  Q+C+G+A+ H    +HR
Sbjct: 88  QGEKSLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHR 141
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYS 123
           +L   N+L+D   + +KI D GLA+A     + Y      +    WY APE L     Y 
Sbjct: 142 NLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFY- 198
Query: 124 TAVDMWSVACIFAELVT 140
            A D+WS      EL+T
Sbjct: 199 YASDVWSFGVTLYELLT 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 132 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 187
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 188 FGVLMWEVFSE 198

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           ++ G  V Y+V EY+     K     R  G+ +PV    + + ++   +++ H  G+++ 
Sbjct: 152 DRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYN 206
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           DLKP N+++  +   LK+ DLG        I  + +   T  ++APE++   T  + A D
Sbjct: 207 DLKPENIMLTEE--QLKLIDLGAVSR----INSFGYLYGTPGFQAPEIV--RTGPTVATD 258
Query: 128 MWSVACIFAEL 138
           +++V    A L
Sbjct: 259 IYTVGRTLAAL 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 153
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 154 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 209
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 210 FGVLMWEVFSE 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 146 LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 201
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 202 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 259
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 260 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 298
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 299 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 103 LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 158
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 159 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 216
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 217 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 255
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 256 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 101 LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 156
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 157 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 214
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 215 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 253
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 254 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLG 89
           F    E++  +     + Q+  GV + H   I H DLKP N+++  K +    +K+ D G
Sbjct: 105 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 164
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           +A        ++ +   T  + APE+ +         DMWS+  I   L++  + F G++
Sbjct: 165 IAHKIEAG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGET 222
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L +I  +    +E+ +   S L                          D + ++L 
Sbjct: 223 KQETLTNISAVNYDFDEEYFSNTSELAK------------------------DFIRRLLV 258
Query: 210 YDPSKRISAKKAMEHPY 226
            DP +R+   +++EH +
Sbjct: 259 KDPKRRMXIAQSLEHSW 275

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 92  LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 147
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 148 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 205
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 244
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 245 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 223 LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 278
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 279 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 336
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 337 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 375
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 376 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V E+++      I +  +  E      + ++   + + ++  H  G++HRD+K  ++
Sbjct: 96  LWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 151
Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K++D G     +  + +    + T ++ APE L+    Y   VD+WS+  +
Sbjct: 152 LLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 209
Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+V     +  +  L+ +  I        + + P    L N H+             P
Sbjct: 210 VIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK-----------VSP 248
Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +L       L+++L  DP++R +A + ++HP+ 
Sbjct: 249 SLK----GFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 29/197 (14%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLG 89
           F    E++  +     + Q+  GV + H   I H DLKP N+++  K +    +K+ D G
Sbjct: 119 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 178
Query: 90  LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           +A        ++ +   T  + APE+ +         DMWS+  I   L++  + F G++
Sbjct: 179 IAHKIEAG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGET 236
Query: 150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 209
           + + L +I  +    +E+ +   S L                          D + ++L 
Sbjct: 237 KQETLTNISAVNYDFDEEYFSNTSELAK------------------------DFIRRLLV 272
Query: 210 YDPSKRISAKKAMEHPY 226
            DP +R+   +++EH +
Sbjct: 273 KDPKRRMXIAQSLEHSW 289

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 108 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 164
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 165 LDEK-FTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 222
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 223 GVLLWELMTRGA 234

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TL 108
           G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T 
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARAS----EKFAQTVMXSRIVGTT 199
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            Y APE L G    +   D++S   +  E++T
Sbjct: 200 AYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TL 108
           G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T 
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARAS----EKFAQTVMXXRIVGTT 199
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            Y APE L G    +   D++S   +  E++T
Sbjct: 200 AYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFAEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q+ + + F H   I+HRDLK  N+LM  +   +++AD G++      ++K    
Sbjct: 119 IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSF 177
Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
           I T ++ APEV++  T     Y    D+WS+     E+     + P   EL  +  + ++
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNPMRVLLKI 234
Query: 161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
             +                     +P +L T       +  D L+  L  +P  R SA +
Sbjct: 235 AKS---------------------DPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQ 272
Query: 221 AMEHPYFDDLDKTR 234
            +EHP+   +   +
Sbjct: 273 LLEHPFVSSITSNK 286

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 61/135 (45%), Gaps = 13/135 (9%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM---YQLCKGVAFCHG---HGILHRDLK 70
           LV EY +      + +     E +P  T    M    Q  +GVA+ H      ++HRDLK
Sbjct: 77  LVMEYAEGG---SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 133
Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P NLL+      LKI D G A          T+   +  + APEV  GS +YS   D++S
Sbjct: 134 PPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGS-NYSEKCDVFS 189
Query: 131 VACIFAELVTKTALF 145
              I  E++T+   F
Sbjct: 190 WGIILWEVITRRKPF 204

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q+ + + F H   I+HRDLK  N+LM  +   +++AD G++      ++K    
Sbjct: 111 IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSF 169
Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 160
           I T ++ APEV++  T     Y    D+WS+     E+     + P   EL  +  + ++
Sbjct: 170 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNPMRVLLKI 226
Query: 161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
             +                     +P +L T       +  D L+  L  +P  R SA +
Sbjct: 227 AKS---------------------DPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQ 264
Query: 221 AMEHPYFDDLDKTR 234
            +EHP+   +   +
Sbjct: 265 LLEHPFVSSITSNK 278

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 137 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 192
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 193 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 246
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 247 VLIYEMAAGYPPFFADQPIQ 266

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +++ D GLA+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGLAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 61/135 (45%), Gaps = 13/135 (9%)
Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM---YQLCKGVAFCHG---HGILHRDLK 70
           LV EY +      + +     E +P  T    M    Q  +GVA+ H      ++HRDLK
Sbjct: 76  LVMEYAEGG---SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P NLL+      LKI D G A          T+   +  + APEV  GS +YS   D++S
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGS-NYSEKCDVFS 188
Query: 131 VACIFAELVTKTALF 145
              I  E++T+   F
Sbjct: 189 WGIILWEVITRRKPF 203

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLXGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLAGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADEPIQ 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 109 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 164
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 165 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 218
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 219 VLIYEMAAGYPPFFADQPIQ 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 102 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 157
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 158 LLIDQQGY-IQVTDFGFAKR----VKGRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALG 211
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 212 VLIYEMAAGYPPFFADQPIQ 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TL 108
           G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T 
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARAS----EKFAQXVMXXRIVGTT 193
Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            Y APE L G    +   D++S   +  E++T
Sbjct: 194 AYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 223

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 110 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 166
Query: 76  MDRKTMTLKIADLGLARAFT----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 167 LDEK-FTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 224
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 225 GVLLWELMTRGA 236

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 198
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 199 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           + +++ ++ KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    
Sbjct: 118 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXF 176
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           + T ++ APEV+  S  Y    D+WS+     EL       P +S+L  +  +F +    
Sbjct: 177 VGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLFLI---- 228
Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                            P+ +P +L        K   + +E  L  DP  R +AK+ ++H
Sbjct: 229 -----------------PKNSPPTLEG---QHSKPFKEFVEACLNKDPRFRPTAKELLKH 268
Query: 225 PY 226
            +
Sbjct: 269 KF 270

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 117 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 173 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 226
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 196
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 197 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 137 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 192
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 193 LLIDQQGY-IQVTDFGFAKR----VKGATWTLCGTPEYLAPEIIL-SKGYNKAVDWWALG 246
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 247 VLIYEMAAGYPPFFADQPIQ 266

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVMEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-- 121
           I+HRD+KP N+L+DR +  +K+ D G++      I K T +     Y APE +  S    
Sbjct: 147 IIHRDIKPSNILLDR-SGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSASRQ 204
Query: 122 -YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
            Y    D+WS+     EL T    +P  +S   QL  + +  G P               
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP--------------- 247
Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             PQ +        P+     ++ +   L  D SKR   K+ ++HP+ 
Sbjct: 248 --PQLSNSEEREFSPSF----INFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 204
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 17/136 (12%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL---------LMDRKT 80
           I   +  G  +  + +  L+  +C+G+   H  G  HRDLKP N+         LMD  +
Sbjct: 121 IERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 81  MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACI---- 134
           M      +  +R   L ++ +  +  T+ YRAPE+    +H       D+WS+ C+    
Sbjct: 181 MNQACIHVEGSRQ-ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 135 -FAELVTKTALFPGDS 149
            F E         GDS
Sbjct: 240 MFGEGPYDMVFQKGDS 255

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 109 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 165
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 166 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 222
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 223 FGVLLWELMTRGA 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 110 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 166
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 167 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 223
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 224 FGVLLWELMTRGA 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 168 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 225 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 281
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 282 FGVLLWELMTRGA 294

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +++  R+    +P    +    ++   + + H  GI++RDLK  N
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 140
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 141 VLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWALGV 198
Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 199 LMFEMMAGRSPF 210

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 109 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 165
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 166 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 222
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 223 FGVLLWELMTRGA 235

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 114 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 170
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 171 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 227
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 228 FGVLLWELMTRGA 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N +
Sbjct: 107 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 163
Query: 76  MDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +D K  T+K+AD GLAR      F     K   ++   W       L +  ++T  D+WS
Sbjct: 164 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWS 220
Query: 131 VACIFAELVTKTA 143
              +  EL+T+ A
Sbjct: 221 FGVLLWELMTRGA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 224
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 225 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVCEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 27/146 (18%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+  + +  K+AD GLAR               PIK          + APE  L    +
Sbjct: 145 ILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFPIK----------WTAPEAAL-YGRF 192
Query: 123 STAVDMWSVACIFAELVTKTAL-FPG 147
           +   D+WS   +  EL TK  + +PG
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 127 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 183
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 184 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 241
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 242 GVLLWELMTRGA 253

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 103 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 158
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D +   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 159 LLIDEQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 212
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 213 VLIYEMAAGYPPFFADQPIQ 232

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           HRD+KP N+L+        + D G+A A T   + +  + + TL+Y APE     +H + 
Sbjct: 157 HRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATY 214
Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
             D++++ C+  E +T +  + GD       HI + +  P+  V PG+
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPS-TVRPGI 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +++  R+    +P    +    ++   + + H  GI++RDLK  N
Sbjct: 81  LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 136
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 137 VLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWALGV 194
Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 195 LMFEMMAGRSPF 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 109 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 165
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 166 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 223
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 224 GVLLWELMTRGA 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA---FTLPIKKYTHEILTLWYR 111
           G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA   F   +   +  + T  Y 
Sbjct: 136 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXX-SRIVGTTAYX 193
Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELVT 140
           APE L G    +   D++S   +  E++T
Sbjct: 194 APEALRGEI--TPKSDIYSFGVVLLEIIT 220

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 97
           E IPV+ V  L++Q+  G+ +      +HRDL   N+L+  +    KI+D GL++A    
Sbjct: 105 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA-KISDFGLSKALGAD 163
Query: 98  IKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
              YT      W   + APE  +    +S+  D+WS      E ++
Sbjct: 164 DSYYTARSAGKWPLKWYAPEC-INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 78  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 135
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 136 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 191
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 192 FGILLTELTTKGRVPYPG 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 76  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 133
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 134 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 189
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 190 FGILLTELTTKGRVPYPG 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 107 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 163
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 164 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 221
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 222 GVLLWELMTRGA 233

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 106 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 162
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 163 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 220
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 221 GVLLWELMTRGA 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 101 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 157
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 158 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 215
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 216 GVLLWELMTRGA 227

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 128 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 184
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 185 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 242
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 243 GVLLWELMTRGA 254

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 161 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 218
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 219 GVLLWELMTRGA 230

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 105
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 226
Query: 106 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 155
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 227 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 156 HIFRLL 161
             FR+L
Sbjct: 286 EGFRML 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 109 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 165
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 166 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 223
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 224 GVLLWELMTRGA 235

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 16/114 (14%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-------------RA 93
           S    +  G+A+ H   I+HRDL  HN L+ R+   + +AD GLA             R+
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 94  FTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP 146
              P +K  + ++   ++ APE++ G + Y   VD++S   +  E++ +    P
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADP 223

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 54/223 (24%)
Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           GR  L +V E +D   + + R   +  +         +M  + + + + H   I HRD+K
Sbjct: 86  GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 71  PHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           P NLL    R    LK+ D G A+  T                          Y  + DM
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDM 181
Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQW 184
           WS+  I   L+     F  +  L                + PG+ + +   +Y    P+W
Sbjct: 182 WSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW 226
Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  S    +         L+  +L+ +P++R++  + M HP+ 
Sbjct: 227 SEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 17  LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N +
Sbjct: 108 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 164
Query: 76  MDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +D K  T+K+AD GLAR         +   T   L + + A E  L +  ++T  D+WS 
Sbjct: 165 LDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSF 222
Query: 132 ACIFAELVTKTA 143
             +  EL+T+ A
Sbjct: 223 GVLLWELMTRGA 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +++  R+    +P    +    ++   + + H  GI++RDLK  N
Sbjct: 96  LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 151
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 152 VLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWALGV 209
Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 210 LMFEMMAGRSPF 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 105
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 221
Query: 106 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 155
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 222 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280
Query: 156 HIFRLL 161
             FR+L
Sbjct: 281 EGFRML 286

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           +G   + LV EY+       + S R       V   + L++  Q+C+G+A+ H    +HR
Sbjct: 83  QGEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHR 136
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYS 123
            L   N+L+D   + +KI D GLA+A     + Y      +    WY APE L     Y 
Sbjct: 137 ALAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFY- 193
Query: 124 TAVDMWSVACIFAELVT 140
            A D+WS      EL+T
Sbjct: 194 YASDVWSFGVTLYELLT 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +++  R+    +P    +    ++   + + H  GI++RDLK  N
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   +K+ D G+ +    P    +    T  Y APE+L G   Y  +VD W++  
Sbjct: 184 VLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGV 241
Query: 134 IFAELVTKTALF 145
           +  E++   + F
Sbjct: 242 LMFEMMAGRSPF 253

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHR 67
           +G   + LV EY+       + S R       V   + L++  Q+C+G+A+ H    +HR
Sbjct: 82  QGEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHR 135
Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRAPEVLLGSTHYS 123
            L   N+L+D   + +KI D GLA+A     + Y      +    WY APE L     Y 
Sbjct: 136 ALAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFY- 192
Query: 124 TAVDMWSVACIFAELVT 140
            A D+WS      EL+T
Sbjct: 193 YASDVWSFGVTLYELLT 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 105
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 219
Query: 106 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 155
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 220 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278
Query: 156 HIFRLL 161
             FR+L
Sbjct: 279 EGFRML 284

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTL 96
           E I +  + S  +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR  +  
Sbjct: 194 EPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKN 252
Query: 97  P--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSE 150
           P  ++K    +   W  APE +     YST  D+WS   +  E+ +   + +PG   D +
Sbjct: 253 PDYVRKGDTRLPLKWM-APESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED 310
Query: 151 LQQLLHIFRLLGTPNEKVWPGVSSLM--NWHEYPQWNPQ 187
               L     +  P E   P +  +M   WH  P+  P+
Sbjct: 311 FCSRLREGMRMRAP-EYSTPEIYQIMLDCWHRDPKERPR 348

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 105
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARH----IKNDSNYVV 226
Query: 106 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 155
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 227 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 156 HIFRLL 161
             FR+L
Sbjct: 286 EGFRML 291

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 87  IYIVTEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 109
           Q+     + H   +++RDLKP NL++D++   +++ D G A+     +K  T  +  T  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPE 203
Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 152
           Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 204 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 6/127 (4%)
Query: 25  DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK 84
           DL  YI      GE       +    Q+   +  CH  G++HRD+K  N+L+D +    K
Sbjct: 125 DLFDYITEKGPLGEG----PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK 180
Query: 85  IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL 144
           + D G      L  + YT    T  Y  PE +    +++    +WS+  +  ++V     
Sbjct: 181 LIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
Query: 145 FPGDSEL 151
           F  D E+
Sbjct: 239 FERDQEI 245

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 105
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 203
Query: 106 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 155
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 204 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 156 HIFRLL 161
             FR+L
Sbjct: 263 EGFRML 268

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM    L  +++S    G  + +  +     Q+ +G+A+      +HRDL+  N
Sbjct: 83  IYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN 140
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+    M  KIAD GLAR   +   +YT        + + APE  +    ++   D+WS
Sbjct: 141 VLVSESLMC-KIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEA-INFGCFTIKSDVWS 196
Query: 131 VACIFAELVTKTAL-FPGDSE------LQQLLHIFRLLGTPNE 166
              +  E+VT   + +PG +       L Q   + R+   P+E
Sbjct: 197 FGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDE 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  ++      F  D  +Q
Sbjct: 226 VLIYQMAAGYPPFFADQPIQ 245

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           L++D++   +++ D G A+     +K  T  +  T  Y APE+++ S  Y+ AVD W++ 
Sbjct: 172 LIIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPEIII-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 47  SLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           S+ Y + KG+ + H     I+HRDLK  NLL+D+K  T+K+ D GL+R            
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKASXFLXSKXA 199
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
             T  + APEVL        + D++S   I  EL T
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL   N
Sbjct: 87  IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAAN 144
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GLAR   +   +YT        + + APE  L    ++   D+WS
Sbjct: 145 ILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 200
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 201 FGILLTELTTKGRVPYPG 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 7/137 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY++  DL  +I+   +  E   V        ++  G+ F    GI++RDLK  N
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----EIAIGLFFLQSKGIIYRDLKLDN 151
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   +KIAD G+ +              T  Y APE+ +    Y  +VD W+   
Sbjct: 152 VMLDSEG-HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI-IAYQPYGKSVDWWAFGV 209
Query: 134 IFAELVTKTALFPGDSE 150
           +  E++   A F G+ E
Sbjct: 210 LLYEMLAGQAPFEGEDE 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM-------------YQLCK 54
            K G  ++ +V      +L  Y+RS R   E +P  T + L              +Q+ K
Sbjct: 102 TKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKTPEDLYKDFLTLEHLICYSFQVAK 159
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEILTLWYR 111
           G+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    +   W  
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLPLKWM- 217
Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLGTPNEK 167
           APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     +  P+  
Sbjct: 218 APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 276
Query: 168 VWPGVSSLMN-WHEYPQWNP 186
                 ++++ WH  P   P
Sbjct: 277 TPEMYQTMLDCWHGEPSQRP 296

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 254 IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 311
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  + +  K+AD GL R   +   +YT        + + APE  L    ++   D+WS
Sbjct: 312 ILVG-ENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWS 367
Query: 131 VACIFAELVTKTAL-FPG 147
              +  EL TK  + +PG
Sbjct: 368 FGILLTELTTKGRVPYPG 385

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 7/137 (5%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY++  DL  +I+   +  E   V        ++  G+ F    GI++RDLK  N
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAV----FYAAEIAIGLFFLQSKGIIYRDLKLDN 472
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   +KIAD G+ +              T  Y APE+ +    Y  +VD W+   
Sbjct: 473 VMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI-IAYQPYGKSVDWWAFGV 530
Query: 134 IFAELVTKTALFPGDSE 150
           +  E++   A F G+ E
Sbjct: 531 LLYEMLAGQAPFEGEDE 547

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 118 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 177 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 222
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 223 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 266
Query: 225 PYF 227
            +F
Sbjct: 267 RFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 172 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 217
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 218 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 225 PYF 227
            +F
Sbjct: 262 RFF 264

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 27/146 (18%)
Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 77  IXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 134
Query: 74  LLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+  + +  K+AD GLAR               PIK          + APE  L    +
Sbjct: 135 ILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFPIK----------WTAPEAAL-YGRF 182
Query: 123 STAVDMWSVACIFAELVTKTAL-FPG 147
           +   D+WS   +  EL TK  + +PG
Sbjct: 183 TIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 26/149 (17%)
Query: 15  LYLVFEYMD-TDLKKYIRSFRQ----------------TGENIPVNTVKSLM---YQLCK 54
           +YL+FEY    DL  Y+RS R+                  E++ V T + L+   YQ+ K
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYR 111
           G+ F      +HRDL   N+L+    + +KI D GLAR   +    Y    +  L + + 
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD-IMSDSNYVVRGNARLPVKWM 241
Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELVT 140
           APE L     Y+   D+WS   +  E+ +
Sbjct: 242 APESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 172 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 217
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 218 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 225 PYF 227
            +F
Sbjct: 262 RFF 264

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T  Y AP ++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEYLAPAIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 25  DLKKYIRSFRQTGENIPVN-------TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNL 74
           +L  Y+RS R   E +P         T++ L+   +Q+ KG+ F      +HRDL   N+
Sbjct: 118 NLSTYLRSKRN--EFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNI 175
Query: 75  LMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L+  K + +KI D GLAR  +  P  ++K    +   W  APE +     Y+   D+WS 
Sbjct: 176 LLSEKNV-VKIXDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSF 232
Query: 132 ACIFAELVTKTAL-FPG---DSELQQLLHIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNP 186
             +  E+ +  A  +PG   D E  + L     +  P+        ++++ WH  P   P
Sbjct: 233 GVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 7/152 (4%)
Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           V+  Q  E   +LYL  E     L+++  ++   G ++P   V   +      +A  H  
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           G++H D+KP N+ +  +    K+ D GL             E     Y APE+L GS  Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRC-KLGDFGLLVELGTAGAGEVQEG-DPRYMAPELLQGS--Y 232
Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQL 154
            TA D++S+     E+     L  G    QQL
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 66/131 (50%), Gaps = 11/131 (8%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LV E+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWS 130
            L+  +   +K++D G+ R F L   +YT    T +   + +PEV    + YS+  D+WS
Sbjct: 135 CLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWS 190
Query: 131 VACIFAELVTK 141
              +  E+ ++
Sbjct: 191 FGVLMWEVFSE 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 172 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 217
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 218 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 225 PYF 227
            +F
Sbjct: 262 RFF 264

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 205 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 264 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 321
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 322 APDYTTPEMYQTMLDCWHGEPSQRP 346

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 4   KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF---- 58
           K+G N E    L+L+  + D   L  Y++     G  I  N +  +   + +G+++    
Sbjct: 79  KRGSNLE--VELWLITAFHDKGSLTDYLK-----GNIITWNELCHVAETMSRGLSYLHED 131
Query: 59  ---CHGHG----ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--LPIKKYTHEILTLW 109
              C G G    I HRD K  N+L+ +  +T  +AD GLA  F    P      ++ T  
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLL-KSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 110 YRAPEVLLGSTHYST----AVDMWSVACIFAELVTKTALFPG 147
           Y APEVL G+ ++       +DM+++  +  ELV++     G
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 207 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 266 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 323
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 324 APDYTTPEMYQTMLDCWHGEPSQRP 348

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 172 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 217
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 218 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 225 PYF 227
            +F
Sbjct: 262 RFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 116 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 175 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 220
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 221 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 264
Query: 225 PYF 227
            +F
Sbjct: 265 RFF 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T  Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW 169
            APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+        
Sbjct: 172 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------- 217
Query: 170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEH 224
                LM    +P+            L  +   LL  +L+ DP +R+      AK+ MEH
Sbjct: 218 -----LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 225 PYF 227
            +F
Sbjct: 262 RFF 264

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 259 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 316
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 317 APDYTTPEMYQTMLDCWHGEPSQRP 341

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 198 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 257 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 314
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 315 APDYTTPEMYQTMLDCWHGEPSQRP 339

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 47  SLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           S+ Y + KG+ + H     I+HR+LK  NLL+D+K  T+K+ D GL+R            
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSA 199
Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
             T  + APEVL        + D++S   I  EL T
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 38  ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 97
           E IPV+ V  L++Q+  G+ +      +HR+L   N+L+  +    KI+D GL++A    
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA-KISDFGLSKALGAD 489
Query: 98  IKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
              YT      W   + APE  +    +S+  D+WS      E ++
Sbjct: 490 DSYYTARSAGKWPLKWYAPEC-INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+   
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+    S  YS   D+++   +  EL+T
Sbjct: 175 LWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMT 208

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ E+M    L  +++S    G  + +  +     Q+ +G+A+      +HRDL+  N
Sbjct: 82  IYIITEFMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN 139
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+    M  KIAD GLAR   +   +YT        + + APE  +    ++   ++WS
Sbjct: 140 VLVSESLMC-KIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEA-INFGCFTIKSNVWS 195
Query: 131 VACIFAELVTKTAL-FPGD------SELQQLLHIFRLLGTPNE 166
              +  E+VT   + +PG       S L Q   + R+   P+E
Sbjct: 196 FGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDE 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 25  DLKKYIRSFRQTGENIPVN-------TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNL 74
           +L  Y+RS R   E +P         T++ L+   +Q+ KG+ F      +HRDL   N+
Sbjct: 118 NLSTYLRSKRN--EFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNI 175
Query: 75  LMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L+  K + +KI D GLAR  +  P  ++K    +   W  APE +     Y+   D+WS 
Sbjct: 176 LLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSF 232
Query: 132 ACIFAELVTKTAL-FPG---DSELQQLLHIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNP 186
             +  E+ +  A  +PG   D E  + L     +  P+        ++++ WH  P   P
Sbjct: 233 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 107
           +  Q  +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 108 ---LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 157
              LW  APEV+    S  YS   D+++   +  EL+T    +   +   Q++ +
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EY+   ++  ++R   +  E       +    Q+     + H   +++RDLKP N
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVA 132
           LL+D++   +++ D G A+     +K  T  +  T    APE++L S  Y+ AVD W++ 
Sbjct: 172 LLIDQQGY-IQVTDFGFAKR----VKGRTWXLCGTPEALAPEIIL-SKGYNKAVDWWALG 225
Query: 133 CIFAELVTKTALFPGDSELQ 152
            +  E+      F  D  +Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 216 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 273
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 274 APDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 214 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 214 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 205 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEI 105
           L+ Q+  G+ +   H ++H+DL   N+L+  K + +KI+DLGL R        K   + +
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQLLHIFRLL 161
           L + + APE ++    +S   D+WS   +  E V    L P     + ++ +++   ++L
Sbjct: 192 LPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWE-VFSYGLQPYCGYSNQDVVEMIRNRQVL 249
Query: 162 GTPNE-KVWPGVSSLMNWHEYPQWNPQ 187
             P++   W     +  W+E+P   P+
Sbjct: 250 PCPDDCPAWVYALMIECWNEFPSRRPR 276

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEI 105
           L+ Q+  G+ +   H ++H+DL   N+L+  K + +KI+DLGL R        K   + +
Sbjct: 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQLLHIFRLL 161
           L + + APE ++    +S   D+WS   +  E V    L P     + ++ +++   ++L
Sbjct: 209 LPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWE-VFSYGLQPYCGYSNQDVVEMIRNRQVL 266
Query: 162 GTPNE-KVWPGVSSLMNWHEYPQWNPQ 187
             P++   W     +  W+E+P   P+
Sbjct: 267 PCPDDCPAWVYALMIECWNEFPSRRPR 293

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    + 
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 214 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 107
           +  Q  +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 108 ---LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
              LW  APEV+    S  YS   D+++   +  EL+T
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    + 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 214 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 251 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 308
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 309 APDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    + 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 205 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    + 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 205 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
            + + ++  G+    L+ E     L ++++     G  +  +TV  + YQ C+ V   H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154
Query: 62  HG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILT 107
               I+HRDLK  NLL+  +  T+K+ D G A   +              +++      T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 108 LWYRAPEVLLGSTHYSTA--VDMWSVACIFAELVTKTALFPGDSELQ 152
             YR PE++   +++      D+W++ CI   L  +   F   ++L+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEIL 106
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    + 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 162
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 205 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 163 TPNEKVWPGVSSLMN-WHEYPQWNP 186
            P+        ++++ WH  P   P
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 2/98 (2%)
Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 107
           +  QL   V +     I+HRD+K  N+++  +  T+K+ D G A A+    K +     T
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSA-AYLERGKLFYTFCGT 192
Query: 108 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 145
           + Y APEVL+G+ +    ++MWS+      LV +   F
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q    + + H + I+HRDLK  N+L       +K+AD G++   T  I++    
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSF 195
Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELV 139
           I T ++ APEV++  T     Y    D+WS+     E+ 
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q    + + H + I+HRDLK  N+L       +K+AD G++   T  I++    
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSF 195
Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELV 139
           I T ++ APEV++  T     Y    D+WS+     E+ 
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 104
           ++ +  Q    + + H + I+HRDLK  N+L       +K+AD G++   T  I++    
Sbjct: 137 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXF 195
Query: 105 ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELV 139
           I T ++ APEV++  T     Y    D+WS+     E+ 
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+LV E+      TDL K  +     G  +    +  +  ++ +G++  H H ++HRD+K
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156
Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH----YSTAV 126
             N+L+  +   +K+ D G++      + +    I T ++ APEV+    +    Y    
Sbjct: 157 GQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 127 DMWSVACIFAELV 139
           D+WS+     E+ 
Sbjct: 216 DLWSLGITAIEMA 228

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 5/76 (6%)
Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV EY +  DL   +  F   GE IP    +  + ++   +   H  G +HRD+KP N
Sbjct: 136 LYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDN 192
Query: 74  LLMDRKTMTLKIADLG 89
           +L+DR    +++AD G
Sbjct: 193 ILLDR-CGHIRLADFG 207

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 198 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 199 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 199 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 17/121 (14%)
Query: 43  NTVKSLMYQLCKGVAFCH--------GH--GILHRDLKPHNLLMDRKTMTLKIADLGLAR 92
           N +  +   + +G+A+ H        GH   I HRD+K  N+L+ +  +T  IAD GLA 
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-KNNLTACIADFGLAL 179
Query: 93  AFTLPIKKY-TH-EILTLWYRAPEVLLGSTHYST----AVDMWSVACIFAELVTKTALFP 146
            F        TH ++ T  Y APEVL G+ ++       +DM+++  +  EL ++     
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 147 G 147
           G
Sbjct: 240 G 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 176 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 191 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 176 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 171 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 171 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 22/139 (15%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  ++   +  + +      +C+ + +  G+  +HRD
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+    +  K++D GL +  +       LP+K          + APE L  +  
Sbjct: 134 LAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK----------WTAPEALREAA- 181
Query: 122 YSTAVDMWSVACIFAELVT 140
           +ST  D+WS   +  E+ +
Sbjct: 182 FSTKSDVWSFGILLWEIYS 200

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 173 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 22/139 (15%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  ++   +  + +      +C+ + +  G+  +HRD
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+    +  K++D GL +  +       LP+K          + APE L     
Sbjct: 128 LAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK----------WTAPEALR-EKK 175
Query: 122 YSTAVDMWSVACIFAELVT 140
           +ST  D+WS   +  E+ +
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 22/139 (15%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  ++   +  + +      +C+ + +  G+  +HRD
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+    +  K++D GL +  +       LP+K          + APE L     
Sbjct: 143 LAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK----------WTAPEALR-EKK 190
Query: 122 YSTAVDMWSVACIFAELVT 140
           +ST  D+WS   +  E+ +
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT--- 107
           Q  +G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+   
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 108 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           LW  APEV+       YS   D+++   +  EL+T
Sbjct: 171 LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 22/139 (15%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  ++   +  + +      +C+ + +  G+  +HRD
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+    +  K++D GL +  +       LP+K          + APE L     
Sbjct: 315 LAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK----------WTAPEALR-EKK 362
Query: 122 YSTAVDMWSVACIFAELVT 140
           +ST  D+WS   +  E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGL 90
           F      + + TV  L  Q+   V F H    LHRD+KP N LM   R+   + I D GL
Sbjct: 93  FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
Query: 91  ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           A+ +       TH+ +   YR  + L G+  Y++
Sbjct: 153 AKKYR---DTSTHQHIP--YRENKNLTGTARYAS 181

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGEN----IPVNTVKSLMYQ--------LCKGV 56
           E R  LYL  EY    +L  ++R  R    +    I  +T  +L  Q        + +G+
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155
Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+    +  KIAD GL+R   + +KK    +   W       
Sbjct: 156 DYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIES-- 212
Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
           L  + Y+T  D+WS   +  E+V+
Sbjct: 213 LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGEN----IPVNTVKSLMYQ--------LCKGV 56
           E R  LYL  EY    +L  ++R  R    +    I  +T  +L  Q        + +G+
Sbjct: 86  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 145
Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+    +  KIAD GL+R   + +KK    +   W       
Sbjct: 146 DYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIES-- 202
Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
           L  + Y+T  D+WS   +  E+V+
Sbjct: 203 LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 18  VFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD 77
           +F  +D  L   +R   Q   +    TVK  + +L   + +     I+HRD+KP N+L+D
Sbjct: 90  MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD 149
Query: 78  RKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACI 134
                + I D  +A    LP + + T    T  Y APE+        YS AVD WS+   
Sbjct: 150 EHG-HVHITDFNIAAM--LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206
Query: 135 FAELVTKTALF--PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
             EL+     +     +  ++++H F          W                       
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW----------------------- 243
Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH-PYFDDLD 231
                ++ + LL+++L+ +P +R S    +++ PY +D++
Sbjct: 244 ----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 5   QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           +G    GR  + +V EYM+   L  ++R+    G+   +  +  ++  +  G+ +    G
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFLRT--HDGQ-FTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKY--THEILTLWYRAPEVLLGST 120
            +HRDL   N+L+D   +  K++D GL+R     P   Y  T   + + + APE +   T
Sbjct: 172 YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 121 HYSTAVDMWSVACIFAELVT 140
            +S+A D+WS   +  E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 74  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT  +     + +  PEVL+ S  +S+  D+W+
Sbjct: 131 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWA 186
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 244
Query: 185 NP 186
            P
Sbjct: 245 RP 246

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 78  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 134
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT  +     + +  PEVL+ S  +S+  D+W+
Sbjct: 135 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWA 190
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 248
Query: 185 NP 186
            P
Sbjct: 249 RP 250

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEI 105
           Q  +G+ + H   I+HRD+K +N+ +  + +T+KI D GLA      + +  +++ T  +
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 106 LTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVT 140
           L   + APEV+    +  +S   D++S   +  EL+T
Sbjct: 199 L---WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 85  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 141
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT  +     + +  PEVL+ S  +S+  D+W+
Sbjct: 142 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWA 197
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 255
Query: 185 NP 186
            P
Sbjct: 256 RP 257

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 79  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 135
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT  +     + +  PEVL+ S  +S+  D+W+
Sbjct: 136 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWA 191
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 249
Query: 185 NP 186
            P
Sbjct: 250 RP 251

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-SLMYQLCKGVA----FCHGHGIL 65
           R  + L+++YM+  +LK+++      G ++P  ++      ++C G A    + H   I+
Sbjct: 107 RNEMILIYKYMENGNLKRHL-----YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLL------ 117
           HRD+K  N+L+D +    KI D G+++  T   + +   ++  TL Y  PE  +      
Sbjct: 162 HRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 118 GSTHYSTAVDMWSVACIFAELV 139
            S  YS  V ++ V C  + +V
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIV 242

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 94  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT  +     + +  PEVL+ S  +S+  D+W+
Sbjct: 151 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWA 206
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 264
Query: 185 NP 186
            P
Sbjct: 265 RP 266

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 60/139 (43%), Gaps = 12/139 (8%)
Query: 13  TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKP 71
           T +++  E M T  +K  +  +     IP   +  +   + K + +    HG++HRD+KP
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153
Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL----LGSTHYSTAVD 127
            N+L+D +   +K+ D G++    +  K          Y APE +         Y    D
Sbjct: 154 SNILLDERGQ-IKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 128 MWSVACIFAELVTKTALFP 146
           +WS+     EL   T  FP
Sbjct: 212 VWSLGISLVELA--TGQFP 228

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-SLMYQLCKGVA----FCHGHGIL 65
           R  + L+++YM+  +LK+++      G ++P  ++      ++C G A    + H   I+
Sbjct: 107 RNEMILIYKYMENGNLKRHL-----YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161
Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLL------ 117
           HRD+K  N+L+D +    KI D G+++  T   + +   ++  TL Y  PE  +      
Sbjct: 162 HRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 118 GSTHYSTAVDMWSVACIFAELV 139
            S  YS  V ++ V C  + +V
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIV 242

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 101
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA       Y
Sbjct: 114 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHY 172
Query: 102 T---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
               H  +   + APE L   T +S A D W       E+ T
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + ++ EYM+   L K++R   + GE   V  +  ++  +  G+ +      +HRDL   N
Sbjct: 121 MMIITEYMENGALDKFLR--EKDGE-FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + APE  +    +++A D+WS
Sbjct: 178 ILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-ISYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E++T
Sbjct: 236 FGIVMWEVMT 245

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 101
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA       Y
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHY 178
Query: 102 T---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
               H  +   + APE L   T +S A D W       E+ T
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 101
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA       Y
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHY 168
Query: 102 T---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
               H  +   + APE L   T +S A D W       E+ T
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 17/134 (12%)
Query: 15  LYLVFEYM-----DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           + +V EYM     DT LKK    F        V  +  ++  +  G+ +    G +HRDL
Sbjct: 98  VMIVTEYMENGSLDTFLKKNDGQFT-------VIQLVGMLRGISAGMKYLSDMGYVHRDL 150
Query: 70  KPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAV 126
              N+L++   +  K++D GL+R     P   YT     + + + APE  +    +++A 
Sbjct: 151 AARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA-IAFRKFTSAS 208
Query: 127 DMWSVACIFAELVT 140
           D+WS   +  E+V+
Sbjct: 209 DVWSYGIVMWEVVS 222

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 25/137 (18%)
Query: 25  DLKKYIRSFR-QTG-ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT 82
           DL  Y+   R +TG ++IP+ T+   M  +  G+ +      LHRDL   N ++ R  MT
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML-RDDMT 185
Query: 83  LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL-----------LGSTHYSTAVDMWSV 131
           + +AD GL++      K Y+ +    +YR   +            L    Y++  D+W+ 
Sbjct: 186 VCVADFGLSK------KIYSGD----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235
Query: 132 ACIFAELVTKTAL-FPG 147
                E+ T+    +PG
Sbjct: 236 GVTMWEIATRGMTPYPG 252

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 101
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA       Y
Sbjct: 114 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHY 172
Query: 102 T---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
               H  +   + APE L   T +S A D W       E+ T
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 101
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA       Y
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHY 168
Query: 102 T---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
               H  +   + APE L   T +S A D W       E+ T
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 10  EGRTVLYLVFEYM-DTDLKKYIRSFRQTGEN----IPVNTVKSLMYQ--------LCKGV 56
           E R  LYL  EY    +L  ++R  R    +    I  +T  +L  Q        + +G+
Sbjct: 93  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 152
Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HR+L   N+L+    +  KIAD GL+R   + +KK    +   W       
Sbjct: 153 DYLSQKQFIHRNLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIES-- 209
Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
           L  + Y+T  D+WS   +  E+V+
Sbjct: 210 LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 65/169 (38%), Gaps = 30/169 (17%)
Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 110
           ++   + + H   I++RDLKP N+L+D +   + + D GL +         +    T  Y
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 111 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 170
            APEV L    Y   VD W +  +  E++     F   +  +   +I             
Sbjct: 206 LAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----------- 253
Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
                          P  L    PN+      LLE +LQ D +KR+ AK
Sbjct: 254 --------------KPLQLK---PNITNSARHLLEGLLQKDRTKRLGAK 285

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------- 62
           T LYL+ +Y +   L  Y++S       +   ++  L Y    G+  CH H         
Sbjct: 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGL--CHLHTEIFSTQGK 160
Query: 63  -GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVL- 116
             I HRDLK  N+L+ +K  T  IADLGLA  F     +        + T  Y  PEVL 
Sbjct: 161 PAIAHRDLKSKNILV-KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 117 --LGSTHYSTAV--DMWSVACIFAELVTKTALFPGDSELQQL 154
             L   H+ + +  DM+S   I  E V +  +  G  E  QL
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQL 260

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 5   QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           +G    GR  + +V EYM+   L  ++R+    G+   +  +  ++  +  G+ +    G
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFLRT--HDGQ-FTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---LPIKKYTHEILTLWYRAPEVLLGST 120
            +HRDL   N+L+D   +  K++D GL+R            T   + + + APE +   T
Sbjct: 172 YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 121 HYSTAVDMWSVACIFAELVT 140
            +S+A D+WS   +  E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GLAR     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 132 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDNDYG 189
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 231
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 232 R-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 131 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDNDYG 188
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 230
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 231 R-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 270 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYG 327
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 369
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 370 R-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 130 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDNDYG 187
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 229
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 230 R-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 156
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 157 LSKALRADENXYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 216 RGMKGSEVTAMLEKGERMGCP 236

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +++RDLK  NL++D K   +KI D GL +              T  Y APEV L    Y 
Sbjct: 273 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYG 330
Query: 124 TAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
            AVD W +  +  E++  +   +  D E      +F L+             LM    +P
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------LMEEIRFP 372
Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 227
           +            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 373 R-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 172
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 173 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 232 RGMKGSEVTAMLEKGERMGCP 252

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 172
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 173 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 232 RGMKGSEVTAMLEKGERMGCP 252

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 150
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 151 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 210 RGMKGSEVTAMLEKGERMGCP 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTH 103
           S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R        +K+   
Sbjct: 154 SFAWQISQGMQYLAEMSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 213 RIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 156
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 157 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 216 RGMKGSEVTAMLEKGERMGCP 236

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 170
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 171 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 230 RGMKGSEVTAMLEKGERMGCP 250

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 152
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 212 RGMKGSEVTAMLEKGERMGCP 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 8/141 (5%)
Query: 30  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 89
           +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI+D G
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFG 162
Query: 90  LARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT---KTA 143
           L++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +   K  
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221
Query: 144 LFPGDSELQQLLHIFRLLGTP 164
                SE+  +L     +G P
Sbjct: 222 RGMKGSEVTAMLEKGERMGCP 242

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 80/181 (44%), Gaps = 17/181 (9%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 94  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTH--EILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            L++ + + +K++D GL+R + L  ++ +       + +  PEVL+ S  +S+  D+W+ 
Sbjct: 151 CLVNDQGV-VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAF 207
Query: 132 ACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQWN 185
             +  E+ +   +    F      + +    RL      +EKV+  + S   WHE     
Sbjct: 208 GVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADER 265
Query: 186 P 186
           P
Sbjct: 266 P 266

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 79  IFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 135
Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYSTAVDMWS 130
            L++ + + +K++D GL+R + L   +YT        + +  PEVL+ S  +S+  D+W+
Sbjct: 136 CLVNDQGV-VKVSDFGLSR-YVLD-DEYTSSRGSKFPVRWSPPEVLMYSK-FSSKSDIWA 191
Query: 131 VACIFAELVTKTAL----FPGDSELQQLLHIFRLLG--TPNEKVWPGVSSLMNWHEYPQW 184
              +  E+ +   +    F      + +    RL      +EKV+  + S   WHE    
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC--WHEKADE 249
Query: 185 NP 186
            P
Sbjct: 250 RP 251

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 173 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 230
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSI 256

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGL 90
           F        + TV  L  Q+   + + H    +HRD+KP N LM   +K   + I D GL
Sbjct: 95  FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154
Query: 91  ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 150
           A+ +       TH+ +   YR  + L G+  Y         A I   L  + +       
Sbjct: 155 AKKYR---DARTHQHIP--YRENKNLTGTARY---------ASINTHLGIEQSRRDDLES 200
Query: 151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK 198
           L  +L  F L   P    W G+ +     +Y + + + ++T +  L K
Sbjct: 201 LGYVLMYFNLGSLP----WQGLKAATKRQKYERISEKKMSTPIEVLCK 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 109 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 165
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 166 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 223
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 224 YGIVLWEVMS 233

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 119 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 175
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 176 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 233
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 234 YGIVLWEVMS 243

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGL 90
           F        + TV  L  Q+   + + H    +HRD+KP N LM   +K   + I D GL
Sbjct: 95  FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154
Query: 91  ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 150
           A+ +       TH+ +   YR  + L G+  Y         A I   L  + +       
Sbjct: 155 AKKYR---DARTHQHIP--YRENKNLTGTARY---------ASINTHLGIEQSRRDDLES 200
Query: 151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK 198
           L  +L  F L   P    W G+ +     +Y + + + ++T +  L K
Sbjct: 201 LGYVLMYFNLGSLP----WQGLKAATKRQKYERISEKKMSTPIEVLCK 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 92  VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 148
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 149 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 206
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 207 YGIVLWEVMS 216

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTH 103
           S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R        +K+   
Sbjct: 154 SFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 213 RIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 33  FRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGL 90
           F        + TV  L  Q+   + + H    +HRD+KP N LM   +K   + I D GL
Sbjct: 93  FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152
Query: 91  ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 150
           A+ +       TH+ +   YR  + L G+  Y         A I   L  + +       
Sbjct: 153 AKKYR---DARTHQHIP--YRENKNLTGTARY---------ASINTHLGIEQSRRDDLES 198
Query: 151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK 198
           L  +L  F L   P    W G+ +     +Y + + + ++T +  L K
Sbjct: 199 LGYVLMYFNLGSLP----WQGLKAATKRQKYERISEKKMSTPIEVLCK 242

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 74  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 134 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 191
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSI 217

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL+R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 100 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 159
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 160 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 217
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 218 HFESFKRADIYAMGLVFWEIARRCSI 243

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 75  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 134
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 135 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 192
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 193 HFESFKRADIYAMGLVFWEIARRCSI 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 77  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 136
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 137 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 194
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 195 HFESFKRADIYAMGLVFWEIARRCSI 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 13  TVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 80  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 139
Query: 69  LKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILTLWYRAPEVL---LGST 120
           LK  N+L+ +K  T  IADLGLA        T+ I    H + T  Y APEVL   +   
Sbjct: 140 LKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMK 197
Query: 121 HYST--AVDMWSVACIFAELVTKTAL 144
           H+ +    D++++  +F E+  + ++
Sbjct: 198 HFESFKRADIYAMGLVFWEIARRCSI 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 70/141 (49%), Gaps = 12/141 (8%)
Query: 5   QGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           +G    G+ V+ +V E+M+   L  ++R  +  G+   +  V  ++  +  G+ +    G
Sbjct: 110 EGVVTRGKPVM-IVIEFMENGALDAFLR--KHDGQFTVIQLV-GMLRGIAAGMRYLADMG 165
Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYT---HEILTLWYRAPEVLLGS 119
            +HRDL   N+L++   +  K++D GL+R     P   YT    +I   W  APE +   
Sbjct: 166 YVHRDLAARNILVN-SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW-TAPEAIQ-Y 222
Query: 120 THYSTAVDMWSVACIFAELVT 140
             +++A D+WS   +  E+++
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 15  LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+      + SF R+      V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177
Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L++   +  K++D GL R     P   YT     + + + +PE  +    +++A D+WS
Sbjct: 178 ILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA-IAYRKFTSASDVWS 235
Query: 131 VACIFAELVT 140
              +  E+++
Sbjct: 236 YGIVLWEVMS 245

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---IKKYTH 103
           S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R        +K+   
Sbjct: 154 SFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 213 RIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 25/149 (16%)
Query: 15  LYLVFEYMD-TDLKKYIRSFR--------------QTGENIPVNTVKSLMYQLC------ 53
           + L+FEYM   DL +++RS                +   + P     S   QLC      
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYR 111
            G+A+      +HRDL   N L+  + M +KIAD GL+R        K   ++ + + + 
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 243
Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELVT 140
            PE +     Y+T  D+W+   +  E+ +
Sbjct: 244 PPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK- 100
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA  LP    
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRA--LPQNDD 176
Query: 101 ----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
                 H  +   + APE L   T +S A D W       E+ T
Sbjct: 177 HXVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYLV +Y +  DL   +  F    + +P    +  + ++   +   H    +HRD+KP N
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 205
Query: 74  LLMDRKTMTLKIADLGLA-RAFTLPIKKYTHEILTLWYRAPEVLL----GSTHYSTAVDM 128
           +LMD     +++AD G   +       + +  + T  Y +PE+L     G   Y    D 
Sbjct: 206 ILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 129 WSVA-CIFAELVTKTALF 145
           WS+  C++  L  +T  +
Sbjct: 265 WSLGVCMYEMLYGETPFY 282

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 12/145 (8%)
Query: 26  LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI 85
           L KY++  R   +      +  L++Q+  G+ +      +HRDL   N+L+  +    KI
Sbjct: 456 LNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KI 510
Query: 86  ADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-- 140
           +D GL++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +  
Sbjct: 511 SDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYG 569
Query: 141 -KTALFPGDSELQQLLHIFRLLGTP 164
            K       SE+  +L     +G P
Sbjct: 570 QKPYRGMKGSEVTAMLEKGERMGCP 594

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 26  LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI 85
           L KY++  R    ++    +  L++Q+  G+ +      +HRDL   N+L+  +    KI
Sbjct: 457 LNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KI 511
Query: 86  ADLGLARAFTLPIKKYTHEILTLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-- 140
           +D GL++A       Y  +    W   + APE  +    +S+  D+WS   +  E  +  
Sbjct: 512 SDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYG 570
Query: 141 -KTALFPGDSELQQLLHIFRLLGTP 164
            K       SE+  +L     +G P
Sbjct: 571 QKPYRGMKGSEVTAMLEKGERMGCP 595

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK- 100
           + T+     Q+ +G+ +      +HRDL   NLL+  + + +KI D GL RA  LP    
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRA--LPQNDD 166
Query: 101 ----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
                 H  +   + APE L   T +S A D W       E+ T
Sbjct: 167 HXVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 2/49 (4%)
Query: 42  VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL 90
           VN  + +  ++ KG+ + H  GILH+DLK  N+  D   +   I D GL
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVV--ITDFGL 175

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 28/132 (21%)
Query: 25  DLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM 81
           DL  ++ + R  GEN   +P+ T+   M  +  G+ +      +HRDL   N ++  + M
Sbjct: 117 DLHAFLLASR-IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDM 174
Query: 82  TLKIADLGLAR------------AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
           T+ +AD GL+R            A  LP+K    E            L    Y+   D+W
Sbjct: 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES-----------LADNLYTVHSDVW 223
Query: 130 SVACIFAELVTK 141
           +      E++T+
Sbjct: 224 AFGVTMWEIMTR 235

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	235
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-142
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-141
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-140
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-138
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-138
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-137
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-137
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-137
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-136
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-135
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-134
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-132
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-126
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-122
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-120
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-119
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-111
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-110
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-103
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-88
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-83
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-80
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-80
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-79
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-79
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-78
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-78
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-72
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-71
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-71
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-71
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-49
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-47
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-47
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-45
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-44
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-44
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-44
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-44
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-43
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-43
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-38
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-36
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-36
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-36
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-35
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-35
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-35
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-35
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-34
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-33
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-33
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-32
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-32
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-32
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-32
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-32
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-31
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-31
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-30
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-30
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-29
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-28
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-27
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-25
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-25
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-14
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-14
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-13
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-13
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-13
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-13
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-13
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-13
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-12
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-12
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-12
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-12
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-11
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-11
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-11
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-10
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-09
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  396 bits (1019), Expect = e-141
 Identities = 113/234 (48%), Positives = 156/234 (66%), Gaps = 11/234 (4%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +DV   +       L LVFE+M+ DLKK +   +     +  + +K  +YQL +GVA CH
Sbjct: 85  IDVIHSERC-----LTLVFEFMEKDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCH 136

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ILHRDLKP NLL++     LK+AD GLARAF +P++ YTHE++TLWYRAP+VL+GS 
Sbjct: 137 QHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            YST+VD+WS+ CIFAE++T   LFPG ++  QL  IF +LGTPN + WP V  L  W +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 181 --YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             +  +  +  ++ +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DLD 
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  393 bits (1012), Expect = e-140
 Identities = 116/232 (50%), Positives = 157/232 (67%), Gaps = 10/232 (4%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV   + +     L LVFE++D DLKK +         +   T KS + QL  G+A+CH
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH 117

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
              +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP+VL+GS 
Sbjct: 118 DRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
            YST +D+WSV CIFAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+ L  +  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
            +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  389 bits (1002), Expect = e-138
 Identities = 97/233 (41%), Positives = 143/233 (61%), Gaps = 6/233 (2%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ++HRDLKP N+L+      +K+AD GLAR ++  +   T  ++TLWYRAPEVLL S+
Sbjct: 138 SHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS 195

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP-RQA 253

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
           +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ 
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  388 bits (998), Expect = e-138
 Identities = 111/234 (47%), Positives = 149/234 (63%), Gaps = 11/234 (4%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            DV     K     L LVFE+ D DLKKY  S      ++    VKS ++QL KG+ FCH
Sbjct: 67  HDVLHSDKK-----LTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
              +LHRDLKP NLL++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P+VL G+ 
Sbjct: 119 SRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 121 HYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
            YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP ++ L ++ 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 180 EYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
            YP +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D   
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  388 bits (999), Expect = e-137
 Identities = 87/220 (39%), Positives = 133/220 (60%), Gaps = 4/220 (1%)

Query: 11  GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
            ++ + LVF++M+TDL+  I+        +  + +K+ M    +G+ + H H ILHRDLK
Sbjct: 83  HKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P+NLL+D     LK+AD GLA++F  P + YTH+++T WYRAPE+L G+  Y   VDMW+
Sbjct: 140 PNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP + SL ++  +  +    L 
Sbjct: 199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 258

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                   D LDL++ +  ++P  RI+A +A++  YF + 
Sbjct: 259 HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  386 bits (995), Expect = e-137
 Identities = 100/231 (43%), Positives = 140/231 (60%), Gaps = 6/231 (2%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           MDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM Q  +G+ F H
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 137

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            + I+HRDLKP N+L+     T+K+AD GLAR ++  +   T  ++TLWYRAPEVLL ST
Sbjct: 138 ANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQST 195

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   SL     
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL-PRGA 253

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y    +
Sbjct: 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  386 bits (994), Expect = e-137
 Identities = 109/234 (46%), Positives = 154/234 (65%), Gaps = 11/234 (4%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            D+   +       L LVFEY+D DLK+Y+      G  I ++ VK  ++QL +G+A+CH
Sbjct: 66  HDIIHTEKS-----LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
              +LHRDLKP NLL++ +   LK+AD GLARA ++P K Y +E++TLWYR P++LLGST
Sbjct: 118 RQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH- 179
            YST +DMW V CIF E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ S   +  
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 180 -EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             YP++  ++L +  P LD DG DLL ++LQ++   RISA+ AM+HP+F  L +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  383 bits (986), Expect = e-136
 Identities = 120/237 (50%), Positives = 162/237 (68%), Gaps = 15/237 (6%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
             V    ++     L+L+FEY + DLKKY+        ++ +  +KS +YQL  GV FCH
Sbjct: 99  KSVIHHNHR-----LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH 149

Query: 61  GHGILHRDLKPHNLLMDR----KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
               LHRDLKP NLL+      +T  LKI D GLARAF +PI+++THEI+TLWYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
           LGS HYST+VD+WS+ACI+AE++ KT LFPGDSE+ QL  IF +LG P++  WPGV++L 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269

Query: 177 NWHE-YPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
           +W + +P++  ++L   +   LD +GLDLL  ML+ DP KRISAK A+EHPYF   D
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  382 bits (984), Expect = e-135
 Identities = 107/240 (44%), Positives = 155/240 (64%), Gaps = 14/240 (5%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAF 58
            DV   +NK     L LVFE+MD DLKKY+  R+   T   + +N VK   +QL +G+AF
Sbjct: 69  YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 59  CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 118
           CH + ILHRDLKP NLL++++   LK+ D GLARAF +P+  ++ E++TLWYRAP+VL+G
Sbjct: 124 CHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182

Query: 119 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
           S  YST++D+WS  CI AE++T   LFPG ++ +QL  IF ++GTPNE +WP V+ L  +
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 179 H-EYPQWNPQSLATAV-----PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           +    Q  P+ L   +       LD + +D L  +LQ +P  R+SAK+A+ HP+F +   
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  379 bits (975), Expect = e-134
 Identities = 76/221 (34%), Positives = 127/221 (57%), Gaps = 7/221 (3%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L+LVFEY D  +   +  +++    +P + VKS+ +Q  + V FCH H  +HRD+KP N+
Sbjct: 77  LHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+ + +  +K+ D G AR  T P   Y  E+ T WYR+PE+L+G T Y   VD+W++ C+
Sbjct: 134 LITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ---SLAT 191
           FAEL++   L+PG S++ QL  I + LG    +     S+   +      +P+    L  
Sbjct: 193 FAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             PN+    L LL+  L  DP++R++ ++ + HPYF+++ +
Sbjct: 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  374 bits (962), Expect = e-132
 Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 7/220 (3%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLVFE++D  +   +  F      +    V+  ++Q+  G+ FCH H I+HRD+KP N+
Sbjct: 99  WYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+ +    +K+ D G AR    P + Y  E+ T WYRAPE+L+G   Y  AVD+W++ C+
Sbjct: 156 LVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL 214

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH--EYPQWNP-QSLAT 191
             E+     LFPGDS++ QL HI   LG    +     +    +     P+    + L  
Sbjct: 215 VTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
             P L +  +DL ++ L  DP KR    + + H +F    
Sbjct: 275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  360 bits (927), Expect = e-126
 Identities = 80/224 (35%), Positives = 134/224 (59%), Gaps = 2/224 (0%)

Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           +K+    L LV EY+   + +  R + +  + +P+  +K  MYQL + +A+ H  GI HR
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL+D  +  LK+ D G A+      +     I + +YRAPE++ G+T+Y+T +D
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSRYYRAPELIFGATNYTTNID 224

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS  C+ AEL+    LFPG+S + QL+ I ++LGTP+ +    ++     H++PQ  P 
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284

Query: 188 SLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
             +    P    D +DL+ ++L+Y PS R++A +A+ HP+FD+L
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  349 bits (899), Expect = e-122
 Identities = 75/234 (32%), Positives = 127/234 (54%), Gaps = 12/234 (5%)

Query: 4   KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           K       +  +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + 
Sbjct: 88  KASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK 144

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGS 119
           ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +YT+ ++TLWYR PE+LLG 
Sbjct: 145 ILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
             Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +   + 
Sbjct: 204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 263

Query: 180 EY--PQWNPQSLATAVPNL--DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           +    +   + +   +     D   LDL++++L  DP++RI +  A+ H +F  
Sbjct: 264 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  346 bits (890), Expect = e-120
 Identities = 82/248 (33%), Positives = 130/248 (52%), Gaps = 30/248 (12%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           ++L+F+Y + DL   I+  R +  N     +P   VKSL+YQ+  G+ + H + +LHRDL
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154

Query: 70  KPHNLLMDR---KTMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYS 123
           KP N+L+     +   +KIAD+G AR F  P+K        ++T WYRAPE+LLG+ HY+
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLGTPNEKVWPGVSS 174
            A+D+W++ CIFAEL+T   +F    E           QL  IF ++G P +K W  +  
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 274

Query: 175 LMNWHE-YPQWNPQS---------LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           +         +   +         +       D     LL+++L  DP KRI++++AM+ 
Sbjct: 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334

Query: 225 PYFDDLDK 232
           PYF +   
Sbjct: 335 PYFLEDPL 342

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  345 bits (886), Expect = e-119
 Identities = 74/224 (33%), Positives = 124/224 (55%), Gaps = 2/224 (0%)

Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
            K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HR
Sbjct: 121 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T Y++++D
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPELIFGATDYTSSID 239

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ    
Sbjct: 240 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299

Query: 188 SLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                  P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  323 bits (830), Expect = e-111
 Identities = 81/226 (35%), Positives = 132/226 (58%), Gaps = 2/226 (0%)

Query: 8   NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           N      L ++ EY+   L K ++SF ++G +IP+N +   +YQL + V F H  GI HR
Sbjct: 106 NPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+KP NLL++ K  TLK+ D G A+    P +     I + +YRAPE++LG+T Y+ ++D
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEPSVAYICSRFYRAPELMLGATEYTPSID 224

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS+ C+F EL+    LF G++ + QL+ I +++GTP ++    ++       +P    +
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 188 SLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                +P       +DLLEQ+L+Y+P  RI+  +AM HP+FD L  
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  319 bits (820), Expect = e-110
 Identities = 74/222 (33%), Positives = 119/222 (53%), Gaps = 7/222 (3%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILHRDLKPH 72
           L +V EY+   L +  R++ +     P   +K  ++QL + +   H     + HRD+KPH
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L++    TLK+ D G A+  + P +     I + +YRAPE++ G+ HY+TAVD+WSV 
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP----QS 188
           CIFAE++    +F GD+   QL  I R+LG P+ +V   ++      +            
Sbjct: 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            +       K+  DLL  +LQY P +R+   +A+ HPYFD+L
Sbjct: 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  301 bits (772), Expect = e-103
 Identities = 66/229 (28%), Positives = 123/229 (53%), Gaps = 19/229 (8%)

Query: 15  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             LVFE+  +TD K+  ++            ++  MY++ K + +CH  GI+HRD+KPHN
Sbjct: 108 PALVFEHVNNTDFKQLYQTL-------TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   L++ D GLA  F  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C
Sbjct: 161 VMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 219

Query: 134 IFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNPQS 188
           + A ++  K   F G     QL+ I ++LGT +   +    ++     +     + + + 
Sbjct: 220 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 279

Query: 189 LATAVPN-----LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
               V +     +  + LD L+++L+YD   R++A++AMEHPYF  + K
Sbjct: 280 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  267 bits (683), Expect = 4e-88
 Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 68/292 (23%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +D+   ++ E    LY+V E  D+D KK  R+       +    +K+L+Y L  GV + H
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH 173

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-------------------- 100
             GILHRDLKP N L++ +  ++K+ D GLAR    P                       
Sbjct: 174 SAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 101 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT----------- 142
                   T  ++T WYRAPE++L   +Y+ A+D+WS+ CIFAEL+              
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292

Query: 143 ALFPGDS--------------------ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY- 181
            LFPG S                       QL  IF +LGTP+E+    +    +   Y 
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK-EDAKRYI 351

Query: 182 ---PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              P+     LA   P    D + LL++ML ++P+KRI+  + + HP+F ++
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  250 bits (640), Expect = 2e-83
 Identities = 73/221 (33%), Positives = 120/221 (54%), Gaps = 10/221 (4%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V EYM+TDL   +       E+      +  MYQL +G+ + H   +LHRDLKP NL
Sbjct: 97  VYIVQEYMETDLANVLEQGPLLEEHA-----RLFMYQLLRGLKYIHSANVLHRDLKPANL 151

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            ++ + + LKI D GLAR            +  ++T WYR+P +LL   +Y+ A+DMW+ 
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH--EYPQWNPQSL 189
            CIFAE++T   LF G  EL+Q+  I   +   +E+    + S++  +         + L
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              +P + ++ +D LEQ+L + P  R++A++A+ HPY    
Sbjct: 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  243 bits (623), Expect = 3e-80
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 9/234 (3%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            D+     +     LYLV E M TDL + I   R          ++  MY +  G+   H
Sbjct: 95  RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ---HIQYFMYHILLGLHVLH 151

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
             G++HRDL P N+L+      + I D  LAR  T      TH +   WYRAPE+++   
Sbjct: 152 EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFK 209

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW-- 178
            ++  VDMWS  C+ AE+  + ALF G +   QL  I  ++GTP  +     SS      
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269

Query: 179 --HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
             +       ++    VP  D   LDL+ +ML+++P +RIS ++A+ HPYF+ L
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  243 bits (622), Expect = 5e-80
 Identities = 81/223 (36%), Positives = 126/223 (56%), Gaps = 14/223 (6%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V + M+TDL K +++   + ++I        +YQ+ +G+ + H   +LHRDLKP NL
Sbjct: 105 VYIVQDLMETDLYKLLKTQHLSNDHI-----CYFLYQILRGLKYIHSANVLHRDLKPSNL 159

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L++  T  LKI D GLAR            T  + T WYRAPE++L S  Y+ ++D+WSV
Sbjct: 160 LLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNPQ 187
            CI AE+++   +FPG   L QL HI  +LG+P+++    + + +    Y    P  N  
Sbjct: 219 GCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-LKARNYLLSLPHKNKV 277

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 PN D   LDLL++ML ++P KRI  ++A+ HPY +  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  240 bits (616), Expect = 3e-79
 Identities = 84/236 (35%), Positives = 122/236 (51%), Gaps = 32/236 (13%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y++ E M TDL + I +   + ++I     +  +YQ  + V   HG  ++HRDLKP NL
Sbjct: 89  VYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY----------THEILTLWYRAPEVLLGSTHYST 124
           L++     LK+ D GLAR                      + T WYRAPEV+L S  YS 
Sbjct: 144 LIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP----------NEKVWPGVSS 174
           A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP          + +    + S
Sbjct: 203 AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262

Query: 175 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           L      P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY    
Sbjct: 263 L------PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  241 bits (616), Expect = 4e-79
 Identities = 83/220 (37%), Positives = 122/220 (55%), Gaps = 14/220 (6%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  +M TDL K ++  +   + I     + L+YQ+ KG+ + H  GI+HRDLKP NL
Sbjct: 105 FYLVMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +   T  ++T WYRAPEV+L    Y+  VD+WSV CI
Sbjct: 160 AVN-EDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 215

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNPQSLA 190
            AE++T   LF G   L QL  I ++ GTP  +    + S      Y    P+   +  A
Sbjct: 216 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS-DEAKNYMKGLPELEKKDFA 274

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           + + N     ++LLE+ML  D  +R++A +A+ HPYF+ L
Sbjct: 275 SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  239 bits (611), Expect = 2e-78
 Identities = 82/219 (37%), Positives = 118/219 (53%), Gaps = 12/219 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++  + T +++     + L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQILRGLKYIHSADIIHRDLKPSNL 163

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   + T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 164 AVN-EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---HEYPQWNPQSLAT 191
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS           Q    + A 
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 279

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                +   +DLLE+ML  D  KRI+A +A+ H YF   
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  237 bits (608), Expect = 4e-78
 Identities = 80/220 (36%), Positives = 116/220 (52%), Gaps = 15/220 (6%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YLV  +M TDL+K +              ++ L+YQ+ KG+ + H  G++HRDLKP NL
Sbjct: 104 FYLVMPFMQTDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++ +   LKI D GLAR     +  Y   ++T WYRAPEV+L   HY+  VD+WSV CI
Sbjct: 158 AVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNPQSLA 190
            AE++T   LF G   L QL  I ++ G P  +    ++       Y    PQ   +   
Sbjct: 214 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND-KAAKSYIQSLPQTPRKDFT 272

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              P       DLLE+ML+ D  KR++A +A+ HP+F+  
Sbjct: 273 QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  224 bits (574), Expect = 2e-72
 Identities = 82/256 (32%), Positives = 126/256 (49%), Gaps = 46/256 (17%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVF+YM+TDL   IR+      +      + ++YQL K + + H  G+LHRD+KP N+
Sbjct: 86  VYLVFDYMETDLHAVIRANILEPVHK-----QYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---------------------THEILTLWYRAP 113
           L++     +K+AD GL+R+F    +                       T  + T WYRAP
Sbjct: 141 LLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP--------- 164
           E+LLGST Y+  +DMWS+ CI  E++    +FPG S + QL  I  ++  P         
Sbjct: 200 EILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQ 259

Query: 165 NEKVWPGVSSL--------MNWHEYPQWNPQSLATAVPNLDK--DGLDLLEQMLQYDPSK 214
           +      + SL         N  +        L    P  D   + LDLL+++LQ++P+K
Sbjct: 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319

Query: 215 RISAKKAMEHPYFDDL 230
           RISA  A++HP+    
Sbjct: 320 RISANDALKHPFVSIF 335

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  224 bits (573), Expect = 1e-71
 Identities = 75/230 (32%), Positives = 109/230 (47%), Gaps = 23/230 (10%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 142 VYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++     TLKI D GLAR         T  ++T +YRAPEV+L    Y   VD+WSV CI
Sbjct: 196 VVK-SDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCI 252

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL-------------MNWHE- 180
             E+V    LFPG   + Q   +   LGTP  +    +                + + + 
Sbjct: 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           +P     + +           DLL +ML  DP+KRIS   A++HPY +  
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  221 bits (566), Expect = 1e-71
 Identities = 75/230 (32%), Positives = 110/230 (47%), Gaps = 23/230 (10%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E MD +L + I+      E +       L+YQ+  G+   H  GI+HRDLKP N+
Sbjct: 105 VYIVMELMDANLCQVIQM-ELDHERM-----SYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           ++     TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+WSV CI
Sbjct: 159 VVK-SDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCI 215

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL-------------MNWHE- 180
             E++    LFPG   + Q   +   LGTP  +    +                 ++ + 
Sbjct: 216 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 275

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           +P     + +           DLL +ML  D SKRIS  +A++HPY +  
Sbjct: 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  223 bits (570), Expect = 2e-71
 Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 62/285 (21%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAF 58
            D+    +      LY+V E  D+DLKK  ++       I +    +K+++Y L  G  F
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHIKTILYNLLLGENF 144

Query: 59  CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----------------- 101
            H  GI+HRDLKP N L++ +  ++K+ D GLAR                          
Sbjct: 145 IHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 102 -----THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-----------KTALF 145
                T  ++T WYRAPE++L   +Y+ ++D+WS  CIFAEL+            +  LF
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 146 PGDSELQ-----------------QLLHIFRLLGTPNEKVWPGVSSLMNW---HEYPQWN 185
           PG S                    QL  IF ++GTP E     ++          +P   
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           P +L    P++  DG++LLE ML+++P+KRI+  +A++HPY  D+
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  164 bits (417), Expect = 9e-49
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 38/245 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN- 73
           + + FE +  +L + I+  +  G    +  V+   + + + +   H + I+H DLKP N 
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           LL  +    +K+ D G +      +  Y   I + +YRAPEV+LG   Y   +DMWS+ C
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYEHQRVYTY---IQSRFYRAPEVILG-ARYGMPIDMWSLGC 287

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV------------------WPGVSSL 175
           I AEL+T   L PG+ E  QL  +  LLG P++K+                  +  V++L
Sbjct: 288 ILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTL 347

Query: 176 MNWHEY------------PQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAM 222
            +                     +    A+   D     D L+Q L++DP+ R++  +A+
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407

Query: 223 EHPYF 227
            HP+ 
Sbjct: 408 RHPWL 412

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  161 bits (408), Expect = 5e-48
 Identities = 74/250 (29%), Positives = 107/250 (42%), Gaps = 54/250 (21%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLL 75
           +VFE +  +L   I+ +   G  IP+  VK +  QL  G+ + H   GI+H D+KP N+L
Sbjct: 107 MVFEVLGENLLALIKKYEHRG--IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164

Query: 76  MD-----RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           M+        + +KIADLG A       + YT+ I T  YR+PEVLLG+  +    D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWS 220

Query: 131 VACIFAELVTKTALFPGDS------ELQQLLHIFRLLGTP-------------------- 164
            AC+  EL+T   LF  D       +   +  I  LLG                      
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280

Query: 165 -----NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
                  K WP    L   +++ +   + +            D L  MLQ DP KR  A 
Sbjct: 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEI-----------SDFLSPMLQLDPRKRADAG 329

Query: 220 KAMEHPYFDD 229
             + HP+  D
Sbjct: 330 GLVNHPWLKD 339

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  157 bits (398), Expect = 4e-47
 Identities = 54/231 (23%), Positives = 83/231 (35%), Gaps = 43/231 (18%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
                +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DL
Sbjct: 98  ITDQYIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTH------ 121
           KP N L+      LK+ D G+A            +    T+ Y  PE +   +       
Sbjct: 154 KPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211

Query: 122 ----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
                S   D+WS+ CI   +      F         LH           + P       
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------AIIDPN------ 256

Query: 178 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
            HE                +KD  D+L+  L+ DP +RIS  + + HPY  
Sbjct: 257 -HEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  158 bits (401), Expect = 8e-47
 Identities = 74/252 (29%), Positives = 104/252 (41%), Gaps = 45/252 (17%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDLKPH 72
           L LVFE +  +L   +R+    G  + +N  +    Q+C  + F       I+H DLKP 
Sbjct: 131 LCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188

Query: 73  N-LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           N LL + K   +KI D G +      I +Y   I + +YR+PEVLLG   Y  A+DMWS+
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYRSPEVLLGMP-YDLAIDMWSL 244

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN-------------------------- 165
            CI  E+ T   LF G +E+ Q+  I  +LG P                           
Sbjct: 245 GCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKK 304

Query: 166 ------EKVWPGVSSLMN----WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
                 E   PG   L N        P       +           DL+ +ML YDP  R
Sbjct: 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364

Query: 216 ISAKKAMEHPYF 227
           I    A++H +F
Sbjct: 365 IQPYYALQHSFF 376

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  153 bits (390), Expect = 2e-45
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 40/252 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN- 73
           + +VFE +      +I+          ++ ++ + YQ+CK V F H + + H DLKP N 
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENI 149

Query: 74  LLMDRKTMTLKIADLGLARAFTLP--IK-------KYTHE-----ILTLWYRAPEVLLGS 119
           L +           +       +   IK        Y  E     + T  YRAPEV+L  
Sbjct: 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA- 208

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV----------- 168
             +S   D+WS+ CI  E      +FP     + L  + R+LG   + +           
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268

Query: 169 -----WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDG---LDLLEQMLQYDPSKRISAKK 220
                W   SS      Y     + L   + + D +     DL+++ML+YDP+KRI+ ++
Sbjct: 269 HDRLDWDEHSSAG---RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325

Query: 221 AMEHPYFDDLDK 232
           A++HP+FD L K
Sbjct: 326 ALKHPFFDLLKK 337

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  153 bits (388), Expect = 3e-45
 Identities = 55/226 (24%), Positives = 87/226 (38%), Gaps = 43/226 (19%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DLKP N 
Sbjct: 84  IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTH----------Y 122
           L+      LK+ D G+A            +    T+ Y  PE +   +            
Sbjct: 140 LIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
           S   D+WS+ CI   +      F         LH    +  PN ++           E+P
Sbjct: 198 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEI-----------EFP 243

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
                         +KD  D+L+  L+ DP +RIS  + + HPY  
Sbjct: 244 DI-----------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  153 bits (388), Expect = 3e-45
 Identities = 38/236 (16%), Positives = 68/236 (28%), Gaps = 27/236 (11%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVA 57
             +  GQ+        L+      DL+    +            +  +  L  QL +  A
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208

Query: 58  FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 117
                G++H    P NL +      L + D+           +     + + Y   E L 
Sbjct: 209 NLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALWKVG---TRGPASSVPVTYAPREFLN 264

Query: 118 GSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
            ST  ++ A++ W +      +      F   +   +       L  P        S   
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS--- 321

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                              L      L+ + L +D  +R+   +AME P F  L  
Sbjct: 322 ----------------CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  153 bits (387), Expect = 1e-44
 Identities = 55/232 (23%), Positives = 86/232 (37%), Gaps = 45/232 (19%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
                +Y+V E  + DL  +++  +    +I     KS    + + V   H HGI+H DL
Sbjct: 126 ITDQYIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181

Query: 70  KPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRAPEVLLGSTH----- 121
           KP N L+      LK+ D G+A      T  + K +  +  + Y  PE +   +      
Sbjct: 182 KPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQ-VGAVNYMPPEAIKDMSSSRENG 238

Query: 122 -----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
                 S   D+WS+ CI   +      F         LH           + P      
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------AIIDPN----- 284

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
             HE                +KD  D+L+  L+ DP +RIS  + + HPY  
Sbjct: 285 --HEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  152 bits (386), Expect = 3e-44
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 40/234 (17%)

Query: 10  EGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           + R   Y+  E     L++Y+  + F   G         +L+ Q   G+A  H   I+HR
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----ITLLQQTTSGLAHLHSLNIVHR 142

Query: 68  DLKPHNLLMDRK----TMTLKIADLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGST 120
           DLKPHN+L+        +   I+D GL +   +    ++       T  + APE+L    
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 121 H--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
               +  VD++S  C+F  ++++ +   G S  +Q      LLG  +      +  L   
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANILLGACS------LDCLHPE 253

Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                           + D    +L+E+M+  DP KR SAK  ++HP+F  L+K
Sbjct: 254 ---------------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  150 bits (382), Expect = 3e-44
 Identities = 48/254 (18%), Positives = 88/254 (34%), Gaps = 48/254 (18%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           L+FE +   L + I      G    +  +K    ++ K + +     + H DLKP N+L+
Sbjct: 113 LIFEPLGPSLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170

Query: 77  DRKTMTLKIADLGLARAFTLPIKK----------------YTHEILTLW-----YRAPEV 115
           D       +  +                            +  +          YRAPEV
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEV 230

Query: 116 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV------- 168
           +L    +  + DMWS  C+ AEL T + LF     ++ L  +  ++    + +       
Sbjct: 231 ILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 169 --------------WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK 214
                         WP  +S +      +   + L        +   D L  +LQ DP+ 
Sbjct: 290 NGSKYVNKDELKLAWPENASSI---NSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346

Query: 215 RISAKKAMEHPYFD 228
           R S  + ++H + +
Sbjct: 347 RPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  150 bits (381), Expect = 4e-44
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 56/256 (21%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM 76
           + FE +  +  ++++         P+  V+ + YQLC  + F H + + H DLKP N+L 
Sbjct: 99  IAFELLGKNTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156

Query: 77  ------------------DRKTMTLKIADLGLARAFTLPIKKYTHE-----ILTLWYRAP 113
                               K  ++++AD G A         + HE     + T  YR P
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--------TFDHEHHTTIVATRHYRPP 208

Query: 114 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV----- 168
           EV+L    ++   D+WS+ CI  E      LF      + L+ + ++LG     +     
Sbjct: 209 EVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTR 267

Query: 169 -----------WPGVSSLMNWHEYPQWNPQSLATAVPNLDKD---GLDLLEQMLQYDPSK 214
                      W   SS      Y + N + L + +     +     DL+ +ML++DP++
Sbjct: 268 KQKYFYKGGLVWDENSSD---GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324

Query: 215 RISAKKAMEHPYFDDL 230
           RI+  +A+ HP+F  L
Sbjct: 325 RITLAEALLHPFFAGL 340

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  147 bits (372), Expect = 3e-43
 Identities = 50/241 (20%), Positives = 91/241 (37%), Gaps = 45/241 (18%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
            VK     + ++ L++  EY +   L   I S      N   +    L  Q+ + +++ H
Sbjct: 77  FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH 133

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-------------- 106
             GI+HRDLKP N+ +D ++  +KI D GLA+     +     +                
Sbjct: 134 SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192

Query: 107 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
           T  Y A EVL G+ HY+  +DM+S+  IF E++       G   +  L  +  +      
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPP 250

Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                   +                           ++  ++ +DP+KR  A+  +   +
Sbjct: 251 DFDDNKMKVEK------------------------KIIRLLIDHDPNKRPGARTLLNSGW 286

Query: 227 F 227
            
Sbjct: 287 L 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  150 bits (380), Expect = 3e-43
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 47/248 (18%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLMYQLCKGVAFCHGHGILH 66
                LY+  E  + +L+  + S   + EN+ +       SL+ Q+  GVA  H   I+H
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138

Query: 67  RDLKPHNLLMDRKTMT------------LKIADLGLARAFTLPIKKYTHEIL----TLWY 110
           RDLKP N+L+   +              + I+D GL +        +   +     T  +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 111 RAPEVLLGSTH------YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
           RAPE+L  S +       + ++D++S+ C+F  +++K    P   +  +  +I R     
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-GKHPFGDKYSRESNIIR----- 252

Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                 G+ SL    +              +L  +  DL+ QM+ +DP KR +A K + H
Sbjct: 253 ------GIFSLDEM-KCLHD---------RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

Query: 225 PYFDDLDK 232
           P F    K
Sbjct: 297 PLFWPKSK 304

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (348), Expect = 2e-39
 Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 45/243 (18%)

Query: 1   MDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 59
             V Q Q    +  LY+  +     +LK ++   R + E+        +  Q+ + V F 
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILT 107
           H  G++HRDLKP N+        +K+ D GL  A                   +T ++ T
Sbjct: 181 HSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 108 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 167
             Y +PE + G  +YS  VD++S+  I  EL+     F    E  +++   R        
Sbjct: 240 KLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR------NL 289

Query: 168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            +P + +     +YPQ +                 +++ ML   P++R  A   +E+  F
Sbjct: 290 KFPLLFT----QKYPQEH----------------MMVQDMLSPSPTERPEATDIIENAIF 329

Query: 228 DDL 230
           ++L
Sbjct: 330 ENL 332

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (342), Expect = 6e-39
 Identities = 55/243 (22%), Positives = 93/243 (38%), Gaps = 45/243 (18%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
             ++ Q    +  LY+  +     +LK ++   R T E    +    +  Q+ + V F H
Sbjct: 77  TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLH 135

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTL 108
             G++HRDLKP N+        +K+ D GL  A                  ++T ++ T 
Sbjct: 136 SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194

Query: 109 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
            Y +PE + G+  YS  VD++S+  I  EL+     F    E  + L   R L  P   +
Sbjct: 195 LYMSPEQIHGN-SYSHKVDIFSLGLILFELLYP---FSTQMERVRTLTDVRNLKFP--PL 248

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
           +                                 +++ ML   P +R  A   +E+  F+
Sbjct: 249 FTQKYPCEY------------------------VMVQDMLSPSPMERPEAINIIENAVFE 284

Query: 229 DLD 231
           DLD
Sbjct: 285 DLD 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (338), Expect = 4e-38
 Identities = 51/213 (23%), Positives = 77/213 (36%), Gaps = 36/213 (16%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           LYL  E     L+++       G ++P   V   +      +A  H  G++H D+KP N+
Sbjct: 132 LYLQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            +       K+ D GL             E     Y APE+L GS  Y TA D++S+   
Sbjct: 189 FLG-PRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGS--YGTAADVFSLGLT 244

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+     L  G    QQL       G    +   G+SS                    
Sbjct: 245 ILEVACNMELPHGGEGWQQLRQ-----GYLPPEFTAGLSS-------------------- 279

Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               +   +L  ML+ DP  R +A+  +  P  
Sbjct: 280 ----ELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (335), Expect = 5e-38
 Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 38/225 (16%)

Query: 4   KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
            +  ++     L++  E+ D   L+++I   ++ GE +       L  Q+ KGV + H  
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGVDYIHSK 141

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
            +++RDLKP N+ +   T  +KI D GL  +     K+      TL Y +PE +     Y
Sbjct: 142 KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRS-KGTLRYMSPEQISSQ-DY 198

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              VD++++  I AEL+         S+    L         +  +              
Sbjct: 199 GKEVDLYALGLILAELLHVCDTAFETSKFFTDL--------RDGIISDIFDKKEK----- 245

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                               LL+++L   P  R +  + +     
Sbjct: 246 -------------------TLLQKLLSKKPEDRPNTSEILRTLTV 271

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (336), Expect = 7e-38
 Identities = 38/231 (16%), Positives = 74/231 (32%), Gaps = 26/231 (11%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             L+ E+     L   +         +P +    ++  +  G+     +GI+HR++KP N
Sbjct: 84  KVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142

Query: 74  LLMDR---KTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGST----- 120
           ++           K+ D G AR           E       T  Y  P++   +      
Sbjct: 143 IMRVIGEDGQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPDMYERAVLRKDH 196

Query: 121 --HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPNEKVWPGVSSLM 176
              Y   VD+WS+   F    T +  F      ++   +    + G P+  +     +  
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
              ++    P S  +    L      +L  +L+ D  K     +       
Sbjct: 257 GPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  131 bits (331), Expect = 2e-37
 Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 35/224 (15%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHG 63
              T LY+V EY +  DL   I    +  + +    V  +M QL   +  CH     GH 
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +LHRDLKP N+ +D     +K+ D GLAR            + T +Y +PE +     Y+
Sbjct: 137 VLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYN 194

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
              D+WS+ C+  EL      F   S+ +    I    G    ++    S  +N      
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF-RRIPYRYSDELN------ 245

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                             +++ +ML      R S ++ +E+P  
Sbjct: 246 ------------------EIITRMLNLKDYHRPSVEEILENPLI 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 6e-37
 Identities = 42/232 (18%), Positives = 82/232 (35%), Gaps = 40/232 (17%)

Query: 7   QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
           + +  +   +L+  +     L   I   +  G  +  + +  L+  +C+G+   H  G  
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156

Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL----------TLWYRAPEV 115
           HRDLKP N+L+  +     + DLG      + ++  + + L          T+ YRAPE+
Sbjct: 157 HRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEG-SRQALTLQDWAAQRCTISYRAPEL 214

Query: 116 LLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
               +H       D+WS+ C+   ++     +    +    + +                
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---------------- 258

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           ++ N    PQ    S              LL  M+  DP +R      +   
Sbjct: 259 AVQNQLSIPQSPRHS---------SALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  132 bits (334), Expect = 1e-36
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            Y+V E M+  +L   +   ++  E     T K   YQ+   V + H +GI+HRDLKP N
Sbjct: 214 YYIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269

Query: 74  LLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMW 129
           +L+  +     +KI D G ++              T  Y APEVL+      Y+ AVD W
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           S+  I    ++    F        L           +++  G  +         W     
Sbjct: 329 SLGVILFICLSGYPPFSEHRTQVSLK----------DQITSGKYNF----IPEVW----- 369

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                 + +  LDL++++L  DP  R + ++A+ HP+  D D  R
Sbjct: 370 ----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  133 bits (337), Expect = 1e-36
 Identities = 66/221 (29%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E     +L   I                 ++ Q+  GV + H H I+HRD
Sbjct: 106 EDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161

Query: 69  LKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K     +KI D GL+  F    KK    + T +Y APEVL     Y    
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPEVLRKK--YDEKC 218

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS+  I   L+     F G ++ + L  + +   T +   W  VS             
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE------------ 266

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                          DL++QMLQ+D  +RISA++A+EHP+ 
Sbjct: 267 ------------GAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  132 bits (334), Expect = 3e-36
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 34/221 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E+ +  +L + I +  +  E        ++M Q+  G+ + H H I+HRD
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDEC----DAANIMKQILSGICYLHKHNIVHRD 171

Query: 69  LKPHNLLMDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           +KP N+L++ K     +KI D GL+  F+    K    + T +Y APEVL     Y+   
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRLGTAYYIAPEVLKKK--YNEKC 228

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L+     F G ++   +  + +     +   W  +S             
Sbjct: 229 DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS------------- 275

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                       +  +L++ ML YD +KR +A++A+   + 
Sbjct: 276 -----------DEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  129 bits (327), Expect = 3e-36
 Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 38/192 (19%)

Query: 46  KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHE 104
            ++M Q+   + + H  GI HRD+KP N L    K+  +K+ D GL++ F        + 
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 105 ILTL----WYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
           + T     ++ APEVL  +   Y    D WS   +   L+     FPG ++         
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD----TIS 286

Query: 160 --LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
             L          +  +S                            DLL  +L  +  +R
Sbjct: 287 QVLNKKLCFENPNYNVLS------------------------PLARDLLSNLLNRNVDER 322

Query: 216 ISAKKAMEHPYF 227
             A +A++HP+ 
Sbjct: 323 FDAMRALQHPWI 334

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  130 bits (327), Expect = 4e-36
 Identities = 36/243 (14%), Positives = 83/243 (34%), Gaps = 50/243 (20%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLK---KYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 58
            V+  +        + ++  M ++L+   + + S   T +++  +    L  Q+ + +A 
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221

Query: 59  CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL-- 116
            H +G++H  L+P ++++D+    + +                    ++  +  PE+   
Sbjct: 222 LHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV----RDGARVVSSVSRGFEPPELEAR 276

Query: 117 --------LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 168
                      T  + + D W++  +   +         D+ L     IFR         
Sbjct: 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR--------- 327

Query: 169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
                                  +  N+ +    LLE  L+Y    R+   +AME P ++
Sbjct: 328 -----------------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364

Query: 229 DLD 231
            L 
Sbjct: 365 QLR 367

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  131 bits (331), Expect = 6e-36
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +   YLV E     +L   I     + +         ++ Q+  G+ + H + I+HRD
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151

Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL++ K+    ++I D GL+  F    KK   +I T +Y APEVL G+  Y    
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIAPEVLHGT--YDEKC 208

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++    F G +E   L  + +   T     W  VS             
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE------------ 256

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                          DL+ +ML Y PS RISA+ A++H + 
Sbjct: 257 ------------SAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (333), Expect = 1e-35
 Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 21/242 (8%)

Query: 2   DVKQGQNK-EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 59
           +V  G  K     +  L  EY +  DL+KY+    +    +    +++L+  +   + + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYL 137

Query: 60  HGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRA 112
           H + I+HRDLKP N+++      +  KI DLG A+           E+      TL Y A
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGELCTEFVGTLQYLA 191

Query: 113 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
           PE+L     Y+  VD WS   +  E +T    F  + +  Q     R     +  V+  +
Sbjct: 192 PELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           +  + +       P  L+  +    +     L+ ML +   +R +  +      F  LD 
Sbjct: 251 TGAVKFSSVLP-TPNHLSGILAGKLE---RWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

Query: 233 TR 234
             
Sbjct: 307 IL 308

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  130 bits (329), Expect = 1e-35
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  +  Y+V E     +L   I   ++  E+        ++ Q+  G+ + H H I+HRD
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHNIVHRD 146

Query: 69  LKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N+L++ K     +KI D GL+  F     K    I T +Y APEVL G+  Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRGT--YDEKC 203

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   I   L++ T  F G +E   L  +       +   W  +S             
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD------------ 251

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                       D  DL+ +ML + PS RI+A + +EHP+ 
Sbjct: 252 ------------DAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  127 bits (320), Expect = 5e-35
 Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 75/281 (26%)

Query: 17  LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLL 75
           +VFE +   L K+I      G  +P+  VK ++ Q+ +G+ + H    I+H D+KP N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 76  M------------------------------------------------DRKTMTLKIAD 87
           +                                                + + + +KIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 88  LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG 147
           LG A       K +T +I T  YR+ EVL+GS  Y+T  D+WS AC+  EL T   LF  
Sbjct: 240 LGNACWVH---KHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEP 295

Query: 148 DSELQ------QLLHIFRLLGTPNEKVWPGVS----------SLMNWHEYPQWNPQSLAT 191
            S  +       +  I  LLG    K+                L +  +   W    +  
Sbjct: 296 HSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV 355

Query: 192 AVPNLDKD----GLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
                 ++      D L  ML+  P KR +A + + HP+ +
Sbjct: 356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (314), Expect = 7e-35
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 31/221 (14%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    +Y+V E  +  +L + I S +  G+ +    V  LM Q+   +A+ H   ++H+D
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKD 149

Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N+L    +    +KI D GLA  F    +  T+   T  Y APEV       +   
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAPEVFKRD--VTFKC 206

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS   +   L+T    F G S  +    +        +K      +        +  P
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEE----VQ-------QKATYKEPNY-----AVECRP 250

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
            +            +DLL+QML  DP +R SA + + H +F
Sbjct: 251 LT---------PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (317), Expect = 8e-35
 Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 32/214 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V +Y +  DL K I    Q G     + +     Q+C  +   H   ILHRD+K  N
Sbjct: 98  LYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +  K  T+++ D G+AR     ++     I T +Y +PE+      Y+   D+W++ C
Sbjct: 156 IFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGC 213

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  EL T    F   S    +L I                       +P  +        
Sbjct: 214 VLYELCTLKHAFEAGSMKNLVLKIIS-------------------GSFPPVSLH------ 248

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                D   L+ Q+ + +P  R S    +E  + 
Sbjct: 249 --YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  126 bits (318), Expect = 8e-35
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 37/230 (16%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
               +LY+VFE+MD  DL   I      G           M Q+ + + +CH + I+HRD
Sbjct: 96  SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155

Query: 69  LKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           +KPH +L+  K  +  +K+   G+A             + T  + APEV+     Y   V
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPV 214

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYP 182
           D+W    I   L++    F G  E      +F   + G      + W  +S         
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHIS--------- 260

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                          +   DL+ +ML  DP++RI+  +A+ HP+  + D+
Sbjct: 261 ---------------ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  125 bits (315), Expect = 9e-35
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 29/214 (13%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V E  D  DL + I+ F++    IP  TV     QLC  +   H   ++HRD+KP N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           + +   T  +K+ DLGL R F+         + T +Y +PE +  +  Y+   D+WS+ C
Sbjct: 167 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGC 224

Query: 134 IFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           +  E+    + F GD   L  L            K+           +YP          
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCK----------KIEQC--------DYPPLPS------ 260

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
             +  ++   L+   +  DP KR       +   
Sbjct: 261 -DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 1e-34
 Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 32/235 (13%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGEN----IPVNTVKSLMYQLCKGVAFCHGH-GILHRD 68
           +Y+++EYM+   + K+   F    +N    IP+  +K ++  +    ++ H    I HRD
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TLWYRAPEVLLGSTHY 122
           +KP N+LMD+    +K++D G +        +Y  +        T  +  PE     + Y
Sbjct: 178 VKPSNILMDKN-GRVKLSDFGES--------EYMVDKKIKGSRGTYEFMPPEFFSNESSY 228

Query: 123 S-TAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPGVSSLMNWHE 180
           +   VD+WS+      +      F     L +L + I           +P   +    H 
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT-----KNIEYPLDRN----HF 279

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
                 +    +   L  + +D L+  L+ +P++RI+++ A++H +  D +   L
Sbjct: 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  122 bits (308), Expect = 5e-34
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 42/225 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  T +YLV E     +L + +   R   E+        +M  +   VA+CH   + HRD
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYCHKLNVAHRD 131

Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N L    +    LK+ D GLA  F  P K    ++ T +Y +P+VL G   Y    
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEGL--YGPEC 188

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYP 182
           D WS   +   L+     F   ++ +    +      GT    EK W  VS         
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREGTFTFPEKDWLNVS--------- 235

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                               L+ ++L   P +RI++ +A+EH +F
Sbjct: 236 ---------------PQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  123 bits (310), Expect = 6e-34
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            Y+V E M+  +L   +   ++  E     T K   YQ+   V + H +GI+HRDLKP N
Sbjct: 89  YYIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144

Query: 74  LLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMW 129
           +L+  +     +KI D G ++              T  Y APEVL+      Y+ AVD W
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 203

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           S+  I    ++    F        L           +++  G  +         W     
Sbjct: 204 SLGVILFICLSGYPPFSEHRTQVSLK----------DQITSGKYNF----IPEVW----- 244

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                 + +  LDL++++L  DP  R + ++A+ HP+  D D  R
Sbjct: 245 ----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 9e-34
 Identities = 38/228 (16%), Positives = 74/228 (32%), Gaps = 26/228 (11%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             L+ E+     L   +         +P +    ++  +  G+     +GI+HR++KP N
Sbjct: 84  KVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142

Query: 74  LLMDR---KTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGST----- 120
           ++           K+ D G AR           E       T  Y  P++   +      
Sbjct: 143 IMRVIGEDGQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPDMYERAVLRKDH 196

Query: 121 --HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPNEKVWPGVSSLM 176
              Y   VD+WS+   F    T +  F      ++   +    + G P+  +     +  
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
              ++    P S  +    L      +L  +L+ D  K     +    
Sbjct: 257 GPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  121 bits (306), Expect = 1e-33
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E  +  Y+V E     +L   I   ++  E+        ++ Q+  G+ + H H I+HRD
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHNIVHRD 146

Query: 69  LKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP N+L++ K     +KI D GL+  F     K    I T +Y APEVL G+  Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRGT--YDEKC 203

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYP 182
           D+WS   I   L++ T  F G +E      I +    G        W  +S         
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTIS--------- 250

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                           D  DL+ +ML + PS RI+A + +EHP
Sbjct: 251 ---------------DDAKDLIRKMLTFHPSLRITATQCLEHP 278

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  122 bits (309), Expect = 1e-33
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 31/191 (16%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTH 103
           + S ++Q+C+ + F H H I H D++P N++   R++ T+KI + G AR    P   +  
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRL 162

Query: 104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 163
                 Y APEV       STA DMWS+  +   L++    F  ++  Q + +I  +   
Sbjct: 163 LFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAE 219

Query: 164 PN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 221
               E+ +  +S                         + +D ++++L  +   R++A +A
Sbjct: 220 YTFDEEAFKEIS------------------------IEAMDFVDRLLVKERKSRMTASEA 255

Query: 222 MEHPYFDDLDK 232
           ++HP+     +
Sbjct: 256 LQHPWLKQKIE 266

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  126 bits (317), Expect = 1e-33
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 39/222 (17%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
           E    + +++E+M   +L + +     + + E+         M Q+CKG+   H +  +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMS-ED----EAVEYMRQVCKGLCHMHENNYVH 278

Query: 67  RDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
            DLKP N++   +++  LK+ D GL      P +       T  + APEV  G       
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEG-KPVGYY 336

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSSLMNWHEYPQ 183
            DMWSV  +   L++  + F G+++ + L ++       N  +  + G+S          
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGIS---------- 384

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                         +DG D + ++L  DP+ R++  +A+EHP
Sbjct: 385 --------------EDGKDFIRKLLLADPNTRMTIHQALEHP 412

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (311), Expect = 1e-33
 Identities = 38/238 (15%), Positives = 79/238 (33%), Gaps = 41/238 (17%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLK---KYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 58
            V+  +        + ++  M ++L+   + + S   T +++  +    L  Q+ + +A 
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226

Query: 59  CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE-ILTLWYRAPEVLL 117
            H +G++H  L+P ++++D+    + +                           A  +L 
Sbjct: 227 LHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285

Query: 118 GSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
              H     + A D W++      +         D+ L     IFR            + 
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS--------CKNI- 336

Query: 174 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 231
                       PQ +             LLE  L+Y    R+   +AME P ++ L 
Sbjct: 337 ------------PQPVR-----------ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  122 bits (307), Expect = 4e-33
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 45/232 (19%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           E +  + LV EY+D         D + Y  +                M Q+C+G+   H 
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIID-ESYNLTELD---------TILFMKQICEGIRHMHQ 205

Query: 62  HGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
             ILH DLKP N+L  +R    +KI D GLAR +  P +K      T  + APEV+    
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVNYD- 263

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
             S   DMWSV  I   L++  + F GD++ + L +I        ++ +  +S       
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS------- 316

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                            ++  + + ++L  + S RISA +A++HP+  D   
Sbjct: 317 -----------------EEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  122 bits (307), Expect = 4e-33
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 27/180 (15%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEI 105
           + M Q C+G+   H H I+H D+KP N++   +K  ++KI D GLA     P +      
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTT 211

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
            T  + APE++          DMW++  +   L++  + F G+ +L+ L ++ R     +
Sbjct: 212 ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           E  +  VS                         +  D ++ +LQ +P KR++   A+EHP
Sbjct: 271 EDAFSSVS------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHP 306

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (302), Expect = 5e-33
 Identities = 58/237 (24%), Positives = 89/237 (37%), Gaps = 58/237 (24%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           E  T  +LVF+ M         T+      S ++T         + +M  L + +   H 
Sbjct: 94  ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKET---------RKIMRALLEVICALHK 142

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-- 119
             I+HRDLKP N+L+D   M +K+ D G +     P +K      T  Y APE++  S  
Sbjct: 143 LNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMN 200

Query: 120 ---THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGV 172
                Y   VDMWS   I   L+  +  F    ++     + R  + G        W   
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRMIMSGNYQFGSPEWDDY 256

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
           S                            DL+ + L   P KR +A++A+ HP+F  
Sbjct: 257 SD------------------------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  120 bits (302), Expect = 1e-32
 Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 34/227 (14%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E RT + L+ E +   +L  ++       E        S + Q+  GV + H   I H D
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVNYLHTKKIAHFD 140

Query: 69  LKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           LKP N+++  K      +K+ D GLA        ++ +   T  + APE++         
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY-EPLGLE 198

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            DMWS+  I   L++  + F GD++ + L +I  +    +E+ +   S            
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS------------ 246

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                       +   D + ++L  +  KR++ ++A+ HP+   +D 
Sbjct: 247 ------------ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  118 bits (299), Expect = 1e-32
 Identities = 38/186 (20%), Positives = 76/186 (40%), Gaps = 33/186 (17%)

Query: 45  VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKY 101
               + Q+  GV + H   I H DLKP N+++   +     +K+ D G+A        ++
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168

Query: 102 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 161
            +   T  + APE++          DMWS+  I   L++  + F G+++ + L +I    
Sbjct: 169 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SA 225

Query: 162 GTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 219
              +  E+ +   S                        +   D + ++L  DP +R++  
Sbjct: 226 VNYDFDEEYFSNTS------------------------ELAKDFIRRLLVKDPKRRMTIA 261

Query: 220 KAMEHP 225
           +++EH 
Sbjct: 262 QSLEHS 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  120 bits (303), Expect = 1e-32
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 58/235 (24%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           E  + ++LVF+ M         T+      S ++T         +S+M  L + V+F H 
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKET---------RSIMRSLLEAVSFLHA 218

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-- 119
           + I+HRDLKP N+L+D   M ++++D G +     P +K      T  Y APE+L  S  
Sbjct: 219 NNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMD 276

Query: 120 ---THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGV 172
                Y   VD+W+   I   L+  +  F    ++     + R  + G        W   
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEGQYQFSSPEWDDR 332

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           SS                           DL+ ++LQ DP  R++A++A++HP+F
Sbjct: 333 SS------------------------TVKDLISRLLQVDPEARLTAEQALQHPFF 363

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  118 bits (299), Expect = 3e-32
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 45/234 (19%)

Query: 10  EGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           E  + + L+ EY          L +         EN     V  L+ Q+ +GV + H + 
Sbjct: 99  ENTSEIILILEYAAGGEIFSLCLPELAEMV---SEN----DVIRLIKQILEGVYYLHQNN 151

Query: 64  ILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           I+H DLKP N+L+        +KI D G++R       +    + T  Y APE+L     
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILNYD-P 209

Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSSLMNWH 179
            +TA DMW++  I   L+T T+ F G+   +  L+I       +  E+ +  VS      
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVDYSEETFSSVS------ 261

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
                             +   D ++ +L  +P KR +A+  + H +    D  
Sbjct: 262 ------------------QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 5e-32
 Identities = 47/232 (20%), Positives = 91/232 (39%), Gaps = 44/232 (18%)

Query: 10  EGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 63
           E +T + L+ E +      D   +K   +  +             + Q+  GV + H   
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEE---------ATEFLKQILNGVYYLHSLQ 134

Query: 64  ILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
           I H DLKP N+++   +     +KI D GLA        ++ +   T  + APE++    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNY-E 192

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
                 DMWS+  I   L++  + F GD++ + L ++  +     ++ +   S       
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS------- 245

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                                D + ++L  DP KR++ + +++HP+    D 
Sbjct: 246 -----------------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (293), Expect = 7e-32
 Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
            T +YL+ EY     + + ++   +  E        + + +L   +++CH   ++HRD+K
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFDEQ----RTATYITELANALSYCHSKRVIHRDIK 136

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDM 128
           P NLL+      LKIAD G +       ++     L  TL Y  PE++ G   +   VD+
Sbjct: 137 PENLLLGSA-GELKIADFGWS-VHAPSSRRTD---LCGTLDYLPPEMIEGRM-HDEKVDL 190

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS+  +  E +     F  ++  +    I R+      +             +P +    
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF-----------TFPDF---- 229

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                  + +   DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 230 -------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  118 bits (297), Expect = 8e-32
 Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 29/188 (15%)

Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHE 104
            + Q+  GV + H   I H DLKP N+++  K      +K+ D GLA        ++ + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
             T  + APE++          DMWS+  I   L++  + F GD++ + L +I  +    
Sbjct: 179 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237

Query: 165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           +E+ +   S                        +   D + ++L  +  KR++ ++A+ H
Sbjct: 238 DEEFFSQTS------------------------ELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 225 PYFDDLDK 232
           P+   +D 
Sbjct: 274 PWITPVDT 281

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 9e-32
 Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 53/231 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +  EY +   L   I    +         +K L+ Q+ +G+ + H   ++H D+KP N
Sbjct: 86  MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145

Query: 74  LLMDRK------------------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 115
           + + R                    +  KI DLG     + P      E     + A EV
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QV-EEGDSRFLANEV 201

Query: 116 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
           L  +  +    D++++A           L     +                         
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------------------------- 236

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
             WHE  Q     +      L ++  +LL+ M+  DP +R SA   ++H  
Sbjct: 237 --WHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  116 bits (292), Expect = 1e-31
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 55/238 (23%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           +  +  YLVF+ +            + Y  S                + Q+ + +A+CH 
Sbjct: 75  QEESFHYLVFDLVTGGELFEDIVAREFY--SEADA---------SHCIQQILESIAYCHS 123

Query: 62  HGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
           +GI+HR+LKP NLL+  K     +K+AD GLA       + +     T  Y +PEVL   
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKD 182

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSL 175
             YS  VD+W+   I   L+     F  + + +    ++     G  +     W  V+  
Sbjct: 183 -PYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVT-- 235

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
                                  +   L++ ML  +P KRI+A +A++ P+  + ++ 
Sbjct: 236 ----------------------PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  116 bits (293), Expect = 2e-31
 Identities = 59/235 (25%), Positives = 88/235 (37%), Gaps = 60/235 (25%)

Query: 10  EGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTVKSLMYQLCKGVAFCHG 61
            G+  L ++ E M          ++  ++F  R+  E         +M  +   + F H 
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE---------IMRDIGTAIQFLHS 146

Query: 62  HGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPE 114
           H I HRD+KP NLL   K     LK+ D G A       K+ T   L     T +Y APE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------KETTQNALQTPCYTPYYVAPE 199

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWP 170
           VL     Y  + DMWS+  I   L+     F  ++       + R   LG        W 
Sbjct: 200 VLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            VS                         D   L+  +L+ DP++R++  + M HP
Sbjct: 259 EVSE------------------------DAKQLIRLLLKTDPTERLTITQFMNHP 289

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  117 bits (296), Expect = 4e-31
 Identities = 54/235 (22%), Positives = 87/235 (37%), Gaps = 64/235 (27%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
                 YL+F+ +            + Y  S                + Q+ + V  CH 
Sbjct: 80  SEEGHHYLIFDLVTGGELFEDIVAREYY--SEADA---------SHCIQQILEAVLHCHQ 128

Query: 62  HGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
            G++HR+LKP NLL+  K     +K+AD GLA       + +     T  Y +PEVL   
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188

Query: 120 THYSTAVDMWSVACIFAELVTKTAL-----FPGDSELQQLLHIFR--LLGTP--NEKVWP 170
             Y   VD+W+   I         L     F  + + +    +++    G        W 
Sbjct: 189 -PYGKPVDLWACGVI-----LYILLVGYPPFWDEDQHR----LYQQIKAGAYDFPSPEWD 238

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            V+                         +  DL+ +ML  +PSKRI+A +A++HP
Sbjct: 239 TVT------------------------PEAKDLINKMLTINPSKRITAAEALKHP 269

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (292), Expect = 5e-31
 Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 65/242 (26%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           +  +  YLVF+ +            + Y  S                + Q+ + +A+CH 
Sbjct: 98  QEESFHYLVFDLVTGGELFEDIVAREFY--SEADA---------SHCIQQILESIAYCHS 146

Query: 62  HGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
           +GI+HR+LKP NLL+  K     +K+AD GLA       + +     T  Y +PEVL   
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKD 205

Query: 120 THYSTAVDMWSVACIFAELVTKTAL-----FPGDSELQQLLHIFR--LLGTPN--EKVWP 170
             YS  VD+W+   I         L     F  + + +    ++     G  +     W 
Sbjct: 206 -PYSKPVDIWACGVI-----LYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWD 255

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
            V+                         +   L++ ML  +P KRI+A +A++ P+  + 
Sbjct: 256 TVT------------------------PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 231 DK 232
           ++
Sbjct: 292 ER 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (287), Expect = 6e-31
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 40/222 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    +YLV E     ++ +Y++      +    N  +  M+Q+  G+ + H HGILHRD
Sbjct: 81  EDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL--TLWYRAPEVLLGSTHYSTA 125
           L   NLL+ R  M +KIAD GLA    +P  K YT   L  T  Y +PE+   S H    
Sbjct: 138 LTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEIATRSAH-GLE 192

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            D+WS+ C+F  L+     F     ++  L           KV      ++  +E P + 
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFD-TDTVKNTL----------NKV------VLADYEMPSF- 234

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     L  +  DL+ Q+L+ +P+ R+S    ++HP+ 
Sbjct: 235 ----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  114 bits (288), Expect = 9e-31
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 25/219 (11%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
             +   +LV E ++  +L + I+  +   E         +M +L   V+  H  G++HRD
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSET----EASYIMRKLVSAVSHMHDVGVVHRD 131

Query: 69  LKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           LKP NLL   +   + +KI D G AR      +       TL Y APE+L  +  Y  + 
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESC 190

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+WS+  I   +++    F              ++    +K+  G  S     E   W  
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----KKIKKGDFSF----EGEAW-- 240

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                   N+ ++  DL++ +L  DP+KR+       + 
Sbjct: 241 -------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (287), Expect = 9e-31
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 41/222 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    +++V E      L +  +  +   E       +  + Q+  G  + H + ++HRD
Sbjct: 85  EDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQIVLGCQYLHRNRVIHRD 140

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL--TLWYRAPEVLLGSTHYSTA 125
           LK  NL ++   + +KI D GLA        +K     L  T  Y APEVL    H S  
Sbjct: 141 LKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGH-SFE 195

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD+WS+ CI   L+     F   S L++             ++        N +  P+  
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFE-TSCLKETY----------LRI------KKNEYSIPKH- 237

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     ++     L+++MLQ DP+ R +  + +   +F
Sbjct: 238 ----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  113 bits (286), Expect = 1e-30
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 46/229 (20%)

Query: 8   NKEGRTVLYLVFEYM---DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 64
             E +  +Y+V EY      ++   +   R      PV        QL  G+ + H  GI
Sbjct: 76  YNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQLIDGLEYLHSQGI 130

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGS 119
           +H+D+KP NLL+     TLKI+ LG+A            +          ++ PE+  G 
Sbjct: 131 VHKDIKPGNLLLTTG-GTLKISALGVAE---ALHPFAADDTCRTSQGSPAFQPPEIANGL 186

Query: 120 THYS-TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
             +S   VD+WS       + T    F GD       +I++L     E +  G       
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGD-------NIYKLF----ENIGKGS------ 229

Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +  P                   DLL+ ML+Y+P+KR S ++  +H +F
Sbjct: 230 YAIPGD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (289), Expect = 2e-30
 Identities = 55/230 (23%), Positives = 85/230 (36%), Gaps = 49/230 (21%)

Query: 10  EGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTVKSLMYQLCKGVAFCHG 61
            GR  L +V E +           +  ++F  R+            +M  + + + + H 
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---------ASEIMKSIGEAIQYLHS 179

Query: 62  HGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
             I HRD+KP NLL   K     LK+ D G A+  T      T    T +Y APEV LG 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEV-LGP 237

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSL 175
             Y  + DMWS+  I   L+     F  +  L     +     +G        W  VS  
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE- 296

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                                 K    L+  +L+ +P++R++  + M HP
Sbjct: 297 ---------------EV-----K---MLIRNLLKTEPTQRMTITEFMNHP 323

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  113 bits (286), Expect = 3e-30
 Identities = 54/238 (22%), Positives = 87/238 (36%), Gaps = 66/238 (27%)

Query: 10  EGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           +    +Y+V E M            K +  S R+           ++++ + K V + H 
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILRQKFF--SEREA---------SAVLFTITKTVEYLHA 134

Query: 62  HGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 118
            G++HRDLKP N+L   ++    +++I D G A+              T  + APEVL  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194

Query: 119 STHYSTAVDMWSVACI----------FAELVTKTALFPGDSELQQLLH-IFRLLGTPNEK 167
              Y  A D+WS+  +          FA     T     +  L ++    F L G     
Sbjct: 195 -QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP----EEILARIGSGKFSLSGGY--- 246

Query: 168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
            W  VS                            DL+ +ML  DP +R++A   + HP
Sbjct: 247 -WNSVSD------------------------TAKDLVSKMLHVDPHQRLTAALVLRHP 279

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (285), Expect = 4e-30
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 41/222 (18%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    +++V E      L +  +  +   E       +  + Q+  G  + H + ++HRD
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQIVLGCQYLHRNRVIHRD 166

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL--TLWYRAPEVLLGSTHYSTA 125
           LK  NL ++   + +KI D GLA        +K     L  T  Y APEVL    H S  
Sbjct: 167 LKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGH-SFE 221

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           VD+WS+ CI   L+     F   S L++             ++        N +  P+  
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFE-TSCLKETY----------LRI------KKNEYSIPKH- 263

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     ++     L+++MLQ DP+ R +  + +   +F
Sbjct: 264 ----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  112 bits (282), Expect = 6e-30
 Identities = 45/207 (21%), Positives = 72/207 (34%), Gaps = 52/207 (25%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTL--PIKKYT 102
            ++  +   + F H  GI HRDLKP N+L +       +KI D  L     L       +
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 103 HEIL-----TLWYRAPEVLLGSTH----YSTAVDMWSVACI-----------FAELVTKT 142
              L     +  Y APEV+   +     Y    D+WS+  I                +  
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

Query: 143 ALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK 198
               G++       +F     G     +K W  +S                  A     K
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC----------------AA-----K 273

Query: 199 DGLDLLEQMLQYDPSKRISAKKAMEHP 225
              DL+ ++L  D  +R+SA + ++HP
Sbjct: 274 ---DLISKLLVRDAKQRLSAAQVLQHP 297

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  112 bits (283), Expect = 8e-30
 Identities = 55/185 (29%), Positives = 77/185 (41%), Gaps = 35/185 (18%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 104
             + Q+ + VA+ H +GI+HRDLKP NLL         LKIAD GL++            
Sbjct: 152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTV 210

Query: 105 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLG 162
             T  Y APE+L G   Y   VDMWSV  I   L+     F  +   Q    +FR  L  
Sbjct: 211 CGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNC 266

Query: 163 TPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 220
                   W  VS                         +  DL+ +++  DP KR++  +
Sbjct: 267 EYYFISPWWDEVS------------------------LNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 221 AMEHP 225
           A++HP
Sbjct: 303 ALQHP 307

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 1e-29
 Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 48/239 (20%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           + + ++  G+    L+ E     L ++++   ++   +  +TV  + YQ C+ V   H  
Sbjct: 97  IGKEESDTGQAEFLLLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155

Query: 63  G--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---------HEIL---TL 108
              I+HRDLK  NLL+  +  T+K+ D G A   +                 EI    T 
Sbjct: 156 KPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 109 WYRAPEV--LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 166
            YR PE+  L  +       D+W++ CI   L  +   F   ++L+ +   +        
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS------- 267

Query: 167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                          P  + Q               L+  MLQ +P +R+S  + +   
Sbjct: 268 --------------IPPHDTQY---------TVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (278), Expect = 1e-29
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 41/216 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +YL+ E+    +L K ++   +  E        + M +L   + +CH   ++HRD+KP N
Sbjct: 89  IYLMLEFAPRGELYKELQKHGRFDEQ----RSATFMEELADALHYCHERKVIHRDIKPEN 144

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           LLM  K   LKIAD G +      +++ T   +  TL Y  PE++ G T +   VD+W  
Sbjct: 145 LLMGYK-GELKIADFGWS-VHAPSLRRRT---MCGTLDYLPPEMIEGKT-HDEKVDLWCA 198

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E +     F   S  +    I  +                   ++P +       
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD-----------------LKFPPF------- 234

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               L     DL+ ++L+Y P +R+  K  MEHP+ 
Sbjct: 235 ----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  110 bits (278), Expect = 2e-29
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 45/224 (20%)

Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
              LY+VFE ++   + +           +  +  +     L KG+ + H   I+HRD+K
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLKP-----LSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGSTH-YS- 123
           P NLL+  +   +KIAD G++  F          +L     T  + APE L  +   +S 
Sbjct: 165 PSNLLVG-EDGHIKIADFGVSNEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSG 218

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
            A+D+W++       V     F  +  +  L            K+           E+P 
Sbjct: 219 KALDVWAMGVTLYCFVFGQCPFMDER-IMCLH----------SKIKSQA------LEFPD 261

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     P++ +D  DL+ +ML  +P  RI   +   HP+ 
Sbjct: 262 Q---------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  109 bits (274), Expect = 8e-29
 Identities = 44/220 (20%), Positives = 77/220 (35%), Gaps = 42/220 (19%)

Query: 10  EGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           E      L+ E  +   DL  +I       E       +S  +Q+ + V  CH  G+LHR
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLEAVRHCHNCGVLHR 173

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+K  N+L+D     LK+ D G      L    YT    T  Y  PE +    ++  +  
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS+  +  ++V      P + + + +                          + Q    
Sbjct: 232 VWSLGILLYDMVCGD--IPFEHDEEIIRGQVF---------------------FRQR--- 265

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   +  +   L+   L   PS R + ++   HP+ 
Sbjct: 266 --------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (274), Expect = 8e-29
 Identities = 49/184 (26%), Positives = 74/184 (40%), Gaps = 37/184 (20%)

Query: 48  LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEI 105
           ++ Q+   V + H +GI+HRDLKP NLL         + I D GL++         +   
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC 168

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGT 163
            T  Y APEVL     YS AVD WS+  I   L+     F  ++E      +F     G 
Sbjct: 169 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKEGY 223

Query: 164 PN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 221
                  W  +S                        +   D +  +L+ DP++R + +KA
Sbjct: 224 YEFESPFWDDIS------------------------ESAKDFICHLLEKDPNERYTCEKA 259

Query: 222 MEHP 225
           + HP
Sbjct: 260 LSHP 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  108 bits (272), Expect = 1e-28
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)

Query: 8   NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--I 64
             +G+  + LV E M +  LK Y++ F+     + +  ++S   Q+ KG+ F H     I
Sbjct: 97  TVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 65  LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST 124
           +HRDLK  N+ +   T ++KI DLGLA        K    I T  + APE+      Y  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM--YEEKYDE 208

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
           +VD+++      E+ T        SE Q    I+R       +V  GV            
Sbjct: 209 SVDVYAFGMCMLEMATSE---YPYSECQNAAQIYR-------RVTSGV------------ 246

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
            P S          +  +++E  ++ +  +R S K  + H +F +
Sbjct: 247 KPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  108 bits (273), Expect = 1e-28
 Identities = 46/220 (20%), Positives = 78/220 (35%), Gaps = 42/220 (19%)

Query: 10  EGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           E +    LV E      DL  YI      GE       +    Q+   +  CH  G++HR
Sbjct: 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVAAIQHCHSRGVVHR 163

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           D+K  N+L+D +    K+ D G   A  L  + YT    T  Y  PE +    +++    
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTDFDGTRVYSPPEWISRHQYHALPAT 221

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           +WS+  +  ++V      P + + + L                          +P     
Sbjct: 222 VWSLGILLYDMVCGD--IPFERDQEILEAELH---------------------FPAH--- 255

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   +  D   L+ + L   PS R S ++ +  P+ 
Sbjct: 256 --------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  108 bits (272), Expect = 2e-28
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 44/223 (19%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
              T + +V EY   +L  YI   ++  E+      +    Q+   + +CH H I+HRDL
Sbjct: 79  TTPTDIVMVIEYAGGELFDYIVEKKRMTED----EGRRFFQQIICAIEYCHRHKIVHRDL 134

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHYST 124
           KP NLL+D   + +KIAD GL+   T          L        Y APEV+ G  +   
Sbjct: 135 KPENLLLDDN-LNVKIADFGLSNIMT------DGNFLKTSCGSPNYAAPEVINGKLYAGP 187

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
            VD+WS   +   ++     F  +  +  L           +KV   V      +  P +
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEF-IPNLF----------KKVNSCV------YVMPDF 230

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      L      L+ +M+  DP +RI+ ++    P+F
Sbjct: 231 -----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  105 bits (265), Expect = 9e-28
 Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 45/224 (20%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
              T  ++V EY+   +L  YI    +  E       + L  Q+   V +CH H ++HRD
Sbjct: 81  STPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHMVVHRD 136

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHYS 123
           LKP N+L+D   M  KIAD GL+   +        E L        Y APEV+ G  +  
Sbjct: 137 LKPENVLLDAH-MNAKIADFGLSNMMS------DGEFLRTSCGSPNYAAPEVISGRLYAG 189

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   I   L+  T  F  +  +  L           +K+  GV         P+
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEH-VPTLF----------KKIRGGV------FYIPE 232

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +           L++    LL  MLQ DP KR + K   EH +F
Sbjct: 233 Y-----------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (267), Expect = 1e-27
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 45/224 (20%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    LYL+ EY    ++  Y+ +  +  E       +S   Q+   V +CH   I+HRD
Sbjct: 84  ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVSAVQYCHQKRIVHRD 139

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGSTHYS 123
           LK  NLL+D   M +KIAD G +  FT          L        Y APE+  G  +  
Sbjct: 140 LKAENLLLDAD-MNIKIADFGFSNEFT------VGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS+  I   LV+ +  F G + L++L           E+V  G       +  P 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQN-LKELR----------ERVLRGK------YRIPF 235

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +           +  D  +LL++ L  +P KR + ++ M+  + 
Sbjct: 236 Y-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  105 bits (264), Expect = 2e-27
 Identities = 46/230 (20%), Positives = 74/230 (32%), Gaps = 70/230 (30%)

Query: 10  EGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTVKSLMYQLCKGVAFCHG 61
            GR  L +V E +           +  ++F  R+            +M  + + + + H 
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---------ASEIMKSIGEAIQYLHS 135

Query: 62  HGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 119
             I HRD+KP NLL   K     LK+ D G                      A E     
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKETTGEK 174

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSL 175
             Y  + DMWS+  I   L+     F  +  L     +     +G        W  VS  
Sbjct: 175 --YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE- 231

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                                 K    L+  +L+ +P++R++  + M HP
Sbjct: 232 ---------------EV-----K---MLIRNLLKTEPTQRMTITEFMNHP 258

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (258), Expect = 8e-27
 Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 34/182 (18%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW- 109
           QL  GV + HG GI HRD+KP NLL+D +   LKI+D GLA   T+        +L    
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLA---TVFRYNNRERLLNKMC 168

Query: 110 ----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
               Y APE+L     ++  VD+WS   +   ++     +   S+  Q            
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------- 219

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                  + L  W +               +D   L LL ++L  +PS RI+     +  
Sbjct: 220 -DWKEKKTYLNPWKK---------------IDSAPLALLHKILVENPSARITIPDIKKDR 263

Query: 226 YF 227
           ++
Sbjct: 264 WY 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  102 bits (257), Expect = 2e-26
 Identities = 40/206 (19%), Positives = 85/206 (41%), Gaps = 31/206 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V ++ +   L  ++ +   +     +  +  +  Q  +G+ + H   I+HRDLK +N
Sbjct: 94  LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150

Query: 74  LLMDRKTMTLKIADLGLAR--AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMW 129
           + +  +  T+KI D GLA   +      ++     ++ + APEV+    S  YS   D++
Sbjct: 151 IFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           +   +  EL+T    +   +   Q   I  ++G  +    P +S +          P+ +
Sbjct: 210 AFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLS--PDLSKV------RSNCPKRM 258

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKR 215
                        L+ + L+    +R
Sbjct: 259 K-----------RLMAECLKKKRDER 273

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  102 bits (256), Expect = 3e-26
 Identities = 48/179 (26%), Positives = 70/179 (39%), Gaps = 16/179 (8%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---GILHRDLK 70
           + LV EY +   L   +                S   Q  +GVA+ H      ++HRDLK
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           P NLL+      LKI D G A          T+   +  + APEV  GS +YS   D++S
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGS-NYSEKCDVFS 188

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGT----PNEKVWPGVSSLMN--WHEYPQ 183
              I  E++T+   F         +      GT      + +   + SLM   W + P 
Sbjct: 189 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIESLMTRCWSKDPS 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 5e-26
 Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 34/182 (18%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW- 109
           QL  GV + HG GI HRD+KP NLL+D +   LKI+D GLA   T+        +L    
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLA---TVFRYNNRERLLNKMC 168

Query: 110 ----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
               Y APE+L     ++  VD+WS   +   ++     +   S+  Q            
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------- 219

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                  + L  W +               +D   L LL ++L  +PS RI+     +  
Sbjct: 220 -DWKEKKTYLNPWKK---------------IDSAPLALLHKILVENPSARITIPDIKKDR 263

Query: 226 YF 227
           ++
Sbjct: 264 WY 265

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  104 bits (260), Expect = 5e-26
 Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 45/224 (20%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
              + +++V EY+   +L  YI    +  E       + L  Q+  GV +CH H ++HRD
Sbjct: 86  STPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQQILSGVDYCHRHMVVHRD 141

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHYS 123
           LKP N+L+D   M  KIAD GL+   +        E L        Y APEV+ G  +  
Sbjct: 142 LKPENVLLDAH-MNAKIADFGLSNMMS------DGEFLRTSCGSPNYAAPEVISGRLYAG 194

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
             VD+WS   I   L+  T  F  D  +  L           +K+  G+         PQ
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDH-VPTLF----------KKICDGIFYT------PQ 237

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           +           L+   + LL+ MLQ DP KR + K   EH +F
Sbjct: 238 Y-----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  100 bits (252), Expect = 2e-25
 Identities = 39/229 (17%), Positives = 72/229 (31%), Gaps = 52/229 (22%)

Query: 12  RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
              + +  E ++   L + I+      E+         + Q  +G+ + H   ILH D+K
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYRAPEVLLGSTHYSTA 125
             N+L+        + D G A          +         T  + APEV++G       
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAK 236

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW- 184
           VD+WS  C+   ++                      G       P       W +Y +  
Sbjct: 237 VDIWSSCCMMLHMLN---------------------GCH-----P-------WTQYFRGP 263

Query: 185 -------NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                   P  +    P+        +++ L+ +P  R SA +      
Sbjct: 264 LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 2e-25
 Identities = 32/150 (21%), Positives = 65/150 (43%), Gaps = 17/150 (11%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +  +  ++ G  V Y+V EY+    LK+         + +PV    + + ++   +++ H
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLH 199

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGS 119
             G+++ DLKP N+++  +   LK+ DLG               +  T  ++APE++   
Sbjct: 200 SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIVRTG 252

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDS 149
              + A D+++V    A L        G  
Sbjct: 253 P--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (250), Expect = 2e-25
 Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 10/177 (5%)

Query: 14  VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLK 70
            L +V EY+    L + +       E +      S+ Y + KG+ + H     I+HR+LK
Sbjct: 108 NLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             NLL+D K  T+K+ D GL+R              T  + APEVL      +   D++S
Sbjct: 167 SPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYS 224

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSSLMN--WHEYPQ 183
              I  EL T    +   +  Q +  +            + P V++++   W   P 
Sbjct: 225 FGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPW 281

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  100 bits (250), Expect = 2e-25
 Identities = 40/226 (17%), Positives = 75/226 (33%), Gaps = 41/226 (18%)

Query: 15  LYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKP 71
           L++V E+     DL++                 KS+++QL   +A         HRDL  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHW 190

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
            N+L+ + ++  K+      ++ T+P       I+               Y+ +      
Sbjct: 191 GNVLLKKTSL-KKLHYTLNGKSSTIPSCGLQVSIID--------------YTLSRLERDG 235

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN--WHEY-------- 181
             +F ++     LF GD + Q    I+RL+   N   W       N  W  Y        
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQ--FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ 293

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             +  +    A+  + +   +    ML +      SA   +     
Sbjct: 294 MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (255), Expect = 4e-25
 Identities = 55/232 (23%), Positives = 86/232 (37%), Gaps = 42/232 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV   M+  D++ +I +  +               Q+  G+   H   I++RDLKP N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKY-----THEILTLWYRAPEVLLGSTHYSTAVDM 128
           +L+D     ++I+DLGLA        K      T       + APE+LLG   Y  +VD 
Sbjct: 320 VLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPG-----FMAPELLLG-EEYDFSVDY 372

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           +++     E++     F    E  +   + +      + V            YP      
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQR--VLEQAV-----------TYPDK---- 415

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
                        D  E +LQ DP KR+     S      HP F D+   +L
Sbjct: 416 -------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 98.5 bits (246), Expect = 4e-25
 Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 17/178 (9%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKP 71
             L+  +M    L   +     T   +  +        + +G+AF H     I    L  
Sbjct: 84  PTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMW 129
            ++++D + MT +I+   +  +F  P + Y        + APE L          + DMW
Sbjct: 142 RSVMID-EDMTARISMADVKFSFQSPGRMYAPA-----WVAPEALQKKPEDTNRRSADMW 195

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSSLMN--WHEYPQ 183
           S A +  ELVT+   F   S ++  + +      P     + P VS LM    +E P 
Sbjct: 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.8 bits (249), Expect = 5e-25
 Identities = 44/225 (19%), Positives = 78/225 (34%), Gaps = 52/225 (23%)

Query: 10  EGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           E +    LV E   +  DL  +I         +       +  QL   V +     I+HR
Sbjct: 99  ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHY 122
           D+K  N+++     T+K+ D G A            ++   +     Y APEVL+G+ + 
Sbjct: 155 DIKDENIVIAED-FTIKLIDFGSAAYLE------RGKLFYTFCGTIEYCAPEVLMGNPYR 207

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
              ++MWS+      LV +   F    E  +                            P
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVE--AAIHP---------------------P 244

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                        + K+ + L+  +LQ  P +R + +K +  P+ 
Sbjct: 245 YL-----------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 99.4 bits (248), Expect = 5e-25
 Identities = 35/188 (18%), Positives = 68/188 (36%), Gaps = 25/188 (13%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L ++        L   +R        + VN  + +  ++ KG+ + H  GILH+DLK  N
Sbjct: 104 LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL---WYR--APEVLLGST-------- 120
           +  D     + I D GL     +       + L +   W    APE++   +        
Sbjct: 161 VFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQ---QLLHIFRLLGTPNEKVWPGVSSLMN 177
            +S   D++++  I+ EL  +   F          Q+    +        +   +S ++ 
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN-LSQIGMGKEISDILL 277

Query: 178 --WHEYPQ 183
             W    +
Sbjct: 278 FCWAFEQE 285

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (249), Expect = 5e-25
 Identities = 32/232 (13%), Positives = 64/232 (27%), Gaps = 47/232 (20%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
             LV E      L   I  ++    + +P   V S   ++   +   H   I+H D+KP 
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201

Query: 73  NLLMDRKTMT----------LKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGST 120
           N ++    +           L + DLG +    L      +T +  T  ++  E+L    
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK- 260

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
            ++  +D + VA     ++  T +   +                                
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGTYMKVKN----------------EGGECKPEGLFRRLPH 304

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
              WN                +    ML       + +   +         +
Sbjct: 305 LDMWN----------------EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.5 bits (246), Expect = 6e-25
 Identities = 41/209 (19%), Positives = 72/209 (34%), Gaps = 38/209 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKP 71
             +V E++   DL   +         I  +    LM  +  G+ +       I+HRDL+ 
Sbjct: 96  PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS 152

Query: 72  HNLLMDRK----TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAV 126
            N+ +        +  K+AD GL++         +  +    + APE +      Y+   
Sbjct: 153 PNIFLQSLDENAPVCAKVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKA 209

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D +S A I   ++T    F   S  +    I  +     E + P           P+  P
Sbjct: 210 DTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRP---------TIPEDCP 256

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKR 215
             L            +++E     DP KR
Sbjct: 257 PRLR-----------NVIELCWSGDPKKR 274

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.7 bits (249), Expect = 6e-25
 Identities = 52/225 (23%), Positives = 81/225 (36%), Gaps = 39/225 (17%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
              T L ++ EY    +L + I +  +  E+      +    QL  GV++CH   I HRD
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSED----EARFFFQQLLSGVSYCHSMQICHRD 141

Query: 69  LKPHNLLMDRK-TMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPEVLLGSTHY 122
           LK  N L+D      LKI D G +++  L      H           Y APEVLL   + 
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
               D+WS       ++     F             R      +++     S+      P
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDP-------EEPRDYRKTIQRILSVKYSI------P 242

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                S          +   L+ ++   DP+ RIS  +   H +F
Sbjct: 243 DDIRIS---------PECCHLISRIFVADPATRISIPEIKTHSWF 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 47/185 (25%), Positives = 72/185 (38%), Gaps = 23/185 (12%)

Query: 14  VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG---ILHRDL 69
            L LV E+     L + +      G+ IP + + +   Q+ +G+ + H      I+HRDL
Sbjct: 80  NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 70  KPHNLLMDRKT-------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           K  N+L+ +K          LKI D GLAR +               + APEV+  S  +
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAGAYAWMAPEVIRAS-MF 191

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSSLMN--W 178
           S   D+WS   +  EL+T    F G   L     +                 + LM   W
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCW 251

Query: 179 HEYPQ 183
           +  P 
Sbjct: 252 NPDPH 256

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 97.9 bits (244), Expect = 2e-24
 Identities = 52/231 (22%), Positives = 83/231 (35%), Gaps = 30/231 (12%)

Query: 11  GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH------- 62
             T LYL+ +Y +   L  Y++S       +   ++  L Y    G+   H         
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160

Query: 63  -GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLL 117
             I HRDLK  N+L+  K  T  IADLGLA  F     +        + T  Y  PEVL 
Sbjct: 161 PAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219

Query: 118 GSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
            S +          DM+S   I  E+  +        E Q   H         E +   V
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279

Query: 173 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                    P +  +  +       +    L+ +   ++P+ R++A +  +
Sbjct: 280 C---IKKLRPSFPNRWSSDECL---RQMGKLMTECWAHNPASRLTALRVKK 324

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 96.6 bits (241), Expect = 3e-24
 Identities = 46/226 (20%), Positives = 82/226 (36%), Gaps = 30/226 (13%)

Query: 12  RTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
              + +  E +    L   +RS     +     T+     Q+ +G+ + H + I+HRD+K
Sbjct: 91  NGFIKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH-YSTAVDMW 129
             N+L++  +  LKI+D G ++              TL Y APE++      Y  A D+W
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209

Query: 130 SVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           S+ C   E+ T    F         +  +         KV P         E P      
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKV------GMFKVHP---------EIP------ 248

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                 ++  +    + +  + DP KR  A   +   +     K +
Sbjct: 249 -----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 96.7 bits (241), Expect = 4e-24
 Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 44/241 (18%)

Query: 8   NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG----- 61
           ++   T L+L+  Y +   L  Y++        +   +   ++  +  G+A  H      
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 62  ---HGILHRDLKPHNLLMDRKTMTLKIADLGLAR----AFTLPIKKYTHEILTLWYRAPE 114
                I HRDLK  N+L+ +      IADLGLA     +           + T  Y APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 115 VLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 169
           VL  +           VD+W+   +  E+  +        + +           P   V 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP----------PFYDVV 237

Query: 170 PGVSSLMNWHEY-------PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
           P   S  +  +        P    +  +            L+++    +PS R++A +  
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA---KLMKECWYQNPSARLTALRIK 294

Query: 223 E 223
           +
Sbjct: 295 K 295

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.2 bits (240), Expect = 6e-24
 Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 8/138 (5%)

Query: 14  VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
            LY+    ++  DL   +R        +      +++ Q+   +   H  G  HRD+KP 
Sbjct: 108 QLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSV 131
           N+L+        + D G+A A T          + TL+Y APE    S   +   D++++
Sbjct: 164 NILVSA-DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYAL 221

Query: 132 ACIFAELVTKTALFPGDS 149
            C+  E +T +  + GD 
Sbjct: 222 TCVLYECLTGSPPYQGDQ 239

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.4 bits (238), Expect = 9e-24
 Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 8/136 (5%)

Query: 16  YLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           YLV EY++   L +YI S       + V+T  +   Q+  G+   H   I+HRD+KP N+
Sbjct: 87  YLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+D    TLKI D G+A+A +      T+ +L T+ Y +PE   G        D++S+  
Sbjct: 143 LID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGI 200

Query: 134 IFAELVTKTALFPGDS 149
           +  E++     F G++
Sbjct: 201 VLYEMLVGEPPFNGET 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.8 bits (241), Expect = 2e-23
 Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 43/231 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV   M+  DLK +I    Q G   P         ++C G+   H   I++RDLKP N
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTHYSTAVDMW 129
           +L+D     ++I+DLGLA              T       Y APEV+     Y+ + D W
Sbjct: 317 ILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG-----YMAPEVVKN-ERYTFSPDWW 369

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           ++ C+  E++   + F    +  +   + R                    EY +      
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKEVPE-----------EYSER----- 411

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
                        L  Q+L  DP++R+     SA++  EHP F  L+  RL
Sbjct: 412 ------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 93.9 bits (234), Expect = 4e-23
 Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 20/154 (12%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L  + EY+    L+  I+S        P +   S    +  G+A+ H   I+HRDL  HN
Sbjct: 82  LNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138

Query: 74  LLMDRKTMTLKIADLGLAR-------------AFTLPIKKY-THEILTLWYRAPEVLLGS 119
            L+  +   + +AD GLAR             +   P +K     +   ++ APE++ G 
Sbjct: 139 CLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 153
             Y   VD++S   +  E++ +    P       
Sbjct: 198 -SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.7 bits (238), Expect = 7e-23
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 44/230 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L  + + M+  DL  ++       E           Y  ++  G+   H   +++RDLKP
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEA------DMRFYAAEIILGLEHMHNRFVVYRDLKP 320

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+D     ++I+DLGLA  F    KK  H  + T  Y APEVL     Y ++ D +S
Sbjct: 321 ANILLDEHG-HVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           + C+  +L+   + F      +    I R+  T    V           E P        
Sbjct: 377 LGCMLFKLLRGHSPFRQHKT-KDKHEIDRM--TLTMAV-----------ELPDS------ 416

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
                   +   LLE +LQ D ++R+      A++  E P+F  LD   +
Sbjct: 417 -----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 93.7 bits (233), Expect = 8e-23
 Identities = 48/238 (20%), Positives = 82/238 (34%), Gaps = 44/238 (18%)

Query: 11  GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH------- 62
             T L+LV +Y +   L  Y+         + V  +  L      G+A  H         
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 63  -GILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAPEVLL 117
             I HRDLK  N+L+  K  T  IADLGLA               H + T  Y APEVL 
Sbjct: 166 PAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224

Query: 118 GST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 172
            S            D++++  +F E+  + ++     + Q   +         E++   V
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284

Query: 173 SSL-------MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                       W        + +A            ++ +    + + R++A +  +
Sbjct: 285 CEQKLRPNIPNRWQSCEA--LRVMA-----------KIMRECWYANGAARLTALRIKK 329

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 92.7 bits (231), Expect = 1e-22
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 11/152 (7%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           D  + +   G    Y+V EY+D   L+  + +       +       ++   C+ + F H
Sbjct: 79  DTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 133

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH--EIL-TLWYRAPEVLL 117
            +GI+HRD+KP N+++   T  +K+ D G+ARA        T    ++ T  Y +PE   
Sbjct: 134 QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 149
           G +      D++S+ C+  E++T    F GDS
Sbjct: 193 GDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.4 bits (212), Expect = 7e-20
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 43/226 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y    +L KYIR              +    ++   + + HG GI+HRDLKP N
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++   M ++I D G A+  +   K+        T  Y +PE+L   +    + D+W++
Sbjct: 161 ILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWAL 218

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      IF       +K+      +   +++P         
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYL----IF-------QKI------IKLEYDFP--------- 252

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYFDDLD 231
                     DL+E++L  D +KR+  ++         HP+F+ + 
Sbjct: 253 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +++V + +   DL+ +++      E     TVK  + +L   + +     I+HRD+KP N
Sbjct: 90  MFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLL--GSTHYSTAVDMW 129
           +L+D     + I D  +A       +  T   +  T  Y APE+        YS AVD W
Sbjct: 146 ILLDEHGH-VHITDFNIAAMLPRETQITT---MAGTKPYMAPEMFSSRKGAGYSFAVDWW 201

Query: 130 SVACIFAELVTKTALFPG--DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           S+     EL+     +     +  ++++H F         V            YP     
Sbjct: 202 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-----TTVV-----------TYP----- 240

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAMEHPYFDDLD 231
                     ++ + LL+++L+ +P +R          PY +D++
Sbjct: 241 ------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 83.6 bits (207), Expect = 4e-19
 Identities = 48/241 (19%), Positives = 87/241 (36%), Gaps = 50/241 (20%)

Query: 11  GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH------- 62
               L+L+  + +   L  +++        +  N +  +   + +G+A+ H         
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147

Query: 63  ---GILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLL 117
               I HRD+K  N+L+    +T  IAD GLA  F           ++ T  Y APEVL 
Sbjct: 148 HKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206

Query: 118 GSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 173
           G+ +        +DM+++  +  EL ++     G  +   L         P E+      
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML---------PFEEEIGQHP 257

Query: 174 SLMNWHEY-----------PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 222
           SL +  E              W   +    +        + +E+   +D   R+SA    
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAML-------CETIEECWDHDAEARLSAGCVG 310

Query: 223 E 223
           E
Sbjct: 311 E 311

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 41/229 (17%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHN 73
           +++  E MDT L K+ +     G+ IP + +  +   + K +   H    ++HRD+KP N
Sbjct: 81  VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWS 130
           +L++     +K+ D G++      + K   +     Y APE +        YS   D+WS
Sbjct: 141 VLINAL-GQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAPERINPELNQKGYSVKSDIWS 198

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL      FP           F+ L    ++V              +       
Sbjct: 199 LGITMIELA--ILRFP----YDSWGTPFQQL----KQV-------------VEEPS---- 231

Query: 191 TAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
              P L  D       D   Q L+ +  +R +  + M+HP+F   +   
Sbjct: 232 ---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.6 bits (204), Expect = 1e-18
 Identities = 45/231 (19%), Positives = 87/231 (37%), Gaps = 26/231 (11%)

Query: 15  LYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPH 72
           + +  E+MD   L + ++   +  E I    +  +   + KG+ +    H I+HRD+KP 
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHKIMHRDVKPS 161

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L++ +   +K+ D G++      +   +  + T  Y +PE L G+ HYS   D+WS+ 
Sbjct: 162 NILVNSR-GEIKLCDFGVSGQLIDSMAN-SF-VGTRSYMSPERLQGT-HYSVQSDIWSMG 217

Query: 133 CIFAELVT------KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
               E+               +      +        P  +      +       P    
Sbjct: 218 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

Query: 187 QSLATAVPNLDKDGL----------DLLEQMLQYDPSKRISAKKAMEHPYF 227
             L   + N     L          D + + L  +P++R   K+ M H + 
Sbjct: 278 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 71/242 (29%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK------------------GV 56
           L+L+ +Y+              GE         L   L +                   +
Sbjct: 134 LHLILDYI------------NGGE---------LFTHLSQRERFTEHEVQIYVGEIVLAL 172

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEV 115
              H  GI++RD+K  N+L+D     + + D GL++ F     +  ++   T+ Y AP++
Sbjct: 173 EHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

Query: 116 LLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 174
           + G    +  AVD WS+  +  EL+T  + F  D E      I R +     +       
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEP------ 283

Query: 175 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDD 229
                 YPQ            +     DL++++L  DP KR+           EH +F  
Sbjct: 284 -----PYPQE-----------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

Query: 230 LD 231
           ++
Sbjct: 328 IN 329

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.0 bits (200), Expect = 3e-18
 Identities = 61/250 (24%), Positives = 89/250 (35%), Gaps = 52/250 (20%)

Query: 8   NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG----- 61
             +GR    LV EY     L KY+             +   L + + +G+A+ H      
Sbjct: 80  TADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRG 134

Query: 62  ----HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY--------THEILTLW 109
                 I HRDL   N+L+     T  I+D GL+   T                E+ T+ 
Sbjct: 135 DHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 110 YRAPEVLLGS------THYSTAVDMWSVACIFAELVT-KTALFPGDS--ELQQLLHIFRL 160
           Y APEVL G+            VDM+++  I+ E+    T LFPG+S  E Q        
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253

Query: 161 LGTPNEKVWPGVSSL-------MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 213
                E +   VS           W E      +SL            + +E     D  
Sbjct: 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLK-----------ETIEDCWDQDAE 301

Query: 214 KRISAKKAME 223
            R++A+ A E
Sbjct: 302 ARLTAQXAEE 311

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.1 bits (201), Expect = 3e-18
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 46/224 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L+ V EY++  DL  +I+S  +   +           ++  G+ F H  GI++RDLK  N
Sbjct: 93  LFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAAEIILGLQFLHSKGIVYRDLKLDN 148

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKY-----THEILTLWYRAPEVLLGSTHYSTAVDM 128
           +L+D+    +KIAD G+ +   L   K      T +     Y APE+LLG   Y+ +VD 
Sbjct: 149 ILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPD-----YIAPEILLG-QKYNHSVDW 201

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS   +  E++   + F G  E +    +F  +    +              YP+W    
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEE----LFHSI--RMDNP-----------FYPRW---- 240

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-MEHPYFDDLD 231
                  L+K+  DLL ++   +P KR+  +    +HP F +++
Sbjct: 241 -------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.0 bits (202), Expect = 4e-18
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 40/223 (17%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY++  DL  +I+   +  E            ++  G+ F    GI++RDLK  N
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   +KIAD G+ +              T  Y APE++     Y  +VD W+   
Sbjct: 473 VMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGV 530

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E++   A F G+ E +    +F+ +      V            YP+          
Sbjct: 531 LLYEMLAGQAPFEGEDEDE----LFQSI--MEHNV-----------AYPKS--------- 564

Query: 194 PNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
             + K+ + + + ++   P KR+       +   EH +F  +D
Sbjct: 565 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 7e-18
 Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 47/232 (20%)

Query: 15  LYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           LYLV EY       T L K+       GE IP    +  + ++   +   H  G +HRD+
Sbjct: 136 LYLVMEYYVGGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG------STHY 122
           KP N+L+DR    +++AD G            +   + T  Y +PE+L        +  Y
Sbjct: 189 KPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
               D W++     E+      F  DS  +     +                ++++ E+ 
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYADSTAE----TYG--------------KIVHYKEHL 289

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
                        + ++  D ++++L   P  R+    A +   HP+F  LD
Sbjct: 290 SLPLVD-----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 44/230 (19%), Positives = 84/230 (36%), Gaps = 45/230 (19%)

Query: 15  LYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           LYLV +Y       T L K+           P    +  + ++   +   H    +HRD+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRL-------PEEMARFYLAEMVIAIDSVHQLHYVHRDI 201

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTH----YST 124
           KP N+LMD     +++AD G            +   + T  Y +PE+L         Y  
Sbjct: 202 KPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
             D WS+     E++     F  +S ++     +  +    E+            ++P  
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKERF-----------QFPTQ 305

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
                   V ++ ++  DL+ +++      R+      +   HP+F  +D
Sbjct: 306 --------VTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGID 346

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.2 bits (193), Expect = 3e-17
 Identities = 44/226 (19%), Positives = 78/226 (34%), Gaps = 36/226 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHN 73
           +++  E M T  +K  +   +    IP   +  +   + K + +    HG++HRD+KP N
Sbjct: 99  VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL----LGSTHYSTAVDMW 129
           +L+D +   +K+ D G++        K         Y APE +         Y    D+W
Sbjct: 156 ILLDER-GQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213

Query: 130 SVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           S+     EL T    +    ++ + L  +                         Q  P  
Sbjct: 214 SLGISLVELATGQFPYKNCKTDFEVLTKV------------------------LQEEPPL 249

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           L         D    ++  L  D  KR    K +EH +    +   
Sbjct: 250 LPGH-MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 5e-17
 Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 55/229 (24%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           LY+V EY+   ++  ++R   +  E        +  Y  Q+     + H   +++RDLKP
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHSLDLIYRDLKP 169

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAPEVLLGSTHYSTAVD 127
            NLL+D++   +++ D G A       K+      TL       APE++L   + + AVD
Sbjct: 170 ENLLIDQQGY-IQVTDFGFA-------KRVKGRTWTLCGTPEALAPEIILSKGY-NKAVD 220

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
            W++  +  E+      F  D  +Q    I+  +   + KV            +P     
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ----IYEKI--VSGKV-----------RFP----- 258

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDDLD 231
                  +   D  DLL  +LQ D +KR    K        H +F   D
Sbjct: 259 ------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.3 bits (191), Expect = 6e-17
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 45/191 (23%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THEI 105
           ++   + + H   +++RD+K  NL++D K   +KI D GL +              T E 
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPE- 170

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
               Y APEVL     Y  AVD W +  +  E++     F      +    +F L+    
Sbjct: 171 ----YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELI--LM 219

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKK 220
           E++            +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 220 EEI-----------RFPRT-----------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257

Query: 221 AMEHPYFDDLD 231
            MEH +F  ++
Sbjct: 258 VMEHRFFLSIN 268

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 77.3 bits (190), Expect = 1e-16
 Identities = 40/243 (16%), Positives = 79/243 (32%), Gaps = 36/243 (14%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V  +M      DL           + +    +  ++  + K + + H  G +HR +K
Sbjct: 101 LWVVTSFMAYGSAKDLICTHF-----MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTH-Y 122
             ++L+      + ++ L    +     ++         + +  L + +PEVL  +   Y
Sbjct: 156 ASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 214

Query: 123 STAVDMWSVACIFAELVTKT----------ALF-------PGDSELQQLLHIFRLLGTPN 165
               D++SV     EL               L        P   +   +      +    
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                G+S  +        N  S +              +EQ LQ +P  R SA   + H
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334

Query: 225 PYF 227
            +F
Sbjct: 335 SFF 337

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 55/231 (23%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V E+++  DL  +I+  R+  E       ++  Y  ++   + F H  GI++RDLK 
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISALMFLHDKGIIYRDLKL 152

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THEILTLWYRAPEVLLGSTHYSTAV 126
            N+L+D +    K+AD G+ +              T +     Y APE+L     Y  AV
Sbjct: 153 DNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD-----YIAPEILQE-MLYGPAV 205

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D W++  +  E++   A F  ++E      +F  +   N++V            YP W  
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDD----LFEAI--LNDEV-----------VYPTW-- 246

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYFDDLD 231
                    L +D   +L+  +  +P+ R+ +         + HP+F ++D
Sbjct: 247 ---------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 76/241 (31%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK------------------GV 56
           LYL+ EY+              GE         L  QL +                   +
Sbjct: 96  LYLILEYL------------SGGE---------LFMQLEREGIFMEDTACFYLAEISMAL 134

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEV 115
              H  GI++RDLKP N++++     +K+ D GL +         TH    T+ Y APE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTV-THTFCGTIEYMAPEI 192

Query: 116 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
           L+ S  ++ AVD WS+  +  +++T    F G++  +        +     K+       
Sbjct: 193 LMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKI--LKCKL------- 238

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDDL 230
                 P +           L ++  DLL+++L+ + + R+ A          HP+F  +
Sbjct: 239 ----NLPPY-----------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

Query: 231 D 231
           +
Sbjct: 284 N 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 50/228 (21%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY V EY++  DL  +I+   +  E            ++  G+ F    GI++RDLK  N
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKY-----THEILTLWYRAPEVLLGSTHYSTAVDM 128
           +++D +   +KIAD G+ +              T +     Y APE++     Y  +VD 
Sbjct: 152 VMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD-----YIAPEIIAY-QPYGKSVDW 204

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           W+   +  E++   A F G+ E +    I          V            YP+     
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNV-----------AYPKS---- 243

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
                  + K+ + + + ++   P KR+       +   EH +F  +D
Sbjct: 244 -------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 3e-16
 Identities = 50/241 (20%), Positives = 89/241 (36%), Gaps = 76/241 (31%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK------------------GV 56
           LYL+ +++            + G+         L  +L K                   +
Sbjct: 101 LYLILDFL------------RGGD---------LFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEV 115
              H  GI++RDLKP N+L+D +   +K+ D GL++      KK  +    T+ Y APEV
Sbjct: 140 DHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEV 197

Query: 116 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
           +     ++ + D WS   +  E++T T  F G    +       ++     K+       
Sbjct: 198 VNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMI--LKAKL------- 243

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDDL 230
                 PQ+           L  +   LL  + + +P+ R+ A          H +F  +
Sbjct: 244 ----GMPQF-----------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288

Query: 231 D 231
           D
Sbjct: 289 D 289

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 75.1 bits (185), Expect = 5e-16
 Identities = 51/225 (22%), Positives = 83/225 (36%), Gaps = 39/225 (17%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM   DL   + ++      +P    +    ++   +   H  G +HRD+KP N
Sbjct: 144 LYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 198

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLL---GSTHYSTAVDMW 129
           +L+D+    LK+AD G                + T  Y +PEVL    G  +Y    D W
Sbjct: 199 MLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           SV     E++     F  DS +      +                +MN      + P   
Sbjct: 258 SVGVFLYEMLVGDTPFYADSLVG----TYS--------------KIMNHKNSLTF-PDD- 297

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 231
                ++ K+  +L+   L  D   R+      E   H +F +  
Sbjct: 298 ----NDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQ 337

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 6e-16
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 41/224 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPH 72
           L  V EY +  +L  ++   R   E+      +    ++   + + H    +++RDLK  
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSALDYLHSEKNVVYRDLKLE 278

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           NL++D K   +KI D GL +              T  Y APEVL     Y  AVD W + 
Sbjct: 279 NLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLG 336

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E++     F      +    +F L+             LM    +P+         
Sbjct: 337 VVMYEMMCGRLPFYNQDHEK----LFELI-------------LMEEIRFPRT-------- 371

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 231
              L  +   LL  +L+ DP +R+      AK+ M+H +F  + 
Sbjct: 372 ---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.1 bits (183), Expect = 7e-16
 Identities = 45/233 (19%), Positives = 97/233 (41%), Gaps = 63/233 (27%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           ++++ +Y++  +L   +R  ++           +  Y  ++C  + + H   I++RDLKP
Sbjct: 81  IFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEYLHSKDIIYRDLKP 134

Query: 72  HNLLMDRKTMTLKIADLGLA-----RAFTL---PIKKYTHEILTLWYRAPEVLLGSTHYS 123
            N+L+D+    +KI D G A       +TL   P      +     Y APEV+    + +
Sbjct: 135 ENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTP------D-----YIAPEVVSTKPY-N 181

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
            ++D WS   +  E++     F   + ++     +  +   N ++            +P 
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKI--LNAEL-----------RFPP 224

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-----MEHPYFDDLD 231
           +            ++D  DLL +++  D S+R+   +        HP+F ++ 
Sbjct: 225 F-----------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.9 bits (182), Expect = 7e-16
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 41/229 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGEN-IPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           L+LV + +      D+ K+I +  +     +  +T+ +++ ++ +G+ + H +G +HRD+
Sbjct: 88  LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE-----ILTLWYRAPEVLLGSTHYST 124
           K  N+L+     +++IAD G++           ++     + T  + APEV+     Y  
Sbjct: 148 KAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF 206

Query: 125 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
             D+WS      EL T  A +     ++ L+                           Q 
Sbjct: 207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLT------------------------LQN 242

Query: 185 NPQSLATAVPNLDKDGL------DLLEQMLQYDPSKRISAKKAMEHPYF 227
           +P SL T V + +           ++   LQ DP KR +A + + H +F
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 40/190 (21%), Positives = 70/190 (36%), Gaps = 44/190 (23%)

Query: 51  QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THEI 105
           ++   + + H   I++RDLKP N+L+D     + + D GL +              T E 
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPE- 204

Query: 106 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 165
               Y APEVL     Y   VD W +  +  E++     F   +  +    ++  +   N
Sbjct: 205 ----YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNI--LN 253

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---- 221
           + +           +               +      LLE +LQ D +KR+ AK      
Sbjct: 254 KPL-----------QLKPN-----------ITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291

Query: 222 MEHPYFDDLD 231
             H +F  ++
Sbjct: 292 KSHVFFSLIN 301

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 73.1 bits (180), Expect = 2e-15
 Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 33/227 (14%)

Query: 15  LYLVFEYMDTDLKK-YIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPH 72
            ++  E M T   K Y   +    + IP   +  +     K +        I+HRD+KP 
Sbjct: 96  CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH---YSTAVDMW 129
           N+L+DR    +K+ D G++      I K T +     Y APE +  S     Y    D+W
Sbjct: 156 NILLDRS-GNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213

Query: 130 SVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           S+     EL T    +P  +S   QL  +                         + +P  
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQV------------------------VKGDPPQ 249

Query: 189 LATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           L+ +         ++ +   L  D SKR   K+ ++HP+    ++  
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 34/170 (20%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
           ++G   + L+ E++ +  LK+Y+   +     I +        Q+CKG+ +      +HR
Sbjct: 94  EDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQYVHR 150

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPE 114
           DL   N+L++     +KI D GL +A                P+          WY APE
Sbjct: 151 DLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF---------WY-APE 199

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
            L+ S  +  A D+WS      EL+T       DS+   +    +++G  
Sbjct: 200 CLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 72.3 bits (178), Expect = 3e-15
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 29/146 (19%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
             GR  L L+ EY+    L+ Y++  +   E I    +     Q+CKG+ +      +HR
Sbjct: 82  SAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPE 114
           DL   N+L++ +   +KI D GL +                 PI          WY APE
Sbjct: 139 DLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF---------WY-APE 187

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVT 140
            L  S  +S A D+WS   +  EL T
Sbjct: 188 SLTESK-FSVASDVWSFGVVLYELFT 212

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 48/232 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V EY++  DL  +++  R+  E        +  Y  ++   + + H  GI++RDLK 
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHERGIIYRDLKL 138

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+D +   +K+ D G+ +    P    T     T  Y APE+L G   Y  +VD W+
Sbjct: 139 DNVLLDSEGH-IKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPEILRG-EDYGFSVDWWA 195

Query: 131 VACIFAELVTKTALFPGDSELQQLL-----HIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           +  +  E++   + F               ++F+++    +++             P+  
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQI-----------RIPRS- 241

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYFDDLD 231
                     L      +L+  L  DP +R+             HP+F ++D
Sbjct: 242 ----------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 72.0 bits (177), Expect = 5e-15
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 29/146 (19%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
             GR  L L+ EY+    L+ Y++  +   E I    +     Q+CKG+ +      +HR
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHR 169

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPE 114
           DL   N+L++ +   +KI D GL +                 PI          WY APE
Sbjct: 170 DLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF---------WY-APE 218

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVT 140
            L  S  +S A D+WS   +  EL T
Sbjct: 219 SLTESK-FSVASDVWSFGVVLYELFT 243

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 1e-14
 Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 48/232 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKP 71
           L+ V EY++  DL  +++  R+  E        +  Y  ++   + + H  GI++RDLK 
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHERGIIYRDLKL 181

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWS 130
            N+L+D +   +K+ D G+ +    P    T     T  Y APE+L G   Y  +VD W+
Sbjct: 182 DNVLLDSEGH-IKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPEILRG-EDYGFSVDWWA 238

Query: 131 VACIFAELVTKTALFPGDSELQQLL-----HIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           +  +  E++   + F               ++F+++    +++             P+  
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQI-----------RIPRS- 284

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYFDDLD 231
                     L      +L+  L  DP +R+             HP+F ++D
Sbjct: 285 ----------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 46/170 (27%), Positives = 66/170 (38%), Gaps = 36/170 (21%)

Query: 9   KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR 67
             G   L LV EY+    L+ Y+        +I +  +     Q+C+G+A+ H    +HR
Sbjct: 104 DAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQHYIHR 158

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPE 114
           DL   N+L+D     +KI D GLA+A                P+          WY APE
Sbjct: 159 DLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------WY-APE 207

Query: 115 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 164
            L     +  A D+WS      EL+T       DS          L+G  
Sbjct: 208 CLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA 251

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 28/129 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + L+ + M    L  Y+R  +   +NI    + +   Q+ KG+ +     ++HRDL   N
Sbjct: 91  VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147

Query: 74  LLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           +L+      +KI D GLA+               +PIK         W  A E +L    
Sbjct: 148 VLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK---------WM-ALESILHRI- 195

Query: 122 YSTAVDMWS 130
           Y+   D+WS
Sbjct: 196 YTHQSDVWS 204

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 69.3 bits (170), Expect = 4e-14
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 29/144 (20%)

Query: 11  GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           GR  L LV EY+ +  L+ +++  R     +  + +     Q+CKG+ +      +HRDL
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDL 153

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVL 116
              N+L++ +   +KIAD GLA+                 PI          WY APE L
Sbjct: 154 AARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIF---------WY-APESL 202

Query: 117 LGSTHYSTAVDMWSVACIFAELVT 140
             +  +S   D+WS   +  EL T
Sbjct: 203 SDNI-FSRQSDVWSFGVVLYELFT 225

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 26/183 (14%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            Y++ E+M   +L  Y+R      + +    +  +  Q+   + +      +HR+L   N
Sbjct: 291 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARN 348

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAPEVLLGSTHYSTAVDMW 129
            L+  +   +K+AD GL+R   +    YT          W  APE L  +  +S   D+W
Sbjct: 349 CLVG-ENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWT-APESLAYNK-FSIKSDVW 403

Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHI---FRLL---GTPNEKVWPGVSSLMN--WHE 180
           +   +  E+ T     +PG    Q    +   +R+    G P       V  LM   W  
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-----EKVYELMRACWQW 458

Query: 181 YPQ 183
            P 
Sbjct: 459 NPS 461

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 26/128 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            Y++ E+M   +L  Y+R      + +    +  +  Q+   + +      +HRDL   N
Sbjct: 84  FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L+      +K+AD GL+R  T            PIK         W  APE L  +  +
Sbjct: 142 CLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WT-APESLAYN-KF 189

Query: 123 STAVDMWS 130
           S   D+W+
Sbjct: 190 SIKSDVWA 197

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 26/139 (18%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ E+M    L  +++S    G   P+  +     Q+ +G+AF      +HRDL+  N
Sbjct: 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   ++  KIAD GLAR               PIK         W  APE +   + +
Sbjct: 315 ILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT-APEAINFGS-F 362

Query: 123 STAVDMWSVACIFAELVTK 141
           +   D+WS   +  E+VT 
Sbjct: 363 TIKSDVWSFGILLMEIVTY 381

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 26/128 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y++ EYM+   L  ++++    G  + +N +  +  Q+ +G+AF      +HRDL+  N
Sbjct: 82  IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+   T++ KIAD GLAR               PIK         W  APE +   T +
Sbjct: 140 ILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIK---------WT-APEAINYGT-F 187

Query: 123 STAVDMWS 130
           +   D+WS
Sbjct: 188 TIKSDVWS 195

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 67.7 bits (166), Expect = 2e-13
 Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 28/129 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V E +   D   ++R+    G  + V T+  ++     G+ +      +HRDL   N
Sbjct: 187 IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243

Query: 74  LLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVLLGSTH 121
            L+  +   LKI+D G++R               +P+K         W  APE L     
Sbjct: 244 CLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVK---------WT-APEALN-YGR 291

Query: 122 YSTAVDMWS 130
           YS+  D+WS
Sbjct: 292 YSSESDVWS 300

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 24/130 (18%), Positives = 48/130 (36%), Gaps = 27/130 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             LV E++    L  Y++  +     I +     +  QL   + F   + ++H ++   N
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN 143

Query: 74  LLMDRK-------TMTLKIADLGLARAFT------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L+ R+          +K++D G++            I          W   PE +    
Sbjct: 144 ILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---------WV-PPECIENPK 193

Query: 121 HYSTAVDMWS 130
           + + A D WS
Sbjct: 194 NLNLATDKWS 203

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 67.6 bits (165), Expect = 3e-13
 Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 26/182 (14%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++     G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 336 IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 393

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAPEVLLGSTHYSTAVDMW 129
           +L+    +  K+AD GLAR   +   +YT          W  APE  L    ++   D+W
Sbjct: 394 ILVGEN-LVCKVADFGLARL--IEDNEYTARQGAKFPIKWT-APEAALYGR-FTIKSDVW 448

Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHI---FRL---LGTPNEKVWPGVSSLMN--WHE 180
           S   +  EL TK  + +PG    + L  +   +R+      P       +  LM   W +
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-----ESLHDLMCQCWRK 503

Query: 181 YP 182
            P
Sbjct: 504 EP 505

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 32/130 (24%), Positives = 55/130 (42%), Gaps = 30/130 (23%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             LV E  +   L KY++       ++    +  L++Q+  G+ +      +HRDL   N
Sbjct: 92  WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 147

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L+  +    KI+D GL++A                P+K         WY APE +    
Sbjct: 148 VLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVK---------WY-APECINYYK 196

Query: 121 HYSTAVDMWS 130
            +S+  D+WS
Sbjct: 197 -FSSKSDVWS 205

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 28/129 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV +Y+    L  ++R  R     +    + +   Q+ KG+ +   HG++HR+L   N
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 145

Query: 74  LLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           +L+      +++AD G+A                 PIK         W  A E +     
Sbjct: 146 VLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---------WM-ALESIH-FGK 193

Query: 122 YSTAVDMWS 130
           Y+   D+WS
Sbjct: 194 YTHQSDVWS 202

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 66.6 bits (163), Expect = 4e-13
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 39/217 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+++ E++     TD+   +   R   E I       +   + + +A+ H  G++HRD+K
Sbjct: 117 LWVLMEFLQGGALTDI---VSQVRLNEEQIAT-----VCEAVLQALAYLHAQGVIHRDIK 168

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             ++L+      +K++D G     +  + K    + T ++ APEV+  S  Y+T VD+WS
Sbjct: 169 SDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWS 226

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +  +  E+V     +  DS +Q +  + R    P  K    VS ++              
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKVSPVLR------------- 272

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      D LE+ML  DP +R +A++ ++HP+ 
Sbjct: 273 -----------DFLERMLVRDPQERATAQELLDHPFL 298

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 66.2 bits (162), Expect = 4e-13
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 28/129 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + L+ + M    L  Y+R  +   +NI    + +   Q+ KG+ +     ++HRDL   N
Sbjct: 91  VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147

Query: 74  LLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           +L+      +KI D GLA+               +PIK         W  A E +L    
Sbjct: 148 VLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK---------WM-ALESILHRI- 195

Query: 122 YSTAVDMWS 130
           Y+   D+WS
Sbjct: 196 YTHQSDVWS 204

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 66.2 bits (162), Expect = 5e-13
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 27/141 (19%)

Query: 5   QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHG 61
           + + K    +  ++  +M   DL  ++ + R  +   N+P+ T+   M  +  G+ +   
Sbjct: 96  RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS 155

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEILTLW 109
              +HRDL   N ++  + MT+ +AD GL+R               LP+K         W
Sbjct: 156 RNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK---------W 205

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             A E L  +  Y+   D+W+
Sbjct: 206 L-ALESLADNL-YTVHSDVWA 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 66.9 bits (163), Expect = 5e-13
 Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 29/130 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV E      L K++   R   E IPV+ V  L++Q+  G+ +      +HR+L   N
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN 466

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L+  +    KI+D GL++A                P+K         WY APE +    
Sbjct: 467 VLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK---------WY-APECINFRK 515

Query: 121 HYSTAVDMWS 130
            +S+  D+WS
Sbjct: 516 -FSSRSDVWS 524

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 66.7 bits (163), Expect = 5e-13
 Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 26/182 (14%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EYM    L  +++     G+ + +  +  +  Q+  G+A+      +HRDL+  N
Sbjct: 253 IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAPEVLLGSTHYSTAVDMW 129
           +L+    +  K+AD GLAR   +   +YT          W  APE  L    ++   D+W
Sbjct: 311 ILVGEN-LVCKVADFGLARL--IEDNEYTARQGAKFPIKWT-APEAALYGR-FTIKSDVW 365

Query: 130 SVACIFAELVTKTAL-FPGDSELQQLLHI---FRL---LGTPNEKVWPGVSSLMN--WHE 180
           S   +  EL TK  + +PG    + L  +   +R+      P       +  LM   W +
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-----ESLHDLMCQCWRK 420

Query: 181 YP 182
            P
Sbjct: 421 EP 422

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 65.8 bits (161), Expect = 5e-13
 Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 43/219 (19%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V EY+     TD+   +         I       +  +  + + F H + ++HRD+K
Sbjct: 92  LWVVMEYLAGGSLTDV---VTETCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIK 143

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L+     ++K+ D G     T    K +  + T ++ APEV+     Y   VD+WS
Sbjct: 144 SDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWS 201

Query: 131 --VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
             +  I  E++     +  ++ L+ L  I                               
Sbjct: 202 LGIMAI--EMIEGEPPYLNENPLRALYLI------------------------ATNGTPE 235

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
           L      L     D L + L+ D  KR SAK+ ++H + 
Sbjct: 236 LQNP-EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 65.7 bits (161), Expect = 6e-13
 Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 22/124 (17%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY+V EYM    L  Y+RS       +  + +      +C+ + +  G+  +HRDL   N
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147

Query: 74  LLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           +L+  +    K++D GL +  +       LP+K         W  APE L     +ST  
Sbjct: 148 VLVS-EDNVAKVSDFGLTKEASSTQDTGKLPVK---------WT-APEALREKK-FSTKS 195

Query: 127 DMWS 130
           D+WS
Sbjct: 196 DVWS 199

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 66.2 bits (162), Expect = 7e-13
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 22/140 (15%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+RS  +    +  + +      +C+ + +  G+  +HRD
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGSTH 121
           L   N+L+       K++D GL +  +       LP+K         W  APE L     
Sbjct: 315 LAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPVK---------WT-APEALREKK- 362

Query: 122 YSTAVDMWSVACIFAELVTK 141
           +ST  D+WS   +  E+ + 
Sbjct: 363 FSTKSDVWSFGILLWEIYSF 382

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 29/130 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV E      L K++       E IPV+ V  L++Q+  G+ +      +HRDL   N
Sbjct: 84  LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L+  +    KI+D GL++A                P+K         WY APE +    
Sbjct: 141 VLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK---------WY-APECINFRK 189

Query: 121 HYSTAVDMWS 130
            +S+  D+WS
Sbjct: 190 -FSSRSDVWS 198

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 65.3 bits (160), Expect = 8e-13
 Identities = 27/128 (21%), Positives = 56/128 (43%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ E     +L+ +++  + +   + + ++    YQL   +A+      +HRD+   N
Sbjct: 90  VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRFVHRDIAARN 146

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+      +K+ D GL+R              LPIK         W  APE +     +
Sbjct: 147 VLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---------WM-APESIN-FRRF 194

Query: 123 STAVDMWS 130
           ++A D+W 
Sbjct: 195 TSASDVWM 202

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 65.4 bits (160), Expect = 8e-13
 Identities = 31/130 (23%), Positives = 56/130 (43%), Gaps = 29/130 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             +V EYM+   L  ++R+         +  +  ++  +  G+ +    G +HRDL   N
Sbjct: 125 AMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L+D   +  K++D GL+R                +PI+         W  APE +    
Sbjct: 182 VLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR---------WT-APEAIA-FR 229

Query: 121 HYSTAVDMWS 130
            +S+A D+WS
Sbjct: 230 TFSSASDVWS 239

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 64.6 bits (158), Expect = 1e-12
 Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 29/130 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V E      L   +R  +    +  + T+     Q+ +G+ +      +HRDL   N
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           LL+  +   +KI D GL RA               +P           W  APE L  + 
Sbjct: 152 LLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WC-APESLK-TR 199

Query: 121 HYSTAVDMWS 130
            +S A D W 
Sbjct: 200 TFSHASDTWM 209

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LV E+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L+      +K++D G+ R               P+K         W  +PEV   S  Y
Sbjct: 135 CLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK---------WA-SPEVFSFSR-Y 182

Query: 123 STAVDMWS 130
           S+  D+WS
Sbjct: 183 SSKSDVWS 190

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
            +++ E     +L  Y+   + +   + V T+     Q+CK +A+      +HRD+   N
Sbjct: 87  TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+      +K+ D GL+R              LPIK         W  +PE +     +
Sbjct: 144 ILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIK---------WM-SPESINFRR-F 191

Query: 123 STAVDMWS 130
           +TA D+W 
Sbjct: 192 TTASDVWM 199

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 63.9 bits (156), Expect = 3e-12
 Identities = 45/225 (20%), Positives = 89/225 (39%), Gaps = 39/225 (17%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L++V EY      +D+ +         + +  + + +++    KG+ + H    +HRD+K
Sbjct: 99  LWIVMEYCGAGSVSDIIRL------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L++ +    K+AD G+A   T  + K    I T ++ APEV+     Y+   D+WS
Sbjct: 153 AGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWS 210

Query: 131 VACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           +  I A E+      +     ++ +  I                        P   P + 
Sbjct: 211 LG-ITAIEMAEGKPPYADIHPMRAIFMI------------------------PTNPPPTF 245

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                    +  D ++Q L   P +R +A + ++HP+        
Sbjct: 246 RKP-ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 94  IFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L++ +   +K++D GL+R               P++         W   PEVL+ S  +
Sbjct: 151 CLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---------WS-PPEVLMYSK-F 198

Query: 123 STAVDMWS 130
           S+  D+W+
Sbjct: 199 SSKSDIWA 206

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 28/138 (20%), Positives = 59/138 (42%), Gaps = 27/138 (19%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ E     +L+ +++  + +   + + ++    YQL   +A+      +HRD+   N
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
           +L+      +K+ D GL+R              LPIK         W  APE +     +
Sbjct: 522 VLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK---------WM-APESIN-FRRF 569

Query: 123 STAVDMWSVACIFAELVT 140
           ++A D+W       E++ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 63.4 bits (155), Expect = 3e-12
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 27/128 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +Y+V EY+    L  Y+RS  +    +  + +  + Y +C+G+AF   H  +HRDL   N
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134

Query: 74  LLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHY 122
            L+D + + +K++D G+ R               P+K         W  APEV      Y
Sbjct: 135 CLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---------WS-APEVFHYFK-Y 182

Query: 123 STAVDMWS 130
           S+  D+W+
Sbjct: 183 SSKSDVWA 190

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 31/141 (21%), Positives = 62/141 (43%), Gaps = 29/141 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + ++ EYM+   L K++R   +      V  +  ++  +  G+ +      +HRDL   N
Sbjct: 121 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 177

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L++   +  K++D GL+R                +PI+         W  APE +    
Sbjct: 178 ILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR---------WT-APEAIS-YR 225

Query: 121 HYSTAVDMWSVACIFAELVTK 141
            +++A D+WS   +  E++T 
Sbjct: 226 KFTSASDVWSFGIVMWEVMTY 246

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 42/239 (17%)

Query: 5   QGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           +         L+LV E+      TDL K  +      E I       +  ++ +G++  H
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREILRGLSHLH 146

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 120
            H ++HRD+K  N+L+      +K+ D G++      + +    I T ++ APEV+    
Sbjct: 147 QHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205

Query: 121 H----YSTAVDMWSVACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 175
           +    Y    D+WS+  I A E+            ++ L  I                  
Sbjct: 206 NPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------------------ 246

Query: 176 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
                 P+     L +      K     +E  L  + S+R + ++ M+HP+  D    R
Sbjct: 247 ------PRNPAPRLKS--KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.1 bits (154), Expect = 6e-12
 Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 31/135 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL------MYQLCKGVAFCHGHGILHR 67
             ++ E M   DLK Y+RS R    N PV    SL        ++  G+A+ + +  +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 68  DLKPHNLLMDRKTMTLKIADLGLAR------------AFTLPIKKYTHEILTLWYRAPEV 115
           DL   N ++  +  T+KI D G+ R               LP++         W  +PE 
Sbjct: 163 DLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---------WM-SPES 211

Query: 116 LLGSTHYSTAVDMWS 130
           L     ++T  D+WS
Sbjct: 212 LKDGV-FTTYSDVWS 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 63.2 bits (154), Expect = 7e-12
 Identities = 30/141 (21%), Positives = 60/141 (42%), Gaps = 29/141 (20%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +V EYM+   L  ++R          V  +  ++  +  G+ +    G +HRDL   N
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177

Query: 74  LLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEILTLWYRAPEVLLGST 120
           +L++   +  K++D GL R                +PI+         W  +PE +    
Sbjct: 178 ILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR---------WT-SPEAIA-YR 225

Query: 121 HYSTAVDMWSVACIFAELVTK 141
            +++A D+WS   +  E+++ 
Sbjct: 226 KFTSASDVWSYGIVLWEVMSY 246

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 62.7 bits (153), Expect = 8e-12
 Identities = 32/136 (23%), Positives = 56/136 (41%), Gaps = 27/136 (19%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 66
           +G     ++  +M   DL  Y+   R     ++IP+ T+   M  +  G+ +      LH
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEILTLWYRAPE 114
           RDL   N ++    MT+ +AD GL++               +P+K         W  A E
Sbjct: 171 RDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---------WI-AIE 219

Query: 115 VLLGSTHYSTAVDMWS 130
            L     Y++  D+W+
Sbjct: 220 SLADRV-YTSKSDVWA 234

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 37/143 (25%), Positives = 55/143 (38%), Gaps = 39/143 (27%)

Query: 15  LYLVFEYM-DTDLKKYIRSFRQTGENIPVN-----------TVKSLM---YQLCKGVAFC 59
             ++ EY    DL  ++R  R +      +            ++ L+   YQ+ KG+AF 
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILT 107
                +HRDL   N+L+       KI D GLAR               LP+K        
Sbjct: 162 ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVK-------- 212

Query: 108 LWYRAPEVLLGSTHYSTAVDMWS 130
            W  APE +     Y+   D+WS
Sbjct: 213 -WM-APESIFNCV-YTFESDVWS 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 35/139 (25%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN-------TVKSLM---YQLCKGVAFCHGHG 63
           + ++ EY    DL  ++R   +  E  P         + + L+    Q+ +G+AF     
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWYR 111
            +HRD+   N+L+       KI D GLAR               LP+K         W  
Sbjct: 185 CIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---------WM- 233

Query: 112 APEVLLGSTHYSTAVDMWS 130
           APE +     Y+   D+WS
Sbjct: 234 APESIFDCV-YTVQSDVWS 251

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+++ E+        +        +    +    ++ +  Q+ + + F H   I+HRDLK
Sbjct: 91  LWIMIEFCPGGAVDAI------MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAV 126
             N+LM  +   +++AD G++      ++K    I T ++ APEV++  T     Y    
Sbjct: 145 AGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203

Query: 127 DMWSVACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
           D+WS+  I   E+          + ++ LL I                         + +
Sbjct: 204 DIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI------------------------AKSD 238

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           P +L T       +  D L+  L  +P  R SA + +EHP+   +   +
Sbjct: 239 PPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 29/134 (21%), Positives = 47/134 (35%), Gaps = 29/134 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL---MYQLCKGVAFCHGHGILHRDLK 70
            +++ E M   DLK ++R  R          +  L      +  G  +   +  +HRD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 71  PHNLLMDRKT--MTLKIADLGLAR------------AFTLPIKKYTHEILTLWYRAPEVL 116
             N L+         KI D G+AR               LP+K         W   PE  
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---------WM-PPEAF 217

Query: 117 LGSTHYSTAVDMWS 130
           +    +++  D WS
Sbjct: 218 MEGI-FTSKTDTWS 230

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 20/207 (9%), Positives = 40/207 (19%), Gaps = 57/207 (27%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
             R    +V E++    L++          +         M  L       H  G+    
Sbjct: 101 HTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAGVALSI 154

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
             P  + +      + +A                                    +   D+
Sbjct: 155 DHPSRVRVSI-DGDVVLAYPA--------------------TMPDA--------NPQDDI 185

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
             +      L+      P       L    R                          P  
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ---------------------PIE 224

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKR 215
            A    ++      +  + +Q D   R
Sbjct: 225 PADIDRDIPFQISAVAARSVQGDGGIR 251

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 29/134 (21%), Positives = 47/134 (35%), Gaps = 29/134 (21%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL---MYQLCKGVAFCHGHGILHRDLK 70
            +++ E M   DLK ++R  R          +  L      +  G  +   +  +HRD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 71  PHNLLMDRKT--MTLKIADLGLARAFT------------LPIKKYTHEILTLWYRAPEVL 116
             N L+         KI D G+AR               LP+K         W   PE  
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---------WM-PPEAF 258

Query: 117 LGSTHYSTAVDMWS 130
           +    +++  D WS
Sbjct: 259 MEGI-FTSKTDTWS 271

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 30/132 (22%)

Query: 14  VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
           + +++  YM   DL ++IRS +    N  V  + S   Q+ +G+ +      +HRDL   
Sbjct: 97  LPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR 153

Query: 73  NLLMDRKTMTLKIADLGLARAFT--------------LPIKKYTHEILTLWYRAPEVLLG 118
           N ++D ++ T+K+AD GLAR                 LP+K         W  A E L  
Sbjct: 154 NCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVK---------WT-ALESLQT 202

Query: 119 STHYSTAVDMWS 130
              ++T  D+WS
Sbjct: 203 YR-FTTKSDVWS 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 60.0 bits (146), Expect = 5e-11
 Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 30/131 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             +V  YM   DL+ +IR+      N  V  +     Q+ KG+ +      +HRDL   N
Sbjct: 102 PLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158

Query: 74  LLMDRKTMTLKIADLGLAR--------------AFTLPIKKYTHEILTLWYRAPEVLLGS 119
            ++D +  T+K+AD GLAR                 LP+K         W  A E L   
Sbjct: 159 CMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK---------WM-ALESLQTQ 207

Query: 120 THYSTAVDMWS 130
             ++T  D+WS
Sbjct: 208 K-FTTKSDVWS 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 59.9 bits (146), Expect = 6e-11
 Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN---------TVKSLM---YQLCKGVAFCHG 61
           L +VFEYM   DL K++R+       +             +  ++    Q+  G+ +   
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLW 109
              +HRDL   N L+    + +KI D G++R               LPI+         W
Sbjct: 152 QHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR---------W 201

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
              PE ++    ++T  D+WS
Sbjct: 202 M-PPESIMYRK-FTTESDVWS 220

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 59.6 bits (145), Expect = 7e-11
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 41/217 (18%)

Query: 15  LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK 70
           L+++ EY+      DL +           +    + +++ ++ KG+ + H    +HRD+K
Sbjct: 95  LWIIMEYLGGGSALDLLE--------PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146

Query: 71  PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
             N+L+      +K+AD G+A   T    K    + T ++ APEV+  S  Y +  D+WS
Sbjct: 147 AANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWS 204

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     EL            ++ L  I                        P+ NP +L 
Sbjct: 205 LGITAIELARGEPPHSELHPMKVLFLI------------------------PKNNPPTLE 240

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
               N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 241 G---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 59.6 bits (145), Expect = 8e-11
 Identities = 35/138 (25%), Positives = 54/138 (39%), Gaps = 34/138 (24%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN---------TVKSL---MYQLCKGVAFCHG 61
           LYL  EY    +L  ++R  R    +             + + L      + +G+ +   
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------LPIKKYTHEILTLWYRA 112
              +HRDL   N+L+  +    KIAD GL+R            LP++         W  A
Sbjct: 161 KQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVR---------WM-A 209

Query: 113 PEVLLGSTHYSTAVDMWS 130
            E L  S  Y+T  D+WS
Sbjct: 210 IESLNYSV-YTTNSDVWS 226

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 60.1 bits (146), Expect = 8e-11
 Identities = 39/141 (27%), Positives = 59/141 (41%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK------------SLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+++ R  G     N               S  YQ+ +G+ +   
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLW 109
              +HRDL   N+L+  +   +KIAD GLAR               LP+K         W
Sbjct: 210 KKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK---------W 259

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             APE L     Y+   D+WS
Sbjct: 260 M-APEALFDRI-YTHQSDVWS 278

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 30/131 (22%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             +V  YM   DL+ +IR+      N  V  +     Q+ KG+ F      +HRDL   N
Sbjct: 166 PLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222

Query: 74  LLMDRKTMTLKIADLGLARAFT--------------LPIKKYTHEILTLWYRAPEVLLGS 119
            ++D +  T+K+AD GLAR                 LP+K         W  A E L   
Sbjct: 223 CMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK---------WM-ALESLQTQ 271

Query: 120 THYSTAVDMWS 130
             ++T  D+WS
Sbjct: 272 K-FTTKSDVWS 281

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 38/141 (26%), Positives = 58/141 (41%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN---------TVKSLM---YQLCKGVAFCHG 61
           L ++ E+    +L  Y+RS R       V          T++ L+   +Q+ KG+ F   
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLW 109
              +HRDL   N+L+  +   +KI D GLAR               LP+K         W
Sbjct: 167 RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLK---------W 216

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             APE +     Y+   D+WS
Sbjct: 217 M-APETIFDRV-YTIQSDVWS 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 36/140 (25%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN--------TVKSLM---YQLCKGVAFCHGH 62
           L +VFEYM   DL +++RS     + +            +  L+    Q+  G+ +  G 
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLWY 110
             +HRDL   N L+ +  + +KI D G++R               LPI+         W 
Sbjct: 178 HFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR---------WM 227

Query: 111 RAPEVLLGSTHYSTAVDMWS 130
             PE +L    ++T  D+WS
Sbjct: 228 -PPESILYRK-FTTESDVWS 245

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 3e-10
 Identities = 19/80 (23%), Positives = 38/80 (47%), Gaps = 4/80 (5%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +++ +   +DL+K    +    +     TV  L  ++   + + H H  +H D+K  NLL
Sbjct: 128 FMIMDRFGSDLQKI---YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184

Query: 76  MDRKTM-TLKIADLGLARAF 94
           ++ K    + + D GLA  +
Sbjct: 185 LNYKNPDQVYLVDYGLAYRY 204

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK------------SLMYQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G     +  +            S  YQL +G+ +   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLW 109
              +HRDL   N+L+  +   +KIAD GLAR               LP+K         W
Sbjct: 176 QKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVK---------W 225

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             APE L     Y+   D+WS
Sbjct: 226 M-APEALFDRV-YTHQSDVWS 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 43/148 (29%), Positives = 59/148 (39%), Gaps = 44/148 (29%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN----------------TVKSLM---YQLCK 54
           +YL+FEY    DL  Y+RS R+      +                 T + L+   YQ+ K
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYT 102
           G+ F      +HRDL   N+L+      +KI D GLAR               LP+K   
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVK--- 239

Query: 103 HEILTLWYRAPEVLLGSTHYSTAVDMWS 130
                 W  APE L     Y+   D+WS
Sbjct: 240 ------WM-APESLFEGI-YTIKSDVWS 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 4e-10
 Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 5/86 (5%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           ++V E +  DL+K              +TV  L  ++   + + H +  +H D+K  NLL
Sbjct: 128 FMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183

Query: 76  MDRKTM-TLKIADLGLARAFTLPIKK 100
           +  K    + +AD GL+  +      
Sbjct: 184 LGYKNPDQVYLADYGLSYRYCPNGNH 209

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 57.4 bits (139), Expect = 5e-10
 Identities = 45/227 (19%), Positives = 87/227 (38%), Gaps = 46/227 (20%)

Query: 15  LYLVFEYMD---TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP 71
            +LV EY     +DL +         + +    + ++ +   +G+A+ H H ++HRD+K 
Sbjct: 129 AWLVMEYCLGSASDLLEV------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182

Query: 72  HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST--HYSTAVDMW 129
            N+L+      +K+ D G A          +  + T ++ APEV+L      Y   VD+W
Sbjct: 183 GNILLSEPG-LVKLGDFGSASIMA---PANSF-VGTPYWMAPEVILAMDEGQYDGKVDVW 237

Query: 130 S--VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           S  + CI  EL  +       + +  L HI                         Q    
Sbjct: 238 SLGITCI--ELAERKPPLFNMNAMSALYHI------------------------AQNESP 271

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
           +L +   +  +   + ++  LQ  P  R +++  ++H +        
Sbjct: 272 ALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 42/141 (29%), Positives = 62/141 (43%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN---------TVKSLM---YQLCKGVAFCHG 61
           LY++ EY    +L++Y+R+ R  G     +         T K L+   YQL +G+ +   
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTLW 109
              +HRDL   N+L+  +   +KIAD GLAR               LP+K         W
Sbjct: 222 QKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVK---------W 271

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             APE L     Y+   D+WS
Sbjct: 272 M-APEALFDRV-YTHQSDVWS 290

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 56.1 bits (136), Expect = 1e-09
 Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 37/141 (26%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVN---------TVKSLM---YQLCKGVAFCHG 61
           L ++F Y    DL +++       +    +              +    Q+  G+ +   
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKYTHEILTLW 109
           H ++H+DL   N+L+  K + +KI+DLGL R               LPI+         W
Sbjct: 147 HHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIR---------W 196

Query: 110 YRAPEVLLGSTHYSTAVDMWS 130
             APE ++    +S   D+WS
Sbjct: 197 M-APEAIMYGK-FSIDSDIWS 215

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 5e-09
 Identities = 13/80 (16%), Positives = 32/80 (40%), Gaps = 3/80 (3%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
           +LV   +   L+  +         +   +V  +  +L   + F H +  +H ++   N+ 
Sbjct: 134 FLVLPSLGRSLQSALD--VSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191

Query: 76  MDRKTM-TLKIADLGLARAF 94
           +D +    + +A  G A  +
Sbjct: 192 VDPEDQSQVTLAGYGFAFRY 211

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 54.2 bits (131), Expect = 6e-09
 Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 45/149 (30%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK--------------------SLMYQLC 53
           L L+ EY     L+ ++R  R+ G     +                       S  +Q+ 
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKY 101
           +G+ +     ++HRDL   N+L+  +   +KI+D GL+R               +P+K  
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-- 217

Query: 102 THEILTLWYRAPEVLLGSTHYSTAVDMWS 130
                  W  A E L     Y+T  D+WS
Sbjct: 218 -------WM-AIESLFDHI-YTTQSDVWS 237

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 54.1 bits (131), Expect = 6e-09
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL-TLW 109
            G+ F H +  +HRD+K  N+L+D    T KI+D GLARA        T     I+ T  
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARAS--EKFAQTVMTSRIVGTTA 200

Query: 110 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
           Y APE L G    +   D++S   +  E++T
Sbjct: 201 YMAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 35/149 (23%), Positives = 57/149 (38%), Gaps = 45/149 (30%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK--------------------SLMYQLC 53
           + L+FEYM   DL +++RS          ++                       +  Q+ 
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKY 101
            G+A+      +HRDL   N L+    M +KIAD GL+R               +PI+  
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIR-- 241

Query: 102 THEILTLWYRAPEVLLGSTHYSTAVDMWS 130
                  W   PE +  +  Y+T  D+W+
Sbjct: 242 -------WM-PPESIFYNR-YTTESDVWA 261

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 28/138 (20%), Positives = 50/138 (36%), Gaps = 23/138 (16%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
            LV + +   L+         G    V TV     Q+   V   H   +++RD+KP N L
Sbjct: 82  VLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL 138

Query: 76  MDRKTM----TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY-STAV---- 126
           + R        + + D G+ + +       T + +   YR  + L G+  Y S       
Sbjct: 139 IGRPNSKNANMIYVVDFGMVKFY---RDPVTKQHIP--YREKKNLSGTARYMSINTHLGR 193

Query: 127 ------DMWSVACIFAEL 138
                 D+ ++  +F   
Sbjct: 194 EQSRRDDLEALGHVFMYF 211

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 3e-08
 Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 10/109 (9%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
            +V E +   L+     F        + TV  L  Q+   + + H    +HRD+KP N L
Sbjct: 81  VMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 137

Query: 76  MDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
           M        + I D GLA+ +    + + H    + YR  + L G+  Y
Sbjct: 138 MGLGKKGNLVYIIDFGLAKKYRDA-RTHQH----IPYRENKNLTGTARY 181

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 21/138 (15%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
            LV + +   L+     F      + + TV  L  Q+   V F H    LHRD+KP N L
Sbjct: 79  VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135

Query: 76  MDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY-STAV------ 126
           M        + I D GLA+ +      + H    + YR  + L G+  Y S         
Sbjct: 136 MGLGRRANQVYIIDFGLAKKYRDT-STHQH----IPYRENKNLTGTARYASVNTHLGIEQ 190

Query: 127 ----DMWSVACIFAELVT 140
               D+ S+  +    + 
Sbjct: 191 SRRDDLESLGYVLMYFLR 208

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.6 bits (124), Expect = 4e-08
 Identities = 31/138 (22%), Positives = 53/138 (38%), Gaps = 23/138 (16%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
            +V E +   L+     F        + TV  +  QL   + + H   +++RD+KP N L
Sbjct: 81  AMVLELLGPSLEDL---FDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL 137

Query: 76  MDRKTM----TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY-STAV---- 126
           + R        + I D  LA+ +  P +   H I    YR  + L G+  Y S       
Sbjct: 138 IGRPGNKTQQVIHIIDFALAKEYIDP-ETKKH-IP---YREHKSLTGTARYMSINTHLGK 192

Query: 127 ------DMWSVACIFAEL 138
                 D+ ++  +F   
Sbjct: 193 EQSRRDDLEALGHMFMYF 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 24/106 (22%)

Query: 47  SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----------- 95
              +Q+ KG+ F      +HRDL   N+L+  +   +KI D GLAR              
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 96  -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 140
            LP+K         W  APE +     Y+   D+WS   +  E+ +
Sbjct: 256 RLPLK---------WM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 48.4 bits (116), Expect = 5e-07
 Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 7/65 (10%)

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL-TLW 109
           +G+ + H   I+HRD+K  N+L+D      KI D G+++         TH    +  TL 
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKG--TELDQTHLSTVVKGTLG 206

Query: 110 YRAPE 114
           Y  PE
Sbjct: 207 YIDPE 211

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 11/68 (16%)

Query: 54  KGVAFCHGHG---ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL- 106
           +G+A+ H H    I+HRD+K  N+L+D +     + D GLA+       K TH    +  
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMD---YKDTHVTTAVRG 197

Query: 107 TLWYRAPE 114
           T+ + APE
Sbjct: 198 TIGHIAPE 205

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 33/245 (13%), Positives = 67/245 (27%), Gaps = 62/245 (25%)

Query: 4   KQGQNKEGRTVLYLVFEYMD-TDLKKYIRS---FRQTGENIPVNTVKSLMYQLCKG---- 55
           K     +  T++      ++  + +K       F     +IP   +  + + + K     
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP-SAHIPTILLSLIWFDVIKSDVMV 406

Query: 56  -VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 114
            V   H + ++ +           K  T+ I  + L     L  +   H  +   Y  P+
Sbjct: 407 VVNKLHKYSLVEKQ---------PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457

Query: 115 VLLGSTHYSTAVDMWSVACIF---------AELVTKTALFPGDSELQQLLHIFRLLGTPN 165
                      +D +     +          E   +  LF        +   FR L    
Sbjct: 458 TFDSDDLIPPYLDQY----FYSHIGHHLKNIEHPERMTLFR------MVFLDFRFLE--- 504

Query: 166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
           +K+          H+   WN               L+ L+Q+  Y     I         
Sbjct: 505 QKI---------RHDSTAWNASG----------SILNTLQQLKFY--KPYICDNDPKYER 543

Query: 226 YFDDL 230
             + +
Sbjct: 544 LVNAI 548

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	235
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.75
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.52
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.41
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.09
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.49
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.33
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.18
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.25
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.75
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.64
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.87
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.89
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.33
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.62
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	88.98
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.88
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	87.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	85.74
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.51
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	83.07
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.63

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-52  Score=325.55  Aligned_cols=199  Identities=26%  Similarity=0.465  Sum_probs=170.1

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.++.+++++++|||||||+| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+|||++.++ 
T Consensus        95 v~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-  169 (311)
T 4aw0_A           95 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-  169 (311)
T ss_dssp             CCEEEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-
T ss_pred             CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-
Confidence            3456677888999999999985 999999773    4699999999999999999999999999999999999999777 


Q ss_pred             eEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      .++|+|||+++.+....  .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+...++..
T Consensus       170 ~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  248 (311)
T 4aw0_A          170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK  248 (311)
T ss_dssp             CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            89999999998765332  2345668999999999998655 89999999999999999999999999888777777654


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCcC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK------AMEHPYFDDLDKT  233 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------ll~hp~f~~~~~~  233 (235)
                      ....                            ....+++++++||++||..||.+|||++|      +++||||++++|+
T Consensus       249 ~~~~----------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          249 LEYD----------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             TCCC----------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             CCCC----------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence            2110                            01247889999999999999999999988      5899999999998


Q ss_pred             CC
Q 026660          234 RL  235 (235)
Q Consensus       234 ~~  235 (235)
                      .|
T Consensus       301 ~l  302 (311)
T 4aw0_A          301 NL  302 (311)
T ss_dssp             TG
T ss_pred             Hh
Confidence            75

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.5e-52  Score=324.30  Aligned_cols=197  Identities=25%  Similarity=0.383  Sum_probs=166.9

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..++.+++++.+|+|||||+| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+|||++.++ .
T Consensus        90 ~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~  164 (304)
T 3ubd_A           90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-H  164 (304)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-C
T ss_pred             eEEEEEEECCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-C
Confidence            445667788899999999985 999999773    4699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus       165 vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  243 (304)
T 3ubd_A          165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL  243 (304)
T ss_dssp             EEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEecccccceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence            99999999987655545556678999999999998655 88999999999999999999999999888777776654211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                      .                            ....+|+++++||++||+.||.+|||     ++|+++||||++++|+.
T Consensus       244 ~----------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          244 G----------------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             C----------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             C----------------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence            0                            01247899999999999999999998     57999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-50  Score=321.16  Aligned_cols=196  Identities=19%  Similarity=0.401  Sum_probs=167.1

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.++.+++++.+|||||||+| +|.+++.+     ..++++.++.++.||+.||+|||++|++||||||+|||++.++ 
T Consensus       134 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-  207 (346)
T 4fih_A          134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-  207 (346)
T ss_dssp             CCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-
T ss_pred             CcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-
Confidence            3455667788899999999985 99999875     3599999999999999999999999999999999999999777 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .+||+|||+++.+...........||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+.+..+....
T Consensus       208 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  286 (346)
T 4fih_A          208 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  286 (346)
T ss_dssp             CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            899999999987766555666778999999999987655 8999999999999999999999999988877776665421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ... .                        .....+++++++||++||..||.+|||++|+++||||++.
T Consensus       287 ~~~-~------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          287 PPR-L------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             CCC-C------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCC-C------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            110 0                        0112478999999999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.5e-50  Score=311.99  Aligned_cols=192  Identities=29%  Similarity=0.437  Sum_probs=154.6

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +.++.+++++.+|+|||||+|+|.+++.+    .+.+++..++.++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus        77 ~~~~~~~~~~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~v  151 (275)
T 3hyh_A           77 KLYDVIKSKDEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NV  151 (275)
T ss_dssp             CEEEEEECSSEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CE
T ss_pred             eEEEEEEECCEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CE
Confidence            44566778889999999999999999976    35699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++..... .......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+......
T Consensus       152 kl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~  230 (275)
T 3hyh_A          152 KIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT  230 (275)
T ss_dssp             EECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             EEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999999765433 23345689999999999987665678999999999999999999999988776666655432110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                                  ....+|++++++|++||+.||.+|||++|+++||||+.
T Consensus       231 ----------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ----------------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                                        01247899999999999999999999999999999973

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-50  Score=321.51  Aligned_cols=197  Identities=26%  Similarity=0.451  Sum_probs=166.4

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |..++.+++++.+|||||||+| +|.+++..  ..+..+++..++.++.||+.||+|||++|++||||||+|||++.++ 
T Consensus        86 V~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-  162 (350)
T 4b9d_A           86 VQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-  162 (350)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-
T ss_pred             CcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-
Confidence            3455667788899999999985 99999986  3455689999999999999999999999999999999999999777 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...++....
T Consensus       163 ~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~  241 (350)
T 4b9d_A          163 TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS  241 (350)
T ss_dssp             CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             CEEEcccccceeecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            899999999986653323334567999999999997655 8999999999999999999999999988877777665431


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..+                           ....+++++++||++||..||.+|||++|+++||||+.-
T Consensus       242 ~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          242 FPP---------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             CCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCC---------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            110                           112578999999999999999999999999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=321.68  Aligned_cols=196  Identities=19%  Similarity=0.404  Sum_probs=167.1

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |..++.+++++.+|||||||+| +|.+++..     ..+++..++.++.||+.||+|||++|++||||||+|||++.++ 
T Consensus       211 V~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-  284 (423)
T 4fie_A          211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-  284 (423)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-
T ss_pred             CceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-
Confidence            3455667778899999999985 99999865     3599999999999999999999999999999999999999777 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .+||+|||+++.+...........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus       285 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  363 (423)
T 4fie_A          285 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  363 (423)
T ss_dssp             CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            899999999987766555566778999999999987655 8999999999999999999999999988877776655421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...                         ......+++++++||++||..||.+|||+.|+|+||||+..
T Consensus       364 ~~~-------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          364 PPR-------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             CCC-------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCC-------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            110                         01112578999999999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=318.28  Aligned_cols=219  Identities=37%  Similarity=0.695  Sum_probs=179.9

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .+++.+.+|||||||+|+|.+++.+    .+.+++..++.++.||+.||+|||++|++||||||+|||++.++ .++++|
T Consensus       127 ~~~~~~~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECC
T ss_pred             ccccCCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEee
Confidence            3556788999999999999999854    45799999999999999999999999999999999999999777 899999


Q ss_pred             cCCcccccCC----CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           88 LGLARAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        88 f~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      ||+++.+...    ........||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999865432    223445689999999999987766899999999999999999999999999999999999998888


Q ss_pred             CCCCCcccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ++...+.........   .......+..+....++.++++++||++||..||.+|||+.|+|+||||+.+.
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            876655443221111   11222333344555667899999999999999999999999999999999764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-48  Score=309.28  Aligned_cols=202  Identities=19%  Similarity=0.267  Sum_probs=162.0

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |..++.+++++.+|||||||+| +|.+++.+.    +.+++..++.++.||+.||+|||+++++||||||+|||++.++.
T Consensus       113 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~  188 (336)
T 4g3f_A          113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS  188 (336)
T ss_dssp             CCEEEEEEETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC
T ss_pred             CcEEEEEEECCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC
Confidence            3455667778899999999985 999999763    46999999999999999999999999999999999999997765


Q ss_pred             eEEEeecCCcccccCCCC-----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIK-----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      .++|+|||+++.......     ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....
T Consensus       189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  267 (336)
T 4g3f_A          189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK  267 (336)
T ss_dssp             CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH
T ss_pred             EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence            699999999986643221     123357899999999998755 89999999999999999999999987655444444


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH-------------hC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-------------ME  223 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l-------------l~  223 (235)
                      +...  .                       .......+.++++++++|++||..||.+|||+.|+             ++
T Consensus       268 i~~~--~-----------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~  322 (336)
T 4g3f_A          268 IASE--P-----------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK  322 (336)
T ss_dssp             HHHS--C-----------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred             HHcC--C-----------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence            4331  0                       01112234688999999999999999999999997             67


Q ss_pred             CCCCCCCCcCC
Q 026660          224 HPYFDDLDKTR  234 (235)
Q Consensus       224 hp~f~~~~~~~  234 (235)
                      |||++.+...+
T Consensus       323 hPw~~~~~~Pr  333 (336)
T 4g3f_A          323 SPWKGEYKEPR  333 (336)
T ss_dssp             SCSSSSCCCCC
T ss_pred             CCCcCCCCCCC
Confidence            99999887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-48  Score=302.25  Aligned_cols=186  Identities=26%  Similarity=0.388  Sum_probs=150.7

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEee
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      +++.+|||||||+| +|.+++.+.    +.+++..+..++.||+.||+|||+++  ++||||||+|||++..+..+||+|
T Consensus       100 ~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          100 GKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             TEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             CCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence            46789999999985 999999763    46999999999999999999999998  999999999999985444899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||+++....  .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.............   ...+
T Consensus       176 FGla~~~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~---~~~~  248 (290)
T 3fpq_A          176 LGLATLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---GVKP  248 (290)
T ss_dssp             TTGGGGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---TCCC
T ss_pred             CcCCEeCCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc---CCCC
Confidence            999975432  33445689999999998864  3899999999999999999999999876554443332211   0000


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                            .......++++++||++||..||.+|||++|+++||||++
T Consensus       249 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                  0011246788999999999999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.5e-48  Score=311.45  Aligned_cols=221  Identities=25%  Similarity=0.414  Sum_probs=161.6

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      .....+++++++|+|||||+| +|.+++.       .++++.++.++.||+.||+|||++|++||||||+|||++.+...
T Consensus        84 ~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~  156 (361)
T 4f9c_A           84 GVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKK  156 (361)
T ss_dssp             CCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred             eEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCe
Confidence            345566788899999999985 9999883       48999999999999999999999999999999999999876459


Q ss_pred             EEEeecCCcccccCCCC----------------------------CcccccccccccCchhhhCCCCCCchhhHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK----------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI  134 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~  134 (235)
                      ++|+|||+++.......                            ......||+.|+|||++.+...++.++||||+||+
T Consensus       157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i  236 (361)
T 4f9c_A          157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI  236 (361)
T ss_dssp             EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence            99999999975432211                            12334689999999999876668999999999999


Q ss_pred             HHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCCCCccc-------------------cccc---ccc--cC--CCCCCcc
Q 026660          135 FAELVTKTALFP-GDSELQQLLHIFRLLGTPNEKVWPG-------------------VSSL---MNW--HE--YPQWNPQ  187 (235)
Q Consensus       135 l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~---~~~--~~--~~~~~~~  187 (235)
                      +|+|++|..||. +.++.+++..+....+.+.......                   ..+.   ...  ..  .......
T Consensus       237 l~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  316 (361)
T 4f9c_A          237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHA  316 (361)
T ss_dssp             HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------------
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccc
Confidence            999999999995 4556666666665544321100000                   0000   000  00  0000000


Q ss_pred             chhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       188 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ........+++++++||++||..||.+|||++|+|+||||++++
T Consensus       317 ~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          317 TNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            11123346889999999999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-46  Score=319.52  Aligned_cols=197  Identities=25%  Similarity=0.368  Sum_probs=162.9

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |..+..+++++++|+|||||+| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+|||++.++ 
T Consensus       255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-  329 (689)
T 3v5w_A          255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-  329 (689)
T ss_dssp             CCEEEEEECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-
T ss_pred             eEEEEEEEECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-
Confidence            3455667888999999999985 999999773    4699999999999999999999999999999999999999877 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIF  158 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~  158 (235)
                      .++|+|||+++.....  ......||+.|+|||++.....++.++|+||+||++|+|++|..||.+...   .+......
T Consensus       330 ~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          330 HVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             CEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             CEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            8999999999866533  334568999999999997555589999999999999999999999975432   22222222


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                      ..   . .                        .....+|+++++||++||..||.+|++     ++++++||||++++|+
T Consensus       408 ~~---~-~------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          408 TM---A-V------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HC---C-C------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             CC---C-C------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            11   0 0                        011247899999999999999999998     7999999999999997


Q ss_pred             C
Q 026660          234 R  234 (235)
Q Consensus       234 ~  234 (235)
                      .
T Consensus       460 ~  460 (689)
T 3v5w_A          460 M  460 (689)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-44  Score=286.14  Aligned_cols=225  Identities=49%  Similarity=0.936  Sum_probs=185.1

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+..++++.+|+||||++|+|.+++..   ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~k  159 (311)
T 3niz_A           84 LIDVIHSERCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALK  159 (311)
T ss_dssp             EEEEECCSSCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEE
T ss_pred             eeeEEccCCEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEE
Confidence            3445567788999999999999998875   234699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||.+.....+........+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....+.+
T Consensus       160 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  239 (311)
T 3niz_A          160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP  239 (311)
T ss_dssp             ECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred             EccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence            99999998776555555566789999999999776668999999999999999999999999888888888888888888


Q ss_pred             CCCCcccccccccccC--CCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ....+........+..  .............+.++++++++|++||+.||.+|||++|+++||||++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence            7776665544322221  11222233445556789999999999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.9e-45  Score=287.24  Aligned_cols=192  Identities=25%  Similarity=0.403  Sum_probs=137.8

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ..+.++|+|||||+| +|.+++..... ....+...++.++.||+.||+|||++|++||||||+|||++.++ .+||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence            345679999999985 99999976321 12245667899999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCC------------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           89 GLARAFTLPIK------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        89 ~~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      |+++.......            ......||+.|+|||++.+.. ++.++||||+||++|+|++   ||....+  ....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQME--RVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence            99976543221            123457899999999997654 8999999999999999996   7754322  2222


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      +..........                        .....++.+.++|++||+.||.+|||+.|+++||||++++|.
T Consensus       237 ~~~~~~~~~p~------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          237 LTDVRNLKFPP------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHTTCCCH------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHhcCCCCC------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            22211111000                        011245677899999999999999999999999999998873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-43  Score=275.85  Aligned_cols=222  Identities=48%  Similarity=0.919  Sum_probs=181.8

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++.+|+||||++|+|.+++..   ..+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl  142 (292)
T 3o0g_A           67 HDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKL  142 (292)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEE
T ss_pred             EeEEEeCCEEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEE
Confidence            344566778999999999988888765   245799999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+.....+........+|+.|+|||++.+...++.++||||+||++++|++|..| |.+....+....+.+..+.+
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            99999987765555566677899999999998766579999999999999999988777 56667777788888888888


Q ss_pred             CCCCcccccccccccCCCCCCc-cchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ....+................. .......+.++++++++|++||+.||.+|||++|+++||||+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            8877776655433332222221 123334457889999999999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-44  Score=305.39  Aligned_cols=202  Identities=25%  Similarity=0.432  Sum_probs=167.9

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-C
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-T   80 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~   80 (235)
                      |.+.+.+++++++|||||||+| +|.+++.+   ..+.+++..++.++.||+.||+|||+++++||||||+||+++.+ .
T Consensus       217 v~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~  293 (573)
T 3uto_A          217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS  293 (573)
T ss_dssp             CCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred             CeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC
Confidence            3455667888999999999985 99998854   23569999999999999999999999999999999999999854 2


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ..++|+|||+++.+... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus       294 ~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~  371 (573)
T 3uto_A          294 NELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC  371 (573)
T ss_dssp             CCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             CCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence            38999999999876533 3334557899999999998655 899999999999999999999999998887777766542


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ....+                        ......+++++++||++||..||.+|||+.|+|+||||+..++.
T Consensus       372 ~~~~~------------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          372 DWNMD------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             CCCCC------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             CCCCC------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            21111                        11223578999999999999999999999999999999987764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-43  Score=278.11  Aligned_cols=228  Identities=45%  Similarity=0.833  Sum_probs=184.0

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ--TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..+..++++.+|+||||++|+|.+++.....  ....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~  146 (317)
T 2pmi_A           68 LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-Q  146 (317)
T ss_dssp             EEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-C
T ss_pred             EEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-C
Confidence            3445567788999999999999999987532  224589999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||.+.....+........+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....+
T Consensus       147 ~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  226 (317)
T 2pmi_A          147 LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG  226 (317)
T ss_dssp             EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999999987655444445567799999999997655588999999999999999999999999999888988888888


Q ss_pred             CCCCCCcccccccccccCC-CCCCccc-----hhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          163 TPNEKVWPGVSSLMNWHEY-PQWNPQS-----LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .+....++........... .......     .......++++++++|++||+.||.+|||+.++++||||+++.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            8888777665443222111 1111111     111223578999999999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=278.44  Aligned_cols=189  Identities=20%  Similarity=0.272  Sum_probs=146.6

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|||||||+ |||.+++..   ....+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+|||++
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla  179 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLA  179 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSC
T ss_pred             CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCc
Confidence            45799999998 599999975   235699999999999999999999999999999999999999766 9999999999


Q ss_pred             ccccCCC--CCcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPI--KKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +......  .......||+.|+|||++.+.  ..++.++|||||||++|||++|..||.+.+...............+  
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p--  257 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP--  257 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC--
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence            7654322  234456889999999999743  3478999999999999999999999988665555444433211110  


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH------hCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYF  227 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l------l~hp~f  227 (235)
                                          .......++++++.++|.+||+.||.+|||+.++      ++|+|-
T Consensus       258 --------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          258 --------------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             --------------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             --------------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                                1111223578899999999999999999999976      567764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.8e-43  Score=275.63  Aligned_cols=222  Identities=51%  Similarity=0.936  Sum_probs=174.5

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++.+|+||||++++|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl  141 (288)
T 1ob3_A           66 YDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKI  141 (288)
T ss_dssp             EEEEECSSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEE
T ss_pred             eeEEccCCeEEEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEE
Confidence            3445566789999999999999998752   35689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+.....+........+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+.+..+.+.
T Consensus       142 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (288)
T 1ob3_A          142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (288)
T ss_dssp             CCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCC
Confidence            99999976654444445567799999999997655689999999999999999999999999988888888888888777


Q ss_pred             CCCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...++......... ......+.........++++++++|++||+.||.+|||+.++++||||++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN  288 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence            66665543322211 1111122223334456899999999999999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=281.49  Aligned_cols=224  Identities=48%  Similarity=0.925  Sum_probs=180.1

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++..|+||||++|+|.+++...   +..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl  141 (324)
T 3mtl_A           66 HDIIHTEKSLTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKL  141 (324)
T ss_dssp             EEEEECSSCEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEE
T ss_pred             eeEEeeCCEEEEEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEE
Confidence            3445567789999999999999999763   34689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+.....+........+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+.+..+.+.
T Consensus       142 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T 3mtl_A          142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT  221 (324)
T ss_dssp             CSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999976655444455567799999999998766689999999999999999999999999999999999999999888


Q ss_pred             CCCccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          166 EKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       166 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ...++.........  ..............+.++++++++|++||+.||.+|||++|+++||||.++...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            88776654322111  222233334455566789999999999999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.2e-44  Score=279.12  Aligned_cols=190  Identities=22%  Similarity=0.302  Sum_probs=155.3

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR---------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN   73 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~n   73 (235)
                      +.++...+++.+|||||||+ |||.+++.+..         .....+++..+..++.||+.||+|||+++++||||||+|
T Consensus        79 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~N  158 (299)
T 4asz_A           79 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRN  158 (299)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhh
Confidence            44556667788999999998 59999998742         234569999999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 026660           74 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  150 (235)
Q Consensus        74 il~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  150 (235)
                      ||++.++ .+||+|||+++.......  ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+.
T Consensus       159 ILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          159 CLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             EEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EEECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999766 899999999975543222  223346789999999998655 8999999999999999998 8999998887


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .+....+......+                           ....+++++.+++.+||+.||.+|||+.+++
T Consensus       237 ~~~~~~i~~~~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          237 NEVIECITQGRVLQ---------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHcCCCCC---------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            77666655421110                           1124788999999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.5e-43  Score=280.79  Aligned_cols=224  Identities=52%  Similarity=0.964  Sum_probs=175.4

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC----C
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----M   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~----~   81 (235)
                      .+..++++.+|+||||++|+|.+++..    ...+++..++.++.||+.||+|||+++++|+||||+||+++.++    .
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A           99 KSVIHHNHRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC
T ss_pred             EEEEecCCEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc
Confidence            344566778999999999999999976    34699999999999999999999999999999999999995332    2


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||.+..............+|..|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  254 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL  254 (329)
T ss_dssp             EEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             eEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence            59999999998766554455556779999999999876668999999999999999999999999999999999998888


Q ss_pred             CCCCCCCcccccccccccCCC-CCCccchhh-cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYP-QWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      +.+....+........|.... ......+.. ....++++++++|++||+.||.+|||+.|+++||||++.+|+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            888877776655443332211 111111111 122378899999999999999999999999999999999885

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=280.05  Aligned_cols=192  Identities=21%  Similarity=0.315  Sum_probs=149.8

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ-----------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP   71 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~   71 (235)
                      +.++...+++.+|||||||+ |||.+++.+...           ....+++..++.++.|++.||+|||+++++||||||
T Consensus       107 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp  186 (329)
T 4aoj_A          107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT  186 (329)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             cEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH
Confidence            44555667788999999998 599999987432           224589999999999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 026660           72 HNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD  148 (235)
Q Consensus        72 ~nil~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  148 (235)
                      +|||++.++ .+||+|||+++......  .......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.
T Consensus       187 ~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~  264 (329)
T 4aoj_A          187 RNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQL  264 (329)
T ss_dssp             GGEEEETTT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred             hhEEECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCC
Confidence            999999766 99999999998654322  2234457899999999998655 8999999999999999998 89999988


Q ss_pred             CHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          149 SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...+....+......+                           ....+++++.+++++||+.||.+|||+.|++++
T Consensus       265 ~~~~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          265 SNTEAIDCITQGRELE---------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CHHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCC---------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8777666655421110                           112478899999999999999999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=272.42  Aligned_cols=218  Identities=44%  Similarity=0.793  Sum_probs=176.7

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+....+++||||++|+|.+++..  .....+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Df  164 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADF  164 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSC
T ss_pred             CCCceeEEEEehhhhcCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeC
Confidence            344557899999999999999987  3334599999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+....+.+....
T Consensus       165 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          165 GLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             SCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccCCC-cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999765433 2334557799999999998655 78999999999999999999999999999999999988888877776


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +........ ...............+.+++++.++|++||+.||.+|||+.|+++||||++.+.
T Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          243 WPRDVSLPR-GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             SCSSCSSCG-GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             ccchhhccc-cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            654333211 122223334445556689999999999999999999999999999999997543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=284.23  Aligned_cols=196  Identities=23%  Similarity=0.352  Sum_probs=161.2

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus        89 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~i  163 (353)
T 3txo_A           89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HC  163 (353)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CE
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CE
Confidence            34455677889999999985 999999773    4699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+....+......
T Consensus       164 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3txo_A          164 KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV  242 (353)
T ss_dssp             EECCCTTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEccccceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999999976544444455667899999999987654 789999999999999999999999998887777766542110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~ll~hp~f~~~~~~~  234 (235)
                                                  ....+++++.++|++||+.||.+||++      +++++||||++++|+.
T Consensus       243 ----------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          243 ----------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence                                        011377899999999999999999998      8999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.6e-43  Score=276.23  Aligned_cols=192  Identities=21%  Similarity=0.275  Sum_probs=155.5

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK   70 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~   70 (235)
                      ..++...+++.+|||||||+ |||.++|.....            ....+++..+..++.||+.||+|||+++++|||||
T Consensus        93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  172 (308)
T 4gt4_A           93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA  172 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            34455566778999999998 599999976421            12458999999999999999999999999999999


Q ss_pred             CCcEEEcCCCCeEEEeecCCcccccCC--CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 026660           71 PHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG  147 (235)
Q Consensus        71 ~~nil~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~  147 (235)
                      |+|||++.++ .+||+|||+++.....  ........||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+
T Consensus       173 ~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~  250 (308)
T 4gt4_A          173 TRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCG  250 (308)
T ss_dssp             GGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCC
Confidence            9999999776 8999999999765432  22344567899999999998665 8999999999999999998 8999998


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ....+....+......                           ....++++++.+++.+||+.||.+|||+.+|+++
T Consensus       251 ~~~~~~~~~i~~~~~~---------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          251 YSNQDVVEMIRNRQVL---------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCHHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8876666554421110                           0112478899999999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.6e-42  Score=281.20  Aligned_cols=223  Identities=35%  Similarity=0.691  Sum_probs=179.1

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .+..++|+||||+++++.+.+..+......+++..++.++.||+.||+|||++|++|+||||+||+++.....++|+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            56677999999999988888887767777899999999999999999999999999999999999998433499999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....+.+....+
T Consensus       188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765433 22334567899999999977666899999999999999999999999999998888888888777765433


Q ss_pred             ccccccccccCCCCCCccchhh-cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ............+......... .....+++++++|++||..||.+|||+.++++||||+++.+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            3222211111222222222222 223588999999999999999999999999999999987664

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-42  Score=276.11  Aligned_cols=223  Identities=39%  Similarity=0.744  Sum_probs=183.7

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+..++++..|+||||++++|.+++..   ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl  153 (346)
T 1ua2_A           78 LDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKL  153 (346)
T ss_dssp             EEEECCTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEE
T ss_pred             EEEEeeCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEE
Confidence            344566778999999999999988864   334689999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+....+.+.
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          154 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT  233 (346)
T ss_dssp             CCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999987765555555667899999999997665578999999999999999999999999999999888888888877


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...|+.........................++++++++|++||..||.+|||+.|+++||||++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence            7766655443332222222222333444578899999999999999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-42  Score=276.71  Aligned_cols=195  Identities=23%  Similarity=0.320  Sum_probs=164.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++.+.+|+||||++| +|.+++.+.    +.++++.++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        71 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vk  145 (337)
T 1o6l_A           71 KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIK  145 (337)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEE
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEE
Confidence            3455667889999999985 999999762    4689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...... 
T Consensus       146 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-  223 (337)
T 1o6l_A          146 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-  223 (337)
T ss_dssp             ECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred             EeeccchhhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999999976544444455667899999999987654 789999999999999999999999988776665555431000 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                                 ....++++++++|++||+.||.+||     +++++++||||++++|+.
T Consensus       224 ---------------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          224 ---------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                       0124788999999999999999999     899999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-42  Score=279.24  Aligned_cols=196  Identities=29%  Similarity=0.437  Sum_probs=165.0

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~v  157 (345)
T 1xjd_A           83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HI  157 (345)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CE
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CE
Confidence            34455677889999999975 999999763    4699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+....+......
T Consensus       158 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  236 (345)
T 1xjd_A          158 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF  236 (345)
T ss_dssp             EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999999976544334455667899999999997655 799999999999999999999999988876666655431000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~hp~f~~~~~~~  234 (235)
                                                  ....++++++++|++||..||.+||++. ++++||||++++|+.
T Consensus       237 ----------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          237 ----------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  280 (345)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             ----------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence                                        0113778999999999999999999998 999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.6e-43  Score=279.91  Aligned_cols=187  Identities=23%  Similarity=0.391  Sum_probs=150.4

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM   76 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~   76 (235)
                      +.++.+|||||||+ |||.++|++....            ...++++.+..++.||+.||+|||+++++||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            44567999999998 5999999874331            3458999999999999999999999999999999999999


Q ss_pred             cCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 026660           77 DRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  153 (235)
Q Consensus        77 ~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  153 (235)
                      +.++ .+||+|||+++.......  ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.
T Consensus       219 ~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9776 899999999986643322  234456789999999998655 8999999999999999998 8999987654343


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .......-..+.                          ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       297 ~~~~i~~g~~~~--------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCC--------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            333332111110                          112467899999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-42  Score=286.60  Aligned_cols=226  Identities=38%  Similarity=0.707  Sum_probs=169.9

Q ss_pred             cccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ++.....++...+|+||||++|+|.+++..    ...+++..++.++.||+.||+|||++|++||||||+|||++.++ .
T Consensus       120 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~  194 (458)
T 3rp9_A          120 IVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-S  194 (458)
T ss_dssp             ECCCSCTTTCCCEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-C
T ss_pred             EEecCCcccCceEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-C
Confidence            333444566788999999999999999865    45699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCC---------------------------CcccccccccccCchhhhCCCCCCchhhHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK---------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF  135 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~---------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l  135 (235)
                      ++|+|||+++.......                           ......+|+.|+|||++.....++.++||||+||++
T Consensus       195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF  274 (458)
T ss_dssp             EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred             EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence            99999999976543211                           223446799999999876556689999999999999


Q ss_pred             HHHHh-----------CCCCCCCCC--------------------HHHHHHHHHHHhCCCCCCCccccccccc---ccCC
Q 026660          136 AELVT-----------KTALFPGDS--------------------ELQQLLHIFRLLGTPNEKVWPGVSSLMN---WHEY  181 (235)
Q Consensus       136 ~~l~~-----------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  181 (235)
                      |+|++           |..+|.+..                    ...++..+...++.+....+........   ....
T Consensus       275 ~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~  354 (458)
T 3rp9_A          275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF  354 (458)
T ss_dssp             HHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS
T ss_pred             HHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc
Confidence            99998           666665543                    2455666667777666543332221100   0111


Q ss_pred             CCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .......+....+..++++++||++||..||.+|||++|+|+||||+++.+.
T Consensus       355 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          355 PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             CCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             CCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            2222334455566789999999999999999999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3e-42  Score=277.49  Aligned_cols=195  Identities=24%  Similarity=0.377  Sum_probs=164.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++.+.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vk  161 (353)
T 2i0e_A           87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIK  161 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEE
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEE
Confidence            3445677889999999975 999999763    3599999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...... 
T Consensus       162 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-  239 (353)
T 2i0e_A          162 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-  239 (353)
T ss_dssp             ECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred             EEeCCcccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-
Confidence            999999976443334445667899999999997655 799999999999999999999999988877766666542100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                                                 ....++++++++|++||..||.+||+     ++++++||||+.++|+.
T Consensus       240 ---------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          240 ---------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence                                       01247889999999999999999994     69999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-41  Score=281.51  Aligned_cols=222  Identities=38%  Similarity=0.732  Sum_probs=167.8

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .....+.+|+||||++|+|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcCCeEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEcc
Confidence            3344477999999999999999865    45699999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCC----------------------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCC--
Q 026660           88 LGLARAFTLPIK----------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA--  143 (235)
Q Consensus        88 f~~~~~~~~~~~----------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~--  143 (235)
                      ||+++.......                      ......+|+.|+|||++.....++.++||||+||++++|++|..  
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999976543221                      23456779999999997666668999999999999999998433  


Q ss_pred             ---------CCCCCC-----------------HHHHHHHHHHHhCCCCCCCccccccccc---ccCCCCCCccchhhcCC
Q 026660          144 ---------LFPGDS-----------------ELQQLLHIFRLLGTPNEKVWPGVSSLMN---WHEYPQWNPQSLATAVP  194 (235)
Q Consensus       144 ---------pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  194 (235)
                               +|.+..                 ...++..+...++.+....+........   ................+
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                     333322                 3566667777777776543332211100   00112222334445556


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       195 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      .+++++++||++||..||.+|||++|+++||||+++.+..
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            7899999999999999999999999999999999988764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=278.97  Aligned_cols=196  Identities=23%  Similarity=0.384  Sum_probs=159.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+||||++| +|..++.+.    +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus       118 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~i  192 (396)
T 4dc2_A          118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HI  192 (396)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CE
T ss_pred             eEEEEEECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CE
Confidence            34455677889999999985 999999763    4699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--------LQ-QL  154 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~-~~  154 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.....        .+ ..
T Consensus       193 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~  271 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  271 (396)
T ss_dssp             EECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred             EEeecceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence            9999999976544444556678899999999998655 89999999999999999999999964321        11 11


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFD  228 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~ll~hp~f~  228 (235)
                      ..+...  .                          ......++++++++|++||+.||.+||++      +++++||||+
T Consensus       272 ~~i~~~--~--------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          272 QVILEK--Q--------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             HHHHHC--C--------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             HHHhcc--c--------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence            111110  0                          00112478899999999999999999985      7999999999


Q ss_pred             CCCcCC
Q 026660          229 DLDKTR  234 (235)
Q Consensus       229 ~~~~~~  234 (235)
                      +++|+.
T Consensus       324 ~i~w~~  329 (396)
T 4dc2_A          324 NVDWDM  329 (396)
T ss_dssp             TCCHHH
T ss_pred             CCCHHH
Confidence            999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-41  Score=270.11  Aligned_cols=193  Identities=27%  Similarity=0.421  Sum_probs=161.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++++.+|+||||++| +|.+++...    +.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus        79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~  153 (328)
T 3fe3_A           79 LFEVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NI  153 (328)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CE
T ss_pred             EEEEEEECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CE
Confidence            34455677889999999975 999999763    4699999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||++...... .......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+......
T Consensus       154 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  232 (328)
T 3fe3_A          154 KIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR  232 (328)
T ss_dssp             EECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999999765433 23445678999999999987765568999999999999999999999988877666655542110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                                  ....+++++.++|++||..||.+|||++++++||||+...
T Consensus       233 ----------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          233 ----------------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                                        0113678999999999999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-41  Score=276.82  Aligned_cols=220  Identities=35%  Similarity=0.698  Sum_probs=176.8

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +++.++++||||++|+|.+.+..+...+..+++..++.++.||+.||+|||++|++|+||||+||+++..+..++|+|||
T Consensus       108 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg  187 (383)
T 3eb0_A          108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG  187 (383)
T ss_dssp             --CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECC
Confidence            56778999999999999999998878888899999999999999999999999999999999999998544489999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      .++..... .......+|..|+|||.+.+...++.++||||+||++++|++|..||.+....+....+....+.+....+
T Consensus       188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~  266 (383)
T 3eb0_A          188 SAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM  266 (383)
T ss_dssp             TCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99765433 23344567889999999887666899999999999999999999999999999999988888877765433


Q ss_pred             ccccccccccCCCCCCccchhh-cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ............+......... .....++++.++|++||..||.+|||+.|+++||||+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            3222221111222222222222 233588999999999999999999999999999999764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-41  Score=278.43  Aligned_cols=222  Identities=33%  Similarity=0.660  Sum_probs=176.1

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .+..++++||||++++|.+.+..+......+++..++.++.||+.||+|||++|++|+||||+||+++.++..++|+|||
T Consensus       123 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence            45667889999999999999888777778899999999999999999999999999999999999999665578999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+.+..+....+.+....+
T Consensus       203 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765432 22334567999999999977656899999999999999999999999999988888888887776654433


Q ss_pred             ccccccccccCCCCCCccchh-hcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          170 PGVSSLMNWHEYPQWNPQSLA-TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ..................... ......++++++||++||..||.+|||+.|+++||||+.+.+
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            322111111111111111111 122357899999999999999999999999999999987654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=269.89  Aligned_cols=193  Identities=23%  Similarity=0.430  Sum_probs=163.2

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+.+++.+.+|+||||++| +|.+++.+    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        71 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~  145 (318)
T 1fot_A           71 MWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HI  145 (318)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CE
T ss_pred             EeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CE
Confidence            34455677889999999985 99999976    34689999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||++.....   ......||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+....+......
T Consensus       146 kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  221 (318)
T 1fot_A          146 KITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR  221 (318)
T ss_dssp             EECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred             EEeecCcceecCC---ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999999976542   233457899999999987654 789999999999999999999999988877766665542100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                                  ....+++++.++|++||..||.+||     +++++++||||++++|+.
T Consensus       222 ----------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          222 ----------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence                                        0124778999999999999999999     899999999999998864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-41  Score=276.53  Aligned_cols=216  Identities=36%  Similarity=0.669  Sum_probs=167.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++...+|+|||||+|+|.+++..     ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG  154 (388)
T 3oz6_A           81 DNDRDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFG  154 (388)
T ss_dssp             TTSSCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCT
T ss_pred             CCCCEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCc
Confidence            44567999999999999999976     3689999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCC---------------------CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 026660           90 LARAFTLP---------------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD  148 (235)
Q Consensus        90 ~~~~~~~~---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  148 (235)
                      +++.....                     ........+|+.|+|||++.+...++.++||||+||++++|++|..||.+.
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99765321                     112234578999999999987566899999999999999999999999999


Q ss_pred             CHHHHHHHHHHHhCCCCCCCcccccccccc--------------cCCCCCCc----c-chhhcCCCCChhHHHHHHHhcc
Q 026660          149 SELQQLLHIFRLLGTPNEKVWPGVSSLMNW--------------HEYPQWNP----Q-SLATAVPNLDKDGLDLLEQMLQ  209 (235)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~----~-~~~~~~~~~~~~~~~li~~~l~  209 (235)
                      ........+....+.+....+.........              .......+    . .........++++++||++||.
T Consensus       235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            999999888888777764433221110000              00000000    0 0001123678999999999999


Q ss_pred             cCCCCCCCHHHHhCCCCCCCCC
Q 026660          210 YDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       210 ~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .||.+|||++|+++||||+.+.
T Consensus       315 ~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          315 FNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             SSGGGSCCHHHHTTSTTTTTTC
T ss_pred             cCcccCCCHHHHhCCHHHHHhc
Confidence            9999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-41  Score=274.46  Aligned_cols=199  Identities=24%  Similarity=0.389  Sum_probs=163.6

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--   81 (235)
                      ..+.+++.+.+|+||||++ |+|.+++..    .+.+++..++.++.||+.||.|||++|++|+||||+||+++..+.  
T Consensus        80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred             EEEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence            3445677788999999997 599999854    457999999999999999999999999999999999999986653  


Q ss_pred             -eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           82 -TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        82 -~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                       .++|+|||++...... .......||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+....+....+...
T Consensus       156 ~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~  233 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV  233 (361)
T ss_dssp             CCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             cCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence             6999999999766543 2334557899999999987654 889999999999999999999999988877766655432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ....                        .......++++++++|++||..||.+|||+.++++||||++.+++
T Consensus       234 ~~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  282 (361)
T 2yab_A          234 SYDF------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ  282 (361)
T ss_dssp             CCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred             CCCC------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence            1110                        011123578899999999999999999999999999999987753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-41  Score=275.40  Aligned_cols=195  Identities=23%  Similarity=0.343  Sum_probs=165.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++.+.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .++
T Consensus       105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ik  179 (373)
T 2r5t_A          105 HFSFQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIV  179 (373)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEE
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEE
Confidence            3455677889999999985 999999762    4689999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...... 
T Consensus       180 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-  257 (373)
T 2r5t_A          180 LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-  257 (373)
T ss_dssp             ECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC-
T ss_pred             EeeCccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC-
Confidence            999999976544444455668899999999997654 889999999999999999999999988877776666542100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ll~hp~f~~~~~~~  234 (235)
                                                 ....++++++++|++||+.||.+||++    .++++||||+.++|+.
T Consensus       258 ---------------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          258 ---------------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             ---------------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                                       112478899999999999999999986    6999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.7e-41  Score=264.89  Aligned_cols=194  Identities=22%  Similarity=0.356  Sum_probs=161.4

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.+..++..|+||||+. |+|.+++.+     ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~k  156 (297)
T 3fxz_A           83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVK  156 (297)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEE
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEE
Confidence            344456678999999997 599999976     2589999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.................
T Consensus       157 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  235 (297)
T 3fxz_A          157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE  235 (297)
T ss_dssp             ECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC
T ss_pred             EeeCCCceecCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            999999887665555556668899999999998655 7899999999999999999999999887766655544321111


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      . .                        ....+++.+.++|++||+.||.+|||+.++++||||+...
T Consensus       236 ~-~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          236 L-Q------------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             C-S------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             C-C------------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            0 0                        0114778899999999999999999999999999998543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-41  Score=272.36  Aligned_cols=196  Identities=23%  Similarity=0.375  Sum_probs=158.2

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        75 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~  149 (345)
T 3a8x_A           75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HI  149 (345)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CE
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CE
Confidence            34455677889999999975 999999763    4699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQL  154 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~  154 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.....         ....
T Consensus       150 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  228 (345)
T 3a8x_A          150 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  228 (345)
T ss_dssp             EECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH
T ss_pred             EEEeccccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH
Confidence            9999999976444444455667899999999997654 78999999999999999999999965211         1111


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFD  228 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~ll~hp~f~  228 (235)
                      ..+...  ..                          .....++.+++++|++||+.||.+||++      .++++||||+
T Consensus       229 ~~i~~~--~~--------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          229 QVILEK--QI--------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             HHHHHC--CC--------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             HHHHcC--CC--------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence            111110  00                          0112478899999999999999999995      8999999999


Q ss_pred             CCCcCC
Q 026660          229 DLDKTR  234 (235)
Q Consensus       229 ~~~~~~  234 (235)
                      +++|+.
T Consensus       281 ~~~w~~  286 (345)
T 3a8x_A          281 NVDWDM  286 (345)
T ss_dssp             TCCHHH
T ss_pred             CCCHHH
Confidence            999853

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-41  Score=278.96  Aligned_cols=219  Identities=29%  Similarity=0.473  Sum_probs=168.6

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC-eEEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~-~~~l   85 (235)
                      +..+..+++|+||||++++|.+++...  ....+++..++.++.||+.||+|||+++++|+||||+||+++.++. .++|
T Consensus       166 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEEETTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred             eecccCCeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEE
Confidence            344556789999999999999999873  3345999999999999999999999999999999999999997762 2999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++.....   ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+....+.++
T Consensus       244 ~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          244 IDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             CCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccceecCC---cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999865432   233457789999999998765 89999999999999999999999999999888888888877776


Q ss_pred             CCCcccccccccccCCCCC-------------------------------CccchhhcCCCCChhHHHHHHHhcccCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQW-------------------------------NPQSLATAVPNLDKDGLDLLEQMLQYDPSK  214 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  214 (235)
                      ...+........+.....+                               ............++++++||++||.+||.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence            5433222111100000000                               000001112235788999999999999999


Q ss_pred             CCCHHHHhCCCCCCCCC
Q 026660          215 RISAKKAMEHPYFDDLD  231 (235)
Q Consensus       215 Rps~~~ll~hp~f~~~~  231 (235)
                      |||+.|+++||||++..
T Consensus       400 Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          400 RMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             SCCHHHHHTSTTTC---
T ss_pred             CCCHHHHhCChhhccCC
Confidence            99999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=266.48  Aligned_cols=223  Identities=35%  Similarity=0.642  Sum_probs=164.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..++||||+++ +|.+++..    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~k  142 (311)
T 4agu_A           68 LEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIK  142 (311)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEE
T ss_pred             hheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEE
Confidence            3445567789999999997 67666543    45699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||.+..............++..|+|||.+.+...++.++|+||+|++++++++|..||.+....+....+.......
T Consensus       143 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (311)
T 4agu_A          143 LCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL  222 (311)
T ss_dssp             ECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             EeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence            99999998766544444556779999999999876668999999999999999999999999988888777776665543


Q ss_pred             CCCCccccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .............   ................+++++++.++|++||+.||.+|||++++++||||+++.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            3221111000000   00000111122334456789999999999999999999999999999999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-41  Score=271.58  Aligned_cols=212  Identities=39%  Similarity=0.693  Sum_probs=172.6

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...+|+||||++++|.+++..     ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  175 (367)
T 1cm8_A          102 FTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA  175 (367)
T ss_dssp             CCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             CceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecc
Confidence            356799999998899999876     3689999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccc
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  171 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (235)
                      +....   ......+|..|+|||++.+...++.++|+||+||++++|++|..||.+.+..+....+....+.++..++..
T Consensus       176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          176 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             EECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            76543   234456799999999998755689999999999999999999999999999999988888888776554433


Q ss_pred             ccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          172 VSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       172 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .......   ...+............+.+++++++|++||..||.+|||+.++++||||+++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            2211000   011122223334445578899999999999999999999999999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-41  Score=292.27  Aligned_cols=196  Identities=23%  Similarity=0.373  Sum_probs=167.1

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++.+.+|+||||++| +|.+++...    +.+++..++.++.||+.||+|||+++++||||||+|||++.++ .+
T Consensus       407 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~i  481 (674)
T 3pfq_A          407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HI  481 (674)
T ss_dssp             EEEECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CE
T ss_pred             EEEEEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cE
Confidence            34456778899999999985 999999873    4699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.+..+....+......
T Consensus       482 kL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  560 (674)
T 3pfq_A          482 KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA  560 (674)
T ss_dssp             EECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC
T ss_pred             EEeecceeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999999986544444455678899999999997655 899999999999999999999999998877776666531100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~hp~f~~~~~~~  234 (235)
                                                  ....+++++++||++||+.||.+||++     +++++||||++++|+.
T Consensus       561 ----------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          561 ----------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ----------------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                                        012478999999999999999999997     9999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-41  Score=275.96  Aligned_cols=200  Identities=23%  Similarity=0.346  Sum_probs=164.6

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++++|+||||++ |+|.+++.+     ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus       134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~i  207 (410)
T 3v8s_A          134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HL  207 (410)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CE
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CE
Confidence            3455667888999999997 599999865     3589999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCC-CcccccccccccCchhhhCCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTH---YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      +|+|||+++....... ......||+.|+|||++.+...   ++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus       208 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             EECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             EEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            9999999976543322 2345678999999999975432   67899999999999999999999999888777776654


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ......                        ......++++++++|++||..+|.+  ||+++++++||||++++|..
T Consensus       288 ~~~~~~------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          288 HKNSLT------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             HHHHCC------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             cccccc------------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence            211000                        0011247899999999999999988  99999999999999998864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4e-40  Score=262.54  Aligned_cols=219  Identities=43%  Similarity=0.809  Sum_probs=175.6

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+....+++||||++|+|.+++...  ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Df  164 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF  164 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecC
Confidence            3467889999999999999999873  334599999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+...... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||.+....+....+....+.+....
T Consensus       165 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          165 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccccccCC-CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            998755422 2233456788999999997655 78999999999999999999999999998888888888777665554


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      +........ .................+++.++++|++||..||.+|||+.++++||||+++++.
T Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          243 WPRDVALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             SCTTCSSCG-GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             Cccccccch-hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            443221111 0111111222334445789999999999999999999999999999999988753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-41  Score=271.10  Aligned_cols=192  Identities=24%  Similarity=0.352  Sum_probs=162.7

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++++..+|+||||++ |+|.+++.+.    +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus       107 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~k  181 (350)
T 1rdq_E          107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQ  181 (350)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEE
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEE
Confidence            344566788999999997 5999999873    3599999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||+++.....   .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....+....+...... 
T Consensus       182 L~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-  256 (350)
T 1rdq_E          182 VTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-  256 (350)
T ss_dssp             ECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred             EcccccceeccCC---cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999999765432   23457899999999997655 789999999999999999999999988877766665542100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                                                 ....+++++.++|++||+.||.+||+     ++++++||||++++|..
T Consensus       257 ---------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~  304 (350)
T 1rdq_E          257 ---------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence                                       01247889999999999999999998     99999999999999853

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-41  Score=279.95  Aligned_cols=195  Identities=23%  Similarity=0.320  Sum_probs=162.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+..++.+.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||+ +|++|+||||+||+++.++ .+
T Consensus       214 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~  288 (446)
T 4ejn_A          214 KYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HI  288 (446)
T ss_dssp             EEEEEETTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CE
T ss_pred             EEEEeeCCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CE
Confidence            3445667789999999985 999999762    469999999999999999999998 8999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+......
T Consensus       289 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  367 (446)
T 4ejn_A          289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR  367 (446)
T ss_dssp             EECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEccCCCceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999999976544444455678899999999997655 899999999999999999999999988876666655432110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                                  ....+++++.++|++||..||.+||     +++++++||||++++|+.
T Consensus       368 ----------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          368 ----------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ----------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence                                        0124778999999999999999999     999999999999998863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-41  Score=277.88  Aligned_cols=204  Identities=22%  Similarity=0.366  Sum_probs=166.5

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+|||||+ |+|.+++.+.   .+.+++..++.++.||+.||+|||+++++||||||+||+++.++ .+
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~v  214 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HI  214 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CE
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CE
Confidence            3445667788999999997 5999999762   35699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCC-cccccccccccCchhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIKK-YTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                      +|+|||+++........ .....||+.|+|||++.    +...++.++|+||+||++|+|++|..||.+.+..+....+.
T Consensus       215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            99999999765543332 33457899999999987    23447899999999999999999999999988877777665


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCcCCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~ll~hp~f~~~~~~~~  235 (235)
                      ........                       ......+++++++||++||..+|.+  ||+++++++||||++++|+.+
T Consensus       295 ~~~~~~~~-----------------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          295 NHKERFQF-----------------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             THHHHCCC-----------------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             hccccccC-----------------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            32110000                       0011247899999999999988888  999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-41  Score=269.31  Aligned_cols=195  Identities=24%  Similarity=0.407  Sum_probs=158.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.++.++.+|+||||++| +|.+++.+.    +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~k  161 (327)
T 3a62_A           87 IYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVK  161 (327)
T ss_dssp             EEEEECSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEE
T ss_pred             eEEEEcCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEE
Confidence            3445667789999999974 999999763    4689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++..............||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+....+....+...... 
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-  239 (327)
T 3a62_A          162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-  239 (327)
T ss_dssp             ECCCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-
T ss_pred             EEeCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-
Confidence            999999875543333344567899999999997654 789999999999999999999999988877666665542110 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                                                 ....++++++++|++||..||.+||     ++.++++||||+.++|+.
T Consensus       240 ---------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~  287 (327)
T 3a62_A          240 ---------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE  287 (327)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence                                       0124778999999999999999999     889999999999998753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-40  Score=269.24  Aligned_cols=222  Identities=33%  Similarity=0.588  Sum_probs=175.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCcEEEcCCCCeEEEee
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh--~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ....++++||||++++|.+.+.........+++..++.++.|++.||.|||  ++|++|+||||+||+++..+..++|+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence            445568999999999999988887777888999999999999999999999  999999999999999996344999999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+.+..+.+...
T Consensus       176 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          176 FGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            9999766533 233445678999999999766668999999999999999999999999999988888888877776654


Q ss_pred             CcccccccccccCCCCCCccc----hhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          168 VWPGVSSLMNWHEYPQWNPQS----LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .+...................    ........++++.++|++||+.||.+|||+.|+++||||+++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            433322111111110001111    11122236788999999999999999999999999999997754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=273.90  Aligned_cols=197  Identities=27%  Similarity=0.400  Sum_probs=164.4

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--C
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--T   80 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~   80 (235)
                      ...+..++++..|+||||+.| +|.+.+..    .+.+++..+..++.||+.||+|||++|++|+||||+||+++..  +
T Consensus        74 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~  149 (444)
T 3soa_A           74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKG  149 (444)
T ss_dssp             CEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTT
T ss_pred             eEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCC
Confidence            344566778899999999985 99999976    3569999999999999999999999999999999999999842  2


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ..++|+|||++..............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+...
T Consensus       150 ~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  228 (444)
T 3soa_A          150 AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG  228 (444)
T ss_dssp             CCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred             CcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC
Confidence            3799999999987765545555678899999999987654 889999999999999999999999988877777666543


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ....+..                        ....++++++++|++||+.||.+|||+.++++||||+.
T Consensus       229 ~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          229 AYDFPSP------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             CCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             CCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            2221111                        12357899999999999999999999999999999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.2e-41  Score=270.59  Aligned_cols=221  Identities=36%  Similarity=0.694  Sum_probs=174.0

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +.....++....|+||||++|+|.+++..     +.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        94 ~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~  167 (364)
T 3qyz_A           94 IRAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DL  167 (364)
T ss_dssp             ECCSSTTTCCCEEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CE
T ss_pred             EecCCccccceEEEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CE
Confidence            33444456678999999999999999976     3599999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      +|+|||.+........   ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+....+...
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  247 (364)
T 3qyz_A          168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  247 (364)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred             EEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence            9999999976543222   1234578999999999876666899999999999999999999999998888888888877


Q ss_pred             hCCCCCCCccccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .+.+....+........   ................++++++++++|++||..||.+|||+.++++||||+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            77765443222111000   00011111122334445788999999999999999999999999999999976

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=276.02  Aligned_cols=202  Identities=25%  Similarity=0.396  Sum_probs=164.0

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++++++|+||||++ |+|.+++.+.   +..+++..++.++.||+.||+|||++|++||||||+||+++.++ .++
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vk  202 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIR  202 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEE
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEE
Confidence            345567788999999997 5999999763   24699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      |+|||+++....... ......||+.|+|||++..      ...++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus       203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i  282 (412)
T 2vd5_A          203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI  282 (412)
T ss_dssp             ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999976654322 2234578999999999873      234789999999999999999999999998877776666


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCC---CCHHHHhCCCCCCCCCcCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR---ISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~ll~hp~f~~~~~~~  234 (235)
                      .........                       ......++++++++|++||. +|.+|   |+++++++||||++++|+.
T Consensus       283 ~~~~~~~~~-----------------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          283 VHYKEHLSL-----------------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             HTHHHHCCC-----------------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             HhcccCcCC-----------------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            532100000                       00112578999999999999 99998   5999999999999999986


Q ss_pred             C
Q 026660          235 L  235 (235)
Q Consensus       235 ~  235 (235)
                      |
T Consensus       339 l  339 (412)
T 2vd5_A          339 L  339 (412)
T ss_dssp             S
T ss_pred             H
Confidence            5

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.1e-41  Score=279.43  Aligned_cols=212  Identities=37%  Similarity=0.631  Sum_probs=161.7

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++.+.+|+||||++++|.+.+..      .+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||
T Consensus       137 ~~~~~~~lv~E~~~~~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG  209 (464)
T 3ttj_A          137 EEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG  209 (464)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             ccCCeEEEEEeCCCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEE
Confidence            55678999999999988887743      489999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++..... .......+|+.|+|||++.+.. ++.++||||+||++++|++|..||.+.+..++...+....+.+....+
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99765432 2344567899999999998754 889999999999999999999999999999999999988888765544


Q ss_pred             cccccccccc--CCCCCCccchhhcCCC------------CChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          170 PGVSSLMNWH--EYPQWNPQSLATAVPN------------LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~~~~--~~~~~~~~~~~~~~~~------------~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..........  ..............+.            .++++++||++||..||.+|||++|+++||||+.+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            3322110000  0000011111111111            15678999999999999999999999999999854

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-40  Score=265.49  Aligned_cols=218  Identities=34%  Similarity=0.660  Sum_probs=171.6

Q ss_pred             ceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .+.+|+||||++|+|.+.+...   ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||.+
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhc
Confidence            5679999999999999888653   34699999999999999999999999999999999999999777 8999999999


Q ss_pred             ccccCC----CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ......    ........+|+.|+|||++.+...++.++||||+||++++|++|..||.+.........+....+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            765422    1223445678999999999776668999999999999999999999999999988888888888888777


Q ss_pred             CcccccccccccCCCCCCc--cchh--hcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          168 VWPGVSSLMNWHEYPQWNP--QSLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .++................  ....  ......+++++++|++||..||.+|||++|+++||||++....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            6665433221111110000  0000  0000136789999999999999999999999999999875543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-40  Score=280.88  Aligned_cols=199  Identities=26%  Similarity=0.375  Sum_probs=163.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...++++..+|+||||++| +|.+++.+.......+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus       251 ~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vk  329 (543)
T 3c4z_A          251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVR  329 (543)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEE
T ss_pred             EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEE
Confidence            3455677889999999985 99999987655566799999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~  160 (235)
                      |+|||++..............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||....    ..+....+...
T Consensus       330 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             ECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             EeecceeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            999999987655444444568899999999997654 8999999999999999999999997653    22333332221


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                      ..                            .....+++++.++|++||+.||.+||+     ++++++||||++++|..
T Consensus       409 ~~----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          409 AV----------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             CC----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred             cc----------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence            00                            001247899999999999999999996     58999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=270.07  Aligned_cols=222  Identities=36%  Similarity=0.723  Sum_probs=164.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE----cCCC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQT-----GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKT   80 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~----~~~~   80 (235)
                      +++..+|+||||++|+|.+++......     ...+++..++.++.||+.||+|||++|++|+||||+||++    +..+
T Consensus        90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence            567789999999999999998754322     2248999999999999999999999999999999999999    4344


Q ss_pred             CeEEEeecCCcccccCCC---CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------
Q 026660           81 MTLKIADLGLARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-------  150 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------  150 (235)
                       .++|+|||++.......   .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.....       
T Consensus       170 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          170 -RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             -CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             -cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence             89999999997654322   2234457799999999998766689999999999999999999999976543       


Q ss_pred             --HHHHHHHHHHhCCCCCCCcccccccccccC---------CCCCCc-cchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          151 --LQQLLHIFRLLGTPNEKVWPGVSSLMNWHE---------YPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       151 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                        .+.+..+...++.+....|...........         ...... ..........++++++||++||..||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              467788888888888777765533211100         000000 00111222347889999999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 026660          219 KKAMEHPYFDDLDK  232 (235)
Q Consensus       219 ~~ll~hp~f~~~~~  232 (235)
                      +|+|+||||++..+
T Consensus       329 ~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          329 EQAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHHTSGGGTSSSC
T ss_pred             HHHhcChhhccCCC
Confidence            99999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-40  Score=268.40  Aligned_cols=200  Identities=26%  Similarity=0.412  Sum_probs=160.7

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--C
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--M   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~   81 (235)
                      ..+..++++.+|+||||++| +|.+++.+....+..+++..++.++.||+.||+|||+++++|+||||+||+++.++  .
T Consensus        91 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             EEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred             EEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence            34455667889999999985 99999988666666799999999999999999999999999999999999997554  2


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||++..............+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.. .+....+....
T Consensus       171 ~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~  248 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK  248 (351)
T ss_dssp             CEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC
T ss_pred             cEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC
Confidence            499999999987665444445567899999999997654 7899999999999999999999998753 23333332210


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...                        .......++++++++|++||..||.+|||+.++++||||++.
T Consensus       249 ~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          249 YKM------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CCC------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCC------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            000                        011123578999999999999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.1e-41  Score=271.01  Aligned_cols=214  Identities=39%  Similarity=0.660  Sum_probs=162.1

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++...+|+|+|+++++|.+++..     ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus       104 ~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG  177 (367)
T 2fst_X          104 EEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFG  177 (367)
T ss_dssp             GGCCCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC--
T ss_pred             ccCCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecc
Confidence            34467899999998899998865     4699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +++.....   .....+|..|+|||++.+...++.++||||+||++++|++|..||.+.+..+....+.+..+.+....+
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98765422   334577999999999987556899999999999999999999999999999999998888888765544


Q ss_pred             ccccccccc---cCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          170 PGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       170 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .........   ...............++.++++++||++||..||.+|||+.++++||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            433221100   011222233444555678899999999999999999999999999999997653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-40  Score=269.66  Aligned_cols=222  Identities=31%  Similarity=0.536  Sum_probs=164.4

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCcEEEcC-CCCe
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILHRDLKPHNLLMDR-KTMT   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh--~~~~~H~di~~~nil~~~-~~~~   82 (235)
                      .+.+...+++|+||||++|+|.+++...  ....+++..++.++.|++.||.|||  +.|++|+||||+||+++. ....
T Consensus       122 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEETTEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeeccCCceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence            3445566789999999999999999873  3345899999999999999999999  579999999999999953 2337


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||++......   .....+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+....+
T Consensus       200 ~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             EEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEEeccCceecccc---cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999999766432   33456789999999998655 88999999999999999999999999999888888888777


Q ss_pred             CCCCCCcccccccc---------ccc------CCCCCCc---cchhhc-----------CCC-------CChhHHHHHHH
Q 026660          163 TPNEKVWPGVSSLM---------NWH------EYPQWNP---QSLATA-----------VPN-------LDKDGLDLLEQ  206 (235)
Q Consensus       163 ~~~~~~~~~~~~~~---------~~~------~~~~~~~---~~~~~~-----------~~~-------~~~~~~~li~~  206 (235)
                      .++...........         .|.      ......+   ..+...           ..+       .++++++||++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            66543322111100         000      0000000   000000           000       11478999999


Q ss_pred             hcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          207 MLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       207 ~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ||+.||.+|||+.|+|+||||++..++
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~~~e  382 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKTADE  382 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC----
T ss_pred             hcCCChhhCCCHHHHhcCcccccCCCC
Confidence            999999999999999999999987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-40  Score=267.52  Aligned_cols=217  Identities=24%  Similarity=0.355  Sum_probs=163.9

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC-------
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-------   78 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~-------   78 (235)
                      .+.+...+..|+||||++++|.+++...  ....+++..++.++.||+.||+|||++|++|+||||+||+++.       
T Consensus       102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEEEETTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred             cceeeECCeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence            3445566789999999988999999873  3345999999999999999999999999999999999999974       


Q ss_pred             -----------------CCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC
Q 026660           79 -----------------KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK  141 (235)
Q Consensus        79 -----------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g  141 (235)
                                       ....++|+|||++.....   ......+|+.|+|||++.+.. ++.++||||+||++|+|++|
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHS
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHC
Confidence                             133899999999975443   223456799999999998655 89999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCCCCccccccc------------ccccCCCCCCc------cchhhcCCCCChhHHHH
Q 026660          142 TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL------------MNWHEYPQWNP------QSLATAVPNLDKDGLDL  203 (235)
Q Consensus       142 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~------~~~~~~~~~~~~~~~~l  203 (235)
                      ..||......+....+.......+..........            ..|........      ..........++.+.++
T Consensus       256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  335 (360)
T 3llt_A          256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF  335 (360)
T ss_dssp             SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred             CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence            9999998888888887777665553322111100            00000000000      00000011235778899


Q ss_pred             HHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          204 LEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       204 i~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                      |++||+.||.+|||+.|+++||||+
T Consensus       336 i~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          336 LYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-40  Score=265.28  Aligned_cols=202  Identities=27%  Similarity=0.422  Sum_probs=161.7

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC---CC
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KT   80 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~---~~   80 (235)
                      ..+..++.+..|+||||+.| +|.+++..  .....+++..++.++.|++.||+|||++|++|+||||+||+++.   .+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC
Confidence            34445677889999999985 99988854  33457999999999999999999999999999999999999986   34


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                       .++|+|||.+....... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||......+....+...
T Consensus       172 -~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  248 (327)
T 3lm5_A          172 -DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV  248 (327)
T ss_dssp             -CEEECCGGGCEEC----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             -cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence             89999999997654332 233456799999999987654 789999999999999999999999988877776665543


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~~  235 (235)
                      .......                        ....+++.++++|++||..||.+|||++++++||||++++|+.+
T Consensus       249 ~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          249 NVDYSEE------------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             CCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             ccccCch------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            2221111                        12257889999999999999999999999999999999988753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-40  Score=267.51  Aligned_cols=197  Identities=24%  Similarity=0.391  Sum_probs=156.6

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--   81 (235)
                      ..+.+++++.+|+||||+.| +|.+++.+    .+.+++..++.++.||+.||+|||++|++|+||||+||++...+.  
T Consensus        81 ~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~  156 (342)
T 2qr7_A           81 LKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNP  156 (342)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSG
T ss_pred             EEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCc
Confidence            34456678889999999975 99999965    356999999999999999999999999999999999999854421  


Q ss_pred             -eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q 026660           82 -TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHI  157 (235)
Q Consensus        82 -~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~  157 (235)
                       .++|+|||++..............+|+.|+|||++.+.. ++.++|+||+||++|+|++|..||...   ...+....+
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i  235 (342)
T 2qr7_A          157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI  235 (342)
T ss_dssp             GGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred             CeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence             499999999987655444445567899999999987544 788999999999999999999999763   333333333


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ........                        ......++++++++|++||..||.+|||+.++++||||.++
T Consensus       236 ~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          236 GSGKFSLS------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHCCCCCC------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccCCcccC------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            32111100                        01123578999999999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-39  Score=262.25  Aligned_cols=221  Identities=37%  Similarity=0.676  Sum_probs=171.7

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..+++....|+||||++|+|.+++..     +.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~  154 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVC  154 (353)
T ss_dssp             SCSTTCCCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEEC
T ss_pred             cccCccceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEE
Confidence            34556688999999999999999876     3699999999999999999999999999999999999999776 89999


Q ss_pred             ecCCcccccCCCC----------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           87 DLGLARAFTLPIK----------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        87 df~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      |||.+........          ......+|+.|+|||++.+...++.++|+||+||++++|++|..||.+....+....
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            9999976543211          122346789999999987656689999999999999999999999999988888887


Q ss_pred             HHHHhCCCCCCCcccccccc----cccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          157 IFRLLGTPNEKVWPGVSSLM----NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +....+.+............    .................+.+++++.++|++||..||.+|||+.++++||||+.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            77776665532211100000    00011112222334445678999999999999999999999999999999998765


Q ss_pred             C
Q 026660          233 T  233 (235)
Q Consensus       233 ~  233 (235)
                      .
T Consensus       315 ~  315 (353)
T 2b9h_A          315 P  315 (353)
T ss_dssp             T
T ss_pred             c
Confidence            3

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=263.32  Aligned_cols=198  Identities=24%  Similarity=0.403  Sum_probs=161.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--   81 (235)
                      ..+.++++...|+||||++| +|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.  
T Consensus        79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           79 LHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred             EEEEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence            34455677889999999975 99999854    456999999999999999999999999999999999999986542  


Q ss_pred             -eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           82 -TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        82 -~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                       .++|+|||++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+...
T Consensus       155 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  232 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV  232 (326)
T ss_dssp             CCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred             CCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence             6999999999766432 2334457899999999987554 889999999999999999999999988776666655432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ....                        .......+++.++++|++||..||.+|||+.++++||||+..++
T Consensus       233 ~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          233 NYEF------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             CCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             CCCc------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            1110                        01112357889999999999999999999999999999997764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.1e-40  Score=264.19  Aligned_cols=218  Identities=34%  Similarity=0.591  Sum_probs=165.6

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+....+|+||||++|+|.+++..   ....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus       103 ~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Df  178 (362)
T 3pg1_A          103 EPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDF  178 (362)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCT
T ss_pred             CCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEec
Confidence            356678999999999999999874   344699999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+...... .......+++.|+|||.+.+...++.++||||+||++|++++|..||.+....+....+....+.+....
T Consensus       179 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          179 NLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             Ccccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999754432 2234456788999999998755589999999999999999999999999998888888887776655332


Q ss_pred             cccccc----cccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          169 WPGVSS----LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       169 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ......    ...................+..++.+.++|++||+.||.+|||+.++++||||+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            111000    000011112223334455567889999999999999999999999999999999763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-40  Score=265.76  Aligned_cols=221  Identities=29%  Similarity=0.514  Sum_probs=167.3

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC------
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK------   79 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~------   79 (235)
                      .+..+.+++.|+||||++++|.+++...  ....+++..++.++.||+.||+|||++|++|+||||+||+++..      
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           83 LEWFEHHGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEEETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             ecccccCCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            3445667789999999988999999873  33468999999999999999999999999999999999999863      


Q ss_pred             ------------CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 026660           80 ------------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG  147 (235)
Q Consensus        80 ------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  147 (235)
                                  ...++++|||.+.....   ......+|+.|+|||++.+.. ++.++||||+||++|++++|..||..
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                        22699999999875432   233456799999999997655 78999999999999999999999999


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCccccccccccc-CCCCCCc---------------cchhhcCCCCChhHHHHHHHhcccC
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNP---------------QSLATAVPNLDKDGLDLLEQMLQYD  211 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~  211 (235)
                      ....+....+.......+...+.......... ....|..               ..........++++.++|++||..|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            88888777777776655543322211100000 0000000               0001111234577899999999999


Q ss_pred             CCCCCCHHHHhCCCCCCCCCc
Q 026660          212 PSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       212 p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      |.+|||+.|+++||||+.++.
T Consensus       317 P~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          317 PAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TTTSCCHHHHTTSGGGGGGGC
T ss_pred             cccccCHHHHhcCHHHHHHhc
Confidence            999999999999999998765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=266.66  Aligned_cols=195  Identities=23%  Similarity=0.362  Sum_probs=158.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ...+++...+|+||||+.| +|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vk  155 (384)
T 4fr4_A           81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVH  155 (384)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEE
T ss_pred             EEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEE
Confidence            4455677889999999975 99999865    45699999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~  159 (235)
                      |+|||++...... .......||+.|+|||++.+  ...++.++|+|||||++|+|++|..||.....   .+.......
T Consensus       156 L~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          156 ITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             EeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            9999999765432 33455678999999999864  23478899999999999999999999975332   222222221


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-HHHHhCCCCCCCCCcCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~ll~hp~f~~~~~~~  234 (235)
                      . ..                           .....+++++.++|++||+.||.+||+ ++++++||||++++|+.
T Consensus       235 ~-~~---------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          235 T-VV---------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             C-CC---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             c-cc---------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence            1 00                           011247889999999999999999998 89999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.2e-40  Score=264.97  Aligned_cols=191  Identities=27%  Similarity=0.419  Sum_probs=154.0

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+..++++.+|+||||++|+|.+++...    +.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        74 l~~~~~~~~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~k  148 (336)
T 3h4j_B           74 LYDVITTPTDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVK  148 (336)
T ss_dssp             EEEEEECSSEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEE
T ss_pred             EEEEEEeCCEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEE
Confidence            34455677789999999999999999763    4699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++...... .......||+.|+|||++.+....+.++||||+|+++|+|++|..||.+.....            
T Consensus       149 l~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------  215 (336)
T 3h4j_B          149 IADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------  215 (336)
T ss_dssp             ECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------
T ss_pred             EEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------
Confidence            9999999765433 233455789999999999766545789999999999999999999997643110            


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                         .......             ........+++++.++|++||..||.+|||++|+++||||+.
T Consensus       216 ---~~~~i~~-------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          216 ---LFKKVNS-------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ---CBCCCCS-------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ---HHHHHHc-------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence               0000000             001112347899999999999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.1e-40  Score=266.57  Aligned_cols=208  Identities=38%  Similarity=0.701  Sum_probs=164.8

Q ss_pred             EEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccc
Q 026660           15 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF   94 (235)
Q Consensus        15 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~   94 (235)
                      .|+||||+.++|.+++.      ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+...
T Consensus       122 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~  194 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHA  194 (371)
T ss_dssp             CEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC---
T ss_pred             EEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccc
Confidence            49999999999988773      2599999999999999999999999999999999999999776 8999999999755


Q ss_pred             cCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccc
Q 026660           95 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  174 (235)
Q Consensus        95 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (235)
                      ...   .....+|+.|+|||++.+...++.++||||+||++++|++|..||.+....+....+....+.+..........
T Consensus       195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          195 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            432   33456789999999998755689999999999999999999999999999888888888777766544332211


Q ss_pred             ccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          175 LMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       175 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...   ................+.++++++++|++||+.||.+|||+.++++||||+++..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence            100   0011122223334445678999999999999999999999999999999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.1e-40  Score=264.57  Aligned_cols=220  Identities=25%  Similarity=0.469  Sum_probs=166.3

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE----------
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----------   76 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~----------   76 (235)
                      +..+..++.|+||||++++|.+++..  .....+++..++.++.||+.||+|||++|++|+||||+||++          
T Consensus        89 ~~~~~~~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeCCeEEEEEeccCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            34456678999999999899998877  333469999999999999999999999999999999999999          


Q ss_pred             ---------cCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 026660           77 ---------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG  147 (235)
Q Consensus        77 ---------~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  147 (235)
                               +..+ .++|+|||.+.....   ......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||..
T Consensus       167 ~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNT-SIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCC-CEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCC-cEEEeecCccccccc---cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     3334 899999999975432   233457799999999997655 88999999999999999999999999


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCcccccccccccCC-CCCCc---------------cchhhcCCCCChhHHHHHHHhcccC
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY-PQWNP---------------QSLATAVPNLDKDGLDLLEQMLQYD  211 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~  211 (235)
                      ....+....+....+..+................ ..+..               ..........+.++.++|++||..|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            8888887777777666554322211110000000 00000               0000111123457899999999999


Q ss_pred             CCCCCCHHHHhCCCCCCCCCcC
Q 026660          212 PSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       212 p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      |.+|||+.++++||||++++++
T Consensus       322 P~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGCCHH
T ss_pred             hhhCcCHHHHhcChhhcCCChh
Confidence            9999999999999999988754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=265.42  Aligned_cols=197  Identities=24%  Similarity=0.435  Sum_probs=161.1

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CCe
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~~   82 (235)
                      ..+..++.+.+|+||||++| +|.+++..   ....+++..++.++.|++.||+|||++|++|+||||+||+++.. +..
T Consensus        66 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~  142 (321)
T 1tki_A           66 LHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST  142 (321)
T ss_dssp             EEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC
T ss_pred             EeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCC
Confidence            34455677889999999985 99998854   23469999999999999999999999999999999999999862 348


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++++|||.+...... .......+|+.|+|||++.+.. ++.++||||+|+++|+|++|..||.+....+....+.....
T Consensus       143 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  220 (321)
T 1tki_A          143 IKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY  220 (321)
T ss_dssp             EEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred             EEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC
Confidence            999999999766432 2234456789999999997654 78999999999999999999999998887777666654311


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ..+                        ......++++++++|++||..||.+|||+.|+++||||++.
T Consensus       221 ~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          221 TFD------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CCC------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCC------------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            111                        11223578999999999999999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-39  Score=258.55  Aligned_cols=193  Identities=22%  Similarity=0.415  Sum_probs=158.5

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +.....+..|+||||++| +|.+++.+     ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|
T Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl  182 (321)
T 2c30_A          109 KSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKL  182 (321)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEE
T ss_pred             EEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEE
Confidence            344556779999999975 99998754     3699999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||++..............||+.|+|||++.+.. ++.++|+||+|+++++|++|..||......+....+........
T Consensus       183 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2c30_A          183 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL  261 (321)
T ss_dssp             CCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC
T ss_pred             eeeeeeeecccCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc
Confidence            99999877655444445667899999999997654 78999999999999999999999988877666554443211000


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                               .....+++++.++|++||..||.+|||+.++++||||....
T Consensus       262 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 -------------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                                     00113678899999999999999999999999999998653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-39  Score=254.03  Aligned_cols=196  Identities=30%  Similarity=0.431  Sum_probs=154.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--CCe
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMT   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~~~   82 (235)
                      .+..++.+..|+||||++| +|.+++......+..+++..++.++.|++.||+|||++|++|+||+|+||+++..  ...
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~  165 (285)
T 3is5_A           86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP  165 (285)
T ss_dssp             EEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCC
T ss_pred             HHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCC
Confidence            4445677789999999985 9999998876667789999999999999999999999999999999999999532  237


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||.+...... .......+++.|+|||.+.+  .++.++|+||+|+++++|++|..||.+....+..........
T Consensus       166 ~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  242 (285)
T 3is5_A          166 IKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP  242 (285)
T ss_dssp             EEECCCCCCCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEEEeeecceecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc
Confidence            999999999765432 22344567899999999853  378999999999999999999999988776555444332110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                        .                       .......+++++.++|++||+.||.+|||+.|+++||||++
T Consensus       243 --~-----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 --N-----------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --C-----------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --c-----------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence              0                       00111236789999999999999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-40  Score=281.27  Aligned_cols=198  Identities=28%  Similarity=0.453  Sum_probs=159.4

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+++++.+|+||||++ |+|.+++...  ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus       249 l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~v  325 (576)
T 2acx_A          249 LAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HI  325 (576)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CE
T ss_pred             EEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-Ce
Confidence            3445667788999999997 5999999763  234599999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRL  160 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~  160 (235)
                      +|+|||++....... ......||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.....   ..........
T Consensus       326 KL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~  403 (576)
T 2acx_A          326 RISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE  403 (576)
T ss_dssp             EECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred             EEEecccceecccCc-cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence            999999997654332 233457899999999997654 78999999999999999999999987532   2222221111


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .   ...                        ....++++++++|++||+.||.+||     +++++++||||++++|+.
T Consensus       404 ~---~~~------------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~  455 (576)
T 2acx_A          404 V---PEE------------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR  455 (576)
T ss_dssp             C---CCC------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred             c---ccc------------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence            0   000                        0124789999999999999999999     799999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-40  Score=263.25  Aligned_cols=202  Identities=24%  Similarity=0.407  Sum_probs=137.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--   81 (235)
                      ..+..+++...|+||||+.| +|.+++.+    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.  
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  146 (325)
T 3kn6_A           71 LHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL  146 (325)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----C
T ss_pred             EEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcc
Confidence            34456677889999999985 99999976    356999999999999999999999999999999999999975432  


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ---LLHIF  158 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~  158 (235)
                      .++|+|||++..............+|+.|+|||++.+.. ++.++||||+|+++|+|++|..||........   .....
T Consensus       147 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  225 (325)
T 3kn6_A          147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM  225 (325)
T ss_dssp             EEEECCCTTCEECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH
T ss_pred             cEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH
Confidence            799999999976654444445567799999999987654 88999999999999999999999976443110   01111


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .........+                    ......+++++++++|++||..||.+|||+.++++||||++..
T Consensus       226 ~~i~~~~~~~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          226 KKIKKGDFSF--------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHTTTCCCC--------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHcCCCCC--------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            1111111000                    0011124789999999999999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-40  Score=262.61  Aligned_cols=221  Identities=32%  Similarity=0.592  Sum_probs=163.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..|+||||+++ +|.+++..    ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~k  164 (331)
T 4aaa_A           90 LEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVK  164 (331)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEE
T ss_pred             EEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEE
Confidence            3445567789999999997 55555432    34699999999999999999999999999999999999999777 999


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||.+..............++..|+|||.+.+...++.++||||+||++|+|++|..||.+....+....+....+..
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (331)
T 4aaa_A          165 LCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL  244 (331)
T ss_dssp             ECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             EEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            99999997665544444556789999999999876568899999999999999999999999998888877777665543


Q ss_pred             CCCCccccccc---ccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSL---MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...........   ..................+.+++++.++|++||+.||.+|||+.|+++||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            32211100000   00000001111223344557899999999999999999999999999999998643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-39  Score=263.84  Aligned_cols=195  Identities=27%  Similarity=0.421  Sum_probs=159.4

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--C
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--M   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~   81 (235)
                      ..+..++++..|+||||+.| +|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++..+  .
T Consensus        93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~  168 (362)
T 2bdw_A           93 LHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA  168 (362)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTC
T ss_pred             EEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence            34456677889999999985 99998864    35689999999999999999999999999999999999997543  2


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+....
T Consensus       169 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~  246 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  246 (362)
T ss_dssp             CEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CEEEeecCcceEecCC-cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            5999999999766533 2334567899999999987654 8899999999999999999999999888766666555432


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...+..                        ....++++++++|++||..||.+|||+.++++||||..
T Consensus       247 ~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          247 YDYPSP------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CCCCTT------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CCCCcc------------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            111111                        11247789999999999999999999999999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-39  Score=259.59  Aligned_cols=215  Identities=29%  Similarity=0.634  Sum_probs=156.2

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....++||||+.+ +|.+++..       +++..++.++.|++.||+|||++|++|+||||+||+++.++..++|+|||+
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            6778999999985 99888743       899999999999999999999999999999999999997766899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCC----
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPN----  165 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~----  165 (235)
                      +...... .......++..|+|||.+.+...++.++||||+||++++|++|..||.. ....+....+....+.+.    
T Consensus       178 a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          178 AEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             CEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             ceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence            9765433 2334456788999999998756689999999999999999999999954 344444444333322111    


Q ss_pred             -----CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          166 -----EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       166 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                           ....+.............+...........++++++++|++||+.||.+|||++|+++||||+++.+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  330 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ  330 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC---
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccCC
Confidence                 000000000000000011111111111223789999999999999999999999999999999998763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-39  Score=258.96  Aligned_cols=198  Identities=24%  Similarity=0.396  Sum_probs=161.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC---
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~---   81 (235)
                      .+..++++..|+||||++| +|.+++..    ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.   
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           81 HDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcC
Confidence            3445667889999999975 99999965    356899999999999999999999999999999999999986653   


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||.+...... .......+|+.|+|||.+.+.. ++.++|+||+|+++++|++|..||.+....+....+....
T Consensus       157 ~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  234 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS  234 (321)
T ss_dssp             CEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred             CEEEccCccceecCcc-ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence            6999999999765543 2234456799999999987654 7899999999999999999999999887766665544311


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ...                        .......+++.+.++|++||..||.+|||+.++++||||++++++
T Consensus       235 ~~~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          235 YDF------------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             CCC------------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             ccc------------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            100                        011123578899999999999999999999999999999988754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.5e-40  Score=257.19  Aligned_cols=197  Identities=22%  Similarity=0.364  Sum_probs=149.8

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..|+||||++|+|.+++......+..+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~k  150 (290)
T 3fme_A           72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVK  150 (290)
T ss_dssp             EEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEE
T ss_pred             eeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEE
Confidence            344456677999999999999999988777778899999999999999999999998 999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhh---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~  160 (235)
                      |+|||.+....... ......+++.|+|||.+.   ....++.++|+||+|++++++++|..||... ............
T Consensus       151 l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (290)
T 3fme_A          151 MCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE  229 (290)
T ss_dssp             BCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred             EeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence            99999987654332 223346789999999973   3444789999999999999999999999863 343433333321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...                          ......+++++.++|++||+.||.+|||+.++++||||+..
T Consensus       230 ~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          230 PSP--------------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCC--------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCC--------------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            100                          00112478899999999999999999999999999999743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=263.08  Aligned_cols=198  Identities=25%  Similarity=0.441  Sum_probs=160.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CCe
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~~   82 (235)
                      ..+..+++..+|+||||+.| +|.+++..   ....+++..++.++.||+.||+|||++|++|+||||+||+++.+ ...
T Consensus       113 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~  189 (387)
T 1kob_A          113 LHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS  189 (387)
T ss_dssp             EEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC
T ss_pred             EEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCc
Confidence            34455677889999999975 99998854   23469999999999999999999999999999999999999743 237


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+.....
T Consensus       190 vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~  267 (387)
T 1kob_A          190 VKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW  267 (387)
T ss_dssp             EEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred             eEEEecccceecCCC-cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999999766533 2233446799999999987654 78999999999999999999999998887766666544211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ....                        .....++++++++|++||..||.+|||+.++++||||+...
T Consensus       268 ~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          268 EFDE------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CCCS------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCc------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            1110                        11225789999999999999999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=258.01  Aligned_cols=189  Identities=25%  Similarity=0.346  Sum_probs=150.4

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+..++++.+|+||||++++|.+++...   +..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus       122 l~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~k  197 (311)
T 3p1a_A          122 LEQAWEEGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCK  197 (311)
T ss_dssp             EEEEEEETTEEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEE
T ss_pred             EEEEEEeCCEEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEE
Confidence            34455677889999999999999999774   34699999999999999999999999999999999999998776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||++...... .......||+.|+|||++.+  .++.++||||+||++++|++|..|+.........   ..   ..
T Consensus       198 l~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~---~~  268 (311)
T 3p1a_A          198 LGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQ---GY  268 (311)
T ss_dssp             ECCCTTCEECC-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TT---TC
T ss_pred             EccceeeeecccC-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hc---cC
Confidence            9999998765433 22334567999999999875  3889999999999999999997777654332211   10   00


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                             ........+++++.++|++||+.||.+|||+.++++||||++
T Consensus       269 -----------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 -----------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -----------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -----------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                                   001112357899999999999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=258.89  Aligned_cols=220  Identities=33%  Similarity=0.629  Sum_probs=165.8

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ..+....|+||||++|+|.+++.+     +.+++..++.++.|++.||+|||++|++|+||||+||+++..+..++|+||
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence            356688999999999999998854     468999999999999999999999999999999999999855558999999


Q ss_pred             CCcccccCCC---CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           89 GLARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        89 ~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      |.+.......   .......++..|+|||.+.+...++.++|+||||++++++++|..||.+....+....+........
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            9997654221   1223445688899999987655689999999999999999999999999888777776665543322


Q ss_pred             CCCccccccccccc--CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          166 EKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       166 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ..............  ..............+.++++++++|++||+.||.+|||+.++++||||+.+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            21111111000000  000001112233445689999999999999999999999999999999988764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-39  Score=265.26  Aligned_cols=226  Identities=19%  Similarity=0.226  Sum_probs=154.2

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+.+.+++.+|+||||+. |+|.+++...  ....+++..++.++.||+.||+|||+++++|+||||+||+++.++ .+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~  167 (389)
T 3gni_B           91 YRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KV  167 (389)
T ss_dssp             EEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CE
T ss_pred             EeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CE
Confidence            3444566778999999998 4999999873  335699999999999999999999999999999999999999777 99


Q ss_pred             EEeecCCcccccCCC-------CCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 026660           84 KIADLGLARAFTLPI-------KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL  155 (235)
Q Consensus        84 ~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  155 (235)
                      +++|||.+.......       .......+|..|+|||++.+. ..++.++||||+||++|+|++|..||.+....+...
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  247 (389)
T 3gni_B          168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL  247 (389)
T ss_dssp             EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred             EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            999999875432211       112234678889999999763 448899999999999999999999998765444433


Q ss_pred             HHHHHhCC--------CCCCCccccccc---------cccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC
Q 026660          156 HIFRLLGT--------PNEKVWPGVSSL---------MNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS  217 (235)
Q Consensus       156 ~~~~~~~~--------~~~~~~~~~~~~---------~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  217 (235)
                      ........        +...........         .... ................+++++++||++||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  327 (389)
T 3gni_B          248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS  327 (389)
T ss_dssp             HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence            32211100        000000000000         0000 00000000011123357899999999999999999999


Q ss_pred             HHHHhCCCCCCCCCcC
Q 026660          218 AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       218 ~~~ll~hp~f~~~~~~  233 (235)
                      +.++++||||+++.+.
T Consensus       328 a~ell~hp~f~~~~~~  343 (389)
T 3gni_B          328 ASTLLNHSFFKQIKRR  343 (389)
T ss_dssp             HHHHTTSGGGGGC---
T ss_pred             HHHHhcCHHHHHHhhc
Confidence            9999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.9e-39  Score=252.02  Aligned_cols=200  Identities=26%  Similarity=0.416  Sum_probs=160.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..+.++..|+||||+++ +|.+++.+.    ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEE
Confidence            3445677889999999985 999999762    4689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhh-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLL-----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      |+|||.+...... .......++..|+|||++.     ....++.++|+||||+++++|++|..||......+....+..
T Consensus       165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          165 LTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            9999998765432 2334456788999999985     233478899999999999999999999988877666555544


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL  235 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~~  235 (235)
                      .......                        .....+++++.++|++||+.||.+|||+.++++||||+++.++++
T Consensus       244 ~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          244 GNYQFGS------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             TCCCCCT------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             CCcccCc------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence            2111110                        011247789999999999999999999999999999999987754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=257.40  Aligned_cols=186  Identities=25%  Similarity=0.391  Sum_probs=151.5

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...+|+||||+++ +|.+++     ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus       109 ~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  182 (298)
T 2zv2_A          109 NEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFG  182 (298)
T ss_dssp             SSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCC
Confidence            36789999999985 887643     235799999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ++..............+|+.|+|||.+.+...  .+.++||||+||++|+|++|..||...........+.......   
T Consensus       183 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  259 (298)
T 2zv2_A          183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF---  259 (298)
T ss_dssp             TCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---
T ss_pred             CccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC---
Confidence            99776544444455678999999999875432  3688999999999999999999998877655544433211000   


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                                             .....+++++.++|++||+.||.+|||+.++++||||+
T Consensus       260 -----------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          260 -----------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             -----------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             -----------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence                                   01135788999999999999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-39  Score=258.70  Aligned_cols=197  Identities=28%  Similarity=0.431  Sum_probs=155.2

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++++..|+||||++| +|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~  144 (323)
T 3tki_A           70 FYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NL  144 (323)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CE
T ss_pred             EEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CE
Confidence            34456677889999999975 99888743    45699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           84 KIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        84 ~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +|+|||++.......  .......||+.|+|||++.+....+.++||||+||++|+|++|..||................
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  224 (323)
T 3tki_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (323)
T ss_dssp             EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred             EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence            999999997554222  223455789999999999876645789999999999999999999997654322211111100


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..                         .......+++++.++|++||..||.+|||+.|+++||||+...
T Consensus       225 ~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          225 KT-------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             CT-------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             cc-------------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            00                         0011124778999999999999999999999999999998643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-39  Score=250.31  Aligned_cols=197  Identities=27%  Similarity=0.423  Sum_probs=160.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--Ce
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MT   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~   82 (235)
                      .+..++++..|+||||+.| +|.+++...    ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++  ..
T Consensus        71 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~  146 (284)
T 3kk8_A           71 HDSIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA  146 (284)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCC
T ss_pred             EEEEEcCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCc
Confidence            3445677789999999985 999988763    4699999999999999999999999999999999999997554  24


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||.+...... .......+++.|+|||.+.+.. ++.++||||+|++++++++|..||.+....+..........
T Consensus       147 ~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (284)
T 3kk8_A          147 VKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  224 (284)
T ss_dssp             EEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             EEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc
Confidence            999999999765433 2234457799999999997655 78999999999999999999999998887766666554322


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ..+.                        .....+++++.++|++||+.||.+|||+.++++||||++..+
T Consensus       225 ~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          225 DYPS------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             CCCT------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             cCCc------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            1111                        112247889999999999999999999999999999987654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.7e-40  Score=266.27  Aligned_cols=194  Identities=17%  Similarity=0.186  Sum_probs=147.6

Q ss_pred             eEEEEEEecCccCHHHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660           13 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTV------KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus        13 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~------~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..+|+||||++|+|.+++.....   .++....      ..++.||+.||+|||++|++|+||||+||+++.++ .++|+
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~  236 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLG  236 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEEC
T ss_pred             eeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEE
Confidence            67999999999999999987532   3455555      67889999999999999999999999999999777 89999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      |||+++.....   .....+++.|+|||++.+ ...++.++||||+||++|+|++|..||.......             
T Consensus       237 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------  300 (371)
T 3q60_A          237 DVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------  300 (371)
T ss_dssp             CGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------
T ss_pred             ecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------
Confidence            99999765422   224455789999999975 1347899999999999999999999997653210             


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ...+.....      ...............+++++.++|++||+.||.+|||+.++++||||+++.+
T Consensus       301 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          301 KGSWKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTCCCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             ccchhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            000000000      0000001111223468899999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-39  Score=262.75  Aligned_cols=198  Identities=24%  Similarity=0.342  Sum_probs=143.1

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC-e
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-T   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~-~   82 (235)
                      ..+...+.+.+|+||||++| +|.+++.+.    +.+++..++.++.|++.||+|||++|++|+||||+||+++.++. .
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~  156 (361)
T 3uc3_A           81 FKEVILTPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR  156 (361)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCce
Confidence            34455667789999999975 999999763    35999999999999999999999999999999999999986542 4


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++..... .......+|+.|+|||++.+....+.++||||+||++|+|++|..||.+...............
T Consensus       157 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  235 (361)
T 3uc3_A          157 LKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL  235 (361)
T ss_dssp             EEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred             EEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence            999999998643322 2233456899999999998766445569999999999999999999987543222222221111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .....                      ......+++++.++|++||..||.+|||+.++++||||..
T Consensus       236 ~~~~~----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          236 SVKYS----------------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             TTCCC----------------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             cCCCC----------------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            10000                      0011247889999999999999999999999999999954

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=262.63  Aligned_cols=198  Identities=30%  Similarity=0.413  Sum_probs=160.6

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC-CCCe
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~-~~~~   82 (235)
                      ..+..++++.+|+||||++| +|.+++...   ...+++..++.++.||+.||+|||+++++|+||||+||++.. ....
T Consensus       151 ~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~  227 (373)
T 2x4f_A          151 LYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ  227 (373)
T ss_dssp             EEEEEECSSEEEEEEECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTE
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCc
Confidence            34455667889999999975 999988752   235899999999999999999999999999999999999842 3348


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+.....
T Consensus       228 ~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  305 (373)
T 2x4f_A          228 IKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW  305 (373)
T ss_dssp             EEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred             EEEEeCCCceecCCc-cccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence            999999999766533 2233456899999999987544 78999999999999999999999999888777766654321


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...                        ......++++++++|++||+.||.+|||+.++++||||++..
T Consensus       306 ~~~------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          306 DLE------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             CSC------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             CCC------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            111                        111235789999999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-39  Score=269.03  Aligned_cols=191  Identities=31%  Similarity=0.462  Sum_probs=158.4

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++...+|+||||++ |+|.+++.+    .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+
T Consensus        81 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~v  155 (476)
T 2y94_A           81 LYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NA  155 (476)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CE
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-Ce
Confidence            3445566778999999997 599998854    45699999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||++...... .......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.........+......
T Consensus       156 kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  234 (476)
T 2y94_A          156 KIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY  234 (476)
T ss_dssp             EECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC
T ss_pred             EEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC
Confidence            99999999765432 23345578999999999987664578999999999999999999999887766555554421100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                                  ....+++++.++|++||+.||.+|||+.++++||||+.
T Consensus       235 ----------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 ----------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ----------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                                        01246789999999999999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-39  Score=264.62  Aligned_cols=213  Identities=36%  Similarity=0.612  Sum_probs=152.9

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++...+|+||||++|+|.+++..      .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus       100 ~~~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  172 (371)
T 2xrw_A          100 EEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG  172 (371)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCC
T ss_pred             ccccceEEEEEcCCCCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEee
Confidence            44568999999999999988853      589999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+....+.+....+
T Consensus       173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             C-----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccccc-cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765432 2233456789999999998654 889999999999999999999999999888887777766555543332


Q ss_pred             ccccccccc--cCCCCCCccchhhcCC------------CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          170 PGVSSLMNW--HEYPQWNPQSLATAVP------------NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       170 ~~~~~~~~~--~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .........  ...............+            ..++++++||++||..||.+|||++++++||||+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            221110000  0000001111111000            1256789999999999999999999999999998653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.2e-39  Score=250.79  Aligned_cols=193  Identities=21%  Similarity=0.278  Sum_probs=150.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC----
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----   80 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~----   80 (235)
                      .+...+++..|+||||++| +|.+++.+.......+++..++.++.||+.||+|||++|++|+||||+||+++..+    
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~  156 (289)
T 1x8b_A           77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA  156 (289)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------
T ss_pred             eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcc
Confidence            3445567789999999975 99999988766667799999999999999999999999999999999999997322    


Q ss_pred             --------------CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 026660           81 --------------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  146 (235)
Q Consensus        81 --------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  146 (235)
                                    ..++++|||.+......    ....++..|+|||.+.+...++.++||||+|++++++++|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             -------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                          26899999998765432    223578999999999876556789999999999999999987775


Q ss_pred             CCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          147 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                      .......   +...   .                        .......+++++.++|++||+.||.+|||+.++++|||
T Consensus       233 ~~~~~~~---~~~~---~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          233 NGDQWHE---IRQG---R------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             SSHHHHH---HHTT---C------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             chhHHHH---HHcC---C------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence            5433221   1110   0                        00111247889999999999999999999999999999


Q ss_pred             CCCCCc
Q 026660          227 FDDLDK  232 (235)
Q Consensus       227 f~~~~~  232 (235)
                      |++...
T Consensus       283 ~~~~~~  288 (289)
T 1x8b_A          283 LLSASR  288 (289)
T ss_dssp             C-----
T ss_pred             hhhhcc
Confidence            987543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=257.39  Aligned_cols=198  Identities=29%  Similarity=0.377  Sum_probs=148.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--CCCe
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMT   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~~~~   82 (235)
                      .+..++.+..|+||||+.| +|.+++..    .+.+++..++.++.|++.||+|||++|++|+||||+||+++.  .+..
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~  189 (349)
T 2w4o_A          114 KEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAP  189 (349)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCC
T ss_pred             eeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCC
Confidence            3445667789999999975 99998854    456899999999999999999999999999999999999974  2338


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-LLHIFRLL  161 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~  161 (235)
                      ++|+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+....
T Consensus       190 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          190 LKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             EEECCCC-----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             EEEccCccccccCcc-cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence            999999998765432 2233456799999999997654 78999999999999999999999977654442 22222110


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ...                        .......++.++.++|++||..||.+|||+.++++||||+....+
T Consensus       268 ~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          268 YYF------------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             CCC------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             Ccc------------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            000                        011123578899999999999999999999999999999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-39  Score=263.49  Aligned_cols=213  Identities=31%  Similarity=0.505  Sum_probs=157.9

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCC---------
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKT---------   80 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~---------   80 (235)
                      +..++|+||||++++|.+++..  .....+++..++.++.||+.||+|||++ |++|+||||+||+++.++         
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence            5678999999999899998876  3335699999999999999999999998 999999999999998553         


Q ss_pred             ---------------------------------------CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCC
Q 026660           81 ---------------------------------------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH  121 (235)
Q Consensus        81 ---------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  121 (235)
                                                             ..++|+|||.+......   .....+|..|+|||++.+.. 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCC-
Confidence                                                   26999999999765432   34456799999999998765 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCCCCcccc----------cccccccCCCCCC
Q 026660          122 YSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLGTPNEKVWPGV----------SSLMNWHEYPQWN  185 (235)
Q Consensus       122 ~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~  185 (235)
                      ++.++|||||||++|+|++|..||....      .......+....+.++...+...          ...........+.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8899999999999999999999997543      45555666666655443221110          0000000000000


Q ss_pred             ccchhh----cCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          186 PQSLAT----AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       186 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ......    .....++++++||++||+.||.+|||+.|+++||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000000    01123467889999999999999999999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-39  Score=261.21  Aligned_cols=205  Identities=23%  Similarity=0.389  Sum_probs=158.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcC------------------------------------CCCCCHHHHHH
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------------------------------GENIPVNTVKS   47 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------------------------------------~~~~~~~~~~~   47 (235)
                      ..+..++++..|+||||++| +|.+++..+...                                    ...+++..++.
T Consensus        93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (345)
T 3hko_A           93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN  172 (345)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred             eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence            34455677889999999974 999998532211                                    12246788999


Q ss_pred             HHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC-eEEEeecCCcccccCCCC----CcccccccccccCchhhhCC-CC
Q 026660           48 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGS-TH  121 (235)
Q Consensus        48 i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~-~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~-~~  121 (235)
                      ++.|++.||+|||+++++|+||||+||+++.++. .++|+|||.+........    ......+|+.|+|||++.+. ..
T Consensus       173 i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            9999999999999999999999999999975432 799999999975533211    23455679999999998742 44


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHH
Q 026660          122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL  201 (235)
Q Consensus       122 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (235)
                      ++.++||||||+++|+|++|..||.+....+..............                        .....+++++.
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~  308 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN------------------------PNYNVLSPLAR  308 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS------------------------GGGGGSCHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC------------------------cccccCCHHHH
Confidence            789999999999999999999999988887776666542111111                        11123678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          202 DLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       202 ~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ++|++||..||.+|||+.++++||||+++.++
T Consensus       309 ~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          309 DLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            99999999999999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-39  Score=265.65  Aligned_cols=192  Identities=27%  Similarity=0.406  Sum_probs=144.5

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--CCeEEEee
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIAD   87 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~~~~~l~d   87 (235)
                      +++++|+||||+.| +|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++..  +..++|+|
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence            47789999999975 999999762  23469999999999999999999999999999999999999862  33899999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ----QLLHIFRLLGT  163 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~  163 (235)
                      ||+++..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.......    ....+......
T Consensus       208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  285 (400)
T ss_dssp             CTTCEECC------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred             cccccccCCC-CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence            9999765432 2234557799999999986544 8899999999999999999999997654211    11111110000


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .                        .......++++++++|++||+.||.+|||+.++++||||...
T Consensus       286 ~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          286 F------------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             C------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             C------------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            0                        001123578999999999999999999999999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=260.18  Aligned_cols=209  Identities=38%  Similarity=0.692  Sum_probs=161.9

Q ss_pred             EEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           14 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        14 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      ..|+||||++++|.+++.      ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             eEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            469999999999887763      2599999999999999999999999999999999999999776 899999999875


Q ss_pred             ccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCccccc
Q 026660           94 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  173 (235)
Q Consensus        94 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (235)
                      ....   .....+|+.|+|||.+.+...++.++|+||+|+++++|++|..||.+....+....+....+.+.........
T Consensus       176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            4422   2344678999999999875558899999999999999999999999988888888887777666544332221


Q ss_pred             cccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          174 SLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       174 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ....   ................+.+++++.++|++||+.||.+|||+.++++||||+.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence            1100   0000111111222334468899999999999999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-38  Score=258.11  Aligned_cols=194  Identities=28%  Similarity=0.475  Sum_probs=158.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+.++.....|+||||+.| +|.+++...    ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ik  240 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIR  240 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEE
Confidence            3445667889999999986 999999762    4699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      ++|||++...... .......+|+.|+|||++.+.     ..++.++|||||||++|+|++|..||...........+..
T Consensus       241 l~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          241 LSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            9999998765533 233456789999999998632     2378899999999999999999999988777666555443


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .....                        ........++++.++|++||..||.+|||+.++++||||+.
T Consensus       320 ~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          320 GQYQF------------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             TCCCC------------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCC------------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            21110                        01112357788999999999999999999999999999973

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.3e-39  Score=250.16  Aligned_cols=192  Identities=28%  Similarity=0.438  Sum_probs=157.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---cCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTM   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~---~~~~~   81 (235)
                      .+..++++..|+||||++| +|.+++...    +.+++..++.++.|++.||+|||++|++|+||+|+||++   +.++ 
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-  146 (277)
T 3f3z_A           72 YETFEDNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-  146 (277)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-
T ss_pred             EEEEecCCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-
Confidence            4445677889999999975 999998762    458999999999999999999999999999999999999   5444 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||.+...... .......+|+.|+|||.+.+.  ++.++|+||+|++++++++|..||......+....+....
T Consensus       147 ~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (277)
T 3f3z_A          147 PLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT  223 (277)
T ss_dssp             CEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cEEEEecccceeccCc-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            8999999998765533 233445679999999998643  7899999999999999999999999888776666655421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...+                        ......+++++.++|++||+.||.+|||+.++++||||++
T Consensus       224 ~~~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          224 FTFP------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             CCCC------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             CCCC------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            1111                        1112247889999999999999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=262.44  Aligned_cols=195  Identities=25%  Similarity=0.415  Sum_probs=153.7

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      ...+.+..+|+||||++| +|.+++...    ..+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|
T Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl  200 (355)
T 1vzo_A          126 YAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVL  200 (355)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEE
T ss_pred             EEEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEE
Confidence            344566789999999985 999999763    3689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCC-CcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Q 026660           86 ADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSE----LQQLLHIFR  159 (235)
Q Consensus        86 ~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~  159 (235)
                      +|||+++....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.....    .........
T Consensus       201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  280 (355)
T 1vzo_A          201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK  280 (355)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred             eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence            99999875532222 23345689999999999753 3468899999999999999999999975332    122222111


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .  .+                          .....++..+.++|++||..||.+||     +++++++||||+.++|+.
T Consensus       281 ~--~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~  332 (355)
T 1vzo_A          281 S--EP--------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  332 (355)
T ss_dssp             C--CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             c--CC--------------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhH
Confidence            0  00                          01124778899999999999999999     999999999999998753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-38  Score=267.13  Aligned_cols=197  Identities=30%  Similarity=0.492  Sum_probs=159.6

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--CC
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TM   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~~   81 (235)
                      ..+..++.+.+|+||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++..  ..
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~  161 (486)
T 3mwu_A           86 LFEILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC  161 (486)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTC
T ss_pred             EEEEEEcCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence            34456678889999999975 999998763    469999999999999999999999999999999999999643  23


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......||+.|+|||++.+.  ++.++||||+||++|+|++|..||.+....+....+....
T Consensus       162 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  238 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK  238 (486)
T ss_dssp             CEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            7999999999765433 233455789999999998753  7899999999999999999999999988877766665432


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .....+                        ....++++++++|++||..||.+|||+.++++||||+....
T Consensus       239 ~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          239 YAFDLP------------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             CCSCSG------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             CCCCCc------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            111111                        11247889999999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=251.46  Aligned_cols=194  Identities=29%  Similarity=0.502  Sum_probs=132.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..|+||||+++ +|.+++..   ....+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~k  152 (278)
T 3cok_A           77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIK  152 (278)
T ss_dssp             EEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEE
T ss_pred             EEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEE
Confidence            3445667889999999975 99999875   235689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............+++.|+|||.+.+.. ++.++|+||+|++++++++|..||......+......    . 
T Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~-  226 (278)
T 3cok_A          153 IADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----L-  226 (278)
T ss_dssp             ECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----S-
T ss_pred             EEeecceeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----h-
Confidence            999999976654444444556789999999987554 7889999999999999999999997654322111100    0 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                       ..      ......++.++.++|++||..||.+|||++++++||||.+...
T Consensus       227 -----------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          227 -----------------AD------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -----------------SC------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -----------------cc------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                             00      0011247889999999999999999999999999999987543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.9e-39  Score=254.82  Aligned_cols=200  Identities=24%  Similarity=0.338  Sum_probs=146.2

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--e
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--T   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--~   82 (235)
                      .+..++++.+|+||||+. |+|.+++.+.    ..+++..++.++.||+.||+|||+++++|+||||+||+++.++.  .
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~  152 (316)
T 2ac3_A           77 IEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSP  152 (316)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCc
Confidence            344556778999999998 5999999773    46899999999999999999999999999999999999986652  3


Q ss_pred             EEEeecCCcccccCCC-------CCcccccccccccCchhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Q 026660           83 LKIADLGLARAFTLPI-------KKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSE-  150 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-  150 (235)
                      ++|+|||++.......       .......+|+.|+|||++.+.    ..++.++||||+||++|+|++|..||..... 
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  232 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS  232 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence            9999999986543211       112234578999999998641    2367899999999999999999999976431 


Q ss_pred             --------------HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC
Q 026660          151 --------------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI  216 (235)
Q Consensus       151 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  216 (235)
                                    ......+....    ..                    ........++++++++|++||..||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~i~~~~----~~--------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  288 (316)
T 2ac3_A          233 DCGWDRGEACPACQNMLFESIQEGK----YE--------------------FPDKDWAHISCAAKDLISKLLVRDAKQRL  288 (316)
T ss_dssp             CSCC----CCHHHHHHHHHHHHHCC----CC--------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             cccccccccchhHHHHHHHHHhccC----cc--------------------cCchhcccCCHHHHHHHHHHhhCChhhCC
Confidence                          11111111100    00                    00111235788999999999999999999


Q ss_pred             CHHHHhCCCCCCCCCcC
Q 026660          217 SAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       217 s~~~ll~hp~f~~~~~~  233 (235)
                      |+.++++||||++..++
T Consensus       289 s~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          289 SAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             CHHHHHHSTTCC-----
T ss_pred             CHHHHhcChhhcCCCCc
Confidence            99999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-39  Score=270.42  Aligned_cols=197  Identities=32%  Similarity=0.482  Sum_probs=161.0

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--CCC
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTM   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~~~   81 (235)
                      ..+..++++..|+||||+.| +|.+++..    .+.+++..++.++.||+.||+|||++|++|+||||+||+++.  ...
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  166 (484)
T 3nyv_A           91 LYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA  166 (484)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred             EEEEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC
Confidence            44556678889999999975 99998865    356999999999999999999999999999999999999952  233


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......+|+.|+|||++.+  .++.++||||+||++|+|++|..||.+....+....+....
T Consensus       167 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  243 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK  243 (484)
T ss_dssp             CEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cEEEEeeeeeEEcccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            8999999998765533 23344568999999999875  37899999999999999999999999988877776665421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .....                        .....++++++++|++||+.||.+|||+.++++||||+...+
T Consensus       244 ~~~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          244 YTFEL------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             CCCCS------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             CCCCC------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            11111                        111247889999999999999999999999999999986554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.8e-39  Score=252.33  Aligned_cols=185  Identities=23%  Similarity=0.285  Sum_probs=134.3

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCcEEEcCCCCeE
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~--------~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+|||||||+ |||.+++.+     ..++++.+.+++.|++.||+|||++        +++||||||+|||++.++ .+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~  147 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TC  147 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CE
T ss_pred             eEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CE
Confidence            47899999998 599999976     3589999999999999999999987        899999999999999776 99


Q ss_pred             EEeecCCcccccCCCC----CcccccccccccCchhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Q 026660           84 KIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSE----  150 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----  150 (235)
                      ||+|||+++.......    ......||+.|+|||++.+..     .++.++|||||||++|||++|..||.....    
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            9999999976543322    123457899999999997532     256799999999999999999877643221    


Q ss_pred             ----------HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH
Q 026660          151 ----------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK  220 (235)
Q Consensus       151 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  220 (235)
                                .+......  ......+.               .+   ........+..+.+++.+||+.||.+|||+.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~--~~~~~rp~---------------~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVV--CEQKLRPN---------------IP---NRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHH--TTSCCCCC---------------CC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             chhcccccchHHHHHHHH--hcccCCCC---------------CC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence                      11111111  00000000               00   00001123356789999999999999999999


Q ss_pred             HhC
Q 026660          221 AME  223 (235)
Q Consensus       221 ll~  223 (235)
                      +++
T Consensus       288 i~~  290 (303)
T 3hmm_A          288 IKK  290 (303)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-38  Score=254.81  Aligned_cols=193  Identities=20%  Similarity=0.309  Sum_probs=157.5

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...+++..|+||||+.|+|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|
T Consensus       120 ~~~~~~~~~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL  195 (348)
T 1u5q_A          120 RGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKL  195 (348)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEE
T ss_pred             EEEEEECCeEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEE
Confidence            3344566789999999999999988653   34699999999999999999999999999999999999999776 9999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||++.....    .....+|+.|+|||++.+  ...++.++|||||||++++|++|..||.+................
T Consensus       196 ~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  271 (348)
T 1u5q_A          196 GDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP  271 (348)
T ss_dssp             CCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             eeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence            99999875542    234567999999999863  344789999999999999999999999888776665544432100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .                          .....+++.+.++|++||+.||.+|||++++++||||.....
T Consensus       272 ~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          272 A--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             C--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             C--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            0                          011246789999999999999999999999999999976543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.2e-39  Score=252.34  Aligned_cols=209  Identities=21%  Similarity=0.338  Sum_probs=151.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~----~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      +....++..|+||||++| +|.+++.....    ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ 
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-  158 (303)
T 2vwi_A           80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-  158 (303)
T ss_dssp             EEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-
T ss_pred             EEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-
Confidence            344556679999999975 99999986433    234589999999999999999999999999999999999999776 


Q ss_pred             eEEEeecCCcccccCCC-----CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           82 TLKIADLGLARAFTLPI-----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      .++|+|||.+.......     .......+++.|+|||.+.+...++.++|+||+|+++++|++|..||...........
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  238 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML  238 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence            89999999886543221     1123446788999999987544478999999999999999999999987665444332


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      ...   .........               .........+++++.++|++||+.||.+|||+.++++||||++...+.
T Consensus       239 ~~~---~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          239 TLQ---NDPPSLETG---------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             HHT---SSCCCTTC--------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             Hhc---cCCCccccc---------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            221   111100000               001112235788999999999999999999999999999999877654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.8e-39  Score=249.63  Aligned_cols=190  Identities=25%  Similarity=0.425  Sum_probs=154.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++....++||||+++ +|.+++.+.    ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~  149 (279)
T 3fdn_A           75 YGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELK  149 (279)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEE
T ss_pred             hheEecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEE
Confidence            3445667789999999985 999999774    4589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |+|||.+......  ......+++.|+|||.+.+.. ++.++||||+|++++++++|..||......+....+...... 
T Consensus       150 l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  225 (279)
T 3fdn_A          150 IADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-  225 (279)
T ss_dssp             ECSCCEESCC----------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-
T ss_pred             EEeccccccCCcc--cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-
Confidence            9999988544322  234456789999999987654 789999999999999999999999988776666555432111 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                                 ....+++++.++|++||+.||.+|||+.++++||||++..
T Consensus       226 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          226 ---------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ---------------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                                       0113678899999999999999999999999999998543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-38  Score=254.12  Aligned_cols=192  Identities=24%  Similarity=0.346  Sum_probs=159.7

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++++.+|+||||+.| +|.+++...    ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++ .+
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~  180 (335)
T 2owb_A          106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EV  180 (335)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CE
T ss_pred             EEEEEecCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CE
Confidence            34455667889999999985 999988763    4689999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+..............++..|+|||++.+.. ++.++||||||+++|+|++|..||......+...........
T Consensus       181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  259 (335)
T 2owb_A          181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS  259 (335)
T ss_dssp             EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             EEeeccCceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999977654444445567899999999997655 789999999999999999999999887766655544331100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                  ....+++++.++|++||+.||.+|||+.++++||||.+.
T Consensus       260 ----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          260 ----------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ----------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                                        012467889999999999999999999999999999754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-38  Score=265.95  Aligned_cols=195  Identities=33%  Similarity=0.507  Sum_probs=160.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--C
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--M   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~   81 (235)
                      ..+..++++.+|+|||||.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++..+  .
T Consensus       101 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  176 (494)
T 3lij_A          101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDA  176 (494)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred             EEEEEEeCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCC
Confidence            44556678889999999985 999988763    4589999999999999999999999999999999999997543  2


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+....+....+....
T Consensus       177 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  253 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK  253 (494)
T ss_dssp             CEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             cEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            5999999999766543 23345578999999999853  38899999999999999999999999988877766665432


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .....                        .....++++++++|++||+.||.+|||+.++++||||+..
T Consensus       254 ~~~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          254 YTFDS------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             CCCCS------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCCCc------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            21111                        1123578899999999999999999999999999999753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-38  Score=267.99  Aligned_cols=196  Identities=27%  Similarity=0.432  Sum_probs=161.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--   81 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--   81 (235)
                      ..+..++++.+|+|||||+| +|.+++.+.    ..+++..++.++.||+.||+|||++|++|+||||+||+++..+.  
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            34556778889999999975 999999763    46999999999999999999999999999999999999986652  


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+....+....+....
T Consensus       187 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             SEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            6999999999766543 23345578999999999863  37899999999999999999999999988877766665421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...                        .......++++++++|++||..||.+|||+.++++||||+...
T Consensus       264 ~~~------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          264 YYF------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCC------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCC------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            110                        0112235789999999999999999999999999999998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=254.64  Aligned_cols=193  Identities=27%  Similarity=0.402  Sum_probs=147.3

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      ..+...+++.+|+|||+.+++|.+++.+    .+.+++..++.++.||+.||+|||+++++|+||||+||+++ ++ .++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~k  147 (343)
T 3dbq_A           74 LYDYEITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLK  147 (343)
T ss_dssp             EEEEEECSSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEE
T ss_pred             EeeeEeeCCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEE
Confidence            3444566788999999877899999976    35699999999999999999999999999999999999998 45 899


Q ss_pred             EeecCCcccccCCCC--CcccccccccccCchhhhC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H
Q 026660           85 IADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLG----------STHYSTAVDMWSVACIFAELVTKTALFPGDSE-L  151 (235)
Q Consensus        85 l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~  151 (235)
                      |+|||++........  ......||+.|+|||++.+          ...++.++||||+||++|+|++|..||..... .
T Consensus       148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  227 (343)
T 3dbq_A          148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  227 (343)
T ss_dssp             ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence            999999976643322  2234578999999999864          23478899999999999999999999976433 2


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .......   ......                       ......++++.++|++||..||.+|||+.++++||||+.
T Consensus       228 ~~~~~~~---~~~~~~-----------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          228 SKLHAII---DPNHEI-----------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HHHHHHH---CTTSCC-----------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHHh---cCCccc-----------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            2222221   111100                       001134678999999999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-38  Score=248.94  Aligned_cols=192  Identities=24%  Similarity=0.346  Sum_probs=158.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||++| +|.+++...    ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~k  155 (294)
T 2rku_A           81 HGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVK  155 (294)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEE
T ss_pred             eeeeccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEE
Confidence            3445667789999999985 999988762    4689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+..............++..|+|||.+.+.. ++.++|+||+|+++++|++|..||......+..........  
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--  232 (294)
T 2rku_A          156 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--  232 (294)
T ss_dssp             ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred             EEeccCceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--
Confidence            999999976654444445567889999999987654 78999999999999999999999988776555444332100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                                .....+++.+.++|++||+.||.+|||++++++||||.+..
T Consensus       233 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          233 --------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             --------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             --------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence                                      01124678899999999999999999999999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-38  Score=250.86  Aligned_cols=198  Identities=22%  Similarity=0.354  Sum_probs=154.3

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +....++..|+||||++| +|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+++
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl  158 (302)
T 2j7t_A           83 GAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRL  158 (302)
T ss_dssp             EEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEE
T ss_pred             eeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEE
Confidence            334456789999999985 999988763   34699999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +|||.+..............++..|+|||.+.    ....++.++|+||+|+++++|++|..||................
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (302)
T 2j7t_A          159 ADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD  238 (302)
T ss_dssp             CCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             EECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence            99998753322212223446788999999984    23447899999999999999999999999877666555443321


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ..  ..                       .....++.++.++|++||..||.+|||+.++++||||+++.+.
T Consensus       239 ~~--~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          239 PP--TL-----------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             CC--CC-----------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             Cc--cc-----------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            00  00                       0112367889999999999999999999999999999988764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=250.22  Aligned_cols=197  Identities=22%  Similarity=0.353  Sum_probs=159.9

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..|+||||++| +|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl  166 (314)
T 3com_A           91 GSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKL  166 (314)
T ss_dssp             EEEEETTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEE
T ss_pred             EEEEeCCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEE
Confidence            344556778999999986 999999742   35699999999999999999999999999999999999999777 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.................  .
T Consensus       167 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~  243 (314)
T 3com_A          167 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--P  243 (314)
T ss_dssp             CCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C
T ss_pred             eecccchhhhhhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--c
Confidence            99999977655444445567899999999987654 78999999999999999999999988776555443322110  0


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                       ..                      .....+++++.++|++||..||.+|||+.++++||||++....
T Consensus       244 -~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          244 -TF----------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             -CC----------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             -cc----------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence             00                      0011367889999999999999999999999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=252.33  Aligned_cols=192  Identities=21%  Similarity=0.395  Sum_probs=149.3

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ...+|+||||+++ +|.+++...  ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcC
Confidence            5789999999985 999999873  234689999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +..............++..|+|||++..    ...++.++|||||||++|+|++|..||..................   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  252 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP---  252 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---
Confidence            8765543333445577899999999862    234788999999999999999999999887765555443321100   


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .                       .....+++.+.++|++||..||.+|||+.++++||||++...
T Consensus       253 ~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          253 R-----------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             C-----------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             c-----------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            0                       011247889999999999999999999999999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-38  Score=248.07  Aligned_cols=191  Identities=28%  Similarity=0.458  Sum_probs=157.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..|+||||+++ +|.+++.+.    +.+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~k  154 (284)
T 2vgo_A           80 YNYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELK  154 (284)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEE
T ss_pred             EEEEEcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEE
Confidence            3445567789999999975 999999773    3589999999999999999999999999999999999999777 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+......  ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||......+....+.....  
T Consensus       155 l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  229 (284)
T 2vgo_A          155 IADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--  229 (284)
T ss_dssp             ECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred             EecccccccCccc--ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--
Confidence            9999988654322  233456789999999987654 78999999999999999999999988776665544432100  


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                                .....++++++++|++||..||.+|||++++++||||+....
T Consensus       230 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          230 --------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             --------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             --------------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                                      001247789999999999999999999999999999986543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=252.54  Aligned_cols=185  Identities=24%  Similarity=0.330  Sum_probs=152.1

Q ss_pred             cCCcCCCceEEEEEEecCc-c-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            5 QGQNKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..+.+++.+..++||||+. | +|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++.++ .
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~  168 (335)
T 3dls_A           94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-T  168 (335)
T ss_dssp             EEEEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-C
T ss_pred             EEEEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-c
Confidence            3445667888999999985 6 99999865    44699999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||.+...... .......+|+.|+|||++.+....+.++|||||||++|+|++|..||......         ..
T Consensus       169 ~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~  238 (335)
T 3dls_A          169 IKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VE  238 (335)
T ss_dssp             EEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TT
T ss_pred             EEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hh
Confidence            999999999766543 22344568999999999987664588999999999999999999999652210         00


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                               ........+++++.++|++||+.||.+|||+.++++||||++
T Consensus       239 -------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          239 -------------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             -------------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             -------------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence                                     000111237889999999999999999999999999999976

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-37  Score=244.35  Aligned_cols=187  Identities=26%  Similarity=0.376  Sum_probs=149.5

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .++..+|+||||+++ +|.+++.+.    ..+++..++.++.|++.||+|||+++  ++|+||+|+||+++.....++|+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence            456889999999975 999999763    46899999999999999999999999  99999999999998444489999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+......  ......+++.|+|||.+.+  .++.++|+||+|+++++|++|..||..................   
T Consensus       175 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---  247 (290)
T 1t4h_A          175 DLGLATLKRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---  247 (290)
T ss_dssp             CTTGGGGCCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---
T ss_pred             eCCCccccccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---
Confidence            99998654332  2334567899999998864  3789999999999999999999999875554443332211000   


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                            ........++++.++|++||+.||.+|||+.++++||||++
T Consensus       248 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ----------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                  00111235688999999999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-38  Score=256.79  Aligned_cols=215  Identities=34%  Similarity=0.546  Sum_probs=155.9

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcC-----CCCeEE
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDR-----KTMTLK   84 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~-----~~~~~~   84 (235)
                      +..++++|||+++++|.+++...  ....+++..++.++.||+.||+|||++ |++|+||||+||+++.     ....++
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~k  178 (373)
T 1q8y_A          101 NGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  178 (373)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             CCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence            34489999999988999999874  334599999999999999999999998 9999999999999952     222799


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIF  158 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~  158 (235)
                      |+|||++......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....      ..+....+.
T Consensus       179 l~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          179 IADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             ECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EcccccccccCCC---CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            9999999765432   33446799999999998755 7899999999999999999999997643      445556666


Q ss_pred             HHhCCCCCCCccccccc----------ccccCCCCCCccchhhc----CCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          159 RLLGTPNEKVWPGVSSL----------MNWHEYPQWNPQSLATA----VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...+..+...+......          ........+........    ...+++++.++|++||+.||.+|||+.++++|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            66655443221111000          00000000000000001    11345788999999999999999999999999


Q ss_pred             CCCCCCC
Q 026660          225 PYFDDLD  231 (235)
Q Consensus       225 p~f~~~~  231 (235)
                      |||++..
T Consensus       335 p~f~~~~  341 (373)
T 1q8y_A          335 PWLKDTL  341 (373)
T ss_dssp             GGGTTCT
T ss_pred             hhhhccc
Confidence            9999754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.6e-38  Score=255.62  Aligned_cols=192  Identities=27%  Similarity=0.405  Sum_probs=147.4

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +....++.+|+|||+.+++|.+++..    ...+++..++.++.||+.||.|||+++++|+||||+||+++ ++ .++|+
T Consensus       123 ~~~~~~~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~  196 (390)
T 2zmd_A          123 DYEITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLI  196 (390)
T ss_dssp             EEEECSSEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEEC
T ss_pred             EEEecCCEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEE
Confidence            34456677999999777899999976    34689999999999999999999999999999999999996 44 89999


Q ss_pred             ecCCcccccCCCC--CcccccccccccCchhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 026660           87 DLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQ  153 (235)
Q Consensus        87 df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~  153 (235)
                      |||++........  ......||+.|+|||++.+.          ..++.++|||||||++|+|++|..||..... ...
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~  276 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  276 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence            9999976643322  23345789999999998752          2478899999999999999999999976533 222


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...+.   ......                       ......+.++.++|++||..||.+|||+.++++||||+..
T Consensus       277 ~~~~~---~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          277 LHAII---DPNHEI-----------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHH---CTTSCC-----------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHh---CccccC-----------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            22222   111000                       0011246789999999999999999999999999999743

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-38  Score=245.01  Aligned_cols=197  Identities=27%  Similarity=0.435  Sum_probs=153.6

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..|+||||++| +|.+++..    ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~k  145 (276)
T 2yex_A           71 YGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLK  145 (276)
T ss_dssp             EEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             eeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEE
Confidence            3445566789999999985 99887743    45699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Q 026660           85 IADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLL  161 (235)
Q Consensus        85 l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~  161 (235)
                      ++|||.+.......  .......++..|+|||.+.+....+.++|+||+|++++++++|..||....... .......  
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--  223 (276)
T 2yex_A          146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--  223 (276)
T ss_dssp             ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--
T ss_pred             EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--
Confidence            99999987553221  123345678899999999766545789999999999999999999997654321 1111111  


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                       ...                       .......+++.+.++|++||+.||.+|||+.++++||||++...+
T Consensus       224 -~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          224 -KKT-----------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             -TCT-----------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             -ccc-----------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence             000                       000112478899999999999999999999999999999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-38  Score=248.92  Aligned_cols=193  Identities=28%  Similarity=0.390  Sum_probs=156.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---cCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTM   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~---~~~~~   81 (235)
                      .+..++.+..|+||||++| +|.+++...    +.+++..++.++.|++.||.|||++|++|+||+|+||++   +..+ 
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-  146 (304)
T 2jam_A           72 EDIYESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-  146 (304)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-
T ss_pred             hhhcccCCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-
Confidence            3445667789999999975 999999763    468999999999999999999999999999999999999   4344 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||.+......  ......+++.|+|||.+.+.. ++.++|+||+|++++++++|..||......+....+....
T Consensus       147 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          147 KIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             CEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred             CEEEccCCcceecCCC--ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            8999999998654322  223446789999999987654 7899999999999999999999998887766665554421


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .....                        .....+++++.++|++||..||.+|||+.++++||||+..
T Consensus       224 ~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          224 YEFES------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             CCCCT------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CCCCc------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            11110                        1122578899999999999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.3e-38  Score=245.86  Aligned_cols=191  Identities=30%  Similarity=0.416  Sum_probs=148.8

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..|+||||+++ +|.+++.+.    ..+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~  151 (276)
T 2h6d_A           77 YQVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAK  151 (276)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEE
T ss_pred             EEEEecCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEE
Confidence            3445567789999999975 999999763    3589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      ++|||.+....... ......+++.|+|||.+.+....+.++|+||+|++++++++|..||......+....+...... 
T Consensus       152 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  229 (276)
T 2h6d_A          152 IADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-  229 (276)
T ss_dssp             ECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred             EeecccccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-
Confidence            99999987654322 2234467889999999976654578999999999999999999999887765555444321100 


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                 ....++.++.++|++||+.||.+|||+.++++||||++.
T Consensus       230 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          230 ---------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                       012367889999999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.5e-38  Score=244.57  Aligned_cols=192  Identities=27%  Similarity=0.393  Sum_probs=156.7

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCcEEEcCCCCeE
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-----ILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~di~~~nil~~~~~~~~   83 (235)
                      +++..+|+||||++| +|.+++.........+++..++.++.|++.||+|||+++     ++|+||+|+||+++.++ .+
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~  155 (279)
T 2w5a_A           77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NV  155 (279)
T ss_dssp             GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CE
Confidence            456789999999975 999999987666677999999999999999999999999     99999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+......
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  234 (279)
T ss_dssp             EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             EEecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence            9999999876544332233456788999999998654 789999999999999999999999887765555544432110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                 .....+++++.++|++||+.||.+|||+.++++|+|+..-
T Consensus       235 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 ---------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ---------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                       0112478899999999999999999999999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-38  Score=248.72  Aligned_cols=198  Identities=22%  Similarity=0.386  Sum_probs=156.0

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC---
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~---   81 (235)
                      .+..+++...|+||||++ ++|.+++.+.    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.   
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           74 HDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred             hheecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence            344556778999999997 5999999762    46899999999999999999999999999999999999986542   


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+|++++++++|..||......+....+....
T Consensus       150 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  227 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN  227 (283)
T ss_dssp             CEEECCCTTCEECC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             ceEEEecccceeccCCC-cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence            69999999987654322 233446788999999987654 7899999999999999999999999887666555443211


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ..                        ........+++.+.+++++||..||.+|||+.++++||||+.+.+.
T Consensus       228 ~~------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          228 YD------------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             CC------------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             cC------------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            00                        0011123578899999999999999999999999999999876544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=243.53  Aligned_cols=201  Identities=21%  Similarity=0.299  Sum_probs=151.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..++||||+++ +|.+++.... ....+++..++.++.|++.||+|||++|++|+||+|+||+++..+..++|
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl  164 (295)
T 2clq_A           86 GSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI  164 (295)
T ss_dssp             EEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEE
T ss_pred             eEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEE
Confidence            344566789999999974 9999998732 23356799999999999999999999999999999999999873448999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+..............++..|+|||++.+. ..++.++|+||||+++|+|++|..||...................
T Consensus       165 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (295)
T 2clq_A          165 SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH  244 (295)
T ss_dssp             CCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC
T ss_pred             eecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc
Confidence            9999997665433334455678999999998653 236889999999999999999999997644322221111111100


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .                         .....+++++.++|++||+.||.+|||+.++++||||+....+
T Consensus       245 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          245 P-------------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             C-------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             c-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            0                         0112478899999999999999999999999999999976543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-37  Score=246.17  Aligned_cols=189  Identities=24%  Similarity=0.365  Sum_probs=156.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...++...|+||||++| +|.+++..     +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl  160 (303)
T 3a7i_A           87 GSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKL  160 (303)
T ss_dssp             EEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEE
T ss_pred             EEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEE
Confidence            344456789999999985 99998854     4699999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +|||.+..............++..|+|||.+.+.. ++.++|+||||++++++++|..||......+..........   
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---  236 (303)
T 3a7i_A          161 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---  236 (303)
T ss_dssp             CCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---
T ss_pred             eecccceecCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---
Confidence            99999977655444445567889999999997654 78999999999999999999999988776555444332100   


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                              ......++..+.++|++||..||.+|||+.++++||||..
T Consensus       237 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          237 ------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             ------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             ------------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence                                    0011247789999999999999999999999999999964

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=245.20  Aligned_cols=192  Identities=28%  Similarity=0.445  Sum_probs=154.4

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++++..|+||||+.++|.+++...  ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++++|||
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg  154 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALG  154 (305)
T ss_dssp             C---CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCCCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccc
Confidence            556789999999998898888773  345699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCC--CCcccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPI--KKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+.......  .......++..|+|||++.+.. ..+.++||||+|+++|+|++|..||.+....+....+.....    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  230 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----  230 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC----
Confidence            987654221  1223456789999999987533 246799999999999999999999998776665554433110    


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                              .....+++++.++|++||..||.+|||+.++++||||++...
T Consensus       231 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          231 ------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             ------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                                    011247789999999999999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-38  Score=255.45  Aligned_cols=215  Identities=20%  Similarity=0.375  Sum_probs=159.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHH------HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEc
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKY------IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMD   77 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~------l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~   77 (235)
                      .+..++.+..|+||||++| +|.++      +..  .....+++..++.++.|++.||+|||+ +|++|+||+|+||+++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            4445567789999999986 99988      432  225679999999999999999999999 9999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST-AVDMWSVACIFAELVTKTALFPGDSE-LQQLL  155 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~  155 (235)
                      .++ .++|+|||.+......  ......++..|+|||.+.+...++. ++|+||+|++++++++|..||..... .+...
T Consensus       187 ~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          187 KNG-RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             TTS-CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CCC-cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            776 8999999999765433  3344567899999999976634555 99999999999999999999987665 33333


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      .+...    ...........     ...............+++++.++|++||+.||.+|||+.++++||||++.+++.
T Consensus       264 ~i~~~----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          264 NIRTK----NIEYPLDRNHF-----LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             HHTSC----CCCCCCSSSSS-----TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             HHhcc----CcCCccchhhh-----hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            33221    11100000000     000011111122246889999999999999999999999999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-37  Score=246.78  Aligned_cols=189  Identities=24%  Similarity=0.378  Sum_probs=143.8

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ..+.++|+||||+.| +|.+++..... ....++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus       131 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Df  208 (332)
T 3qd2_B          131 SPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF  208 (332)
T ss_dssp             -CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCC
T ss_pred             CCCceEEEEEEecCCCCHHHHHhcccC-ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeec
Confidence            445679999999986 99999987322 22356677999999999999999999999999999999999776 9999999


Q ss_pred             CCcccccCCC------------CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           89 GLARAFTLPI------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        89 ~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                      |++.......            .......+|+.|+|||.+.+.. ++.++||||+|+++++|++|..|+..     ....
T Consensus       209 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~-----~~~~  282 (332)
T 3qd2_B          209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME-----RVRI  282 (332)
T ss_dssp             TTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHH
T ss_pred             CcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH-----HHHH
Confidence            9997665432            1223456899999999998655 79999999999999999998665321     1111


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .........                        .......++++.++|++||+.||.+|||+.++++||||+++
T Consensus       283 ~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          283 ITDVRNLKF------------------------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHTTCC------------------------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HHHhhccCC------------------------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            111111100                        00011245778899999999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-38  Score=257.28  Aligned_cols=180  Identities=17%  Similarity=0.282  Sum_probs=142.3

Q ss_pred             EEEEEecCccCHHHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           15 LYLVFEYMDTDLKKYIRSFRQTG---ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        15 ~~lv~e~~~g~L~~~l~~~~~~~---~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .|+||||++|+|.+++.+.....   ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus       175 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a  253 (377)
T 3byv_A          175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHL  253 (377)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGC
T ss_pred             EEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhh
Confidence            78999999999999998743211   1234588899999999999999999999999999999999776 9999999999


Q ss_pred             ccccCCCCCcccccccccccCchhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      +....   ......| +.|+|||++.+.          ..++.++|||||||++|+|++|..||......+..       
T Consensus       254 ~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~-------  322 (377)
T 3byv_A          254 VRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS-------  322 (377)
T ss_dssp             EETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS-------
T ss_pred             eecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch-------
Confidence            75332   2334456 889999999865          24889999999999999999999999654321100       


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                                               .........+++++.++|++||+.||.+|||+.++++||||+++.
T Consensus       323 -------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          323 -------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             -------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             -------------------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                                     001111236789999999999999999999999999999997643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-38  Score=254.42  Aligned_cols=221  Identities=20%  Similarity=0.290  Sum_probs=154.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+...+++..|+||||++| +|.+++.+.    +.+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .+
T Consensus        97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~  171 (360)
T 3eqc_A           97 YGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EI  171 (360)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CE
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CE
Confidence            3444567789999999985 999999773    3589999999999999999999986 999999999999999777 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+......  ......+|+.|+|||++.+.. ++.++||||+||++++|++|..||......+...........
T Consensus       172 kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  248 (360)
T 3eqc_A          172 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG  248 (360)
T ss_dssp             EECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----
T ss_pred             EEEECCCCcccccc--cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence            99999998654322  223446789999999997654 889999999999999999999999887654443322111111


Q ss_pred             CCCCCcccc---cccccccCCCCCCc-------------cchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          164 PNEKVWPGV---SSLMNWHEYPQWNP-------------QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       164 ~~~~~~~~~---~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                      .........   ..............             .........++.+++++|++||..||.+|||+.++++||||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  328 (360)
T 3eqc_A          249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI  328 (360)
T ss_dssp             -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence            000000000   00000000000000             00001112478899999999999999999999999999999


Q ss_pred             CCCCcCC
Q 026660          228 DDLDKTR  234 (235)
Q Consensus       228 ~~~~~~~  234 (235)
                      +..+++.
T Consensus       329 ~~~~~~~  335 (360)
T 3eqc_A          329 KRSDAEE  335 (360)
T ss_dssp             HHHHHSC
T ss_pred             hcchHhh
Confidence            8766543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-38  Score=252.58  Aligned_cols=194  Identities=26%  Similarity=0.447  Sum_probs=129.8

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeEEEee
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIAD   87 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~~l~d   87 (235)
                      +++.+|+||||+.| +|.+++..  .....+++..++.++.||+.||+|||++|++|+||||+||+++..+  ..++|+|
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence            46779999999985 99999986  3335699999999999999999999999999999999999997532  2599999


Q ss_pred             cCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           88 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        88 f~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ||.+......  ......+|+.|+|||++.+.. ++.++||||+|+++|+|++|..||..................... 
T Consensus       175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  250 (336)
T 3fhr_A          175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-  250 (336)
T ss_dssp             CTTCEEC------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             cccceecccc--ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-
Confidence            9998755432  233456689999999986544 788999999999999999999999765433221111111000000 


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                         .........+++++.++|++||+.||.+|||+.++++||||++
T Consensus       251 -------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 -------------------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -------------------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence                               0001112357899999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.4e-38  Score=244.79  Aligned_cols=196  Identities=31%  Similarity=0.508  Sum_probs=157.6

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTL   83 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~   83 (235)
                      +..++.+..|+|||++.+ +|.+++.+.    ..+++..++.++.||+.||.+||++|++|+||+|+||+++..+  ..+
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~  163 (287)
T 2wei_A           88 EILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI  163 (287)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             EEEeCCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccE
Confidence            445567789999999975 999988763    3689999999999999999999999999999999999997543  269


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+....... ......++..|+|||.+.+.  ++.++|+||||++++++++|..||.+....+....+......
T Consensus       164 kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (287)
T 2wei_A          164 KIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA  240 (287)
T ss_dssp             EECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEeccCcceeecCCC-ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999999987654332 22334568899999998653  789999999999999999999999988776655554432111


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ..                        ......+++++.++|++||+.||.+|||+.++++||||+++.++
T Consensus       241 ~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          241 FD------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             CC------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             CC------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence            00                        01123578899999999999999999999999999999987665

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=259.44  Aligned_cols=199  Identities=27%  Similarity=0.396  Sum_probs=145.4

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC----CC
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----TM   81 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~----~~   81 (235)
                      .+..++++.+|+|||||+|+|.+++...   ....++..++.++.||+.||+|||++|++|+||||+||+++..    ..
T Consensus        84 ~~~~~~~~~~~lv~E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~  160 (432)
T 3p23_A           84 FCTEKDRQFQYIAIELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKI  160 (432)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred             EEEEecCCEEEEEEECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCce
Confidence            3445667789999999999999999762   2345566778999999999999999999999999999999532    22


Q ss_pred             eEEEeecCCcccccCCC---CCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026660           82 TLKIADLGLARAFTLPI---KKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  155 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  155 (235)
                      .++|+|||++.......   .......||+.|+|||++.+  ...++.++||||+||+++++++ |..||..........
T Consensus       161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~  240 (432)
T 3p23_A          161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI  240 (432)
T ss_dssp             CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH
T ss_pred             eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH
Confidence            57899999997665332   22344568999999999874  3346789999999999999999 899986654332211


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .    ........                     .......+..++++|++||+.||.+|||+.++++||||.++++
T Consensus       241 ~----~~~~~~~~---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          241 L----LGACSLDC---------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             H----TTCCCCTT---------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             H----hccCCccc---------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            1    11100000                     0001123456889999999999999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.1e-37  Score=240.46  Aligned_cols=194  Identities=28%  Similarity=0.443  Sum_probs=143.0

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .++....|+||||++| +|.+++.+   ....+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++++|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEee
Confidence            3567889999999975 99999976   234578899999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCC--------------CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 026660           88 LGLARAFTLP--------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ  153 (235)
Q Consensus        88 f~~~~~~~~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  153 (235)
                      ||.+......              ........++..|+|||++.+...++.++|+||+||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765422              1122345678899999999765558899999999999999998   5544322222


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .........   ..+                    ........++.+.++|++||+.||.+|||+.++++||||+...+
T Consensus       237 ~~~~~~~~~---~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          237 ILKKLRSVS---IEF--------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHHHHSTT---CCC--------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             HHHhccccc---ccc--------------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            221111100   000                    00011246678899999999999999999999999999986554

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-37  Score=255.88  Aligned_cols=203  Identities=27%  Similarity=0.404  Sum_probs=144.0

Q ss_pred             cCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--
Q 026660            5 QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--   79 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~---~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--   79 (235)
                      ..+..++++.+|+|||||+|+|.+++.........   .++..++.++.||+.||+|||++|++|+||||+||+++..  
T Consensus        74 ~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~  153 (434)
T 2rio_A           74 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSR  153 (434)
T ss_dssp             EEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHH
T ss_pred             EEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcc
Confidence            34455677889999999999999999764322211   2344678899999999999999999999999999999743  


Q ss_pred             ----------CCeEEEeecCCcccccCCCC----CcccccccccccCchhhhC------CCCCCchhhHHHHHHHHHHHH
Q 026660           80 ----------TMTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELV  139 (235)
Q Consensus        80 ----------~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~~l~  139 (235)
                                ...++|+|||++........    ......||+.|+|||++.+      ...++.++||||+||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell  233 (434)
T 2rio_A          154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL  233 (434)
T ss_dssp             HHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence                      23799999999986654322    1234578999999999965      244789999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          140 T-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       140 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                      + |..||......+  ..+..........              .       ......+++++.++|++||+.||.+|||+
T Consensus       234 t~g~~Pf~~~~~~~--~~i~~~~~~~~~~--------------~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (434)
T 2rio_A          234 SKGKHPFGDKYSRE--SNIIRGIFSLDEM--------------K-------CLHDRSLIAEATDLISQMIDHDPLKRPTA  290 (434)
T ss_dssp             TTSCCTTCSTTTHH--HHHHHTCCCCCCC--------------T-------TCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hCCCCCCCCchhhH--HHHhcCCCCcccc--------------c-------ccccccchHHHHHHHHHHhhCChhhCCCH
Confidence            9 999997654433  1222111000000              0       00011245789999999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 026660          219 KKAMEHPYFDDL  230 (235)
Q Consensus       219 ~~ll~hp~f~~~  230 (235)
                      .++++||||.+.
T Consensus       291 ~eil~hp~f~~~  302 (434)
T 2rio_A          291 MKVLRHPLFWPK  302 (434)
T ss_dssp             HHHHTSGGGSCH
T ss_pred             HHHHhCCccCCc
Confidence            999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-37  Score=256.38  Aligned_cols=192  Identities=28%  Similarity=0.451  Sum_probs=142.6

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeEEEeecC
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG   89 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~~l~df~   89 (235)
                      ...|+||||+.| +|.+++..    ...+++..++.++.|++.||+|||+++++|+||||+||+++..+  ..++|+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            347999999975 99887743    45799999999999999999999999999999999999997543  259999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +++..... .......||+.|+|||++.+  ...++.++||||+||++|+|++|..||.................   . 
T Consensus       288 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~---~-  362 (419)
T 3i6u_A          288 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---Y-  362 (419)
T ss_dssp             TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC---C-
T ss_pred             cceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC---C-
Confidence            99766532 22344578999999999853  34477899999999999999999999976433222211111000   0 


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                         .........+++++.++|++||+.||.+|||++++++||||++.++
T Consensus       363 -------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          363 -------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             -------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             -------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence                               0011122357899999999999999999999999999999987654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.9e-37  Score=241.26  Aligned_cols=201  Identities=16%  Similarity=0.191  Sum_probs=156.6

Q ss_pred             cCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC----eE
Q 026660            8 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM----TL   83 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~----~~   83 (235)
                      ..++....|+||||++++|.+++...   +..+++..++.++.|++.||+|||++|++|+||||+||+++.++.    .+
T Consensus        74 ~~~~~~~~~lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           74 FGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EEEETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             ecCCCceeEEEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeE
Confidence            34566788999999977999999763   346999999999999999999999999999999999999986541    39


Q ss_pred             EEeecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHH
Q 026660           84 KIADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQ  153 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~  153 (235)
                      +|+|||.+........       ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.   ...+.
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  229 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  229 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence            9999999976654322       234456799999999987655 799999999999999999999999874   33333


Q ss_pred             HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC----------
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----------  223 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~----------  223 (235)
                      ...+......                       .........+++++.+++++||+.||.+||+++++++          
T Consensus       230 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          230 YERIGEKKQS-----------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHhhccC-----------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            3333221110                       0111223357899999999999999999999998743          


Q ss_pred             CCCCCCCCcCCC
Q 026660          224 HPYFDDLDKTRL  235 (235)
Q Consensus       224 hp~f~~~~~~~~  235 (235)
                      ......++|+.|
T Consensus       287 ~~~~~~~dw~~l  298 (298)
T 1csn_A          287 TTEDENFDWNLL  298 (298)
T ss_dssp             CCSCSCCGGGCC
T ss_pred             CCCCCccccCCC
Confidence            466777888765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-37  Score=245.49  Aligned_cols=187  Identities=25%  Similarity=0.355  Sum_probs=152.1

Q ss_pred             CCcCCCceEEEEEEecCc--cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+..+.++..++|+|++.  ++|.+++...    ..+++..++.++.|++.||+|||+++++|+||+|+||+++.+...+
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence            344556778999999996  6999999762    4689999999999999999999999999999999999998443499


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+......  ......+|+.|+|||++.+....+.++||||||+++|+|++|..||.....      ....  .
T Consensus       190 kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~  259 (320)
T 3a99_A          190 KLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q  259 (320)
T ss_dssp             EECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C
T ss_pred             EEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c
Confidence            99999998765432  233456789999999987666457889999999999999999999965321      1110  0


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      .                          .....+++++.++|++||..||.+|||++++++||||++...
T Consensus       260 ~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          260 V--------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             C--------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             c--------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            0                          011247889999999999999999999999999999998753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.1e-37  Score=242.27  Aligned_cols=189  Identities=25%  Similarity=0.295  Sum_probs=143.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCe
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~   82 (235)
                      .+..++...+|+||||+.| +|.+++.+... ...+++..++.++.|++.||+|||++|  ++|+||||+||+++.++ .
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~  177 (309)
T 3p86_A          100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-T  177 (309)
T ss_dssp             EEEECSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-C
T ss_pred             EEEEEECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-c
Confidence            3445666778999999985 99999976321 123899999999999999999999999  99999999999999776 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.............+|+.|+|||++.+.. ++.++||||+|+++|++++|..||......+..........
T Consensus       178 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  256 (309)
T 3p86_A          178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK  256 (309)
T ss_dssp             EEECCCC-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC
T ss_pred             EEECCCCCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999999976554433445567899999999997655 78999999999999999999999998877665554432111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..                          .....+++++.++|++||+.||.+|||+.++++
T Consensus       257 ~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          257 RL--------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            10                          111257889999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-36  Score=240.48  Aligned_cols=194  Identities=27%  Similarity=0.397  Sum_probs=146.1

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      .+...+++.+|+|||+.+++|.+++.+    ...+++..++.++.|++.||+|||+++++|+||+|+||+++ ++ .++|
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL  167 (313)
T 3cek_A           94 YDYEITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKL  167 (313)
T ss_dssp             EEEEECSSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEE
T ss_pred             EEEeecCCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEE
Confidence            344556778999999777899999976    34689999999999999999999999999999999999997 44 8999


Q ss_pred             eecCCcccccCCCC--CcccccccccccCchhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH
Q 026660           86 ADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQ  152 (235)
Q Consensus        86 ~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~  152 (235)
                      +|||.+........  ......+++.|+|||.+.+.          ..++.++||||||+++++|++|..||..... ..
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  247 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence            99999976543322  12344678999999998651          3478899999999999999999999976543 22


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ......   ......                       ......++++.++|++||+.||.+|||+.++++||||+...
T Consensus       248 ~~~~~~---~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          248 KLHAII---DPNHEI-----------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHHHHH---CTTSCC-----------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HHHHHH---hccccc-----------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            222221   110000                       00113567899999999999999999999999999998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-37  Score=245.58  Aligned_cols=203  Identities=22%  Similarity=0.327  Sum_probs=137.6

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEE
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~   84 (235)
                      +...+++..|+||||++|+|.+++..... ....+++..++.++.|++.||.|||++ |++|+||+|+||+++.++ .++
T Consensus        88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~k  166 (327)
T 3aln_A           88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIK  166 (327)
T ss_dssp             EEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEE
T ss_pred             eEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEE
Confidence            34455678999999999999998876433 356799999999999999999999999 999999999999999776 999


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhh---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      |+|||.+....... ......++..|+|||.+.   ....++.++||||||+++++|++|..||.........  .    
T Consensus       167 l~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----  239 (327)
T 3aln_A          167 LCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L----  239 (327)
T ss_dssp             ECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred             EccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H----
Confidence            99999997654332 223346788999999984   2334789999999999999999999999764321100  0    


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      ......                ..+.........+++++.++|++||+.||.+|||+.++++||||...+++
T Consensus       240 ~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          240 TQVVKG----------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCCS----------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             HHHhcC----------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence            000000                00000011123578999999999999999999999999999999765443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=243.63  Aligned_cols=206  Identities=19%  Similarity=0.286  Sum_probs=148.5

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE----cCCCCeEE
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKTMTLK   84 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~----~~~~~~~~   84 (235)
                      .+....|+||||++ ++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+||++    +..+ .++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~k  156 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYK  156 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEE
Confidence            34557899999997 599999987432 3349999999999999999999999999999999999998    5443 799


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-------STHYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQ  153 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~  153 (235)
                      |+|||.+....... ......+|..|+|||++..       ...++.++||||+||++|+|++|..||....    ..+.
T Consensus       157 L~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          157 LTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             EccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            99999997665432 3334568999999999862       2447899999999999999999999996432    2333


Q ss_pred             HHHHHHHhCCCCCCCccccccccc----ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMN----WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                      ...+..   ..+...+........    |...  .  .........+++.+.++|++||+.||.+|||++|+++||
T Consensus       236 ~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          236 MYKIIT---GKPSGAISGVQKAENGPIDWSGD--M--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHH---HCCTTCCEEEECSTTCCEEEESS--C--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHHHhc---CCCcccchhhhcccCCccccCcc--C--CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            333332   222222222211111    1000  0  000011123556788999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-36  Score=241.60  Aligned_cols=187  Identities=24%  Similarity=0.408  Sum_probs=146.9

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|+||||++| +|.+++...    +.+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||.+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             cccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            356999999975 999999763    4699999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           92 RAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        92 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ........   ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....+..........      
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------  236 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------  236 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC------
Confidence            76543322   223456799999999998655 88999999999999999999999998877665554443211      


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                                        .........+++++.++|.+||..||.+||++.+++.|+|++.
T Consensus       237 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 ------------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ------------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                              1112223458899999999999999999999999999998763

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=241.48  Aligned_cols=196  Identities=21%  Similarity=0.336  Sum_probs=144.8

Q ss_pred             CCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~-~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..|+||||+++.+..+....   ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++ .++
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~k  165 (318)
T 2dyl_A           90 FGTFITNTDVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIK  165 (318)
T ss_dssp             EEEEECSSEEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEE
T ss_pred             EEEEecCCcEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEE
Confidence            3444566789999999976776665542   35699999999999999999999996 999999999999999776 899


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~  159 (235)
                      |+|||.+...... .......+++.|+|||++..    ...++.++||||+|+++++|++|..||... ...+.......
T Consensus       166 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (318)
T 2dyl_A          166 LCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ  244 (318)
T ss_dssp             ECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred             EEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence            9999998655432 22334467899999999852    334788999999999999999999999874 34444444333


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ....   .                      ......+++++.++|++||..||.+|||++++++||||++++
T Consensus       245 ~~~~---~----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          245 EEPP---L----------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SCCC---C----------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             cCCC---C----------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            1100   0                      001124788999999999999999999999999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.6e-37  Score=244.16  Aligned_cols=189  Identities=29%  Similarity=0.474  Sum_probs=147.0

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--eEEEeecCCc
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIADLGLA   91 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--~~~l~df~~~   91 (235)
                      .|+||||+.| +|.+++..    ...+++..++.++.||+.||+|||++|++|+||||+||+++..+.  .++|+|||.+
T Consensus        89 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            7999999975 99998854    457999999999999999999999999999999999999986542  4999999998


Q ss_pred             ccccCCCCCcccccccccccCchhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCCCC
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL-LHIFRLLGTPNEKV  168 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~  168 (235)
                      ...... .......+++.|+|||++.  +...++.++|||||||++|++++|..||......... ..+.....      
T Consensus       165 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  237 (322)
T 2ycf_A          165 KILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY------  237 (322)
T ss_dssp             EECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC------
T ss_pred             eecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc------
Confidence            765432 1123346788999999974  2344789999999999999999999999764332111 11111100      


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                        .........+++++.++|++||..||.+|||+.++++||||++.++
T Consensus       238 ------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          238 ------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             ------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             ------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence                              0001112357889999999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.1e-36  Score=244.16  Aligned_cols=190  Identities=26%  Similarity=0.396  Sum_probs=150.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      .+...+++.+|+||||+.| +|.+++.....            ....+++..++.++.||+.||+|||++|++|+||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            3445667779999999985 99999987432            1245899999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS  149 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  149 (235)
                      ||+++.++ .++|+|||+++.......  ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999777 899999999976543222  223345578899999998655 8999999999999999999 999998766


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..+....+.....                           ......+++++.++|++||..||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5444433322100                           00112477899999999999999999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.3e-36  Score=239.73  Aligned_cols=189  Identities=21%  Similarity=0.314  Sum_probs=138.7

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTG--ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~--~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      .++||||+.+ +|.+++.......  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+
T Consensus       106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl~Dfg~a  184 (323)
T 3qup_A          106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLS  184 (323)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-
T ss_pred             cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEEeecccc
Confidence            4999999985 9999997643222  2589999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           92 RAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        92 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ........  ......+++.|+|||.+.+.. ++.++||||+||++|++++ |..||.+....+...........     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----  258 (323)
T 3qup_A          185 RKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-----  258 (323)
T ss_dssp             ----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             ccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-----
Confidence            76543221  122334567899999987655 7899999999999999999 99999887765555444321100     


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-------HHHHhCCCCCCCCCc
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-------AKKAMEHPYFDDLDK  232 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~ll~hp~f~~~~~  232 (235)
                                            .....+++++.+++++||+.||.+|||       ++++++|||+.+...
T Consensus       259 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          259 ----------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             ----------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence                                  111247789999999999999999999       777899999987544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-36  Score=239.26  Aligned_cols=198  Identities=18%  Similarity=0.187  Sum_probs=153.1

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---cCCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~---~~~~~~~~l~   86 (235)
                      ++....++||||++++|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||++   +..+ .++|+
T Consensus        75 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~  150 (296)
T 4hgt_A           75 AEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYII  150 (296)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEEC
T ss_pred             CCCCceEEEEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEe
Confidence            456778999999977999999752   3469999999999999999999999999999999999999   5455 89999


Q ss_pred             ecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Q 026660           87 DLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLH  156 (235)
Q Consensus        87 df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~  156 (235)
                      |||.+........       ......+|+.|+|||.+.+.. ++.++||||+||++|++++|..||.+...   .+....
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            9999976554322       223457789999999997655 88999999999999999999999976322   111111


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC----------CCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----------HPY  226 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~----------hp~  226 (235)
                      .......                       .........+++++.+++++||+.||.+|||+.++++          ..+
T Consensus       230 ~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          230 ISEKKMS-----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             hhccccc-----------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            1111000                       0111122357899999999999999999999998865          467


Q ss_pred             CCCCCcCCC
Q 026660          227 FDDLDKTRL  235 (235)
Q Consensus       227 f~~~~~~~~  235 (235)
                      -..++|+.|
T Consensus       287 ~~~~dw~~~  295 (296)
T 4hgt_A          287 DYVFDWNML  295 (296)
T ss_dssp             TCCCGGGGC
T ss_pred             cCccchhhc
Confidence            777888754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-36  Score=243.02  Aligned_cols=190  Identities=25%  Similarity=0.395  Sum_probs=152.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      .+..++++.+|+||||+.| +|.+++.....            ....+++..++.++.||+.||+|||+++++|+||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            3445566779999999975 99999988532            1245899999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS  149 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  149 (235)
                      ||+++.++ .++|+|||++.......  .......+|..|+|||++.+.. ++.++|||||||+++++++ |..||.+..
T Consensus       221 NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999776 89999999997654332  2233445678899999998655 8899999999999999999 999998877


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..+....+......                           .....+++++.++|++||+.||.+|||+.+++++
T Consensus       299 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66555444321110                           0112477899999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.5e-36  Score=235.58  Aligned_cols=193  Identities=24%  Similarity=0.422  Sum_probs=146.8

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..++++..|+||||++| +|.+++.+.    +.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus        76 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~  150 (294)
T 4eqm_A           76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TL  150 (294)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CE
T ss_pred             EEEeeeeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CE
Confidence            34455677889999999986 999999773    4699999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      +|+|||.+........ ......+|+.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.............  
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--  227 (294)
T 4eqm_A          151 KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--  227 (294)
T ss_dssp             EECCCSSSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--
T ss_pred             EEEeCCCccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--
Confidence            9999999976543322 233456799999999998755 789999999999999999999999988765554433211  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                       ..                    +.........+++.+.++|.+||..||.+||+..+.+.+.|
T Consensus       228 -~~--------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          228 -SV--------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             -CC--------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             -cC--------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence             00                    01112223458899999999999999999995444444433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-36  Score=232.85  Aligned_cols=187  Identities=20%  Similarity=0.322  Sum_probs=150.0

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||++| +|.+++..   ....++++.++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~k  146 (269)
T 4hcu_A           71 YGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIK  146 (269)
T ss_dssp             EEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEE
T ss_pred             EEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEE
Confidence            3445566779999999985 99999965   234689999999999999999999999999999999999998776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||.+........ ......++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+..........
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~  225 (269)
T 4hcu_A          147 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR  225 (269)
T ss_dssp             ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             eccccccccccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc
Confidence            999999875533211 223344577899999997655 8899999999999999999 9999988877666555443211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..                           .....++++.+++++||+.||.+|||+.++++|
T Consensus       226 ~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 LY---------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC---------------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            10                           111367889999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=238.46  Aligned_cols=187  Identities=23%  Similarity=0.341  Sum_probs=145.5

Q ss_pred             CCcCCCceEEEEEEec-Cc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            6 GQNKEGRTVLYLVFEY-MD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~-~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      .+..++++..++|+|+ +. ++|.+++.+.    ..+++..++.++.|++.||+|||++|++|+||+|+||+++..+..+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence            3445667788999998 56 5999999773    3589999999999999999999999999999999999998433389


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.+......  ......++..|+|||++.+....+.++||||+|++++++++|..||.....      ....  .
T Consensus       180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~  249 (312)
T 2iwi_A          180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--E  249 (312)
T ss_dssp             EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--C
T ss_pred             EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--c
Confidence            99999998765432  234456789999999987655445689999999999999999999975321      1110  0


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                                                ......++.++.++|++||+.||.+|||+.++++||||+....
T Consensus       250 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          250 --------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             --------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                                      0011247789999999999999999999999999999997543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.2e-36  Score=232.55  Aligned_cols=187  Identities=21%  Similarity=0.336  Sum_probs=150.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||++| +|.+++...   +..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~  144 (268)
T 3sxs_A           69 YGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVK  144 (268)
T ss_dssp             EEEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEE
T ss_pred             EEEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEE
Confidence            3445667779999999975 999999774   23589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|||.+........ ......++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+..........
T Consensus       145 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  223 (268)
T 3sxs_A          145 VSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR  223 (268)
T ss_dssp             ECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC
Confidence            999999876543322 223334567799999997655 7899999999999999998 9999988777665555432111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..                           .....++++.+++++||+.||.+|||+.+++++
T Consensus       224 ~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 LY---------------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CC---------------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CC---------------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                           011367889999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=243.37  Aligned_cols=193  Identities=19%  Similarity=0.280  Sum_probs=152.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ---TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-   80 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-   80 (235)
                      .+...+....|+||||+.| +|.+++.....   ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ 
T Consensus       140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence            3445566778999999975 99999988542   224589999999999999999999999999999999999998443 


Q ss_pred             -CeEEEeecCCcccccCC--CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026660           81 -MTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  156 (235)
Q Consensus        81 -~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  156 (235)
                       ..++|+|||+++.....  ........+|+.|+|||++.+.. ++.++|||||||++++|++ |..||......+....
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~  298 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  298 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence             25999999998754221  12233456688999999987655 8899999999999999998 9999988877666555


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                      +......                           .....+++.+.+++++||+.||.+|||+.++++|.+
T Consensus       299 i~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          299 VTSGGRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHcCCCC---------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            4432110                           011247788999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=237.82  Aligned_cols=186  Identities=19%  Similarity=0.306  Sum_probs=148.3

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||+.| +|.+++..   ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus       116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~k  191 (325)
T 3kul_A          116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCK  191 (325)
T ss_dssp             EEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEE
Confidence            3445667789999999975 99999965   234699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      |+|||++.........   .....+|+.|+|||.+.+.. ++.++||||+|+++|++++ |..||......+....+...
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            9999999766433221   22234467899999997654 7899999999999999999 99999888776666555432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...+                           ....+++++.++|++||..||.+|||+.++++
T Consensus       271 ~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          271 YRLP---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1111                           11247889999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-35  Score=237.48  Aligned_cols=188  Identities=18%  Similarity=0.210  Sum_probs=146.2

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe----
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT----   82 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~----   82 (235)
                      +..+..+..|+||||++++|.+++...   .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .    
T Consensus        72 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~  147 (330)
T 2izr_A           72 YFGPCGKYNAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQ  147 (330)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTT
T ss_pred             EEEecCCccEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCc
Confidence            344556789999999977999999863   35799999999999999999999999999999999999998665 4    


Q ss_pred             -EEEeecCCcccccCCCCC-------cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH
Q 026660           83 -LKIADLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---EL  151 (235)
Q Consensus        83 -~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~  151 (235)
                       ++|+|||++.........       .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+..   ..
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~  226 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK  226 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence             999999999865443221       24567899999999998655 7899999999999999999999998743   23


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      +....+.......                       .........+ ++.++++.||+.||.+||+++++++
T Consensus       227 ~~~~~i~~~~~~~-----------------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          227 ERYQKIGDTKRAT-----------------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHHHHS-----------------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhccC-----------------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            3333322211000                       0011111244 8999999999999999999988755

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.1e-36  Score=236.11  Aligned_cols=190  Identities=22%  Similarity=0.336  Sum_probs=149.7

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT--------------------GENIPVNTVKSLMYQLCKGVAFCHGHGI   64 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~   64 (235)
                      .+..++++..|+||||+. |+|.+++......                    ...+++..++.++.||+.||+|||++|+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  171 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL  171 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            344556677999999998 5999999875431                    2348999999999999999999999999


Q ss_pred             eecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-C
Q 026660           65 LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-K  141 (235)
Q Consensus        65 ~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g  141 (235)
                      +|+||||+||+++.++ .++|+|||.+........  ......+++.|+|||.+.+.. ++.++||||+|+++|+|++ |
T Consensus       172 vH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          172 VHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             ECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred             cccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999776 899999999876543322  223345577899999997654 7899999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 026660          142 TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA  221 (235)
Q Consensus       142 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  221 (235)
                      ..||.+....+..........                           ......+++++.++|++||+.||.+|||+.++
T Consensus       250 ~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  302 (314)
T 2ivs_A          250 GNPYPGIPPERLFNLLKTGHR---------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADI  302 (314)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCHHHHHHHhhcCCc---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999987665444433322100                           00112578899999999999999999999999


Q ss_pred             hCC
Q 026660          222 MEH  224 (235)
Q Consensus       222 l~h  224 (235)
                      +++
T Consensus       303 ~~~  305 (314)
T 2ivs_A          303 SKD  305 (314)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-35  Score=231.75  Aligned_cols=187  Identities=18%  Similarity=0.291  Sum_probs=150.3

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||+. ++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~k  160 (283)
T 3gen_A           85 YGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVK  160 (283)
T ss_dssp             EEEECSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEE
T ss_pred             EEEEecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEE
Confidence            344566778999999997 5999999763   23599999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++|++++ |..||......+....+.....
T Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~  239 (283)
T 3gen_A          161 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR  239 (283)
T ss_dssp             ECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EccccccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC
Confidence            999999875532211 122334567899999998655 7899999999999999998 9999998877666655543211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..                           .....++.+.++|++||+.||.+|||+.++++|
T Consensus       240 ~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 LY---------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CC---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CC---------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            11                           011357889999999999999999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-36  Score=247.75  Aligned_cols=182  Identities=18%  Similarity=0.248  Sum_probs=146.2

Q ss_pred             ceEEEEEEecCccCHHHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           12 RTVLYLVFEYMDTDLKKYIRSF---RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        12 ~~~~~lv~e~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ....+++|+++.++|.+++...   ......+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+||
T Consensus       177 ~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DF  255 (413)
T 3dzo_A          177 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGF  255 (413)
T ss_dssp             CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCG
T ss_pred             ccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEec
Confidence            3457899999999999999643   22344578889999999999999999999999999999999999777 7999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhh---------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLL---------GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      |+++.....   .....| +.|+|||++.         ....++.++|||||||++|+|++|..||......+...    
T Consensus       256 G~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----  327 (413)
T 3dzo_A          256 EHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE----  327 (413)
T ss_dssp             GGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----
T ss_pred             cceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----
Confidence            998755432   334456 8899999984         33347789999999999999999999997654211000    


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                                                  ........+++++.++|++||..||.+||++.++++||||+.+
T Consensus       328 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          328 ----------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             ----------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence                                        0111123578999999999999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-35  Score=237.84  Aligned_cols=191  Identities=24%  Similarity=0.332  Sum_probs=148.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT-------------------GENIPVNTVKSLMYQLCKGVAFCHGHGIL   65 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~   65 (235)
                      .+.....+..|+||||++| +|.+++......                   ...+++..++.++.||+.||+|||++|++
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  194 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  194 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            3445566779999999975 999999874221                   13479999999999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CC
Q 026660           66 HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KT  142 (235)
Q Consensus        66 H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~  142 (235)
                      |+||||+||+++.++ .++|+|||.+........  ......+|+.|+|||.+.+.. ++.++||||||+++++|++ |.
T Consensus       195 H~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          195 HRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             ETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCC
Confidence            999999999999776 999999999976543322  123345577899999987655 7899999999999999998 99


Q ss_pred             CCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          143 ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       143 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .||.+................+                          .....+++++.++|++||+.||.+|||+.+++
T Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  326 (344)
T 1rjb_A          273 NPYPGIPVDANFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  326 (344)
T ss_dssp             CSSTTCCCSHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCcccCCcHHHHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            9998765444333333211000                          01124678999999999999999999999998


Q ss_pred             CC
Q 026660          223 EH  224 (235)
Q Consensus       223 ~h  224 (235)
                      +|
T Consensus       327 ~~  328 (344)
T 1rjb_A          327 SF  328 (344)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-35  Score=238.45  Aligned_cols=189  Identities=21%  Similarity=0.294  Sum_probs=149.1

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT--------------------GENIPVNTVKSLMYQLCKGVAFCHGHGIL   65 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~   65 (235)
                      +..++.+..|+||||++| +|.+++......                    ...+++..++.++.||+.||.|||++|++
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv  196 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  196 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            344566778999999985 999999874321                    25689999999999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CC
Q 026660           66 HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KT  142 (235)
Q Consensus        66 H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~  142 (235)
                      |+||||+||+++.++ .++|+|||.+.......  .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++ |.
T Consensus       197 H~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          197 HRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCC
Confidence            999999999999776 89999999987543221  1223445688899999987655 8899999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          143 ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       143 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .||.+....+....+.....                           ......+++++.++|++||+.||.+|||+.+++
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CcCCCCChHHHHHHHhCCCc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            99988776655544432100                           001124778999999999999999999999987


Q ss_pred             CC
Q 026660          223 EH  224 (235)
Q Consensus       223 ~h  224 (235)
                      ++
T Consensus       328 ~~  329 (343)
T 1luf_A          328 RI  329 (343)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-35  Score=236.74  Aligned_cols=196  Identities=23%  Similarity=0.349  Sum_probs=153.8

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK   79 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~   79 (235)
                      +...+.+..|+||||++| +|.+++......      ...+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence            344566778999999985 999999874321      2457899999999999999999999999999999999999977


Q ss_pred             CCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026660           80 TMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  156 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  156 (235)
                      + .++|+|||.+........  ......+++.|+|||.+.+.. ++.++||||+|+++|++++ |..||......+....
T Consensus       175 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          175 F-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             C-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             C-eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            6 899999999875543221  122335578899999987655 7899999999999999999 8999988776555544


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC------CCCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH------PYFDDL  230 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h------p~f~~~  230 (235)
                      ......                           ......+++.+.++|++||+.||.+|||+.++++|      |+|+.+
T Consensus       253 ~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          253 VMEGGL---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HHcCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            432100                           00112578899999999999999999999999876      666543


Q ss_pred             C
Q 026660          231 D  231 (235)
Q Consensus       231 ~  231 (235)
                      +
T Consensus       306 ~  306 (322)
T 1p4o_A          306 S  306 (322)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=236.79  Aligned_cols=192  Identities=10%  Similarity=0.091  Sum_probs=145.9

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-CeEEEeecC
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-~~~~l~df~   89 (235)
                      +++..|+||||++++|.+++...  ....+++..++.++.||+.||+|||+++++|+||||+||+++.++ ..++|+|||
T Consensus       129 ~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg  206 (352)
T 2jii_A          129 QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG  206 (352)
T ss_dssp             TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGG
T ss_pred             CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCc
Confidence            36789999999977999999873  235699999999999999999999999999999999999999654 279999999


Q ss_pred             CcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHh
Q 026660           90 LARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLL  161 (235)
Q Consensus        90 ~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~  161 (235)
                      ++........       ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ............
T Consensus       207 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  285 (352)
T 2jii_A          207 FAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF  285 (352)
T ss_dssp             GCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH
T ss_pred             ceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc
Confidence            9976543211       123447789999999997654 8899999999999999999999998653 222222222211


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ......+..                  .......+++++.++|++||+.||.+|||+.++++
T Consensus       286 ~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          286 VDKPGPFVG------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHSCCCEEC------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCChhhhhh------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            111111100                  00011247899999999999999999999999854

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-35  Score=240.06  Aligned_cols=190  Identities=14%  Similarity=0.170  Sum_probs=143.0

Q ss_pred             CceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc--CCCCeEEEeec
Q 026660           11 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADL   88 (235)
Q Consensus        11 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~--~~~~~~~l~df   88 (235)
                      +..+.|+||||++++|.+++..   ....+++..++.++.||+.||+|||+++++|+||||+||+++  ..+ .++|+||
T Consensus       123 ~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~-~~kl~DF  198 (364)
T 3op5_A          123 GKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDY  198 (364)
T ss_dssp             TEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT-CEEECCC
T ss_pred             CcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC-eEEEEEC
Confidence            3577999999996699999976   235699999999999999999999999999999999999998  555 8999999


Q ss_pred             CCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Q 026660           89 GLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL-HIFRL  160 (235)
Q Consensus        89 ~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~  160 (235)
                      |+++.......       ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+........ .....
T Consensus       199 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~  277 (364)
T 3op5_A          199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR  277 (364)
T ss_dssp             TTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH
T ss_pred             CcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHH
Confidence            99976543211       113345899999999997655 8999999999999999999999998532211111 11111


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ........                  ........++++++.++++.|++.||.+||++.++++
T Consensus       278 ~~~~~~~~------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          278 YRENIASL------------------MDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHCHHHH------------------HHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hhhhHHHH------------------HHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            00000000                  0000011357899999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-35  Score=239.82  Aligned_cols=157  Identities=23%  Similarity=0.389  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhh
Q 026660           40 IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLL  117 (235)
Q Consensus        40 ~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~  117 (235)
                      +++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++........  ......+|+.|+|||++.
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  268 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  268 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCCCceeEChhhhc
Confidence            89999999999999999999999999999999999999766 899999999976543322  233456688899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCC
Q 026660          118 GSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL  196 (235)
Q Consensus       118 ~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (235)
                      +.. ++.++||||+|+++|+|++ |..||.+....+.............                          ....+
T Consensus       269 ~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  321 (359)
T 3vhe_A          269 DRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--------------------------APDYT  321 (359)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--------------------------CCTTC
T ss_pred             CCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--------------------------CCCCC
Confidence            654 7899999999999999998 9999987654343333332211110                          11246


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          197 DKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       197 ~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ++++.+++.+||+.||.+|||+.++++|
T Consensus       322 ~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          322 TPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            7899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-35  Score=232.89  Aligned_cols=191  Identities=23%  Similarity=0.333  Sum_probs=149.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK   70 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~   70 (235)
                      .+..+.++..++||||+++ +|.+++.....              ....+++..++.++.|++.||.|||++|++|+|||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            3445566778999999975 99999987432              12358999999999999999999999999999999


Q ss_pred             CCcEEEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 026660           71 PHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG  147 (235)
Q Consensus        71 ~~nil~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~  147 (235)
                      |+||+++.++ .++|+|||.+.........  .....++..|+|||.+.+.. ++.++||||+|+++++|++ |..||..
T Consensus       173 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          173 ARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             GGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999776 9999999998766543221  23345577899999987654 8899999999999999998 9999987


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .................                          .....+++++.++|++||..||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          251 MPVDSKFYKMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCSSHHHHHHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchhHHHHHhccCCCC--------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            65444333333221110                          0112477899999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.2e-35  Score=231.16  Aligned_cols=186  Identities=17%  Similarity=0.192  Sum_probs=144.7

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc---CCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD---RKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~---~~~~~~~l~   86 (235)
                      .+....++||||++++|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||+++   .++ .++|+
T Consensus        75 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~  150 (296)
T 3uzp_A           75 AEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYII  150 (296)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEEC
T ss_pred             CCCCceEEEEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEe
Confidence            456678999999977999999752   34699999999999999999999999999999999999994   444 89999


Q ss_pred             ecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Q 026660           87 DLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLH  156 (235)
Q Consensus        87 df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~  156 (235)
                      |||.+........       ......+|+.|+|||.+.+.. ++.++||||+|+++|++++|..||.....   .+....
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            9999976554322       124457789999999997655 78999999999999999999999976321   112222


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .......                       .........+++++.+++++||+.||.+|||+.++++
T Consensus       230 ~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          230 ISEKKMS-----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcccccC-----------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1111000                       0011122357899999999999999999999998855

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.9e-36  Score=237.42  Aligned_cols=189  Identities=25%  Similarity=0.341  Sum_probs=148.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      .+..++.+.+|+||||+++ +|.+++.+..            .....+++..++.++.||+.||+|||++|++|+||||+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~  171 (327)
T 1fvr_A           92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR  171 (327)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             ceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence            3445667789999999975 9999997743            23457999999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      ||+++.++ .++|+|||++...... .......++..|+|||.+.+.. ++.++||||+|+++|+|++ |..||.+....
T Consensus       172 NIl~~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~  248 (327)
T 1fvr_A          172 NILVGENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  248 (327)
T ss_dssp             GEEECGGG-CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             eEEEcCCC-eEEEcccCcCcccccc-ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence            99999776 8999999998643321 1223335577899999987554 7899999999999999998 99999887765


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +....+.....                           ......+++++.++|++||..||.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          249 ELYEKLPQGYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHHGGGTCC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhcCCC---------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            54443321100                           00112477899999999999999999999999764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-35  Score=229.26  Aligned_cols=185  Identities=26%  Similarity=0.359  Sum_probs=140.1

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCcEEEcCC--
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG---ILHRDLKPHNLLMDRK--   79 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~---~~H~di~~~nil~~~~--   79 (235)
                      .+...+++..|+||||++| +|.+++..     +.+++..++.++.|++.||+|||+++   ++|+||||+||+++..  
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~  146 (271)
T 3dtc_A           72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE  146 (271)
T ss_dssp             EEEECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred             EEEEecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence            3445667789999999975 99988843     46999999999999999999999999   8899999999999852  


Q ss_pred             -----CCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 026660           80 -----TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL  154 (235)
Q Consensus        80 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  154 (235)
                           ...++++|||.+.......  .....+++.|+|||.+.+.. ++.++|+||+|++++++++|..||.+.......
T Consensus       147 ~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  223 (271)
T 3dtc_A          147 NGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA  223 (271)
T ss_dssp             SSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             cccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                 3379999999997654332  23446789999999997655 789999999999999999999999887765554


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .........                          ......+++.+.+++++||+.||.+|||+.++++|
T Consensus       224 ~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          224 YGVAMNKLA--------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHTSCCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhhcCCCC--------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            443321000                          00112477899999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-35  Score=246.64  Aligned_cols=196  Identities=19%  Similarity=0.211  Sum_probs=153.9

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc---CCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD---RKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~---~~~~~~~l~   86 (235)
                      .+....|+||||++++|.+++...   ...+++..++.++.||+.||+|||+++++|+||||+||+++   ..+ .++|+
T Consensus        73 ~~~~~~~lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~  148 (483)
T 3sv0_A           73 VEGDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYII  148 (483)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEEC
T ss_pred             eeCCEEEEEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEE
Confidence            356678999999988999999752   34699999999999999999999999999999999999994   444 89999


Q ss_pred             ecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Q 026660           87 DLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLH  156 (235)
Q Consensus        87 df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~  156 (235)
                      |||+++.......       ......+|..|+|||.+.+.. ++.++|||||||++|+|++|..||.+...   .+.+..
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            9999976654322       122557899999999998655 88999999999999999999999976432   333333


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC----------CCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----------HPY  226 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~----------hp~  226 (235)
                      +......                       ........++++++.++|..||+.+|.+||++.++++          ++|
T Consensus       228 i~~~~~~-----------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~  284 (483)
T 3sv0_A          228 ISEKKVA-----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF  284 (483)
T ss_dssp             HHHHHHH-----------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             Hhhcccc-----------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence            2221000                       0111222357899999999999999999999987643          788


Q ss_pred             CCCCCcC
Q 026660          227 FDDLDKT  233 (235)
Q Consensus       227 f~~~~~~  233 (235)
                      +..++|+
T Consensus       285 ~~~~dW~  291 (483)
T 3sv0_A          285 DYVFDWT  291 (483)
T ss_dssp             SSCCHHH
T ss_pred             cCCcCch
Confidence            8888875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4e-35  Score=232.26  Aligned_cols=188  Identities=23%  Similarity=0.307  Sum_probs=143.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..++||||+.| +|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~k  148 (310)
T 3s95_A           73 IGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVV  148 (310)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEE
T ss_pred             EEEEecCCeeEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEE
Confidence            3444566789999999975 999999762   45699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCC--------------cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 026660           85 IADLGLARAFTLPIKK--------------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE  150 (235)
Q Consensus        85 l~df~~~~~~~~~~~~--------------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  150 (235)
                      |+|||.+.........              .....||+.|+|||.+.+.. ++.++||||+|+++|++++|..||.....
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence            9999999765432221              11456899999999997654 78999999999999999999998865321


Q ss_pred             HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          151 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...             .......            ..........+++++.+++++||+.||.+|||+.++++
T Consensus       228 ~~~-------------~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          228 RTM-------------DFGLNVR------------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             BCT-------------TSSBCHH------------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHH-------------HHhhhhh------------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            000             0000000            00001112357889999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-35  Score=231.52  Aligned_cols=190  Identities=26%  Similarity=0.457  Sum_probs=139.2

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..++||||+.+ +|.+++.........+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl  177 (310)
T 2wqm_A           99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKL  177 (310)
T ss_dssp             EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEE
T ss_pred             EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEE
Confidence            344456789999999986 99999998777777899999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~  164 (235)
                      +|||.+..............++..|+|||.+.+.. ++.++|+||||+++++|++|..||.+.. ..............+
T Consensus       178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  256 (310)
T 2wqm_A          178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP  256 (310)
T ss_dssp             CCC------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred             EeccceeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence            99999876554433344556788999999987654 7899999999999999999999997542 111221111110000


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                         .....+++++.++|++||+.||.+|||+.++++
T Consensus       257 ~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 P-------------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             C-------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C-------------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                         001247889999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-35  Score=229.90  Aligned_cols=187  Identities=20%  Similarity=0.318  Sum_probs=149.3

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++..|+||||++ ++|.+++..  .....+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~  151 (288)
T 3kfa_A           75 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVK  151 (288)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEE
T ss_pred             EEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEE
Confidence            344556677999999998 599999977  3345699999999999999999999999999999999999998776 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|++++++++ |..||......+..........
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~  230 (288)
T 3kfa_A          152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR  230 (288)
T ss_dssp             ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EccCccceeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence            999999976553322 223344577899999997655 7899999999999999999 9999987665444443332110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                           .....+++++.+++++||..||.+|||+.++++
T Consensus       231 ~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 M---------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C---------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            0                           011247789999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=231.94  Aligned_cols=187  Identities=19%  Similarity=0.302  Sum_probs=143.7

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++.+..++||||++| +|.+++..   ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~k  187 (333)
T 1mqb_A          112 EGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCK  187 (333)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEE
T ss_pred             EEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEE
Confidence            3445667789999999985 99999976   235699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      |+|||.+.........   .....++..|+|||.+.+.. ++.++||||+|++++++++ |..||......+....+...
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  266 (333)
T 1mqb_A          188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  266 (333)
T ss_dssp             ECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             ECCCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence            9999999765433221   12234467899999997655 7899999999999999998 99999887766555444321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...+                           ....+++++.+++++||+.||.+||++.+++++
T Consensus       267 ~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          267 FRLP---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCCC---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcCC---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1100                           112477899999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-35  Score=229.35  Aligned_cols=180  Identities=20%  Similarity=0.339  Sum_probs=135.1

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..|+||||+++ +|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  163 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS  163 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred             CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccc
Confidence            457999999985 999999762   34689999999999999999999999999999999999999776 9999999998


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........ ......+++.|+|||.+.+.. ++.++|+||+|+++|++++ |..||.+....+....+......      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------  236 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------  236 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred             cccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC------
Confidence            76543322 122334567899999997554 7899999999999999996 99999877665554443321000      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                           .....+++++.+++++||+.||.+|||+.+++++
T Consensus       237 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 ---------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                 0122578899999999999999999999998763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-35  Score=234.73  Aligned_cols=205  Identities=20%  Similarity=0.216  Sum_probs=149.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCcEEEcCCC
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---GILHRDLKPHNLLMDRKT   80 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~---~~~H~di~~~nil~~~~~   80 (235)
                      ..+...+.+..++||||+.| +|.+++.........+++..++.++.|++.||+|||++   |++|+||||+||+++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            34445566778999999975 99999988666666799999999999999999999999   999999999999999776


Q ss_pred             CeEEEeecCCcccccCCCCC-cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQLL  155 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~  155 (235)
                       .++|+|||.+......... .....+|+.|+|||.+.+.. ++.++||||+|+++|+|++|..||....    ......
T Consensus       172 -~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          172 -EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             -CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             -CEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence             8999999999765433222 33445899999999987655 7899999999999999999999995211    000001


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ........  .........           ...........++++.+++.+||+.||.+|||+.++++|
T Consensus       250 ~~~~~~~~--~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  305 (326)
T 3uim_A          250 DWVKGLLK--EKKLEALVD-----------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM  305 (326)
T ss_dssp             HHHTTTTS--SCCSTTSSC-----------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHhh--chhhhhhcC-----------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence            11100000  000000000           000000111244678999999999999999999999886

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-35  Score=233.08  Aligned_cols=190  Identities=26%  Similarity=0.396  Sum_probs=150.4

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH   72 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~   72 (235)
                      .+...+++.+|+||||+.| +|.+++......            ...+++..++.++.||+.||+|||++|++|+||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            3445566789999999975 999999874321            234899999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 026660           73 NLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS  149 (235)
Q Consensus        73 nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  149 (235)
                      ||+++.++ .++|+|||.+........  ......+++.|+|||++.+.. ++.++||||+|+++|+|++ |..||.+..
T Consensus       187 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999776 899999999876543322  123335577899999987654 7899999999999999999 999998877


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..+....+......                           .....+++++.++|++||+.||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            66555544332110                           0112477899999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-35  Score=231.54  Aligned_cols=183  Identities=16%  Similarity=0.211  Sum_probs=141.5

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe--
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT--   82 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~--   82 (235)
                      .+..++++..|+||||+. |+|.+++.+.   ...+++..++.++.|++.||.|||+++++|+||||+||+++.++ .  
T Consensus        78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~  153 (289)
T 4fvq_A           78 YGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRK  153 (289)
T ss_dssp             EEEECCTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGG
T ss_pred             EEEEEeCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-ccc
Confidence            344456667899999998 5999999773   23489999999999999999999999999999999999998766 4  


Q ss_pred             ------EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026660           83 ------LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  156 (235)
Q Consensus        83 ------~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  156 (235)
                            ++++|||.+.....    .....++..|+|||++.+...++.++||||+|+++|+|++|..|+...........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~  229 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ  229 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             ccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence                  99999998864432    12335678899999998745589999999999999999996555544333333322


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .......                            .....++++.+++++||+.||.+|||+.++++|
T Consensus       230 ~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          230 FYEDRHQ----------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHTTCC----------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HhhccCC----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2221100                            011346778899999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-35  Score=235.09  Aligned_cols=190  Identities=18%  Similarity=0.286  Sum_probs=148.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL   74 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~----------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~ni   74 (235)
                      .+..++.+.+|+||||+++ +|.+++.....          ....+++..++.++.|++.||+|||++|++|+||||+||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence            3445566779999999975 99999987532          134689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 026660           75 LMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  151 (235)
Q Consensus        75 l~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  151 (235)
                      +++.++ .++|+|||++........  ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....
T Consensus       196 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          196 LLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             EEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             EECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999776 899999999976543322  123345577899999987655 7899999999999999998 99999876544


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..............                          .....++++.++|++||+.||.+|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          274 SKFYKLVKDGYQMA--------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCC--------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            44433333211110                          11235788999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.2e-35  Score=230.41  Aligned_cols=183  Identities=19%  Similarity=0.291  Sum_probs=140.4

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~--~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ...|+||||+.+ +|.+++....  .....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~Dfg  192 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFG  192 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEECSCS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEeecC
Confidence            457999999985 9999996533  2345699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+...........   
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---  268 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL---  268 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence            9876543221  223345577899999997655 7899999999999999999 88999877665554443321100   


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                              .....+++++.++|++||..||.+|||+.+++++
T Consensus       269 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 ------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    0112477899999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-35  Score=239.28  Aligned_cols=186  Identities=23%  Similarity=0.340  Sum_probs=146.5

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+++.+|+||||++ |+|.+++.+.   +..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus       178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~k  253 (377)
T 3cbl_A          178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLK  253 (377)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEEecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEE
Confidence            344456677899999997 5999999763   23589999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 026660           85 IADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        85 l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      |+|||+++........  .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+....+.........
T Consensus       254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  332 (377)
T 3cbl_A          254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG  332 (377)
T ss_dssp             ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC
T ss_pred             ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998754322111  11223466799999987654 7899999999999999998 999998877655544433211


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..+                           ....+++++.++|++||+.||.+|||+.++++
T Consensus       333 ~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 RLP---------------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            000                           11246788999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-35  Score=226.76  Aligned_cols=186  Identities=19%  Similarity=0.316  Sum_probs=148.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+++..|+||||++| +|.+++.+.   ...+++..++.++.|++.||++||++|++|+||+|+||+++.++ .+++
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl  145 (267)
T 3t9t_A           70 GVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKV  145 (267)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEE
T ss_pred             EEEccCCCeEEEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEE
Confidence            344556678999999975 999999762   34689999999999999999999999999999999999998766 8999


Q ss_pred             eecCCcccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+....... .......++..|+|||.+.+.. ++.++|+||+|+++++|++ |..||......+....+......
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~  224 (267)
T 3t9t_A          146 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL  224 (267)
T ss_dssp             CCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             cccccccccccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC
Confidence            9999987553221 1122334577899999997554 7899999999999999999 89999887766655544321100


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                 ......++.+.+++++||+.||.+|||+.+++++
T Consensus       225 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 ---------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                       0111367889999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.2e-35  Score=237.17  Aligned_cols=186  Identities=18%  Similarity=0.300  Sum_probs=138.0

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+.+..|+||||++ |+|.+++.+   ....+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~k  187 (373)
T 2qol_A          112 EGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCK  187 (373)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEE
T ss_pred             EEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEE
Confidence            344556677899999997 599999975   234699999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           85 IADLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        85 l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      |+|||+++........   .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||......+....+...
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~  266 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG  266 (373)
T ss_dssp             ECCC----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999765433221   11223366899999997655 8899999999999999998 99999887765555444321


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...+                           ....++.++.+++.+||+.||.+||++.++++
T Consensus       267 ~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          267 YRLP---------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             EECC---------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC---------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            1100                           11247789999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.5e-35  Score=234.80  Aligned_cols=188  Identities=16%  Similarity=0.145  Sum_probs=144.0

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-CeEEEeec
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-~~~~l~df   88 (235)
                      +++...|+||||++++|.+++...    +.+++..++.++.||+.||+|||+++++|+||||+||+++.++ ..++|+||
T Consensus       122 ~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Df  197 (345)
T 2v62_A          122 KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY  197 (345)
T ss_dssp             SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCC
T ss_pred             CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeC
Confidence            447889999999966999998653    2699999999999999999999999999999999999998543 27999999


Q ss_pred             CCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHH
Q 026660           89 GLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD--SELQQLLHIFR  159 (235)
Q Consensus        89 ~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~  159 (235)
                      |+++.......       ......+|..|+|||++.+.. ++.++|||||||++|+|++|..||...  ...........
T Consensus       198 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  276 (345)
T 2v62_A          198 GLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN  276 (345)
T ss_dssp             TTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH
T ss_pred             CCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh
Confidence            99976532211       123456799999999998654 899999999999999999999999642  22222222211


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhc--CCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA--VPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .....+                     ......  ...+++++.++|++||+.||.+|||+.++++
T Consensus       277 ~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          277 LLDELP---------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHTTT---------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hccccc---------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            111110                     011111  1258889999999999999999999998865

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.6e-35  Score=233.43  Aligned_cols=181  Identities=20%  Similarity=0.250  Sum_probs=141.9

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +...++||||+. |+|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||+
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~  161 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGV  161 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCc
Confidence            445899999998 5999999752   34689999999999999999999999999999999999998776 899999999


Q ss_pred             cccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      ++.......  ......++..|+|||.+.+.. ++.++||||+|+++|++++ |..||.+....+....+......    
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----  236 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL----  236 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC----
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----
Confidence            986643322  223445677899999997655 8899999999999999999 99999876654444433321000    


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                             .....++.++.+++++||..||.+|||+.++++|
T Consensus       237 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 -----------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -----------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -----------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   0011356677899999999999999999998753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-34  Score=226.19  Aligned_cols=188  Identities=21%  Similarity=0.326  Sum_probs=137.9

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ......++||||+.| +|.+++..   ....+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Df  164 (289)
T 3og7_A           89 STAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDF  164 (289)
T ss_dssp             ECSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCC
T ss_pred             ccCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccc
Confidence            344567999999985 99998854   235689999999999999999999999999999999999999776 9999999


Q ss_pred             CCcccccCC--CCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           89 GLARAFTLP--IKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        89 ~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      |.+......  ........+|+.|+|||.+..  ...++.++||||+|++++++++|..||......+............
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS  244 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence            998754421  122334567999999999862  3347889999999999999999999998866655554444321111


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                      ........+++++.++|++||+.||.+|||+.++++
T Consensus       245 ~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 P----------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             C----------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c----------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1                      011112357889999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-35  Score=234.08  Aligned_cols=193  Identities=19%  Similarity=0.278  Sum_probs=150.0

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC-
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT---GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-   80 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~-   80 (235)
                      .+...++...|+||||++ |+|.+++......   ...+++..++.++.|++.||.|||++|++|+||+|+||+++..+ 
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A           99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            344455667899999996 5999999875321   24589999999999999999999999999999999999998432 


Q ss_pred             -CeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026660           81 -MTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  156 (235)
Q Consensus        81 -~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  156 (235)
                       ..++|+|||.+.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence             369999999886543222  1223445688899999987655 7899999999999999998 9999988776555544


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                      +......                           .....+++.+.++|++||+.||.+|||+.++++|.+
T Consensus       258 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          258 VTSGGRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcCCCC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            4321100                           011247789999999999999999999999998854

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-34  Score=239.02  Aligned_cols=179  Identities=22%  Similarity=0.363  Sum_probs=142.5

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ++..+|+||||+++ +|.+++.+.  ....+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||
T Consensus       258 ~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG  334 (450)
T 1k9a_A          258 EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFG  334 (450)
T ss_dssp             TTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCC
Confidence            44578999999975 999999873  334479999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      +++.....   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......     
T Consensus       335 ~a~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----  405 (450)
T 1k9a_A          335 LTKEASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-----  405 (450)
T ss_dssp             TCEECC---------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred             Cccccccc---ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            98754322   12224578899999998655 8999999999999999998 99999876554444333221100     


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            .....+++++.++|++||+.||.+|||+.++++
T Consensus       406 ----------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 ----------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  011257889999999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.8e-36  Score=238.64  Aligned_cols=203  Identities=18%  Similarity=0.210  Sum_probs=147.2

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||+.| +|.+++.........+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~k  179 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPK  179 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEE
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEE
Confidence            3445667789999999985 99998866443445689999999999999999999999999999999999999776 899


Q ss_pred             EeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Q 026660           85 IADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ---LLHIFR  159 (235)
Q Consensus        85 l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~  159 (235)
                      ++|||.+........  ......+|+.|+|||.+.+.. ++.++||||+|+++|+|++|..||......+.   ......
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  258 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE  258 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence            999999875442211  223445789999999987655 78999999999999999999999975432111   000000


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .......      ...        ..........+..+.++.+++.+||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~------~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          259 SHNNGQL------EQI--------VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HHTTTCC------CSS--------SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccccH------HHh--------cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000000      000        00000001112355778999999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.6e-35  Score=250.70  Aligned_cols=214  Identities=23%  Similarity=0.335  Sum_probs=150.3

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC--eEEEe
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~--~~~l~   86 (235)
                      ..++..|+||||++| +|.+++.... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.  .++++
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence            346778999999975 9999998742 2336899999999999999999999999999999999999986542  48999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||.+...... .......+++.|+|||.+.+.. ++.++||||+|+++|++++|..||.....................
T Consensus       167 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          167 DLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             SCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccc-cccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            99999766533 2334557899999999987554 889999999999999999999999876543321111000000000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...........+...    ..........+++.+.++|++||..||.+|||+.++++||||+.+
T Consensus       245 ~~~~~l~g~~~~~~~----lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSV----LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSCCCCSSSCCCCSS----SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhhhccccccccc----cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            000000000000000    000111122367889999999999999999999999999999754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-34  Score=225.44  Aligned_cols=179  Identities=21%  Similarity=0.273  Sum_probs=141.1

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..|+||||+++ +|.+++.+.   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++++|||.+.
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  161 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSR  161 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGG
T ss_pred             CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCc
Confidence            35899999985 999999763   34689999999999999999999999999999999999999776 99999999987


Q ss_pred             cccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           93 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        93 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      ....... ......++..|+|||.+.+.. ++.++|+||||++++++++ |..||......+...........+      
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~------  234 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP------  234 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC------
T ss_pred             ccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC------
Confidence            6543322 223345577899999987554 7899999999999999998 999998765544444333211100      


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                           ....+++.+.++|++||..||.+|||+.+++++
T Consensus       235 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ---------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                 112467889999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-34  Score=226.72  Aligned_cols=180  Identities=22%  Similarity=0.306  Sum_probs=145.6

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..++||||+++ +|.+++.+   ....+++..++.++.|++.||.+||+++++|+||+|+||+++.++ .++|+|||.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~  157 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLS  157 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             CCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccce
Confidence            458999999985 99999864   345699999999999999999999999999999999999999776 9999999999


Q ss_pred             ccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      .........   .....+++.|+|||.+.+.. ++.++|+||+|+++++|++ |..||......+....+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-----  231 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  231 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-----
Confidence            766433221   22334578899999987554 7899999999999999998 9999988766555444332100     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                            ......+++++.++|++||..||.+||++.++++|
T Consensus       232 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          232 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  00112578899999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-34  Score=231.36  Aligned_cols=178  Identities=21%  Similarity=0.289  Sum_probs=141.6

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++|+|++. |+|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||+++.
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL  166 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeE
Confidence            678999997 5999999762   35699999999999999999999999999999999999999777 999999999976


Q ss_pred             ccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      .......  .....+|..|+|||.+.+.. ++.++|||||||++|++++ |..||.+....+...........       
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------  238 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------  238 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred             ccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-------
Confidence            5433222  22334577899999998655 8899999999999999999 99999876654443333221100       


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                          .....++.++.+++++||+.||.+|||+.+++++
T Consensus       239 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 --------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                0112467889999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-34  Score=222.41  Aligned_cols=178  Identities=21%  Similarity=0.283  Sum_probs=142.7

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEeec
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+..++||||++| +|.+++.+  .....+++..++.++.|++.||+|||+++  ++|+||||+||+++.++ .+++.||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~  157 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMA  157 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGG
T ss_pred             CCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEec
Confidence            3778999999985 99999976  33345899999999999999999999999  99999999999999776 7889888


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +++....     .....+|+.|+|||.+.+...  .+.++||||+|+++|++++|..||......+...........+  
T Consensus       158 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  230 (271)
T 3kmu_A          158 DVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--  230 (271)
T ss_dssp             GSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--
T ss_pred             cceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--
Confidence            8764432     223466889999999976432  2348999999999999999999998887766655443321111  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                              .....+++++.+++++||+.||.+|||+.++++
T Consensus       231 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    011247889999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.6e-35  Score=242.35  Aligned_cols=186  Identities=23%  Similarity=0.410  Sum_probs=148.5

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +..+|+||||+. |+|.+++....  ...+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||+
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~  330 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGL  330 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTG
T ss_pred             CCccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCC
Confidence            345899999997 59999997632  23588999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ++...... .......++..|+|||++.... ++.++||||||+++++|++ |..||.+....+....+......+    
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----  405 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----  405 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence            97654221 1122334567899999997655 8899999999999999999 999999887766666554421111    


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFD  228 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--hp~f~  228 (235)
                                             ....+++++.++|++||..||.+|||++++++  ..++.
T Consensus       406 -----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 -----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                                   11247889999999999999999999999876  34444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-35  Score=231.92  Aligned_cols=177  Identities=24%  Similarity=0.437  Sum_probs=134.0

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC--CCeEEEe
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~--~~~~~l~   86 (235)
                      ++++.+|+||||++| +|.+++..  .....+++..++.++.|++.||+|||++|++|+||||+||+++..  +..++++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence            347889999999985 99999987  334469999999999999999999999999999999999999863  3389999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||++....                       ...++.++|+||+||++|+|++|..||............       ..
T Consensus       163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~  212 (299)
T 3m2w_A          163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KT  212 (299)
T ss_dssp             CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CC
T ss_pred             ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HH
Confidence            999875332                       122678999999999999999999999765432211000       00


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ..    .       ...  ..........+++++.++|++||+.||.+|||+.++++||||++..
T Consensus       213 ~~----~-------~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 RI----R-------MGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SS----C-------TTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HH----h-------hcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            00    0       000  0011112246889999999999999999999999999999997643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.9e-35  Score=243.84  Aligned_cols=187  Identities=20%  Similarity=0.316  Sum_probs=148.3

Q ss_pred             CCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+...+|+||||+. |+|.+++.+.  ....+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++
T Consensus       282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~k  358 (495)
T 1opk_A          282 LGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVK  358 (495)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEE
T ss_pred             EEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEE
Confidence            344456677899999998 5999999873  335689999999999999999999999999999999999998766 899


Q ss_pred             EeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           85 IADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        85 l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      |+|||+++....... ......++..|+|||++.... ++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  437 (495)
T 1opk_A          359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR  437 (495)
T ss_dssp             ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EeecccceeccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999976543221 222334567899999987654 7899999999999999999 9999987665444433322100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                                 ......+++++.++|++||+.||.+|||+.++++
T Consensus       438 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 ---------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                       0111247889999999999999999999999976

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.2e-34  Score=225.11  Aligned_cols=179  Identities=21%  Similarity=0.301  Sum_probs=143.4

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .+..|+||||+. ++|.+++..    .+.+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  163 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGL  163 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence            455799999998 599999976    34699999999999999999999999999999999999999776 999999999


Q ss_pred             cccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      +.........   .....++..|+|||.+.+.. ++.++|+||||+++++|++ |..||......+..........    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----  238 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----  238 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----
Confidence            8765433221   12234467899999997654 7899999999999999999 9999988776555444332100    


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             ......+++++.++|++||+.||.+|||+.++++
T Consensus       239 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 -----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   0011257889999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.2e-35  Score=241.31  Aligned_cols=187  Identities=25%  Similarity=0.416  Sum_probs=145.4

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|+||||+++ +|.+++.+.  .+..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a  327 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLA  327 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTT
T ss_pred             CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccc
Confidence            457999999975 999999763  234589999999999999999999999999999999999999666 8999999999


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +....... ......++..|+|||.+.... ++.++||||||+++|+|++ |..||.+....+....+......+     
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----  401 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----  401 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            76543211 122334577899999987654 8899999999999999999 999998887766655543221110     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDDL  230 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--hp~f~~~  230 (235)
                                            ....+++.+.++|++||+.||.+|||++++++  +.++...
T Consensus       402 ----------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          402 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                                  11247889999999999999999999999987  4666543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-34  Score=229.34  Aligned_cols=186  Identities=23%  Similarity=0.388  Sum_probs=145.2

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD   77 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~   77 (235)
                      .+..+|+||||++| +|.+++......            ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            34568999999985 999999874321            22388999999999999999999999999999999999998


Q ss_pred             CCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQL  154 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~  154 (235)
                      .++ .++|+|||.+........  ......+++.|+|||++.+.. ++.++||||+|+++|+|++ |..||.+....+..
T Consensus       183 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          183 EKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             GGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            666 899999999976543322  123345678899999997655 7899999999999999998 99999876543333


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..........                          .....+++++.++|.+||+.||.+|||+.++++|
T Consensus       261 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKEGTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCccC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3222211100                          0112367899999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-34  Score=226.26  Aligned_cols=183  Identities=23%  Similarity=0.327  Sum_probs=141.9

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .++++..|+||||++| +|.+++.+   ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++++|
T Consensus        96 ~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~D  171 (298)
T 3f66_A           96 LRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVAD  171 (298)
T ss_dssp             CCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECS
T ss_pred             EcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECc
Confidence            4556678999999986 99999965   345689999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCC----CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           88 LGLARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        88 f~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ||.+.......    .......+|+.|+|||.+.+.. ++.++|+||+|++++++++ |..||......+..........
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            99997554321    1223345577899999997655 7899999999999999999 5556665544443333322110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .                           .....+++.+.+++++||+.||.+|||+.++++
T Consensus       251 ~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 L---------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0                           011236788999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-34  Score=234.94  Aligned_cols=184  Identities=23%  Similarity=0.323  Sum_probs=135.3

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      .+.++..|+||||+.+ +|.+++.+   ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|
T Consensus       160 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~D  235 (373)
T 3c1x_A          160 LRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVAD  235 (373)
T ss_dssp             CCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECC
T ss_pred             EcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEee
Confidence            3445678999999985 99999965   344688999999999999999999999999999999999999776 899999


Q ss_pred             cCCcccccCCCC----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 026660           88 LGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        88 f~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ||+++.......    ......++..|+|||.+.+.. ++.++||||||+++|++++ |..||......+..........
T Consensus       236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~  314 (373)
T 3c1x_A          236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  314 (373)
T ss_dssp             C---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred             ccccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence            999975533211    123345577899999997655 7899999999999999999 6777766544333332221100


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                                 ......+++.+.+++++||..||.+|||+.+++++
T Consensus       315 ---------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       00112477899999999999999999999998763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-34  Score=228.70  Aligned_cols=177  Identities=21%  Similarity=0.295  Sum_probs=136.6

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++|+|++. |+|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC---
T ss_pred             ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeE
Confidence            688999997 5999999763   34699999999999999999999999999999999999999776 899999999976


Q ss_pred             ccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      .......  .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+....+....+......       
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------  238 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------  238 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            5433221  22334577899999998655 8899999999999999999 99999877655444433221100       


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                          .....++.++.++|++||..||.+|||+.++++
T Consensus       239 --------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 --------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             --------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                011247788999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-34  Score=227.52  Aligned_cols=186  Identities=22%  Similarity=0.313  Sum_probs=138.0

Q ss_pred             CcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +..+.++.+|+||||++| +|.+++.+.    ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++ .++|
T Consensus       101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl  175 (309)
T 2h34_A          101 DFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYL  175 (309)
T ss_dssp             EEEEETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEE
T ss_pred             EEEeeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEE
Confidence            344556789999999985 999999763    4689999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           86 ADLGLARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        86 ~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +|||.+....... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||............ ..  ..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~--~~  251 (309)
T 2h34_A          176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQ--AI  251 (309)
T ss_dssp             CSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HS--CC
T ss_pred             ecCccCccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-cc--CC
Confidence            9999986554332 1233456789999999987654 789999999999999999999999876544222222 11  00


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-CHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~ll~  223 (235)
                                            ........++++++.++|++||+.||.+|| +++++++
T Consensus       252 ----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ----------------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ----------------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----------------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                  011122345788999999999999999999 8888765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-34  Score=229.90  Aligned_cols=189  Identities=22%  Similarity=0.292  Sum_probs=138.8

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CceecCCCCCcEEEcCCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH----------GILHRDLKPHNLLMDRKT   80 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~----------~~~H~di~~~nil~~~~~   80 (235)
                      ...+|+||||+++ +|.+++..     ..+++..++.++.|++.||+|||+.          +++|+||||+||+++.++
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            4568999999975 99999976     3599999999999999999999999          999999999999999776


Q ss_pred             CeEEEeecCCcccccCCCC--CcccccccccccCchhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Q 026660           81 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-  153 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-  153 (235)
                       .++|+|||.++.......  ......+|+.|+|||++.+.    ..++.++||||+||++|+|++|..||.+...... 
T Consensus       169 -~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          169 -TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             -CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             -eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence             899999999976543322  23345789999999999763    2345688999999999999999999975432100 


Q ss_pred             -----------HHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          154 -----------LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       154 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                                 ..............                 ............++++.++|++||+.||.+|||+.+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  310 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKR-----------------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG  310 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCC-----------------CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCC-----------------CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence                       00011000000000                 00000000112335689999999999999999999987


Q ss_pred             C
Q 026660          223 E  223 (235)
Q Consensus       223 ~  223 (235)
                      +
T Consensus       311 ~  311 (322)
T 3soc_A          311 E  311 (322)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.8e-34  Score=222.20  Aligned_cols=180  Identities=26%  Similarity=0.398  Sum_probs=145.1

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .....+|+||||+++ +|.+++.+.  ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df  166 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDF  166 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcc
Confidence            456779999999986 999999873  345699999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+....... ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..|+....  ........   ..    
T Consensus       167 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---~~----  235 (284)
T 2a19_B          167 GLVTSLKNDG-KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---GI----  235 (284)
T ss_dssp             TTCEESSCCS-CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---TC----
T ss_pred             hhheeccccc-cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---cc----
Confidence            9987665432 233456789999999998655 7899999999999999999988864211  11111110   00    


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  226 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~  226 (235)
                                             ....+++++.++|++||+.||.+|||+.++++|.+
T Consensus       236 -----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          236 -----------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                                   01236788999999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=230.30  Aligned_cols=184  Identities=24%  Similarity=0.403  Sum_probs=129.5

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEe
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      .++....+++|||++|+|.+++.... ....+++..++.++.||+.||+|||+++  ++|+||||+||+++.++ .++|+
T Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBC
T ss_pred             ccCCceEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEe
Confidence            46778899999999999999998753 3446999999999999999999999999  99999999999999776 89999


Q ss_pred             ecCCcccccCCCCC------------cccccccccccCchhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 026660           87 DLGLARAFTLPIKK------------YTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ  152 (235)
Q Consensus        87 df~~~~~~~~~~~~------------~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  152 (235)
                      |||.+.........            .....+++.|+|||++.  ....++.++||||||+++|+|++|..||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999765432211            11335788999999984  23347889999999999999999999997644322


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      .....   .                           ........+..+.++|++||+.||.+|||+.++++|
T Consensus       261 ~~~~~---~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          261 IVNGK---Y---------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             --------C---------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCc---c---------------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            11100   0                           001112456778899999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-34  Score=227.38  Aligned_cols=189  Identities=22%  Similarity=0.328  Sum_probs=140.7

Q ss_pred             CCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCcEEEcCC
Q 026660            9 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--------GHGILHRDLKPHNLLMDRK   79 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh--------~~~~~H~di~~~nil~~~~   79 (235)
                      .+....+|+||||+++ +|.+++..     ..+++..++.++.|++.||+|||        +.+++|+||||+||+++.+
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence            3456779999999985 99999943     46999999999999999999999        9999999999999999977


Q ss_pred             CCeEEEeecCCcccccCCCCC----cccccccccccCchhhhCCC-----CCCchhhHHHHHHHHHHHHhC---------
Q 026660           80 TMTLKIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTK---------  141 (235)
Q Consensus        80 ~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~~g---------  141 (235)
                      + .++|+|||++.........    .....+|+.|+|||++.+..     .++.++||||+||++|+|++|         
T Consensus       150 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          150 G-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             S-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             C-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            6 8999999998765433222    23347899999999997653     234789999999999999999         


Q ss_pred             -CCCCCCCC----HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC
Q 026660          142 -TALFPGDS----ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI  216 (235)
Q Consensus       142 -~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  216 (235)
                       ..||....    ................ ..                +.   .......++++.+++++||+.||.+||
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rp  288 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NI----------------PN---RWFSDPTLTSLAKLMKECWYQNPSARL  288 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCC-CC----------------CG---GGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             ccccccccCCCCcchhhhhHHHhccCCCC-CC----------------Ch---hhccCccHHHHHHHHHHHhhcChhhCC
Confidence             78885432    1222222211100000 00                00   000112457799999999999999999


Q ss_pred             CHHHHhC
Q 026660          217 SAKKAME  223 (235)
Q Consensus       217 s~~~ll~  223 (235)
                      |+.++++
T Consensus       289 s~~~i~~  295 (301)
T 3q4u_A          289 TALRIKK  295 (301)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-34  Score=223.89  Aligned_cols=179  Identities=24%  Similarity=0.330  Sum_probs=139.0

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...++||||+. |+|.+++.+   ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~  171 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLA  171 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCc
Confidence            34489999996 599999965   345689999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCC----CCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCC
Q 026660           92 RAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        92 ~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ......    ........++..|+|||.+.+.. ++.++||||+|+++|+|++|..|+ ......+...........   
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---  247 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---  247 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---
Confidence            754322    12233445678899999997655 789999999999999999965555 444433333322221100   


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                              .....+++++.+++++||+.||.+|||+.++++
T Consensus       248 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 ------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                    011246789999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.5e-34  Score=226.00  Aligned_cols=187  Identities=20%  Similarity=0.265  Sum_probs=143.9

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+...+....++||||+.| +|.+++..   ....+++..++.++.|++.||+|||++|++|+||+|+||+++ ++ .++
T Consensus        95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~  169 (319)
T 2y4i_B           95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVV  169 (319)
T ss_dssp             CEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCE
T ss_pred             EEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEE
Confidence            3444556679999999974 99999865   234689999999999999999999999999999999999998 44 899


Q ss_pred             EeecCCcccccCC-----CCCcccccccccccCchhhhC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 026660           85 IADLGLARAFTLP-----IKKYTHEILTLWYRAPEVLLG--------STHYSTAVDMWSVACIFAELVTKTALFPGDSEL  151 (235)
Q Consensus        85 l~df~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  151 (235)
                      ++|||++......     ........++..|+|||.+.+        ...++.++||||||+++|++++|..||......
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999987644211     122334457889999999874        233688999999999999999999999887766


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .............                          .....++.++.+++++||..||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          250 AIIWQMGTGMKPN--------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHTTCCCC--------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHhccCCCCC--------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            5554443211000                          011146788999999999999999999999876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.3e-35  Score=229.73  Aligned_cols=201  Identities=24%  Similarity=0.286  Sum_probs=146.5

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEE
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI   85 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l   85 (235)
                      +...+.+..|+||||++ |+|.+++... .....+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .+++
T Consensus        97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl  174 (307)
T 2nru_A           97 GFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKI  174 (307)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEE
T ss_pred             EEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEE
Confidence            34455667899999997 5999999764 2345699999999999999999999999999999999999999776 8999


Q ss_pred             eecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           86 ADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        86 ~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|||.+........  ......+++.|+|||.+.+.  ++.++|+||||+++|+|++|..||......+....+......
T Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (307)
T 2nru_A          175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED  252 (307)
T ss_dssp             CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT
T ss_pred             eecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh
Confidence            99999876543222  12345678999999988643  789999999999999999999999765432222222211111


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..........             ..........++.+.+++.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          253 EEKTIEDYID-------------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             TSCCHHHHSC-------------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhhhhhhcc-------------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1100000000             00000111245678999999999999999999999763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-34  Score=224.07  Aligned_cols=180  Identities=23%  Similarity=0.398  Sum_probs=144.1

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..|+||||+. ++|.+++....  +..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~  156 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLA  156 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCccc
Confidence            34799999997 59999996532  23589999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........ ......++..|+|||.+.+.. ++.++||||+|+++++|++ |..||.+....+....+......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  229 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------  229 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             ccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC------
Confidence            76543321 222334577899999987544 7899999999999999999 99999887776655544321100      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           .....+++++.+++++||+.||.+|||+.++++
T Consensus       230 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 ---------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                 011247789999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-34  Score=225.31  Aligned_cols=180  Identities=22%  Similarity=0.362  Sum_probs=137.0

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +.++..|+||||+++ +|.+++.+..  ...+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++++||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Df  161 (278)
T 1byg_A           85 EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDF  161 (278)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCC
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeec
Confidence            445578999999985 9999998742  22378999999999999999999999999999999999999776 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      |.+......   .....++..|+|||.+.+.. ++.++|+||+|++++++++ |..||......+..........     
T Consensus       162 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----  232 (278)
T 1byg_A          162 GLTKEASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----  232 (278)
T ss_dssp             CC---------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----
T ss_pred             ccccccccc---ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----
Confidence            998654432   12334577899999987654 7899999999999999998 9999987655443332221100     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ......+++++.++|++||+.||.+|||+.++++
T Consensus       233 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          233 ----------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                                  0111257889999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-34  Score=227.26  Aligned_cols=187  Identities=25%  Similarity=0.376  Sum_probs=144.2

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ++++.+|+||||++ ++|.+++....   ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Df  171 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADF  171 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEccc
Confidence            46778999999996 59999998742   2589999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------
Q 026660           89 GLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL-----------  154 (235)
Q Consensus        89 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----------  154 (235)
                      |.+........   ......++..|+|||.+.+.. ++.++||||||+++++|++|..||.........           
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            99976543322   223345677899999987654 789999999999999999999998654322110           


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..........                       ........+++++.++|++||..||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 SRLLELLEEG-----------------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHTT-----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcc-----------------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0001000000                       0011123578999999999999999999999999653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-34  Score=226.34  Aligned_cols=194  Identities=21%  Similarity=0.349  Sum_probs=137.3

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .+.+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||+
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~  160 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGL  160 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence            4568999999975 999999773   23589999999999999999999999999999999999999776 999999999


Q ss_pred             cccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           91 ARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        91 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +........   ......++..|+|||.+.+.. ++.++||||+|++++++++|..|+.......  ..   ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~---~~~~~~~~  234 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MR---MIGNDKQG  234 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HH---HHCTTCCT
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHH--Hh---hhcCcccc
Confidence            976543321   122334567799999997655 7899999999999999999999986532210  00   00000000


Q ss_pred             Ccc--cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWP--GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...  .......  .      .........+++++.++|++||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~--~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          235 QMIVFHLIELLK--N------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHHH--T------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHHh--c------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000  0000000  0      0000112357899999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-33  Score=220.87  Aligned_cols=176  Identities=22%  Similarity=0.288  Sum_probs=138.0

Q ss_pred             EEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCC----eEEEeec
Q 026660           16 YLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTM----TLKIADL   88 (235)
Q Consensus        16 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~----~~~l~df   88 (235)
                      ++||||++ |+|.+++.+   ....+++..++.++.|++.||+|||+++  ++|+||||+||+++..+.    .++|+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            69999998 599998865   3457999999999999999999999999  999999999999986552    2999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ--LLHIFRLLGTPN  165 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~  165 (235)
                      |.+.....   ......+++.|+|||.+.. ...++.++||||+|+++|++++|..||........  ....... ... 
T Consensus       174 g~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~-  248 (287)
T 4f0f_A          174 GLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GLR-  248 (287)
T ss_dssp             TTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CCC-
T ss_pred             Cccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CCC-
Confidence            99864432   3344577999999999843 33367899999999999999999999976543222  2222211 000 


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                              ......+++++.++|++||+.||.+|||+.++++
T Consensus       249 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 ------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                    0011247889999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.4e-34  Score=244.25  Aligned_cols=178  Identities=21%  Similarity=0.307  Sum_probs=142.6

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla  516 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLS  516 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHH
T ss_pred             CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCc
Confidence            347899999984 99999965    35699999999999999999999999999999999999999776 9999999999


Q ss_pred             ccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +.......   ......+|..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......    
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----  591 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----  591 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred             cccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            76543322   122334567899999997655 8899999999999999998 99999988776665554432110    


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                             .....+++++.++|++||+.||.+||++.++++
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   011247889999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-33  Score=222.76  Aligned_cols=195  Identities=24%  Similarity=0.435  Sum_probs=140.8

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +.+.+++||||+++ +|.+++.+.   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccc
Confidence            34678999999975 999999663   34699999999999999999999999999999999999999777 99999999


Q ss_pred             CcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+........   ......+|..|+|||.+.+.. ++.++|+||+|++++++++|..|+......  ..   ........
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMAL--FL---KMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HH---HHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhH--Hh---hccCCccc
Confidence            9976654332   233445677899999987655 789999999999999999999886432110  00   00000000


Q ss_pred             CCcc-cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWP-GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .... .......        ..........+++++.++|++||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLK--------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHH--------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHh--------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0000 0000000        00001112357899999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=230.08  Aligned_cols=213  Identities=23%  Similarity=0.299  Sum_probs=141.1

Q ss_pred             cCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceecCCCCCcEEEc
Q 026660            8 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---------GILHRDLKPHNLLMD   77 (235)
Q Consensus         8 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~---------~~~H~di~~~nil~~   77 (235)
                      ..++...+|+||||++| +|.+++..     ...++..++.++.||+.||+|||+.         +++|+||||+||+++
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence            45667788999999974 99999976     2458999999999999999999999         999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCC--------CCcccccccccccCchhhhCC------CCCCchhhHHHHHHHHHHHHhCCC
Q 026660           78 RKTMTLKIADLGLARAFTLPI--------KKYTHEILTLWYRAPEVLLGS------THYSTAVDMWSVACIFAELVTKTA  143 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~  143 (235)
                      .++ .++|+|||++.......        .......||+.|+|||++.+.      ..++.++|||||||++|+|++|..
T Consensus       155 ~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          155 NDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             TTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             CCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            776 89999999997654321        122344689999999998752      225578999999999999999977


Q ss_pred             CCCCCCHHHHH-HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          144 LFPGDSELQQL-LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       144 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      ||......... ..........+.  ............. ..............++++.++|++||+.||.+|||+.+++
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPT--FEDMQVLVSREKQ-RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCC--HHHHHHHHTTSCC-CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCch--HHHHHhhhccccc-CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            76432210000 000000000000  0000000000000 0000000001112445799999999999999999999994


Q ss_pred             C------CCCCCC
Q 026660          223 E------HPYFDD  229 (235)
Q Consensus       223 ~------hp~f~~  229 (235)
                      +      ++|-++
T Consensus       311 ~~L~~ll~~~~~~  323 (336)
T 3g2f_A          311 ERMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHHCCCC-
T ss_pred             HHHHHHHHHHHhc
Confidence            4      566554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.8e-34  Score=223.43  Aligned_cols=178  Identities=23%  Similarity=0.301  Sum_probs=142.2

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++|+||+. ++|.+++.+.   ...+++..++.++.|++.||.+||+++++|+||+|+||+++.++ .++|+|||.+..
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRA  170 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEE
T ss_pred             ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEcccccccc
Confidence            789999998 5999999873   23589999999999999999999999999999999999999776 899999999876


Q ss_pred             ccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           94 FTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        94 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ......   ......++..|+|||.+.+.. ++.++|+||||++++++++ |..||......+............     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  244 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----  244 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-----
Confidence            543322   122334577899999987654 7899999999999999999 999998887666555443211000     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           .....+++++.++|++||..||.+|||+.++++
T Consensus       245 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 ---------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 011257889999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=239.05  Aligned_cols=204  Identities=19%  Similarity=0.295  Sum_probs=144.9

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE----cCCCCeEE
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKTMTLK   84 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~----~~~~~~~~   84 (235)
                      .+....|+||||++ |+|.+++..... ...+++..++.++.||+.||+|||++|++|+||||+||++    +..+ .++
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~k  156 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYK  156 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEE
Confidence            34557899999997 599999976432 3349999999999999999999999999999999999998    4333 799


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-------THYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQ  153 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~  153 (235)
                      |+|||.++..... .......+|..|+|||++.+.       ..++.++||||+||++|+|++|..||....    ..+.
T Consensus       157 L~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          157 LTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             ECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             EecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            9999999765433 223445689999999998641       236789999999999999999999996422    2333


Q ss_pred             HHHHHHHhCCCCCCCccccccccc----ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          154 LLHIFRLLGTPNEKVWPGVSSLMN----WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ...+   ....+...+........    |....    .........+++.+.+++++||..||.+|||++++++
T Consensus       236 ~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          236 MYKI---ITGKPSGAISGVQKAENGPIDWSGDM----PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHH---HHSCCTTCCEEEECSTTCCEEEESSC----CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHH---hcCCCcccchhheeccCCCcccCccC----CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            3333   22333332222221111    11000    0000111235567889999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.6e-34  Score=242.21  Aligned_cols=188  Identities=24%  Similarity=0.410  Sum_probs=149.5

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|+||||+.+ +|.+++...  .+..+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a  410 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLA  410 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTST
T ss_pred             ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccc
Confidence            457999999975 999999763  234589999999999999999999999999999999999998666 8999999999


Q ss_pred             ccccCCC-CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +...... .......++..|+|||++.... ++.++||||||+++|+|++ |..||.+....+....+......      
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------  483 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------  483 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             eecCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            7654211 1122334567899999987654 8899999999999999999 99999888776665554322110      


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDDLD  231 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--hp~f~~~~  231 (235)
                                           .....+++++.++|++||..||.+|||++++++  ..+|...+
T Consensus       484 ---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          484 ---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                                 011247789999999999999999999999987  36666443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-33  Score=226.29  Aligned_cols=185  Identities=25%  Similarity=0.356  Sum_probs=135.7

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCcEEEcCCCCeE
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~--------~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+|+||||+.| +|.+++..     ..+++..++.++.|++.||.|||++        +++|+||||+||+++.++ .+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~  181 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TC  181 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CE
T ss_pred             CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CE
Confidence            689999999975 99999966     3599999999999999999999998        999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCC----cccccccccccCchhhhCCCCCCc------hhhHHHHHHHHHHHHhC----------CC
Q 026660           84 KIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYST------AVDMWSVACIFAELVTK----------TA  143 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~------~~Di~slG~~l~~l~~g----------~~  143 (235)
                      +|+|||++.........    .....||+.|+|||++.+.. .+.      ++||||+||++|+|++|          ..
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            99999999765433222    12456899999999997654 333      49999999999999999          66


Q ss_pred             CCCCCC----HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH
Q 026660          144 LFPGDS----ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK  219 (235)
Q Consensus       144 pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  219 (235)
                      ||....    ........... .......                   ........+++++.++|++||+.||.+|||+.
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCI-KKLRPSF-------------------PNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTT-SCCCCCC-------------------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cHhhhcCCCCchhhhHHHHhh-hccCccc-------------------cccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence            664321    11111111110 0000000                   00001113567799999999999999999999


Q ss_pred             HHhCC
Q 026660          220 KAMEH  224 (235)
Q Consensus       220 ~ll~h  224 (235)
                      ++++|
T Consensus       321 ell~~  325 (337)
T 3mdy_A          321 RVKKT  325 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=242.42  Aligned_cols=179  Identities=22%  Similarity=0.302  Sum_probs=141.4

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|+||||+.| +|.+++..   ....+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            348999999985 99999864   245699999999999999999999999999999999999999776 9999999999


Q ss_pred             ccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           92 RAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        92 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      +........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.....     
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  557 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  557 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            765432221   12233467899999997654 8999999999999999998 9999988776665554432110     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ......+++++.++|++||..||.+||++.++++
T Consensus       558 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  0111247899999999999999999999999854

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=222.82  Aligned_cols=177  Identities=28%  Similarity=0.386  Sum_probs=133.6

Q ss_pred             EEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---cCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           15 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG---HGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        15 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~---~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      .|+||||++| +|.+++.... ....++...++.++.|++.||+|||+   ++++|+||||+||+++.++..++|+|||.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             cEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            6899999975 9999997631 22347899999999999999999999   89999999999999987775589999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~  168 (235)
                      +......   .....+|..|+|||.+.+.. ++.++||||||+++++|++|..||.....  .........   ...   
T Consensus       153 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~---  222 (307)
T 2eva_A          153 ACDIQTH---MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---GTR---  222 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---TCC---
T ss_pred             ccccccc---cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---CCC---
Confidence            8654322   23345789999999997654 78999999999999999999999975432  222111111   000   


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                           ......+++.+.+++++||+.||.+|||++++++
T Consensus       223 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 ---------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                 0011247889999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=227.44  Aligned_cols=187  Identities=20%  Similarity=0.375  Sum_probs=143.8

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .....|+||||+.+ +|.+++.........+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++++|||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg  179 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLG  179 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCS
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecC
Confidence            56789999999986 99999998777777899999999999999999999999999999999999998776 89999999


Q ss_pred             CcccccCCCCC---------cccccccccccCchhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Q 026660           90 LARAFTLPIKK---------YTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHI  157 (235)
Q Consensus        90 ~~~~~~~~~~~---------~~~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~  157 (235)
                      .+.........         .....+++.|+|||.+.+..  .++.++||||||+++|+|++|..||....... .....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            87654321110         12234588899999986432  25789999999999999999999995311000 00001


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...  ..                        .......+++++.++|++||+.||.+|||+.+++++
T Consensus       260 ~~~--~~------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          260 VQN--QL------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHC--C--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhc--cC------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            100  00                        000113578899999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=231.61  Aligned_cols=182  Identities=16%  Similarity=0.167  Sum_probs=140.2

Q ss_pred             CcCCCceEEEEEEecCc-cCHHHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC------
Q 026660            7 QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR------   78 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~------   78 (235)
                      +....++..|+||||++ |+|.+++..... ....+++..++.++.||+.||+|||++|++||||||+||+++.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            34445677899999998 599999987654 3456999999999999999999999999999999999999986      


Q ss_pred             -----CCCeEEEeecCCcccccC--CCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 026660           79 -----KTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL  151 (235)
Q Consensus        79 -----~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  151 (235)
                           .+ .++|+|||+++....  .........||..|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus       214 ~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          214 DEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             -----CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                 44 899999999965432  222344567899999999998755 899999999999999999999998543210


Q ss_pred             HHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          152 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      .                + ....        .       ......++.+.+++..||+.+|.+|++..+.+
T Consensus       292 ~----------------~-~~~~--------~-------~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          292 E----------------C-KPEG--------L-------FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             E----------------E-EECS--------C-------CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             c----------------e-eech--------h-------ccccCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            0                0 0000        0       00002356788999999999999997544433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-33  Score=224.41  Aligned_cols=183  Identities=25%  Similarity=0.383  Sum_probs=140.8

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...+++||||+++ +|.+++.+     ..+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  179 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFG  179 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGG
T ss_pred             CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCcc
Confidence            35789999999985 99999865     2499999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------HHH
Q 026660           90 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-----------QLL  155 (235)
Q Consensus        90 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------~~~  155 (235)
                      .+........   ......++..|+|||.+.+.. ++.++||||+|+++++|++|..||.......           ...
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            9976654322   123345677899999997655 7899999999999999999999987543211           011


Q ss_pred             HHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          156 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..........                       .......+++++.++|++||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          259 RLTELLERGE-----------------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHTTC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccc-----------------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1111100000                       01112357889999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-32  Score=237.28  Aligned_cols=179  Identities=21%  Similarity=0.350  Sum_probs=143.4

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|+||||++ |+|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a  538 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS  538 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCC
Confidence            45799999998 5999999762   34689999999999999999999999999999999999999776 9999999999


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      ........ ......+++.|+|||++.+.. ++.++||||+|+++|+|++ |..||.+....+....+......+     
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-----  612 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-----  612 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-----
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            76543322 122334567899999997654 8899999999999999997 999999887766665554321110     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                                            ....+++.+.++|++||..||.+|||+.++++
T Consensus       613 ----------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          613 ----------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  11247789999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-32  Score=220.88  Aligned_cols=186  Identities=23%  Similarity=0.302  Sum_probs=138.3

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCcEEEcCCCCeE
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--------GHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh--------~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+|+||||+++ +|.+++.+     ..+++..++.++.|++.||+|||        +.+++|+||||+||+++.++ .+
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~  186 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TC  186 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CE
T ss_pred             ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CE
Confidence            378999999985 99999976     35899999999999999999999        89999999999999999776 89


Q ss_pred             EEeecCCcccccCCCC----CcccccccccccCchhhhCCCC-----CCchhhHHHHHHHHHHHHhC----------CCC
Q 026660           84 KIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTK----------TAL  144 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~-----~~~~~Di~slG~~l~~l~~g----------~~p  144 (235)
                      +|+|||.+........    ......+|+.|+|||++.+...     ++.++||||||+++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999976554322    2234567899999999875432     23689999999999999999          778


Q ss_pred             CCCCC----HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH
Q 026660          145 FPGDS----ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK  220 (235)
Q Consensus       145 f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  220 (235)
                      |....    ..+.......  ........+               .   .......++.+.+++++||+.||.+|||+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---------------~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVC--EQKLRPNIP---------------N---RWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHT--TSCCCCCCC---------------G---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccCcCcccHHHHHHHHH--HHHhCCCCc---------------c---cccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence            76532    1122211110  000000000               0   0001124467889999999999999999999


Q ss_pred             HhCC
Q 026660          221 AMEH  224 (235)
Q Consensus       221 ll~h  224 (235)
                      +++|
T Consensus       327 i~~~  330 (342)
T 1b6c_B          327 IKKT  330 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-32  Score=218.23  Aligned_cols=195  Identities=22%  Similarity=0.365  Sum_probs=139.3

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...+++||||+++ +|.+++.+.   ...+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg  190 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFG  190 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCc
Confidence            34578999999975 999999763   34589999999999999999999999999999999999999776 99999999


Q ss_pred             CcccccCCCCC---cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+.........   .....++..|+|||.+.+.. ++.++||||||+++++|++|..||.....  ....   .......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~---~~~~~~~  264 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMR---MIGNDKQ  264 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHH---HHCTTCC
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHH---hhccccc
Confidence            99766543221   22334567799999987654 78999999999999999999998864311  0000   0000000


Q ss_pred             CCcc--cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          167 KVWP--GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       167 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ....  ........        .........+++++.++|++||+.||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          265 GQMIVFHLIELLKN--------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             THHHHHHHHHHHHT--------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhhHHHHHHHhhc--------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000  00000000        0000112357889999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.4e-32  Score=219.93  Aligned_cols=180  Identities=17%  Similarity=0.206  Sum_probs=133.2

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEcCCC--------
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKT--------   80 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~~~~--------   80 (235)
                      +++.+|+||||+. |++.+.+.+     +.+++..++.++.||+.||+||| +++++||||||+||+++.++        
T Consensus       133 ~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~  207 (336)
T 2vuw_A          133 KDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL  207 (336)
T ss_dssp             CTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEE
T ss_pred             ccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeec
Confidence            4678999999996 555555522     46899999999999999999999 99999999999999998664        


Q ss_pred             -----------CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCC
Q 026660           81 -----------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGD  148 (235)
Q Consensus        81 -----------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~~  148 (235)
                                 ..++|+|||+++.....     ...||+.|+|||++.+..  +.++||||+|++ .+++++|..||.+.
T Consensus       208 ~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~  280 (336)
T 2vuw_A          208 NGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNV  280 (336)
T ss_dssp             TTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred             cCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcch
Confidence                       27999999999765532     347799999999997543  789999998777 67788898888432


Q ss_pred             CHHH-HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh-CCCC
Q 026660          149 SELQ-QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPY  226 (235)
Q Consensus       149 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll-~hp~  226 (235)
                      .... ....+.........                     ........+++++++||++||+.|     |++|++ +|||
T Consensus       281 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          281 LWLHYLTDKMLKQMTFKTK---------------------CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHHHHHHHHTCCCSSC---------------------CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             hhhhHHHHhhhhhhccCcc---------------------cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence            1111 11111111111000                     001111236788999999999976     999999 9999


Q ss_pred             CC
Q 026660          227 FD  228 (235)
Q Consensus       227 f~  228 (235)
                      |+
T Consensus       335 f~  336 (336)
T 2vuw_A          335 FK  336 (336)
T ss_dssp             GC
T ss_pred             cC
Confidence            95

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.4e-31  Score=232.46  Aligned_cols=168  Identities=23%  Similarity=0.350  Sum_probs=131.7

Q ss_pred             ceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ....|+||||++| +|.+++..      .+++..++.++.||+.||.|||++|++|+||||+||+++. + .++|+|||+
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~-~~kl~DFG~  227 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-E-QLKLIDLGA  227 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-S-CEEECCCTT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-C-cEEEEeccc
Confidence            3447999999985 99886643      6999999999999999999999999999999999999985 4 799999999


Q ss_pred             cccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           91 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      +......    ....||+.|+|||++.+.  .+.++|||||||++++|++|..||.+....               .   
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~---  283 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------G---  283 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------S---
T ss_pred             chhcccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc---------------c---
Confidence            9765432    445689999999998754  478999999999999999998887642100               0   


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                       .         .   ..   ......++.+.++|.+||..||.+||+..+.+.|+|+
T Consensus       284 -~---------~---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          284 -L---------P---ED---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -C---------C---TT---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -c---------c---cc---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             0         0   00   0000245788999999999999999998888877765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=6.3e-29  Score=194.53  Aligned_cols=161  Identities=13%  Similarity=0.058  Sum_probs=121.5

Q ss_pred             CCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEE
Q 026660            6 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK   84 (235)
Q Consensus         6 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~   84 (235)
                      .+..++++..|+||||++| +|.+++.+      ......+..++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus        97 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~k  169 (286)
T 3uqc_A           97 LDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVV  169 (286)
T ss_dssp             EEEEEETTEEEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEE
T ss_pred             eEEEEECCcEEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEE
Confidence            3445567789999999985 99999843      246667899999999999999999999999999999999776 788


Q ss_pred             EeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 026660           85 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  164 (235)
Q Consensus        85 l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  164 (235)
                      +++++                    |++        .++.++|||||||++|+|++|..||.+....+...         
T Consensus       170 l~~~~--------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------  212 (286)
T 3uqc_A          170 LAYPA--------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------  212 (286)
T ss_dssp             ECSCC--------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------
T ss_pred             EEecc--------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------
Confidence            76333                    222        26899999999999999999999998754211000         


Q ss_pred             CCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          165 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                        ..          ................++++++.++|.+||+.||.+| |+.++++
T Consensus       213 --~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          213 --PA----------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             --EC----------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             --HH----------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence              00          0000001112233445789999999999999999999 9999875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=4.1e-29  Score=212.16  Aligned_cols=129  Identities=18%  Similarity=0.178  Sum_probs=93.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ++.+..|+++.+||||||++| +|.++|.+    .+.+++.   +++.||+.||+|+|++|++||||||+|||++.++ .
T Consensus       306 ~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~  377 (569)
T 4azs_A          306 AVLAHGENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-H  377 (569)
T ss_dssp             CEEEEEECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-C
T ss_pred             EEEEEEEECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-C
Confidence            456778899999999999987 99999976    3456654   5789999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT  142 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~  142 (235)
                      +||+|||+++.............||+.|+|||++.+.  +..++|+|++|++++.+.++.
T Consensus       378 vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          378 ARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             EEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             EEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            9999999998776555556667889999999998754  567899999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.75  E-value=8.4e-20  Score=154.26  Aligned_cols=118  Identities=21%  Similarity=0.326  Sum_probs=94.6

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ...|+||||++ ++|.+++.+            +..++.|++.||+|||+++++|+||||+||+++.   .++|+|||++
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla  476 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLG  476 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTC
T ss_pred             CccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccC
Confidence            34599999997 599998854            5689999999999999999999999999999996   7999999999


Q ss_pred             ccccCCCCC-------cccccccccccCchhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 026660           92 RAFTLPIKK-------YTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALF  145 (235)
Q Consensus        92 ~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf  145 (235)
                      +........       .....||+.|+|||++... ..++..+|+|+..+-..+-..++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            876532211       1245679999999999751 22677889999888777766665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.52  E-value=8.2e-15  Score=114.06  Aligned_cols=79  Identities=22%  Similarity=0.230  Sum_probs=65.1

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +..|+||||++| +|.+ +          .......++.|++.||.+||++|++|+||||+||+++ ++ .++|+|||++
T Consensus       173 ~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~DFG~a  239 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIIDFPQS  239 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECCCTTC
T ss_pred             cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEECCCC
Confidence            456999999986 9887 3          1234567999999999999999999999999999999 65 9999999988


Q ss_pred             ccccCCCCCcccccccccccCchhhh
Q 026660           92 RAFTLPIKKYTHEILTLWYRAPEVLL  117 (235)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~y~~PE~~~  117 (235)
                      ..             +..+.|||.+.
T Consensus       240 ~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          240 VE-------------VGEEGWREILE  252 (282)
T ss_dssp             EE-------------TTSTTHHHHHH
T ss_pred             eE-------------CCCCCHHHHHH
Confidence            53             33467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.41  E-value=2.7e-13  Score=104.18  Aligned_cols=71  Identities=18%  Similarity=0.268  Sum_probs=59.3

Q ss_pred             EEEEEEecCcc------CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEcCCCCeEEEe
Q 026660           14 VLYLVFEYMDT------DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus        14 ~~~lv~e~~~g------~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh-~~~~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      ..++||||+++      +|.++...       .++..+..++.|++.||.+|| +.|++|+||||+||+++.   .++|+
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~li  211 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFI  211 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEEC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEE
Confidence            35899999953      67665432       346678899999999999999 999999999999999986   79999


Q ss_pred             ecCCcccc
Q 026660           87 DLGLARAF   94 (235)
Q Consensus        87 df~~~~~~   94 (235)
                      |||++...
T Consensus       212 DFG~a~~~  219 (258)
T 1zth_A          212 DMGQAVTL  219 (258)
T ss_dssp             CCTTCEET
T ss_pred             ECcccccC
Confidence            99998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.09  E-value=7.4e-11  Score=94.88  Aligned_cols=69  Identities=20%  Similarity=0.279  Sum_probs=55.4

Q ss_pred             EEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC---------eEEE
Q 026660           16 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---------TLKI   85 (235)
Q Consensus        16 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~---------~~~l   85 (235)
                      +|||||++| +|..+          ...+....++.||+.+|.+||+.|++||||||.|||++.++.         .+.+
T Consensus       187 ~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~i  256 (397)
T 4gyi_A          187 TIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPII  256 (397)
T ss_dssp             EEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEE
T ss_pred             eEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEE
Confidence            699999987 76432          223355778999999999999999999999999999986541         3789


Q ss_pred             eecCCcccc
Q 026660           86 ADLGLARAF   94 (235)
Q Consensus        86 ~df~~~~~~   94 (235)
                      +||+.+...
T Consensus       257 ID~~Q~V~~  265 (397)
T 4gyi_A          257 IXFPQMVSM  265 (397)
T ss_dssp             CCCTTCEET
T ss_pred             EEeCCcccC
Confidence            999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.49  E-value=1.5e-07  Score=71.99  Aligned_cols=71  Identities=14%  Similarity=0.117  Sum_probs=55.1

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG----------------------------   61 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~----------------------------   61 (235)
                      +.+..|+|||+++| +|.+..         .+......++.+++.+++.||+                            
T Consensus        81 ~~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           81 HDGWSNLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             cCCceEEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            44678999999998 877642         1223345788899999999998                            


Q ss_pred             -------------------------------cCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           62 -------------------------------HGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        62 -------------------------------~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                                                     ..++|+|+++.||+++.+. .+.++||+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a  211 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRS  211 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTC
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhc
Confidence                                           4489999999999998542 5679999966

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.33  E-value=1.9e-05  Score=58.00  Aligned_cols=99  Identities=13%  Similarity=0.085  Sum_probs=63.9

Q ss_pred             CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccc
Q 026660           25 DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH  103 (235)
Q Consensus        25 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~~~~~  103 (235)
                      ||.+.|..+   +.+++++++|.++.|.+.+|.-+-. +.-..+-+.+..|++..+| ++.+.+ ..+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            899999886   4689999999999999999887632 2212344456788888777 555542 1110           


Q ss_pred             ccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCC
Q 026660          104 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT  142 (235)
Q Consensus       104 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~  142 (235)
                       .....+.|||...  ...+.+.-|||||+++|..+--.
T Consensus        98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence             0122356787653  23568889999999999988633

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.28  E-value=4.4e-07  Score=70.99  Aligned_cols=125  Identities=17%  Similarity=0.204  Sum_probs=78.3

Q ss_pred             EEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 026660           14 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-------------------------------   61 (235)
Q Consensus        14 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-------------------------------   61 (235)
                      .-|+||++++| +|.+....      .++.+....++.|++..++.||+                               
T Consensus        90 ~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             CSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            34889999998 77653322      36777778888888888888885                               


Q ss_pred             ---------------------------cCceecCCCCCcEEEcCC-CCeEEEeecCCcccccCCCCCcccccccccccCc
Q 026660           62 ---------------------------HGILHRDLKPHNLLMDRK-TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP  113 (235)
Q Consensus        62 ---------------------------~~~~H~di~~~nil~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~P  113 (235)
                                                 ..++|+|+++.||+++.+ +..+.++||+.+.... +............-..|
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~~~~~~~~~~~  242 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFISLMEDDEEYGM  242 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHTTCCTTTSCCH
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHHHHhhccccCH
Confidence                                       136999999999999964 4367899999875432 11111000000000122


Q ss_pred             hhhh----CCCC---------CCchhhHHHHHHHHHHHHhCCCCC
Q 026660          114 EVLL----GSTH---------YSTAVDMWSVACIFAELVTKTALF  145 (235)
Q Consensus       114 E~~~----~~~~---------~~~~~Di~slG~~l~~l~~g~~pf  145 (235)
                      +...    ....         .....+.|++|.+++.+.+|..+|
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2211    0000         112368999999999999987554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.11  E-value=4.2e-06  Score=66.94  Aligned_cols=74  Identities=16%  Similarity=0.258  Sum_probs=58.4

Q ss_pred             eEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q 026660           13 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG------------------------------   61 (235)
Q Consensus        13 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~------------------------------   61 (235)
                      +..|+|||+++| .+.+.      .-..++.+....++.+++..|..||+                              
T Consensus       114 g~~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             SSCEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence            446899999998 55331      11246788889999999999999997                              


Q ss_pred             ----------------------------cCceecCCCCCcEEEcCCCC-eEEEeecCCcc
Q 026660           62 ----------------------------HGILHRDLKPHNLLMDRKTM-TLKIADLGLAR   92 (235)
Q Consensus        62 ----------------------------~~~~H~di~~~nil~~~~~~-~~~l~df~~~~   92 (235)
                                                  ..++|+|+++.||+++.++. .+.++||+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                        35899999999999986642 36899999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.09  E-value=3.1e-06  Score=64.30  Aligned_cols=27  Identities=19%  Similarity=0.224  Sum_probs=23.0

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ++|+|+++.||+++.++ .+.++||+.+
T Consensus       186 l~HgDl~~~Nil~~~~~-~~~liD~~~a  212 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGR-FSGFIDCGRL  212 (264)
T ss_dssp             EECSSCCGGGEEEETTE-EEEECCCTTC
T ss_pred             EECCCCCCCcEEEECCc-EEEEEcchhc
Confidence            99999999999998543 5669999976

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.56  E-value=0.00031  Score=54.88  Aligned_cols=31  Identities=32%  Similarity=0.478  Sum_probs=24.6

Q ss_pred             CceecCCCCCcEEEcC---CCCeEEEeecCCccc
Q 026660           63 GILHRDLKPHNLLMDR---KTMTLKIADLGLARA   93 (235)
Q Consensus        63 ~~~H~di~~~nil~~~---~~~~~~l~df~~~~~   93 (235)
                      .++|+|+++.||+++.   ++..+.++||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            3599999999999986   343458999997743

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.18  E-value=0.0014  Score=49.87  Aligned_cols=28  Identities=25%  Similarity=0.436  Sum_probs=23.3

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ++|+|+.+.||+++..+ .+-|+||+.+.
T Consensus       195 l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             EECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             EEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence            58999999999998554 56799999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.25  E-value=0.0031  Score=50.09  Aligned_cols=30  Identities=17%  Similarity=0.203  Sum_probs=24.7

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++|+|+.+.||+++. +..+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEET-TEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeC-CcEEEEEcccccc
Confidence            46899999999999984 4257899999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.01  E-value=0.011  Score=46.29  Aligned_cols=30  Identities=20%  Similarity=0.334  Sum_probs=25.6

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++|+|+++.||+++.++ .+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            4799999999999997555 78999999763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.75  E-value=0.028  Score=45.74  Aligned_cols=32  Identities=13%  Similarity=0.353  Sum_probs=26.5

Q ss_pred             HhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           60 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        60 h~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      +...++|+|+++.||+++.++  +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC--EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC--CEEEeCccccc
Confidence            345799999999999998553  99999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.64  E-value=0.067  Score=41.25  Aligned_cols=28  Identities=21%  Similarity=0.141  Sum_probs=23.1

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+.. ++ .+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil~~-~~-~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFLDT-GE-RMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEEEC-SS-CEEECCCTTCE
T ss_pred             eeeccCCCcCCEEEC-CC-CEEEEeccccc
Confidence            489999999999944 44 68999998774

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.87  E-value=0.067  Score=41.56  Aligned_cols=30  Identities=23%  Similarity=0.331  Sum_probs=24.4

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .+++|+|+.+.||+++.+. .+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence            3689999999999998543 45799998763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.89  E-value=0.16  Score=39.56  Aligned_cols=28  Identities=32%  Similarity=0.250  Sum_probs=23.8

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++|+|+++.||+++ +  .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D--GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S--SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C--CCEEEECCCCC
Confidence            3588999999999998 3  68999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.56  E-value=0.099  Score=40.90  Aligned_cols=32  Identities=25%  Similarity=0.326  Sum_probs=25.9

Q ss_pred             cCceecCCCCCcEEEcCC---CCeEEEeecCCccc
Q 026660           62 HGILHRDLKPHNLLMDRK---TMTLKIADLGLARA   93 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~---~~~~~l~df~~~~~   93 (235)
                      ..++|+|+.+.||+++.+   ...+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            369999999999999853   13789999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.33  E-value=0.2  Score=39.39  Aligned_cols=29  Identities=21%  Similarity=0.333  Sum_probs=24.9

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.++ .+.++||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCe
Confidence            589999999999998555 78999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.62  E-value=0.44  Score=37.78  Aligned_cols=28  Identities=25%  Similarity=0.457  Sum_probs=23.4

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.+  .+.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNK--CLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC---CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCC--cEEEEEecCCC
Confidence            58999999999999844  48999998773

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=88.98  E-value=0.4  Score=38.43  Aligned_cols=29  Identities=21%  Similarity=0.361  Sum_probs=24.7

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++|+|+.+.||+++.+  .+.++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~~~--~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH--ETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEeCC--CeEEEeCcccc
Confidence            469999999999999854  58899998774

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.88  E-value=0.4  Score=39.50  Aligned_cols=15  Identities=27%  Similarity=0.352  Sum_probs=14.0

Q ss_pred             CceecCCCCCcEEEc
Q 026660           63 GILHRDLKPHNLLMD   77 (235)
Q Consensus        63 ~~~H~di~~~nil~~   77 (235)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            589999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=87.10  E-value=0.24  Score=40.38  Aligned_cols=17  Identities=29%  Similarity=0.550  Sum_probs=14.7

Q ss_pred             CceecCCCCCcEEEcCC
Q 026660           63 GILHRDLKPHNLLMDRK   79 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~   79 (235)
                      .++|+|+.+.||+++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            48999999999999864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=85.74  E-value=0.43  Score=38.24  Aligned_cols=30  Identities=20%  Similarity=0.350  Sum_probs=25.0

Q ss_pred             CceecCCCCCcEEEcCC---CCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRK---TMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~---~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.+   ...+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            58999999999999865   2378999999874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.52  E-value=0.52  Score=38.00  Aligned_cols=29  Identities=21%  Similarity=0.348  Sum_probs=23.6

Q ss_pred             ceecCCCCCcEEEcC-----CCCeEEEeecCCcc
Q 026660           64 ILHRDLKPHNLLMDR-----KTMTLKIADLGLAR   92 (235)
Q Consensus        64 ~~H~di~~~nil~~~-----~~~~~~l~df~~~~   92 (235)
                      ++|+|+.+.||++..     +...+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            689999999999932     33479999999874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.63  E-value=2.6  Score=30.85  Aligned_cols=72  Identities=17%  Similarity=0.151  Sum_probs=51.1

Q ss_pred             CCceEEEEEEecCc-c-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEee
Q 026660           10 EGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD   87 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~d   87 (235)
                      ++++.+.+.++.-+ + +... ++       .++....++++.+|+.... -|...-+|--++|+|++++.++ .+++.-
T Consensus        58 ~~eD~~~i~y~~~~~~~~f~~-i~-------~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~-~p~i~h  127 (219)
T 4ano_A           58 VSEDEVKVVIKPPSSFLTFAA-IR-------KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL-EPFFLH  127 (219)
T ss_dssp             ECSSEEEEEEECCTTCEEHHH-HH-------TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC-CEEESC
T ss_pred             EeCCEEEEEEEcCcccCcHHH-HH-------hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC-cEEEEE
Confidence            44566677777653 3 5553 33       3889999999999887544 1234558889999999999666 888887


Q ss_pred             cCCc
Q 026660           88 LGLA   91 (235)
Q Consensus        88 f~~~   91 (235)
                      .|.-
T Consensus       128 RGi~  131 (219)
T 4ano_A          128 VGVK  131 (219)
T ss_dssp             CEET
T ss_pred             cCCc
Confidence            7754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	235
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-62
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-61
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-53
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-53
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-46
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-29
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-26
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-26
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-25
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-25
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-23
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 6e-62
 Identities = 74/223 (33%), Positives = 125/223 (56%), Gaps = 2/223 (0%)

Query: 9   KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H  GI HRD
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           +KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T Y++++D+
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYTSSIDV 206

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      ++PQ     
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266

Query: 189 LATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                 P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-61
 Identities = 127/231 (54%), Positives = 168/231 (72%), Gaps = 4/231 (1%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           VK          LYLVFE++  DLKK++         IP+  +KS ++QL +G+AFCH H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
            +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE+LLG  +Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EY 181
           STAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S+ ++   +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 6e-59
 Identities = 87/221 (39%), Positives = 133/221 (60%), Gaps = 4/221 (1%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
             ++ + LVF++M+TDL+  I+        +  + +K+ M    +G+ + H H ILHRDL
Sbjct: 70  GHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
           KP+NLL+D     LK+AD GLA++F  P + YTH+++T WYRAPE+L G+  Y   VDMW
Sbjct: 127 KPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           +V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP + SL ++  +  +    L
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                    D LDL++ +  ++P  RI+A +A++  YF + 
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  180 bits (456), Expect = 1e-56
 Identities = 114/216 (52%), Positives = 152/216 (70%), Gaps = 5/216 (2%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L LVFE++D DLKK +         +   T KS + QL  G+A+CH   +LHRDLKP NL
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP+VL+GS  YST +D+WSV CI
Sbjct: 132 LINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH-EYPQWNPQSLATAV 193
           FAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+ L  +   +  + P    + +
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
             LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-55
 Identities = 97/233 (41%), Positives = 142/233 (60%), Gaps = 6/233 (2%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL +G+ F H 
Sbjct: 77  DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLHS 134

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
           H ++HRDLKP N+L+      +K+AD GLAR ++      T  ++TLWYRAPEVLL S  
Sbjct: 135 HRVVHRDLKPQNILVTSS-GQIKLADFGLARIYS-FQMALTSVVVTLWYRAPEVLLQS-S 191

Query: 122 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   +L     +
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-F 250

Query: 182 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 234
              + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ +
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-53
 Identities = 82/235 (34%), Positives = 128/235 (54%), Gaps = 12/235 (5%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           D+ +    E    +YLV   M  DL K +++     +++  + +   +YQ+ +G+ + H 
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS 127

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---IKKYTHEILTLWYRAPEVLLG 118
             +LHRDLKP NLL++  T  LKI D GLAR            T  + T WYRAPE++L 
Sbjct: 128 ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 119 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
           S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + +L   
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 179 H---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +  
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-53
 Identities = 75/221 (33%), Positives = 121/221 (54%), Gaps = 12/221 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLVF++ + DL   + +         ++ +K +M  L  G+ + H + ILHRD+K  N+
Sbjct: 92  IYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148

Query: 75  LMDRKTMTLKIADLGLARAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 130
           L+ R    LK+AD GLARAF+L       +YT+ ++TLWYR PE+LLG   Y   +D+W 
Sbjct: 149 LITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY----PQWNP 186
             CI AE+ T++ +  G++E  QL  I +L G+   +VWP V +   + +      Q   
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     D   LDL++++L  DP++RI +  A+ H +F
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 6e-53
 Identities = 109/230 (47%), Positives = 148/230 (64%), Gaps = 6/230 (2%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
           V+          L LVFE+ D DLKKY  S      ++    VKS ++QL KG+ FCH  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
            +LHRDLKP NLL++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P+VL G+  Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 123 STAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 181
           ST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP ++ L ++  Y
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 182 PQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           P +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (430), Expect = 3e-52
 Identities = 67/229 (29%), Positives = 124/229 (54%), Gaps = 19/229 (8%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
             LVFE+++ TD K+  ++            ++  MY++ K + +CH  GI+HRD+KPHN
Sbjct: 107 PALVFEHVNNTDFKQLYQTL-------TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 159

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +++D +   L++ D GLA  +  P ++Y   + + +++ PE+L+    Y  ++DMWS+ C
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 218

Query: 134 IFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW---------PGVSSLMNWHEYPQ 183
           + A ++  K   F G     QL+ I ++LGT +   +         P  + ++  H   +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
           W     +     +  + LD L+++L+YD   R++A++AMEHPYF  + K
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-50
 Identities = 84/231 (36%), Positives = 127/231 (54%), Gaps = 12/231 (5%)

Query: 6   GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 65
            +  +  T  YLV  +M TDL K ++      E +  + ++ L+YQ+ KG+ + H  GI+
Sbjct: 89  DETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGII 143

Query: 66  HRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           HRDLKP NL ++ +   LKI D GLAR       + T  ++T WYRAPEV+L    Y+  
Sbjct: 144 HRDLKPGNLAVN-EDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH---EYP 182
           VD+WSV CI AE++T   LF G   L QL  I ++ GTP  +    + S    +     P
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 233
           +   +  A+ + N     ++LLE+ML  D  +R++A +A+ HPYF+ L  T
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 2e-47
 Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 31/220 (14%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + +++E+M   +L + +         +  +     M Q+CKG+   H +  +H DLKP N
Sbjct: 98  MVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154

Query: 74  LLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           ++   +++  LK+ D GL      P +       T  + APEV  G        DMWSV 
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVG 212

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +   L++  + F G+++ + L ++       ++  + G+S                   
Sbjct: 213 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS------------------- 253

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                +DG D + ++L  DP+ R++  +A+EHP+    + 
Sbjct: 254 -----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-46
 Identities = 51/236 (21%), Positives = 95/236 (40%), Gaps = 26/236 (11%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPH 72
           + +  E+MD   L + ++   +    IP   +  +   + KG+ +    H I+HRD+KP 
Sbjct: 79  ISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L++ +   +K+ D G++    L        + T  Y +PE L G+ HYS   D+WS+ 
Sbjct: 135 NILVNSR-GEIKLCDFGVSGQ--LIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMG 190

Query: 133 CIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY-----PQWNP 186
               E+       P  D++  +L+   ++ G   E      +       Y     P    
Sbjct: 191 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAI 250

Query: 187 QSLATAVPN----------LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
             L   + N             +  D + + L  +P++R   K+ M H +    D 
Sbjct: 251 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-46
 Identities = 81/219 (36%), Positives = 114/219 (52%), Gaps = 12/219 (5%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +YLV   M  DL   ++      + +  + V+ L+YQ+ +G+ + H   I+HRDLKP NL
Sbjct: 98  VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 152

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
            ++      KI D GLAR     +  Y     T WYRAPE++L   HY+  VD+WSV CI
Sbjct: 153 AVNEDCEL-KILDFGLARHTDDEMTGYVA---TRWYRAPEIMLNWMHYNQTVDIWSVGCI 208

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL---MNWHEYPQWNPQSLAT 191
            AEL+T   LFPG   + QL  I RL+GTP  ++   +SS           Q    + A 
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
                +   +DLLE+ML  D  KRI+A +A+ H YF   
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-46
 Identities = 41/217 (18%), Positives = 84/217 (38%), Gaps = 32/217 (14%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L+++ E+        +    +    +  + ++ +  Q    + + H + I+HRDLK  N+
Sbjct: 84  LWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAVDMWS 130
           L       +K+AD G++   T  I++    I T ++ APEV++  T     Y    D+WS
Sbjct: 142 LFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200

Query: 131 VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
           +     E+          + ++ LL I +    P     P                    
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTLAQP-------------------- 238

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                   +  D L++ L+ +   R +  + ++HP+ 
Sbjct: 239 ---SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (389), Expect = 8e-46
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 31/220 (14%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  + L+ E++   +L   I         +    V + M Q C+G+   H H I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152

Query: 69  LKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           +KP N++ + +K  ++KI D GLA     P +       T  + APE++          D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDRE-PVGFYTD 210

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           MW++  +   L++  + F G+ +L+ L ++ R     +E  +  VS              
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS-------------- 256

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      +  D ++ +LQ +P KR++   A+EHP+ 
Sbjct: 257 ----------PEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  151 bits (383), Expect = 9e-46
 Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 36/231 (15%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           ++     E  T  +LVF+ M   +L  Y+         +     + +M  L + +   H 
Sbjct: 73  IQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK 128

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 121
             I+HRDLKP N+L+D   M +K+ D G +     P +K      T  Y APE++  S +
Sbjct: 129 LNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMN 186

Query: 122 -----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
                Y   VDMWS   I   L+  +  F    ++  L  I           W   S   
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS--- 243

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                                    DL+ + L   P KR +A++A+ HP+F
Sbjct: 244 ---------------------DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-45
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 35/223 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHG 63
              T LY+V EY +  DL   I    +  + +    V  +M QL   +  CH     GH 
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 64  ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 123
           +LHRDLKP N+ +D K   +K+ D GLAR            + T +Y +PE +     Y+
Sbjct: 135 VLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYN 192

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
              D+WS+ C+  EL      F   S+ +    I                    +   P 
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----------------GKFRRIP- 235

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 226
                          +  +++ +ML      R S ++ +E+P 
Sbjct: 236 ----------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-45
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 31/220 (14%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E    L ++FE++   D+ + I     +   +    + S ++Q+C+ + F H H I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127

Query: 69  LKPHN-LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVD 127
           ++P N +   R++ T+KI + G AR                 Y APEV       STA D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT-APEYYAPEVHQHD-VVSTATD 185

Query: 128 MWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 187
           MWS+  +   L++    F  ++  Q + +I     T +E+ +  +S              
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS-------------- 231

Query: 188 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                      + +D ++++L  +   R++A +A++HP+ 
Sbjct: 232 ----------IEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-44
 Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 31/216 (14%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            YL  EY        +    +    +P    +   +QL  GV + HG GI HRD+KP NL
Sbjct: 78  QYLFLEYCSGGE---LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           L+D +   LKI+D GLA  F    ++        TL Y APE+L     ++  VD+WS  
Sbjct: 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +   ++     +   S+  Q    ++   T                    W        
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------LNPW-------- 229

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 228
              +D   L LL ++L  +PS RI+     +  +++
Sbjct: 230 -KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-44
 Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           +YL+ EY     + + ++               + + +L   +++CH   ++HRD+KP N
Sbjct: 81  VYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           LL+      LKIAD G +     P  + T    TL Y  PE++ G   +   VD+WS+  
Sbjct: 137 LLLGSA-GELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGV 192

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E +     F  ++  +    I R+  T                              
Sbjct: 193 LCYEFLVGKPPFEANTYQETYKRISRVEFTFP---------------------------- 224

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             + +   DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-43
 Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 31/213 (14%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           L++V EY+       + +     E      + ++  +  + + F H + ++HRD+K  N+
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+     ++K+ D G     T    K +  + T ++ APEV+     Y   VD+WS+  +
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIM 205

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E++     +  ++ L+ L  I    GTP  +    +S                     
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLS--------------------- 243

Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                  D L + L  D  KR SAK+ ++H + 
Sbjct: 244 ---AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-43
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 27/226 (11%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
            GR  L +V E +D  +L   I+   +  +         +M  + + + + H   I HRD
Sbjct: 79  AGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136

Query: 69  LKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           +KP NLL         LK+ D G A+  T      T    T +Y APEVL     Y  + 
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEVLGP-EKYDKSC 194

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L+     F  +  L     +   +              M  +E+P    
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------------RMGQYEFPNPEW 241

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 232
                    + ++   L+  +L+ +P++R++  + M HP+     K
Sbjct: 242 -------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-42
 Identities = 47/221 (21%), Positives = 89/221 (40%), Gaps = 36/221 (16%)

Query: 10  EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILH 66
           +G+  + LV E M +  LK Y++ F+     + +  ++S   Q+ KG+ F H     I+H
Sbjct: 82  KGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIH 137

Query: 67  RDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           RDLK  N+ +   T ++KI DLGLA             I T  + APE+      Y  +V
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVIGTPEFMAPEMYEE--KYDESV 193

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           D+++      E+ T    +       Q+                    + +  +   ++ 
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRR-----------------VTSGVKPASFD- 235

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                       +  +++E  ++ +  +R S K  + H +F
Sbjct: 236 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (358), Expect = 9e-42
 Identities = 41/215 (19%), Positives = 82/215 (38%), Gaps = 36/215 (16%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            +LV EY        +   ++    +    + ++ +   +G+A+ H H ++HRD+K  N+
Sbjct: 90  AWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVA 132
           L+      +K+ D G A             + T ++ APEV+L      Y   VD+WS+ 
Sbjct: 147 LLSEP-GLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
               EL  +       + +  L HI +                   +E P          
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIAQ-------------------NESPALQS------ 236

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
             +  +   + ++  LQ  P  R +++  ++H + 
Sbjct: 237 -GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 1e-40
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 43/230 (18%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LY    Y    +L KYIR              +    ++   + + HG GI+HRDLKP N
Sbjct: 83  LYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +L++   M ++I D G A+  +   K  +    + T  Y +PE+L        + D+W++
Sbjct: 139 ILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWAL 196

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            CI  +LV     F   +E      I +L     EK +P                     
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP--------------------- 235

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEHPYFDDLDKTRL 235
                     DL+E++L  D +KR+  ++         HP+F+ +    L
Sbjct: 236 -------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (345), Expect = 9e-40
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           LYL+ + +   +L   I                 L++Q+   V + H  GI+HRDLKP N
Sbjct: 82  LYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137

Query: 74  LLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           LL     +   + I+D GL++    P    +    T  Y APEVL     YS AVD WS+
Sbjct: 138 LLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSI 195

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             I   L+     F  +++ +    I +     +   W  +S                  
Sbjct: 196 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS------------------ 237

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 227
                     D +  +++ DP KR + ++A++HP+ 
Sbjct: 238 ------DSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-39
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           + +  L+ V EY++  DL  +I+S  +      ++       ++  G+ F H  GI++RD
Sbjct: 73  QTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKGIVYRD 128

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           LK  N+L+D K   +KIAD G+ +   L   K      T  Y APE+LLG   Y+ +VD 
Sbjct: 129 LKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDW 186

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS   +  E++   + F G  E +    I                  M+   YP+W    
Sbjct: 187 WSFGVLLYEMLIGQSPFHGQDEEELFHSI-----------------RMDNPFYPRW---- 225

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-MEHPYFDDLDKTRL 235
                  L+K+  DLL ++   +P KR+  +    +HP F +++   L
Sbjct: 226 -------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-39
 Identities = 78/235 (33%), Positives = 112/235 (47%), Gaps = 23/235 (9%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E    +YLV E MD +L + I+        +    +  L+YQ+  G+   H  GI+HRDL
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 129
           KP N+++     TLKI D GLAR         T  ++T +YRAPEV+LG   Y   VD+W
Sbjct: 146 KPSNIVVKSD-CTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIW 202

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH--EYPQWNPQ 187
           SV CI  E+V    LFPG   + Q   +   LGTP  +    +   +  +    P++   
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262

Query: 188 SLATAVPN------------LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
           +     P+                  DLL +ML  DP+KRIS   A++HPY +  
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-39
 Identities = 47/229 (20%), Positives = 92/229 (40%), Gaps = 32/229 (13%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
           E +T + L+ E +       +  F    E++        + Q+  GV + H   I H DL
Sbjct: 83  ENKTDVILILELVA---GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139

Query: 70  KPHNLLMDRK---TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAV 126
           KP N+++  +      +KI D GLA        ++ +   T  + APE++          
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNYE-PLGLEA 197

Query: 127 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 186
           DMWS+  I   L++  + F GD++ + L ++  +     ++ +   S             
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS------------- 244

Query: 187 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 235
                          D + ++L  DP KR++ + +++HP+    D  + 
Sbjct: 245 -----------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-38
 Identities = 37/215 (17%), Positives = 81/215 (37%), Gaps = 31/215 (14%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L +V ++ + + L  ++           +  +  +  Q  +G+ + H   I+HRDLK +N
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134

Query: 74  LLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMW 129
           + +    +T+KI D GLA   +      ++     ++ + APEV+       YS   D++
Sbjct: 135 IFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193

Query: 130 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
           +   +  EL+T    +   +   Q++ +                          +    L
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------------------GYLSPDL 231

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           +    N  K    L+ + L+    +R    + +  
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-38
 Identities = 46/218 (21%), Positives = 78/218 (35%), Gaps = 42/218 (19%)

Query: 15  LYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH 72
             L+ E  +   DL  +I         +     +S  +Q+ + V  CH  G+LHRD+K  
Sbjct: 84  FVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 139

Query: 73  NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           N+L+D     LK+ D G      L    YT    T  Y  PE +    ++  +  +WS+ 
Sbjct: 140 NILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  ++V     F  D E+ +    FR                                 
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVFFR--------------------------------- 224

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 230
              +  +   L+   L   PS R + ++   HP+  D+
Sbjct: 225 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (337), Expect = 4e-38
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L  + + M+  DL  ++       E      ++    ++  G+   H   +++RDLKP N
Sbjct: 82  LSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAEIILGLEHMHNRFVVYRDLKPAN 137

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           +L+D +   ++I+DLGLA  F+   KK    + T  Y APEVL     Y ++ D +S+ C
Sbjct: 138 ILLD-EHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  +L+   + F      +    I R+  T   ++    S                    
Sbjct: 195 MLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVELPDSFS-------------------- 233

Query: 194 PNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL 235
                +   LLE +LQ D ++R+      A++  E P+F  LD   +
Sbjct: 234 ----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (319), Expect = 1e-35
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 24/238 (10%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHN 73
           +++V  +            +     IP+  VK +  QL  G+ + H   GI+H D+KP N
Sbjct: 97  VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156

Query: 74  LLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +LM+       +  + +A         + YT+ I T  YR+PEVLLG+  +    D+WS 
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWST 215

Query: 132 ACIFAELVTKTALFPGDS------ELQQLLHIFRLLGTPNEKVWPGVSS----------L 175
           AC+  EL+T   LF  D       +   +  I  LLG     +                L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275

Query: 176 MNWHEYPQWNPQSLATA----VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 229
            N  +   W  + + T       +  K+  D L  MLQ DP KR  A   + HP+  D
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 4e-32
 Identities = 47/238 (19%), Positives = 80/238 (33%), Gaps = 38/238 (15%)

Query: 3   VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 62
                  +    L  V EY +      +               +    ++   + + H  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 63  GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 122
            +++RD+K  NL++D K   +KI D GL +              T  Y APEVL  +  Y
Sbjct: 125 DVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DY 182

Query: 123 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP 182
             AVD W +  +  E++     F      +    I        E  +P            
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFP------------ 225

Query: 183 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL 235
                        L  +   LL  +L+ DP +R+      AK+ MEH +F  ++   +
Sbjct: 226 -----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-32
 Identities = 38/216 (17%), Positives = 78/216 (36%), Gaps = 34/216 (15%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           E +  LY+V EYM    L  Y+R   +    +  + +      +C+ + +  G+  +HRD
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDM 128
           L   N+L+  +    K++D GL +  +          L + + APE L     +ST  D+
Sbjct: 129 LAARNVLVS-EDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALREK-KFSTKSDV 183

Query: 129 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           WS   +  E+ +   +      L+ ++                   +   ++        
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPR-----------------VEKGYKMDAP---- 222

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                        ++++     D + R S  +  E 
Sbjct: 223 -----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 51/228 (22%), Positives = 86/228 (37%), Gaps = 35/228 (15%)

Query: 2   DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 60
           D  + +   G  + Y+V EY+D   L+  + +       +       ++   C+ + F H
Sbjct: 74  DTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 128

Query: 61  GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLL 117
            +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T  Y +PE   
Sbjct: 129 QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 118 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 177
           G        D++S+ C+  E++T    F GDS +       R    P      G+S    
Sbjct: 188 GD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS---- 242

Query: 178 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 225
                                D   ++ + L  +P  R      M   
Sbjct: 243 --------------------ADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (289), Expect = 1e-31
 Identities = 46/226 (20%), Positives = 90/226 (39%), Gaps = 41/226 (18%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           ++++ +Y++      + S  +  +  P    K    ++C  + + H   I++RDLKP N+
Sbjct: 79  IFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+D+    +KI D G A+                 Y APEV+     Y+ ++D WS   +
Sbjct: 136 LLDKN-GHIKITDFGFAKYVPDVTYTLCGTP---DYIAPEVVSTK-PYNKSIDWWSFGIL 190

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E++     F   + ++    I        E  +P                       P
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKILN-----AELRFP-----------------------P 222

Query: 195 NLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL 235
             ++D  DLL +++  D S+R+       +    HP+F ++   +L
Sbjct: 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-31
 Identities = 48/241 (19%), Positives = 94/241 (39%), Gaps = 37/241 (15%)

Query: 3   VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 61
           V      +  T L+L+ +Y++  +L  ++    +       + V+  + ++   +   H 
Sbjct: 92  VTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHK 147

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGS 119
            GI++RD+K  N+L+D     + + D GL++ F     +  ++      +     V  G 
Sbjct: 148 LGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 120 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
           + +  AVD WS+  +  EL+T  + F  D E      I R +          +S      
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS------ 260

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR 234
                                 DL++++L  DP KR+      A +  EH +F  ++   
Sbjct: 261 ------------------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302

Query: 235 L 235
           L
Sbjct: 303 L 303

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 7e-31
 Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 34/221 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y+V EYM            +TG+ + +  +  +  Q+  G+A+      +HRDL+  N+
Sbjct: 86  IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144

Query: 75  LMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+    +  K+AD GLAR                + + APE  L    ++   D+WS   
Sbjct: 145 LVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGI 202

Query: 134 IFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
           +  EL T     +PG    + L  + R    P                            
Sbjct: 203 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-------------------------- 236

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAK--KAMEHPYFDDLD 231
            P   +   DL+ Q  + +P +R + +  +A    YF   +
Sbjct: 237 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 9e-31
 Identities = 46/233 (19%), Positives = 77/233 (33%), Gaps = 51/233 (21%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGEN-------------------IPVNTVKSLMYQLCK 54
           +YL+FEY    DL  Y+RS R+                       +    +    YQ+ K
Sbjct: 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175

Query: 55  GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRA 112
           G+ F      +HRDL   N+L+      +KI D GLAR            +  L + + A
Sbjct: 176 GMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234

Query: 113 PEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG 171
           PE L     Y+   D+WS   +  E+ +     +PG         + +            
Sbjct: 235 PESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM------- 286

Query: 172 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                   + P +  + +             +++    +D  KR S       
Sbjct: 287 --------DQPFYATEEIY-----------IIMQSCWAFDSRKRPSFPNLTSF 320

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-29
 Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 20/224 (8%)

Query: 13  TVLYLVFEYMDT-DLKKYIRSFRQTGE---NIPVNTVKSLMYQLCKGVAFCHGHGILHRD 68
           T L+LV +Y +   L  Y+  +  T E    + ++T   L +   + V       I HRD
Sbjct: 74  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133

Query: 69  LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTH--- 121
           LK  N+L+ +   T  IADLGLA               H + T  Y APEVL  S +   
Sbjct: 134 LKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192

Query: 122 --YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 179
                  D++++  +F E+  + ++     + Q   +         E++   V       
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 252

Query: 180 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
             P               +    ++ +    + + R++A +  +
Sbjct: 253 NIPNRWQS------CEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-29
 Identities = 46/227 (20%), Positives = 78/227 (34%), Gaps = 40/227 (17%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           L LV E      L K++   R   E IPV+ V  L++Q+  G+ +      +HRDL   N
Sbjct: 83  LMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 139

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWS 130
           +L+  +    KI+D GL++A       YT        L + APE +     +S+  D+WS
Sbjct: 140 VLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWS 197

Query: 131 VACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 189
                 E ++     +      + +  I +                    +  +      
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------------------GKRMECP---- 234

Query: 190 ATAVPNLDKDGLDLLEQMLQYDPSKRISAK---KAMEHPYFDDLDKT 233
               P    +   L+     Y    R       + M   Y+    K 
Sbjct: 235 ----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (273), Expect = 5e-29
 Identities = 41/201 (20%), Positives = 68/201 (33%), Gaps = 38/201 (18%)

Query: 40  IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK 99
                 +    Q+     + H   +++RDLKP NLL+D++   +++ D G A+       
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTW 196

Query: 100 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 159
                       APE++L    Y+ AVD W++  +  E+      F  D  +Q    I  
Sbjct: 197 TLCGTP---EALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252

Query: 160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI--- 216
                                +P            +   D  DLL  +LQ D +KR    
Sbjct: 253 -----------------GKVRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNL 284

Query: 217 --SAKKAMEHPYFDDLDKTRL 235
                    H +F   D   +
Sbjct: 285 KNGVNDIKNHKWFATTDWIAI 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-28
 Identities = 39/225 (17%), Positives = 78/225 (34%), Gaps = 39/225 (17%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LV E  +      +  + Q   ++    +  L++Q+  G+ +      +HRDL   N+
Sbjct: 82  WMLVMEMAELGP---LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L+  +    KI+D GL++A       Y   TH    + + APE +     +S+  D+WS 
Sbjct: 139 LLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSF 196

Query: 132 ACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
             +  E  +     + G    +    + +                    E          
Sbjct: 197 GVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------------GERMGCP----- 232

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAK---KAMEHPYFDDLDK 232
                  ++  DL+     YD   R         + + Y+D +++
Sbjct: 233 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (257), Expect = 4e-27
 Identities = 34/230 (14%), Positives = 64/230 (27%), Gaps = 36/230 (15%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
                  +V E +   L+     F        + TV  L  Q+   + + H    +HRD+
Sbjct: 73  AEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 129

Query: 70  KPHNLLMDRKTMTLKI--ADLGLARAFT-------LPIKKYTHEILTLWYRAPEVLLGST 120
           KP N LM        +   D GLA+ +        +P ++  +   T  Y +    LG  
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-I 188

Query: 121 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 180
             S   D+ S+  +       +  + G     +     R                    E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------------------ISE 230

Query: 181 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAMEHPYF 227
                P  +         +    L          +      ++   + + 
Sbjct: 231 KKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-27
 Identities = 42/214 (19%), Positives = 73/214 (34%), Gaps = 34/214 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + +V E     L   +   R+   +  + T+     Q+ +G+ +      +HRDL   NL
Sbjct: 85  MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L+  +   +KI D GL RA       Y    H  +   + APE L     +S A D W  
Sbjct: 143 LLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMF 200

Query: 132 ACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 190
                E+ T     + G +  Q L  I +                      P+       
Sbjct: 201 GVTLWEMFTYGQEPWIGLNGSQILHKIDK-----------------EGERLPRP------ 237

Query: 191 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
               +  +D  +++ Q   + P  R +     + 
Sbjct: 238 ---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 7e-27
 Identities = 48/228 (21%), Positives = 79/228 (34%), Gaps = 42/228 (18%)

Query: 10  EGRTVLYLVFEYMD-TDLKKYIR------------SFRQTGENIPVNTVKSLMYQLCKGV 56
           E R  LYL  EY    +L  ++R                T   +    +      + +G+
Sbjct: 81  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140

Query: 57  AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 116
            +      +HRDL   N+L+       KIAD GL+R   + +KK     L + + A E L
Sbjct: 141 DYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESL 198

Query: 117 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
             S  Y+T  D+WS   +  E+V+            +L                    L 
Sbjct: 199 NYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-----------------LP 240

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
             +   +           N D +  DL+ Q  +  P +R S  + +  
Sbjct: 241 QGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  102 bits (255), Expect = 8e-27
 Identities = 31/220 (14%), Positives = 60/220 (27%), Gaps = 35/220 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
             LV + +   L+  +      G    V TV     Q+   V   H   +++RD+KP N 
Sbjct: 76  NVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132

Query: 75  LMDRKTM----TLKIADLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYS 123
           L+ R        + + D G+ + +  P+ K         +   T  Y +    LG    S
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQS 191

Query: 124 TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ 183
              D+ ++  +F   +  +  + G           R+                       
Sbjct: 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK------------------- 232

Query: 184 WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                L        ++    +                   
Sbjct: 233 -QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-26
 Identities = 36/212 (16%), Positives = 77/212 (36%), Gaps = 33/212 (15%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           + LVFE+M+   L  Y+R+ R         T+  +   +C+G+A+     ++HRDL   N
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131

Query: 74  LLMDRKTMTLKIADLGLARAFTLPIKKYTHEI-LTLWYRAPEVLLGSTHYSTAVDMWSVA 132
            L+      +K++D G+ R         +      + + +PEV   S  YS+  D+WS  
Sbjct: 132 CLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFG 189

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
            +  E+ ++  +   +    +++                         +  + P      
Sbjct: 190 VLMWEVFSEGKIPYENRSNSEVVEDIS-------------------TGFRLYKP------ 224

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                     ++    +  P  R +  + +  
Sbjct: 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-26
 Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 32/216 (14%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           +Y++ EYM+            +G  + +N +  +  Q+ +G+AF      +HRDL+  N+
Sbjct: 82  IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140

Query: 75  LMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 133
           L+   T++ KIAD GLAR                + + APE +     ++   D+WS   
Sbjct: 141 LV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGI 198

Query: 134 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 193
           +  E+VT   +        +++                   L   +   +          
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQN-----------------LERGYRMVRP--------- 232

Query: 194 PNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYF 227
            N  ++   L+    +  P  R +          +F
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 6e-26
 Identities = 34/213 (15%), Positives = 75/213 (35%), Gaps = 35/213 (16%)

Query: 15  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 73
           ++++ EYM    L  Y+R  R          +  +   +C+ + +      LHRDL   N
Sbjct: 74  IFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130

Query: 74  LLMDRKTMTLKIADLGLARAFT-LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
            L++ +   +K++D GL+R                + +  PEVL+ S  +S+  D+W+  
Sbjct: 131 CLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFG 188

Query: 133 CIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
            +  E+ +   + +   +  +   HI + L      +                       
Sbjct: 189 VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS--------------------- 227

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                 +    ++         +R + K  + +
Sbjct: 228 ------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.2 bits (246), Expect = 2e-25
 Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 53/233 (22%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGEN--------------------IPVNTVKSLMYQLC 53
           + L+FEYM   DL +++RS                           +       +  Q+ 
Sbjct: 91  MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150

Query: 54  KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYR 111
            G+A+      +HRDL   N L+    M +KIAD GL+R        K   ++ + + + 
Sbjct: 151 AGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 209

Query: 112 APEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP 170
            PE +     Y+T  D+W+   +  E+ +     + G +  + + ++             
Sbjct: 210 PPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD----------- 257

Query: 171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                 N    P+  P  L            +L+       P+ R S      
Sbjct: 258 -----GNILACPENCPLELY-----------NLMRLCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-25
 Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 43/237 (18%)

Query: 3   VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG------------ENIPVNTVKSLM 49
           +           LY++ EY    +L++Y+++ R  G            E +    + S  
Sbjct: 82  INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141

Query: 50  YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 107
           YQ+ +G+ +      +HRDL   N+L+      +KIAD GLAR        KK T+  L 
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLP 200

Query: 108 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 167
           + + APE L     Y+   D+WS   +  E+ T          +++L  +          
Sbjct: 201 VKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---------- 249

Query: 168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
                  L   H   +           N   +   ++       PS+R + K+ +E 
Sbjct: 250 -------LKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 5e-25
 Identities = 45/219 (20%), Positives = 73/219 (33%), Gaps = 34/219 (15%)

Query: 10  EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL 69
                  +V  YM     +          N  V  +     Q+ KG+ F      +HRDL
Sbjct: 99  RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 156

Query: 70  KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE----ILTLWYRAPEVLLGSTHYSTA 125
              N ++D K  T+K+AD GLAR          H      L + + A E L     ++T 
Sbjct: 157 AARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTK 214

Query: 126 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN 185
            D+WS   +  EL+T+ A    D     +             +  G   L      P++ 
Sbjct: 215 SDVWSFGVLLWELMTRGAPPYPDVNTFDIT----------VYLLQGRRLL-----QPEYC 259

Query: 186 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           P  L            +++ +        R S  + +  
Sbjct: 260 PDPLY-----------EVMLKCWHPKAEMRPSFSELVSR 287

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.4 bits (239), Expect = 2e-24
 Identities = 35/216 (16%), Positives = 76/216 (35%), Gaps = 37/216 (17%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + ++ E+M+          RQ      V  +  ++  +  G+ +      +HRDL   N+
Sbjct: 102 VMIITEFMENGSLDSF--LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTH-----EILTLWYRAPEVLLGSTHYSTAVDMW 129
           L++   +  K++D GL+R         T+       + + + APE +     +++A D+W
Sbjct: 160 LVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVW 217

Query: 130 SVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS 188
           S   +  E+++     +   +    +  I +    P                 P   P +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP----------------PPMDCPSA 261

Query: 189 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           L             L+    Q D + R    + +  
Sbjct: 262 LH-----------QLMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 2e-24
 Identities = 30/210 (14%), Positives = 65/210 (30%), Gaps = 29/210 (13%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           ++++ E       +     R+    + + ++    YQL   +A+      +HRD+   N+
Sbjct: 82  VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+      +K+ D GL+R           +            +    +++A D+W     
Sbjct: 140 LVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E++          +   ++                   + N    P           P
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIG-----------------RIENGERLPMP---------P 232

Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
           N       L+ +   YDPS+R    +    
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 3e-24
 Identities = 41/212 (19%), Positives = 75/212 (35%), Gaps = 32/212 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + L+ + M       +   R+  +NI    + +   Q+ KG+ +     ++HRDL   N+
Sbjct: 85  VQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYRAPEVLLGSTHYSTAVDMWSVA 132
           L+      +KI D GLA+      K+Y  E   + + + A E +L    Y+   D+WS  
Sbjct: 143 LVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYG 200

Query: 133 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA 192
               EL+T  +         ++  I                 L      PQ         
Sbjct: 201 VTVWELMTFGSKPYDGIPASEISSI-----------------LEKGERLPQP-------- 235

Query: 193 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
            P    D   ++ +    D   R   ++ +  
Sbjct: 236 -PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 4e-24
 Identities = 44/226 (19%), Positives = 79/226 (34%), Gaps = 44/226 (19%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGEN------------IPVNTVKSLMYQLCKGVAFCHG 61
           L ++ E+    +L  Y+RS R                 + +  +    +Q+ KG+ F   
Sbjct: 93  LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152

Query: 62  HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGS 119
              +HRDL   N+L+  K   +KI D GLAR         +     L L + APE +   
Sbjct: 153 RKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211

Query: 120 THYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 178
             Y+   D+WS   +  E+ +  A  +PG    ++     +                   
Sbjct: 212 -VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------- 256

Query: 179 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 224
              P +    +              +      +PS+R +  + +EH
Sbjct: 257 -RAPDYTTPEMY-----------QTMLDCWHGEPSQRPTFSELVEH 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.0 bits (233), Expect = 1e-23
 Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 28/209 (13%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
            Y++ E+M               E +    +  +  Q+   + +      +HRDL   N 
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI 134
           L+  +   +K+AD GL+R  T                     L    +S   D+W+   +
Sbjct: 147 LVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 135 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP 194
             E+ T         +L Q+  +                      E P+  P+ +     
Sbjct: 206 LWEIATYGMSPYPGIDLSQVYELLEKDYRM---------------ERPEGCPEKVY---- 246

Query: 195 NLDKDGLDLLEQMLQYDPSKRISAKKAME 223
                  +L+    Q++PS R S  +  +
Sbjct: 247 -------ELMRACWQWNPSDRPSFAEIHQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 2e-23
 Identities = 31/212 (14%), Positives = 75/212 (35%), Gaps = 33/212 (15%)

Query: 15  LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL 74
           + ++ EYM+          R+      V  +  ++  +  G+ +      +HRDL   N+
Sbjct: 84  MMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141

Query: 75  LMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           L++   +  K++D GL+R      +     +   + + + APE +     +++A D+WS 
Sbjct: 142 LVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSF 199

Query: 132 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT 191
             +  E++T       +    +++                   + +    P         
Sbjct: 200 GIVMWEVMTYGERPYWELSNHEVMKA-----------------INDGFRLPTP------- 235

Query: 192 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
              +       L+ Q  Q + ++R      + 
Sbjct: 236 --MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 4e-23
 Identities = 45/227 (19%), Positives = 82/227 (36%), Gaps = 46/227 (20%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGEN--------------IPVNTVKSLMYQLCKGVAFC 59
             ++ EY    DL  ++R  R +                 + +  + S  YQ+ KG+AF 
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 60  HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY--THEILTLWYRAPEVLL 117
                +HRDL   N+L+       KI D GLAR            +  L + + APE + 
Sbjct: 162 ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220

Query: 118 GSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 176
               Y+   D+WS      EL +  ++ +PG     +   + +                 
Sbjct: 221 NC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----------------- 262

Query: 177 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 223
               +   +P        +   +  D+++     DP KR + K+ ++
Sbjct: 263 --EGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 5e-23
 Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 45/233 (19%)

Query: 15  LYLVFEYMD-TDLKKYIRSFRQTGENIPV------NTVKSLMYQLCKGVAFCHGHGILHR 67
             ++ E M   DLK Y+RS R    N PV      + +  +  ++  G+A+ + +  +HR
Sbjct: 98  TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157

Query: 68  DLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTA 125
           DL   N ++     T+KI D G+ R    T   +K    +L + + +PE L     ++T 
Sbjct: 158 DLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTY 215

Query: 126 VDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW 184
            D+WS   +  E+ T     + G S  Q L  +                           
Sbjct: 216 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------------------- 250

Query: 185 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME------HPYFDDLD 231
               L     N      +L+    QY+P  R S  + +        P F ++ 
Sbjct: 251 --GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 59.4 bits (143), Expect = 1e-11
 Identities = 18/120 (15%), Positives = 38/120 (31%), Gaps = 24/120 (20%)

Query: 16  YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL 75
            ++ E +D      +R                ++  + + VA  +  GI+H DL  +N+L
Sbjct: 86  AVLMELIDAKELYRVRVENP----------DEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135

Query: 76  MDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTHYSTAVDMWSV 131
           +      + I D   +        +         +  ++           Y T  D+ S 
Sbjct: 136 VSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSA 185

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	235
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.44
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.17
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	91.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	89.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	88.5
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	80.52

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=307.50  Aligned_cols=225  Identities=39%  Similarity=0.734  Sum_probs=189.5

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ...+.+++++++|+||||+.|++...+.   .....+++..++.++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus        64 ~~~~~~~~~~~~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~  139 (299)
T d1ua2a_          64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VL  139 (299)
T ss_dssp             CEEEEECCTTCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CE
T ss_pred             EEEeeeccCCceeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-cc
Confidence            4455667778899999999975544443   3356799999999999999999999999999999999999999777 99


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||.++.............+|+.|+|||++.....++.++||||+||++|+|++|..||.+....+.+..+.+..+.
T Consensus       140 KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~  219 (299)
T d1ua2a_         140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  219 (299)
T ss_dssp             EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence            99999999877655555556678999999999977666899999999999999999999999999999999999999988


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +....+....+......................++++++||++||+.||.+|||++|+|+||||++...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            888877766655544444444445555566688999999999999999999999999999999997653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=301.23  Aligned_cols=226  Identities=56%  Similarity=1.052  Sum_probs=190.4

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..++.++++.++|+||||+.|++.+++..  .....+++..++.++.|++.||+|||++|++||||||+||+++.++ .+
T Consensus        65 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~  141 (298)
T d1gz8a_          65 KLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AI  141 (298)
T ss_dssp             CEEEEEEETTEEEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CE
T ss_pred             EeccccccccceeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cc
Confidence            44556677889999999999988887766  3445699999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||.++....+........+|+.|+|||.+.....++.++|+||+||++|+|++|..||.+.+..+....+....+.
T Consensus       142 kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         142 KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             EECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             eeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999999877665555666788999999999887776789999999999999999999999999988888888888888


Q ss_pred             CCCCCccccccccccc-CCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          164 PNEKVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      +....+.......... ....+.........+.+++++++||++||..||.+|||++|+++||||++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            8877776654433322 22233334445566688999999999999999999999999999999998865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=304.53  Aligned_cols=198  Identities=26%  Similarity=0.468  Sum_probs=163.7

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++.+++++.+|+|||||+| +|.+++...    +.+++..++.++.|++.||+|||++|++||||||+||+++.++ .
T Consensus        72 ~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~  146 (288)
T d1uu3a_          72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-H  146 (288)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-C
T ss_pred             EEEEEEEECCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-e
Confidence            345566778899999999985 999998763    4699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++++|||+++......  .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+...++.+.
T Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~  225 (288)
T d1uu3a_         147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL  225 (288)
T ss_dssp             EEECCCTTCEECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred             EEecccccceecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC
Confidence            9999999998664332  2234557899999999998765 899999999999999999999999988877766655431


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK------AMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------ll~hp~f~~~~~~~  234 (235)
                      ...                            ....+++++++||++||+.||.+|||++|      +++||||++++|++
T Consensus       226 ~~~----------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         226 EYD----------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             CCC----------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             CCC----------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence            000                            01247899999999999999999999998      58899999999987


Q ss_pred             C
Q 026660          235 L  235 (235)
Q Consensus       235 ~  235 (235)
                      |
T Consensus       278 l  278 (288)
T d1uu3a_         278 L  278 (288)
T ss_dssp             G
T ss_pred             h
Confidence            5

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=300.87  Aligned_cols=194  Identities=22%  Similarity=0.354  Sum_probs=163.2

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++.+++++++|+|||||+| +|.+++.+     +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        81 ~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~  154 (293)
T d1yhwa1          81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-S  154 (293)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-C
T ss_pred             eEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-c
Confidence            344556677889999999985 99988765     3699999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+..........
T Consensus       155 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~  233 (293)
T d1yhwa1         155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (293)
T ss_dssp             EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             EeeccchhheeeccccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999999987765555556678999999999997654 78999999999999999999999998887776665544311


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .. ..                        ....++++++++|++||+.||.+|||++|+++||||+.
T Consensus       234 ~~-~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         234 PE-LQ------------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CC-CS------------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CC-CC------------------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            11 00                        01247889999999999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=297.67  Aligned_cols=190  Identities=25%  Similarity=0.429  Sum_probs=160.5

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++..++++.+|+|||||+| +|.+++.+.    +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        70 ~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~  144 (263)
T d2j4za1          70 RLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-E  144 (263)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-C
T ss_pred             eEEEEEEECCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-C
Confidence            445666788899999999985 999999763    4699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||++.....  .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+.+...
T Consensus       145 ~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~  221 (263)
T d2j4za1         145 LKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF  221 (263)
T ss_dssp             EEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred             EeecccceeeecCC--CcccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999999976543  2334567899999999998755 78999999999999999999999988877666655443110


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      .                            ....++++++++|++||+.||.+|||++|+++||||++
T Consensus       222 ~----------------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 T----------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             C----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             C----------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            0                            01247889999999999999999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=304.33  Aligned_cols=196  Identities=23%  Similarity=0.320  Sum_probs=167.9

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      .....+++++++|+|||||+| +|.+++.+    .+.++++.++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        69 ~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~  143 (337)
T d1o6la_          69 ALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-H  143 (337)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-C
T ss_pred             EEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-C
Confidence            455667888999999999985 99999877    34699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+....+.....
T Consensus       144 vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~  222 (337)
T d1o6la_         144 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI  222 (337)
T ss_dssp             EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEEeecccccccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC
Confidence            99999999987655545556678999999999997665 79999999999999999999999999887766655543210


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  233 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~  233 (235)
                      .                            ....+|+++++||++||+.||.+|++     ++++++||||++++|+
T Consensus       223 ~----------------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         223 R----------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             C----------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             C----------------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence            0                            01247899999999999999999994     8999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=299.71  Aligned_cols=196  Identities=29%  Similarity=0.449  Sum_probs=157.5

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++.+++++.+|+|||||+| +|.+++.+    ...++++.++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        67 ~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~  141 (271)
T d1nvra_          67 KFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-N  141 (271)
T ss_dssp             CEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-C
T ss_pred             eEeeeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-C
Confidence            445566778899999999985 99988843    45799999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||+++......  .......||+.|+|||++.+...++.++||||+||++|+|++|..||...............
T Consensus       142 ~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~  221 (271)
T d1nvra_         142 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE  221 (271)
T ss_dssp             EEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT
T ss_pred             EEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence            9999999998654332  23445678999999999987665578899999999999999999999765443222222211


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...                         .......++++++++|++||+.||.+|||++|+++||||+.
T Consensus       222 ~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         222 KKT-------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             TCT-------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CCC-------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            000                         00111247889999999999999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-47  Score=296.86  Aligned_cols=225  Identities=42%  Similarity=0.777  Sum_probs=180.9

Q ss_pred             cccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ++.....+...++|++|||+++++..+...  .....++++.++.++.|++.||+|||+++++||||||+|||++..+ .
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~  154 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-Q  154 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-C
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-C
Confidence            333444567789999999999866665554  3456799999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++++|||.+...... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+....+
T Consensus       155 ~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  232 (305)
T d1blxa_         155 IKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  232 (305)
T ss_dssp             EEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence            999999998754322 3345668899999999997655 89999999999999999999999999999999999988888


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .+....++........ ................+++++++||++||+.||.+|||++|+++||||+++++-
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CCCGGGSCTTCSSCGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CCchhcccccccchhh-hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            8776655443222111 111222223334455788999999999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=296.51  Aligned_cols=189  Identities=27%  Similarity=0.404  Sum_probs=147.7

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCcEEEcCCCCeE
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-----ILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~di~~~nil~~~~~~~~   83 (235)
                      ++++.+|+|||||+ |+|.+++.+..+.+..+++..++.++.||+.||+|||+++     ++||||||+||+++.++ .+
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~v  153 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NV  153 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cE
Confidence            55677999999998 4999999887777788999999999999999999999976     99999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +|+|||+++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus       154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~  232 (269)
T d2java1         154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  232 (269)
T ss_dssp             EECCHHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred             EEeeccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999999987765544455678899999999997654 899999999999999999999999988776666555432110


Q ss_pred             CCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  227 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f  227 (235)
                                                 .....+++++.++|++||+.||.+|||++|+++|||+
T Consensus       233 ---------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 ---------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                       0112478999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=297.67  Aligned_cols=197  Identities=20%  Similarity=0.313  Sum_probs=160.9

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ...+..++++.+|+|||||+| +|.+++.+.   .+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .
T Consensus        73 ~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~  148 (288)
T d2jfla1          73 KLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-D  148 (288)
T ss_dssp             CEEEEEEETTEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-C
T ss_pred             eEEEEEeeCCeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-C
Confidence            345556677889999999985 999988763   34699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                      ++|+|||++..............||+.|+|||++..    ...++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus       149 ~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~  228 (288)
T d2jfla1         149 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA  228 (288)
T ss_dssp             EEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             EEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            999999998765433333445678999999999852    3347899999999999999999999999877766665554


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ....  +.                       ......+++++++||++||+.||.+|||++|+++||||+.
T Consensus       229 ~~~~--~~-----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         229 KSEP--PT-----------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HSCC--CC-----------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             cCCC--CC-----------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            3210  00                       0011247899999999999999999999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-47  Score=296.53  Aligned_cols=196  Identities=26%  Similarity=0.408  Sum_probs=151.2

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--CC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KT   80 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~~   80 (235)
                      +..+.+++++.+|+|||||+ |+|.+++.+    .+.++++.+..++.||+.||+|||++|++||||||+||++..  .+
T Consensus        71 ~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~  146 (307)
T d1a06a_          71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED  146 (307)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT
T ss_pred             cEEEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCC
Confidence            44566778889999999998 599999965    457999999999999999999999999999999999999953  23


Q ss_pred             CeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           81 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        81 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ..++++|||+++..... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+...
T Consensus       147 ~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~  224 (307)
T d1a06a_         147 SKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA  224 (307)
T ss_dssp             CCEEECCC-------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT
T ss_pred             ceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence            38999999999765433 2334567899999999997655 899999999999999999999999988877766665542


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ....+.                        ....++|++++++|++||+.||.+|||++|+++||||++
T Consensus       225 ~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         225 EYEFDS------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             CCCCCT------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCCCC------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            111111                        112358899999999999999999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=300.00  Aligned_cols=197  Identities=29%  Similarity=0.455  Sum_probs=168.2

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..++.+++++.+|+|||||+| +|.+++...    ..+++..++.++.||+.||+|||+++++||||||+||+++..+ .
T Consensus        67 ~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~  141 (320)
T d1xjda_          67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-H  141 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-C
T ss_pred             EEEEEEccCCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-c
Confidence            445567788899999999985 999999763    4689999999999999999999999999999999999999776 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++++|||.++.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+...  
T Consensus       142 ~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--  218 (320)
T d1xjda_         142 IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--  218 (320)
T ss_dssp             EEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred             eeccccchhhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--
Confidence            99999999987665555566678899999999998655 889999999999999999999999988877766665431  


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~hp~f~~~~~~~  234 (235)
                      .+.                          ....+++++++||++||..||.+|||+. ++++||||++++|+.
T Consensus       219 ~~~--------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~  265 (320)
T d1xjda_         219 NPF--------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  265 (320)
T ss_dssp             CCC--------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             CCC--------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence            110                          0124789999999999999999999996 899999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-47  Score=304.15  Aligned_cols=199  Identities=26%  Similarity=0.362  Sum_probs=161.7

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ...+.+++++.+|+|||||+ |+|.+++.+.    ..+++..++.++.||+.||+|||++|++||||||+|||++.++ .
T Consensus        71 ~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~  145 (364)
T d1omwa3          71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-H  145 (364)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-C
T ss_pred             EEEEEEEECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-c
Confidence            34456677889999999998 5999999763    4689999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.....  ......||+.|+|||++.....++.++||||+||++|+|++|..||.......... +.....
T Consensus       146 iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~  222 (364)
T d1omwa3         146 VRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL  222 (364)
T ss_dssp             EEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSS
T ss_pred             EEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcc
Confidence            999999999866533  33456789999999999765568999999999999999999999997654322222 111111


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ll~hp~f~~~~~~~  234 (235)
                      ....                        .....+++++++||++||..||.+|||     ++++++||||++++|+.
T Consensus       223 ~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         223 TMAV------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             SCCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred             cCCC------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence            1110                        011257899999999999999999999     79999999999998853

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-46  Score=296.00  Aligned_cols=194  Identities=23%  Similarity=0.432  Sum_probs=165.1

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++.+++++.+|+|||||.| +|..++..    ...++++.++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        68 ~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~  142 (316)
T d1fota_          68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-H  142 (316)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-C
T ss_pred             heeeeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-C
Confidence            445566788899999999985 98888876    45689999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.....   .....||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus       143 vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~  218 (316)
T d1fota_         143 IKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL  218 (316)
T ss_dssp             EEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred             EEEecCccceEeccc---cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence            999999999776432   34567899999999987654 78999999999999999999999999888777766654211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .                            ..+.++++++++|++||..||.+|+     |++++++||||++++|+.
T Consensus       219 ~----------------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         219 R----------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             C----------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             C----------------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence            0                            1124788999999999999999996     999999999999998864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=292.88  Aligned_cols=202  Identities=23%  Similarity=0.401  Sum_probs=163.9

Q ss_pred             cccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            3 VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         3 ~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      |+.++.+++++.+|+|||||+| +|.+++...    +.+++..++.++.|++.||+|||+++++||||||+||+++..+.
T Consensus        76 v~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          76 ITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             CCEEEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS
T ss_pred             CcEEEEEEECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC
Confidence            3455667888999999999985 999999763    46999999999999999999999999999999999999986653


Q ss_pred             ---eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026660           82 ---TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  158 (235)
Q Consensus        82 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  158 (235)
                         .++++|||++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus       152 ~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~  229 (293)
T d1jksa_         152 PKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS  229 (293)
T ss_dssp             SSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence               5999999999766433 3344557789999999997654 8999999999999999999999999888777666554


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcCC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~~  234 (235)
                      .....                        ......+++|+++++||++||+.||.+|||++|+++||||++.++++
T Consensus       230 ~~~~~------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         230 AVNYE------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             TTCCC------------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             hcCCC------------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence            32110                        01112235789999999999999999999999999999999888764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5e-46  Score=287.75  Aligned_cols=197  Identities=26%  Similarity=0.422  Sum_probs=164.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +..+.+++++++|+|||||+| ||.+++...    +.++++.++.++.||+.||+|||++|++||||||+||+++.++ .
T Consensus        74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~  148 (277)
T d1phka_          74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-N  148 (277)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-C
T ss_pred             EEEeecccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-C
Confidence            455667788999999999975 999999762    4699999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  157 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  157 (235)
                      ++|+|||++...... .......||..|+|||.+.+     ...++.++||||+||++|+|++|..||.+.+.......+
T Consensus       149 ~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i  227 (277)
T d1phka_         149 IKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  227 (277)
T ss_dssp             EEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence            999999999876543 23345678999999999863     334678999999999999999999999998877766666


Q ss_pred             HHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          158 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .........                        ....++|++++++|++||+.||.+|||++|+++||||+.+
T Consensus       228 ~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         228 MSGNYQFGS------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHTCCCCCT------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HhCCCCCCC------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            543211111                        1122588999999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-46  Score=298.24  Aligned_cols=201  Identities=24%  Similarity=0.433  Sum_probs=165.6

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~   81 (235)
                      ...+.+++++.+|+|||||+| +|.+++.+   ..+.+++..++.++.||+.||+|||++|++||||||+||+++.+ +.
T Consensus        87 ~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~  163 (350)
T d1koaa2          87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN  163 (350)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC
T ss_pred             cEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC
Confidence            445566778899999999985 99999854   23569999999999999999999999999999999999999643 33


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||+++..... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+....
T Consensus       164 ~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  241 (350)
T d1koaa2         164 ELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  241 (350)
T ss_dssp             CEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             eEEEeecchheecccc-cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            7999999999766533 3344567899999999998755 7899999999999999999999999888877777665432


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                      .....                        ....++++++++||++||+.||.+|||++|+++||||+..++.
T Consensus       242 ~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         242 WNMDD------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             CCSCC------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             CCCCc------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            21111                        1122478899999999999999999999999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=285.80  Aligned_cols=186  Identities=26%  Similarity=0.386  Sum_probs=150.4

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEcCCCCeEEEe
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~--~~H~di~~~nil~~~~~~~~~l~   86 (235)
                      +++..+|+|||||+| +|.+++.+.    ..++++.++.++.||+.||+|||+++  ++||||||+||+++..+..++|+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence            456789999999985 999999763    46999999999999999999999998  99999999999997544489999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||+++....  .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.............  ....
T Consensus       158 DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~~  231 (270)
T d1t4ha_         158 DLGLATLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKP  231 (270)
T ss_dssp             CTTGGGGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCCC
T ss_pred             ecCcceeccC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCCC
Confidence            9999975432  23345678999999999864  3899999999999999999999999876544443322211  0000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  228 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~  228 (235)
                                             .......+++++++|++||+.||.+|||++|+++||||+
T Consensus       232 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                   011124678899999999999999999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=295.14  Aligned_cols=222  Identities=33%  Similarity=0.661  Sum_probs=178.8

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .++..++|+|||||++++.+.+.........+++..++.++.||+.||+|||++|++||||||+|||++.++..++|+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence            35677899999999988888777766677789999999999999999999999999999999999999977668999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |++...... .......++..|+|||.+.+...++.++||||+||++|+|++|..||......+.+..+....+.+....
T Consensus       168 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         168 GSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             TTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            999766433 2334457899999999988766689999999999999999999999999998888888888877776554


Q ss_pred             cccccccccccCCCCCCccc-hhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQS-LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      +................... ........++++.+||++||..||.+|||+.|+|+||||+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            44333222222222221111 1223346889999999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5e-46  Score=296.66  Aligned_cols=198  Identities=25%  Similarity=0.442  Sum_probs=164.0

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC-CCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~-~~~   81 (235)
                      ..++.+++++.+|+|||||+| +|.+++.+   .+..+++..++.++.||+.||+|||++|++||||||+|||++. ...
T Consensus        90 ~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~  166 (352)
T d1koba_          90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS  166 (352)
T ss_dssp             CEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC
T ss_pred             cEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC
Confidence            445667788999999999985 99887644   3456999999999999999999999999999999999999973 233


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++|+|||++...... .......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+....
T Consensus       167 ~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  244 (352)
T d1koba_         167 SVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD  244 (352)
T ss_dssp             CEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred             eEEEeecccceecCCC-CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            8999999999876543 3344567799999999997655 8999999999999999999999999988887777666532


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ...+..                        ...++++++++||++||+.||.+|||+.|+++||||+..
T Consensus       245 ~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         245 WEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            221111                        123578999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=300.81  Aligned_cols=223  Identities=21%  Similarity=0.306  Sum_probs=157.1

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~   81 (235)
                      +..+.++++.++|+|||||.| +|.+++.+.    +.+++..++.++.|++.||.|||+ +|++||||||+|||++.++ 
T Consensus        68 ~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-  142 (322)
T d1s9ja_          68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-  142 (322)
T ss_dssp             CEEEEEECSSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-
T ss_pred             cEEEEEEECCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-
Confidence            445666778889999999985 999999763    469999999999999999999997 5999999999999999777 


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRL  160 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~  160 (235)
                      .++|+|||++......  ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+.... ....
T Consensus       143 ~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  219 (322)
T d1s9ja_         143 EIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  219 (322)
T ss_dssp             CEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred             CEEEeeCCCccccCCC--ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            8999999999765432  234558899999999998755 89999999999999999999999987554322111 1111


Q ss_pred             hCCCCCC----Ccccccc-cccccCCCCCCccc----------hhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 026660          161 LGTPNEK----VWPGVSS-LMNWHEYPQWNPQS----------LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  225 (235)
Q Consensus       161 ~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp  225 (235)
                      .+.....    ....... ..............          .......+|.+++++|++||..||.+|||++|+|+||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence            1110000    0000000 00000000000000          0001124678999999999999999999999999999


Q ss_pred             CCCCCCcCC
Q 026660          226 YFDDLDKTR  234 (235)
Q Consensus       226 ~f~~~~~~~  234 (235)
                      ||++.++++
T Consensus       300 f~~~~~~~~  308 (322)
T d1s9ja_         300 FIKRSDAEE  308 (322)
T ss_dssp             HHHHHHHSC
T ss_pred             hhCcCCccc
Confidence            998766654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.7e-45  Score=285.75  Aligned_cols=222  Identities=52%  Similarity=0.938  Sum_probs=177.8

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ..+..+.+++..|+++|++.+++...+..   ..+.+++..++.++.||+.||+|||+.+++||||||+||+++.++ .+
T Consensus        64 ~~~~~~~~~~~~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~  139 (286)
T d1ob3a_          64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-EL  139 (286)
T ss_dssp             CEEEEEECSSCEEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CE
T ss_pred             eeeeecccCCceeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CE
Confidence            34555677788999999999866665543   346799999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  163 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  163 (235)
                      +++|||.+.....+........+++.|+|||.+.+...++.++|+||+||++++|++|+.||.+.+..+...++....+.
T Consensus       140 kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (286)
T d1ob3a_         140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (286)
T ss_dssp             EECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999999876655444555567899999999987776899999999999999999999999999988888888888888


Q ss_pred             CCCCCcccccccccccC-CCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          164 PNEKVWPGVSSLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       164 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      +....+........... ................++++++||++||+.||++|||++|+++||||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            88777766544333221 1222223334445578899999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-46  Score=296.39  Aligned_cols=194  Identities=25%  Similarity=0.349  Sum_probs=165.1

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ...+.+++.+.+|+||||+.| +|..++.+.    +.+++..++.++.||+.||.|||+++++||||||+|||++.++ .
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~  179 (350)
T d1rdqe_         105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-Y  179 (350)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-C
T ss_pred             ecccccccccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-C
Confidence            445566778889999999985 999999763    4699999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  162 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  162 (235)
                      ++|+|||+++.....   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       180 ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~  255 (350)
T d1rdqe_         180 IQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV  255 (350)
T ss_dssp             EEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             EEeeeceeeeecccc---cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Confidence            999999999876532   33457899999999998655 78999999999999999999999998887777666654211


Q ss_pred             CCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      ..                            ...+++++.++|++||..||.+|+     |++++++||||++++|+.
T Consensus       256 ~~----------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~  304 (350)
T d1rdqe_         256 RF----------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             CC----------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             CC----------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHH
Confidence            10                            124789999999999999999994     999999999999998853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-45  Score=290.01  Aligned_cols=192  Identities=20%  Similarity=0.293  Sum_probs=157.2

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +..+.+.+++.+|+|||||.| +|..++..    .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .
T Consensus        79 ~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~  153 (309)
T d1u5ra_          79 QYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-L  153 (309)
T ss_dssp             CEEEEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-E
T ss_pred             eEEEEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-C
Confidence            445556677889999999986 66544433    35799999999999999999999999999999999999999776 9


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||++.....    .....||+.|+|||++.+  ...++.++||||+||++|+|++|..||.+....+....+...
T Consensus       154 ~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~  229 (309)
T d1u5ra_         154 VKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  229 (309)
T ss_dssp             EEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             EEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            99999999976542    234578999999999864  234789999999999999999999999988877766655542


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      ....                          .....+++++++||++||+.||.+|||++|+++||||..-
T Consensus       230 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         230 ESPA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CCCC--------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCC--------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            1110                          0112478999999999999999999999999999999753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=286.65  Aligned_cols=214  Identities=39%  Similarity=0.695  Sum_probs=173.8

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      +...++|+||||++++|..++.+     ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .++++|||
T Consensus        93 ~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg  166 (346)
T d1cm8a_          93 DDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFG  166 (346)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCT
T ss_pred             cccceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-cccccccc
Confidence            45567899999998888887754     4699999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           90 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      .++....   ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+....+.......+.++...+
T Consensus       167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            9976543   3345678999999999987666789999999999999999999999999998888888887777665443


Q ss_pred             cccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCc
Q 026660          170 PGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  232 (235)
Q Consensus       170 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~  232 (235)
                      ........   .................+.++++++||++||..||.+|||++|+|+||||+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            32211100   0111222233344455678999999999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=282.43  Aligned_cols=188  Identities=24%  Similarity=0.362  Sum_probs=155.2

Q ss_pred             ccCCcCCCceEEEEEEecCc--cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~   81 (235)
                      +.++.+++++..|+||||+.  +++.+++.+    ...++++.++.++.||+.||+|||++|++||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          73 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred             EEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC
Confidence            45566778889999999996  388888876    246999999999999999999999999999999999999986655


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||+++....  .......||+.|+|||++.+...++.++||||+||++|+|++|..||.....      +... 
T Consensus       149 ~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~-  219 (273)
T d1xwsa_         149 ELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-  219 (273)
T ss_dssp             EEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-
T ss_pred             eEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc-
Confidence            899999999976543  3345567899999999998766567889999999999999999999976321      1110 


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                       ..                          .....+|++++++|++||+.||.+|||++|+++||||+++.
T Consensus       220 -~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -QV--------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -CC--------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -cc--------------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence             00                          01124789999999999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=292.78  Aligned_cols=197  Identities=25%  Similarity=0.422  Sum_probs=152.1

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCC--CeEEEe
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIA   86 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~--~~~~l~   86 (235)
                      ..+.++|+|||||+ |||.+++.+  .....+++..++.++.||+.||+|||++|++||||||+||+++..+  ..++++
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence            34688999999998 599999976  3345699999999999999999999999999999999999998532  369999


Q ss_pred             ecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           87 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        87 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      |||+++..... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+....+....+.........
T Consensus       157 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~  234 (335)
T d2ozaa1         157 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  234 (335)
T ss_dssp             CCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred             ccceeeeccCC-CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence            99999766543 3345567899999999987554 889999999999999999999999765543333322211110000


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      .                .+    ......+++++++||++||+.||.+|||+.|+++||||++.
T Consensus       235 ~----------------~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         235 E----------------FP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             S----------------CC----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             C----------------CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            0                00    01112478999999999999999999999999999999643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=285.88  Aligned_cols=197  Identities=24%  Similarity=0.429  Sum_probs=162.5

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC-CC
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TM   81 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~-~~   81 (235)
                      +.++.+++++++|+|||||+| +|.+++..   .+..++++.++.++.||+.||+|||++|++||||||+||+++.+ ..
T Consensus        65 ~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~  141 (321)
T d1tkia_          65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS  141 (321)
T ss_dssp             CEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred             eEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCce
Confidence            455667788899999999985 99999864   23469999999999999999999999999999999999999753 23


Q ss_pred             eEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           82 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      .++++|||++...... .......+++.|+|||...+.. ++.++||||+||++|+|++|..||.+.+..+....+.+..
T Consensus       142 ~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~  219 (321)
T d1tkia_         142 TIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             CEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             EEEEcccchhhccccC-CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            7899999999766432 2234456789999999987655 8899999999999999999999999988877777766531


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...                        .....+.+++++++||++||..||.+|||++|+++||||+.
T Consensus       220 ~~~------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         220 YTF------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CCC------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CCC------------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            111                        11222357899999999999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=271.86  Aligned_cols=222  Identities=45%  Similarity=0.848  Sum_probs=176.3

Q ss_pred             cCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            5 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      ....+.+..+.++++|++.| +|..++..    .+.+++..++.++.|++.||+|||++|++||||||+||+++..+ .+
T Consensus        66 ~~~~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~  140 (292)
T d1unla_          66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-EL  140 (292)
T ss_dssp             EEEEEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CE
T ss_pred             eccccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ce
Confidence            34456777889999999987 66555543    45789999999999999999999999999999999999999776 89


Q ss_pred             EEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhC
Q 026660           84 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP-GDSELQQLLHIFRLLG  162 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~  162 (235)
                      +++|||.++.............++..|.|||.+.....++.++||||+||++++|++|+.||. +.+..+....+.....
T Consensus       141 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  220 (292)
T d1unla_         141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             EECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             eeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence            999999998776655555556678889999998876667899999999999999999999864 5566667777777777


Q ss_pred             CCCCCCcccccccccccCCCCCC-ccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          163 TPNEKVWPGVSSLMNWHEYPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .+....+................ ..........+++++++||++||..||.+|||++|+|+||||+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            77766655544433322222111 1223344457889999999999999999999999999999999764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=279.93  Aligned_cols=222  Identities=36%  Similarity=0.677  Sum_probs=171.6

Q ss_pred             ccCCcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeE
Q 026660            4 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL   83 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~   83 (235)
                      +.........++|+++++++|||.+++..     +.+++..++.++.|++.||+|||++|++||||||+||+++.++ .+
T Consensus        75 ~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~  148 (345)
T d1pmea_          75 IRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DL  148 (345)
T ss_dssp             ECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CE
T ss_pred             EeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CE
Confidence            33344555567888888877899999975     3699999999999999999999999999999999999999777 89


Q ss_pred             EEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           84 KIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        84 ~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      +|+|||++........   ......+|+.|+|||++.....++.++||||+||++|+|++|..||.+....+........
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~  228 (345)
T d1pmea_         149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  228 (345)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence            9999999875533211   2345568999999999876666889999999999999999999999998887777777766


Q ss_pred             hCCCCCCCcccccccc---cccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          161 LGTPNEKVWPGVSSLM---NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      ...+............   .................++.++++++||++||..||.+|||++|+|+||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence            6655533221111000   0001112222333445567889999999999999999999999999999998553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-43  Score=280.68  Aligned_cols=216  Identities=29%  Similarity=0.620  Sum_probs=159.4

Q ss_pred             CCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      +.+..+|+|||||++ +|..+.       +.+++..++.++.||+.||+|||++|++||||||+|||++.++..++++||
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred             cCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccc
Confidence            456779999999985 876542       359999999999999999999999999999999999999877657999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCC-
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNE-  166 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-  166 (235)
                      |.++..... .......+|+.|+|||.+.+...++.++||||+||+++++++|..||.... .......+....+.+.. 
T Consensus       175 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         175 GLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             GGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             ccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            999766533 334555779999999999877768999999999999999999999997654 34444444433332110 


Q ss_pred             --------CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCcC
Q 026660          167 --------KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  233 (235)
Q Consensus       167 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~~~  233 (235)
                              .................+...........+++++++||++||..||.+|||++|+|+||||+++.|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                    0001111000000000000011111222478899999999999999999999999999999999885

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=274.37  Aligned_cols=216  Identities=35%  Similarity=0.675  Sum_probs=164.3

Q ss_pred             CCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           10 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        10 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ..++++|+||||+++++.....   .....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++++|||
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg  162 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG  162 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecc
Confidence            3456799999999976655443   3445789999999999999999999999999999999999999777 89999999


Q ss_pred             CcccccCCC----CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           90 LARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        90 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      ++.......    .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.........+.+..+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            997554322    1223346799999999998766689999999999999999999999999999888888888888877


Q ss_pred             CCCcccccccccccCCCCCCcc--chh--hcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQ--SLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  229 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~  229 (235)
                      ...+..................  ...  ......++++++||++||+.||++|||++|+++||||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            6655544332222111111110  000  001124678899999999999999999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-43  Score=276.37  Aligned_cols=193  Identities=23%  Similarity=0.331  Sum_probs=153.4

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ-------------------TGENIPVNTVKSLMYQLCKGVAFCHGHG   63 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~   63 (235)
                      ..++..++.+.+|+|||||+ |+|.+++.+...                   ....+++..++.++.|++.||+|||+++
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44556677888999999998 599999976321                   1235899999999999999999999999


Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-  140 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-  140 (235)
                      ++||||||+||+++.++ .++|+|||+++........  .....+|+.|+|||++.+.. ++.++||||+||++|+|++ 
T Consensus       185 IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             EEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTT
T ss_pred             eeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhC
Confidence            99999999999999776 9999999999765543332  23456789999999987655 8999999999999999997 


Q ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH
Q 026660          141 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK  220 (235)
Q Consensus       141 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  220 (235)
                      |..||.+....+....+......++                          ....+++++++||++||+.||.+|||++|
T Consensus       263 g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~e  316 (325)
T d1rjba_         263 GVNPYPGIPVDANFYKLIQNGFKMD--------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPN  316 (325)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCC--------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            8999987665555544443211110                          11247889999999999999999999999


Q ss_pred             HhCC
Q 026660          221 AMEH  224 (235)
Q Consensus       221 ll~h  224 (235)
                      |++|
T Consensus       317 i~~~  320 (325)
T d1rjba_         317 LTSF  320 (325)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=267.24  Aligned_cols=187  Identities=20%  Similarity=0.292  Sum_probs=145.9

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      +..+|+|||||+ |+|.+++..   ....+++..+..++.||+.||+|||+++++||||||+|||++.++ .++|+|||+
T Consensus        75 ~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGl  150 (276)
T d1uwha_          75 APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGL  150 (276)
T ss_dssp             SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCC
T ss_pred             ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccc
Confidence            445899999998 599999975   234699999999999999999999999999999999999999776 899999999


Q ss_pred             cccccCCC--CCcccccccccccCchhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           91 ARAFTLPI--KKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        91 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      ++......  .......||+.|+|||++.+.  ..++.++||||+||++|+|++|..||.+.................  
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--  228 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--  228 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC--
T ss_pred             eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--
Confidence            97654322  233456789999999998643  347899999999999999999999998866555544443321111  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                          ........++++++.++|.+||+.||.+|||+++++++
T Consensus       229 --------------------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 --------------------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                11122233578999999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=276.49  Aligned_cols=202  Identities=24%  Similarity=0.382  Sum_probs=160.1

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.+...++++.+|++|||+.| +|.+++...    +.+++..++.++.||+.||+|||+++++|+||||+||+++.++ .
T Consensus        93 ~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~  167 (322)
T d1vzoa_          93 TLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-H  167 (322)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-C
T ss_pred             EeeeeeccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-C
Confidence            445667778899999999985 999999773    3578999999999999999999999999999999999999777 8


Q ss_pred             EEEeecCCcccccCC-CCCcccccccccccCchhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||+++..... ........+++.|++||.+.+.. .++.++||||+||++|+|++|..||.+....+....+...
T Consensus       168 vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~  247 (322)
T d1vzoa_         168 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR  247 (322)
T ss_dssp             EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred             EEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999999765432 22344557789999999997543 4678999999999999999999999775543333333322


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCcCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  234 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~hp~f~~~~~~~  234 (235)
                      .......                        ....++++++++|++||+.||.+||     |++|+++||||++++|..
T Consensus       248 ~~~~~~~------------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~  302 (322)
T d1vzoa_         248 ILKSEPP------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  302 (322)
T ss_dssp             HHHCCCC------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             cccCCCC------------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence            1111000                        1125789999999999999999999     489999999999998754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=274.59  Aligned_cols=214  Identities=39%  Similarity=0.657  Sum_probs=166.3

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .++.+.+++++++++|+|.+++..     +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .++++||
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~df  165 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDF  165 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             cccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-ccccccc
Confidence            355566677766666799998843     4699999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.+.....   ......++..|+|||...+...++.++||||+||++|+|++|..||.+.+.......+.+....+....
T Consensus       166 g~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         166 GLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             ----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             chhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            99865432   234456788999999988776678999999999999999999999999998888888887776655433


Q ss_pred             ccccccccc---ccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 026660          169 WPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  231 (235)
Q Consensus       169 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~~  231 (235)
                      .........   .................+.++++++||++||..||.+|||++|+|+||||+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            222111100   011122233344455567899999999999999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-42  Score=266.28  Aligned_cols=182  Identities=21%  Similarity=0.344  Sum_probs=147.0

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..|+|||||+ |+|.+++.+    ...+++..++.++.||+.||+|||+++++||||||+||+++.++ .++++|||+++
T Consensus        81 ~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~  155 (277)
T d1xbba_          81 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSK  155 (277)
T ss_dssp             SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             CEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhh
Confidence            4689999998 599999876    45699999999999999999999999999999999999999777 99999999997


Q ss_pred             cccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           93 AFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        93 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      .......   ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.+....     
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-----  229 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  229 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             hccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6543322   223446788999999997655 7899999999999999997 89999988776655444321100     


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH---hCCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYFD  228 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~hp~f~  228 (235)
                                            .....+++++.++|.+||+.||.+|||++++   |+|+|++
T Consensus       230 ----------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 ----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                                  0112478899999999999999999999998   5677654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-41  Score=265.02  Aligned_cols=189  Identities=17%  Similarity=0.278  Sum_probs=143.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ...+...+++.+|+|||||+| +|.+++..   ..+.+++..+..++.||+.||+|||+++++||||||+|||++.++ .
T Consensus        91 ~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~  166 (299)
T d1jpaa_          91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-V  166 (299)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-C
T ss_pred             cEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-c
Confidence            344555667789999999984 99998865   344699999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCCC-----cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKK-----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  156 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  156 (235)
                      ++|+|||+++........     .....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....
T Consensus       167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~  245 (299)
T d1jpaa_         167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA  245 (299)
T ss_dssp             EEECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999765432221     12235688999999998655 8899999999999999998 8999998887666655


Q ss_pred             HHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      +......+                           ...++++++.+++++||+.||.+|||+.+++++
T Consensus       246 i~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         246 IEQDYRLP---------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCCC---------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            54321111                           112478899999999999999999999988653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-42  Score=273.89  Aligned_cols=213  Identities=36%  Similarity=0.605  Sum_probs=156.8

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      .+..+++|+|||||.|++.+.+.      ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++++||
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df  163 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDF  163 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             cccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeech
Confidence            36778999999999988777663      3589999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      |.++..... .......+|+.|+|||++.+.. ++.++||||+||++++|++|+.||.+.+.......+......+....
T Consensus       164 ~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             CC----------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhhhccccc-cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            988765533 2334556789999999997654 89999999999999999999999999988888888887777665544


Q ss_pred             cccccccccc--cCCCCCCccch------------hhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 026660          169 WPGVSSLMNW--HEYPQWNPQSL------------ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  230 (235)
Q Consensus       169 ~~~~~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~hp~f~~~  230 (235)
                      +.........  ...........            .......++++++||++||..||.+||||+|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            3322111000  00000000000            00011246788999999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-41  Score=262.87  Aligned_cols=190  Identities=19%  Similarity=0.291  Sum_probs=151.1

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +.++...+++.+|+|||||+ |+|.+++..  .....+++..++.++.|++.||+|||+++++||||||+|||++.++ .
T Consensus        77 ~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~  153 (287)
T d1opja_          77 QLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-L  153 (287)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-C
T ss_pred             cCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-c
Confidence            34555667788999999998 599999976  3456799999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 026660           83 LKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  161 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  161 (235)
                      ++|+|||+++....... ......+++.|+|||++.+.. ++.++||||+||++|+|++|..||....+...........
T Consensus       154 ~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~  232 (287)
T d1opja_         154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD  232 (287)
T ss_dssp             EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEEccccceeecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence            99999999986654322 233445688899999987655 8999999999999999999777765554444443333211


Q ss_pred             CCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          162 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ..+                          .....+++++.++|++||+.||.+|||++++++
T Consensus       233 ~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 YRM--------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC--------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            000                          011257889999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=259.44  Aligned_cols=189  Identities=20%  Similarity=0.321  Sum_probs=141.2

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..++...+++.+|+|||||+ |+|.+++.+   ....++++.+..++.|++.||+|||+++++||||||+||+++.++ .
T Consensus        64 ~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~  139 (263)
T d1sm2a_          64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-V  139 (263)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-C
T ss_pred             cccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-C
Confidence            34445566677999999998 599999875   235689999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|+|+++ ..||......+....+...
T Consensus       140 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~  218 (263)
T d1sm2a_         140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  218 (263)
T ss_dssp             EEECSCC------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred             eEecccchheeccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence            99999999976543322 223456789999999997655 89999999999999999995 5556555555555544432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ....                           .....++++.+++++||+.||.+|||++++++|
T Consensus       219 ~~~~---------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         219 FRLY---------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            1111                           011367899999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=263.64  Aligned_cols=182  Identities=23%  Similarity=0.331  Sum_probs=148.2

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .+|+|||||+ |+|.+++..   ....+++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||+++
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~  157 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSK  157 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhh
Confidence            4799999998 499998754   345699999999999999999999999999999999999999776 99999999998


Q ss_pred             cccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           93 AFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        93 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      .......   ......+|+.|+|||++.+.. ++.++||||+||++|++++ |..||.+....+....+......     
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-----  231 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----  231 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----
T ss_pred             cccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6654322   223446788999999987655 8999999999999999998 89999887766655544321110     


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHH---hCCCCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYF  227 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~hp~f  227 (235)
                                            ....++++++.++|++||+.||.+|||+.++   |+|+|+
T Consensus       232 ----------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 ----------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                                  1122578899999999999999999999887   567776

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-41  Score=262.90  Aligned_cols=188  Identities=23%  Similarity=0.385  Sum_probs=142.7

Q ss_pred             CCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEE
Q 026660            9 KEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL   75 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil   75 (235)
                      .+++..+++|||||+ |+|.+++.....            ....+++..++.++.||+.||+|||+++++||||||+||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            445667899999998 599999987432            1345899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 026660           76 MDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQ  152 (235)
Q Consensus        76 ~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~  152 (235)
                      ++.++ .++|+|||+++.......  ......||+.|+|||++.+.. ++.++||||+||++|+|++| ..||.+....+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99776 899999999976543322  334567899999999998655 89999999999999999986 45777655444


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...........+.                          ....++++++++|++||+.||.+|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC--------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433332211110                          112477899999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-41  Score=255.47  Aligned_cols=189  Identities=17%  Similarity=0.288  Sum_probs=154.3

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      +..+...+++.+++||||++ |+|..++...   ...++++.+++++.|++.||+|||++|++|+||||+||+++.++ .
T Consensus        63 ~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~  138 (258)
T d1k2pa_          63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-V  138 (258)
T ss_dssp             CEEEEECCSSSEEEEEECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-C
T ss_pred             eEEEEEeeCCceEEEEEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-c
Confidence            34455567788999999997 6999887652   34689999999999999999999999999999999999999776 8


Q ss_pred             EEEeecCCcccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  160 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  160 (235)
                      ++|+|||+++....... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..||.+....+....+...
T Consensus       139 ~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~  217 (258)
T d1k2pa_         139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG  217 (258)
T ss_dssp             EEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            99999999976544322 233456789999999998655 7899999999999999998 89999988877766555432


Q ss_pred             hCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          161 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ...+                           .....++++.++|++||+.||.+|||++++++|
T Consensus       218 ~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         218 LRLY---------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CCCC---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---------------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            1111                           111467899999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=261.77  Aligned_cols=186  Identities=23%  Similarity=0.417  Sum_probs=147.3

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+|+||||++ |+|.+++...  .+..+++..++.++.||+.||.|||+++++||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla  156 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLA  156 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccce
Confidence            45699999998 5999987653  233589999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +....... ......+|+.|+|||++.+.. ++.++||||+||++|+|++|..| +......+....+......+     
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-----  230 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-----  230 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----
T ss_pred             EEccCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence            87653322 234456788999999987655 88999999999999999996555 45555544444433211100     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDD  229 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--hp~f~~  229 (235)
                                            ....+++++.+++++||+.||.+|||++++++  |+||.+
T Consensus       231 ----------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 ----------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                  11247889999999999999999999999998  788753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.3e-40  Score=254.43  Aligned_cols=185  Identities=25%  Similarity=0.428  Sum_probs=142.4

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      ....+|+||||++| +|.+++...    +.++++.++.++.||+.||+|||++|++||||||+||+++..+ ..+++|||
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~  156 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFG  156 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCT
T ss_pred             CCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhh
Confidence            44568999999985 999988763    4699999999999999999999999999999999999999776 89999999


Q ss_pred             CcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCC
Q 026660           90 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  166 (235)
Q Consensus        90 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  166 (235)
                      .+........   ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+...........+  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--  233 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--  233 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC--
Confidence            8865443322   334557899999999987654 8899999999999999999999999888777665554321111  


Q ss_pred             CCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCC-CHHHHhCCCC
Q 026660          167 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAMEHPY  226 (235)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~ll~hp~  226 (235)
                                            ......++|+++.++|++||+.||.+|| |+++++ |+|
T Consensus       234 ----------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l  271 (277)
T d1o6ya_         234 ----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADL  271 (277)
T ss_dssp             ----------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred             ----------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence                                  1122335889999999999999999999 566554 444

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=256.02  Aligned_cols=188  Identities=26%  Similarity=0.413  Sum_probs=144.5

Q ss_pred             eEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           13 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        13 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      +.+++|||||. |+|..++...  ....+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchh
Confidence            34689999998 5999888763  334699999999999999999999999999999999999999776 8999999999


Q ss_pred             ccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCCCCc
Q 026660           92 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNEKVW  169 (235)
Q Consensus        92 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~  169 (235)
                      +....... ......+|+.|+|||.+.... ++.++||||+||++|+|++|..|+ ......+....+......+     
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-----  234 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----  234 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----
T ss_pred             hhccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence            76543322 233456789999999997655 789999999999999999966555 4455544444443211110     


Q ss_pred             ccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCCC
Q 026660          170 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDDLD  231 (235)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--hp~f~~~~  231 (235)
                                            ....++++++++|++||+.||++|||++++++  |+||.+..
T Consensus       235 ----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ----------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                                  11247889999999999999999999999988  89997654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-40  Score=255.13  Aligned_cols=181  Identities=20%  Similarity=0.343  Sum_probs=137.7

Q ss_pred             ceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCC
Q 026660           12 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL   90 (235)
Q Consensus        12 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~   90 (235)
                      ++.+|+||||++ |+|.+++.+   ....+++..++.++.||+.||+|||+++++||||||+||+++..+ .++++|||+
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchh
Confidence            356899999998 599998765   345689999999999999999999999999999999999999777 999999999


Q ss_pred             cccccCCCC-CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           91 ARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        91 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      ++....... ......+|+.|+|||++.+.. ++.++||||+||++|+|++ |..||.+....+....+......     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            976543322 234456788999999997655 8899999999999999998 89999887766655554321110     


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                            ...+++++++.++|++||+.||.+|||+.++++|
T Consensus       229 ----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  1123578999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-39  Score=250.14  Aligned_cols=188  Identities=18%  Similarity=0.273  Sum_probs=140.3

Q ss_pred             ccCCcCCCceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCe
Q 026660            4 KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT   82 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~   82 (235)
                      ..++...+++.+++|||||.+ ++.+++.+   ....+++..+..++.|++.||+|||+++++||||||+|||++.++ .
T Consensus        73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~  148 (283)
T d1mqba_          73 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-V  148 (283)
T ss_dssp             CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-C
T ss_pred             eeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-e
Confidence            344555667789999999985 88887765   345799999999999999999999999999999999999999776 9


Q ss_pred             EEEeecCCcccccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q 026660           83 LKIADLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIF  158 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~  158 (235)
                      ++|+|||+++.......   ......||+.|+|||++.+.. ++.++|||||||++|+|+++..|+.. ....+....+.
T Consensus       149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~  227 (283)
T d1mqba_         149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  227 (283)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh
Confidence            99999999976543322   223345788999999997655 89999999999999999996666544 44444433332


Q ss_pred             HHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          159 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      .....                           ....+.++++.++|.+||+.||.+|||+.++++
T Consensus       228 ~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         228 DGFRL---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCCC---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccCCC---------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            21110                           011247788999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-39  Score=251.80  Aligned_cols=191  Identities=25%  Similarity=0.381  Sum_probs=152.4

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK   70 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~   70 (235)
                      ...+...+++.+++|||||. |+|.+++.....            ....+++..++.++.||+.||+|||+++++|||||
T Consensus        83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence            34455566778999999998 599999976421            23458999999999999999999999999999999


Q ss_pred             CCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 026660           71 PHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG  147 (235)
Q Consensus        71 ~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~  147 (235)
                      |+|||++.++ .++|+|||.+........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus       163 p~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         163 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             GGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            9999999777 899999999986654322  234456788999999997655 8999999999999999998 7888887


Q ss_pred             CCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          148 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ....+....+.+... +.                          ....+++++.++|++||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~i~~~~~-~~--------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         241 VPVEELFKLLKEGHR-MD--------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CCHHHHHHHHHTTCC-CC--------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCC-CC--------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            776555443332111 00                          11247789999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=248.33  Aligned_cols=181  Identities=22%  Similarity=0.360  Sum_probs=138.5

Q ss_pred             CCceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeec
Q 026660           10 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL   88 (235)
Q Consensus        10 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df   88 (235)
                      ++++.+|+||||++ |+|.+++.+..  ...++++.+++++.||+.||.|||+++++|+||+|+||+++.++ .++++||
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~df  147 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDF  147 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCC
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeeccc
Confidence            45566899999997 59999997632  23489999999999999999999999999999999999999777 8999999


Q ss_pred             CCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCC
Q 026660           89 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  167 (235)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  167 (235)
                      |+++.....   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.....     
T Consensus       148 g~s~~~~~~---~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-----  218 (262)
T d1byga_         148 GLTKEASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----  218 (262)
T ss_dssp             CC---------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----
T ss_pred             ccceecCCC---CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            999765432   23345688999999997655 8999999999999999998 7888877655554444321100     


Q ss_pred             CcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          168 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                            ......+++++.++|++||+.||.+|||+.+++++
T Consensus       219 ----------------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         219 ----------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                                  01122477899999999999999999999998763

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-38  Score=250.91  Aligned_cols=178  Identities=22%  Similarity=0.303  Sum_probs=141.5

Q ss_pred             EEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCccc
Q 026660           15 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA   93 (235)
Q Consensus        15 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~   93 (235)
                      .++++|++. |+|.+++..   ....+++..++.++.||+.||+|||+++++||||||+||+++.++ .++|+|||+++.
T Consensus        85 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~  160 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL  160 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHH
T ss_pred             eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeecccccee
Confidence            567777776 699998876   345799999999999999999999999999999999999999776 999999999986


Q ss_pred             ccCCCCC--cccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCCcc
Q 026660           94 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  170 (235)
Q Consensus        94 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  170 (235)
                      .......  .....||+.|+|||++.+.. ++.++||||+||++|+|++ |..||.+....+....+......+      
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~------  233 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------  233 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC------
T ss_pred             cccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            6433222  23346789999999998665 8999999999999999998 788888766555444443321111      


Q ss_pred             cccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          171 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                           ....+++++.+++++||+.||.+|||+.++++|
T Consensus       234 ---------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 ---------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ---------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                 112477899999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-39  Score=251.91  Aligned_cols=191  Identities=25%  Similarity=0.334  Sum_probs=150.2

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHh------------hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSF------------RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK   70 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~   70 (235)
                      +..+...+++.+|+||||++ |+|.+++...            ......+++..++.++.||+.||.|||+++++|||||
T Consensus        75 ~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlk  154 (309)
T d1fvra_          75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  154 (309)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccc
Confidence            34445566778999999998 5999999753            2345679999999999999999999999999999999


Q ss_pred             CCcEEEcCCCCeEEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC
Q 026660           71 PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT-ALFPGDS  149 (235)
Q Consensus        71 ~~nil~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~  149 (235)
                      |+|||++.++ .++|+|||+++...... ......+|..|+|||.+.+.. ++.++|||||||++|+|++|. .||.+.+
T Consensus       155 p~NIL~~~~~-~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         155 ARNILVGENY-VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             GGGEEECGGG-CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cceEEEcCCC-ceEEccccccccccccc-cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            9999999776 89999999987554322 223446788999999997655 889999999999999999965 5677766


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          150 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                      ..+....+.....                           .....++++++.+||++||+.||++|||+.++++|
T Consensus       232 ~~~~~~~i~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         232 CAELYEKLPQGYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHHHHHGGGTCC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCC---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6555544332100                           01112478999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=245.86  Aligned_cols=178  Identities=23%  Similarity=0.293  Sum_probs=143.9

Q ss_pred             EEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           14 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        14 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      ..++|||||. |++.+++...   ...+++..++.++.|++.||.|||+++++||||||+||+++.++ .++++|||+++
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~  159 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMR  159 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCE
T ss_pred             chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhh
Confidence            5689999998 5999888763   23599999999999999999999999999999999999999776 99999999998


Q ss_pred             cccCCCC---CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCCCC
Q 026660           93 AFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  168 (235)
Q Consensus        93 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  168 (235)
                      .......   ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......+    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~----  234 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL----  234 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC----
Confidence            7644322   122345677899999998654 8899999999999999998 899999888877766654321110    


Q ss_pred             cccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          169 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                                            ....++++++.++|.+||+.||++|||+.+++
T Consensus       235 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         235 ----------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ----------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                                  11225788999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-38  Score=247.09  Aligned_cols=192  Identities=23%  Similarity=0.333  Sum_probs=150.9

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ--------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD   68 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~d   68 (235)
                      +.++..++++.+|+|||||+ |+|.+++.....              ....+++..+..++.||+.||+|||+++++|||
T Consensus        91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD  170 (311)
T d1t46a_          91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (311)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            44556677788999999998 599999987432              223589999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 026660           69 LKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALF  145 (235)
Q Consensus        69 i~~~nil~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  145 (235)
                      |||+||+++..+ .++++|||.++.......  ......+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||
T Consensus       171 LKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         171 LAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCC
Confidence            999999999776 999999999986654322  234457789999999997655 8999999999999999998 55556


Q ss_pred             CCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 026660          146 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  223 (235)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  223 (235)
                      ......+....+......+.                          .....++++.+||.+||+.||.+|||++++++
T Consensus       249 ~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         249 PGMPVDSKFYKMIKEGFRML--------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             TTCCSSHHHHHHHHHTCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCC--------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            56555444444443211111                          11246789999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-38  Score=246.07  Aligned_cols=191  Identities=21%  Similarity=0.288  Sum_probs=148.8

Q ss_pred             ccCCcCCCceEEEEEEecCc-cCHHHHHHHhh--------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 026660            4 KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR--------------------QTGENIPVNTVKSLMYQLCKGVAFCHGH   62 (235)
Q Consensus         4 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~ql~~~l~~Lh~~   62 (235)
                      ...+...+...++++|||++ |+|.+++....                    .....+++..+..++.|++.||+|||++
T Consensus        80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence            33445566778999999998 59999997531                    1223488999999999999999999999


Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHh
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT  140 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~  140 (235)
                      +++||||||+||+++.++ .++|+|||+++......  .......+++.|+|||.+.+.. ++.++|||||||++|+|++
T Consensus       160 ~ivHrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             TCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CeEeeEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHc
Confidence            999999999999999776 89999999997543221  2233456788999999998655 8999999999999999999


Q ss_pred             CC-CCCCCCCHHHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHH
Q 026660          141 KT-ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK  219 (235)
Q Consensus       141 g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  219 (235)
                      |. .||.+....+....+......                           .....+++++.++|++||+.||.+|||+.
T Consensus       238 ~~~~p~~~~~~~e~~~~v~~~~~~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         238 YGLQPYYGMAHEEVIYYVRDGNIL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             TTCCTTTTSCHHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            85 577777776666554321110                           11225778999999999999999999999


Q ss_pred             HHhC
Q 026660          220 KAME  223 (235)
Q Consensus       220 ~ll~  223 (235)
                      |+++
T Consensus       291 ev~~  294 (301)
T d1lufa_         291 SIHR  294 (301)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9854

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-38  Score=245.15  Aligned_cols=197  Identities=23%  Similarity=0.332  Sum_probs=155.4

Q ss_pred             cCCcCCCceEEEEEEecCc-cCHHHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEc
Q 026660            5 QGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD   77 (235)
Q Consensus         5 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~   77 (235)
                      ..+....+..+++|||||. |+|.+++.....      ....++...+..++.|++.||.|||+++++||||||+|||++
T Consensus        88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld  167 (308)
T d1p4oa_          88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  167 (308)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence            3444556677999999997 599999976321      123468999999999999999999999999999999999999


Q ss_pred             CCCCeEEEeecCCcccccCCCC--CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 026660           78 RKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQL  154 (235)
Q Consensus        78 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~  154 (235)
                      .++ .++|+|||+++.......  ......+|+.|+|||.+.+.. ++.++||||+|+++|+|++| ..||.+.+..+..
T Consensus       168 ~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         168 EDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             TTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             CCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            776 999999999976543322  223346789999999998655 78999999999999999998 4777777776666


Q ss_pred             HHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC------CCCCC
Q 026660          155 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME------HPYFD  228 (235)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~------hp~f~  228 (235)
                      ..+.+....                           .....+++.+.++|.+||+.||.+|||+.++++      +|+|+
T Consensus       246 ~~i~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         246 RFVMEGGLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             HHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHHhCCCC---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            555432110                           011247789999999999999999999999987      78877


Q ss_pred             CC
Q 026660          229 DL  230 (235)
Q Consensus       229 ~~  230 (235)
                      +.
T Consensus       299 ~~  300 (308)
T d1p4oa_         299 EV  300 (308)
T ss_dssp             HH
T ss_pred             CC
Confidence            53

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-37  Score=243.76  Aligned_cols=195  Identities=16%  Similarity=0.183  Sum_probs=146.3

Q ss_pred             CCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcC--CCCeEEEe
Q 026660            9 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIA   86 (235)
Q Consensus         9 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~--~~~~~~l~   86 (235)
                      ..+++..++||||++++|.+.+..   ..+.+++..+..++.|++.||+|||++|++||||||+||+++.  .+..++++
T Consensus        72 ~~~~~~~~ivme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          72 GAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EecCCEEEEEEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeee
Confidence            345667899999999998887765   3457999999999999999999999999999999999999753  23369999


Q ss_pred             ecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 026660           87 DLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  159 (235)
Q Consensus        87 df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  159 (235)
                      |||+++.......       ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||..............
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            9999987653322       234557899999999998655 89999999999999999999999987554333322221


Q ss_pred             HhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHH---HhCCCCC
Q 026660          160 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK---AMEHPYF  227 (235)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~---ll~hp~f  227 (235)
                      ......                    .........++++++.++|++||+.||.+||++++   +++|+|.
T Consensus       228 ~~~~~~--------------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         228 ISEKKM--------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHH--------------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhcccC--------------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            100000                    00112223468899999999999999999999874   4666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=241.72  Aligned_cols=183  Identities=24%  Similarity=0.290  Sum_probs=141.6

Q ss_pred             CceEEEEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecC
Q 026660           11 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG   89 (235)
Q Consensus        11 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~   89 (235)
                      .++..++|||||++ +|.+++..   .....++..++.++.|++.||.|||+.+++||||||+|||++..+ .++|+|||
T Consensus       100 ~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG  175 (311)
T d1r0pa_         100 SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFG  175 (311)
T ss_dssp             TTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSG
T ss_pred             cCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEeccc
Confidence            45678999999985 99998865   344678889999999999999999999999999999999999666 99999999


Q ss_pred             CcccccCCCC----CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 026660           90 LARAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  165 (235)
Q Consensus        90 ~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  165 (235)
                      +++.......    ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||..................+ 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-  253 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-  253 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-
T ss_pred             chhhccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9976543322    223346788999999987655 8999999999999999999888887654332222221110000 


Q ss_pred             CCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 026660          166 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  224 (235)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  224 (235)
                                               ......++++.++|.+||..||.+|||+.|+++|
T Consensus       254 -------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                     0112467899999999999999999999999887

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-37  Score=238.01  Aligned_cols=202  Identities=16%  Similarity=0.183  Sum_probs=152.3

Q ss_pred             CcCCCceEEEEEEecCccCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCC----CCe
Q 026660            7 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----TMT   82 (235)
Q Consensus         7 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~----~~~   82 (235)
                      ...+++...|+||||++++|.+++...   +..++...+..++.|++.||+|||++|++||||||+||+++..    ...
T Consensus        68 ~~~~~~~~~~~vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~  144 (293)
T d1csna_          68 YFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM  144 (293)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             EEeecCCccEEEEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCc
Confidence            344567788999999999999988662   3469999999999999999999999999999999999999742    237


Q ss_pred             EEEeecCCcccccCCCC-------CcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHH
Q 026660           83 LKIADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---ELQ  152 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~  152 (235)
                      ++++|||+++.......       ......||+.|+|||++.+.. ++.++||||+|+++|+|++|..||.+..   ..+
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~  223 (293)
T d1csna_         145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  223 (293)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence            99999999987643321       234457899999999998655 8999999999999999999999997543   222


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCHHHHhC---------
Q 026660          153 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---------  223 (235)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~---------  223 (235)
                      ....+......                       ........++++++.+++..|+..+|.+||+.+.+.+         
T Consensus       224 ~~~~i~~~~~~-----------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         224 KYERIGEKKQS-----------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhccCC-----------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            22222211000                       0111223457899999999999999999998665422         


Q ss_pred             -CCCCCCCCcCCC
Q 026660          224 -HPYFDDLDKTRL  235 (235)
Q Consensus       224 -hp~f~~~~~~~~  235 (235)
                       ..+-..++|+-|
T Consensus       281 ~~~~~~~~Dw~~~  293 (293)
T d1csna_         281 NTTEDENFDWNLL  293 (293)
T ss_dssp             TCCSCSCCGGGCC
T ss_pred             CCCCCCCCCCCcC
Confidence             344445667643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-36  Score=241.41  Aligned_cols=216  Identities=33%  Similarity=0.516  Sum_probs=148.2

Q ss_pred             CceEEEEEEecCc--cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEcCCCC-----e
Q 026660           11 GRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM-----T   82 (235)
Q Consensus        11 ~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~-~~~~H~di~~~nil~~~~~~-----~   82 (235)
                      +....+++++++.  ++.......  .....+++..++.++.|++.||+|||+ .|++||||||+||+++.++.     .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            3344556666554  455554444  445568999999999999999999998 88999999999999975442     4


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccCchhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH
Q 026660           83 LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLH  156 (235)
Q Consensus        83 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~  156 (235)
                      ++++|||.+.....   ......+|+.|+|||++.... ++.++|+||+||++++|++|+.||....      .......
T Consensus       171 ~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeeccccccccc---ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            89999999875543   234456799999999998655 7899999999999999999999996432      3344555


Q ss_pred             HHHHhCCCCCCCcccccccccc-------cCCCC---CCccchhh----cCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 026660          157 IFRLLGTPNEKVWPGVSSLMNW-------HEYPQ---WNPQSLAT----AVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  222 (235)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  222 (235)
                      ....++..+.............       .....   ........    .....++++++||.+||.+||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            5555555443322111100000       00000   00000000    1113457889999999999999999999999


Q ss_pred             CCCCCCCCCc
Q 026660          223 EHPYFDDLDK  232 (235)
Q Consensus       223 ~hp~f~~~~~  232 (235)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999996643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-36  Score=232.96  Aligned_cols=187  Identities=22%  Similarity=0.277  Sum_probs=135.5

Q ss_pred             CceEEEEEEecCc-cCHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCcEEEcCCCC
Q 026660           11 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG--------HGILHRDLKPHNLLMDRKTM   81 (235)
Q Consensus        11 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~--------~~~~H~di~~~nil~~~~~~   81 (235)
                      ....+|+|||||+ |+|.+++.+     ..++++..++++.|++.||+|||+        ++++||||||+||+++.++ 
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-  145 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  145 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-
T ss_pred             cceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-
Confidence            3457899999997 599999976     358999999999999999999996        5899999999999999776 


Q ss_pred             eEEEeecCCcccccCCCC----CcccccccccccCchhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Q 026660           82 TLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSE--  150 (235)
Q Consensus        82 ~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--  150 (235)
                      .++|+|||+++.......    ......||+.|+|||++.+..     .++.++|||||||++|+|++|..||.....  
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            999999999976654322    223457899999999987532     146789999999999999999888743221  


Q ss_pred             ------------HHHHHHHHHHhCCCCCCCcccccccccccCCCCCCccchhhcCCCCChhHHHHHHHhcccCCCCCCCH
Q 026660          151 ------------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  218 (235)
Q Consensus       151 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  218 (235)
                                  .+.......  .....                  +..............+.+++++||+.||.+|||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~--~~~~~------------------p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  285 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVC--EQKLR------------------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHT--TSCCC------------------CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             cchhhcccccchHHHHHHHHh--ccccC------------------CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence                        111111110  00000                  0000000111233468899999999999999999


Q ss_pred             HHHhC
Q 026660          219 KKAME  223 (235)
Q Consensus       219 ~~ll~  223 (235)
                      .|+++
T Consensus       286 ~ei~~  290 (303)
T d1vjya_         286 LRIKK  290 (303)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.44  E-value=7.1e-14  Score=100.81  Aligned_cols=95  Identities=21%  Similarity=0.216  Sum_probs=69.6

Q ss_pred             EEEEecCcc-CHHHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEcCCCCeEEEeecCCcccc
Q 026660           16 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF   94 (235)
Q Consensus        16 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~Lh~~~~~H~di~~~nil~~~~~~~~~l~df~~~~~~   94 (235)
                      +++||++++ .+.           .++...+..++.|++.++++||++|++|+||||+||+++..  .++++|||.+...
T Consensus        86 ~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a~~~  152 (191)
T d1zara2          86 AVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEV  152 (191)
T ss_dssp             EEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCEET
T ss_pred             EEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCcccC
Confidence            689999987 322           25667788999999999999999999999999999999954  6899999988654


Q ss_pred             cCCCCCcccccccccccC------chhhhCCCCCCchhhHHHHHH
Q 026660           95 TLPIKKYTHEILTLWYRA------PEVLLGSTHYSTAVDMWSVAC  133 (235)
Q Consensus        95 ~~~~~~~~~~~~~~~y~~------PE~~~~~~~~~~~~Di~slG~  133 (235)
                      ..+...        .|..      .+.+  ...++.++|+||+.-
T Consensus       153 ~~~~~~--------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~  187 (191)
T d1zara2         153 GEEGWR--------EILERDVRNIITYF--SRTYRTEKDINSAID  187 (191)
T ss_dssp             TSTTHH--------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHH
T ss_pred             CCCCcH--------HHHHHHHHHHHHHH--cCCCCCcccHHHHHH
Confidence            422111        1111      1222  123678899999654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.97  E-value=0.00086  Score=48.96  Aligned_cols=27  Identities=26%  Similarity=0.386  Sum_probs=22.5

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ++|+|+.+.||+++.++ .+.++||+.+
T Consensus       185 l~HgD~~~~Nil~~~~~-~~~lIDwe~a  211 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGK-VSGFIDLGRS  211 (263)
T ss_dssp             EECSCCCTTSEEEETTE-EEEECCCTTC
T ss_pred             EEEeeccCcceeecCCc-eEEEeechhc
Confidence            68999999999998543 5569999976

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.17  E-value=0.017  Score=43.15  Aligned_cols=30  Identities=23%  Similarity=0.331  Sum_probs=25.2

Q ss_pred             cCceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           62 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        62 ~~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .|++|+|+.++|++++.+. ...++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc-ceeEecccccc
Confidence            3799999999999999654 56899999773

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=91.66  E-value=0.039  Score=39.47  Aligned_cols=27  Identities=19%  Similarity=0.224  Sum_probs=23.0

Q ss_pred             ceecCCCCCcEEEcCCCCeEEEeecCCc
Q 026660           64 ILHRDLKPHNLLMDRKTMTLKIADLGLA   91 (235)
Q Consensus        64 ~~H~di~~~nil~~~~~~~~~l~df~~~   91 (235)
                      ++|+|+.+.||+++.+. .+.|+||+.+
T Consensus       177 liHgD~~~~Nvl~~~~~-~~~iID~~~~  203 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGR-FSGFIDCGRL  203 (255)
T ss_dssp             EECSSCCGGGEEEETTE-EEEECCCTTC
T ss_pred             EEeCCCCCcceEEeCCc-eEEEEEchhc
Confidence            79999999999998553 5679999966

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=89.38  E-value=0.26  Score=36.60  Aligned_cols=27  Identities=33%  Similarity=0.284  Sum_probs=22.0

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      +++|+|+.+.||+++ ++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~-~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWR-DG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEES-SS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEe-CC--ceEEechhcc
Confidence            589999999999997 43  3579999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=88.50  E-value=0.1  Score=40.08  Aligned_cols=28  Identities=21%  Similarity=0.369  Sum_probs=24.3

Q ss_pred             CceecCCCCCcEEEcCCCCeEEEeecCCcc
Q 026660           63 GILHRDLKPHNLLMDRKTMTLKIADLGLAR   92 (235)
Q Consensus        63 ~~~H~di~~~nil~~~~~~~~~l~df~~~~   92 (235)
                      .++|+|+.+.||+++.+  .++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH--ETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSS--CEEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCC--ceEEechhhcc
Confidence            58999999999999855  58999998874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=80.52  E-value=0.32  Score=37.14  Aligned_cols=15  Identities=33%  Similarity=0.656  Sum_probs=13.2

Q ss_pred             ceecCCCCCcEEEcC
Q 026660           64 ILHRDLKPHNLLMDR   78 (235)
Q Consensus        64 ~~H~di~~~nil~~~   78 (235)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            689999999999853